{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "7eccb39e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ID   RBL1_HUMAN              Reviewed;        1068 AA.\r\n",
      "AC   P28749; A8K2W5; Q4VXA0; Q8N5K6; Q9H1L5; Q9H1M1;\r\n",
      "DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   07-MAR-2006, sequence version 3.\r\n",
      "DT   03-MAY-2023, entry version 223.\r\n",
      "DE   RecName: Full=Retinoblastoma-like protein 1;\r\n",
      "DE   AltName: Full=107 kDa retinoblastoma-associated protein;\r\n",
      "DE            Short=p107;\r\n",
      "DE   AltName: Full=pRb1;\r\n",
      "GN   Name=RBL1;\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.\r\n",
      "RX   PubMed=8319904; DOI=10.1101/gad.7.7a.1111;\r\n",
      "RA   Zhu L., van den Heuvel S., Helin K., Fattaey A., Ewen M., Livingston D.,\r\n",
      "RA   Dyson N., Harlow E.;\r\n",
      "RT   \"Inhibition of cell proliferation by p107, a relative of the retinoblastoma\r\n",
      "RT   protein.\";\r\n",
      "RL   Genes Dev. 7:1111-1125(1993).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).\r\n",
      "RC   TISSUE=Tongue;\r\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\r\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\r\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\r\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\r\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\r\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\r\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\r\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\r\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\r\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\r\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\r\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\r\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\r\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\r\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\r\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\r\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\r\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\r\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\r\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\r\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\r\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\r\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\r\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\r\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\r\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\r\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\r\n",
      "RA   Isogai T., Sugano S.;\r\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\r\n",
      "RT   cDNAs.\";\r\n",
      "RL   Nat. Genet. 36:40-45(2004).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RX   PubMed=11780052; DOI=10.1038/414865a;\r\n",
      "RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,\r\n",
      "RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,\r\n",
      "RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,\r\n",
      "RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,\r\n",
      "RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,\r\n",
      "RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,\r\n",
      "RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,\r\n",
      "RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,\r\n",
      "RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,\r\n",
      "RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,\r\n",
      "RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,\r\n",
      "RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,\r\n",
      "RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,\r\n",
      "RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,\r\n",
      "RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,\r\n",
      "RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,\r\n",
      "RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,\r\n",
      "RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,\r\n",
      "RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,\r\n",
      "RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,\r\n",
      "RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,\r\n",
      "RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,\r\n",
      "RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;\r\n",
      "RT   \"The DNA sequence and comparative analysis of human chromosome 20.\";\r\n",
      "RL   Nature 414:865-871(2001).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,\r\n",
      "RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,\r\n",
      "RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,\r\n",
      "RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,\r\n",
      "RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,\r\n",
      "RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,\r\n",
      "RA   Hunkapiller M.W., Myers E.W., Venter J.C.;\r\n",
      "RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).\r\n",
      "RC   TISSUE=Testis;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 134-1068 (ISOFORM 1), AND PARTIAL PROTEIN\r\n",
      "RP   SEQUENCE.\r\n",
      "RX   PubMed=1833063; DOI=10.1016/0092-8674(91)90038-z;\r\n",
      "RA   Ewen M.E., Xing Y., Lawrence J.B., Livingston D.M.;\r\n",
      "RT   \"Molecular cloning, chromosomal mapping, and expression of the cDNA for\r\n",
      "RT   p107, a retinoblastoma gene product-related protein.\";\r\n",
      "RL   Cell 66:1155-1164(1991).\r\n",
      "RN   [7]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-52.\r\n",
      "RX   PubMed=7791762; DOI=10.1128/mcb.15.7.3552;\r\n",
      "RA   Zhu L., Zhu L., Xie E., Chang L.S.;\r\n",
      "RT   \"Differential roles of two tandem E2F sites in repression of the human p107\r\n",
      "RT   promoter by retinoblastoma and p107 proteins.\";\r\n",
      "RL   Mol. Cell. Biol. 15:3552-3562(1995).\r\n",
      "RN   [8]\r\n",
      "RP   PROTEIN SEQUENCE OF 320-334; 364-374; 635-657; 949-977 AND 1006-1012,\r\n",
      "RP   PHOSPHORYLATION AT THR-332; THR-369; THR-385; SER-640; SER-762; SER-964;\r\n",
      "RP   SER-975; SER-988; THR-997 AND SER-1009, MUTAGENESIS OF SER-640; SER-643;\r\n",
      "RP   SER-650 AND 657-LYS--LEU-660, AND IDENTIFICATION BY MASS SPECTROMETRY.\r\n",
      "RX   PubMed=11884610; DOI=10.1128/mcb.22.7.2242-2254.2002;\r\n",
      "RA   Leng X., Noble M., Adams P.D., Qin J., Harper J.W.;\r\n",
      "RT   \"Reversal of growth suppression by p107 via direct phosphorylation by\r\n",
      "RT   cyclin D1/cyclin-dependent kinase 4.\";\r\n",
      "RL   Mol. Cell. Biol. 22:2242-2254(2002).\r\n",
      "RN   [9]\r\n",
      "RP   INTERACTION WITH SV40 AND JC VIRUS LARGE T ANTIGEN (MICROBIAL INFECTION).\r\n",
      "RX   PubMed=2546678; DOI=10.1016/0092-8674(89)90839-8;\r\n",
      "RA   Dyson N., Buchkovich K., Whyte P., Harlow E.;\r\n",
      "RT   \"The cellular 107K protein that binds to adenovirus E1A also associates\r\n",
      "RT   with the large T antigens of SV40 and JC virus.\";\r\n",
      "RL   Cell 58:249-255(1989).\r\n",
      "RN   [10]\r\n",
      "RP   INTERACTION WITH KDM5A.\r\n",
      "RX   PubMed=7935440; DOI=10.1128/mcb.14.11.7256-7264.1994;\r\n",
      "RA   Kim Y.W., Otterson G.A., Kratzke R.A., Coxon A.B., Kaye F.J.;\r\n",
      "RT   \"Differential specificity for binding of retinoblastoma binding protein 2\r\n",
      "RT   to RB, p107, and TATA-binding protein.\";\r\n",
      "RL   Mol. Cell. Biol. 14:7256-7264(1994).\r\n",
      "RN   [11]\r\n",
      "RP   INTERACTION WITH AATF.\r\n",
      "RX   PubMed=12450794; DOI=10.1016/s1535-6108(02)00182-4;\r\n",
      "RA   Bruno T., De Angelis R., De Nicola F., Barbato C., Di Padova M., Corbi N.,\r\n",
      "RA   Libri V., Benassi B., Mattei E., Chersi A., Soddu S., Floridi A.,\r\n",
      "RA   Passananti C., Fanciulli M.;\r\n",
      "RT   \"Che-1 affects cell growth by interfering with the recruitment of HDAC1 by\r\n",
      "RT   Rb.\";\r\n",
      "RL   Cancer Cell 2:387-399(2002).\r\n",
      "RN   [12]\r\n",
      "RP   PHOSPHORYLATION AT THR-369 AND SER-650.\r\n",
      "RX   PubMed=12006580; DOI=10.1074/jbc.m200381200;\r\n",
      "RA   Farkas T., Hansen K., Holm K., Lukas J., Bartek J.;\r\n",
      "RT   \"Distinct phosphorylation events regulate p130- and p107-mediated\r\n",
      "RT   repression of E2F-4.\";\r\n",
      "RL   J. Biol. Chem. 277:26741-26752(2002).\r\n",
      "RN   [13]\r\n",
      "RP   INTERACTION WITH E2F4 AND TFDP1.\r\n",
      "RX   PubMed=16360038; DOI=10.1016/j.cell.2005.09.044;\r\n",
      "RA   Rubin S.M., Gall A.-L., Zheng N., Pavletich N.P.;\r\n",
      "RT   \"Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for\r\n",
      "RT   phosphorylation-induced E2F release.\";\r\n",
      "RL   Cell 123:1093-1106(2005).\r\n",
      "RN   [14]\r\n",
      "RP   FUNCTION, AND IDENTIFICATION IN THE DREAM COMPLEX.\r\n",
      "RX   PubMed=17671431; DOI=10.4161/cc.6.15.4512;\r\n",
      "RA   Schmit F., Korenjak M., Mannefeld M., Schmitt K., Franke C., von Eyss B.,\r\n",
      "RA   Gagrica S., Haenel F., Brehm A., Gaubatz S.;\r\n",
      "RT   \"LINC, a human complex that is related to pRB-containing complexes in\r\n",
      "RT   invertebrates regulates the expression of G2/M genes.\";\r\n",
      "RL   Cell Cycle 6:1903-1913(2007).\r\n",
      "RN   [15]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-385; SER-749 AND SER-762, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [16]\r\n",
      "RP   INTERACTION WITH JC VIRUS SMALL T ANTIGEN (MICROBIAL INFECTION).\r\n",
      "RX   PubMed=20485545; DOI=10.1371/journal.pone.0010606;\r\n",
      "RA   Bollag B., Hofstetter C.A., Reviriego-Mendoza M.M., Frisque R.J.;\r\n",
      "RT   \"JC virus small T antigen binds phosphatase PP2A and Rb family proteins and\r\n",
      "RT   is required for efficient viral DNA replication activity.\";\r\n",
      "RL   PLoS ONE 5:e10606-e10606(2010).\r\n",
      "RN   [17]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-332; THR-369; THR-385;\r\n",
      "RP   SER-640; SER-749; SER-762; SER-988 AND SER-1041, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "CC   -!- FUNCTION: Key regulator of entry into cell division (PubMed:17671431).\r\n",
      "CC       Directly involved in heterochromatin formation by maintaining overall\r\n",
      "CC       chromatin structure and, in particular, that of constitutive\r\n",
      "CC       heterochromatin by stabilizing histone methylation (By similarity).\r\n",
      "CC       Recruits and targets histone methyltransferases KMT5B and KMT5C,\r\n",
      "CC       leading to epigenetic transcriptional repression (By similarity).\r\n",
      "CC       Controls histone H4 'Lys-20' trimethylation (By similarity). Probably\r\n",
      "CC       acts as a transcription repressor by recruiting chromatin-modifying\r\n",
      "CC       enzymes to promoters (By similarity). Potent inhibitor of E2F-mediated\r\n",
      "CC       trans-activation (PubMed:8319904). May act as a tumor suppressor\r\n",
      "CC       (PubMed:8319904). {ECO:0000250|UniProtKB:Q64701,\r\n",
      "CC       ECO:0000269|PubMed:17671431, ECO:0000269|PubMed:8319904}.\r\n",
      "CC   -!- SUBUNIT: Component of the DREAM complex (also named LINC complex) at\r\n",
      "CC       least composed of E2F4, E2F5, LIN9, LIN37, LIN52, LIN54, MYBL1, MYBL2,\r\n",
      "CC       RBL1, RBL2, RBBP4, TFDP1 and TFDP2 (PubMed:17671431, PubMed:16360038).\r\n",
      "CC       The complex exists in quiescent cells where it represses cell cycle-\r\n",
      "CC       dependent genes (PubMed:17671431). It dissociates in S phase when LIN9,\r\n",
      "CC       LIN37, LIN52 and LIN54 form a subcomplex that binds to MYBL2\r\n",
      "CC       (PubMed:17671431). Interacts with AATF (PubMed:12450794). Interacts\r\n",
      "CC       with KDM5A (PubMed:7935440). Interacts with KMT5B and KMT5C (By\r\n",
      "CC       similarity). Interacts with USP4 (By similarity). Interacts with RBBP9\r\n",
      "CC       (By similarity). {ECO:0000250|UniProtKB:D3ZS28,\r\n",
      "CC       ECO:0000250|UniProtKB:Q64701, ECO:0000269|PubMed:12450794,\r\n",
      "CC       ECO:0000269|PubMed:16360038, ECO:0000269|PubMed:17671431,\r\n",
      "CC       ECO:0000269|PubMed:7935440}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with SV40 and JC virus large T\r\n",
      "CC       antigens. Large T antigen, but not E1A, binds only to the\r\n",
      "CC       unphosphorylated form. {ECO:0000269|PubMed:2546678}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with JC virus small t antigen.\r\n",
      "CC       {ECO:0000269|PubMed:20485545}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       P28749; Q9BUH8: BEGAIN; NbExp=2; IntAct=EBI-971402, EBI-742722;\r\n",
      "CC       P28749; P11802: CDK4; NbExp=2; IntAct=EBI-971402, EBI-295644;\r\n",
      "CC       P28749; Q13574-2: DGKZ; NbExp=2; IntAct=EBI-971402, EBI-715527;\r\n",
      "CC       P28749; Q13627: DYRK1A; NbExp=4; IntAct=EBI-971402, EBI-1053596;\r\n",
      "CC       P28749; Q9Y463: DYRK1B; NbExp=4; IntAct=EBI-971402, EBI-634187;\r\n",
      "CC       P28749; O43524: FOXO3; NbExp=3; IntAct=EBI-971402, EBI-1644164;\r\n",
      "CC       P28749; Q14653: IRF3; NbExp=2; IntAct=EBI-971402, EBI-2650369;\r\n",
      "CC       P28749; P67775: PPP2CA; NbExp=2; IntAct=EBI-971402, EBI-712311;\r\n",
      "CC       P28749; P03129: E7; Xeno; NbExp=4; IntAct=EBI-971402, EBI-866453;\r\n",
      "CC       P28749; P24610: Pax3; Xeno; NbExp=3; IntAct=EBI-971402, EBI-1208116;\r\n",
      "CC       P28749; Q923E4: Sirt1; Xeno; NbExp=2; IntAct=EBI-971402, EBI-1802585;\r\n",
      "CC       P28749; P03255; Xeno; NbExp=3; IntAct=EBI-971402, EBI-2603114;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=2;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=P28749-1; Sequence=Displayed;\r\n",
      "CC       Name=2;\r\n",
      "CC         IsoId=P28749-2; Sequence=VSP_017496;\r\n",
      "CC   -!- PTM: Cell-cycle arrest properties are inactivated by phosphorylation on\r\n",
      "CC       Thr-332, Ser-640, Ser-964 and Ser-975 by CDK4.\r\n",
      "CC       {ECO:0000269|PubMed:11884610, ECO:0000269|PubMed:12006580}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; L14812; AAA02489.1; -; mRNA.\r\n",
      "DR   EMBL; AK290380; BAF83069.1; -; mRNA.\r\n",
      "DR   EMBL; AL136172; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AL365505; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AL391114; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; CH471077; EAW76088.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; BC032247; AAH32247.1; -; mRNA.\r\n",
      "DR   EMBL; M74547; AAA36397.1; -; mRNA.\r\n",
      "DR   EMBL; S78664; AAD14290.1; -; Genomic_DNA.\r\n",
      "DR   CCDS; CCDS13289.1; -. [P28749-1]\r\n",
      "DR   CCDS; CCDS13290.1; -. [P28749-2]\r\n",
      "DR   PIR; A47319; A40265.\r\n",
      "DR   RefSeq; NP_002886.2; NM_002895.4. [P28749-1]\r\n",
      "DR   RefSeq; NP_899662.1; NM_183404.3. [P28749-2]\r\n",
      "DR   PDB; 1H28; X-ray; 2.80 A; E/F=653-663.\r\n",
      "DR   PDB; 4YOO; X-ray; 2.40 A; A=391-600, A=781-972.\r\n",
      "DR   PDB; 4YOS; X-ray; 2.30 A; A=391-599.\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DR   PDB; 4YOZ; X-ray; 2.25 A; A=391-593, A=777-972.\r\n",
      "DR   PDB; 5TUV; X-ray; 2.90 A; C/F=994-1031.\r\n",
      "DR   PDB; 7SMC; X-ray; 2.70 A; A/C=391-972.\r\n",
      "DR   PDB; 7SMD; X-ray; 2.15 A; A=391-972.\r\n",
      "DR   PDB; 7SME; X-ray; 2.64 A; A=391-972.\r\n",
      "DR   PDB; 7SMF; X-ray; 3.00 A; A/C=391-972.\r\n",
      "DR   PDBsum; 1H28; -.\r\n",
      "DR   PDBsum; 4YOO; -.\r\n",
      "DR   PDBsum; 4YOS; -.\r\n",
      "DR   PDBsum; 4YOZ; -.\r\n",
      "DR   PDBsum; 5TUV; -.\r\n",
      "DR   PDBsum; 7SMC; -.\r\n",
      "DR   PDBsum; 7SMD; -.\r\n",
      "DR   PDBsum; 7SME; -.\r\n",
      "DR   PDBsum; 7SMF; -.\r\n",
      "DR   AlphaFoldDB; P28749; -.\r\n",
      "DR   SMR; P28749; -.\r\n",
      "DR   BioGRID; 111868; 97.\r\n",
      "DR   CORUM; P28749; -.\r\n",
      "DR   DIP; DIP-148N; -.\r\n",
      "DR   ELM; P28749; -.\r\n",
      "DR   IntAct; P28749; 56.\r\n",
      "DR   MINT; P28749; -.\r\n",
      "DR   STRING; 9606.ENSP00000362768; -.\r\n",
      "DR   GlyGen; P28749; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; P28749; -.\r\n",
      "DR   PhosphoSitePlus; P28749; -.\r\n",
      "DR   BioMuta; RBL1; -.\r\n",
      "DR   DMDM; 90103515; -.\r\n",
      "DR   EPD; P28749; -.\r\n",
      "DR   jPOST; P28749; -.\r\n",
      "DR   MassIVE; P28749; -.\r\n",
      "DR   MaxQB; P28749; -.\r\n",
      "DR   PaxDb; P28749; -.\r\n",
      "DR   PeptideAtlas; P28749; -.\r\n",
      "DR   ProteomicsDB; 54497; -. [P28749-1]\r\n",
      "DR   ProteomicsDB; 54498; -. [P28749-2]\r\n",
      "DR   Antibodypedia; 11876; 440 antibodies from 35 providers.\r\n",
      "DR   CPTC; P28749; 1 antibody.\r\n",
      "DR   DNASU; 5933; -.\r\n",
      "DR   Ensembl; ENST00000344359.7; ENSP00000343646.3; ENSG00000080839.12. [P28749-2]\r\n",
      "DR   Ensembl; ENST00000373664.8; ENSP00000362768.3; ENSG00000080839.12. [P28749-1]\r\n",
      "DR   GeneID; 5933; -.\r\n",
      "DR   KEGG; hsa:5933; -.\r\n",
      "DR   MANE-Select; ENST00000373664.8; ENSP00000362768.3; NM_002895.5; NP_002886.2.\r\n",
      "DR   UCSC; uc002xgi.5; human. [P28749-1]\r\n",
      "DR   AGR; HGNC:9893; -.\r\n",
      "DR   CTD; 5933; -.\r\n",
      "DR   DisGeNET; 5933; -.\r\n",
      "DR   GeneCards; RBL1; -.\r\n",
      "DR   HGNC; HGNC:9893; RBL1.\r\n",
      "DR   HPA; ENSG00000080839; Tissue enhanced (bone).\r\n",
      "DR   MIM; 116957; gene.\r\n",
      "DR   neXtProt; NX_P28749; -.\r\n",
      "DR   OpenTargets; ENSG00000080839; -.\r\n",
      "DR   PharmGKB; PA34257; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000080839; -.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00950000183202; -.\r\n",
      "DR   HOGENOM; CLU_008943_0_1_1; -.\r\n",
      "DR   InParanoid; P28749; -.\r\n",
      "DR   OMA; AILCELH; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; P28749; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   PathwayCommons; P28749; -.\r\n",
      "DR   Reactome; R-HSA-1362277; Transcription of E2F targets under negative control by DREAM complex.\r\n",
      "DR   Reactome; R-HSA-1362300; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1.\r\n",
      "DR   Reactome; R-HSA-1538133; G0 and Early G1.\r\n",
      "DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.\r\n",
      "DR   Reactome; R-HSA-6804114; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest.\r\n",
      "DR   Reactome; R-HSA-69205; G1/S-Specific Transcription.\r\n",
      "DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.\r\n",
      "DR   SignaLink; P28749; -.\r\n",
      "DR   SIGNOR; P28749; -.\r\n",
      "DR   BioGRID-ORCS; 5933; 27 hits in 1165 CRISPR screens.\r\n",
      "DR   ChiTaRS; RBL1; human.\r\n",
      "DR   EvolutionaryTrace; P28749; -.\r\n",
      "DR   GeneWiki; Retinoblastoma-like_protein_1; -.\r\n",
      "DR   GenomeRNAi; 5933; -.\r\n",
      "DR   Pharos; P28749; Tbio.\r\n",
      "DR   PRO; PR:P28749; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 20.\r\n",
      "DR   RNAct; P28749; protein.\r\n",
      "DR   Bgee; ENSG00000080839; Expressed in buccal mucosa cell and 154 other tissues.\r\n",
      "DR   ExpressionAtlas; P28749; baseline and differential.\r\n",
      "DR   Genevisible; P28749; HS.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:CAFA.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; IBA:GO_Central.\r\n",
      "DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:MGI.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:2000773; P:negative regulation of cellular senescence; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:MGI.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; IDA:UniProtKB.\r\n",
      "DR   CDD; cd20605; CYCLIN_RBL1; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 3.\r\n",
      "DR   IDEAL; IID00130; -.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   PANTHER; PTHR13742:SF20; RETINOBLASTOMA-LIKE PROTEIN 1; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Alternative splicing; Cell cycle; Chromatin regulator;\r\n",
      "KW   Direct protein sequencing; Host-virus interaction; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Repressor; Transcription; Transcription regulation;\r\n",
      "KW   Tumor suppressor.\r\n",
      "FT   CHAIN           1..1068\r\n",
      "FT                   /note=\"Retinoblastoma-like protein 1\"\r\n",
      "FT                   /id=\"PRO_0000167839\"\r\n",
      "FT   REGION          385..949\r\n",
      "FT                   /note=\"Pocket; binds T and E1A\"\r\n",
      "FT                   /evidence=\"ECO:0000305|PubMed:7935440\"\r\n",
      "FT   REGION          385..584\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   REGION          585..780\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   REGION          781..949\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   MOD_RES         332\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK2\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         369\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK4\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610,\r\n",
      "FT                   ECO:0000269|PubMed:12006580, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         385\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK2\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         640\r\n",
      "FT                   /note=\"Phosphoserine; by CDK2 and CDK4\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         650\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:12006580\"\r\n",
      "FT   MOD_RES         749\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         762\r\n",
      "FT                   /note=\"Phosphoserine; by CDK2\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         964\r\n",
      "FT                   /note=\"Phosphoserine; by CDK2 and CDK4\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\r\n",
      "FT   MOD_RES         975\r\n",
      "FT                   /note=\"Phosphoserine; by CDK2 and CDK4\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\r\n",
      "FT   MOD_RES         988\r\n",
      "FT                   /note=\"Phosphoserine; by CDK2\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         997\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK2\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\r\n",
      "FT   MOD_RES         1009\r\n",
      "FT                   /note=\"Phosphoserine; by CDK2\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\r\n",
      "FT   MOD_RES         1041\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   VAR_SEQ         1013..1068\r\n",
      "FT                   /note=\"SLKDINNMIRQGEQRTKKRVIAIDSDAESPAKRVCQENDDVLLKRLQDVVSE\r\n",
      "FT                   RANH -> VR (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_017496\"\r\n",
      "FT   VARIANT         1035\r\n",
      "FT                   /note=\"I -> M (in dbSNP:rs8114297)\"\r\n",
      "FT                   /id=\"VAR_034443\"\r\n",
      "FT   MUTAGEN         640\r\n",
      "FT                   /note=\"S->A: Strongly reduces phosphorylation by CDK2 and\r\n",
      "FT                   CDK4.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\r\n",
      "FT   MUTAGEN         643\r\n",
      "FT                   /note=\"S->R: No effect on S-640 phosphorylation, but\r\n",
      "FT                   strongly increases S-640 phosphorylation; when associated\r\n",
      "FT                   with 657-A--A-660.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\r\n",
      "FT   MUTAGEN         650\r\n",
      "FT                   /note=\"S->A: No effect on phosphorylation by CDK2.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\r\n",
      "FT   MUTAGEN         657..660\r\n",
      "FT                   /note=\"KRRL->AAAA: Reduces S-640 phosphorylation by CDK2\r\n",
      "FT                   and CDK4.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\r\n",
      "FT   CONFLICT        326\r\n",
      "FT                   /note=\"Missing (in Ref. 8; AA sequence)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        928\r\n",
      "FT                   /note=\"G -> S (in Ref. 1 and 6)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   HELIX           392..400\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   TURN            401..403\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           410..417\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   STRAND          419..421\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           424..442\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   STRAND          447..449\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           454..477\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           480..483\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           489..492\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           495..512\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           521..525\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           530..533\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           535..543\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           549..564\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           566..568\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           573..580\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   TURN            581..583\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           588..591\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           785..809\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           814..830\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           832..835\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           840..854\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   STRAND          855..857\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOS\"\r\n",
      "FT   HELIX           861..868\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           877..880\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   STRAND          881..883\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           930..936\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   HELIX           938..946\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\r\n",
      "FT   STRAND          1001..1005\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:5TUV\"\r\n",
      "FT   TURN            1006..1008\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:5TUV\"\r\n",
      "FT   HELIX           1011..1023\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:5TUV\"\r\n",
      "SQ   SEQUENCE   1068 AA;  120847 MW;  2BC4876EA04BDB31 CRC64;\r\n",
      "     MFEDKPHAEG AAVVAAAGEA LQALCQELNL DEGSAAEALD DFTAIRGNYS LEGEVTHWLA\r\n",
      "     CSLYVACRKS IIPTVGKGIM EGNCVSLTRI LRSAKLSLIQ FFSKMKKWMD MSNLPQEFRE\r\n",
      "     RIERLERNFE VSTVIFKKYE PIFLDIFQNP YEEPPKLPRS RKQRRIPCSV KDLFNFCWTL\r\n",
      "     FVYTKGNFRM IGDDLVNSYH LLLCCLDLIF ANAIMCPNRQ DLLNPSFKGL PSDFHTADFT\r\n",
      "     ASEEPPCIIA VLCELHDGLL VEAKGIKEHY FKPYISKLFD RKILKGECLL DLSSFTDNSK\r\n",
      "     AVNKEYEEYV LTVGDFDERI FLGADAEEEI GTPRKFTRDT PLGKLTAQAN VEYNLQQHFE\r\n",
      "     KKRSFAPSTP LTGRRYLREK EAVITPVASA TQSVSRLQSI VAGLKNAPSD QLINIFESCV\r\n",
      "     RNPVENIMKI LKGIGETFCQ HYTQSTDEQP GSHIDFAVNR LKLAEILYYK ILETVMVQET\r\n",
      "     RRLHGMDMSV LLEQDIFHRS LMACCLEIVL FAYSSPRTFP WIIEVLNLQP FYFYKVIEVV\r\n",
      "     IRSEEGLSRD MVKHLNSIEE QILESLAWSH DSALWEALQV SANKVPTCEE VIFPNNFETG\r\n",
      "     NGGNVQGHLP LMPMSPLMHP RVKEVRTDSG SLRRDMQPLS PISVHERYSS PTAGSAKRRL\r\n",
      "     FGEDPPKEML MDKIITEGTK LKIAPSSSIT AENVSILPGQ TLLTMATAPV TGTTGHKVTI\r\n",
      "     PLHGVANDAG EITLIPLSMN TNQESKVKSP VSLTAHSLIG ASPKQTNLTK AQEVHSTGIN\r\n",
      "     RPKRTGSLAL FYRKVYHLAS VRLRDLCLKL DVSNELRRKI WTCFEFTLVH CPDLMKDRHL\r\n",
      "     DQLLLCAFYI MAKVTKEERT FQEIMKSYRN QPQANSHVYR SVLLKSIPRE VVAYNKNIND\r\n",
      "     DFEMIDCDLE DATKTPDCSS GPVKEERGDL IKFYNTIYVG RVKSFALKYD LANQDHMMDA\r\n",
      "     PPLSPFPHIK QQPGSPRRIS QQHSIYISPH KNGSGLTPRS ALLYKFNGSP SKSLKDINNM\r\n",
      "     IRQGEQRTKK RVIAIDSDAE SPAKRVCQEN DDVLLKRLQD VVSERANH\r\n",
      "//\r\n",
      "ID   RBL2_HUMAN              Reviewed;        1139 AA.\r\n",
      "AC   Q08999; B7Z913; Q15073; Q16084; Q8NE70; Q92812;\r\n",
      "DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   17-OCT-2006, sequence version 3.\r\n",
      "DT   03-MAY-2023, entry version 206.\r\n",
      "DE   RecName: Full=Retinoblastoma-like protein 2;\r\n",
      "DE   AltName: Full=130 kDa retinoblastoma-associated protein;\r\n",
      "DE            Short=p130;\r\n",
      "DE   AltName: Full=Retinoblastoma-related protein 2;\r\n",
      "DE            Short=RBR-2;\r\n",
      "DE   AltName: Full=pRb2;\r\n",
      "GN   Name=RBL2; Synonyms=RB2;\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).\r\n",
      "RC   TISSUE=Placenta, and Spleen;\r\n",
      "RX   PubMed=8253383; DOI=10.1101/gad.7.12a.2366;\r\n",
      "RA   Li Y., Graham C., Lacy S., Duncan A.M.V., Whyte P.;\r\n",
      "RT   \"The adenovirus E1A-associated 130-kD protein is encoded by a member of the\r\n",
      "RT   retinoblastoma gene family and physically interacts with cyclins A and E.\";\r\n",
      "RL   Genes Dev. 7:2366-2377(1993).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).\r\n",
      "RX   PubMed=8253384; DOI=10.1101/gad.7.12a.2378;\r\n",
      "RA   Hannon G.J., Demetrick D., Beach D.;\r\n",
      "RT   \"Isolation of the Rb-related p130 through its interaction with CDK2 and\r\n",
      "RT   cyclins.\";\r\n",
      "RL   Genes Dev. 7:2378-2391(1993).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).\r\n",
      "RC   TISSUE=Trachea;\r\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\r\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\r\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\r\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\r\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\r\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\r\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\r\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\r\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\r\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\r\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\r\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\r\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\r\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\r\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\r\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\r\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\r\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\r\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\r\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\r\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\r\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\r\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\r\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\r\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\r\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\r\n",
      "RA   Isogai T., Sugano S.;\r\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\r\n",
      "RT   cDNAs.\";\r\n",
      "RL   Nat. Genet. 36:40-45(2004).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RX   PubMed=15616553; DOI=10.1038/nature03187;\r\n",
      "RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,\r\n",
      "RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,\r\n",
      "RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,\r\n",
      "RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,\r\n",
      "RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,\r\n",
      "RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,\r\n",
      "RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,\r\n",
      "RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,\r\n",
      "RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,\r\n",
      "RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,\r\n",
      "RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,\r\n",
      "RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,\r\n",
      "RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,\r\n",
      "RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,\r\n",
      "RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,\r\n",
      "RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,\r\n",
      "RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,\r\n",
      "RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,\r\n",
      "RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,\r\n",
      "RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,\r\n",
      "RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,\r\n",
      "RA   Myers R.M., Rubin E.M., Pennacchio L.A.;\r\n",
      "RT   \"The sequence and analysis of duplication-rich human chromosome 16.\";\r\n",
      "RL   Nature 432:988-994(2004).\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).\r\n",
      "RC   TISSUE=Testis;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 58-1139 (ISOFORM 1).\r\n",
      "RX   PubMed=8361765;\r\n",
      "RA   Mayol X., Grana X., Baldi A., Sang N., Hu Q., Giordano A.;\r\n",
      "RT   \"Cloning of a new member of the retinoblastoma gene family (pRb2) which\r\n",
      "RT   binds to the E1A transforming domain.\";\r\n",
      "RL   Oncogene 8:2561-2566(1993).\r\n",
      "RN   [7]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-80.\r\n",
      "RC   TISSUE=Placenta;\r\n",
      "RX   PubMed=8643454; DOI=10.1073/pnas.93.10.4629;\r\n",
      "RA   Baldi A., Boccia V., Claudio P.P., de Luca A., Giordano A.;\r\n",
      "RT   \"Genomic structure of the human retinoblastoma-related Rb2/p130 gene.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 93:4629-4632(1996).\r\n",
      "RN   [8]\r\n",
      "RP   PHOSPHORYLATION AT SER-639; SER-952; SER-966; SER-971; SER-972; SER-973;\r\n",
      "RP   THR-974; SER-981; SER-982 AND THR-986, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY.\r\n",
      "RX   PubMed=11042701; DOI=10.1038/sj.onc.1203893;\r\n",
      "RA   Canhoto A.J., Chestukhin A., Litovchick L., DeCaprio J.A.;\r\n",
      "RT   \"Phosphorylation of the retinoblastoma-related protein p130 in growth-\r\n",
      "RT   arrested cells.\";\r\n",
      "RL   Oncogene 19:5116-5122(2000).\r\n",
      "RN   [9]\r\n",
      "RP   INTERACTION WITH AATF.\r\n",
      "RX   PubMed=12450794; DOI=10.1016/s1535-6108(02)00182-4;\r\n",
      "RA   Bruno T., De Angelis R., De Nicola F., Barbato C., Di Padova M., Corbi N.,\r\n",
      "RA   Libri V., Benassi B., Mattei E., Chersi A., Soddu S., Floridi A.,\r\n",
      "RA   Passananti C., Fanciulli M.;\r\n",
      "RT   \"Che-1 affects cell growth by interfering with the recruitment of HDAC1 by\r\n",
      "RT   Rb.\";\r\n",
      "RL   Cancer Cell 2:387-399(2002).\r\n",
      "RN   [10]\r\n",
      "RP   PHOSPHORYLATION AT SER-672.\r\n",
      "RX   PubMed=12435635; DOI=10.1101/gad.1011202;\r\n",
      "RA   Tedesco D., Lukas J., Reed S.I.;\r\n",
      "RT   \"The pRb-related protein p130 is regulated by phosphorylation-dependent\r\n",
      "RT   proteolysis via the protein-ubiquitin ligase SCF(Skp2).\";\r\n",
      "RL   Genes Dev. 16:2946-2957(2002).\r\n",
      "RN   [11]\r\n",
      "RP   INTERACTION WITH RINT1.\r\n",
      "RX   PubMed=16600870; DOI=10.1016/j.molcel.2006.02.016;\r\n",
      "RA   Kong L.-J., Meloni A.R., Nevins J.R.;\r\n",
      "RT   \"The Rb-related p130 protein controls telomere lengthening through an\r\n",
      "RT   interaction with a Rad50-interacting protein, RINT-1.\";\r\n",
      "RL   Mol. Cell 22:63-71(2006).\r\n",
      "RN   [12]\r\n",
      "RP   IDENTIFICATION IN THE DREAM COMPLEX.\r\n",
      "RX   PubMed=17671431; DOI=10.4161/cc.6.15.4512;\r\n",
      "RA   Schmit F., Korenjak M., Mannefeld M., Schmitt K., Franke C., von Eyss B.,\r\n",
      "RA   Gagrica S., Haenel F., Brehm A., Gaubatz S.;\r\n",
      "RT   \"LINC, a human complex that is related to pRB-containing complexes in\r\n",
      "RT   invertebrates regulates the expression of G2/M genes.\";\r\n",
      "RL   Cell Cycle 6:1903-1913(2007).\r\n",
      "RN   [13]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19413330; DOI=10.1021/ac9004309;\r\n",
      "RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;\r\n",
      "RT   \"Lys-N and trypsin cover complementary parts of the phosphoproteome in a\r\n",
      "RT   refined SCX-based approach.\";\r\n",
      "RL   Anal. Chem. 81:4493-4501(2009).\r\n",
      "RN   [14]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;\r\n",
      "RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,\r\n",
      "RA   Mann M., Daub H.;\r\n",
      "RT   \"Large-scale proteomics analysis of the human kinome.\";\r\n",
      "RL   Mol. Cell. Proteomics 8:1751-1764(2009).\r\n",
      "RN   [15]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-662; SER-672 AND SER-1035,\r\n",
      "RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [16]\r\n",
      "RP   INTERACTION WITH JC VIRUS SMALL T ANTIGEN (MICROBIAL INFECTION).\r\n",
      "RX   PubMed=20485545; DOI=10.1371/journal.pone.0010606;\r\n",
      "RA   Bollag B., Hofstetter C.A., Reviriego-Mendoza M.M., Frisque R.J.;\r\n",
      "RT   \"JC virus small T antigen binds phosphatase PP2A and Rb family proteins and\r\n",
      "RT   is required for efficient viral DNA replication activity.\";\r\n",
      "RL   PLoS ONE 5:e10606-e10606(2010).\r\n",
      "RN   [17]\r\n",
      "RP   INTERACTION WITH PML.\r\n",
      "RX   PubMed=22002537; DOI=10.1038/emboj.2011.370;\r\n",
      "RA   Martin N., Benhamed M., Nacerddine K., Demarque M.D., van Lohuizen M.,\r\n",
      "RA   Dejean A., Bischof O.;\r\n",
      "RT   \"Physical and functional interaction between PML and TBX2 in the\r\n",
      "RT   establishment of cellular senescence.\";\r\n",
      "RL   EMBO J. 31:95-109(2012).\r\n",
      "RN   [18]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-413; SER-662; SER-688;\r\n",
      "RP   SER-1068; SER-1080 AND SER-1112, AND IDENTIFICATION BY MASS SPECTROMETRY\r\n",
      "RP   [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [19]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;\r\n",
      "RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,\r\n",
      "RA   Ye M., Zou H.;\r\n",
      "RT   \"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteomics 96:253-262(2014).\r\n",
      "RN   [20]\r\n",
      "RP   VARIANT PHE-99.\r\n",
      "RX   PubMed=23033978; DOI=10.1056/nejmoa1206524;\r\n",
      "RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,\r\n",
      "RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P., Gilissen C.,\r\n",
      "RA   del Rosario M., Hoischen A., Scheffer H., de Vries B.B., Brunner H.G.,\r\n",
      "RA   Veltman J.A., Vissers L.E.;\r\n",
      "RT   \"Diagnostic exome sequencing in persons with severe intellectual\r\n",
      "RT   disability.\";\r\n",
      "RL   N. Engl. J. Med. 367:1921-1929(2012).\r\n",
      "RN   [21]\r\n",
      "RP   VARIANT BRUWAG 186-ARG--HIS-1139 DEL, AND INVOLVEMENT IN BRUWAG.\r\n",
      "RX   PubMed=32105419; DOI=10.1002/acn3.50992;\r\n",
      "RA   Brunet T., Radivojkov-Blagojevic M., Lichtner P., Kraus V., Meitinger T.,\r\n",
      "RA   Wagner M.;\r\n",
      "RT   \"Biallelic loss-of-function variants in RBL2 in siblings with a\r\n",
      "RT   neurodevelopmental disorder.\";\r\n",
      "RL   Ann. Clin. Transl. Neurol. 7:390-396(2020).\r\n",
      "RN   [22]\r\n",
      "RP   INVOLVEMENT IN BRUWAG.\r\n",
      "RX   PubMed=33980986; DOI=10.1038/s10038-021-00931-z;\r\n",
      "RA   Samra N., Toubiana S., Yttervik H., Tzur-Gilat A., Morani I., Itzkovich C.,\r\n",
      "RA   Giladi L., Abu Jabal K., Cao J.Z., Godley L.A., Mory A., Baris Feldman H.,\r\n",
      "RA   Tveten K., Selig S., Weiss K.;\r\n",
      "RT   \"RBL2 bi-allelic truncating variants cause severe motor and cognitive\r\n",
      "RT   impairment without evidence for abnormalities in DNA methylation or\r\n",
      "RT   telomeric function.\";\r\n",
      "RL   J. Hum. Genet. 66:1101-1112(2021).\r\n",
      "CC   -!- FUNCTION: Key regulator of entry into cell division. Directly involved\r\n",
      "CC       in heterochromatin formation by maintaining overall chromatin structure\r\n",
      "CC       and, in particular, that of constitutive heterochromatin by stabilizing\r\n",
      "CC       histone methylation. Recruits and targets histone methyltransferases\r\n",
      "CC       KMT5B and KMT5C, leading to epigenetic transcriptional repression.\r\n",
      "CC       Controls histone H4 'Lys-20' trimethylation. Probably acts as a\r\n",
      "CC       transcription repressor by recruiting chromatin-modifying enzymes to\r\n",
      "CC       promoters. Potent inhibitor of E2F-mediated trans-activation,\r\n",
      "CC       associates preferentially with E2F5. Binds to cyclins A and E. Binds to\r\n",
      "CC       and may be involved in the transforming capacity of the adenovirus E1A\r\n",
      "CC       protein. May act as a tumor suppressor.\r\n",
      "CC   -!- SUBUNIT: Interacts with AATF. Interacts with KMT5B, KMT5C and USP4 (By\r\n",
      "CC       similarity). Component of the DREAM complex (also named LINC complex)\r\n",
      "CC       at least composed of E2F4, E2F5, LIN9, LIN37, LIN52, LIN54, MYBL1,\r\n",
      "CC       MYBL2, RBL1, RBL2, RBBP4, TFDP1 and TFDP2. The complex exists in\r\n",
      "CC       quiescent cells where it represses cell cycle-dependent genes. It\r\n",
      "CC       dissociates in S phase when LIN9, LIN37, LIN52 and LIN54 form a\r\n",
      "CC       subcomplex that binds to MYBL2. Interacts with RINT1. Interacts with\r\n",
      "CC       PML (isoform PML-1, isoform PML-2, isoform PML-3, isoform PML-4 and\r\n",
      "CC       isoform PML-5). Interacts with RBBP9 (By similarity). {ECO:0000250,\r\n",
      "CC       ECO:0000250|UniProtKB:O55081, ECO:0000269|PubMed:12450794,\r\n",
      "CC       ECO:0000269|PubMed:16600870, ECO:0000269|PubMed:17671431,\r\n",
      "CC       ECO:0000269|PubMed:22002537}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with JC virus small t antigen.\r\n",
      "CC       {ECO:0000269|PubMed:20485545}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q08999; Q13574-2: DGKZ; NbExp=2; IntAct=EBI-971439, EBI-715527;\r\n",
      "CC       Q08999; Q16254: E2F4; NbExp=7; IntAct=EBI-971439, EBI-448943;\r\n",
      "CC       Q08999; Q6MZP7: LIN54; NbExp=10; IntAct=EBI-971439, EBI-1389411;\r\n",
      "CC       Q08999; P67775: PPP2CA; NbExp=2; IntAct=EBI-971439, EBI-712311;\r\n",
      "CC       Q08999; I6L8A6: RBBP8; NbExp=3; IntAct=EBI-971439, EBI-11525639;\r\n",
      "CC       Q08999; Q99708-2: RBBP8; NbExp=3; IntAct=EBI-971439, EBI-10203615;\r\n",
      "CC       Q08999; P24610: Pax3; Xeno; NbExp=3; IntAct=EBI-971439, EBI-1208116;\r\n",
      "CC       Q08999; Q923E4: Sirt1; Xeno; NbExp=2; IntAct=EBI-971439, EBI-1802585;\r\n",
      "CC       Q08999; Q61412: Vsx2; Xeno; NbExp=4; IntAct=EBI-971439, EBI-1208174;\r\n",
      "CC       Q08999; P03255; Xeno; NbExp=2; IntAct=EBI-971439, EBI-2603114;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=2;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=Q08999-1; Sequence=Displayed;\r\n",
      "CC       Name=2;\r\n",
      "CC         IsoId=Q08999-2; Sequence=VSP_054328, VSP_054329;\r\n",
      "CC   -!- DEVELOPMENTAL STAGE: G0-restricted expression.\r\n",
      "CC   -!- PTM: During G0 and early G1 phase of the cell cycle, phosphorylated on\r\n",
      "CC       Ser-639 and on 5 sites within the domain B. Phosphorylation on Ser-672\r\n",
      "CC       in G1 leads to its ubiquitin-dependent proteolysis.\r\n",
      "CC       {ECO:0000269|PubMed:11042701, ECO:0000269|PubMed:12435635}.\r\n",
      "CC   -!- DISEASE: Brunet-Wagner neurodevelopmental syndrome (BRUWAG)\r\n",
      "CC       [MIM:619690]: An autosomal recessive disorder characterized by severe\r\n",
      "CC       developmental delay, intellectual disability, poor or absent speech,\r\n",
      "CC       infantile hypotonia, inability to walk, behavioral abnormalities, and\r\n",
      "CC       dysmorphic features. {ECO:0000269|PubMed:32105419,\r\n",
      "CC       ECO:0000269|PubMed:33980986}. Note=The disease is caused by variants\r\n",
      "CC       affecting the gene represented in this entry.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and\r\n",
      "CC       Haematology;\r\n",
      "CC       URL=\"https://atlasgeneticsoncology.org/gene/443/RBL2\";\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; X76061; CAA53661.1; -; mRNA.\r\n",
      "DR   EMBL; S67171; AAB29227.1; -; mRNA.\r\n",
      "DR   EMBL; AK304283; BAH14149.1; -; mRNA.\r\n",
      "DR   EMBL; AC007342; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; BC034490; AAH34490.1; -; mRNA.\r\n",
      "DR   EMBL; X74594; CAA52671.1; -; mRNA.\r\n",
      "DR   EMBL; U53220; AAC50479.1; -; Genomic_DNA.\r\n",
      "DR   CCDS; CCDS10748.1; -. [Q08999-1]\r\n",
      "DR   PIR; A49370; A49370.\r\n",
      "DR   RefSeq; NP_001310537.1; NM_001323608.1. [Q08999-1]\r\n",
      "DR   RefSeq; NP_005602.3; NM_005611.3. [Q08999-1]\r\n",
      "DR   PDB; 4XI9; X-ray; 3.10 A; E/F/G/H=416-422.\r\n",
      "DR   PDB; 5C1D; X-ray; 2.05 A; C=416-422.\r\n",
      "DR   PDBsum; 4XI9; -.\r\n",
      "DR   PDBsum; 5C1D; -.\r\n",
      "DR   AlphaFoldDB; Q08999; -.\r\n",
      "DR   SMR; Q08999; -.\r\n",
      "DR   BioGRID; 111869; 77.\r\n",
      "DR   CORUM; Q08999; -.\r\n",
      "DR   DIP; DIP-425N; -.\r\n",
      "DR   ELM; Q08999; -.\r\n",
      "DR   IntAct; Q08999; 48.\r\n",
      "DR   MINT; Q08999; -.\r\n",
      "DR   STRING; 9606.ENSP00000262133; -.\r\n",
      "DR   GlyCosmos; Q08999; 1 site, 1 glycan.\r\n",
      "DR   GlyGen; Q08999; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; Q08999; -.\r\n",
      "DR   PhosphoSitePlus; Q08999; -.\r\n",
      "DR   BioMuta; RBL2; -.\r\n",
      "DR   DMDM; 116242746; -.\r\n",
      "DR   EPD; Q08999; -.\r\n",
      "DR   jPOST; Q08999; -.\r\n",
      "DR   MassIVE; Q08999; -.\r\n",
      "DR   MaxQB; Q08999; -.\r\n",
      "DR   PaxDb; Q08999; -.\r\n",
      "DR   PeptideAtlas; Q08999; -.\r\n",
      "DR   ProteomicsDB; 58652; -. [Q08999-1]\r\n",
      "DR   ProteomicsDB; 6997; -.\r\n",
      "DR   Antibodypedia; 4299; 476 antibodies from 39 providers.\r\n",
      "DR   DNASU; 5934; -.\r\n",
      "DR   Ensembl; ENST00000262133.11; ENSP00000262133.6; ENSG00000103479.17. [Q08999-1]\r\n",
      "DR   GeneID; 5934; -.\r\n",
      "DR   KEGG; hsa:5934; -.\r\n",
      "DR   MANE-Select; ENST00000262133.11; ENSP00000262133.6; NM_005611.4; NP_005602.3.\r\n",
      "DR   UCSC; uc002ehi.5; human. [Q08999-1]\r\n",
      "DR   AGR; HGNC:9894; -.\r\n",
      "DR   CTD; 5934; -.\r\n",
      "DR   DisGeNET; 5934; -.\r\n",
      "DR   GeneCards; RBL2; -.\r\n",
      "DR   HGNC; HGNC:9894; RBL2.\r\n",
      "DR   HPA; ENSG00000103479; Low tissue specificity.\r\n",
      "DR   MalaCards; RBL2; -.\r\n",
      "DR   MIM; 180203; gene.\r\n",
      "DR   MIM; 619690; phenotype.\r\n",
      "DR   neXtProt; NX_Q08999; -.\r\n",
      "DR   OpenTargets; ENSG00000103479; -.\r\n",
      "DR   PharmGKB; PA34258; -.\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DR   VEuPathDB; HostDB:ENSG00000103479; -.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00950000183202; -.\r\n",
      "DR   HOGENOM; CLU_008943_0_0_1; -.\r\n",
      "DR   InParanoid; Q08999; -.\r\n",
      "DR   OMA; MHWLACA; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; Q08999; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   PathwayCommons; Q08999; -.\r\n",
      "DR   Reactome; R-HSA-1362277; Transcription of E2F targets under negative control by DREAM complex.\r\n",
      "DR   Reactome; R-HSA-1362300; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1.\r\n",
      "DR   Reactome; R-HSA-1538133; G0 and Early G1.\r\n",
      "DR   Reactome; R-HSA-6804114; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest.\r\n",
      "DR   Reactome; R-HSA-69202; Cyclin E associated events during G1/S transition.\r\n",
      "DR   Reactome; R-HSA-69205; G1/S-Specific Transcription.\r\n",
      "DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.\r\n",
      "DR   Reactome; R-HSA-69656; Cyclin A:Cdk2-associated events at S phase entry.\r\n",
      "DR   Reactome; R-HSA-9617828; FOXO-mediated transcription of cell cycle genes.\r\n",
      "DR   SignaLink; Q08999; -.\r\n",
      "DR   SIGNOR; Q08999; -.\r\n",
      "DR   BioGRID-ORCS; 5934; 15 hits in 1157 CRISPR screens.\r\n",
      "DR   ChiTaRS; RBL2; human.\r\n",
      "DR   GeneWiki; Retinoblastoma-like_protein_2; -.\r\n",
      "DR   GenomeRNAi; 5934; -.\r\n",
      "DR   Pharos; Q08999; Tbio.\r\n",
      "DR   PRO; PR:Q08999; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 16.\r\n",
      "DR   RNAct; Q08999; protein.\r\n",
      "DR   Bgee; ENSG00000103479; Expressed in germinal epithelium of ovary and 203 other tissues.\r\n",
      "DR   ExpressionAtlas; Q08999; baseline and differential.\r\n",
      "DR   Genevisible; Q08999; HS.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0005694; C:chromosome; IDA:HPA.\r\n",
      "DR   GO; GO:0005829; C:cytosol; IDA:HPA.\r\n",
      "DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.\r\n",
      "DR   GO; GO:0005730; C:nucleolus; IDA:HPA.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; IBA:GO_Central.\r\n",
      "DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:MGI.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:MGI.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:InterPro.\r\n",
      "DR   CDD; cd20606; CYCLIN_RBL2; 1.\r\n",
      "DR   CDD; cd00043; CYCLIN_SF; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 3.\r\n",
      "DR   IDEAL; IID00663; -.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   PANTHER; PTHR13742:SF8; RETINOBLASTOMA-LIKE PROTEIN 2; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 2.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 3.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Alternative splicing; Cell cycle; Chromatin regulator;\r\n",
      "KW   Disease variant; DNA-binding; Host-virus interaction;\r\n",
      "KW   Intellectual disability; Nucleus; Phosphoprotein; Reference proteome;\r\n",
      "KW   Repressor; Transcription; Transcription regulation; Tumor suppressor.\r\n",
      "FT   CHAIN           1..1139\r\n",
      "FT                   /note=\"Retinoblastoma-like protein 2\"\r\n",
      "FT                   /id=\"PRO_0000167841\"\r\n",
      "FT   REGION          1..45\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          417..1024\r\n",
      "FT                   /note=\"Pocket; binds E1A\"\r\n",
      "FT   REGION          417..616\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT   REGION          617..827\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT   REGION          654..678\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          810..832\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          828..1024\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT   REGION          933..999\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1..19\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        20..34\r\n",
      "FT                   /note=\"Acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        657..678\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         413\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         417\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q64700\"\r\n",
      "FT   MOD_RES         639\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11042701\"\r\n",
      "FT   MOD_RES         642\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q64700\"\r\n",
      "FT   MOD_RES         662\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         672\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:12435635,\r\n",
      "FT                   ECO:0007744|PubMed:19690332\"\r\n",
      "FT   MOD_RES         688\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         948\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q64700\"\r\n",
      "FT   MOD_RES         952\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11042701\"\r\n",
      "FT   MOD_RES         966\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11042701\"\r\n",
      "FT   MOD_RES         971\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000305|PubMed:11042701\"\r\n",
      "FT   MOD_RES         972\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000305|PubMed:11042701\"\r\n",
      "FT   MOD_RES         973\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000305|PubMed:11042701\"\r\n",
      "FT   MOD_RES         974\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000305|PubMed:11042701\"\r\n",
      "FT   MOD_RES         981\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000305|PubMed:11042701\"\r\n",
      "FT   MOD_RES         982\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11042701\"\r\n",
      "FT   MOD_RES         986\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11042701\"\r\n",
      "FT   MOD_RES         1035\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332\"\r\n",
      "FT   MOD_RES         1068\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1080\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1112\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   VAR_SEQ         1..216\r\n",
      "FT                   /note=\"Missing (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:14702039\"\r\n",
      "FT                   /id=\"VSP_054328\"\r\n",
      "FT   VAR_SEQ         638..1042\r\n",
      "FT                   /note=\"Missing (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:14702039\"\r\n",
      "FT                   /id=\"VSP_054329\"\r\n",
      "FT   VARIANT         99\r\n",
      "FT                   /note=\"V -> F\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:23033978\"\r\n",
      "FT                   /id=\"VAR_069377\"\r\n",
      "FT   VARIANT         186..1139\r\n",
      "FT                   /note=\"Missing (in BRUWAG)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:32105419\"\r\n",
      "FT                   /id=\"VAR_086722\"\r\n",
      "FT   VARIANT         210\r\n",
      "FT                   /note=\"Y -> C (in dbSNP:rs17800727)\"\r\n",
      "FT                   /id=\"VAR_028437\"\r\n",
      "FT   CONFLICT        37\r\n",
      "FT                   /note=\"P -> S (in Ref. 1; CAA53661 and 7; AAC50479)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        64\r\n",
      "FT                   /note=\"A -> P (in Ref. 1 and 7)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        206\r\n",
      "FT                   /note=\"V -> M (in Ref. 6; CAA52671)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1093\r\n",
      "FT                   /note=\"R -> H (in Ref. 5; AAH34490)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   1139 AA;  128367 MW;  D129032FB1F383D4 CRC64;\r\n",
      "     MPSGGDQSPP PPPPPPAAAA SDEEEEDDGE AEDAAPPAES PTPQIQQRFD ELCSRLNMDE\r\n",
      "     AARAEAWDSY RSMSESYTLE GNDLHWLACA LYVACRKSVP TVSKGTVEGN YVSLTRILKC\r\n",
      "     SEQSLIEFFN KMKKWEDMAN LPPHFRERTE RLERNFTVSA VIFKKYEPIF QDIFKYPQEE\r\n",
      "     QPRQQRGRKQ RRQPCTVSEI FHFCWVLFIY AKGNFPMISD DLVNSYHLLL CALDLVYGNA\r\n",
      "     LQCSNRKELV NPNFKGLSED FHAKDSKPSS DPPCIIEKLC SLHDGLVLEA KGIKEHFWKP\r\n",
      "     YIRKLYEKKL LKGKEENLTG FLEPGNFGES FKAINKAYEE YVLSVGNLDE RIFLGEDAEE\r\n",
      "     EIGTLSRCLN AGSGTETAER VQMKNILQQH FDKSKALRIS TPLTGVRYIK ENSPCVTPVS\r\n",
      "     TATHSLSRLH TMLTGLRNAP SEKLEQILRT CSRDPTQAIA NRLKEMFEIY SQHFQPDEDF\r\n",
      "     SNCAKEIASK HFRFAEMLYY KVLESVIEQE QKRLGDMDLS GILEQDAFHR SLLACCLEVV\r\n",
      "     TFSYKPPGNF PFITEIFDVP LYHFYKVIEV FIRAEDGLCR EVVKHLNQIE EQILDHLAWK\r\n",
      "     PESPLWEKIR DNENRVPTCE EVMPPQNLER ADEICIAGSP LTPRRVTEVR ADTGGLGRSI\r\n",
      "     TSPTTLYDRY SSPPASTTRR RLFVENDSPS DGGTPGRMPP QPLVNAVPVQ NVSGETVSVT\r\n",
      "     PVPGQTLVTM ATATVTANNG QTVTIPVQGI ANENGGITFF PVQVNVGGQA QAVTGSIQPL\r\n",
      "     SAQALAGSLS SQQVTGTTLQ VPGQVAIQQI SPGGQQQKQG QSVTSSSNRP RKTSSLSLFF\r\n",
      "     RKVYHLAAVR LRDLCAKLDI SDELRKKIWT CFEFSIIQCP ELMMDRHLDQ LLMCAIYVMA\r\n",
      "     KVTKEDKSFQ NIMRCYRTQP QARSQVYRSV LIKGKRKRRN SGSSDSRSHQ NSPTELNKDR\r\n",
      "     TSRDSSPVMR SSSTLPVPQP SSAPPTPTRL TGANSDMEEE ERGDLIQFYN NIYIKQIKTF\r\n",
      "     AMKYSQANMD APPLSPYPFV RTGSPRRIQL SQNHPVYISP HKNETMLSPR EKIFYYFSNS\r\n",
      "     PSKRLREINS MIRTGETPTK KRGILLEDGS ESPAKRICPE NHSALLRRLQ DVANDRGSH\r\n",
      "//\r\n",
      "ID   RB_HUMAN                Reviewed;         928 AA.\r\n",
      "AC   P06400; A8K5E3; P78499; Q5VW46; Q8IZL4;\r\n",
      "DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   01-JAN-1990, sequence version 2.\r\n",
      "DT   03-MAY-2023, entry version 273.\r\n",
      "DE   RecName: Full=Retinoblastoma-associated protein;\r\n",
      "DE   AltName: Full=p105-Rb;\r\n",
      "DE   AltName: Full=p110-RB1 {ECO:0000303|PubMed:8336704};\r\n",
      "DE   AltName: Full=pRb;\r\n",
      "DE            Short=Rb;\r\n",
      "DE   AltName: Full=pp110;\r\n",
      "GN   Name=RB1;\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=3657987; DOI=10.1038/329642a0;\r\n",
      "RA   Lee W.-H., Shew J.-Y., Hong F.D., Sery T.W., Donoso L.A., Young L.-J.S.,\r\n",
      "RA   Bookstein R., Lee E.Y.-H.P.;\r\n",
      "RT   \"The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein\r\n",
      "RT   associated with DNA binding activity.\";\r\n",
      "RL   Nature 329:642-645(1987).\r\n",
      "RN   [2]\r\n",
      "RP   SEQUENCE REVISION.\r\n",
      "RX   PubMed=3823889; DOI=10.1126/science.3823889;\r\n",
      "RA   Lee W.-H., Bookstein R., Hong F.D., Young L.-J., Shew J.-Y., Lee E.Y.-H.P.;\r\n",
      "RT   \"Human retinoblastoma susceptibility gene: cloning, identification, and\r\n",
      "RT   sequence.\";\r\n",
      "RL   Science 235:1394-1399(1987).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=3480530; DOI=10.1073/pnas.84.24.9059;\r\n",
      "RA   Friend S.H., Horowitz J.M., Gerber M.R., Wang X.-F., Bogenmann E., Li F.P.,\r\n",
      "RA   Weinberg R.A.;\r\n",
      "RT   \"Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors:\r\n",
      "RT   organization of the sequence and its encoded protein.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 84:9059-9063(1987).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].\r\n",
      "RX   PubMed=2701949; DOI=10.1016/0378-1119(89)90256-4;\r\n",
      "RA   McGee T.L., Yandell D.W., Dryja T.P.;\r\n",
      "RT   \"Structure and partial genomic sequence of the human retinoblastoma\r\n",
      "RT   susceptibility gene.\";\r\n",
      "RL   Gene 80:119-128(1989).\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].\r\n",
      "RC   TISSUE=Carcinoma;\r\n",
      "RX   PubMed=1352398;\r\n",
      "RA   Hogg A., Onadim Z., Baird P.N., Cowell J.K.;\r\n",
      "RT   \"Detection of heterozygous mutations in the RB1 gene in retinoblastoma\r\n",
      "RT   patients using single-strand conformation polymorphism analysis and\r\n",
      "RT   polymerase chain reaction sequencing.\";\r\n",
      "RL   Oncogene 7:1445-1451(1992).\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].\r\n",
      "RX   PubMed=7902321; DOI=10.1006/geno.1993.1368;\r\n",
      "RA   Toguchida J., McGee T.L., Paterson J.C., Eagle J.R., Tucker S.,\r\n",
      "RA   Yandell D.W., Dryja T.P.;\r\n",
      "RT   \"Complete genomic sequence of the human retinoblastoma susceptibility\r\n",
      "RT   gene.\";\r\n",
      "RL   Genomics 17:535-543(1993).\r\n",
      "RN   [7]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LYS-436 AND GLY-525.\r\n",
      "RG   NIEHS SNPs program;\r\n",
      "RL   Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [8]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\r\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\r\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\r\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\r\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\r\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\r\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\r\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\r\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\r\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\r\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\r\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\r\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\r\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\r\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\r\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\r\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\r\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\r\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\r\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\r\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\r\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\r\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\r\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\r\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\r\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\r\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\r\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\r\n",
      "RA   Isogai T., Sugano S.;\r\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\r\n",
      "RT   cDNAs.\";\r\n",
      "RL   Nat. Genet. 36:40-45(2004).\r\n",
      "RN   [9]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RX   PubMed=15057823; DOI=10.1038/nature02379;\r\n",
      "RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,\r\n",
      "RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,\r\n",
      "RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,\r\n",
      "RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,\r\n",
      "RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,\r\n",
      "RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,\r\n",
      "RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,\r\n",
      "RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,\r\n",
      "RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,\r\n",
      "RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,\r\n",
      "RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,\r\n",
      "RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,\r\n",
      "RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,\r\n",
      "RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,\r\n",
      "RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,\r\n",
      "RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,\r\n",
      "RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,\r\n",
      "RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,\r\n",
      "RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,\r\n",
      "RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,\r\n",
      "RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,\r\n",
      "RA   Rogers J., Ross M.T.;\r\n",
      "RT   \"The DNA sequence and analysis of human chromosome 13.\";\r\n",
      "RL   Nature 428:522-528(2004).\r\n",
      "RN   [10]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,\r\n",
      "RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,\r\n",
      "RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,\r\n",
      "RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,\r\n",
      "RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,\r\n",
      "RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,\r\n",
      "RA   Hunkapiller M.W., Myers E.W., Venter J.C.;\r\n",
      "RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [11]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\r\n",
      "RC   TISSUE=Cervix, and Testis;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [12]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-45.\r\n",
      "RX   PubMed=2717184;\r\n",
      "RA   T'Ang A., Wu K.J., Hashimoto T., Liu W.Y., Takahashi R., Shi X.H.,\r\n",
      "RA   Mihara K., Zhang F.H., Chen Y.Y., Du C., Qian J., Lin Y.G., Murphree A.L.,\r\n",
      "RA   Qiu W.R., Thompson T., Benedict W.F., Fung Y.K.T.;\r\n",
      "RT   \"Genomic organization of the human retinoblastoma gene.\";\r\n",
      "RL   Oncogene 4:401-407(1989).\r\n",
      "RN   [13]\r\n",
      "RP   PROTEIN SEQUENCE OF 47-65, AND INVOLVEMENT IN RETINOBLASTOMA.\r\n",
      "RX   PubMed=7881418; DOI=10.1093/hmg/3.12.2187;\r\n",
      "RA   Lohmann D.R., Brandt B., Hopping W., Passarge E., Horsthemke B.;\r\n",
      "RT   \"Spectrum of small length germline mutations in the RB1 gene.\";\r\n",
      "RL   Hum. Mol. Genet. 3:2187-2193(1994).\r\n",
      "RN   [14]\r\n",
      "RP   INTERACTION WITH SV40 LARGE T ANTIGEN AND HPV E7 PROTEIN (MICROBIAL\r\n",
      "RP   INFECTION).\r\n",
      "RX   PubMed=1316611; DOI=10.1073/pnas.89.10.4549;\r\n",
      "RA   Chellappan S., Kraus V.B., Kroger B., Munger K., Howley P.M., Phelps W.C.,\r\n",
      "RA   Nevins J.R.;\r\n",
      "RT   \"Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7\r\n",
      "RT   protein share the capacity to disrupt the interaction between transcription\r\n",
      "RT   factor E2F and the retinoblastoma gene product.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 89:4549-4553(1992).\r\n",
      "RN   [15]\r\n",
      "RP   INTERACTION WITH E2F1.\r\n",
      "RX   PubMed=8336704; DOI=10.1128/mcb.13.8.4588-4599.1993;\r\n",
      "RA   Zacksenhaus E., Bremner R., Phillips R.A., Gallie B.L.;\r\n",
      "RT   \"A bipartite nuclear localization signal in the retinoblastoma gene product\r\n",
      "RT   and its importance for biological activity.\";\r\n",
      "RL   Mol. Cell. Biol. 13:4588-4599(1993).\r\n",
      "RN   [16]\r\n",
      "RP   PHOSPHORYLATION BY CDK6.\r\n",
      "RX   PubMed=8114739; DOI=10.1128/mcb.14.3.2077-2086.1994;\r\n",
      "RA   Meyerson M., Harlow E.;\r\n",
      "RT   \"Identification of G1 kinase activity for cdk6, a novel cyclin D partner.\";\r\n",
      "RL   Mol. Cell. Biol. 14:2077-2086(1994).\r\n",
      "RN   [17]\r\n",
      "RP   INTERACTION WITH SV40 LARGE T ANTIGEN (MICROBIAL INFECTION).\r\n",
      "RX   PubMed=2839300; DOI=10.1016/0092-8674(88)90559-4;\r\n",
      "RA   Decaprio J.A., Ludlow J.W., Figge J., Shew J.-Y., Huang C.-M., Lee W.-H.,\r\n",
      "RA   Marsilio E., Paucha E., Livingston D.M.;\r\n",
      "RT   \"SV40 large tumor antigen forms a specific complex with the product of the\r\n",
      "RT   retinoblastoma susceptibility gene.\";\r\n",
      "RL   Cell 54:275-283(1988).\r\n",
      "RN   [18]\r\n",
      "RP   INVOLVEMENT IN RETINOBLASTOMA.\r\n",
      "RX   PubMed=3413073; DOI=10.1073/pnas.85.16.6017;\r\n",
      "RA   Lee E.Y.-H.P., Bookstein R., Young L.-J., Lin C.-J., Rosenfeld M.G.,\r\n",
      "RA   Lee W.-H.;\r\n",
      "RT   \"Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma\r\n",
      "RT   cell line Y79.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 85:6017-6021(1988).\r\n",
      "RN   [19]\r\n",
      "RP   PHOSPHORYLATION AT SER-249; THR-252; THR-373; SER-807 AND SER-811.\r\n",
      "RX   PubMed=1756735; DOI=10.1002/j.1460-2075.1991.tb05006.x;\r\n",
      "RA   Lees J.A., Buchkovich K.J., Marshak D.R., Anderson C.W., Harlow E.;\r\n",
      "RT   \"The retinoblastoma protein is phosphorylated on multiple sites by human\r\n",
      "RT   cdc2.\";\r\n",
      "RL   EMBO J. 10:4279-4290(1991).\r\n",
      "RN   [20]\r\n",
      "RP   INTERACTION WITH KDM5A AND ARID4A.\r\n",
      "RX   PubMed=8414517;\r\n",
      "RA   Fattaey A.R., Helin K., Dembski M.S., Dyson N., Harlow E., Vuocolo G.A.,\r\n",
      "RA   Hanobik M.G., Haskell K.M., Oliff A., Defeo-Jones D., Jones R.E.;\r\n",
      "RT   \"Characterization of the retinoblastoma binding proteins RBP1 and RBP2.\";\r\n",
      "RL   Oncogene 8:3149-3156(1993).\r\n",
      "RN   [21]\r\n",
      "RP   INTERACTION WITH THOC1.\r\n",
      "RX   PubMed=7525595; DOI=10.1083/jcb.127.3.609;\r\n",
      "RA   Durfee T., Mancini M.A., Jones D., Elledge S.J., Lee W.H.;\r\n",
      "RT   \"The amino-terminal region of the retinoblastoma gene product binds a novel\r\n",
      "RT   nuclear matrix protein that co-localizes to centers for RNA processing.\";\r\n",
      "RL   J. Cell Biol. 127:609-622(1994).\r\n",
      "RN   [22]\r\n",
      "RP   INTERACTION WITH KDM5A.\r\n",
      "RX   PubMed=7935440; DOI=10.1128/mcb.14.11.7256-7264.1994;\r\n",
      "RA   Kim Y.W., Otterson G.A., Kratzke R.A., Coxon A.B., Kaye F.J.;\r\n",
      "RT   \"Differential specificity for binding of retinoblastoma binding protein 2\r\n",
      "RT   to RB, p107, and TATA-binding protein.\";\r\n",
      "RL   Mol. Cell. Biol. 14:7256-7264(1994).\r\n",
      "RN   [23]\r\n",
      "RP   INTERACTION WITH HHV-5 PROTEIN UL123 (MICROBIAL INFECTION).\r\n",
      "RX   PubMed=8892909; DOI=10.1128/jvi.70.11.7867-7877.1996;\r\n",
      "RA   Poma E.E., Kowalik T.F., Zhu L., Sinclair J.H., Huang E.S.;\r\n",
      "RT   \"The human cytomegalovirus IE1-72 protein interacts with the cellular p107\r\n",
      "RT   protein and relieves p107-mediated transcriptional repression of an E2F-\r\n",
      "RT   responsive promoter.\";\r\n",
      "RL   J. Virol. 70:7867-7877(1996).\r\n",
      "RN   [24]\r\n",
      "RP   INTERACTION WITH ARID3B.\r\n",
      "RX   PubMed=10446990;\r\n",
      "RA   Numata S., Claudio P.P., Dean C., Giordano A., Croce C.M.;\r\n",
      "RT   \"Bdp, a new member of a family of DNA-binding proteins, associates with the\r\n",
      "RT   retinoblastoma gene product.\";\r\n",
      "RL   Cancer Res. 59:3741-3747(1999).\r\n",
      "RN   [25]\r\n",
      "RP   FUNCTION, PHOSPHORYLATION AT SER-567 BY CDK2, AND PHOSPHORYLATION BY CDK4\r\n",
      "RP   AND CDK6.\r\n",
      "RX   PubMed=10499802; DOI=10.1016/s0092-8674(00)81519-6;\r\n",
      "RA   Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., Dean D.C.;\r\n",
      "RT   \"Cdk phosphorylation triggers sequential intramolecular interactions that\r\n",
      "RT   progressively block Rb functions as cells move through G1.\";\r\n",
      "RL   Cell 98:859-869(1999).\r\n",
      "RN   [26]\r\n",
      "RP   INTERACTION WITH NDC80.\r\n",
      "RX   PubMed=10409732; DOI=10.1128/mcb.19.8.5417;\r\n",
      "RA   Zheng L., Chen Y., Lee W.-H.;\r\n",
      "RT   \"Hec1p, an evolutionarily conserved coiled-coil protein, modulates\r\n",
      "RT   chromosome segregation through interaction with SMC proteins.\";\r\n",
      "RL   Mol. Cell. Biol. 19:5417-5428(1999).\r\n",
      "RN   [27]\r\n",
      "RP   INTERACTION WITH NDC80.\r\n",
      "RX   PubMed=10779342; DOI=10.1128/mcb.20.10.3529-3537.2000;\r\n",
      "RA   Zheng L., Chen Y., Riley D.J., Chen P.-L., Lee W.-H.;\r\n",
      "RT   \"Retinoblastoma protein enhances the fidelity of chromosome segregation\r\n",
      "RT   mediated by hsHec1p.\";\r\n",
      "RL   Mol. Cell. Biol. 20:3529-3537(2000).\r\n",
      "RN   [28]\r\n",
      "RP   INTERACTION WITH TAF1.\r\n",
      "RX   PubMed=9858607; DOI=10.1128/mcb.19.1.846;\r\n",
      "RA   Siegert J.L., Robbins P.D.;\r\n",
      "RT   \"Rb inhibits the intrinsic kinase activity of TATA-binding protein-\r\n",
      "RT   associated factor TAFII250.\";\r\n",
      "RL   Mol. Cell. Biol. 19:846-854(1999).\r\n",
      "RN   [29]\r\n",
      "RP   INTERACTION WITH PAX5.\r\n",
      "RX   PubMed=10197586;\r\n",
      "RA   Eberhard D., Busslinger M.;\r\n",
      "RT   \"The partial homeodomain of the transcription factor Pax-5 (BSAP) is an\r\n",
      "RT   interaction motif for the retinoblastoma and TATA-binding proteins.\";\r\n",
      "RL   Cancer Res. 59:1716-1724(1999).\r\n",
      "RN   [30]\r\n",
      "RP   INTERACTION WITH E4F1.\r\n",
      "RX   PubMed=10869426; DOI=10.1073/pnas.130198397;\r\n",
      "RA   Fajas L., Paul C., Zugasti O., Le Cam L., Polanowska J., Fabbrizio E.,\r\n",
      "RA   Medema R., Vignais M.-L., Sardet C.;\r\n",
      "RT   \"pRB binds to and modulates the transrepressing activity of the E1A-\r\n",
      "RT   regulated transcription factor p120E4F.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 97:7738-7743(2000).\r\n",
      "RN   [31]\r\n",
      "RP   INTERACTION WITH EID1.\r\n",
      "RX   PubMed=11223246; DOI=10.1016/s0378-1119(00)00585-0;\r\n",
      "RA   Wen H., Ao S.;\r\n",
      "RT   \"Identification and characterization of a novel human cDNA encoding a 21\r\n",
      "RT   kDa pRb-associated protein.\";\r\n",
      "RL   Gene 263:85-92(2001).\r\n",
      "RN   [32]\r\n",
      "RP   INTERACTION WITH DNMT1.\r\n",
      "RX   PubMed=10888886; DOI=10.1038/77124;\r\n",
      "RA   Robertson K.D., Ait-Si-Ali S., Yokochi T., Wade P.A., Jones P.L.,\r\n",
      "RA   Wolffe A.P.;\r\n",
      "RT   \"DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription\r\n",
      "RT   from E2F-responsive promoters.\";\r\n",
      "RL   Nat. Genet. 25:338-342(2000).\r\n",
      "RN   [33]\r\n",
      "RP   INTERACTION WITH SUV39H1.\r\n",
      "RX   PubMed=11484059; DOI=10.1038/35087620;\r\n",
      "RA   Nielsen S.J., Schneider R., Bauer U.-M., Bannister A.J., Morrison A.,\r\n",
      "RA   O'Carroll D., Firestein R., Cleary M.L., Jenuwein T., Herrera R.E.,\r\n",
      "RA   Kouzarides T.;\r\n",
      "RT   \"Rb targets histone H3 methylation and HP1 to promoters.\";\r\n",
      "RL   Nature 412:561-565(2001).\r\n",
      "RN   [34]\r\n",
      "RP   INTERACTION WITH USP4.\r\n",
      "RX   PubMed=11571652; DOI=10.1038/sj.onc.1204824;\r\n",
      "RA   DeSalle L.M., Latres E., Lin D., Graner E., Montagnoli A., Baker R.T.,\r\n",
      "RA   Pagano M., Loda M.;\r\n",
      "RT   \"The de-ubiquitinating enzyme Unp interacts with the retinoblastoma\r\n",
      "RT   protein.\";\r\n",
      "RL   Oncogene 20:5538-5542(2001).\r\n",
      "RN   [35]\r\n",
      "RP   INTERACTION WITH AATF.\r\n",
      "RX   PubMed=12450794; DOI=10.1016/s1535-6108(02)00182-4;\r\n",
      "RA   Bruno T., De Angelis R., De Nicola F., Barbato C., Di Padova M., Corbi N.,\r\n",
      "RA   Libri V., Benassi B., Mattei E., Chersi A., Soddu S., Floridi A.,\r\n",
      "RA   Passananti C., Fanciulli M.;\r\n",
      "RT   \"Che-1 affects cell growth by interfering with the recruitment of HDAC1 by\r\n",
      "RT   Rb.\";\r\n",
      "RL   Cancer Cell 2:387-399(2002).\r\n",
      "RN   [36]\r\n",
      "RP   INTERACTION WITH TMPO-ALPHA AND LMNA.\r\n",
      "RX   PubMed=12475961; DOI=10.1091/mbc.e02-07-0450;\r\n",
      "RA   Markiewicz E., Dechat T., Foisner R., Quinlan R.A., Hutchison C.J.;\r\n",
      "RT   \"Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of\r\n",
      "RT   retinoblastoma protein.\";\r\n",
      "RL   Mol. Biol. Cell 13:4401-4413(2002).\r\n",
      "RN   [37]\r\n",
      "RP   INTERACTION WITH SNW1.\r\n",
      "RX   PubMed=12466551; DOI=10.1093/nar/gkf658;\r\n",
      "RA   Prathapam T., Kuhne C., Banks L.;\r\n",
      "RT   \"Skip interacts with the retinoblastoma tumor suppressor and inhibits its\r\n",
      "RT   transcriptional repression activity.\";\r\n",
      "RL   Nucleic Acids Res. 30:5261-5268(2002).\r\n",
      "RN   [38]\r\n",
      "RP   INTERACTION WITH P-TEFB COMPLEX.\r\n",
      "RX   PubMed=12037672; DOI=10.1038/sj.onc.1205511;\r\n",
      "RA   Simone C., Bagella L., Bellan C., Giordano A.;\r\n",
      "RT   \"Physical interaction between pRb and cdk9/cyclinT2 complex.\";\r\n",
      "RL   Oncogene 21:4158-4165(2002).\r\n",
      "RN   [39]\r\n",
      "RP   INTERACTION WITH PELP1.\r\n",
      "RX   PubMed=12682072; DOI=10.1074/jbc.m212822200;\r\n",
      "RA   Balasenthil S., Vadlamudi R.K.;\r\n",
      "RT   \"Functional interactions between the estrogen receptor coactivator\r\n",
      "RT   PELP1/MNAR and retinoblastoma protein.\";\r\n",
      "RL   J. Biol. Chem. 278:22119-22127(2003).\r\n",
      "RN   [40]\r\n",
      "RP   INTERACTION WITH HUMAN CYTOMEGALOVIRUS PROTEIN UL82 (MICROBIAL INFECTION).\r\n",
      "RX   PubMed=12626766; DOI=10.1073/pnas.0538058100;\r\n",
      "RA   Kalejta R.F., Shenk T.;\r\n",
      "RT   \"Proteasome-dependent, ubiquitin-independent degradation of the Rb family\r\n",
      "RT   of tumor suppressors by the human cytomegalovirus pp71 protein.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 100:3263-3268(2003).\r\n",
      "RN   [41]\r\n",
      "RP   FUNCTION IN G0-G1 TRANSITION, AND PHOSPHORYLATION AT SER-807 AND SER-811 BY\r\n",
      "RP   CDK3.\r\n",
      "RX   PubMed=15084261; DOI=10.1016/s0092-8674(04)00300-9;\r\n",
      "RA   Ren S., Rollins B.J.;\r\n",
      "RT   \"Cyclin C/cdk3 promotes Rb-dependent G0 exit.\";\r\n",
      "RL   Cell 117:239-251(2004).\r\n",
      "RN   [42]\r\n",
      "RP   INTERACTION WITH LIN9.\r\n",
      "RX   PubMed=15538385; DOI=10.1038/sj.emboj.7600470;\r\n",
      "RA   Gagrica S., Hauser S., Kolfschoten I., Osterloh L., Agami R., Gaubatz S.;\r\n",
      "RT   \"Inhibition of oncogenic transformation by mammalian Lin-9, a pRB-\r\n",
      "RT   associated protein.\";\r\n",
      "RL   EMBO J. 23:4627-4638(2004).\r\n",
      "RN   [43]\r\n",
      "RP   INTERACTION WITH CEBPA.\r\n",
      "RX   PubMed=15107404; DOI=10.1101/gad.1183304;\r\n",
      "RA   Wang G.L., Iakova P., Wilde M., Awad S., Timchenko N.A.;\r\n",
      "RT   \"Liver tumors escape negative control of proliferation via PI3K/Akt-\r\n",
      "RT   mediated block of C/EBP alpha growth inhibitory activity.\";\r\n",
      "RL   Genes Dev. 18:912-925(2004).\r\n",
      "RN   [44]\r\n",
      "RP   INTERACTION WITH LIMD1.\r\n",
      "RX   PubMed=15542589; DOI=10.1073/pnas.0407123101;\r\n",
      "RA   Sharp T.V., Munoz F., Bourboulia D., Presneau N., Darai E., Wang H.-W.,\r\n",
      "RA   Cannon M., Butcher D.N., Nicholson A.G., Klein G., Imreh S., Boshoff C.;\r\n",
      "RT   \"LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at\r\n",
      "RT   chromosome 3p21.3, binds pRB and represses E2F-driven transcription.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 101:16531-16536(2004).\r\n",
      "RN   [45]\r\n",
      "RP   PHOSPHORYLATION AT THR-821 AND THR-826.\r\n",
      "RX   PubMed=15809340; DOI=10.1093/jb/mvi050;\r\n",
      "RA   Takaki T., Fukasawa K., Suzuki-Takahashi I., Semba K., Kitagawa M.,\r\n",
      "RA   Taya Y., Hirai H.;\r\n",
      "RT   \"Preferences for phosphorylation sites in the retinoblastoma protein of D-\r\n",
      "RT   type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.\";\r\n",
      "RL   J. Biochem. 137:381-386(2005).\r\n",
      "RN   [46]\r\n",
      "RP   INTERACTION WITH KDM4A.\r\n",
      "RX   PubMed=15927959; DOI=10.1074/jbc.m413687200;\r\n",
      "RA   Gray S.G., Iglesias A.H., Lizcano F., Villanueva R., Camelo S., Jingu H.,\r\n",
      "RA   Teh B.T., Koibuchi N., Chin W.W., Kokkotou E., Dangond F.;\r\n",
      "RT   \"Functional characterization of JMJD2A, a histone deacetylase- and\r\n",
      "RT   retinoblastoma-binding protein.\";\r\n",
      "RL   J. Biol. Chem. 280:28507-28518(2005).\r\n",
      "RN   [47]\r\n",
      "RP   INTERACTION WITH KDM5B.\r\n",
      "RX   PubMed=15803180; DOI=10.1038/modpathol.3800413;\r\n",
      "RA   Roesch A., Becker B., Meyer S., Wild P., Hafner C., Landthaler M., Vogt T.;\r\n",
      "RT   \"Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding\r\n",
      "RT   protein downregulated in malignant melanomas.\";\r\n",
      "RL   Mod. Pathol. 18:1249-1257(2005).\r\n",
      "RN   [48]\r\n",
      "RP   INTERACTION WITH KDM5A.\r\n",
      "RX   PubMed=15949438; DOI=10.1016/j.molcel.2005.05.012;\r\n",
      "RA   Benevolenskaya E.V., Murray H.L., Branton P., Young R.A., Kaelin W.G. Jr.;\r\n",
      "RT   \"Binding of pRB to the PHD protein RBP2 promotes cellular\r\n",
      "RT   differentiation.\";\r\n",
      "RL   Mol. Cell 18:623-635(2005).\r\n",
      "RN   [49]\r\n",
      "RP   INTERACTION WITH PSMA3.\r\n",
      "RX   PubMed=16337594; DOI=10.1016/j.molcel.2005.10.017;\r\n",
      "RA   Sdek P., Ying H., Chang D.L., Qiu W., Zheng H., Touitou R., Allday M.J.,\r\n",
      "RA   Xiao Z.X.;\r\n",
      "RT   \"MDM2 promotes proteasome-dependent ubiquitin-independent degradation of\r\n",
      "RT   retinoblastoma protein.\";\r\n",
      "RL   Mol. Cell 20:699-708(2005).\r\n",
      "RN   [50]\r\n",
      "RP   INTERACTION WITH ZUBR1.\r\n",
      "RX   PubMed=16214886; DOI=10.1073/pnas.0507458102;\r\n",
      "RA   Nakatani Y., Konishi H., Vassilev A., Kurooka H., Ishiguro K., Sawada J.,\r\n",
      "RA   Ikura T., Korsmeyer S.J., Qin J., Herlitz A.M.;\r\n",
      "RT   \"p600, a unique protein required for membrane morphogenesis and cell\r\n",
      "RT   survival.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 102:15093-15098(2005).\r\n",
      "RN   [51]\r\n",
      "RP   INTERACTION WITH KDM5B.\r\n",
      "RX   PubMed=16645588; DOI=10.1038/sj.jid.5700324;\r\n",
      "RA   Roesch A., Becker B., Schneider-Brachert W., Hagen I., Landthaler M.,\r\n",
      "RA   Vogt T.;\r\n",
      "RT   \"Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals\r\n",
      "RT   tumor-suppressive functions in highly metastatic melanoma cells.\";\r\n",
      "RL   J. Invest. Dermatol. 126:1850-1859(2006).\r\n",
      "RN   [52]\r\n",
      "RP   PHOSPHORYLATION AT SER-612 BY CHEK2, AND INTERACTION WITH CHEK2.\r\n",
      "RX   PubMed=17380128; DOI=10.1038/sj.emboj.7601652;\r\n",
      "RA   Inoue Y., Kitagawa M., Taya Y.;\r\n",
      "RT   \"Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB\r\n",
      "RT   and E2F-1 after DNA damage.\";\r\n",
      "RL   EMBO J. 26:2083-2093(2007).\r\n",
      "RN   [53]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249; THR-252 AND THR-356, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18220336; DOI=10.1021/pr0705441;\r\n",
      "RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;\r\n",
      "RT   \"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient\r\n",
      "RT   phosphoproteomic analysis.\";\r\n",
      "RL   J. Proteome Res. 7:1346-1351(2008).\r\n",
      "RN   [54]\r\n",
      "RP   INTERACTION WITH MOLLUSCUM CONTAGIOSUM VIRUS PROTEIN MC007 (MICROBIAL\r\n",
      "RP   FUNCTION).\r\n",
      "RX   PubMed=18701596; DOI=10.1128/jvi.01187-08;\r\n",
      "RA   Mohr S., Grandemange S., Massimi P., Darai G., Banks L., Martinou J.C.,\r\n",
      "RA   Zeier M., Muranyi W.;\r\n",
      "RT   \"Targeting the retinoblastoma protein by MC007L, gene product of the\r\n",
      "RT   molluscum contagiosum virus: detection of a novel virus-cell interaction by\r\n",
      "RT   a member of the poxviruses.\";\r\n",
      "RL   J. Virol. 82:10625-10633(2008).\r\n",
      "RN   [55]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; SER-249; THR-252;\r\n",
      "RP   SER-612; SER-807; SER-811; THR-823 AND THR-826, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;\r\n",
      "RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,\r\n",
      "RA   Elledge S.J., Gygi S.P.;\r\n",
      "RT   \"A quantitative atlas of mitotic phosphorylation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).\r\n",
      "RN   [56]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19413330; DOI=10.1021/ac9004309;\r\n",
      "RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;\r\n",
      "RT   \"Lys-N and trypsin cover complementary parts of the phosphoproteome in a\r\n",
      "RT   refined SCX-based approach.\";\r\n",
      "RL   Anal. Chem. 81:4493-4501(2009).\r\n",
      "RN   [57]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; SER-249; THR-373; SER-807\r\n",
      "RP   AND THR-841, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE\r\n",
      "RP   ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [58]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19608861; DOI=10.1126/science.1175371;\r\n",
      "RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,\r\n",
      "RA   Olsen J.V., Mann M.;\r\n",
      "RT   \"Lysine acetylation targets protein complexes and co-regulates major\r\n",
      "RT   cellular functions.\";\r\n",
      "RL   Science 325:834-840(2009).\r\n",
      "RN   [59]\r\n",
      "RP   METHYLATION AT LYS-860, INTERACTION WITH L3MBTL1, AND MUTAGENESIS OF\r\n",
      "RP   LYS-860; LYS-870 AND 873-LYS-LYS-874.\r\n",
      "RX   PubMed=20870719; DOI=10.1074/jbc.m110.137612;\r\n",
      "RA   Saddic L.A., West L.E., Aslanian A., Yates J.R. III, Rubin S.M., Gozani O.,\r\n",
      "RA   Sage J.;\r\n",
      "RT   \"Methylation of the retinoblastoma tumor suppressor by SMYD2.\";\r\n",
      "RL   J. Biol. Chem. 285:37733-37740(2010).\r\n",
      "RN   [60]\r\n",
      "RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, ACETYLATION AT LYS-873 AND\r\n",
      "RP   LYS-874, AND MUTAGENESIS OF 873-LYS--LYS-874.\r\n",
      "RX   PubMed=20940255; DOI=10.1242/jcs.068924;\r\n",
      "RA   Pickard A., Wong P.P., McCance D.J.;\r\n",
      "RT   \"Acetylation of Rb by PCAF is required for nuclear localization and\r\n",
      "RT   keratinocyte differentiation.\";\r\n",
      "RL   J. Cell Sci. 123:3718-3726(2010).\r\n",
      "RN   [61]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-821 AND THR-826, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;\r\n",
      "RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,\r\n",
      "RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;\r\n",
      "RT   \"Quantitative phosphoproteomics reveals widespread full phosphorylation\r\n",
      "RT   site occupancy during mitosis.\";\r\n",
      "RL   Sci. Signal. 3:RA3-RA3(2010).\r\n",
      "RN   [62]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;\r\n",
      "RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,\r\n",
      "RA   Bennett K.L., Superti-Furga G., Colinge J.;\r\n",
      "RT   \"Initial characterization of the human central proteome.\";\r\n",
      "RL   BMC Syst. Biol. 5:17-17(2011).\r\n",
      "RN   [63]\r\n",
      "RP   INTERACTION WITH UHRF2.\r\n",
      "RX   PubMed=21952639; DOI=10.4161/cc.10.19.17176;\r\n",
      "RA   Mori T., Ikeda D.D., Fukushima T., Takenoshita S., Kochi H.;\r\n",
      "RT   \"NIRF constitutes a nodal point in the cell cycle network and is a\r\n",
      "RT   candidate tumor suppressor.\";\r\n",
      "RL   Cell Cycle 10:3284-3299(2011).\r\n",
      "RN   [64]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;\r\n",
      "RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,\r\n",
      "RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;\r\n",
      "RT   \"System-wide temporal characterization of the proteome and phosphoproteome\r\n",
      "RT   of human embryonic stem cell differentiation.\";\r\n",
      "RL   Sci. Signal. 4:RS3-RS3(2011).\r\n",
      "RN   [65]\r\n",
      "RP   METHYLATION AT LYS-810 BY SMYD2.\r\n",
      "RX   PubMed=22787429; DOI=10.1593/neo.12656;\r\n",
      "RA   Cho H.S., Hayami S., Toyokawa G., Maejima K., Yamane Y., Suzuki T.,\r\n",
      "RA   Dohmae N., Kogure M., Kang D., Neal D.E., Ponder B.A., Yamaue H.,\r\n",
      "RA   Nakamura Y., Hamamoto R.;\r\n",
      "RT   \"RB1 methylation by SMYD2 enhances cell cycle progression through an\r\n",
      "RT   increase of RB1 phosphorylation.\";\r\n",
      "RL   Neoplasia 14:476-486(2012).\r\n",
      "RN   [66]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249; THR-252; THR-356;\r\n",
      "RP   THR-373; SER-624; SER-780; SER-788; SER-795; SER-807; SER-811; THR-821;\r\n",
      "RP   THR-823; THR-826 AND SER-855, AND IDENTIFICATION BY MASS SPECTROMETRY\r\n",
      "RP   [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [67]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;\r\n",
      "RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,\r\n",
      "RA   Ye M., Zou H.;\r\n",
      "RT   \"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteomics 96:253-262(2014).\r\n",
      "RN   [68]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 378-562.\r\n",
      "RX   PubMed=9145110; DOI=10.1038/nsb0597-390;\r\n",
      "RA   Kim H.Y., Cho Y.;\r\n",
      "RT   \"Structural similarity between the pocket region of retinoblastoma tumour\r\n",
      "RT   suppressor and the cyclin-box.\";\r\n",
      "RL   Nat. Struct. Biol. 4:390-395(1997).\r\n",
      "RN   [69]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 380-785.\r\n",
      "RX   PubMed=9495340; DOI=10.1038/36038;\r\n",
      "RA   Lee J.O., Russo A.A., Pavletich N.P.;\r\n",
      "RT   \"Structure of the retinoblastoma tumour-suppressor pocket domain bound to a\r\n",
      "RT   peptide from HPV E7.\";\r\n",
      "RL   Nature 391:859-865(1998).\r\n",
      "RN   [70]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 860-876 IN COMPLEX WITH KPNA2.\r\n",
      "RX   PubMed=12695505; DOI=10.1074/jbc.m303275200;\r\n",
      "RA   Fontes M.R.M., Teh T., Jans D., Brinkworth R.I., Kobe B.;\r\n",
      "RT   \"Structural basis for the specificity of bipartite nuclear localization\r\n",
      "RT   sequence binding by importin-alpha.\";\r\n",
      "RL   J. Biol. Chem. 278:27981-27987(2003).\r\n",
      "RN   [71]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 829-874 IN COMPLEX WITH E2F1 AND\r\n",
      "RP   TFDP1, INTERACTION WITH HETERODIMERIC COMPLEXES CONTAINING TFDP1 AND EITHER\r\n",
      "RP   E2F1; E2F3; E2F4 OR E2F5, MUTAGENESIS OF THR-821 AND THR-826, AND\r\n",
      "RP   PHOSPHORYLATION AT THR-821 AND THR-826.\r\n",
      "RX   PubMed=16360038; DOI=10.1016/j.cell.2005.09.044;\r\n",
      "RA   Rubin S.M., Gall A.-L., Zheng N., Pavletich N.P.;\r\n",
      "RT   \"Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for\r\n",
      "RT   phosphorylation-induced E2F release.\";\r\n",
      "RL   Cell 123:1093-1106(2005).\r\n",
      "RN   [72]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (1.67 ANGSTROMS) OF 380-787 IN COMPLEX WITH HUMAN\r\n",
      "RP   ADENOVIRUS E1A PROTEIN (MICROBIAL INFECTION).\r\n",
      "RX   PubMed=17974914; DOI=10.1101/gad.1590607;\r\n",
      "RA   Liu X., Marmorstein R.;\r\n",
      "RT   \"Structure of the retinoblastoma protein bound to adenovirus E1A reveals\r\n",
      "RT   the molecular basis for viral oncoprotein inactivation of a tumor\r\n",
      "RT   suppressor.\";\r\n",
      "RL   Genes Dev. 21:2711-2716(2007).\r\n",
      "RN   [73]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 52-355, PARTIAL PROTEIN SEQUENCE,\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH THOC1 AND GRIP1, AND\r\n",
      "RP   INTERACTION OF THE UNPHOSPHORYLATED PROTEIN WITH EID1.\r\n",
      "RX   PubMed=17996702; DOI=10.1016/j.molcel.2007.08.023;\r\n",
      "RA   Hassler M., Singh S., Yue W.W., Luczynski M., Lakbir R.,\r\n",
      "RA   Sanchez-Sanchez F., Bader T., Pearl L.H., Mittnacht S.;\r\n",
      "RT   \"Crystal structure of the retinoblastoma protein N domain provides insight\r\n",
      "RT   into tumor suppression, ligand interaction, and holoprotein architecture.\";\r\n",
      "RL   Mol. Cell 28:371-385(2007).\r\n",
      "RN   [74]\r\n",
      "RP   VARIANT RB LEU-567.\r\n",
      "RX   PubMed=2594029; DOI=10.1056/nejm198912213212501;\r\n",
      "RA   Yandell D.W., Campbell T.A., Dayton S.H., Petersen R., Walton D.,\r\n",
      "RA   Little J.B., McConkie-Rosell A., Buckley E., Dryja T.P.;\r\n",
      "RT   \"Oncogenic point mutations in the human retinoblastoma gene: their\r\n",
      "RT   application to genetic counseling.\";\r\n",
      "RL   N. Engl. J. Med. 321:1689-1695(1989).\r\n",
      "RN   [75]\r\n",
      "RP   VARIANT RB TRP-661.\r\n",
      "RX   PubMed=1352883; DOI=10.1073/pnas.89.13.6177;\r\n",
      "RA   Onadim Z., Hogg A., Baird P.N., Cowell J.K.;\r\n",
      "RT   \"Oncogenic point mutations in exon 20 of the RB1 gene in families showing\r\n",
      "RT   incomplete penetrance and mild expression of the retinoblastoma\r\n",
      "RT   phenotype.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 89:6177-6181(1992).\r\n",
      "RN   [76]\r\n",
      "RP   VARIANT RB ARG-457.\r\n",
      "RX   PubMed=8346255; DOI=10.1073/pnas.90.15.7351;\r\n",
      "RA   Hogg A., Bia B., Onadim Z., Cowell J.K.;\r\n",
      "RT   \"Molecular mechanisms of oncogenic mutations in tumors from patients with\r\n",
      "RT   bilateral and unilateral retinoblastoma.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 90:7351-7355(1993).\r\n",
      "RN   [77]\r\n",
      "RP   VARIANT RB ARG-530.\r\n",
      "RX   PubMed=7704558; DOI=10.1159/000472372;\r\n",
      "RA   Cowell J.K., Smith T., Bia B.;\r\n",
      "RT   \"Frequent constitutional C to T mutations in CGA-arginine codons in the RB1\r\n",
      "RT   gene produce premature stop codons in patients with bilateral (hereditary)\r\n",
      "RT   retinoblastoma.\";\r\n",
      "RL   Eur. J. Hum. Genet. 2:281-290(1994).\r\n",
      "RN   [78]\r\n",
      "RP   VARIANTS RB ASN-480 DEL AND TRP-661.\r\n",
      "RX   PubMed=7927327; DOI=10.1007/bf00201591;\r\n",
      "RA   Lohmann D.R., Brandt B., Hoepping W., Passarge E., Horsthemke B.;\r\n",
      "RT   \"Distinct RB1 gene mutations with low penetrance in hereditary\r\n",
      "RT   retinoblastoma.\";\r\n",
      "RL   Hum. Genet. 94:349-354(1994).\r\n",
      "RN   [79]\r\n",
      "RP   VARIANTS RB GLN-72; TYR-549 AND LYS-803.\r\n",
      "RX   PubMed=8605116; DOI=10.1002/gcc.2870140406;\r\n",
      "RA   Liu Z., Song Y., Bia B., Cowell J.K.;\r\n",
      "RT   \"Germline mutations in the RB1 gene in patients with hereditary\r\n",
      "RT   retinoblastoma.\";\r\n",
      "RL   Genes Chromosomes Cancer 14:277-284(1995).\r\n",
      "RN   [80]\r\n",
      "RP   VARIANTS RB THR-185; PRO-635; GLU-654 AND PRO-685.\r\n",
      "RX   PubMed=7795591; DOI=10.1093/hmg/4.3.383;\r\n",
      "RA   Blanquet V., Turleau C., Gross-Morand M.S., Senamaud-Beaufort C., Doz F.,\r\n",
      "RA   Besmond C.;\r\n",
      "RT   \"Spectrum of germline mutations in the RB1 gene: a study of 232 patients\r\n",
      "RT   with hereditary and non hereditary retinoblastoma.\";\r\n",
      "RL   Hum. Mol. Genet. 4:383-388(1995).\r\n",
      "RN   [81]\r\n",
      "RP   VARIANTS RB GLY-358; PRO-657 AND TRP-661.\r\n",
      "RX   PubMed=8776589; DOI=10.1093/hmg/5.6.755;\r\n",
      "RA   Van Orsouw N.J., Li D., van der Vlies P., Scheffer H., Eng C.,\r\n",
      "RA   Buys C.H.C.M., Li F.P., Vijg J.;\r\n",
      "RT   \"Mutational scanning of large genes by extensive PCR multiplexing and two-\r\n",
      "RT   dimensional electrophoresis: application to the RB1 gene.\";\r\n",
      "RL   Hum. Mol. Genet. 5:755-761(1996).\r\n",
      "RN   [82]\r\n",
      "RP   VARIANTS RB ASP-137 AND TRP-661.\r\n",
      "RX   PubMed=9311732; DOI=10.1086/514845;\r\n",
      "RA   Lohmann D.R., Gerick M., Brandt B., Oelschlaeger U., Lorenz B.,\r\n",
      "RA   Passarge E., Horsthemke B.;\r\n",
      "RT   \"Constitutional RB1-gene mutations in patients with isolated unilateral\r\n",
      "RT   retinoblastoma.\";\r\n",
      "RL   Am. J. Hum. Genet. 61:282-294(1997).\r\n",
      "RN   [83]\r\n",
      "RP   VARIANT RB GLN-447.\r\n",
      "RX   PubMed=9140452; DOI=10.1016/s0165-4608(96)00387-1;\r\n",
      "RA   Mateu E., Sanchez F., Najera C., Beneyto M., Castell V., Hernandez M.,\r\n",
      "RA   Serra I., Prieto F.;\r\n",
      "RT   \"Genetics of retinoblastoma: a study.\";\r\n",
      "RL   Cancer Genet. Cytogenet. 95:40-50(1997).\r\n",
      "RN   [84]\r\n",
      "RP   VARIANTS RB LEU-567; PRO-662 AND ARG-712.\r\n",
      "RX   PubMed=10671068;\r\n",
      "RA   Yilmaz S., Horsthemke B., Lohmann D.R.;\r\n",
      "RT   \"Twelve novel RB1 gene mutations in patients with hereditary\r\n",
      "RT   retinoblastoma.\";\r\n",
      "RL   Hum. Mutat. 12:434-434(1998).\r\n",
      "RN   [85]\r\n",
      "RP   VARIANT RB GLU-310.\r\n",
      "RX   PubMed=9973307; DOI=10.1086/302254;\r\n",
      "RA   Klutz M., Horsthemke B., Lohmann D.R.;\r\n",
      "RT   \"RB1 gene mutations in peripheral blood DNA of patients with isolated\r\n",
      "RT   unilateral retinoblastoma.\";\r\n",
      "RL   Am. J. Hum. Genet. 64:667-668(1999).\r\n",
      "RN   [86]\r\n",
      "RP   VARIANTS RB GLY-500 AND GLU-616.\r\n",
      "RX   PubMed=11524739; DOI=10.1002/humu.1184;\r\n",
      "RA   Yu Y.S., Kim I.-J., Ku J.-L., Park J.-G.;\r\n",
      "RT   \"Identification of four novel RB1 germline mutations in Korean\r\n",
      "RT   retinoblastoma patients.\";\r\n",
      "RL   Hum. Mutat. 18:252-252(2001).\r\n",
      "RN   [87]\r\n",
      "RP   VARIANT HIS-173.\r\n",
      "RX   PubMed=23033978; DOI=10.1056/nejmoa1206524;\r\n",
      "RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,\r\n",
      "RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P., Gilissen C.,\r\n",
      "RA   del Rosario M., Hoischen A., Scheffer H., de Vries B.B., Brunner H.G.,\r\n",
      "RA   Veltman J.A., Vissers L.E.;\r\n",
      "RT   \"Diagnostic exome sequencing in persons with severe intellectual\r\n",
      "RT   disability.\";\r\n",
      "RL   N. Engl. J. Med. 367:1921-1929(2012).\r\n",
      "CC   -!- FUNCTION: Tumor suppressor that is a key regulator of the G1/S\r\n",
      "CC       transition of the cell cycle (PubMed:10499802). The hypophosphorylated\r\n",
      "CC       form binds transcription regulators of the E2F family, preventing\r\n",
      "CC       transcription of E2F-responsive genes (PubMed:10499802). Both\r\n",
      "CC       physically blocks E2Fs transactivating domain and recruits chromatin-\r\n",
      "CC       modifying enzymes that actively repress transcription\r\n",
      "CC       (PubMed:10499802). Cyclin and CDK-dependent phosphorylation of RB1\r\n",
      "CC       induces its dissociation from E2Fs, thereby activating transcription of\r\n",
      "CC       E2F responsive genes and triggering entry into S phase\r\n",
      "CC       (PubMed:10499802). RB1 also promotes the G0-G1 transition upon\r\n",
      "CC       phosphorylation and activation by CDK3/cyclin-C (PubMed:15084261).\r\n",
      "CC       Directly involved in heterochromatin formation by maintaining overall\r\n",
      "CC       chromatin structure and, in particular, that of constitutive\r\n",
      "CC       heterochromatin by stabilizing histone methylation. Recruits and\r\n",
      "CC       targets histone methyltransferases SUV39H1, KMT5B and KMT5C, leading to\r\n",
      "CC       epigenetic transcriptional repression. Controls histone H4 'Lys-20'\r\n",
      "CC       trimethylation. Inhibits the intrinsic kinase activity of TAF1.\r\n",
      "CC       Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a\r\n",
      "CC       histone deacetylase (HDAC) complex to the c-FOS promoter. In resting\r\n",
      "CC       neurons, transcription of the c-FOS promoter is inhibited by BRG1-\r\n",
      "CC       dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon\r\n",
      "CC       calcium influx, RB1 is dephosphorylated by calcineurin, which leads to\r\n",
      "CC       release of the repressor complex (By similarity).\r\n",
      "CC       {ECO:0000250|UniProtKB:P13405, ECO:0000250|UniProtKB:P33568,\r\n",
      "CC       ECO:0000269|PubMed:10499802, ECO:0000269|PubMed:15084261}.\r\n",
      "CC   -!- FUNCTION: (Microbial infection) In case of viral infections,\r\n",
      "CC       interactions with SV40 large T antigen, HPV E7 protein or adenovirus\r\n",
      "CC       E1A protein induce the disassembly of RB1-E2F1 complex thereby\r\n",
      "CC       disrupting RB1's activity. {ECO:0000269|PubMed:1316611,\r\n",
      "CC       ECO:0000269|PubMed:17974914, ECO:0000269|PubMed:18701596,\r\n",
      "CC       ECO:0000269|PubMed:2839300, ECO:0000269|PubMed:8892909}.\r\n",
      "CC   -!- SUBUNIT: Interacts with ATAD5. Interacts with PRMT2, CDK1 and CDK2 (By\r\n",
      "CC       similarity). The hypophosphorylated form interacts with and sequesters\r\n",
      "CC       the E2F1 transcription factor (PubMed:8336704, PubMed:20940255).\r\n",
      "CC       Interacts with heterodimeric E2F/DP transcription factor complexes\r\n",
      "CC       containing TFDP1 and either E2F1, E2F3, E2F4 or E2F5, or TFDP2 and\r\n",
      "CC       E2F4. The unphosphorylated form interacts with EID1, ARID3B, KDM5A,\r\n",
      "CC       SUV39H1, MJD2A/JHDM3A and THOC1. Interacts with the N-terminal domain\r\n",
      "CC       of TAF1. Interacts with SNW1, AATF, DNMT1, LIN9, LMNA, KMT5B, KMT5C,\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CC       PELP1, UHRF2 and TMPO-alpha. May interact with NDC80. Interacts with\r\n",
      "CC       GRIP1 and UBR4. Interacts with ARID4A and KDM5B. Interacts with E4F1\r\n",
      "CC       and LIMD1. Interacts with SMARCA4/BRG1 and HDAC1 (By similarity).\r\n",
      "CC       Interacts with PSMA3 and USP4. Interacts (when methylated at Lys-860)\r\n",
      "CC       with L3MBTL1. Interacts with CHEK2; phosphorylates RB1. Interacts with\r\n",
      "CC       CEBPA (PubMed:15107404). P-TEFB complex interacts with RB1; promotes\r\n",
      "CC       phosphorylation of RB1 (PubMed:12037672). Interacts with RBBP9; the\r\n",
      "CC       interaction disrupts RB1 binding to E2F1 (By similarity). Interacts\r\n",
      "CC       with KAT2B/PCAF and EP300/P300 (By similarity). Interacts with PAX5\r\n",
      "CC       (PubMed:10197586). {ECO:0000250|UniProtKB:P13405,\r\n",
      "CC       ECO:0000250|UniProtKB:P33568, ECO:0000269|PubMed:10197586,\r\n",
      "CC       ECO:0000269|PubMed:10409732, ECO:0000269|PubMed:10446990,\r\n",
      "CC       ECO:0000269|PubMed:10779342, ECO:0000269|PubMed:10869426,\r\n",
      "CC       ECO:0000269|PubMed:10888886, ECO:0000269|PubMed:11223246,\r\n",
      "CC       ECO:0000269|PubMed:11484059, ECO:0000269|PubMed:11571652,\r\n",
      "CC       ECO:0000269|PubMed:12037672, ECO:0000269|PubMed:12450794,\r\n",
      "CC       ECO:0000269|PubMed:12466551, ECO:0000269|PubMed:12475961,\r\n",
      "CC       ECO:0000269|PubMed:12682072, ECO:0000269|PubMed:12695505,\r\n",
      "CC       ECO:0000269|PubMed:15107404, ECO:0000269|PubMed:15538385,\r\n",
      "CC       ECO:0000269|PubMed:15542589, ECO:0000269|PubMed:15803180,\r\n",
      "CC       ECO:0000269|PubMed:15927959, ECO:0000269|PubMed:15949438,\r\n",
      "CC       ECO:0000269|PubMed:16214886, ECO:0000269|PubMed:16337594,\r\n",
      "CC       ECO:0000269|PubMed:16360038, ECO:0000269|PubMed:16645588,\r\n",
      "CC       ECO:0000269|PubMed:17380128, ECO:0000269|PubMed:17996702,\r\n",
      "CC       ECO:0000269|PubMed:20870719, ECO:0000269|PubMed:20940255,\r\n",
      "CC       ECO:0000269|PubMed:21952639, ECO:0000269|PubMed:7525595,\r\n",
      "CC       ECO:0000269|PubMed:7935440, ECO:0000269|PubMed:8336704,\r\n",
      "CC       ECO:0000269|PubMed:8414517, ECO:0000269|PubMed:9858607}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with adenovirus E1A protein.\r\n",
      "CC       {ECO:0000269|PubMed:17974914}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with HPV E7 protein.\r\n",
      "CC       {ECO:0000269|PubMed:1316611}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with SV40 large T antigen.\r\n",
      "CC       {ECO:0000269|PubMed:1316611, ECO:0000269|PubMed:2839300}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with human\r\n",
      "CC       cytomegalovirus/HHV-5 proteins UL82 and UL123.\r\n",
      "CC       {ECO:0000269|PubMed:12626766, ECO:0000269|PubMed:8892909}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with molluscum contagiosum\r\n",
      "CC       virus protein MC007. {ECO:0000269|PubMed:18701596}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       P06400; Q9UKV8: AGO2; NbExp=3; IntAct=EBI-491274, EBI-528269;\r\n",
      "CC       P06400; P24863: CCNC; NbExp=4; IntAct=EBI-491274, EBI-395261;\r\n",
      "CC       P06400; P24941: CDK2; NbExp=3; IntAct=EBI-491274, EBI-375096;\r\n",
      "CC       P06400; O14757: CHEK1; NbExp=3; IntAct=EBI-491274, EBI-974488;\r\n",
      "CC       P06400; O96017: CHEK2; NbExp=3; IntAct=EBI-491274, EBI-1180783;\r\n",
      "CC       P06400; Q13574-2: DGKZ; NbExp=6; IntAct=EBI-491274, EBI-715527;\r\n",
      "CC       P06400; Q13627: DYRK1A; NbExp=4; IntAct=EBI-491274, EBI-1053596;\r\n",
      "CC       P06400; Q9Y463: DYRK1B; NbExp=4; IntAct=EBI-491274, EBI-634187;\r\n",
      "CC       P06400; Q01094: E2F1; NbExp=26; IntAct=EBI-491274, EBI-448924;\r\n",
      "CC       P06400; Q14209: E2F2; NbExp=5; IntAct=EBI-491274, EBI-718476;\r\n",
      "CC       P06400; O00716: E2F3; NbExp=5; IntAct=EBI-491274, EBI-765551;\r\n",
      "CC       P06400; Q15329: E2F5; NbExp=2; IntAct=EBI-491274, EBI-1389773;\r\n",
      "CC       P06400; O43524: FOXO3; NbExp=2; IntAct=EBI-491274, EBI-1644164;\r\n",
      "CC       P06400; P42685: FRK; NbExp=3; IntAct=EBI-491274, EBI-1383583;\r\n",
      "CC       P06400; P15976: GATA1; NbExp=2; IntAct=EBI-491274, EBI-3909284;\r\n",
      "CC       P06400; P62993: GRB2; NbExp=4; IntAct=EBI-491274, EBI-401755;\r\n",
      "CC       P06400; O60381: HBP1; NbExp=2; IntAct=EBI-491274, EBI-954175;\r\n",
      "CC       P06400; Q13547: HDAC1; NbExp=16; IntAct=EBI-491274, EBI-301834;\r\n",
      "CC       P06400; Q14653: IRF3; NbExp=2; IntAct=EBI-491274, EBI-2650369;\r\n",
      "CC       P06400; P29375: KDM5A; NbExp=2; IntAct=EBI-491274, EBI-1560836;\r\n",
      "CC       P06400; Q16539: MAPK14; NbExp=4; IntAct=EBI-491274, EBI-73946;\r\n",
      "CC       P06400; Q00987: MDM2; NbExp=5; IntAct=EBI-491274, EBI-389668;\r\n",
      "CC       P06400; O15151: MDM4; NbExp=4; IntAct=EBI-491274, EBI-398437;\r\n",
      "CC       P06400; Q9Y676: MRPS18B; NbExp=2; IntAct=EBI-491274, EBI-750085;\r\n",
      "CC       P06400; Q14686: NCOA6; NbExp=3; IntAct=EBI-491274, EBI-78670;\r\n",
      "CC       P06400; P07197: NEFM; NbExp=2; IntAct=EBI-491274, EBI-1105035;\r\n",
      "CC       P06400; Q9UQ80: PA2G4; NbExp=4; IntAct=EBI-491274, EBI-924893;\r\n",
      "CC       P06400; P62136: PPP1CA; NbExp=2; IntAct=EBI-491274, EBI-357253;\r\n",
      "CC       P06400; P55345: PRMT2; NbExp=3; IntAct=EBI-491274, EBI-78458;\r\n",
      "CC       P06400; Q00577: PURA; NbExp=6; IntAct=EBI-491274, EBI-1045860;\r\n",
      "CC       P06400; P04049: RAF1; NbExp=3; IntAct=EBI-491274, EBI-365996;\r\n",
      "CC       P06400; P06400: RB1; NbExp=3; IntAct=EBI-491274, EBI-491274;\r\n",
      "CC       P06400; Q99708: RBBP8; NbExp=2; IntAct=EBI-491274, EBI-745715;\r\n",
      "CC       P06400; O75150: RNF40; NbExp=3; IntAct=EBI-491274, EBI-744408;\r\n",
      "CC       P06400; Q8WTS6: SETD7; NbExp=4; IntAct=EBI-491274, EBI-1268586;\r\n",
      "CC       P06400; Q96PU4: UHRF2; NbExp=4; IntAct=EBI-491274, EBI-625304;\r\n",
      "CC       P06400; Q93009: USP7; NbExp=8; IntAct=EBI-491274, EBI-302474;\r\n",
      "CC       P06400; P30285: Cdk4; Xeno; NbExp=2; IntAct=EBI-491274, EBI-847225;\r\n",
      "CC       P06400; Q155P7: Cenpf; Xeno; NbExp=4; IntAct=EBI-491274, EBI-2211248;\r\n",
      "CC       P06400; A0MPS7: E7; Xeno; NbExp=2; IntAct=EBI-491274, EBI-7014709;\r\n",
      "CC       P06400; P03129: E7; Xeno; NbExp=23; IntAct=EBI-491274, EBI-866453;\r\n",
      "CC       P06400; P04020: E7; Xeno; NbExp=3; IntAct=EBI-491274, EBI-7005254;\r\n",
      "CC       P06400; P06464: E7; Xeno; NbExp=3; IntAct=EBI-491274, EBI-6944797;\r\n",
      "CC       P06400; P06465: E7; Xeno; NbExp=3; IntAct=EBI-491274, EBI-963841;\r\n",
      "CC       P06400; P06788: E7; Xeno; NbExp=4; IntAct=EBI-491274, EBI-1776887;\r\n",
      "CC       P06400; P52927: Hmga2; Xeno; NbExp=5; IntAct=EBI-491274, EBI-912574;\r\n",
      "CC       P06400; Q9R002: Ifi202; Xeno; NbExp=5; IntAct=EBI-491274, EBI-3043899;\r\n",
      "CC       P06400; Q8VSP9: ospF; Xeno; NbExp=2; IntAct=EBI-491274, EBI-6506625;\r\n",
      "CC       P06400; Q9Z2X2: Psmd10; Xeno; NbExp=3; IntAct=EBI-491274, EBI-8377084;\r\n",
      "CC       P06400; PRO_0000037321 [P0C6X7]: rep; Xeno; NbExp=3; IntAct=EBI-491274, EBI-25487301;\r\n",
      "CC       P06400; Q923E4: Sirt1; Xeno; NbExp=4; IntAct=EBI-491274, EBI-1802585;\r\n",
      "CC       P06400; Q3TKT4: Smarca4; Xeno; NbExp=4; IntAct=EBI-491274, EBI-1210244;\r\n",
      "CC       P06400; P03070; Xeno; NbExp=6; IntAct=EBI-491274, EBI-617698;\r\n",
      "CC       P06400; P03254; Xeno; NbExp=3; IntAct=EBI-491274, EBI-8599077;\r\n",
      "CC       P06400; P03255; Xeno; NbExp=10; IntAct=EBI-491274, EBI-2603114;\r\n",
      "CC       P06400; P03255-1; Xeno; NbExp=2; IntAct=EBI-491274, EBI-6692439;\r\n",
      "CC       P06400; P03255-2; Xeno; NbExp=3; IntAct=EBI-491274, EBI-6859460;\r\n",
      "CC       P06400; PRO_0000041225 [Q86500]; Xeno; NbExp=3; IntAct=EBI-491274, EBI-2568719;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20940255}.\r\n",
      "CC       Note=During keratinocyte differentiation, acetylation by KAT2B/PCAF is\r\n",
      "CC       required for nuclear localization. {ECO:0000269|PubMed:20940255}.\r\n",
      "CC   -!- TISSUE SPECIFICITY: Expressed in the retina. Expressed in foreskin\r\n",
      "CC       keratinocytes (at protein level) (PubMed:20940255).\r\n",
      "CC       {ECO:0000269|PubMed:20940255}.\r\n",
      "CC   -!- DOMAIN: The Pocket domain binds to the threonine-phosphorylated domain\r\n",
      "CC       C, thereby preventing interaction with heterodimeric E2F/DP\r\n",
      "CC       transcription factor complexes.\r\n",
      "CC   -!- PTM: Phosphorylated by CDK6 and CDK4, and subsequently by CDK2 at Ser-\r\n",
      "CC       567 in G1, thereby releasing E2F1 which is then able to activate cell\r\n",
      "CC       growth. Dephosphorylated at the late M phase. SV40 large T antigen, HPV\r\n",
      "CC       E7 and adenovirus E1A bind to the underphosphorylated, active form of\r\n",
      "CC       pRb. Phosphorylation at Thr-821 and Thr-826 promotes interaction\r\n",
      "CC       between the C-terminal domain C and the Pocket domain, and thereby\r\n",
      "CC       inhibits interactions with heterodimeric E2F/DP transcription factor\r\n",
      "CC       complexes. Dephosphorylated at Ser-795 by calcineruin upon calcium\r\n",
      "CC       stimulation. CDK3/cyclin-C-mediated phosphorylation at Ser-807 and Ser-\r\n",
      "CC       811 is required for G0-G1 transition. Phosphorylated by CDK1 and CDK2\r\n",
      "CC       upon TGFB1-mediated apoptosis. {ECO:0000269|PubMed:10499802,\r\n",
      "CC       ECO:0000269|PubMed:8114739}.\r\n",
      "CC   -!- PTM: N-terminus is methylated by METTL11A/NTM1 (By similarity).\r\n",
      "CC       Monomethylation at Lys-810 by SMYD2 enhances phosphorylation at Ser-807\r\n",
      "CC       and Ser-811, and promotes cell cycle progression. Monomethylation at\r\n",
      "CC       Lys-860 by SMYD2 promotes interaction with L3MBTL1. {ECO:0000250,\r\n",
      "CC       ECO:0000269|PubMed:15084261, ECO:0000269|PubMed:15809340,\r\n",
      "CC       ECO:0000269|PubMed:16360038, ECO:0000269|PubMed:17380128,\r\n",
      "CC       ECO:0000269|PubMed:1756735, ECO:0000269|PubMed:20870719,\r\n",
      "CC       ECO:0000269|PubMed:22787429}.\r\n",
      "CC   -!- PTM: Acetylated during keratinocyte differentiation. Acetylation at\r\n",
      "CC       Lys-873 and Lys-874 regulates subcellular localization. Can be\r\n",
      "CC       deacetylated by SIRT1. {ECO:0000269|PubMed:20940255}.\r\n",
      "CC   -!- DISEASE: Childhood cancer retinoblastoma (RB) [MIM:180200]: Congenital\r\n",
      "CC       malignant tumor that arises from the nuclear layers of the retina. It\r\n",
      "CC       occurs in about 1:20'000 live births and represents about 2% of\r\n",
      "CC       childhood malignancies. It is bilateral in about 30% of cases. Although\r\n",
      "CC       most RB appear sporadically, about 20% are transmitted as an autosomal\r\n",
      "CC       dominant trait with incomplete penetrance. The diagnosis is usually\r\n",
      "CC       made before the age of 2 years when strabismus or a gray to yellow\r\n",
      "CC       reflex from pupil ('cat eye') is investigated.\r\n",
      "CC       {ECO:0000269|PubMed:10671068, ECO:0000269|PubMed:11524739,\r\n",
      "CC       ECO:0000269|PubMed:1352883, ECO:0000269|PubMed:2594029,\r\n",
      "CC       ECO:0000269|PubMed:7704558, ECO:0000269|PubMed:7795591,\r\n",
      "CC       ECO:0000269|PubMed:7927327, ECO:0000269|PubMed:8346255,\r\n",
      "CC       ECO:0000269|PubMed:8605116, ECO:0000269|PubMed:8776589,\r\n",
      "CC       ECO:0000269|PubMed:9140452, ECO:0000269|PubMed:9311732,\r\n",
      "CC       ECO:0000269|PubMed:9973307}. Note=The disease is caused by variants\r\n",
      "CC       affecting the gene represented in this entry.\r\n",
      "CC   -!- DISEASE: Bladder cancer (BLC) [MIM:109800]: A malignancy originating in\r\n",
      "CC       tissues of the urinary bladder. It often presents with multiple tumors\r\n",
      "CC       appearing at different times and at different sites in the bladder.\r\n",
      "CC       Most bladder cancers are transitional cell carcinomas that begin in\r\n",
      "CC       cells that normally make up the inner lining of the bladder. Other\r\n",
      "CC       types of bladder cancer include squamous cell carcinoma (cancer that\r\n",
      "CC       begins in thin, flat cells) and adenocarcinoma (cancer that begins in\r\n",
      "CC       cells that make and release mucus and other fluids). Bladder cancer is\r\n",
      "CC       a complex disorder with both genetic and environmental influences.\r\n",
      "CC       Note=Disease susceptibility is associated with variants affecting the\r\n",
      "CC       gene represented in this entry.\r\n",
      "CC   -!- DISEASE: Osteogenic sarcoma (OSRC) [MIM:259500]: A sarcoma originating\r\n",
      "CC       in bone-forming cells, affecting the ends of long bones. Note=The\r\n",
      "CC       disease is caused by variants affecting the gene represented in this\r\n",
      "CC       entry.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   -!- WEB RESOURCE: Name=RB1base; Note=RB1 mutation db;\r\n",
      "CC       URL=\"http://rb1-lsdb.d-lohmann.de/\";\r\n",
      "CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and\r\n",
      "CC       Haematology;\r\n",
      "CC       URL=\"https://atlasgeneticsoncology.org/gene/90/RB1\";\r\n",
      "CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;\r\n",
      "CC       URL=\"http://egp.gs.washington.edu/data/rb1/\";\r\n",
      "CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Retinoblastoma protein entry;\r\n",
      "CC       URL=\"https://en.wikipedia.org/wiki/Retinoblastoma_protein\";\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; M15400; AAA69807.1; ALT_SEQ; mRNA.\r\n",
      "DR   EMBL; M28419; AAA69808.1; -; mRNA.\r\n",
      "DR   EMBL; M33647; AAA69806.1; -; mRNA.\r\n",
      "DR   EMBL; L41870; AAB59465.1; -; mRNA.\r\n",
      "DR   EMBL; M27866; AAA53484.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; M27845; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27846; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27847; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27849; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27850; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27851; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; L35146; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27852; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27853; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27854; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27855; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27856; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27857; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27858; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27859; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27860; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; L35147; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27862; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27863; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27864; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27865; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; L41889; AAB59467.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41890; AAA65735.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41891; AAA65736.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41893; AAA65737.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41894; AAA65738.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41895; AAA65739.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41896; AAA65740.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41897; AAA65741.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41898; AAB59471.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41899; AAB59473.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41997; AAB59482.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; X16439; CAA34462.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; AF551763; AAN64133.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; AK291258; BAF83947.1; -; mRNA.\r\n",
      "DR   EMBL; AL136960; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AL392048; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; CH471075; EAX08793.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; BC039060; AAH39060.1; -; mRNA.\r\n",
      "DR   EMBL; BC040540; AAH40540.1; -; mRNA.\r\n",
      "DR   EMBL; L11910; AAA53483.1; -; Genomic_DNA.\r\n",
      "DR   CCDS; CCDS31973.1; -.\r\n",
      "DR   PIR; JS0276; RBHU.\r\n",
      "DR   RefSeq; NP_000312.2; NM_000321.2.\r\n",
      "DR   PDB; 1AD6; X-ray; 2.30 A; A=378-562.\r\n",
      "DR   PDB; 1GH6; X-ray; 3.20 A; B=379-577, B=645-772.\r\n",
      "DR   PDB; 1GUX; X-ray; 1.85 A; A=372-589, B=636-787.\r\n",
      "DR   PDB; 1H25; X-ray; 2.50 A; E=868-878.\r\n",
      "DR   PDB; 1N4M; X-ray; 2.20 A; A/B=380-785.\r\n",
      "DR   PDB; 1O9K; X-ray; 2.60 A; A/C/E/G=372-589, B/D/F/H=636-787.\r\n",
      "DR   PDB; 1PJM; X-ray; 2.50 A; A=858-881.\r\n",
      "DR   PDB; 2AZE; X-ray; 2.55 A; C=829-874.\r\n",
      "DR   PDB; 2QDJ; X-ray; 2.00 A; A=52-355.\r\n",
      "DR   PDB; 2R7G; X-ray; 1.67 A; A/C=380-787.\r\n",
      "DR   PDB; 3N5U; X-ray; 3.20 A; C=870-882.\r\n",
      "DR   PDB; 3POM; X-ray; 2.50 A; A/B=380-577, A/B=643-783.\r\n",
      "DR   PDB; 4CRI; X-ray; 2.35 A; C/D=802-817.\r\n",
      "DR   PDB; 4ELJ; X-ray; 2.70 A; A=53-787.\r\n",
      "DR   PDB; 4ELL; X-ray; 1.98 A; A/B=380-787.\r\n",
      "DR   PDBsum; 1AD6; -.\r\n",
      "DR   PDBsum; 1GH6; -.\r\n",
      "DR   PDBsum; 1GUX; -.\r\n",
      "DR   PDBsum; 1H25; -.\r\n",
      "DR   PDBsum; 1N4M; -.\r\n",
      "DR   PDBsum; 1O9K; -.\r\n",
      "DR   PDBsum; 1PJM; -.\r\n",
      "DR   PDBsum; 2AZE; -.\r\n",
      "DR   PDBsum; 2QDJ; -.\r\n",
      "DR   PDBsum; 2R7G; -.\r\n",
      "DR   PDBsum; 3N5U; -.\r\n",
      "DR   PDBsum; 3POM; -.\r\n",
      "DR   PDBsum; 4CRI; -.\r\n",
      "DR   PDBsum; 4ELJ; -.\r\n",
      "DR   PDBsum; 4ELL; -.\r\n",
      "DR   AlphaFoldDB; P06400; -.\r\n",
      "DR   SMR; P06400; -.\r\n",
      "DR   BioGRID; 111860; 358.\r\n",
      "DR   ComplexPortal; CPX-155; RB1-E2F1-TFDP1 transcription repressor complex.\r\n",
      "DR   ComplexPortal; CPX-175; RB1-E2F2-TFDP1 transcription repressor complex.\r\n",
      "DR   ComplexPortal; CPX-469; L3MBTL1 complex.\r\n",
      "DR   CORUM; P06400; -.\r\n",
      "DR   DIP; DIP-582N; -.\r\n",
      "DR   IntAct; P06400; 160.\r\n",
      "DR   MINT; P06400; -.\r\n",
      "DR   STRING; 9606.ENSP00000267163; -.\r\n",
      "DR   BindingDB; P06400; -.\r\n",
      "DR   ChEMBL; CHEMBL5288; -.\r\n",
      "DR   GlyGen; P06400; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; P06400; -.\r\n",
      "DR   PhosphoSitePlus; P06400; -.\r\n",
      "DR   BioMuta; RB1; -.\r\n",
      "DR   DMDM; 132164; -.\r\n",
      "DR   CPTAC; CPTAC-1328; -.\r\n",
      "DR   CPTAC; CPTAC-3251; -.\r\n",
      "DR   CPTAC; CPTAC-3288; -.\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DR   CPTAC; CPTAC-898; -.\r\n",
      "DR   CPTAC; CPTAC-941; -.\r\n",
      "DR   CPTAC; CPTAC-942; -.\r\n",
      "DR   EPD; P06400; -.\r\n",
      "DR   jPOST; P06400; -.\r\n",
      "DR   MassIVE; P06400; -.\r\n",
      "DR   MaxQB; P06400; -.\r\n",
      "DR   PaxDb; P06400; -.\r\n",
      "DR   PeptideAtlas; P06400; -.\r\n",
      "DR   ProteomicsDB; 51900; -.\r\n",
      "DR   Antibodypedia; 3758; 3544 antibodies from 52 providers.\r\n",
      "DR   CPTC; P06400; 6 antibodies.\r\n",
      "DR   DNASU; 5925; -.\r\n",
      "DR   Ensembl; ENST00000267163.6; ENSP00000267163.4; ENSG00000139687.16.\r\n",
      "DR   GeneID; 5925; -.\r\n",
      "DR   KEGG; hsa:5925; -.\r\n",
      "DR   MANE-Select; ENST00000267163.6; ENSP00000267163.4; NM_000321.3; NP_000312.2.\r\n",
      "DR   UCSC; uc001vcb.4; human.\r\n",
      "DR   AGR; HGNC:9884; -.\r\n",
      "DR   CTD; 5925; -.\r\n",
      "DR   DisGeNET; 5925; -.\r\n",
      "DR   GeneCards; RB1; -.\r\n",
      "DR   GeneReviews; RB1; -.\r\n",
      "DR   HGNC; HGNC:9884; RB1.\r\n",
      "DR   HPA; ENSG00000139687; Low tissue specificity.\r\n",
      "DR   MalaCards; RB1; -.\r\n",
      "DR   MIM; 109800; phenotype.\r\n",
      "DR   MIM; 180200; phenotype.\r\n",
      "DR   MIM; 259500; phenotype.\r\n",
      "DR   MIM; 614041; gene.\r\n",
      "DR   neXtProt; NX_P06400; -.\r\n",
      "DR   OpenTargets; ENSG00000139687; -.\r\n",
      "DR   Orphanet; 357027; Hereditary retinoblastoma.\r\n",
      "DR   Orphanet; 1587; Monosomy 13q14.\r\n",
      "DR   Orphanet; 357034; Non-hereditary retinoblastoma.\r\n",
      "DR   Orphanet; 668; Osteosarcoma.\r\n",
      "DR   Orphanet; 70573; Small cell lung cancer.\r\n",
      "DR   PharmGKB; PA295; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000139687; -.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00950000183202; -.\r\n",
      "DR   HOGENOM; CLU_015754_0_0_1; -.\r\n",
      "DR   InParanoid; P06400; -.\r\n",
      "DR   OMA; VKDIGCI; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; P06400; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   PathwayCommons; P06400; -.\r\n",
      "DR   Reactome; R-HSA-113501; Inhibition of replication initiation of damaged DNA by RB1/E2F1.\r\n",
      "DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.\r\n",
      "DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.\r\n",
      "DR   Reactome; R-HSA-2559584; Formation of Senescence-Associated Heterochromatin Foci (SAHF).\r\n",
      "DR   Reactome; R-HSA-2559585; Oncogene Induced Senescence.\r\n",
      "DR   Reactome; R-HSA-69200; Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes.\r\n",
      "DR   Reactome; R-HSA-69202; Cyclin E associated events during G1/S transition.\r\n",
      "DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.\r\n",
      "DR   Reactome; R-HSA-69656; Cyclin A:Cdk2-associated events at S phase entry.\r\n",
      "DR   Reactome; R-HSA-8940973; RUNX2 regulates osteoblast differentiation.\r\n",
      "DR   Reactome; R-HSA-9661069; Defective binding of RB1 mutants to E2F1,(E2F2, E2F3).\r\n",
      "DR   Reactome; R-HSA-9661070; Defective translocation of RB1 mutants to the nucleus.\r\n",
      "DR   Reactome; R-HSA-9682706; Replication of the SARS-CoV-1 genome.\r\n",
      "DR   Reactome; R-HSA-9687136; Aberrant regulation of mitotic exit in cancer due to RB1 defects.\r\n",
      "DR   Reactome; R-HSA-9694686; Replication of the SARS-CoV-2 genome.\r\n",
      "DR   SignaLink; P06400; -.\r\n",
      "DR   SIGNOR; P06400; -.\r\n",
      "DR   BioGRID-ORCS; 5925; 32 hits in 1194 CRISPR screens.\r\n",
      "DR   ChiTaRS; RB1; human.\r\n",
      "DR   EvolutionaryTrace; P06400; -.\r\n",
      "DR   GeneWiki; Retinoblastoma_protein; -.\r\n",
      "DR   GenomeRNAi; 5925; -.\r\n",
      "DR   Pharos; P06400; Tchem.\r\n",
      "DR   PRO; PR:P06400; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 13.\r\n",
      "DR   RNAct; P06400; protein.\r\n",
      "DR   Bgee; ENSG00000139687; Expressed in epithelium of nasopharynx and 198 other tissues.\r\n",
      "DR   ExpressionAtlas; P06400; baseline and differential.\r\n",
      "DR   Genevisible; P06400; HS.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0061793; C:chromatin lock complex; IPI:ComplexPortal.\r\n",
      "DR   GO; GO:0005829; C:cytosol; TAS:Reactome.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:CAFA.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; IDA:CAFA.\r\n",
      "DR   GO; GO:0005819; C:spindle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0016514; C:SWI/SNF complex; TAS:BHF-UCL.\r\n",
      "DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.\r\n",
      "DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.\r\n",
      "DR   GO; GO:0061676; F:importin-alpha family protein binding; IPI:CAFA.\r\n",
      "DR   GO; GO:0019900; F:kinase binding; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0060090; F:molecular adaptor activity; EXP:DisProt.\r\n",
      "DR   GO; GO:0051219; F:phosphoprotein binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ARUK-UCL.\r\n",
      "DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0003180; P:aortic valve morphogenesis; ISS:BHF-UCL.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0051301; P:cell division; IEA:Ensembl.\r\n",
      "DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0002062; P:chondrocyte differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006338; P:chromatin remodeling; TAS:BHF-UCL.\r\n",
      "DR   GO; GO:0051276; P:chromosome organization; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0048565; P:digestive tract development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043353; P:enucleate erythrocyte differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050673; P:epithelial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0034349; P:glial cell apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0014009; P:glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031507; P:heterochromatin formation; IDA:ComplexPortal.\r\n",
      "DR   GO; GO:0034088; P:maintenance of mitotic sister chromatid cohesion; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0045445; P:myoblast differentiation; IMP:UniProtKB.\r\n",
      "DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; ISS:ARUK-UCL.\r\n",
      "DR   GO; GO:0045786; P:negative regulation of cell cycle; ISS:ARUK-UCL.\r\n",
      "DR   GO; GO:0030308; P:negative regulation of cell growth; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.\r\n",
      "DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IDA:ComplexPortal.\r\n",
      "DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:MGI.\r\n",
      "DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:1903944; P:negative regulation of hepatocyte apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISS:BHF-UCL.\r\n",
      "DR   GO; GO:1904761; P:negative regulation of myofibroblast differentiation; ISS:BHF-UCL.\r\n",
      "DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0071901; P:negative regulation of protein serine/threonine kinase activity; ISS:ARUK-UCL.\r\n",
      "DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl.\r\n",
      "DR   GO; GO:1902948; P:negative regulation of tau-protein kinase activity; ISS:ARUK-UCL.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; TAS:BHF-UCL.\r\n",
      "DR   GO; GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:BHF-UCL.\r\n",
      "DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0042551; P:neuron maturation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031175; P:neuron projection development; IBA:GO_Central.\r\n",
      "DR   GO; GO:1904028; P:positive regulation of collagen fibril organization; ISS:BHF-UCL.\r\n",
      "DR   GO; GO:1903055; P:positive regulation of extracellular matrix organization; ISS:BHF-UCL.\r\n",
      "DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IDA:MGI.\r\n",
      "DR   GO; GO:0071459; P:protein localization to chromosome, centromeric region; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0007265; P:Ras protein signal transduction; IEP:BHF-UCL.\r\n",
      "DR   GO; GO:0051726; P:regulation of cell cycle; TAS:BHF-UCL.\r\n",
      "DR   GO; GO:0090230; P:regulation of centromere complex assembly; TAS:BHF-UCL.\r\n",
      "DR   GO; GO:0006355; P:regulation of DNA-templated transcription; NAS:UniProtKB.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0007346; P:regulation of mitotic cell cycle; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0031134; P:sister chromatid biorientation; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0001894; P:tissue homeostasis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   CDD; cd20599; CYCLIN_RB; 1.\r\n",
      "DR   DisProt; DP01426; -.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 6.10.140.1380; -; 1.\r\n",
      "DR   Gene3D; 6.10.250.530; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 2.\r\n",
      "DR   IDEAL; IID00017; -.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Acetylation; Cell cycle; Chromatin regulator;\r\n",
      "KW   Direct protein sequencing; Disease variant; DNA-binding;\r\n",
      "KW   Host-virus interaction; Methylation; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Repressor; Transcription; Transcription regulation;\r\n",
      "KW   Tumor suppressor.\r\n",
      "FT   INIT_MET        1\r\n",
      "FT                   /note=\"Removed\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   CHAIN           2..928\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein\"\r\n",
      "FT                   /id=\"PRO_0000167836\"\r\n",
      "FT   REGION          1..42\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          373..771\r\n",
      "FT                   /note=\"Pocket; binds T and E1A\"\r\n",
      "FT   REGION          373..579\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT   REGION          580..639\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT   REGION          610..632\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          640..771\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT   REGION          763..928\r\n",
      "FT                   /note=\"Interaction with LIMD1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:15542589\"\r\n",
      "FT   REGION          771..928\r\n",
      "FT                   /note=\"Domain C; mediates interaction with E4F1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10869426\"\r\n",
      "FT   REGION          860..928\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOTIF           860..876\r\n",
      "FT                   /note=\"Bipartite nuclear localization signal\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   COMPBIAS        18..32\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        613..632\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        871..893\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        899..918\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         2\r\n",
      "FT                   /note=\"N,N-dimethylproline\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   MOD_RES         37\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         249\r\n",
      "FT                   /note=\"Phosphoserine; by CDK1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:1756735,\r\n",
      "FT                   ECO:0007744|PubMed:18220336, ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:21406692,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         252\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:1756735,\r\n",
      "FT                   ECO:0007744|PubMed:18220336, ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         356\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18220336,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         373\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:1756735,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         567\r\n",
      "FT                   /note=\"Phosphoserine; by CDK2\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10499802\"\r\n",
      "FT   MOD_RES         608\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   MOD_RES         612\r\n",
      "FT                   /note=\"Phosphoserine; by CHEK2 and CHEK1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:17380128,\r\n",
      "FT                   ECO:0007744|PubMed:18669648\"\r\n",
      "FT   MOD_RES         624\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         780\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         788\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         795\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         807\r\n",
      "FT                   /note=\"Phosphoserine; by CDK1 and CDK3\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:15084261,\r\n",
      "FT                   ECO:0000269|PubMed:1756735, ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         810\r\n",
      "FT                   /note=\"N6-methyllysine; by SMYD2\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:22787429\"\r\n",
      "FT   MOD_RES         811\r\n",
      "FT                   /note=\"Phosphoserine; by CDK1 and CDK3\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:15084261,\r\n",
      "FT                   ECO:0000269|PubMed:1756735, ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         821\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK6\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:15809340,\r\n",
      "FT                   ECO:0000269|PubMed:16360038, ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         823\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         826\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK4\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:15809340,\r\n",
      "FT                   ECO:0000269|PubMed:16360038, ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         841\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332\"\r\n",
      "FT   MOD_RES         855\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         860\r\n",
      "FT                   /note=\"N6-methyllysine; by SMYD2\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20870719\"\r\n",
      "FT   MOD_RES         873\r\n",
      "FT                   /note=\"N6-acetyllysine; by PCAF\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20940255\"\r\n",
      "FT   MOD_RES         874\r\n",
      "FT                   /note=\"N6-acetyllysine; by PCAF\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20940255\"\r\n",
      "FT   VARIANT         72\r\n",
      "FT                   /note=\"E -> Q (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8605116\"\r\n",
      "FT                   /id=\"VAR_005572\"\r\n",
      "FT   VARIANT         133\r\n",
      "FT                   /note=\"N -> H (in dbSNP:rs3092900)\"\r\n",
      "FT                   /id=\"VAR_051909\"\r\n",
      "FT   VARIANT         137\r\n",
      "FT                   /note=\"E -> D (in RB; unilateral form; dbSNP:rs3092902)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:9311732\"\r\n",
      "FT                   /id=\"VAR_005573\"\r\n",
      "FT   VARIANT         173\r\n",
      "FT                   /note=\"Y -> H\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:23033978\"\r\n",
      "FT                   /id=\"VAR_069376\"\r\n",
      "FT   VARIANT         185\r\n",
      "FT                   /note=\"I -> T (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:7795591\"\r\n",
      "FT                   /id=\"VAR_005574\"\r\n",
      "FT   VARIANT         310\r\n",
      "FT                   /note=\"G -> E (in RB; unknown pathological significance;\r\n",
      "FT                   dbSNP:rs200844292)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:9973307\"\r\n",
      "FT                   /id=\"VAR_010045\"\r\n",
      "FT   VARIANT         358\r\n",
      "FT                   /note=\"R -> G (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8776589\"\r\n",
      "FT                   /id=\"VAR_010046\"\r\n",
      "FT   VARIANT         358\r\n",
      "FT                   /note=\"R -> Q (in RB; dbSNP:rs767011440)\"\r\n",
      "FT                   /id=\"VAR_005575\"\r\n",
      "FT   VARIANT         436\r\n",
      "FT                   /note=\"Q -> K (in dbSNP:rs4151534)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|Ref.7\"\r\n",
      "FT                   /id=\"VAR_019379\"\r\n",
      "FT   VARIANT         447\r\n",
      "FT                   /note=\"K -> Q (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:9140452\"\r\n",
      "FT                   /id=\"VAR_010048\"\r\n",
      "FT   VARIANT         457\r\n",
      "FT                   /note=\"M -> R (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8346255\"\r\n",
      "FT                   /id=\"VAR_005576\"\r\n",
      "FT   VARIANT         480\r\n",
      "FT                   /note=\"Missing (in RB; mild form)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:7927327\"\r\n",
      "FT                   /id=\"VAR_005577\"\r\n",
      "FT   VARIANT         500\r\n",
      "FT                   /note=\"R -> G (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11524739\"\r\n",
      "FT                   /id=\"VAR_011580\"\r\n",
      "FT   VARIANT         525\r\n",
      "FT                   /note=\"A -> G (in dbSNP:rs4151539)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|Ref.7\"\r\n",
      "FT                   /id=\"VAR_019380\"\r\n",
      "FT   VARIANT         530\r\n",
      "FT                   /note=\"K -> R (in RB; dbSNP:rs1948534047)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:7704558\"\r\n",
      "FT                   /id=\"VAR_010049\"\r\n",
      "FT   VARIANT         549\r\n",
      "FT                   /note=\"H -> Y (in RB; dbSNP:rs1050717570)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8605116\"\r\n",
      "FT                   /id=\"VAR_005578\"\r\n",
      "FT   VARIANT         567\r\n",
      "FT                   /note=\"S -> L (in RB; dbSNP:rs137853292)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10671068,\r\n",
      "FT                   ECO:0000269|PubMed:2594029\"\r\n",
      "FT                   /id=\"VAR_005579\"\r\n",
      "FT   VARIANT         569\r\n",
      "FT                   /note=\"L -> F (in dbSNP:rs3092895)\"\r\n",
      "FT                   /id=\"VAR_051910\"\r\n",
      "FT   VARIANT         616\r\n",
      "FT                   /note=\"K -> E (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11524739\"\r\n",
      "FT                   /id=\"VAR_011581\"\r\n",
      "FT   VARIANT         635\r\n",
      "FT                   /note=\"A -> P (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:7795591\"\r\n",
      "FT                   /id=\"VAR_005580\"\r\n",
      "FT   VARIANT         654\r\n",
      "FT                   /note=\"V -> E (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:7795591\"\r\n",
      "FT                   /id=\"VAR_005581\"\r\n",
      "FT   VARIANT         657\r\n",
      "FT                   /note=\"L -> P (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8776589\"\r\n",
      "FT                   /id=\"VAR_010050\"\r\n",
      "FT   VARIANT         661\r\n",
      "FT                   /note=\"R -> W (in RB; mild form; dbSNP:rs137853294)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:1352883,\r\n",
      "FT                   ECO:0000269|PubMed:7927327, ECO:0000269|PubMed:8776589,\r\n",
      "FT                   ECO:0000269|PubMed:9311732\"\r\n",
      "FT                   /id=\"VAR_005582\"\r\n",
      "FT   VARIANT         662\r\n",
      "FT                   /note=\"L -> P (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10671068\"\r\n",
      "FT                   /id=\"VAR_005583\"\r\n",
      "FT   VARIANT         673\r\n",
      "FT                   /note=\"H -> P (in RB)\"\r\n",
      "FT                   /id=\"VAR_005584\"\r\n",
      "FT   VARIANT         685\r\n",
      "FT                   /note=\"Q -> P (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:7795591\"\r\n",
      "FT                   /id=\"VAR_005585\"\r\n",
      "FT   VARIANT         697\r\n",
      "FT                   /note=\"D -> E (in dbSNP:rs3092903)\"\r\n",
      "FT                   /id=\"VAR_051911\"\r\n",
      "FT   VARIANT         706\r\n",
      "FT                   /note=\"C -> Y (in RB)\"\r\n",
      "FT                   /id=\"VAR_005586\"\r\n",
      "FT   VARIANT         712\r\n",
      "FT                   /note=\"C -> R (in RB; dbSNP:rs137853296)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10671068\"\r\n",
      "FT                   /id=\"VAR_005587\"\r\n",
      "FT   VARIANT         746\r\n",
      "FT                   /note=\"E -> G (in dbSNP:rs3092905)\"\r\n",
      "FT                   /id=\"VAR_034442\"\r\n",
      "FT   VARIANT         803\r\n",
      "FT                   /note=\"N -> K (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8605116\"\r\n",
      "FT                   /id=\"VAR_005588\"\r\n",
      "FT   MUTAGEN         821\r\n",
      "FT                   /note=\"T->A: Abolishes interaction with Pocket domain; when\r\n",
      "FT                   associated with A-826.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16360038\"\r\n",
      "FT   MUTAGEN         826\r\n",
      "FT                   /note=\"T->A: Abolishes interaction with Pocket domain; when\r\n",
      "FT                   associated with A-821.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16360038\"\r\n",
      "FT   MUTAGEN         860\r\n",
      "FT                   /note=\"K->R: Abolishes monomethylation by SMYD2 and\r\n",
      "FT                   subsequent interaction with L3MBTL1.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20870719\"\r\n",
      "FT   MUTAGEN         870\r\n",
      "FT                   /note=\"K->R: Does not affect the ability to be methylated\r\n",
      "FT                   by SMYD2; when associated with 873-R-R-874.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20870719\"\r\n",
      "FT   MUTAGEN         873..874\r\n",
      "FT                   /note=\"KK->R: Does not affect the ability to be methylated\r\n",
      "FT                   by SMYD2; when associated with 873-R-R-874.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20870719,\r\n",
      "FT                   ECO:0000269|PubMed:20940255\"\r\n",
      "FT   MUTAGEN         873..874\r\n",
      "FT                   /note=\"KK->RR: Does not alter Rb localization in cycling\r\n",
      "FT                   cells, but mislocalizes to the cytoplasm during\r\n",
      "FT                   keratinocyte differentiation. Does not affect the ability\r\n",
      "FT                   to arrest cell growth. Probable loss of acetylation by\r\n",
      "FT                   PCAF.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20870719,\r\n",
      "FT                   ECO:0000269|PubMed:20940255\"\r\n",
      "FT   CONFLICT        500..501\r\n",
      "FT                   /note=\"RS -> SN (in Ref. 7; AAN64133)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   HELIX           55..63\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           68..82\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           95..110\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           117..124\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           128..135\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           142..172\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   STRAND          180..182\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           188..204\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   STRAND          207..209\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4ELJ\"\r\n",
      "FT   HELIX           212..228\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           232..234\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   TURN            237..240\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           241..243\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           272..281\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           285..294\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           296..299\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           302..306\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4ELJ\"\r\n",
      "FT   HELIX           314..328\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           333..338\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           341..343\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           347..353\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           382..391\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           398..405\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          407..409\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           412..434\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           436..438\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           439..468\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           474..477\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           480..501\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   TURN            504..506\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:1N4M\"\r\n",
      "FT   STRAND          511..513\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4ELJ\"\r\n",
      "FT   HELIX           516..521\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           525..529\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           532..538\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           544..559\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           561..563\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          564..566\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4ELJ\"\r\n",
      "FT   HELIX           569..577\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           582..586\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4ELL\"\r\n",
      "FT   HELIX           602..607\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4ELL\"\r\n",
      "FT   HELIX           645..669\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           676..690\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           692..695\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           700..714\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           721..728\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          731..733\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:1N4M\"\r\n",
      "FT   HELIX           737..740\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          741..743\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          745..747\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          748..750\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4ELJ\"\r\n",
      "FT   HELIX           752..758\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           760..770\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          773..775\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          830..836\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   TURN            838..840\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   HELIX           841..853\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "SQ   SEQUENCE   928 AA;  106159 MW;  C8E746111E19CC32 CRC64;\r\n",
      "     MPPKTPRKTA ATAAAAAAEP PAPPPPPPPE EDPEQDSGPE DLPLVRLEFE ETEEPDFTAL\r\n",
      "     CQKLKIPDHV RERAWLTWEK VSSVDGVLGG YIQKKKELWG ICIFIAAVDL DEMSFTFTEL\r\n",
      "     QKNIEISVHK FFNLLKEIDT STKVDNAMSR LLKKYDVLFA LFSKLERTCE LIYLTQPSSS\r\n",
      "     ISTEINSALV LKVSWITFLL AKGEVLQMED DLVISFQLML CVLDYFIKLS PPMLLKEPYK\r\n",
      "     TAVIPINGSP RTPRRGQNRS ARIAKQLEND TRIIEVLCKE HECNIDEVKN VYFKNFIPFM\r\n",
      "     NSLGLVTSNG LPEVENLSKR YEEIYLKNKD LDARLFLDHD KTLQTDSIDS FETQRTPRKS\r\n",
      "     NLDEEVNVIP PHTPVRTVMN TIQQLMMILN SASDQPSENL ISYFNNCTVN PKESILKRVK\r\n",
      "     DIGYIFKEKF AKAVGQGCVE IGSQRYKLGV RLYYRVMESM LKSEEERLSI QNFSKLLNDN\r\n",
      "     IFHMSLLACA LEVVMATYSR STSQNLDSGT DLSFPWILNV LNLKAFDFYK VIESFIKAEG\r\n",
      "     NLTREMIKHL ERCEHRIMES LAWLSDSPLF DLIKQSKDRE GPTDHLESAC PLNLPLQNNH\r\n",
      "     TAADMYLSPV RSPKKKGSTT RVNSTANAET QATSAFQTQK PLKSTSLSLF YKKVYRLAYL\r\n",
      "     RLNTLCERLL SEHPELEHII WTLFQHTLQN EYELMRDRHL DQIMMCSMYG ICKVKNIDLK\r\n",
      "     FKIIVTAYKD LPHAVQETFK RVLIKEEEYD SIIVFYNSVF MQRLKTNILQ YASTRPPTLS\r\n",
      "     PIPHIPRSPY KFPSSPLRIP GGNIYISPLK SPYKISEGLP TPTKMTPRSR ILVSIGESFG\r\n",
      "     TSEKFQKINQ MVCNSDRVLK RSAEGSNPPK PLKKLRFDIE GSDEADGSKH LPGESKFQQK\r\n",
      "     LAEMTSTRTR MQKQKMNDSM DTSNKEEK\r\n",
      "//\r\n",
      "ID   RBL1_MOUSE              Reviewed;        1063 AA.\r\n",
      "AC   Q64701; Q3U1D4;\r\n",
      "DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   27-JUL-2011, sequence version 3.\r\n",
      "DT   03-MAY-2023, entry version 188.\r\n",
      "DE   RecName: Full=Retinoblastoma-like protein 1;\r\n",
      "DE   AltName: Full=107 kDa retinoblastoma-associated protein;\r\n",
      "DE            Short=p107;\r\n",
      "DE   AltName: Full=pRb1;\r\n",
      "GN   Name=Rbl1;\r\n",
      "OS   Mus musculus (Mouse).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Mus; Mus.\r\n",
      "OX   NCBI_TaxID=10090;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RC   STRAIN=BALB/cJ;\r\n",
      "RX   PubMed=8661722; DOI=10.1007/s003359900102;\r\n",
      "RA   Huppi K., Siwarski D., Mock B.A., Dosik J., Hamel P.A.;\r\n",
      "RT   \"Molecular cloning, chromosomal mapping, and expression of the mouse p107\r\n",
      "RT   gene.\";\r\n",
      "RL   Mamm. Genome 7:353-355(1996).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT).\r\n",
      "RX   PubMed=7490090; DOI=10.1006/geno.1995.1184;\r\n",
      "RA   Kim K.K., Soonpaa M.H., Wang H., Field L.J.;\r\n",
      "RT   \"Developmental expression of p107 mRNA and evidence for alternative\r\n",
      "RT   splicing of the p107 (RBL1) gene product.\";\r\n",
      "RL   Genomics 28:520-529(1995).\r\n",
      "RN   [3]\r\n",
      "RP   SEQUENCE REVISION.\r\n",
      "RA   Kim K.K., Soonpaa M.H., Wang H., Field L.J.;\r\n",
      "RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\r\n",
      "RC   STRAIN=NOD; TISSUE=Spleen;\r\n",
      "RX   PubMed=16141072; DOI=10.1126/science.1112014;\r\n",
      "RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,\r\n",
      "RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,\r\n",
      "RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,\r\n",
      "RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,\r\n",
      "RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,\r\n",
      "RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,\r\n",
      "RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,\r\n",
      "RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,\r\n",
      "RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,\r\n",
      "RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,\r\n",
      "RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,\r\n",
      "RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,\r\n",
      "RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,\r\n",
      "RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,\r\n",
      "RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,\r\n",
      "RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,\r\n",
      "RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,\r\n",
      "RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,\r\n",
      "RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,\r\n",
      "RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,\r\n",
      "RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,\r\n",
      "RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,\r\n",
      "RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,\r\n",
      "RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,\r\n",
      "RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,\r\n",
      "RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,\r\n",
      "RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,\r\n",
      "RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,\r\n",
      "RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,\r\n",
      "RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,\r\n",
      "RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,\r\n",
      "RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,\r\n",
      "RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,\r\n",
      "RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;\r\n",
      "RT   \"The transcriptional landscape of the mammalian genome.\";\r\n",
      "RL   Science 309:1559-1563(2005).\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RC   STRAIN=C57BL/6J;\r\n",
      "RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;\r\n",
      "RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,\r\n",
      "RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,\r\n",
      "RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,\r\n",
      "RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,\r\n",
      "RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,\r\n",
      "RA   Eichler E.E., Ponting C.P.;\r\n",
      "RT   \"Lineage-specific biology revealed by a finished genome assembly of the\r\n",
      "RT   mouse.\";\r\n",
      "RL   PLoS Biol. 7:E1000112-E1000112(2009).\r\n",
      "RN   [6]\r\n",
      "RP   INTERACTION WITH USP4.\r\n",
      "RX   PubMed=11571651; DOI=10.1038/sj.onc.1204823;\r\n",
      "RA   Blanchette P., Gilchrist C.A., Baker R.T., Gray D.A.;\r\n",
      "RT   \"Association of UNP, a ubiquitin-specific protease, with the pocket\r\n",
      "RT   proteins pRb, p107 and p130.\";\r\n",
      "RL   Oncogene 20:5533-5537(2001).\r\n",
      "RN   [7]\r\n",
      "RP   FUNCTION, AND INTERACTION WITH KMT5B AND KMT5C.\r\n",
      "RX   PubMed=15750587; DOI=10.1038/ncb1235;\r\n",
      "RA   Gonzalo S., Garcia-Cao M., Fraga M.F., Schotta G., Peters A.H.F.M.,\r\n",
      "RA   Cotter S.E., Eguia R., Dean D.C., Esteller M., Jenuwein T., Blasco M.A.;\r\n",
      "RT   \"Role of the RB1 family in stabilizing histone methylation at constitutive\r\n",
      "RT   heterochromatin.\";\r\n",
      "RL   Nat. Cell Biol. 7:420-428(2005).\r\n",
      "RN   [8]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1036, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;\r\n",
      "RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;\r\n",
      "RT   \"Large-scale phosphorylation analysis of mouse liver.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).\r\n",
      "RN   [9]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-332; SER-959 AND SER-1036,\r\n",
      "RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Kidney, Lung, Spleen, and Testis;\r\n",
      "RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;\r\n",
      "RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,\r\n",
      "RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;\r\n",
      "RT   \"A tissue-specific atlas of mouse protein phosphorylation and expression.\";\r\n",
      "RL   Cell 143:1174-1189(2010).\r\n",
      "CC   -!- FUNCTION: Key regulator of entry into cell division (By similarity).\r\n",
      "CC       Directly involved in heterochromatin formation by maintaining overall\r\n",
      "CC       chromatin structure and, in particular, that of constitutive\r\n",
      "CC       heterochromatin by stabilizing histone methylation (PubMed:15750587).\r\n",
      "CC       Recruits and targets histone methyltransferases KMT5B and KMT5C,\r\n",
      "CC       leading to epigenetic transcriptional repression (PubMed:15750587).\r\n",
      "CC       Controls histone H4 'Lys-20' trimethylation (PubMed:15750587). Probably\r\n",
      "CC       acts as a transcription repressor by recruiting chromatin-modifying\r\n",
      "CC       enzymes to promoters (PubMed:15750587). Potent inhibitor of E2F-\r\n",
      "CC       mediated trans-activation (By similarity). May act as a tumor\r\n",
      "CC       suppressor (By similarity). {ECO:0000250|UniProtKB:P28749,\r\n",
      "CC       ECO:0000269|PubMed:15750587}.\r\n",
      "CC   -!- SUBUNIT: Component of the DREAM complex (also named LINC complex) at\r\n",
      "CC       least composed of E2F4, E2F5, LIN9, LIN37, LIN52, LIN54, MYBL1, MYBL2,\r\n",
      "CC       RBL1, RBL2, RBBP4, TFDP1 and TFDP2 (By similarity). The complex exists\r\n",
      "CC       in quiescent cells where it represses cell cycle-dependent genes (By\r\n",
      "CC       similarity). It dissociates in S phase when LIN9, LIN37, LIN52 and\r\n",
      "CC       LIN54 form a subcomplex that binds to MYBL2 (By similarity). Interacts\r\n",
      "CC       with AATF (By similarity). Interacts with KDM5A (By similarity).\r\n",
      "CC       Interacts with KMT5B and KMT5C (PubMed:11571651). Interacts with USP4\r\n",
      "CC       (PubMed:15750587). Interacts with RBBP9 (By similarity).\r\n",
      "CC       {ECO:0000250|UniProtKB:D3ZS28, ECO:0000250|UniProtKB:P28749,\r\n",
      "CC       ECO:0000269|PubMed:11571651, ECO:0000269|PubMed:15750587}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q64701; Q155P7: Cenpf; NbExp=3; IntAct=EBI-1213109, EBI-2211248;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=2;\r\n",
      "CC       Name=Long;\r\n",
      "CC         IsoId=Q64701-1; Sequence=Displayed;\r\n",
      "CC       Name=Short;\r\n",
      "CC         IsoId=Q64701-2; Sequence=VSP_005537, VSP_005538;\r\n",
      "CC   -!- TISSUE SPECIFICITY: Highly expressed in fetal heart and liver.\r\n",
      "CC       Expressed at low levels in all other fetal tissues except skeletal\r\n",
      "CC       muscle. High levels in neonatal spleen and thymus with low levels in\r\n",
      "CC       other tissues. In adult, highly expressed in testis. Barely detectable\r\n",
      "CC       in other tissues.\r\n",
      "CC   -!- DEVELOPMENTAL STAGE: Highly expressed in fetal tissues. Expression\r\n",
      "CC       markedly decreased in adult.\r\n",
      "CC   -!- PTM: Cell-cycle arrest properties are inactivated by phosphorylation on\r\n",
      "CC       Thr-332, Ser-640, Ser-959 and Ser-970 by CDK4.\r\n",
      "CC       {ECO:0000250|UniProtKB:P28749}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; U33320; AAB18279.1; -; mRNA.\r\n",
      "DR   EMBL; U27177; AAB53235.1; -; mRNA.\r\n",
      "DR   EMBL; U27178; AAB53236.1; -; mRNA.\r\n",
      "DR   EMBL; AK156055; BAE33564.1; -; mRNA.\r\n",
      "DR   EMBL; AL669828; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   CCDS; CCDS16974.1; -. [Q64701-1]\r\n",
      "DR   PIR; I49328; I49328.\r\n",
      "DR   RefSeq; NP_001132988.1; NM_001139516.1. [Q64701-2]\r\n",
      "DR   RefSeq; NP_035379.2; NM_011249.2. [Q64701-1]\r\n",
      "DR   AlphaFoldDB; Q64701; -.\r\n",
      "DR   SMR; Q64701; -.\r\n",
      "DR   BioGRID; 202819; 28.\r\n",
      "DR   CORUM; Q64701; -.\r\n",
      "DR   IntAct; Q64701; 4.\r\n",
      "DR   STRING; 10090.ENSMUSP00000029170; -.\r\n",
      "DR   GlyGen; Q64701; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; Q64701; -.\r\n",
      "DR   PhosphoSitePlus; Q64701; -.\r\n",
      "DR   EPD; Q64701; -.\r\n",
      "DR   jPOST; Q64701; -.\r\n",
      "DR   MaxQB; Q64701; -.\r\n",
      "DR   PaxDb; Q64701; -.\r\n",
      "DR   PeptideAtlas; Q64701; -.\r\n",
      "DR   ProteomicsDB; 300314; -. [Q64701-1]\r\n",
      "DR   ProteomicsDB; 300315; -. [Q64701-2]\r\n",
      "DR   Antibodypedia; 11876; 440 antibodies from 35 providers.\r\n",
      "DR   DNASU; 19650; -.\r\n",
      "DR   Ensembl; ENSMUST00000029170.8; ENSMUSP00000029170.8; ENSMUSG00000027641.14.\r\n",
      "DR   GeneID; 19650; -.\r\n",
      "DR   KEGG; mmu:19650; -.\r\n",
      "DR   UCSC; uc008noq.2; mouse. [Q64701-1]\r\n",
      "DR   UCSC; uc008nos.2; mouse. [Q64701-2]\r\n",
      "DR   AGR; MGI:103300; -.\r\n",
      "DR   CTD; 5933; -.\r\n",
      "DR   MGI; MGI:103300; Rbl1.\r\n",
      "DR   VEuPathDB; HostDB:ENSMUSG00000027641; -.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00950000183202; -.\r\n",
      "DR   HOGENOM; CLU_008943_0_1_1; -.\r\n",
      "DR   InParanoid; Q64701; -.\r\n",
      "DR   OMA; AILCELH; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; Q64701; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   Reactome; R-MMU-1538133; G0 and Early G1.\r\n",
      "DR   Reactome; R-MMU-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.\r\n",
      "DR   Reactome; R-MMU-69231; Cyclin D associated events in G1.\r\n",
      "DR   BioGRID-ORCS; 19650; 6 hits in 80 CRISPR screens.\r\n",
      "DR   ChiTaRS; Rbl1; mouse.\r\n",
      "DR   PRO; PR:Q64701; -.\r\n",
      "DR   Proteomes; UP000000589; Chromosome 2.\r\n",
      "DR   RNAct; Q64701; protein.\r\n",
      "DR   Bgee; ENSMUSG00000027641; Expressed in paneth cell and 199 other tissues.\r\n",
      "DR   Genevisible; Q64701; MM.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IDA:MGI.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; IDA:MGI.\r\n",
      "DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:MGI.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:2000773; P:negative regulation of cellular senescence; ISO:MGI.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:MGI.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:MGI.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; ISO:MGI.\r\n",
      "DR   CDD; cd20605; CYCLIN_RBL1; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 3.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   PANTHER; PTHR13742:SF20; RETINOBLASTOMA-LIKE PROTEIN 1; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Alternative splicing; Cell cycle; Chromatin regulator; Nucleus;\r\n",
      "KW   Phosphoprotein; Reference proteome; Repressor; Transcription;\r\n",
      "KW   Transcription regulation; Tumor suppressor.\r\n",
      "FT   CHAIN           1..1063\r\n",
      "FT                   /note=\"Retinoblastoma-like protein 1\"\r\n",
      "FT                   /id=\"PRO_0000167840\"\r\n",
      "FT   REGION          383..944\r\n",
      "FT                   /note=\"Pocket; binds T and E1A\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   REGION          383..584\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   REGION          585..779\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   REGION          780..944\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   MOD_RES         332\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         369\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         385\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         640\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         650\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         748\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         761\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         959\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         970\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         983\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         992\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         1004\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         1036\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355,\r\n",
      "FT                   ECO:0007744|PubMed:21183079\"\r\n",
      "FT   VAR_SEQ         592..594\r\n",
      "FT                   /note=\"IFP -> SQG (in isoform Short)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:7490090\"\r\n",
      "FT                   /id=\"VSP_005537\"\r\n",
      "FT   VAR_SEQ         595..1063\r\n",
      "FT                   /note=\"Missing (in isoform Short)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:7490090\"\r\n",
      "FT                   /id=\"VSP_005538\"\r\n",
      "FT   CONFLICT        26\r\n",
      "FT                   /note=\"Q -> P (in Ref. 1; AAB18279)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        430\r\n",
      "FT                   /note=\"I -> T (in Ref. 1; AAB18279)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        863\r\n",
      "FT                   /note=\"I -> R (in Ref. 2; AAB53235)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        989\r\n",
      "FT                   /note=\"A -> C (in Ref. 1; AAB18279)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   1063 AA;  119456 MW;  85BEA8EC064EC06E CRC64;\r\n",
      "     MFEDEPHAEG AAAVAAAREA LQALCQELNL DEGSAAEALD DFTAIRGNYS LEGEVIHWLA\r\n",
      "     CSLYVACRKS IIPTVGKGVM EGNCVSLTRI LRSAKLSLIQ FFSKMKKWMD MSNLPQEFRE\r\n",
      "     RIERLERNFE VSTVIFKKFE PIFLDIFQNP YEEPPKLPRS RKQRRIPCSV KDLFNFCWTL\r\n",
      "     FVYTKGNFRM IGDDLVNSYH LLLCCLDLIF ANAIMCPNRR DLLNPSFKGL PSDFHAPDFK\r\n",
      "     AAEEPPCIIA VLCDLHDGLL VEAKGIKEHY FKPYISKLFD KKILKGECLL DLSSFTDNSK\r\n",
      "     AVNKEYEEYV LTVGDFDERI FLGADAEEEI GTPRKFTADT PFGKLTSQAS VECNLQQHFE\r\n",
      "     KKRSFAPSTP LTGRRYLQEK EAVTTPVASA TQSVSRLQSI VAGLKSAPSE QLLNIFESCM\r\n",
      "     RNPMGNIIKI VKGIGETFCQ HYTQSTDKQP GSHIDFAVNR LKLAEILYYK ILETIMVQET\r\n",
      "     RRLHGMDMSV LLEQDIFHKS LMACCLEIVL FAYSSPRTFP WIIEVLDLQP FYFYKVIEVV\r\n",
      "     IRSEEGLSRD MVKHLNSIEE QILESLAWTN NSALWEALHA SANRVPSCEE VIFPNNFEIG\r\n",
      "     NGGNVQGHLP MMPMSPIIHP RVKEVRTDSG SLRQDMQPLS PISVHERYSS PAAGSAKRRL\r\n",
      "     FGDDPPKDTL MDKIMAEGTK LKIAPSSVTA ESLSISPGQA LLTMATTTVT GTTGRKVTVP\r\n",
      "     LHGIANDAGE ITLVPISMNP TQESTAESPV SLTAQSLIGT SPKQTHLTKA QDAHLTGVSK\r\n",
      "     PKRTGSLALF YRKVYHLASV RLRDLCLKLD VSNELRRKIW TCFEFTLVHC PDLMKDRHLD\r\n",
      "     QLLLCAFYIM AKVTKEERTF QEIMKSYRNQ PQANSHVYRS VLLKSIPGGV VVYNGDCEMT\r\n",
      "     DGDIEDATKT PNCSSEPVKE ERGDLIKFYN TVYVGRVKSF ALKYDLSNQD HIMDAPPLSP\r\n",
      "     FPHIKQQPGS PRRISQQHSL YVSPHKNGAG LTPRSALLYK FNGSPSKSLK DINNMIRQGE\r\n",
      "     QKTKKRVIAI SGDADSPAKR LCQENDDVLL KRLQDVVSER ANH\r\n",
      "//\r\n",
      "ID   E2F1_HUMAN              Reviewed;         437 AA.\r\n",
      "AC   Q01094; Q13143; Q92768;\r\n",
      "DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   01-JUL-1993, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 243.\r\n",
      "DE   RecName: Full=Transcription factor E2F1 {ECO:0000303|PubMed:8964493};\r\n",
      "DE            Short=E2F-1 {ECO:0000303|PubMed:8964493};\r\n",
      "DE   AltName: Full=PBR3;\r\n",
      "DE   AltName: Full=Retinoblastoma-associated protein 1 {ECO:0000303|PubMed:1638635};\r\n",
      "DE            Short=RBAP-1 {ECO:0000303|PubMed:1638635};\r\n",
      "DE   AltName: Full=Retinoblastoma-binding protein 3 {ECO:0000303|PubMed:1638634};\r\n",
      "DE            Short=RBBP-3 {ECO:0000303|PubMed:1638634};\r\n",
      "DE   AltName: Full=pRB-binding protein E2F-1;\r\n",
      "GN   Name=E2F1 {ECO:0000303|PubMed:8964493, ECO:0000312|HGNC:HGNC:3113};\r\n",
      "GN   Synonyms=RBBP3 {ECO:0000303|PubMed:1638634};\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=1638634; DOI=10.1016/0092-8674(92)90107-n;\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RA   Helin K., Lees J.A., Vidal M., Dyson N.J., Harlow E., Fattaey A.;\r\n",
      "RT   \"A cDNA encoding a pRB-binding protein with properties of the transcription\r\n",
      "RT   factor E2F.\";\r\n",
      "RL   Cell 70:337-350(1992).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=1638635; DOI=10.1016/0092-8674(92)90108-o;\r\n",
      "RA   Kaelin W.G. Jr., Krek W., Sellers W.R., Decaprio J.A., Ajchenbaum F.,\r\n",
      "RA   Fuchs C.S., Chittenden T., Li Y., Farnham P.J., Blanar M.A.,\r\n",
      "RA   Livingston D.M., Flemington E.K.;\r\n",
      "RT   \"Expression cloning of a cDNA encoding a retinoblastoma-binding protein\r\n",
      "RT   with E2F-like properties.\";\r\n",
      "RL   Cell 70:351-364(1992).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=1448092; DOI=10.1128/mcb.12.12.5620-5631.1992;\r\n",
      "RA   Shan B., Zhu X., Chen P.L., Durfee T., Yang Y., Sharp D., Lee W.H.;\r\n",
      "RT   \"Molecular cloning of cellular genes encoding retinoblastoma-associated\r\n",
      "RT   proteins: identification of a gene with properties of the transcription\r\n",
      "RT   factor E2F.\";\r\n",
      "RL   Mol. Cell. Biol. 12:5620-5631(1992).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].\r\n",
      "RX   PubMed=8964493; DOI=10.1016/0378-1119(96)00184-9;\r\n",
      "RA   Neuman E., Sellers W.R.S., McNeil J.A., Lawrence J.B., Kaelin W.G. Jr.;\r\n",
      "RT   \"Structure and partial genomic sequence of the human E2F1 gene.\";\r\n",
      "RL   Gene 173:163-169(1996).\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-252; MET-276; ASN-311\r\n",
      "RP   AND SER-393.\r\n",
      "RG   NIEHS SNPs program;\r\n",
      "RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RX   PubMed=11780052; DOI=10.1038/414865a;\r\n",
      "RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,\r\n",
      "RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,\r\n",
      "RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,\r\n",
      "RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,\r\n",
      "RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,\r\n",
      "RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,\r\n",
      "RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,\r\n",
      "RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,\r\n",
      "RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,\r\n",
      "RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,\r\n",
      "RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,\r\n",
      "RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,\r\n",
      "RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,\r\n",
      "RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,\r\n",
      "RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,\r\n",
      "RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,\r\n",
      "RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,\r\n",
      "RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,\r\n",
      "RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,\r\n",
      "RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,\r\n",
      "RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,\r\n",
      "RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,\r\n",
      "RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;\r\n",
      "RT   \"The DNA sequence and comparative analysis of human chromosome 20.\";\r\n",
      "RL   Nature 414:865-871(2001).\r\n",
      "RN   [7]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\r\n",
      "RC   TISSUE=Pancreas, and Skin;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [8]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-111.\r\n",
      "RX   PubMed=7958836; DOI=10.1101/gad.8.13.1514;\r\n",
      "RA   Johnson D.G., Ohtani K., Nevins J.R.;\r\n",
      "RT   \"Autoregulatory control of E2F1 expression in response to positive and\r\n",
      "RT   negative regulators of cell cycle progression.\";\r\n",
      "RL   Genes Dev. 8:1514-1525(1994).\r\n",
      "RN   [9]\r\n",
      "RP   INTERACTION WITH RB1.\r\n",
      "RX   PubMed=8336704; DOI=10.1128/mcb.13.8.4588-4599.1993;\r\n",
      "RA   Zacksenhaus E., Bremner R., Phillips R.A., Gallie B.L.;\r\n",
      "RT   \"A bipartite nuclear localization signal in the retinoblastoma gene product\r\n",
      "RT   and its importance for biological activity.\";\r\n",
      "RL   Mol. Cell. Biol. 13:4588-4599(1993).\r\n",
      "RN   [10]\r\n",
      "RP   TRANSACTIVATION INHIBITION, AND MUTAGENESIS OF TYR-411.\r\n",
      "RX   PubMed=8413249; DOI=10.1128/mcb.13.10.6501-6508.1993;\r\n",
      "RA   Helin K., Harlow E., Fattaey A.;\r\n",
      "RT   \"Inhibition of E2F-1 transactivation by direct binding of the\r\n",
      "RT   retinoblastoma protein.\";\r\n",
      "RL   Mol. Cell. Biol. 13:6501-6508(1993).\r\n",
      "RN   [11]\r\n",
      "RP   DOMAIN CYCLIN A:CDK2 BINDING.\r\n",
      "RX   PubMed=8033208; DOI=10.1016/0092-8674(94)90582-7;\r\n",
      "RA   Krek W., Ewen M.E., Shirodkar S., Arany Z., Kaelin W.G. Jr.,\r\n",
      "RA   Livingston D.M.;\r\n",
      "RT   \"Negative regulation of the growth-promoting transcription factor E2F-1 by\r\n",
      "RT   a stably bound cyclin A-dependent protein kinase.\";\r\n",
      "RL   Cell 78:161-172(1994).\r\n",
      "RN   [12]\r\n",
      "RP   DIFFERENTIAL REGULATION BY CYCLIN/CDK2 KINASES.\r\n",
      "RX   PubMed=7958856; DOI=10.1101/gad.8.15.1772;\r\n",
      "RA   Dynlacht B.D., Flores O., Lees J.A., Harlow E.;\r\n",
      "RT   \"Differential regulation of E2F transactivation by cyclin/cdk2 complexes.\";\r\n",
      "RL   Genes Dev. 8:1772-1786(1994).\r\n",
      "RN   [13]\r\n",
      "RP   INHIBITION OF DNA-BINDING.\r\n",
      "RX   PubMed=7969176; DOI=10.1128/mcb.14.12.8420-8431.1994;\r\n",
      "RA   Xu M., Sheppard K.-A., Peng C.-Y., Yee A.S., Piwnica-Worms H.;\r\n",
      "RT   \"Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding\r\n",
      "RT   activity of E2F-1/DP-1 by phosphorylation.\";\r\n",
      "RL   Mol. Cell. Biol. 14:8420-8431(1994).\r\n",
      "RN   [14]\r\n",
      "RP   FUNCTION IN APOPTOSIS.\r\n",
      "RX   PubMed=8170954; DOI=10.1073/pnas.91.9.3602;\r\n",
      "RA   Wu X., Levine A.J.;\r\n",
      "RT   \"P53 and E2F-1 cooperate to mediate apoptosis.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 91:3602-3606(1994).\r\n",
      "RN   [15]\r\n",
      "RP   INTERACTION WITH HHV-5 PROTEIN UL123.\r\n",
      "RX   PubMed=7494286; DOI=10.1128/jvi.69.12.7759-7767.1995;\r\n",
      "RA   Margolis M.J., Pajovic S., Wong E.L., Wade M., Jupp R., Nelson J.A.,\r\n",
      "RA   Azizkhan J.C.;\r\n",
      "RT   \"Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product\r\n",
      "RT   with E2F1 coincides with E2F-dependent activation of dihydrofolate\r\n",
      "RT   reductase transcription.\";\r\n",
      "RL   J. Virol. 69:7759-7767(1995).\r\n",
      "RN   [16]\r\n",
      "RP   PHOSPHORYLATION.\r\n",
      "RX   PubMed=7838523;\r\n",
      "RA   Kitagawa M., Higashi H., Suzuki-Takahashi I., Segawa K., Hanks S.K.,\r\n",
      "RA   Taya Y., Nishimura S., Okuyama A.;\r\n",
      "RT   \"Phosphorylation of E2F-1 by cyclin A-cdk2.\";\r\n",
      "RL   Oncogene 10:229-236(1995).\r\n",
      "RN   [17]\r\n",
      "RP   REGULATION BY CYCLIN-DEPENDENT KINASES.\r\n",
      "RX   PubMed=9199321; DOI=10.1128/mcb.17.7.3867;\r\n",
      "RA   Dynlacht B.D., Moberg K., Lees J.A., Harlow E., Zhu L.;\r\n",
      "RT   \"Specific regulation of E2F family members by cyclin-dependent kinases.\";\r\n",
      "RL   Mol. Cell. Biol. 17:3867-3875(1997).\r\n",
      "RN   [18]\r\n",
      "RP   INTERACTION WITH ARID3A.\r\n",
      "RX   PubMed=9780002; DOI=10.1038/sj.onc.1202163;\r\n",
      "RA   Suzuki M., Okuyama S., Okamoto S., Shirasuna K., Nakajima T., Hachiya T.,\r\n",
      "RA   Nojima H., Sekiya S., Oda K.;\r\n",
      "RT   \"A novel E2F binding protein with Myc-type HLH motif stimulates E2F-\r\n",
      "RT   dependent transcription by forming a heterodimer.\";\r\n",
      "RL   Oncogene 17:853-865(1998).\r\n",
      "RN   [19]\r\n",
      "RP   ACETYLATION AT LYS-117; LYS-120 AND LYS-125, DNA-BINDING, INTERACTION WITH\r\n",
      "RP   KAT2B, FUNCTION, AND MUTAGENESIS OF LYS-117; LYS-120 AND LYS-125.\r\n",
      "RX   PubMed=10675335; DOI=10.1093/emboj/19.4.662;\r\n",
      "RA   Martinez-Balbas M.A., Bauer U.M., Nielsen S.J., Brehm A., Kouzarides T.;\r\n",
      "RT   \"Regulation of E2F1 activity by acetylation.\";\r\n",
      "RL   EMBO J. 19:662-671(2000).\r\n",
      "RN   [20]\r\n",
      "RP   INTERACTION WITH TRRAP.\r\n",
      "RX   PubMed=11418595; DOI=10.1074/jbc.m102067200;\r\n",
      "RA   Lang S.E., McMahon S.B., Cole M.D., Hearing P.;\r\n",
      "RT   \"E2F transcriptional activation requires TRRAP and GCN5 cofactors.\";\r\n",
      "RL   J. Biol. Chem. 276:32627-32634(2001).\r\n",
      "RN   [21]\r\n",
      "RP   INTERACTION WITH TOPBP1.\r\n",
      "RX   PubMed=12697828; DOI=10.1128/mcb.23.9.3287-3304.2003;\r\n",
      "RA   Liu K., Lin F.-T., Ruppert J.M., Lin W.-C.;\r\n",
      "RT   \"Regulation of E2F1 by BRCT domain-containing protein TopBP1.\";\r\n",
      "RL   Mol. Cell. Biol. 23:3287-3304(2003).\r\n",
      "RN   [22]\r\n",
      "RP   FUNCTION IN TRANSCRIPTION REGULATION, FUNCTION IN APOPTOSIS,\r\n",
      "RP   PHOSPHORYLATION AT SER-364 BY CHEK2, AND MUTAGENESIS OF SER-364.\r\n",
      "RX   PubMed=12717439; DOI=10.1038/ncb974;\r\n",
      "RA   Stevens C., Smith L., La Thangue N.B.;\r\n",
      "RT   \"Chk2 activates E2F-1 in response to DNA damage.\";\r\n",
      "RL   Nat. Cell Biol. 5:401-409(2003).\r\n",
      "RN   [23]\r\n",
      "RP   INTERACTION WITH RB1 AND TFDP1.\r\n",
      "RX   PubMed=16360038; DOI=10.1016/j.cell.2005.09.044;\r\n",
      "RA   Rubin S.M., Gall A.-L., Zheng N., Pavletich N.P.;\r\n",
      "RT   \"Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for\r\n",
      "RT   phosphorylation-induced E2F release.\";\r\n",
      "RL   Cell 123:1093-1106(2005).\r\n",
      "RN   [24]\r\n",
      "RP   INTERACTION WITH EAPP.\r\n",
      "RX   PubMed=15716352; DOI=10.1091/mbc.e04-11-0975;\r\n",
      "RA   Novy M., Pohn R., Andorfer P., Novy-Weiland T., Galos B., Schwarzmayr L.,\r\n",
      "RA   Rotheneder H.;\r\n",
      "RT   \"EAPP, a novel E2F binding protein that modulates E2F-dependent\r\n",
      "RT   transcription.\";\r\n",
      "RL   Mol. Biol. Cell 16:2181-2190(2005).\r\n",
      "RN   [25]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;\r\n",
      "RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;\r\n",
      "RT   \"Global, in vivo, and site-specific phosphorylation dynamics in signaling\r\n",
      "RT   networks.\";\r\n",
      "RL   Cell 127:635-648(2006).\r\n",
      "RN   [26]\r\n",
      "RP   FUNCTION, PHOSPHORYLATION AT SER-403 AND THR-433, AND MUTAGENESIS OF\r\n",
      "RP   SER-403 AND THR-433.\r\n",
      "RX   PubMed=17050006; DOI=10.1016/j.bbamcr.2006.09.015;\r\n",
      "RA   Garcia-Alvarez G., Ventura V., Ros O., Aligue R., Gil J., Tauler A.;\r\n",
      "RT   \"Glycogen synthase kinase-3beta binds to E2F1 and regulates its\r\n",
      "RT   transcriptional activity.\";\r\n",
      "RL   Biochim. Biophys. Acta 1773:375-382(2007).\r\n",
      "RN   [27]\r\n",
      "RP   INTERACTION WITH HDAC1 AND TRIM28, FUNCTION, ACETYLATION, AND\r\n",
      "RP   DEACETYLATION.\r\n",
      "RX   PubMed=17704056; DOI=10.1074/jbc.m704757200;\r\n",
      "RA   Wang C., Rauscher F.J. III, Cress W.D., Chen J.;\r\n",
      "RT   \"Regulation of E2F1 function by the nuclear corepressor KAP1.\";\r\n",
      "RL   J. Biol. Chem. 282:29902-29909(2007).\r\n",
      "RN   [28]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=18625225; DOI=10.1016/j.febslet.2008.07.009;\r\n",
      "RA   Wang C., Xiao Y., Hu Z., Chen Y., Liu N., Hu G.;\r\n",
      "RT   \"PEG10 directly regulated by E2Fs might have a role in the development of\r\n",
      "RT   hepatocellular carcinoma.\";\r\n",
      "RL   FEBS Lett. 582:2793-2798(2008).\r\n",
      "RN   [29]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;\r\n",
      "RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,\r\n",
      "RA   Elledge S.J., Gygi S.P.;\r\n",
      "RT   \"A quantitative atlas of mitotic phosphorylation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).\r\n",
      "RN   [30]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [31]\r\n",
      "RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH RRP1B.\r\n",
      "RX   PubMed=20040599; DOI=10.1074/jbc.m109.072074;\r\n",
      "RA   Paik J.C., Wang B., Liu K., Lue J.K., Lin W.C.;\r\n",
      "RT   \"Regulation of E2F1-induced apoptosis by the nucleolar protein RRP1B.\";\r\n",
      "RL   J. Biol. Chem. 285:6348-6363(2010).\r\n",
      "RN   [32]\r\n",
      "RP   FUNCTION, INTERACTION WITH CEBPA, AND MUTAGENESIS OF LEU-132 AND TYR-411.\r\n",
      "RX   PubMed=20176812; DOI=10.1128/mcb.01619-09;\r\n",
      "RA   Zaragoza K., Begay V., Schuetz A., Heinemann U., Leutz A.;\r\n",
      "RT   \"Repression of transcriptional activity of C/EBPalpha by E2F-dimerization\r\n",
      "RT   partner complexes.\";\r\n",
      "RL   Mol. Cell. Biol. 30:2293-2304(2010).\r\n",
      "RN   [33]\r\n",
      "RP   METHYLATION AT LYS-185, AND MUTAGENESIS OF LYS-185.\r\n",
      "RX   PubMed=20603083; DOI=10.1016/j.molcel.2010.06.006;\r\n",
      "RA   Kontaki H., Talianidis I.;\r\n",
      "RT   \"Lysine methylation regulates E2F1-induced cell death.\";\r\n",
      "RL   Mol. Cell 39:152-160(2010).\r\n",
      "RN   [34]\r\n",
      "RP   INTERACTION WITH BIRC2, AND ACTIVITY REGULATION.\r\n",
      "RX   PubMed=21653699; DOI=10.1074/jbc.m110.191239;\r\n",
      "RA   Cartier J., Berthelet J., Marivin A., Gemble S., Edmond V., Plenchette S.,\r\n",
      "RA   Lagrange B., Hammann A., Dupoux A., Delva L., Eymin B., Solary E.,\r\n",
      "RA   Dubrez L.;\r\n",
      "RT   \"Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1\r\n",
      "RT   transcription factor-mediated control of cyclin transcription.\";\r\n",
      "RL   J. Biol. Chem. 286:26406-26417(2011).\r\n",
      "RN   [35]\r\n",
      "RP   INTERACTION WITH KMT2E AND HCFC1.\r\n",
      "RX   PubMed=23629655; DOI=10.1074/jbc.m112.439729;\r\n",
      "RA   Zhou P., Wang Z., Yuan X., Zhou C., Liu L., Wan X., Zhang F., Ding X.,\r\n",
      "RA   Wang C., Xiong S., Wang Z., Yuan J., Li Q., Zhang Y.;\r\n",
      "RT   \"Mixed lineage leukemia 5 (MLL5) protein regulates cell cycle progression\r\n",
      "RT   and E2F1-responsive gene expression via association with host cell factor-1\r\n",
      "RT   (HCF-1).\";\r\n",
      "RL   J. Biol. Chem. 288:17532-17543(2013).\r\n",
      "RN   [36]\r\n",
      "RP   FUNCTION, SUBCELLULAR LOCATION, UBIQUITINATION, DEUBIQUITINATION,\r\n",
      "RP   PHOSPHORYLATION AT SER-403, AND MUTAGENESIS OF SER-403.\r\n",
      "RX   PubMed=28992046; DOI=10.1093/jmcb/mjx034;\r\n",
      "RA   Wang D., Zhao J., Li S., Wei J., Nan L., Mallampalli R.K.,\r\n",
      "RA   Weathington N.M., Ma H., Zhao Y.;\r\n",
      "RT   \"Phosphorylated E2F1 is stabilized by nuclear USP11 to drive Peg10 gene\r\n",
      "RT   expression and activate lung epithelial cells.\";\r\n",
      "RL   J. Mol. Cell Biol. 10:60-73(2018).\r\n",
      "RN   [37]\r\n",
      "RP   INTERACTION WITH DCAF5 AND L3MBTL3, AND MUTAGENESIS OF LYS-185.\r\n",
      "RX   PubMed=29691401; DOI=10.1038/s41467-018-04019-9;\r\n",
      "RA   Leng F., Yu J., Zhang C., Alejo S., Hoang N., Sun H., Lu F., Zhang H.;\r\n",
      "RT   \"Methylated DNMT1 and E2F1 are targeted for proteolysis by L3MBTL3 and\r\n",
      "RT   CRL4-DCAF5 ubiquitin ligase.\";\r\n",
      "RL   Nat. Commun. 9:1641-1641(2018).\r\n",
      "RN   [38]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 87-95.\r\n",
      "RX   PubMed=12501191; DOI=10.1021/bi0268910;\r\n",
      "RA   Lowe E.D., Tews I., Cheng K.Y., Brown N.R., Gul S., Noble M.E.M.,\r\n",
      "RA   Gamblin S.J., Johnson L.N.;\r\n",
      "RT   \"Specificity determinants of recruitment peptides bound to phospho-\r\n",
      "RT   CDK2/cyclin A.\";\r\n",
      "RL   Biochemistry 41:15625-15634(2002).\r\n",
      "RN   [39]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 409-426 IN COMPLEX WITH RB1.\r\n",
      "RX   PubMed=12598654; DOI=10.1073/pnas.0436813100;\r\n",
      "RA   Xiao B., Spencer J., Clements A., Ali-Khan N., Mittnacht S., Broceno C.,\r\n",
      "RA   Burghammer M., Perrakis A., Marmorstein R., Gamblin S.J.;\r\n",
      "RT   \"Crystal structure of the retinoblastoma tumor suppressor protein bound to\r\n",
      "RT   E2F and the molecular basis of its regulation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 100:2363-2368(2003).\r\n",
      "CC   -!- FUNCTION: Transcription activator that binds DNA cooperatively with DP\r\n",
      "CC       proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in\r\n",
      "CC       the promoter region of a number of genes whose products are involved in\r\n",
      "CC       cell cycle regulation or in DNA replication (PubMed:10675335,\r\n",
      "CC       PubMed:12717439, PubMed:17704056, PubMed:17050006, PubMed:18625225,\r\n",
      "CC       PubMed:28992046). The DRTF1/E2F complex functions in the control of\r\n",
      "CC       cell-cycle progression from G1 to S phase (PubMed:10675335,\r\n",
      "CC       PubMed:12717439, PubMed:17704056). E2F1 binds preferentially RB1 in a\r\n",
      "CC       cell-cycle dependent manner (PubMed:10675335, PubMed:12717439,\r\n",
      "CC       PubMed:17704056). It can mediate both cell proliferation and TP53/p53-\r\n",
      "CC       dependent apoptosis (PubMed:8170954). Blocks adipocyte differentiation\r\n",
      "CC       by binding to specific promoters repressing CEBPA binding to its target\r\n",
      "CC       gene promoters (PubMed:20176812). Directly activates transcription of\r\n",
      "CC       PEG10 (PubMed:17050006, PubMed:18625225, PubMed:28992046). Positively\r\n",
      "CC       regulates transcription of RRP1B (PubMed:20040599).\r\n",
      "CC       {ECO:0000269|PubMed:10675335, ECO:0000269|PubMed:12717439,\r\n",
      "CC       ECO:0000269|PubMed:17050006, ECO:0000269|PubMed:17704056,\r\n",
      "CC       ECO:0000269|PubMed:18625225, ECO:0000269|PubMed:20040599,\r\n",
      "CC       ECO:0000269|PubMed:20176812, ECO:0000269|PubMed:28992046,\r\n",
      "CC       ECO:0000269|PubMed:8170954}.\r\n",
      "CC   -!- ACTIVITY REGULATION: BIRC2/c-IAP1 stimulates its transcriptional\r\n",
      "CC       activity. {ECO:0000269|PubMed:21653699}.\r\n",
      "CC   -!- SUBUNIT: Component of the DRTF1/E2F transcription factor complex. Forms\r\n",
      "CC       heterodimers with DP family members. The E2F1 complex binds\r\n",
      "CC       specifically hypophosphorylated retinoblastoma protein RB1\r\n",
      "CC       (PubMed:8336704). During the cell cycle, RB1 becomes phosphorylated in\r\n",
      "CC       mid-to-late G1 phase, detaches from the DRTF1/E2F complex, rendering\r\n",
      "CC       E2F transcriptionally active. Viral oncoproteins, notably E1A, T-\r\n",
      "CC       antigen and HPV E7, are capable of sequestering RB1, thus releasing the\r\n",
      "CC       active complex. Interacts with TRRAP, which probably mediates its\r\n",
      "CC       interaction with histone acetyltransferase complexes, leading to\r\n",
      "CC       transcription activation. Binds TOPBP1 and EAPP. Interacts with ARID3A.\r\n",
      "CC       Interacts with TRIM28; the interaction inhibits E2F1 acetylation\r\n",
      "CC       through recruiting HDAC1 and represses its transcriptional activity.\r\n",
      "CC       Interaction with KAT2B; the interaction acetylates E2F1 enhancing its\r\n",
      "CC       DNA-binding and transcriptional activity. Interacts with BIRC2/c-IAP1\r\n",
      "CC       (via BIR domains). The complex TFDP1:E2F1 interacts with CEBPA; the\r\n",
      "CC       interaction prevents CEBPA binding to target genes promoters and\r\n",
      "CC       represses its transcriptional activity (PubMed:20176812). Interacts\r\n",
      "CC       with RRP1B (PubMed:20040599). Interacts with HCFC1 (PubMed:23629655).\r\n",
      "CC       Interacts with KMT2E; the interaction is probably indirect and is\r\n",
      "CC       mediated via HCFC1 (PubMed:23629655). Interacts with DCAF5 and L3MBTL3;\r\n",
      "CC       the interaction requires methylation at Lys-185 and is necessary to\r\n",
      "CC       target E2F1 for ubiquitination by the CRL4-DCAF5 E3 ubiquitin ligase\r\n",
      "CC       complex (PubMed:29691401). {ECO:0000250|UniProtKB:Q61501,\r\n",
      "CC       ECO:0000269|PubMed:10675335, ECO:0000269|PubMed:11418595,\r\n",
      "CC       ECO:0000269|PubMed:12598654, ECO:0000269|PubMed:12697828,\r\n",
      "CC       ECO:0000269|PubMed:15716352, ECO:0000269|PubMed:16360038,\r\n",
      "CC       ECO:0000269|PubMed:17704056, ECO:0000269|PubMed:20040599,\r\n",
      "CC       ECO:0000269|PubMed:20176812, ECO:0000269|PubMed:21653699,\r\n",
      "CC       ECO:0000269|PubMed:23629655, ECO:0000269|PubMed:29691401,\r\n",
      "CC       ECO:0000269|PubMed:8336704, ECO:0000269|PubMed:9780002}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with human\r\n",
      "CC       cytomegalovirus/HHV-5 protein UL123. {ECO:0000269|PubMed:7494286}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q01094; P05067: APP; NbExp=3; IntAct=EBI-448924, EBI-77613;\r\n",
      "CC       Q01094; Q14201: BTG3; NbExp=3; IntAct=EBI-448924, EBI-948192;\r\n",
      "CC       Q01094; P49336: CDK8; NbExp=3; IntAct=EBI-448924, EBI-394377;\r\n",
      "CC       Q01094; Q92466: DDB2; NbExp=2; IntAct=EBI-448924, EBI-1176171;\r\n",
      "CC       Q01094; Q13547: HDAC1; NbExp=2; IntAct=EBI-448924, EBI-301834;\r\n",
      "CC       Q01094; Q92830: KAT2A; NbExp=3; IntAct=EBI-448924, EBI-477622;\r\n",
      "CC       Q01094; Q96JM7: L3MBTL3; NbExp=2; IntAct=EBI-448924, EBI-2686809;\r\n",
      "CC       Q01094; Q8NEM0: MCPH1; NbExp=6; IntAct=EBI-448924, EBI-1565483;\r\n",
      "CC       Q01094; Q9Y618: NCOR2; NbExp=2; IntAct=EBI-448924, EBI-80830;\r\n",
      "CC       Q01094; P09874: PARP1; NbExp=3; IntAct=EBI-448924, EBI-355676;\r\n",
      "CC       Q01094; Q96IZ0: PAWR; NbExp=2; IntAct=EBI-448924, EBI-595869;\r\n",
      "CC       Q01094; O14744: PRMT5; NbExp=8; IntAct=EBI-448924, EBI-351098;\r\n",
      "CC       Q01094; P06400: RB1; NbExp=26; IntAct=EBI-448924, EBI-491274;\r\n",
      "CC       Q01094; Q14684: RRP1B; NbExp=10; IntAct=EBI-448924, EBI-372051;\r\n",
      "CC       Q01094; Q96EB6: SIRT1; NbExp=3; IntAct=EBI-448924, EBI-1802965;\r\n",
      "CC       Q01094; P08047: SP1; NbExp=2; IntAct=EBI-448924, EBI-298336;\r\n",
      "CC       Q01094; P42224: STAT1; NbExp=2; IntAct=EBI-448924, EBI-1057697;\r\n",
      "CC       Q01094; Q14186: TFDP1; NbExp=14; IntAct=EBI-448924, EBI-749713;\r\n",
      "CC       Q01094; Q92547: TOPBP1; NbExp=3; IntAct=EBI-448924, EBI-308302;\r\n",
      "CC       Q01094; O95361: TRIM16; NbExp=2; IntAct=EBI-448924, EBI-727384;\r\n",
      "CC       Q01094; P03129: E7; Xeno; NbExp=2; IntAct=EBI-448924, EBI-866453;\r\n",
      "CC       Q01094; Q923E4: Sirt1; Xeno; NbExp=3; IntAct=EBI-448924, EBI-1802585;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20040599,\r\n",
      "CC       ECO:0000269|PubMed:28992046}.\r\n",
      "CC   -!- PTM: Phosphorylated by CDK2 and cyclin A-CDK2 in the S-phase\r\n",
      "CC       (PubMed:12717439, PubMed:7838523). Phosphorylation at Ser-364 by CHEK2\r\n",
      "CC       stabilizes E2F1 upon DNA damage and regulates its effect on\r\n",
      "CC       transcription and apoptosis (PubMed:12717439). Phosphorylation at Ser-\r\n",
      "CC       403 by GSK3B promotes interaction with USP11, leading to its\r\n",
      "CC       deubiquitination and stabilization (PubMed:28992046).\r\n",
      "CC       {ECO:0000269|PubMed:12717439, ECO:0000269|PubMed:28992046,\r\n",
      "CC       ECO:0000269|PubMed:7838523}.\r\n",
      "CC   -!- PTM: Ubiquitinated via 'Lys-63'-linked ubiquitin, leading to its\r\n",
      "CC       degradation (PubMed:28992046). Deubiquitinated by USP11 follwong\r\n",
      "CC       phosphorylation by GSK3B, promoting its stability (PubMed:28992046).\r\n",
      "CC       {ECO:0000269|PubMed:28992046}.\r\n",
      "CC   -!- PTM: Acetylation stimulates DNA-binding. Enhanced under stress\r\n",
      "CC       conditions such as DNA damage and inhibited by retinoblastoma protein\r\n",
      "CC       RB1. Regulated by KAP1/TRIM28 which recruits HDAC1 to E2F1 resulting in\r\n",
      "CC       deacetylation. Acetylated by P/CAF/KAT2B. {ECO:0000269|PubMed:10675335,\r\n",
      "CC       ECO:0000269|PubMed:17704056}.\r\n",
      "CC   -!- PTM: Methylation at Lys-185 by SETD7 promotes E2F1 ubiquitin-dependent\r\n",
      "CC       proteasomal degradation. {ECO:0000269|PubMed:20603083,\r\n",
      "CC       ECO:0000269|PubMed:29691401}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the E2F/DP family. {ECO:0000305}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=AAB24289.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};\r\n",
      "CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and\r\n",
      "CC       Haematology;\r\n",
      "CC       URL=\"https://atlasgeneticsoncology.org/gene/40382/E2F1\";\r\n",
      "CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;\r\n",
      "CC       URL=\"http://egp.gs.washington.edu/data/e2f1/\";\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; M96577; AAA35782.1; -; mRNA.\r\n",
      "DR   EMBL; U47677; AAC50719.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; U47675; AAC50719.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; U47676; AAC50719.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; S49592; AAB24289.1; ALT_INIT; mRNA.\r\n",
      "DR   EMBL; AF516106; AAM47604.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; AL121906; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; BC050369; AAH50369.1; -; mRNA.\r\n",
      "DR   EMBL; BC058902; AAH58902.1; -; mRNA.\r\n",
      "DR   EMBL; S74230; AAD14150.1; -; Genomic_DNA.\r\n",
      "DR   CCDS; CCDS13224.1; -.\r\n",
      "DR   PIR; JC4929; JC4929.\r\n",
      "DR   RefSeq; NP_005216.1; NM_005225.2.\r\n",
      "DR   PDB; 1H24; X-ray; 2.50 A; E=87-95.\r\n",
      "DR   PDB; 1O9K; X-ray; 2.60 A; P/Q/R/S=409-426.\r\n",
      "DR   PDB; 2AZE; X-ray; 2.55 A; B=200-301.\r\n",
      "DR   PDB; 5M9N; X-ray; 1.95 A; C=104-120.\r\n",
      "DR   PDB; 5M9O; X-ray; 1.45 A; B=108-116.\r\n",
      "DR   PDB; 6G0P; X-ray; 1.30 A; B=114-129.\r\n",
      "DR   PDB; 6ULS; X-ray; 1.50 A; B=114-123.\r\n",
      "DR   PDBsum; 1H24; -.\r\n",
      "DR   PDBsum; 1O9K; -.\r\n",
      "DR   PDBsum; 2AZE; -.\r\n",
      "DR   PDBsum; 5M9N; -.\r\n",
      "DR   PDBsum; 5M9O; -.\r\n",
      "DR   PDBsum; 6G0P; -.\r\n",
      "DR   PDBsum; 6ULS; -.\r\n",
      "DR   AlphaFoldDB; Q01094; -.\r\n",
      "DR   SASBDB; Q01094; -.\r\n",
      "DR   SMR; Q01094; -.\r\n",
      "DR   BioGRID; 108201; 170.\r\n",
      "DR   ComplexPortal; CPX-155; RB1-E2F1-TFDP1 transcription repressor complex.\r\n",
      "DR   ComplexPortal; CPX-1971; E2F1-DP1 transcription factor complex.\r\n",
      "DR   CORUM; Q01094; -.\r\n",
      "DR   DIP; DIP-24227N; -.\r\n",
      "DR   ELM; Q01094; -.\r\n",
      "DR   IntAct; Q01094; 65.\r\n",
      "DR   MINT; Q01094; -.\r\n",
      "DR   STRING; 9606.ENSP00000345571; -.\r\n",
      "DR   ChEMBL; CHEMBL4382; -.\r\n",
      "DR   iPTMnet; Q01094; -.\r\n",
      "DR   PhosphoSitePlus; Q01094; -.\r\n",
      "DR   BioMuta; E2F1; -.\r\n",
      "DR   DMDM; 400928; -.\r\n",
      "DR   MassIVE; Q01094; -.\r\n",
      "DR   MaxQB; Q01094; -.\r\n",
      "DR   PaxDb; Q01094; -.\r\n",
      "DR   PeptideAtlas; Q01094; -.\r\n",
      "DR   ProteomicsDB; 57915; -.\r\n",
      "DR   Antibodypedia; 3771; 1472 antibodies from 48 providers.\r\n",
      "DR   DNASU; 1869; -.\r\n",
      "DR   Ensembl; ENST00000343380.6; ENSP00000345571.5; ENSG00000101412.13.\r\n",
      "DR   GeneID; 1869; -.\r\n",
      "DR   KEGG; hsa:1869; -.\r\n",
      "DR   MANE-Select; ENST00000343380.6; ENSP00000345571.5; NM_005225.3; NP_005216.1.\r\n",
      "DR   UCSC; uc002wzu.5; human.\r\n",
      "DR   AGR; HGNC:3113; -.\r\n",
      "DR   CTD; 1869; -.\r\n",
      "DR   DisGeNET; 1869; -.\r\n",
      "DR   GeneCards; E2F1; -.\r\n",
      "DR   HGNC; HGNC:3113; E2F1.\r\n",
      "DR   HPA; ENSG00000101412; Tissue enhanced (bone).\r\n",
      "DR   MIM; 189971; gene.\r\n",
      "DR   neXtProt; NX_Q01094; -.\r\n",
      "DR   OpenTargets; ENSG00000101412; -.\r\n",
      "DR   PharmGKB; PA152; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000101412; -.\r\n",
      "DR   eggNOG; KOG2577; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00940000159472; -.\r\n",
      "DR   HOGENOM; CLU_032091_0_1_1; -.\r\n",
      "DR   InParanoid; Q01094; -.\r\n",
      "DR   OMA; HVMEQQI; -.\r\n",
      "DR   OrthoDB; 1761at2759; -.\r\n",
      "DR   PhylomeDB; Q01094; -.\r\n",
      "DR   TreeFam; TF105566; -.\r\n",
      "DR   PathwayCommons; Q01094; -.\r\n",
      "DR   Reactome; R-HSA-111448; Activation of NOXA and translocation to mitochondria.\r\n",
      "DR   Reactome; R-HSA-113501; Inhibition of replication initiation of damaged DNA by RB1/E2F1.\r\n",
      "DR   Reactome; R-HSA-1362277; Transcription of E2F targets under negative control by DREAM complex.\r\n",
      "DR   Reactome; R-HSA-1362300; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1.\r\n",
      "DR   Reactome; R-HSA-139915; Activation of PUMA and translocation to mitochondria.\r\n",
      "DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.\r\n",
      "DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.\r\n",
      "DR   Reactome; R-HSA-2559585; Oncogene Induced Senescence.\r\n",
      "DR   Reactome; R-HSA-6804116; TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest.\r\n",
      "DR   Reactome; R-HSA-68911; G2 Phase.\r\n",
      "DR   Reactome; R-HSA-69202; Cyclin E associated events during G1/S transition.\r\n",
      "DR   Reactome; R-HSA-69205; G1/S-Specific Transcription.\r\n",
      "DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.\r\n",
      "DR   Reactome; R-HSA-69656; Cyclin A:Cdk2-associated events at S phase entry.\r\n",
      "DR   Reactome; R-HSA-8953750; Transcriptional Regulation by E2F6.\r\n",
      "DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.\r\n",
      "DR   Reactome; R-HSA-9661069; Defective binding of RB1 mutants to E2F1,(E2F2, E2F3).\r\n",
      "DR   SignaLink; Q01094; -.\r\n",
      "DR   SIGNOR; Q01094; -.\r\n",
      "DR   BioGRID-ORCS; 1869; 91 hits in 1191 CRISPR screens.\r\n",
      "DR   ChiTaRS; E2F1; human.\r\n",
      "DR   EvolutionaryTrace; Q01094; -.\r\n",
      "DR   GeneWiki; E2F1; -.\r\n",
      "DR   GenomeRNAi; 1869; -.\r\n",
      "DR   Pharos; Q01094; Tbio.\r\n",
      "DR   PRO; PR:Q01094; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 20.\r\n",
      "DR   RNAct; Q01094; protein.\r\n",
      "DR   Bgee; ENSG00000101412; Expressed in ganglionic eminence and 150 other tissues.\r\n",
      "DR   Genevisible; Q01094; HS.\r\n",
      "DR   GO; GO:0005813; C:centrosome; IDA:HPA.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IDA:BHF-UCL.\r\n",
      "DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.\r\n",
      "DR   GO; GO:0000228; C:nuclear chromosome; IEA:Ensembl.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; IDA:BHF-UCL.\r\n",
      "DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; IPI:ComplexPortal.\r\n",
      "DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0001216; F:DNA-binding transcription activator activity; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0060090; F:molecular adaptor activity; EXP:DisProt.\r\n",
      "DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.\r\n",
      "DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.\r\n",
      "DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.\r\n",
      "DR   GO; GO:0043276; P:anoikis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071398; P:cellular response to fatty acid; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.\r\n",
      "DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0000077; P:DNA damage checkpoint signaling; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0006351; P:DNA-templated transcription; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IEA:Ensembl.\r\n",
      "DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IMP:UniProtKB.\r\n",
      "DR   GO; GO:1990086; P:lens fiber cell apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0048255; P:mRNA stabilization; IDA:BHF-UCL.\r\n",
      "DR   GO; GO:0043392; P:negative regulation of DNA binding; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IDA:ComplexPortal.\r\n",
      "DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0070345; P:negative regulation of fat cell proliferation; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:BHF-UCL.\r\n",
      "DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:BHF-UCL.\r\n",
      "DR   GO; GO:0060252; P:positive regulation of glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IDA:UniProtKB.\r\n",
      "DR   GO; GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.\r\n",
      "DR   GO; GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; IDA:ComplexPortal.\r\n",
      "DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.\r\n",
      "DR   CDD; cd14660; E2F_DD; 1.\r\n",
      "DR   DisProt; DP01427; -.\r\n",
      "DR   Gene3D; 6.10.250.540; -; 1.\r\n",
      "DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.\r\n",
      "DR   IDEAL; IID00064; -.\r\n",
      "DR   InterPro; IPR015633; E2F.\r\n",
      "DR   InterPro; IPR037241; E2F-DP_heterodim.\r\n",
      "DR   InterPro; IPR032198; E2F_CC-MB.\r\n",
      "DR   InterPro; IPR003316; E2F_WHTH_DNA-bd_dom.\r\n",
      "DR   InterPro; IPR036388; WH-like_DNA-bd_sf.\r\n",
      "DR   InterPro; IPR036390; WH_DNA-bd_sf.\r\n",
      "DR   PANTHER; PTHR12081; TRANSCRIPTION FACTOR E2F; 1.\r\n",
      "DR   PANTHER; PTHR12081:SF43; TRANSCRIPTION FACTOR E2F1; 1.\r\n",
      "DR   Pfam; PF16421; E2F_CC-MB; 1.\r\n",
      "DR   Pfam; PF02319; E2F_TDP; 1.\r\n",
      "DR   SMART; SM01372; E2F_TDP; 1.\r\n",
      "DR   SUPFAM; SSF144074; E2F-DP heterodimerization region; 1.\r\n",
      "DR   SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Acetylation; Activator; Apoptosis; Cell cycle; DNA-binding;\r\n",
      "KW   Host-virus interaction; Methylation; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Transcription; Transcription regulation;\r\n",
      "KW   Ubl conjugation.\r\n",
      "FT   CHAIN           1..437\r\n",
      "FT                   /note=\"Transcription factor E2F1\"\r\n",
      "FT                   /id=\"PRO_0000219461\"\r\n",
      "FT   DNA_BIND        110..194\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   REGION          42..87\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          67..108\r\n",
      "FT                   /note=\"Cyclin A:CDK2 binding\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8033208\"\r\n",
      "FT   REGION          89..191\r\n",
      "FT                   /note=\"Interaction with BIRC2/c-IAP1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:21653699\"\r\n",
      "FT   REGION          101..128\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          153..174\r\n",
      "FT                   /note=\"Leucine-zipper\"\r\n",
      "FT   REGION          192..382\r\n",
      "FT                   /note=\"Required for interaction with TRIM28\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:17704056\"\r\n",
      "FT   REGION          195..284\r\n",
      "FT                   /note=\"Dimerization\"\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   REGION          300..349\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          368..437\r\n",
      "FT                   /note=\"Transactivation\"\r\n",
      "FT   REGION          409..426\r\n",
      "FT                   /note=\"RB1 binding\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:12598654\"\r\n",
      "FT   MOTIF           158..194\r\n",
      "FT                   /note=\"DEF box\"\r\n",
      "FT   MOD_RES         117\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10675335\"\r\n",
      "FT   MOD_RES         120\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10675335\"\r\n",
      "FT   MOD_RES         125\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10675335\"\r\n",
      "FT   MOD_RES         185\r\n",
      "FT                   /note=\"N6-methyllysine; by SETD7\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20603083\"\r\n",
      "FT   MOD_RES         364\r\n",
      "FT                   /note=\"Phosphoserine; by CHEK2\"\r\n",
      "FT                   /evidence=\"ECO:0000305|PubMed:12717439\"\r\n",
      "FT   MOD_RES         375\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332\"\r\n",
      "FT   MOD_RES         403\r\n",
      "FT                   /note=\"Phosphoserine; by GSK3-beta\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:17050006,\r\n",
      "FT                   ECO:0000269|PubMed:28992046\"\r\n",
      "FT   MOD_RES         433\r\n",
      "FT                   /note=\"Phosphothreonine; by GSK3-beta\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:17050006\"\r\n",
      "FT   VARIANT         200\r\n",
      "FT                   /note=\"G -> S (in dbSNP:rs35385772)\"\r\n",
      "FT                   /id=\"VAR_048907\"\r\n",
      "FT   VARIANT         252\r\n",
      "FT                   /note=\"R -> H (in dbSNP:rs3213172)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|Ref.5\"\r\n",
      "FT                   /id=\"VAR_013607\"\r\n",
      "FT   VARIANT         276\r\n",
      "FT                   /note=\"V -> M (in dbSNP:rs3213173)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|Ref.5\"\r\n",
      "FT                   /id=\"VAR_013608\"\r\n",
      "FT   VARIANT         311\r\n",
      "FT                   /note=\"T -> N (in dbSNP:rs3213174)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|Ref.5\"\r\n",
      "FT                   /id=\"VAR_013609\"\r\n",
      "FT   VARIANT         393\r\n",
      "FT                   /note=\"G -> S (in dbSNP:rs3213176)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|Ref.5\"\r\n",
      "FT                   /id=\"VAR_013610\"\r\n",
      "FT   MUTAGEN         117\r\n",
      "FT                   /note=\"K->R: Abolishes acetylation; when associated with\r\n",
      "FT                   R-120 and R-125.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10675335\"\r\n",
      "FT   MUTAGEN         120\r\n",
      "FT                   /note=\"K->R: Abolishes acetylation; when associated with\r\n",
      "FT                   R-117 and R-125.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10675335\"\r\n",
      "FT   MUTAGEN         125\r\n",
      "FT                   /note=\"K->R: Abolishes acetylation; when associated with\r\n",
      "FT                   R-117 and R-120.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10675335\"\r\n",
      "FT   MUTAGEN         132\r\n",
      "FT                   /note=\"L->E: Abolishes interaction with and repression of\r\n",
      "FT                   CEBPA and inhibition of adipogenesis.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20176812\"\r\n",
      "FT   MUTAGEN         185\r\n",
      "FT                   /note=\"K->R: Abrogates methylation by SETD7. Loss of\r\n",
      "FT                   interaction with L3MBTL3. Loss of ubiquitination by the\r\n",
      "FT                   CRL4-DCAF5 E3 ubiquitin ligase complex.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20603083,\r\n",
      "FT                   ECO:0000269|PubMed:29691401\"\r\n",
      "FT   MUTAGEN         364\r\n",
      "FT                   /note=\"S->A: Abrogates in vitro phosphorylation by CHEK2\r\n",
      "FT                   and CHEK2-dependent stabilization of E2F1 upon DNA damage.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:12717439\"\r\n",
      "FT   MUTAGEN         403\r\n",
      "FT                   /note=\"S->A: Decreased phosphorylation by GSK3B, leading to\r\n",
      "FT                   abolished interaction with USP11 and subsequent\r\n",
      "FT                   deubiquitination.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:17050006,\r\n",
      "FT                   ECO:0000269|PubMed:28992046\"\r\n",
      "FT   MUTAGEN         411\r\n",
      "FT                   /note=\"Y->C: No retinoblastoma protein binding. No effect\r\n",
      "FT                   on interaction with and repression of CEBPA.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20176812,\r\n",
      "FT                   ECO:0000269|PubMed:8413249\"\r\n",
      "FT   MUTAGEN         433\r\n",
      "FT                   /note=\"T->A: Decreased phosphorylation by GSK3B.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:17050006\"\r\n",
      "FT   CONFLICT        89..111\r\n",
      "FT                   /note=\"KRRLDLETDHQYLAESSGPARGR -> RTPGTPRRQRRLCPPRRPGRAPC\r\n",
      "FT                   (in Ref. 8; AAD14150)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        313\r\n",
      "FT                   /note=\"S -> Y (in Ref. 4; AAC50719)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        322\r\n",
      "FT                   /note=\"N -> T (in Ref. 4; AAC50719)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        329\r\n",
      "FT                   /note=\"T -> N (in Ref. 4; AAC50719)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   HELIX           202..236\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   HELIX           238..243\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   STRAND          245..247\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   HELIX           248..252\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   TURN            257..259\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   STRAND          260..266\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   STRAND          272..277\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   STRAND          282..287\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   STRAND          289..291\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   STRAND          294..296\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   HELIX           421..424\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:1O9K\"\r\n",
      "SQ   SEQUENCE   437 AA;  46920 MW;  003B3F654F0C60DF CRC64;\r\n",
      "     MALAGAPAGG PCAPALEALL GAGALRLLDS SQIVIISAAQ DASAPPAPTG PAAPAAGPCD\r\n",
      "     PDLLLFATPQ APRPTPSAPR PALGRPPVKR RLDLETDHQY LAESSGPARG RGRHPGKGVK\r\n",
      "     SPGEKSRYET SLNLTTKRFL ELLSHSADGV VDLNWAAEVL KVQKRRIYDI TNVLEGIQLI\r\n",
      "     AKKSKNHIQW LGSHTTVGVG GRLEGLTQDL RQLQESEQQL DHLMNICTTQ LRLLSEDTDS\r\n",
      "     QRLAYVTCQD LRSIADPAEQ MVMVIKAPPE TQLQAVDSSE NFQISLKSKQ GPIDVFLCPE\r\n",
      "     ETVGGISPGK TPSQEVTSEE ENRATDSATI VSPPPSSPPS SLTTDPSQSL LSLEQEPLLS\r\n",
      "     RMGSLRAPVD EDRLSPLVAA DSLLEHVRED FSGLLPEEFI SLSPPHEALD YHFGLEEGEG\r\n",
      "     IRDLFDCDFG DLTPLDF\r\n",
      "//\r\n",
      "ID   RB_RAT                  Reviewed;         920 AA.\r\n",
      "AC   P33568; Q63527;\r\n",
      "DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   09-FEB-2010, sequence version 3.\r\n",
      "DT   03-MAY-2023, entry version 191.\r\n",
      "DE   RecName: Full=Retinoblastoma-associated protein;\r\n",
      "DE   AltName: Full=pRb;\r\n",
      "DE            Short=Rb;\r\n",
      "DE   AltName: Full=pp105;\r\n",
      "GN   Name=Rb1; Synonyms=Rb-1;\r\n",
      "OS   Rattus norvegicus (Rat).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Rattus.\r\n",
      "OX   NCBI_TaxID=10116;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RC   STRAIN=Brown Norway;\r\n",
      "RX   PubMed=15057822; DOI=10.1038/nature02426;\r\n",
      "RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,\r\n",
      "RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,\r\n",
      "RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,\r\n",
      "RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,\r\n",
      "RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,\r\n",
      "RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,\r\n",
      "RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,\r\n",
      "RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,\r\n",
      "RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,\r\n",
      "RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,\r\n",
      "RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,\r\n",
      "RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,\r\n",
      "RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,\r\n",
      "RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,\r\n",
      "RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,\r\n",
      "RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,\r\n",
      "RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,\r\n",
      "RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,\r\n",
      "RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,\r\n",
      "RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,\r\n",
      "RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,\r\n",
      "RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,\r\n",
      "RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,\r\n",
      "RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,\r\n",
      "RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,\r\n",
      "RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,\r\n",
      "RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,\r\n",
      "RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,\r\n",
      "RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,\r\n",
      "RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,\r\n",
      "RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,\r\n",
      "RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,\r\n",
      "RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,\r\n",
      "RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,\r\n",
      "RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,\r\n",
      "RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,\r\n",
      "RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,\r\n",
      "RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,\r\n",
      "RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,\r\n",
      "RA   Mockrin S., Collins F.S.;\r\n",
      "RT   \"Genome sequence of the Brown Norway rat yields insights into mammalian\r\n",
      "RT   evolution.\";\r\n",
      "RL   Nature 428:493-521(2004).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 22-920.\r\n",
      "RC   STRAIN=Sprague-Dawley; TISSUE=Liver;\r\n",
      "RX   PubMed=7665085; DOI=10.1016/0378-1119(95)00154-x;\r\n",
      "RA   Esumi M., Idutsu T., Kinugasa S., Ohno M., Nakabayashi H., Ikeda T.,\r\n",
      "RA   Shikata T.;\r\n",
      "RT   \"Isolation and sequence polymorphism of a rat retinoblastoma (RB) cDNA.\";\r\n",
      "RL   Gene 161:231-235(1995).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 806-920.\r\n",
      "RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;\r\n",
      "RX   PubMed=8441612; DOI=10.1093/nar/21.1.170;\r\n",
      "RA   Roy N.K., Ballesteros A., Garte S.J.;\r\n",
      "RT   \"Cloning and sequence of the rat retinoblastoma (Rb) gene cDNA.\";\r\n",
      "RL   Nucleic Acids Res. 21:170-170(1993).\r\n",
      "RN   [4]\r\n",
      "RP   INTERACTION WITH RBBP9.\r\n",
      "RX   PubMed=9697699; DOI=10.1038/1258;\r\n",
      "RA   Woitach J.T., Zhang M., Niu C.-H., Thorgeirsson S.S.;\r\n",
      "RT   \"A retinoblastoma-binding protein that affects cell-cycle control and\r\n",
      "RT   confers transforming ability.\";\r\n",
      "RL   Nat. Genet. 19:371-374(1998).\r\n",
      "RN   [5]\r\n",
      "RP   PHOSPHORYLATION BY CDK1 AND CDK2, AND INTERACTION WITH CDK1 AND CDK2.\r\n",
      "RX   PubMed=10542199; DOI=10.1074/jbc.274.45.31775;\r\n",
      "RA   Choi K.S., Eom Y.W., Kang Y., Ha M.J., Rhee H., Yoon J.-W., Kim S.-J.;\r\n",
      "RT   \"Cdc2 and Cdk2 kinase activated by transforming growth factor-beta1 trigger\r\n",
      "RT   apoptosis through the phosphorylation of retinoblastoma protein in FaO\r\n",
      "RT   hepatoma cells.\";\r\n",
      "RL   J. Biol. Chem. 274:31775-31783(1999).\r\n",
      "RN   [6]\r\n",
      "RP   INTERACTION WITH DNMT1.\r\n",
      "RX   PubMed=10888886; DOI=10.1038/77124;\r\n",
      "RA   Robertson K.D., Ait-Si-Ali S., Yokochi T., Wade P.A., Jones P.L.,\r\n",
      "RA   Wolffe A.P.;\r\n",
      "RT   \"DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription\r\n",
      "RT   from E2F-responsive promoters.\";\r\n",
      "RL   Nat. Genet. 25:338-342(2000).\r\n",
      "RN   [7]\r\n",
      "RP   FUNCTION, INTERACTION WITH SMARCA4 AND HDAC1, PHOSPHORYLATION AT SER-787,\r\n",
      "RP   DEPHOSPHORYLATION, AND MUTAGENESIS OF SER-772; SER-780 AND SER-787.\r\n",
      "RX   PubMed=19081374; DOI=10.1016/j.neuron.2008.09.040;\r\n",
      "RA   Qiu Z., Ghosh A.;\r\n",
      "RT   \"A calcium-dependent switch in a CREST-BRG1 complex regulates activity-\r\n",
      "RT   dependent gene expression.\";\r\n",
      "RL   Neuron 60:775-787(2008).\r\n",
      "RN   [8]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; THR-363; THR-366 AND\r\n",
      "RP   SER-799, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=22673903; DOI=10.1038/ncomms1871;\r\n",
      "RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,\r\n",
      "RA   Olsen J.V.;\r\n",
      "RT   \"Quantitative maps of protein phosphorylation sites across 14 different rat\r\n",
      "RT   organs and tissues.\";\r\n",
      "RL   Nat. Commun. 3:876-876(2012).\r\n",
      "CC   -!- FUNCTION: Tumor suppressor that is a key regulator of the G1/S\r\n",
      "CC       transition of the cell cycle. The hypophosphorylated form binds\r\n",
      "CC       transcription regulators of the E2F family, preventing transcription of\r\n",
      "CC       E2F-responsive genes. Both physically blocks E2Fs transactivating\r\n",
      "CC       domain and recruits chromatin-modifying enzymes that actively repress\r\n",
      "CC       transcription. Cyclin and CDK-dependent phosphorylation of RB1 induces\r\n",
      "CC       its dissociation from E2Fs, thereby activating transcription of E2F\r\n",
      "CC       responsive genes and triggering entry into S phase. RB1 also promotes\r\n",
      "CC       the G0-G1 transition upon phosphorylation and activation by\r\n",
      "CC       CDK3/cyclin-C. Directly involved in heterochromatin formation by\r\n",
      "CC       maintaining overall chromatin structure and, in particular, that of\r\n",
      "CC       constitutive heterochromatin by stabilizing histone methylation.\r\n",
      "CC       Recruits and targets histone methyltransferases SUV39H1, KMT5B and\r\n",
      "CC       KMT5C, leading to epigenetic transcriptional repression. Controls\r\n",
      "CC       histone H4 'Lys-20' trimethylation. Inhibits the intrinsic kinase\r\n",
      "CC       activity of TAF1. Mediates transcriptional repression by SMARCA4/BRG1\r\n",
      "CC       by recruiting a histone deacetylase (HDAC) complex to the c-FOS\r\n",
      "CC       promoter (PubMed:19081374). In resting neurons, transcription of the c-\r\n",
      "CC       FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-\r\n",
      "CC       RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is\r\n",
      "CC       dephosphorylated by calcineurin, which leads to release of the\r\n",
      "CC       repressor complex (By similarity). {ECO:0000250|UniProtKB:P06400,\r\n",
      "CC       ECO:0000250|UniProtKB:P13405, ECO:0000269|PubMed:19081374}.\r\n",
      "CC   -!- SUBUNIT: The hypophosphorylated form interacts with and sequesters the\r\n",
      "CC       E2F1 transcription factor. Interacts with heterodimeric E2F/DP\r\n",
      "CC       transcription factor complexes containing TFDP1 and either E2F1, E2F3,\r\n",
      "CC       E2F4 or E2F5, or TFDP2 and E2F4. The unphosphorylated form interacts\r\n",
      "CC       with EID1, ARID3B, KDM5A, SUV39H1, MJD2A/JHDM3A and THOC1. Interacts\r\n",
      "CC       with the N-terminal domain of TAF1. Interacts with SNW1, ATAD5, AATF,\r\n",
      "CC       DNMT1, LIN9, LMNA, KMT5B, KMT5C, PELP1, UHRF2 and TMPO-alpha. May\r\n",
      "CC       interact with NDC80. Interacts with GRIP1 and UBR4. Interacts with\r\n",
      "CC       ARID4A and KDM5B. Interacts with E4F1, LIMD1 and USP4. Interacts with\r\n",
      "CC       PRMT2. Interacts (when methylated at Lys-852) with L3MBTL. Interacts\r\n",
      "CC       with CHEK2; phosphorylates RB1 (By similarity). Interacts with\r\n",
      "CC       SMARCA4/BRG1 and HDAC1. Binds to CDK1 and CDK2. P-TEFB complex\r\n",
      "CC       interacts with RB1; promotes phosphorylation of RB1 (By similarity).\r\n",
      "CC       Interacts with RBBP9; the interaction disrupts RB1 binding to E2F1\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CC       (PubMed:9697699). Interacts with KAT2B/PCAF and EP300/P300 (By\r\n",
      "CC       similarity). Interacts with PAX5 (By similarity).\r\n",
      "CC       {ECO:0000250|UniProtKB:P06400, ECO:0000250|UniProtKB:P13405,\r\n",
      "CC       ECO:0000269|PubMed:10542199, ECO:0000269|PubMed:10888886,\r\n",
      "CC       ECO:0000269|PubMed:19081374, ECO:0000269|PubMed:9697699}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       P33568; O09139: E2f1; NbExp=2; IntAct=EBI-1162932, EBI-1211101;\r\n",
      "CC       P33568; O88350: Rbbp9; NbExp=4; IntAct=EBI-1162932, EBI-1211014;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P13405}.\r\n",
      "CC   -!- PTM: Phosphorylated by CDK6 and CDK4, and subsequently by CDK2 at Ser-\r\n",
      "CC       560 in G1, thereby releasing E2F1 which is then able to activate cell\r\n",
      "CC       growth. Dephosphorylated at the late M phase. Phosphorylation of\r\n",
      "CC       threonine residues in domain C promotes interaction between the C-\r\n",
      "CC       terminal domain C and the Pocket domain, and thereby inhibits\r\n",
      "CC       interactions with heterodimeric E2F/DP transcription factor complexes.\r\n",
      "CC       CDK3/cyclin-C-mediated phosphorylation at Ser-799 and Ser-803 is\r\n",
      "CC       required for G0-G1 transition (By similarity). Dephosphorylated at Ser-\r\n",
      "CC       787 by calcineruin upon calcium stimulation. {ECO:0000250,\r\n",
      "CC       ECO:0000269|PubMed:10542199, ECO:0000269|PubMed:19081374}.\r\n",
      "CC   -!- PTM: N-terminus is methylated by METTL11A/NTM1. Monomethylation at Lys-\r\n",
      "CC       802 by SMYD2 enhances phosphorylation at Ser-799 and Ser-803, and\r\n",
      "CC       promotes cell cycle progression. Monomethylation at Lys-852 by SMYD2\r\n",
      "CC       promotes interaction with L3MBTL1 (By similarity). {ECO:0000250}.\r\n",
      "CC   -!- PTM: Acetylated during keratinocyte differentiation. Acetylation at\r\n",
      "CC       Ser-799 and Ser-803 regulates subcellular localization. Can be\r\n",
      "CC       deacetylated by SIRT1. {ECO:0000250|UniProtKB:P06400}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; D25233; BAA04958.1; -; mRNA.\r\n",
      "DR   EMBL; L07126; AAA42090.1; -; mRNA.\r\n",
      "DR   PIR; S35544; S35544.\r\n",
      "DR   RefSeq; NP_058741.1; NM_017045.1.\r\n",
      "DR   AlphaFoldDB; P33568; -.\r\n",
      "DR   SMR; P33568; -.\r\n",
      "DR   BioGRID; 246837; 5.\r\n",
      "DR   IntAct; P33568; 3.\r\n",
      "DR   STRING; 10116.ENSRNOP00000021752; -.\r\n",
      "DR   iPTMnet; P33568; -.\r\n",
      "DR   PhosphoSitePlus; P33568; -.\r\n",
      "DR   PaxDb; P33568; -.\r\n",
      "DR   DNASU; 24708; -.\r\n",
      "DR   Ensembl; ENSRNOT00000021752.6; ENSRNOP00000021752.6; ENSRNOG00000016029.6.\r\n",
      "DR   GeneID; 24708; -.\r\n",
      "DR   KEGG; rno:24708; -.\r\n",
      "DR   UCSC; RGD:3540; rat.\r\n",
      "DR   AGR; RGD:3540; -.\r\n",
      "DR   CTD; 5925; -.\r\n",
      "DR   RGD; 3540; Rb1.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   InParanoid; P33568; -.\r\n",
      "DR   OMA; VKDIGCI; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; P33568; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   Reactome; R-RNO-113501; Inhibition of replication initiation of damaged DNA by RB1/E2F1.\r\n",
      "DR   Reactome; R-RNO-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.\r\n",
      "DR   Reactome; R-RNO-2299718; Condensation of Prophase Chromosomes.\r\n",
      "DR   Reactome; R-RNO-2559584; Formation of Senescence-Associated Heterochromatin Foci (SAHF).\r\n",
      "DR   Reactome; R-RNO-69200; Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes.\r\n",
      "DR   Reactome; R-RNO-69202; Cyclin E associated events during G1/S transition.\r\n",
      "DR   Reactome; R-RNO-69231; Cyclin D associated events in G1.\r\n",
      "DR   Reactome; R-RNO-69656; Cyclin A:Cdk2-associated events at S phase entry.\r\n",
      "DR   PRO; PR:P33568; -.\r\n",
      "DR   Proteomes; UP000002494; Chromosome 15.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0061793; C:chromatin lock complex; ISO:RGD.\r\n",
      "DR   GO; GO:0008024; C:cyclin/CDK positive transcription elongation factor complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; ISO:RGD.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IDA:RGD.\r\n",
      "DR   GO; GO:0016605; C:PML body; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0005819; C:spindle; ISO:RGD.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.\r\n",
      "DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.\r\n",
      "DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.\r\n",
      "DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.\r\n",
      "DR   GO; GO:0061676; F:importin-alpha family protein binding; ISO:RGD.\r\n",
      "DR   GO; GO:0019900; F:kinase binding; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.\r\n",
      "DR   GO; GO:0051219; F:phosphoprotein binding; ISO:RGD.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.\r\n",
      "DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.\r\n",
      "DR   GO; GO:0003180; P:aortic valve morphogenesis; ISO:RGD.\r\n",
      "DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0051301; P:cell division; ISO:RGD.\r\n",
      "DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.\r\n",
      "DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISO:RGD.\r\n",
      "DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; ISO:RGD.\r\n",
      "DR   GO; GO:0002062; P:chondrocyte differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0051276; P:chromosome organization; ISO:RGD.\r\n",
      "DR   GO; GO:0048565; P:digestive tract development; ISO:RGD.\r\n",
      "DR   GO; GO:0043353; P:enucleate erythrocyte differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.\r\n",
      "DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; ISO:RGD.\r\n",
      "DR   GO; GO:0034349; P:glial cell apoptotic process; ISO:RGD.\r\n",
      "DR   GO; GO:0014009; P:glial cell proliferation; ISO:RGD.\r\n",
      "DR   GO; GO:0097284; P:hepatocyte apoptotic process; ISO:RGD.\r\n",
      "DR   GO; GO:0031507; P:heterochromatin formation; ISO:RGD.\r\n",
      "DR   GO; GO:0034088; P:maintenance of mitotic sister chromatid cohesion; ISO:RGD.\r\n",
      "DR   GO; GO:0045445; P:myoblast differentiation; ISS:UniProtKB.\r\n",
      "DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IMP:ARUK-UCL.\r\n",
      "DR   GO; GO:0045786; P:negative regulation of cell cycle; IMP:ARUK-UCL.\r\n",
      "DR   GO; GO:0030308; P:negative regulation of cell growth; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.\r\n",
      "DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.\r\n",
      "DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; ISO:RGD.\r\n",
      "DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.\r\n",
      "DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; ISO:RGD.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; ISO:RGD.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.\r\n",
      "DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; ISO:RGD.\r\n",
      "DR   GO; GO:1903944; P:negative regulation of hepatocyte apoptotic process; IMP:RGD.\r\n",
      "DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.\r\n",
      "DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; ISO:RGD.\r\n",
      "DR   GO; GO:1904761; P:negative regulation of myofibroblast differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0006469; P:negative regulation of protein kinase activity; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IMP:ARUK-UCL.\r\n",
      "DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; ISO:RGD.\r\n",
      "DR   GO; GO:1902948; P:negative regulation of tau-protein kinase activity; IMP:ARUK-UCL.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.\r\n",
      "DR   GO; GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; ISO:RGD.\r\n",
      "DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.\r\n",
      "DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0042551; P:neuron maturation; ISO:RGD.\r\n",
      "DR   GO; GO:0031175; P:neuron projection development; ISO:RGD.\r\n",
      "DR   GO; GO:1904028; P:positive regulation of collagen fibril organization; ISO:RGD.\r\n",
      "DR   GO; GO:1903055; P:positive regulation of extracellular matrix organization; ISO:RGD.\r\n",
      "DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; ISO:RGD.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.\r\n",
      "DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; ISO:RGD.\r\n",
      "DR   GO; GO:0071459; P:protein localization to chromosome, centromeric region; ISO:RGD.\r\n",
      "DR   GO; GO:0007265; P:Ras protein signal transduction; ISO:RGD.\r\n",
      "DR   GO; GO:0051726; P:regulation of cell cycle; ISO:RGD.\r\n",
      "DR   GO; GO:0001558; P:regulation of cell growth; ISO:RGD.\r\n",
      "DR   GO; GO:0071922; P:regulation of cohesin loading; ISO:RGD.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0007346; P:regulation of mitotic cell cycle; ISO:RGD.\r\n",
      "DR   GO; GO:0031134; P:sister chromatid biorientation; ISO:RGD.\r\n",
      "DR   GO; GO:0035914; P:skeletal muscle cell differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0007224; P:smoothened signaling pathway; ISO:RGD.\r\n",
      "DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.\r\n",
      "DR   GO; GO:0051146; P:striated muscle cell differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0001894; P:tissue homeostasis; ISO:RGD.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.\r\n",
      "DR   CDD; cd20599; CYCLIN_RB; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 6.10.140.1380; -; 1.\r\n",
      "DR   Gene3D; 6.10.250.530; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 2.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Acetylation; Cell cycle; Chromatin regulator; DNA-binding; Methylation;\r\n",
      "KW   Nucleus; Phosphoprotein; Reference proteome; Repressor; Transcription;\r\n",
      "KW   Transcription regulation; Tumor suppressor.\r\n",
      "FT   INIT_MET        1\r\n",
      "FT                   /note=\"Removed\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   CHAIN           2..920\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein\"\r\n",
      "FT                   /id=\"PRO_0000167838\"\r\n",
      "FT   REGION          1..34\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          340..362\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          366..763\r\n",
      "FT                   /note=\"Pocket; binds T and E1A\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          366..572\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          573..631\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          632..763\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          755..920\r\n",
      "FT                   /note=\"Interaction with LIMD1\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          763..920\r\n",
      "FT                   /note=\"Domain C; mediates interaction with E4F1\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          895..920\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOTIF           852..868\r\n",
      "FT                   /note=\"Bipartite nuclear localization signal\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   COMPBIAS        1..25\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        340..355\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        895..910\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         2\r\n",
      "FT                   /note=\"N,N-dimethylproline\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   MOD_RES         30\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         242\r\n",
      "FT                   /note=\"Phosphoserine; by CDK1\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         245\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK1\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         349\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         363\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         366\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         560\r\n",
      "FT                   /note=\"Phosphoserine; by CDK2\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         600\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   MOD_RES         604\r\n",
      "FT                   /note=\"Phosphoserine; by CHEK2 and CHEK1\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         616\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         772\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400, ECO:0000255\"\r\n",
      "FT   MOD_RES         780\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400, ECO:0000255\"\r\n",
      "FT   MOD_RES         787\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:19081374\"\r\n",
      "FT   MOD_RES         799\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         802\r\n",
      "FT                   /note=\"N6-methyllysine; by SMYD2\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         803\r\n",
      "FT                   /note=\"Phosphoserine; by CDK1 and CDK3\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         813\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK6\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         815\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         818\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK4\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         833\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         847\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         852\r\n",
      "FT                   /note=\"N6-methyllysine; by SMYD2\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         865\r\n",
      "FT                   /note=\"N6-acetyllysine; by PCAF\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         866\r\n",
      "FT                   /note=\"N6-acetyllysine; by PCAF\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MUTAGEN         772\r\n",
      "FT                   /note=\"S->A: Decreased association with HDAC1; when\r\n",
      "FT                   associated with A-780 and A-787.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:19081374\"\r\n",
      "FT   MUTAGEN         780\r\n",
      "FT                   /note=\"S->A: Decreased association with HDAC1; when\r\n",
      "FT                   associated with A-772 and A-787.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:19081374\"\r\n",
      "FT   MUTAGEN         787\r\n",
      "FT                   /note=\"S->A: Decreased association with HDAC1; when\r\n",
      "FT                   associated with A-772 and A-780.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:19081374\"\r\n",
      "FT   CONFLICT        668\r\n",
      "FT                   /note=\"L -> P (in Ref. 2; BAA04958)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        798\r\n",
      "FT                   /note=\"I -> M (in Ref. 2; BAA04958)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        866..867\r\n",
      "FT                   /note=\"KL -> TW (in Ref. 3; AAA42090)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   920 AA;  105025 MW;  3BA735EA59927301 CRC64;\r\n",
      "     MPPKAPRRTA AAEPPPPPPP PPEDDPAQDS DPEELPLIRL EFEKIEEPEF IALCQKLKVP\r\n",
      "     DHVRERAWLT WEKVSSVDGI LEGYIQKKKE LWGICIFIAA VDLDEMPFTF TELQKSIETS\r\n",
      "     VYKFFDLLKE IDTSTKVDNA VSRLLKKYNV LCALYSKLER TCGLIYLTQP SSGLSTEINS\r\n",
      "     MLVLKVSWIT FLLAKGEVVQ MEDDLVISFQ LMLCVLDYFI KLSPPALLRE PYKTAATPIN\r\n",
      "     GSPRTPRRGQ NRSARIAKQL ESDTRTIEVL CKEHECNVDE VKNVYFKNFI PFISSLGIVS\r\n",
      "     SNGLPELESL SKRYEEVYLK SKDLDARLFL DHDKTLQTDT IDSFETERTP RKSNPDEEAN\r\n",
      "     MVTPHTPVRT VMNTIQQLMV ILNSASDQPS ENLISYFSNC TVNPKENILK RVKDVGHIFK\r\n",
      "     EKFASAVGQG CIDIGAQRYK LGVRLYYRVM ESMLKSEEER LSIQNFSKLL NDNIFHMSLL\r\n",
      "     ACALEVVMAT YSRSMLQNLD SGTDLSFPWI LNVLNLKAFD FYKVIESFIK VEANLTREMI\r\n",
      "     KHLERCEHRI MESLAWLSDS PLFDLIKQSK DGEGPDHLES ACSLSLPLQS NHTAADMYLS\r\n",
      "     PIRSPKKRTS TTRVNSAANT ETQAASAFHT QKPLKSTSLS LFYKKVYRLA YLRLNTLCAR\r\n",
      "     LLSDHPELEH IIWTLFQHTL ENEYELMKDR HLDQIMMCSM YGICKVKNID LKFKIIVTAY\r\n",
      "     KDLPHAAQET FKRVLIREEE FDSIIVFYNS VFMQRLKTNI LQYASTRPPT LSPIPHIPRS\r\n",
      "     PYKFSSSPLR IPGGNIYISP LKSPYKISEG LPTPTKMTPR SRILVSIGES FGTSEKFQKI\r\n",
      "     NQMVCNSDRV LKRSAEGGNP PKPLKKLRFD IEGSDEADGS KHLPAESKFQ QKLAEMTSTR\r\n",
      "     TRMQKQKLND SMEISNKEEK\r\n",
      "//\r\n",
      "ID   RBL2_MOUSE              Reviewed;        1135 AA.\r\n",
      "AC   Q64700; Q3TVP8;\r\n",
      "DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   27-JUL-2011, sequence version 3.\r\n",
      "DT   03-MAY-2023, entry version 181.\r\n",
      "DE   RecName: Full=Retinoblastoma-like protein 2;\r\n",
      "DE   AltName: Full=130 kDa retinoblastoma-associated protein;\r\n",
      "DE            Short=p130;\r\n",
      "DE   AltName: Full=Retinoblastoma-related protein 2;\r\n",
      "DE            Short=RBR-2;\r\n",
      "DE   AltName: Full=pRb2;\r\n",
      "GN   Name=Rbl2;\r\n",
      "OS   Mus musculus (Mouse).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Mus; Mus.\r\n",
      "OX   NCBI_TaxID=10090;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=8621630; DOI=10.1074/jbc.271.16.9567;\r\n",
      "RA   Chen G., Guy C.T., Chen H.W., Hu N., Lee E.Y.H.P., Lee W.H.;\r\n",
      "RT   \"Molecular cloning and developmental expression of mouse p130, a member of\r\n",
      "RT   the retinoblastoma gene family.\";\r\n",
      "RL   J. Biol. Chem. 271:9567-9572(1996).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=9019172;\r\n",
      "RA   Pertile P., Baldi A., de Luca A., Virgilio L., Pisano M.M., Giordano A.;\r\n",
      "RT   \"Molecular cloning, expression, and developmental characterization of the\r\n",
      "RT   murine retinoblastoma-related gene Rb2/p130.\";\r\n",
      "RL   Cell Growth Differ. 6:1659-1664(1995).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=8622859;\r\n",
      "RA   Lecouter J.E., Whyte P.F.M., Rudnicki M.A.;\r\n",
      "RT   \"Cloning and expression of the Rb-related mouse p130 mRNA.\";\r\n",
      "RL   Oncogene 12:1433-1440(1996).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\r\n",
      "RC   STRAIN=C57BL/6J;\r\n",
      "RX   PubMed=16141072; DOI=10.1126/science.1112014;\r\n",
      "RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,\r\n",
      "RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,\r\n",
      "RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,\r\n",
      "RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,\r\n",
      "RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,\r\n",
      "RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,\r\n",
      "RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,\r\n",
      "RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,\r\n",
      "RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,\r\n",
      "RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,\r\n",
      "RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,\r\n",
      "RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,\r\n",
      "RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,\r\n",
      "RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,\r\n",
      "RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,\r\n",
      "RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,\r\n",
      "RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,\r\n",
      "RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,\r\n",
      "RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,\r\n",
      "RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,\r\n",
      "RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,\r\n",
      "RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,\r\n",
      "RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,\r\n",
      "RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,\r\n",
      "RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,\r\n",
      "RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,\r\n",
      "RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,\r\n",
      "RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,\r\n",
      "RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,\r\n",
      "RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,\r\n",
      "RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,\r\n",
      "RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,\r\n",
      "RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,\r\n",
      "RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;\r\n",
      "RT   \"The transcriptional landscape of the mammalian genome.\";\r\n",
      "RL   Science 309:1559-1563(2005).\r\n",
      "RN   [5]\r\n",
      "RP   INTERACTION WITH USP4.\r\n",
      "RX   PubMed=11571651; DOI=10.1038/sj.onc.1204823;\r\n",
      "RA   Blanchette P., Gilchrist C.A., Baker R.T., Gray D.A.;\r\n",
      "RT   \"Association of UNP, a ubiquitin-specific protease, with the pocket\r\n",
      "RT   proteins pRb, p107 and p130.\";\r\n",
      "RL   Oncogene 20:5533-5537(2001).\r\n",
      "RN   [6]\r\n",
      "RP   FUNCTION, AND INTERACTION WITH KMT5B AND KMT5C.\r\n",
      "RX   PubMed=15750587; DOI=10.1038/ncb1235;\r\n",
      "RA   Gonzalo S., Garcia-Cao M., Fraga M.F., Schotta G., Peters A.H.F.M.,\r\n",
      "RA   Cotter S.E., Eguia R., Dean D.C., Esteller M., Jenuwein T., Blasco M.A.;\r\n",
      "RT   \"Role of the RB1 family in stabilizing histone methylation at constitutive\r\n",
      "RT   heterochromatin.\";\r\n",
      "RL   Nat. Cell Biol. 7:420-428(2005).\r\n",
      "RN   [7]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-636; THR-639 AND SER-942, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;\r\n",
      "RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;\r\n",
      "RT   \"Large-scale phosphorylation analysis of mouse liver.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).\r\n",
      "RN   [8]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-410; THR-414; SER-636;\r\n",
      "RP   THR-639; SER-942; SER-965; SER-976 AND THR-980, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Brown adipose tissue, Kidney, Liver, Lung, Pancreas, and\r\n",
      "RC   Spleen;\r\n",
      "RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;\r\n",
      "RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,\r\n",
      "RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;\r\n",
      "RT   \"A tissue-specific atlas of mouse protein phosphorylation and expression.\";\r\n",
      "RL   Cell 143:1174-1189(2010).\r\n",
      "CC   -!- FUNCTION: Key regulator of entry into cell division. Directly involved\r\n",
      "CC       in heterochromatin formation by maintaining overall chromatin structure\r\n",
      "CC       and, in particular, that of constitutive heterochromatin by stabilizing\r\n",
      "CC       histone methylation. Recruits and targets histone methyltransferases\r\n",
      "CC       KMT5B and KMT5C, leading to epigenetic transcriptional repression.\r\n",
      "CC       Controls histone H4 'Lys-20' trimethylation. Probably acts as a\r\n",
      "CC       transcription repressor by recruiting chromatin-modifying enzymes to\r\n",
      "CC       promoters. Potent inhibitor of E2F-mediated trans-activation,\r\n",
      "CC       associates preferentially with E2F5. Binds to cyclins A and E. Binds to\r\n",
      "CC       and may be involved in the transforming capacity of the adenovirus E1A\r\n",
      "CC       protein. May act as a tumor suppressor. {ECO:0000269|PubMed:15750587}.\r\n",
      "CC   -!- SUBUNIT: Interacts with AATF and RINT1. Component of the DREAM complex\r\n",
      "CC       (also named LINC complex) at least composed of E2F4, E2F5, LIN9, LIN37,\r\n",
      "CC       LIN52, LIN54, MYBL1, MYBL2, RBL1, RBL2, RBBP4, TFDP1 and TFDP2. The\r\n",
      "CC       complex exists in quiescent cells where it represses cell cycle-\r\n",
      "CC       dependent genes. It dissociates in S phase when LIN9, LIN37, LIN52 and\r\n",
      "CC       LIN54 form a subcomplex that binds to MYBL2. Interacts with USP4 (By\r\n",
      "CC       similarity). Interacts with KMT5B, KMT5C and USP4. Interacts with PML\r\n",
      "CC       (By similarity). Interacts with RBBP9 (By similarity). {ECO:0000250,\r\n",
      "CC       ECO:0000250|UniProtKB:O55081}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q64700; Q155P7: Cenpf; NbExp=3; IntAct=EBI-2271232, EBI-2211248;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus.\r\n",
      "CC   -!- PTM: During G0 and early G1 phase of the cell cycle, phosphorylated on\r\n",
      "CC       Ser-636 and on 5 sites within the domain B. Phosphorylation on Ser-669\r\n",
      "CC       in G1 leads to its ubiquitin-dependent proteolysis (By similarity).\r\n",
      "CC       {ECO:0000250}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; U36799; AAB48991.1; -; mRNA.\r\n",
      "DR   EMBL; U50850; AAC52598.1; -; mRNA.\r\n",
      "DR   EMBL; U47333; AAC52555.1; -; mRNA.\r\n",
      "DR   EMBL; AK160027; BAE35570.1; -; mRNA.\r\n",
      "DR   CCDS; CCDS22518.1; -.\r\n",
      "DR   RefSeq; NP_001268929.1; NM_001282000.1.\r\n",
      "DR   RefSeq; NP_001268930.1; NM_001282001.1.\r\n",
      "DR   RefSeq; NP_035380.3; NM_011250.4.\r\n",
      "DR   AlphaFoldDB; Q64700; -.\r\n",
      "DR   SMR; Q64700; -.\r\n",
      "DR   BioGRID; 202820; 19.\r\n",
      "DR   CORUM; Q64700; -.\r\n",
      "DR   IntAct; Q64700; 5.\r\n",
      "DR   MINT; Q64700; -.\r\n",
      "DR   STRING; 10090.ENSMUSP00000034091; -.\r\n",
      "DR   iPTMnet; Q64700; -.\r\n",
      "DR   PhosphoSitePlus; Q64700; -.\r\n",
      "DR   EPD; Q64700; -.\r\n",
      "DR   jPOST; Q64700; -.\r\n",
      "DR   MaxQB; Q64700; -.\r\n",
      "DR   PaxDb; Q64700; -.\r\n",
      "DR   PeptideAtlas; Q64700; -.\r\n",
      "DR   ProteomicsDB; 254996; -.\r\n",
      "DR   Antibodypedia; 4299; 476 antibodies from 39 providers.\r\n",
      "DR   DNASU; 19651; -.\r\n",
      "DR   Ensembl; ENSMUST00000034091.8; ENSMUSP00000034091.8; ENSMUSG00000031666.16.\r\n",
      "DR   GeneID; 19651; -.\r\n",
      "DR   KEGG; mmu:19651; -.\r\n",
      "DR   UCSC; uc012gid.2; mouse.\r\n",
      "DR   AGR; MGI:105085; -.\r\n",
      "DR   CTD; 5934; -.\r\n",
      "DR   MGI; MGI:105085; Rbl2.\r\n",
      "DR   VEuPathDB; HostDB:ENSMUSG00000031666; -.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00950000183202; -.\r\n",
      "DR   HOGENOM; CLU_008943_0_0_1; -.\r\n",
      "DR   InParanoid; Q64700; -.\r\n",
      "DR   OMA; MHWLACA; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; Q64700; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   Reactome; R-MMU-1538133; G0 and Early G1.\r\n",
      "DR   Reactome; R-MMU-69231; Cyclin D associated events in G1.\r\n",
      "DR   BioGRID-ORCS; 19651; 2 hits in 79 CRISPR screens.\r\n",
      "DR   ChiTaRS; Rbl2; mouse.\r\n",
      "DR   PRO; PR:Q64700; -.\r\n",
      "DR   Proteomes; UP000000589; Chromosome 8.\r\n",
      "DR   RNAct; Q64700; protein.\r\n",
      "DR   Bgee; ENSMUSG00000031666; Expressed in parotid gland and 243 other tissues.\r\n",
      "DR   ExpressionAtlas; Q64700; baseline and differential.\r\n",
      "DR   Genevisible; Q64700; MM.\r\n",
      "DR   GO; GO:0000785; C:chromatin; ISO:MGI.\r\n",
      "DR   GO; GO:0005694; C:chromosome; ISO:MGI.\r\n",
      "DR   GO; GO:0005829; C:cytosol; ISO:MGI.\r\n",
      "DR   GO; GO:0005730; C:nucleolus; ISO:MGI.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IDA:MGI.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; IDA:MGI.\r\n",
      "DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:MGI.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:MGI.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; ISO:MGI.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:InterPro.\r\n",
      "DR   CDD; cd20606; CYCLIN_RBL2; 1.\r\n",
      "DR   CDD; cd00043; CYCLIN_SF; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 3.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   PANTHER; PTHR13742:SF8; RETINOBLASTOMA-LIKE PROTEIN 2; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 2.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Cell cycle; Chromatin regulator; DNA-binding; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Repressor; Transcription; Transcription regulation;\r\n",
      "KW   Tumor suppressor.\r\n",
      "FT   CHAIN           1..1135\r\n",
      "FT                   /note=\"Retinoblastoma-like protein 2\"\r\n",
      "FT                   /id=\"PRO_0000167842\"\r\n",
      "FT   REGION          1..43\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          414..1021\r\n",
      "FT                   /note=\"Pocket; binds E1A\"\r\n",
      "FT   REGION          414..613\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT   REGION          614..824\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT   REGION          661..698\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          825..1021\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT   REGION          930..994\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1..16\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        661..696\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        939..971\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         410\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         414\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         636\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355,\r\n",
      "FT                   ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         639\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355,\r\n",
      "FT                   ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         659\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         669\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         684\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         942\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355,\r\n",
      "FT                   ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         946\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         960\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         965\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         967\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         968\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         975\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         976\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         980\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         1031\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         1064\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         1076\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         1108\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   CONFLICT        209..251\r\n",
      "FT                   /note=\"Missing (in Ref. 3; AAC52555)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        341\r\n",
      "FT                   /note=\"A -> P (in Ref. 1; AAB48991)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        342\r\n",
      "FT                   /note=\"A -> P (in Ref. 3; AAC52555)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        381\r\n",
      "FT                   /note=\"R -> T (in Ref. 2; AAC52598)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        428\r\n",
      "FT                   /note=\"T -> S (in Ref. 2; AAC52598)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        431\r\n",
      "FT                   /note=\"S -> T (in Ref. 2; AAC52598)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        443\r\n",
      "FT                   /note=\"R -> Q (in Ref. 2; AAC52598)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        483..492\r\n",
      "FT                   /note=\"Missing (in Ref. 1; AAB48991)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        768\r\n",
      "FT                   /note=\"A -> R (in Ref. 2; AAC52598)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        826\r\n",
      "FT                   /note=\"P -> A (in Ref. 3; AAC52555)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        947..948\r\n",
      "FT                   /note=\"PT -> RA (in Ref. 3; AAC52555)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1023\r\n",
      "FT                   /note=\"A -> S (in Ref. 2; AAC52598)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1044\r\n",
      "FT                   /note=\"V -> I (in Ref. 2; AAC52598)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   1135 AA;  127485 MW;  F509E68A156929B2 CRC64;\r\n",
      "     MASGGNQSPP PPPAAAASSE EEEEDGDAAD RAQPAGSPSH QIQQRFEELC SRLNMDEAAR\r\n",
      "     AEAWSSYRSM SESYTLEGND LHWLACALYV ACRKSVPTVS KGTAEGNYVS LTRILRCSEQ\r\n",
      "     SLIEFFNKMK KWEDMANLPP HFRERTERLE RNFTVSAVIF KKYEPIFQDI FKYPQEEQPR\r\n",
      "     QQRGRKQRRQ PCTTSEIFHF CWVLFIYAKG NFPMISDDLV NSYHLLLCAL DLVYGNALQC\r\n",
      "     SNRKELVNPN FKGLSEDCHP KDSKASSDPP CVIEKLCSLH DGLVLEAKGI KEHFWKPYIR\r\n",
      "     KLFEKKLLKG KEENLTGFLE PGNFGESFKA VNKAYEEYVL AAGNLDERVF LGEDAEEEVG\r\n",
      "     TLSRCLSAAS GTESAERTQM RDILQQHLDK SKALRVCTPL TGVRYVQENS PCVTPVSTAA\r\n",
      "     HSLSRLHTML SGLRNAPSEK LERILRSCSR DPTQAIADRL KEMYEIYSQH FQPDENFSNC\r\n",
      "     AKEIANKHFR FAEMLYYKVL ESVIEQEQKR LGDMDLSGVL EHDAFHRSLL ACCLEVVAFS\r\n",
      "     HKPPGNFPFI AEIFDVPHYH FYKVIEVFIR AEDGLCREVV KHLNQIEEQI LDHLAWKTKS\r\n",
      "     PLWDRIRDNE NRVPTCEEVM PPQNLERTDE IYIAGSPLTP RRVGEVRADA GGLGRSITSP\r\n",
      "     TTLYDRYSSP TVSTTRRRLF ENDSPSEGST SGRIPPQPLV NAVPVQNVPG ETVSVTPVPG\r\n",
      "     QTLVTMATAT VTANNGQTVT IPVQGIANEN GGITFFPVQV NVGGQAQAVA GSIQPLSAQA\r\n",
      "     LAGSLSSQQV TGTTLQVPGP VAIQQISPGG QQQNPGQPLT SSSIRPRKTS SLALFFRKVY\r\n",
      "     YLAGVRLRDL CIKLDISDEL RKKIWTCFEF SIIQCTELMM DRHLDQLLMC AIYVMAKVTK\r\n",
      "     EDRSFQNIMR CYRTQPQARS QVYRSVLIKG KRRNSGSSES RSHQNSPTEL NTDRASRDSS\r\n",
      "     PVMRSNSTLP VPQPSSAPPT PTRLTGASSD VEEEERGDLI QFYNNIYRKQ IQAFAMKYSQ\r\n",
      "     ANAQTDTPPL SPYPFVRTGS PRRVQLSQSH PIYISPHNNE AMPSPREKIF YYFSNSPSKR\r\n",
      "     LREINSMIRT GETPTKKRGI LLDDGSESPA KRICPENHSA LLRRLQDVAN DRGSQ\r\n",
      "//\r\n",
      "ID   TASOR_HUMAN             Reviewed;        1670 AA.\r\n",
      "AC   Q9UK61; A1L3A4; B5ME28; Q9H2F7; Q9UPP7;\r\n",
      "DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   05-MAY-2009, sequence version 3.\r\n",
      "DT   03-MAY-2023, entry version 138.\r\n",
      "DE   RecName: Full=Protein TASOR {ECO:0000305};\r\n",
      "DE   AltName: Full=CTCL tumor antigen se89-1 {ECO:0000303|PubMed:11149944};\r\n",
      "DE   AltName: Full=Retinoblastoma-associated protein RAP140 {ECO:0000303|PubMed:18726359};\r\n",
      "DE   AltName: Full=Transgene activation suppressor protein {ECO:0000303|PubMed:26022416};\r\n",
      "GN   Name=TASOR {ECO:0000303|PubMed:26022416, ECO:0000312|HGNC:HGNC:30314};\r\n",
      "GN   Synonyms=C3orf63 {ECO:0000312|HGNC:HGNC:30314}, FAM208A\r\n",
      "GN   {ECO:0000312|HGNC:HGNC:30314}, KIAA1105 {ECO:0000303|PubMed:10470851};\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT ARG-1046.\r\n",
      "RC   TISSUE=Fetal brain;\r\n",
      "RX   PubMed=18726359; DOI=10.1007/bf02882285;\r\n",
      "RA   Li Q., Wen H., Ao S.;\r\n",
      "RT   \"Identification and cloning of the cDNA of a Rb-associated protein\r\n",
      "RT   RAP140a.\";\r\n",
      "RL   Sci. China, Ser. C, Life Sci. 43:637-647(2000).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RX   PubMed=16641997; DOI=10.1038/nature04728;\r\n",
      "RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,\r\n",
      "RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,\r\n",
      "RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,\r\n",
      "RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,\r\n",
      "RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,\r\n",
      "RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,\r\n",
      "RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,\r\n",
      "RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,\r\n",
      "RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,\r\n",
      "RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,\r\n",
      "RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,\r\n",
      "RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,\r\n",
      "RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,\r\n",
      "RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,\r\n",
      "RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,\r\n",
      "RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,\r\n",
      "RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,\r\n",
      "RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,\r\n",
      "RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;\r\n",
      "RT   \"The DNA sequence, annotation and analysis of human chromosome 3.\";\r\n",
      "RL   Nature 440:1194-1198(2006).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-598 (ISOFORM 1).\r\n",
      "RC   TISSUE=Cerebellum;\r\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\r\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\r\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\r\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\r\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\r\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\r\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\r\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\r\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\r\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\r\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\r\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\r\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\r\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\r\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\r\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\r\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\r\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\r\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\r\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\r\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\r\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\r\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\r\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\r\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\r\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\r\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\r\n",
      "RA   Isogai T., Sugano S.;\r\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\r\n",
      "RT   cDNAs.\";\r\n",
      "RL   Nat. Genet. 36:40-45(2004).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 376-1670 (ISOFORM 3).\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 523-1274 (ISOFORM 4), AND VARIANTS ARG-1046\r\n",
      "RP   AND VAL-1435.\r\n",
      "RC   TISSUE=Testis;\r\n",
      "RX   PubMed=11149944; DOI=10.1073/pnas.98.2.629;\r\n",
      "RA   Eichmueller S., Usener D., Dummer R., Stein A., Thiel D., Schadendorf D.;\r\n",
      "RT   \"Serological detection of cutaneous T-cell lymphoma-associated antigens.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 98:629-634(2001).\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 941-1274 (ISOFORM 1), AND VARIANT\r\n",
      "RP   ARG-1046.\r\n",
      "RC   TISSUE=Brain;\r\n",
      "RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;\r\n",
      "RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N., Tanaka A.,\r\n",
      "RA   Kotani H., Nomura N., Ohara O.;\r\n",
      "RT   \"Prediction of the coding sequences of unidentified human genes. XIV. The\r\n",
      "RT   complete sequences of 100 new cDNA clones from brain which code for large\r\n",
      "RT   proteins in vitro.\";\r\n",
      "RL   DNA Res. 6:197-205(1999).\r\n",
      "RN   [7]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-927, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;\r\n",
      "RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;\r\n",
      "RT   \"Global, in vivo, and site-specific phosphorylation dynamics in signaling\r\n",
      "RT   networks.\";\r\n",
      "RL   Cell 127:635-648(2006).\r\n",
      "RN   [8]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-927, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=16964243; DOI=10.1038/nbt1240;\r\n",
      "RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;\r\n",
      "RT   \"A probability-based approach for high-throughput protein phosphorylation\r\n",
      "RT   analysis and site localization.\";\r\n",
      "RL   Nat. Biotechnol. 24:1285-1292(2006).\r\n",
      "RN   [9]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;\r\n",
      "RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,\r\n",
      "RA   Greff Z., Keri G., Stemmann O., Mann M.;\r\n",
      "RT   \"Kinase-selective enrichment enables quantitative phosphoproteomics of the\r\n",
      "RT   kinome across the cell cycle.\";\r\n",
      "RL   Mol. Cell 31:438-448(2008).\r\n",
      "RN   [10]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;\r\n",
      "RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,\r\n",
      "RA   Elledge S.J., Gygi S.P.;\r\n",
      "RT   \"A quantitative atlas of mitotic phosphorylation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).\r\n",
      "RN   [11]\r\n",
      "RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR\r\n",
      "RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY\r\n",
      "RP   [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19413330; DOI=10.1021/ac9004309;\r\n",
      "RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;\r\n",
      "RT   \"Lys-N and trypsin cover complementary parts of the phosphoproteome in a\r\n",
      "RT   refined SCX-based approach.\";\r\n",
      "RL   Anal. Chem. 81:4493-4501(2009).\r\n",
      "RN   [12]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-633; SER-636; SER-927 AND\r\n",
      "RP   SER-979, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [13]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-633; SER-636; SER-927;\r\n",
      "RP   THR-982 AND SER-1103, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE\r\n",
      "RP   ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;\r\n",
      "RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,\r\n",
      "RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;\r\n",
      "RT   \"Quantitative phosphoproteomics reveals widespread full phosphorylation\r\n",
      "RT   site occupancy during mitosis.\";\r\n",
      "RL   Sci. Signal. 3:RA3-RA3(2010).\r\n",
      "RN   [14]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-927 AND SER-1103, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;\r\n",
      "RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,\r\n",
      "RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;\r\n",
      "RT   \"System-wide temporal characterization of the proteome and phosphoproteome\r\n",
      "RT   of human embryonic stem cell differentiation.\";\r\n",
      "RL   Sci. Signal. 4:RS3-RS3(2011).\r\n",
      "RN   [15]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-344; SER-673; SER-800;\r\n",
      "RP   SER-927; SER-971; SER-979; THR-1049; SER-1103 AND SER-1552, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [16]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-927 AND SER-1103, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;\r\n",
      "RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,\r\n",
      "RA   Ye M., Zou H.;\r\n",
      "RT   \"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteomics 96:253-262(2014).\r\n",
      "RN   [17]\r\n",
      "RP   FUNCTION, SUBCELLULAR LOCATION, AND IDENTIFICATION IN THE HUSH COMPLEX.\r\n",
      "RX   PubMed=26022416; DOI=10.1126/science.aaa7227;\r\n",
      "RA   Tchasovnikarova I.A., Timms R.T., Matheson N.J., Wals K., Antrobus R.,\r\n",
      "RA   Goettgens B., Dougan G., Dawson M.A., Lehner P.J.;\r\n",
      "RT   \"Epigenetic silencing by the HUSH complex mediates position-effect\r\n",
      "RT   variegation in human cells.\";\r\n",
      "RL   Science 348:1481-1485(2015).\r\n",
      "RN   [18]\r\n",
      "RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH MORC2.\r\n",
      "RX   PubMed=28581500; DOI=10.1038/ng.3878;\r\n",
      "RA   Tchasovnikarova I.A., Timms R.T., Douse C.H., Roberts R.C., Dougan G.,\r\n",
      "RA   Kingston R.E., Modis Y., Lehner P.J.;\r\n",
      "RT   \"Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease\r\n",
      "RT   mutation in MORC2.\";\r\n",
      "RL   Nat. Genet. 49:1035-1044(2017).\r\n",
      "RN   [19]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-586; LYS-823; LYS-832 AND\r\n",
      "RP   LYS-872, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=28112733; DOI=10.1038/nsmb.3366;\r\n",
      "RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,\r\n",
      "RA   Nielsen M.L.;\r\n",
      "RT   \"Site-specific mapping of the human SUMO proteome reveals co-modification\r\n",
      "RT   with phosphorylation.\";\r\n",
      "RL   Nat. Struct. Mol. Biol. 24:325-336(2017).\r\n",
      "RN   [20]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=29211708; DOI=10.1038/nature25179;\r\n",
      "RA   Liu N., Lee C.H., Swigut T., Grow E., Gu B., Bassik M.C., Wysocka J.;\r\n",
      "RT   \"Selective silencing of euchromatic L1s revealed by genome-wide screens for\r\n",
      "RT   L1 regulators.\";\r\n",
      "RL   Nature 553:228-232(2018).\r\n",
      "RN   [21]\r\n",
      "RP   FUNCTION, AND INTERACTION WITH ZNF638.\r\n",
      "RX   PubMed=30487602; DOI=10.1038/s41586-018-0750-6;\r\n",
      "RA   Zhu Y., Wang G.Z., Cingoez O., Goff S.P.;\r\n",
      "RT   \"NP220 mediates silencing of unintegrated retroviral DNA.\";\r\n",
      "RL   Nature 564:278-282(2018).\r\n",
      "CC   -!- FUNCTION: Component of the HUSH complex, a multiprotein complex that\r\n",
      "CC       mediates epigenetic repression (PubMed:26022416, PubMed:28581500). The\r\n",
      "CC       HUSH complex is recruited to genomic loci rich in H3K9me3 and is\r\n",
      "CC       required to maintain transcriptional silencing by promoting recruitment\r\n",
      "CC       of SETDB1, a histone methyltransferase that mediates further deposition\r\n",
      "CC       of H3K9me3, as well as MORC2 (PubMed:26022416, PubMed:28581500). Also\r\n",
      "CC       represses L1 retrotransposons in collaboration with MORC2 and,\r\n",
      "CC       probably, SETDB1, the silencing is dependent of repressive epigenetic\r\n",
      "CC       modifications, such as H3K9me3 mark. Silencing events often occur\r\n",
      "CC       within introns of transcriptionally active genes, and lead to the down-\r\n",
      "CC       regulation of host gene expression (PubMed:29211708). The HUSH complex\r\n",
      "CC       is also involved in the silencing of unintegrated retroviral DNA by\r\n",
      "CC       being recruited by ZNF638: some part of the retroviral DNA formed\r\n",
      "CC       immediately after infection remains unintegrated in the host genome and\r\n",
      "CC       is transcriptionally repressed (PubMed:30487602). Plays a crucial role\r\n",
      "CC       in early embryonic development (By similarity). Involved in the\r\n",
      "CC       organization of spindle poles and spindle apparatus assembly during\r\n",
      "CC       zygotic division (By similarity). Plays an important role in\r\n",
      "CC       maintaining epiblast fitness or potency (By similarity).\r\n",
      "CC       {ECO:0000250|UniProtKB:Q69ZR9, ECO:0000269|PubMed:26022416,\r\n",
      "CC       ECO:0000269|PubMed:28581500, ECO:0000269|PubMed:29211708,\r\n",
      "CC       ECO:0000269|PubMed:30487602}.\r\n",
      "CC   -!- SUBUNIT: Component of the HUSH complex; at least composed of TASOR,\r\n",
      "CC       PPHLN1 and MPHOSPH8 (PubMed:26022416). Interacts with MORC2; the\r\n",
      "CC       interaction associateS MORC2 with the HUSH complex which recruits MORC2\r\n",
      "CC       to heterochromatic loci (PubMed:28581500). Interacts with ZNF638;\r\n",
      "CC       leading to recruitment of the HUSH complex to unintegrated retroviral\r\n",
      "CC       DNA (PubMed:30487602). Interacts with INPP5A, EML1, SV1L, GPSM2,\r\n",
      "CC       ITGB3BP, CNTN1, ETFA, PSMD8, S100A10, MPHOSPH8, TMEM100, ALB, PARPBP,\r\n",
      "CC       HCFC2, NCBP1 and SETDB1 (By similarity). {ECO:0000250|UniProtKB:Q69ZR9,\r\n",
      "CC       ECO:0000269|PubMed:26022416, ECO:0000269|PubMed:28581500,\r\n",
      "CC       ECO:0000269|PubMed:30487602}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q9UK61; Q99549: MPHOSPH8; NbExp=3; IntAct=EBI-308354, EBI-2653928;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26022416,\r\n",
      "CC       ECO:0000269|PubMed:28581500}. Chromosome {ECO:0000269|PubMed:26022416,\r\n",
      "CC       ECO:0000269|PubMed:28581500}. Note=Localizes to chromatin.\r\n",
      "CC       {ECO:0000269|PubMed:26022416, ECO:0000269|PubMed:28581500}.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=4;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=Q9UK61-1; Sequence=Displayed;\r\n",
      "CC       Name=2;\r\n",
      "CC         IsoId=Q9UK61-2; Sequence=VSP_027030, VSP_027032;\r\n",
      "CC       Name=3;\r\n",
      "CC         IsoId=Q9UK61-3; Sequence=VSP_027033, VSP_027034;\r\n",
      "CC       Name=4;\r\n",
      "CC         IsoId=Q9UK61-4; Sequence=VSP_027031;\r\n",
      "CC   -!- MISCELLANEOUS: [Isoform 1]: Gene prediction based on partial mRNA data.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the TASOR family. {ECO:0000305}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=AAG34913.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=AAI29988.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AF180425; AAD55098.1; -; mRNA.\r\n",
      "DR   EMBL; AC099781; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AK094486; -; NOT_ANNOTATED_CDS; mRNA.\r\n",
      "DR   EMBL; BC129987; AAI29988.1; ALT_INIT; mRNA.\r\n",
      "DR   EMBL; AF273053; AAG34913.1; ALT_INIT; mRNA.\r\n",
      "DR   EMBL; AB029028; BAA83057.1; -; mRNA.\r\n",
      "DR   CCDS; CCDS2877.1; -. [Q9UK61-2]\r\n",
      "DR   CCDS; CCDS46853.1; -. [Q9UK61-3]\r\n",
      "DR   CCDS; CCDS87094.1; -. [Q9UK61-4]\r\n",
      "DR   CCDS; CCDS93292.1; -. [Q9UK61-1]\r\n",
      "DR   RefSeq; NP_001106207.1; NM_001112736.1. [Q9UK61-3]\r\n",
      "DR   RefSeq; NP_056039.2; NM_015224.3. [Q9UK61-2]\r\n",
      "DR   RefSeq; XP_005265056.1; XM_005264999.1.\r\n",
      "DR   RefSeq; XP_011531854.1; XM_011533552.2.\r\n",
      "DR   PDB; 6SWG; X-ray; 2.51 A; C=1013-1095.\r\n",
      "DR   PDB; 6TL1; X-ray; 2.03 A; A/B=110-332.\r\n",
      "DR   PDBsum; 6SWG; -.\r\n",
      "DR   PDBsum; 6TL1; -.\r\n",
      "DR   AlphaFoldDB; Q9UK61; -.\r\n",
      "DR   SMR; Q9UK61; -.\r\n",
      "DR   BioGRID; 116873; 101.\r\n",
      "DR   CORUM; Q9UK61; -.\r\n",
      "DR   DIP; DIP-56150N; -.\r\n",
      "DR   IntAct; Q9UK61; 33.\r\n",
      "DR   MINT; Q9UK61; -.\r\n",
      "DR   STRING; 9606.ENSP00000417509; -.\r\n",
      "DR   GlyCosmos; Q9UK61; 3 sites, 2 glycans.\r\n",
      "DR   GlyGen; Q9UK61; 5 sites, 2 O-linked glycans (5 sites).\r\n",
      "DR   iPTMnet; Q9UK61; -.\r\n",
      "DR   PhosphoSitePlus; Q9UK61; -.\r\n",
      "DR   SwissPalm; Q9UK61; -.\r\n",
      "DR   BioMuta; FAM208A; -.\r\n",
      "DR   DMDM; 229462994; -.\r\n",
      "DR   EPD; Q9UK61; -.\r\n",
      "DR   jPOST; Q9UK61; -.\r\n",
      "DR   MassIVE; Q9UK61; -.\r\n",
      "DR   MaxQB; Q9UK61; -.\r\n",
      "DR   PaxDb; Q9UK61; -.\r\n",
      "DR   PeptideAtlas; Q9UK61; -.\r\n",
      "DR   ProteomicsDB; 84729; -. [Q9UK61-1]\r\n",
      "DR   ProteomicsDB; 84730; -. [Q9UK61-2]\r\n",
      "DR   ProteomicsDB; 84731; -. [Q9UK61-3]\r\n",
      "DR   ProteomicsDB; 84732; -. [Q9UK61-4]\r\n",
      "DR   Antibodypedia; 1875; 29 antibodies from 13 providers.\r\n",
      "DR   DNASU; 23272; -.\r\n",
      "DR   Ensembl; ENST00000355628.9; ENSP00000347845.5; ENSG00000163946.14. [Q9UK61-4]\r\n",
      "DR   Ensembl; ENST00000431842.6; ENSP00000399410.2; ENSG00000163946.14. [Q9UK61-2]\r\n",
      "DR   Ensembl; ENST00000493960.6; ENSP00000417509.2; ENSG00000163946.14. [Q9UK61-3]\r\n",
      "DR   Ensembl; ENST00000683822.1; ENSP00000508241.1; ENSG00000163946.14. [Q9UK61-1]\r\n",
      "DR   GeneID; 23272; -.\r\n",
      "DR   KEGG; hsa:23272; -.\r\n",
      "DR   MANE-Select; ENST00000683822.1; ENSP00000508241.1; NM_001365635.2; NP_001352564.1.\r\n",
      "DR   UCSC; uc003dic.5; human. [Q9UK61-1]\r\n",
      "DR   AGR; HGNC:30314; -.\r\n",
      "DR   CTD; 23272; -.\r\n",
      "DR   DisGeNET; 23272; -.\r\n",
      "DR   GeneCards; TASOR; -.\r\n",
      "DR   HGNC; HGNC:30314; TASOR.\r\n",
      "DR   HPA; ENSG00000163946; Low tissue specificity.\r\n",
      "DR   MIM; 616493; gene.\r\n",
      "DR   neXtProt; NX_Q9UK61; -.\r\n",
      "DR   OpenTargets; ENSG00000163946; -.\r\n",
      "DR   PharmGKB; PA128395774; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000163946; -.\r\n",
      "DR   eggNOG; ENOG502QUY9; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00530000063735; -.\r\n",
      "DR   HOGENOM; CLU_004573_0_0_1; -.\r\n",
      "DR   InParanoid; Q9UK61; -.\r\n",
      "DR   OMA; AHSNGAQ; -.\r\n",
      "DR   OrthoDB; 2969374at2759; -.\r\n",
      "DR   PhylomeDB; Q9UK61; -.\r\n",
      "DR   TreeFam; TF336055; -.\r\n",
      "DR   PathwayCommons; Q9UK61; -.\r\n",
      "DR   SignaLink; Q9UK61; -.\r\n",
      "DR   BioGRID-ORCS; 23272; 29 hits in 1168 CRISPR screens.\r\n",
      "DR   ChiTaRS; FAM208A; human.\r\n",
      "DR   GenomeRNAi; 23272; -.\r\n",
      "DR   Pharos; Q9UK61; Tbio.\r\n",
      "DR   PRO; PR:Q9UK61; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 3.\r\n",
      "DR   RNAct; Q9UK61; protein.\r\n",
      "DR   Bgee; ENSG00000163946; Expressed in secondary oocyte and 206 other tissues.\r\n",
      "DR   ExpressionAtlas; Q9UK61; baseline and differential.\r\n",
      "DR   Genevisible; Q9UK61; HS.\r\n",
      "DR   GO; GO:0000792; C:heterochromatin; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.\r\n",
      "DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.\r\n",
      "DR   GO; GO:0008595; P:anterior/posterior axis specification, embryo; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0060809; P:mesodermal to mesenchymal transition involved in gastrulation; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0045869; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0090309; P:positive regulation of DNA methylation-dependent heterochromatin formation; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0097355; P:protein localization to heterochromatin; IDA:UniProtKB.\r\n",
      "DR   CDD; cd22569; TASOR_PBD; 1.\r\n",
      "DR   InterPro; IPR046432; TASOR.\r\n",
      "DR   InterPro; IPR022188; TASOR_DUF3715.\r\n",
      "DR   PANTHER; PTHR16207:SF1; PROTEIN TASOR; 1.\r\n",
      "DR   PANTHER; PTHR16207; UNCHARACTERIZED; 1.\r\n",
      "DR   Pfam; PF12509; DUF3715; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Acetylation; Alternative splicing; Chromosome;\r\n",
      "KW   Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome; Repressor;\r\n",
      "KW   Transcription; Transcription regulation; Ubl conjugation.\r\n",
      "FT   INIT_MET        1\r\n",
      "FT                   /note=\"Removed\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19413330\"\r\n",
      "FT   CHAIN           2..1670\r\n",
      "FT                   /note=\"Protein TASOR\"\r\n",
      "FT                   /id=\"PRO_0000295728\"\r\n",
      "FT   REGION          1..110\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          921..947\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1532..1558\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1638..1670\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        90..110\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1542..1558\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1656..1670\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         2\r\n",
      "FT                   /note=\"N-acetylalanine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19413330\"\r\n",
      "FT   MOD_RES         344\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         633\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         636\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         673\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         800\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         843\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q69ZR9\"\r\n",
      "FT   MOD_RES         927\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:16964243,\r\n",
      "FT                   ECO:0007744|PubMed:17081983, ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,\r\n",
      "FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         971\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         979\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         982\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         1049\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1103\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,\r\n",
      "FT                   ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         1552\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   CROSSLNK        586\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        823\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        832\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        872\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   VAR_SEQ         1..396\r\n",
      "FT                   /note=\"Missing (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:18726359\"\r\n",
      "FT                   /id=\"VSP_027030\"\r\n",
      "FT   VAR_SEQ         921..981\r\n",
      "FT                   /note=\"Missing (in isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:11149944\"\r\n",
      "FT                   /id=\"VSP_027031\"\r\n",
      "FT   VAR_SEQ         942..982\r\n",
      "FT                   /note=\"Missing (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:18726359\"\r\n",
      "FT                   /id=\"VSP_027032\"\r\n",
      "FT   VAR_SEQ         1495..1512\r\n",
      "FT                   /note=\"ALLENDEKDEEDMSLDSG -> DAVLTLTPLELGVGISQH (in isoform\r\n",
      "FT                   3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_027033\"\r\n",
      "FT   VAR_SEQ         1513..1670\r\n",
      "FT                   /note=\"Missing (in isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_027034\"\r\n",
      "FT   VARIANT         38\r\n",
      "FT                   /note=\"Q -> P (in dbSNP:rs958755)\"\r\n",
      "FT                   /id=\"VAR_059595\"\r\n",
      "FT   VARIANT         831\r\n",
      "FT                   /note=\"A -> G (in dbSNP:rs17056999)\"\r\n",
      "FT                   /id=\"VAR_033350\"\r\n",
      "FT   VARIANT         998\r\n",
      "FT                   /note=\"V -> I (in dbSNP:rs2291498)\"\r\n",
      "FT                   /id=\"VAR_055092\"\r\n",
      "FT   VARIANT         1046\r\n",
      "FT                   /note=\"T -> R (in dbSNP:rs9835332)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10470851,\r\n",
      "FT                   ECO:0000269|PubMed:11149944, ECO:0000269|PubMed:18726359\"\r\n",
      "FT                   /id=\"VAR_033351\"\r\n",
      "FT   VARIANT         1435\r\n",
      "FT                   /note=\"I -> V (in dbSNP:rs2291498)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11149944\"\r\n",
      "FT                   /id=\"VAR_033352\"\r\n",
      "FT   CONFLICT        941\r\n",
      "FT                   /note=\"P -> I (in Ref. 6; BAA83057)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1129\r\n",
      "FT                   /note=\"N -> S (in Ref. 1; AAD55098)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1135\r\n",
      "FT                   /note=\"E -> G (in Ref. 1; AAD55098)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   STRAND          113..115\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           121..131\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           137..141\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          143..151\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           154..169\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           174..177\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          180..186\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   TURN            188..190\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           191..197\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   TURN            212..214\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          215..221\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          226..228\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          235..243\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          247..251\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          255..257\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          276..280\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           283..285\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           294..297\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          299..302\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          307..310\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          317..327\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           1016..1038\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6SWG\"\r\n",
      "FT   HELIX           1075..1091\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6SWG\"\r\n",
      "SQ   SEQUENCE   1670 AA;  189032 MW;  A8BE5ED05A96C897 CRC64;\r\n",
      "     MATAVETEAC QPTDASWESG GGGDDEMKQA LPELESSQQN GGGGGLNIAE PSGGAGREEN\r\n",
      "     AGAEAAQSLS HEQPQDSSEA GAAALPRGPE EPERPVRRSF QIPRKSREKK ALFQPLTPGS\r\n",
      "     REFEDVVNIL HSSYLEPTSV TNFNYRRACL VHNELLEKEF TEKRRELKFD GRLDKELSES\r\n",
      "     YAFLMVDRYQ VQTICEKGLH VGQSKITILG SPSMGVYLSR YADLLQANPL DTGAMGDVVI\r\n",
      "     FKIMKGKIKS IYDPMGVKSL ESMLNKSALD PTPKHECHVS KNANRITSLL AYRAYELTQY\r\n",
      "     YFYEYGFDEL RRRPRHVCPY AVVSFTYKDD IQTPKFVPSS RSNSFNTDRN IDKYNYTLWK\r\n",
      "     GQLLNKGKLL CYISLRSATR AFLPIKLPEK LDVETVMSID HLKQKIPPAL FYKETYLGPN\r\n",
      "     EVLKNGMYCS LYEVVEKTRI GSNMESLLQK LDREKLVLVK PLGDRGYLFL LSPYQMVPPY\r\n",
      "     EYQTAKSRVL HALFLFQEPR SIVTSQKGST NAAPQERHES MPDVLKIAQF LQFSLIQCRK\r\n",
      "     EFKNISAINF HSVVEKYVSE FFKRGFGSGK REFIMFPYDS RLDDKKFLYS APRNKSHIDT\r\n",
      "     CLHAYIFRPE VYQLPICKLK ELFEENRKLQ QFSPLSDYEG QEEEMNGTKM KFGKRNNSRG\r\n",
      "     EAIISGKQRS SHSLDYDKDR VKELINLIQC RKKSVGGDSD TEDMRSKTVL KRKLEDLPEN\r\n",
      "     MRKLAKTSNL SENCHLYEES PQPIGSLGHD ADLRRQQQDT CNSGIADIHR LFNWLSETLA\r\n",
      "     NARHSDASLT DTVNKALGLS TDDAYEELRQ KHEYELNSTP DKKDYEQPTC AKVENAQFKG\r\n",
      "     TQSLLLEVDA TSKYSVAIST SEVGTDHKLH LKEDPNLISV NNFEDCSLCP SVPIEHGFRR\r\n",
      "     QQSKSNNVEE TEIHWKLIPI TGGNARSPED QLGKHGEKQT PGMKSPEEQL VCVPPQEAFP\r\n",
      "     NDPRVINRQR SSDYQFPSSP FTDTLKGTTE DDVLTGQVEE QCVPAAEAEP PAVSETTERT\r\n",
      "     VLGEYNLFSR KIEEILKQKN VSYVSTVSTP IFSTQEKMKR LSEFIYSKTS KAGVQEFVDG\r\n",
      "     LHEKLNTIII KASAKGGNLP PVSPNDSGAK IASNPLERHV IPVSSSDFNN KHLLEPLCSD\r\n",
      "     PLKDTNSDEQ HSTSALTEVE MNQPQHATEL MVTSDHIVPG DMAREPVEET TKSPSDVNIS\r\n",
      "     AQPALSNFIS QLEPEVFNSL VKIMKDVQKN TVKFYIHEEE ESVLCKEIKE YLIKLGNTEC\r\n",
      "     HPEQFLERRS KLDKLLIIIQ NEDIAGFIHK IPGLVTLKKL PCVSFAGVDS LDDVKNHTYN\r\n",
      "     ELFVSGGFIV SDESILNPEV VTVENLKNFL TFLEELSTPE GKWQWKVHCK FQKKLKELGR\r\n",
      "     LNAKALSLLT LLNVYQKKHL VEILSYHNCD SQTRNAPELD CLIRLQAQNI QQRHIVFLTE\r\n",
      "     KNIKMLSSYT DNGIVVATAE DFMQNFKNLV GYHNSITEEN LPQLGANENL ESQSALLEND\r\n",
      "     EKDEEDMSLD SGDEISHIEV CSNFHSEIWE KETKGSRGTD QKKNTQIELQ SSPDVQNSLL\r\n",
      "     EDKTYLDSEE RTSIDIVCSE GENSNSTEQD SYSNFQVYHS QLNMSHQFSH FNVLTHQTFL\r\n",
      "     GTPYALSSSQ SQENENYFLS AYTESLDRDK SPPPLSWGKS DSSRPYSQEK\r\n",
      "//\r\n",
      "ID   UBR4_HUMAN              Reviewed;        5183 AA.\r\n",
      "AC   Q5T4S7; A8MPT2; A8MQ33; A8MQB1; O60646; O75050; Q4QRK5; Q5T4S8; Q5T4S9;\r\n",
      "AC   Q5TBN8; Q5TBP2; Q6DKH8; Q6P4A4; Q7L8P7; Q8IXJ4; Q8TDN5; Q8WV67; Q9HA46;\r\n",
      "AC   Q9P2N9; Q9UG82;\r\n",
      "DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   21-DEC-2004, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 172.\r\n",
      "DE   RecName: Full=E3 ubiquitin-protein ligase UBR4;\r\n",
      "DE            EC=2.3.2.27;\r\n",
      "DE   AltName: Full=600 kDa retinoblastoma protein-associated factor;\r\n",
      "DE   AltName: Full=N-recognin-4;\r\n",
      "DE   AltName: Full=RING-type E3 ubiquitin transferase UBR4;\r\n",
      "DE   AltName: Full=Retinoblastoma-associated factor of 600 kDa;\r\n",
      "DE            Short=RBAF600;\r\n",
      "DE            Short=p600;\r\n",
      "DE   AltName: Full=Zinc finger UBR1-type protein 1;\r\n",
      "GN   Name=UBR4; Synonyms=KIAA0462, KIAA1307, RBAF600, ZUBR1;\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH RB1 AND CALM,\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND FUNCTION.\r\n",
      "RX   PubMed=16214886; DOI=10.1073/pnas.0507458102;\r\n",
      "RA   Nakatani Y., Konishi H., Vassilev A., Kurooka H., Ishiguro K., Sawada J.,\r\n",
      "RA   Ikura T., Korsmeyer S.J., Qin J., Herlitz A.M.;\r\n",
      "RT   \"p600, a unique protein required for membrane morphogenesis and cell\r\n",
      "RT   survival.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 102:15093-15098(2005).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).\r\n",
      "RC   TISSUE=Mammary gland;\r\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\r\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\r\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\r\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\r\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\r\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\r\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\r\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\r\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\r\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\r\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\r\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\r\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\r\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\r\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\r\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\r\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\r\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\r\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\r\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\r\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\r\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\r\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\r\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\r\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\r\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\r\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\r\n",
      "RA   Isogai T., Sugano S.;\r\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\r\n",
      "RT   cDNAs.\";\r\n",
      "RL   Nat. Genet. 36:40-45(2004).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RX   PubMed=16710414; DOI=10.1038/nature04727;\r\n",
      "RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,\r\n",
      "RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,\r\n",
      "RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,\r\n",
      "RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,\r\n",
      "RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,\r\n",
      "RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,\r\n",
      "RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,\r\n",
      "RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,\r\n",
      "RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,\r\n",
      "RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,\r\n",
      "RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,\r\n",
      "RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,\r\n",
      "RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,\r\n",
      "RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,\r\n",
      "RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,\r\n",
      "RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,\r\n",
      "RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,\r\n",
      "RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,\r\n",
      "RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,\r\n",
      "RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,\r\n",
      "RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,\r\n",
      "RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,\r\n",
      "RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,\r\n",
      "RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,\r\n",
      "RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,\r\n",
      "RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,\r\n",
      "RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,\r\n",
      "RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,\r\n",
      "RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;\r\n",
      "RT   \"The DNA sequence and biological annotation of human chromosome 1.\";\r\n",
      "RL   Nature 441:315-321(2006).\r\n",
      "RN   [4]\r\n",
      "RP   PROTEIN SEQUENCE OF 166-185; 435-443; 850-857; 921-931; 1065-1079;\r\n",
      "RP   1131-1141; 1175-1192; 1195-1208; 1286-1293; 1337-1349; 1434-1440;\r\n",
      "RP   1464-1470; 1478-1489; 1731-1757; 1838-1850; 1875-1886; 1909-1918;\r\n",
      "RP   1921-1931; 2048-2058; 2131-2138; 2211-2218; 2354-2381; 2527-2536;\r\n",
      "RP   2564-2572; 2713-2721; 2981-2989; 3046-3065; 3229-3238; 3243-3252;\r\n",
      "RP   3589-3606; 3618-3628; 3735-3745; 3809-3816; 3827-3836; 3845-3857;\r\n",
      "RP   3889-3915; 4131-4142; 4204-4215; 4320-4334; 4414-4426; 4608-4637;\r\n",
      "RP   4686-4696; 4717-4724; 4803-4814; 4852-4860; 5013-5022 AND 5062-5069,\r\n",
      "RP   PHOSPHORYLATION AT SER-2719, AND IDENTIFICATION BY MASS SPECTROMETRY.\r\n",
      "RC   TISSUE=Hepatoma;\r\n",
      "RA   Bienvenut W.V., Boldt K., von Kriegsheim A.F., Kolch W.;\r\n",
      "RL   Submitted (JUL-2007) to UniProtKB.\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 779-5183 (ISOFORM 5).\r\n",
      "RC   TISSUE=Brain;\r\n",
      "RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;\r\n",
      "RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;\r\n",
      "RT   \"Prediction of the coding sequences of unidentified human genes. XVI. The\r\n",
      "RT   complete sequences of 150 new cDNA clones from brain which code for large\r\n",
      "RT   proteins in vitro.\";\r\n",
      "RL   DNA Res. 7:65-73(2000).\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2908-5183 (ISOFORM 1).\r\n",
      "RC   TISSUE=Brain;\r\n",
      "RX   PubMed=9455484; DOI=10.1093/dnares/4.5.345;\r\n",
      "RA   Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D.,\r\n",
      "RA   Nomura N., Ohara O.;\r\n",
      "RT   \"Characterization of cDNA clones in size-fractionated cDNA libraries from\r\n",
      "RT   human brain.\";\r\n",
      "RL   DNA Res. 4:345-349(1997).\r\n",
      "RN   [7]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4385-5183 (ISOFORMS 1 AND 2), AND\r\n",
      "RP   VARIANT LEU-4867.\r\n",
      "RC   TISSUE=Kidney, Liver, Lung, and Spleen;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [8]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4583-5183 (ISOFORM 1), AND VARIANTS LEU-4867\r\n",
      "RP   AND ARG-4924.\r\n",
      "RX   PubMed=16247014; DOI=10.1073/pnas.0500090102;\r\n",
      "RA   Lennerz V., Fatho M., Gentilini C., Frye R.A., Lifke A., Ferel D.,\r\n",
      "RA   Woelfel C., Huber C., Woelfel T.;\r\n",
      "RT   \"The response of autologous T cells to a human melanoma is dominated by\r\n",
      "RT   mutated neoantigens.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 102:16013-16018(2005).\r\n",
      "RN   [9]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4686-5183 (ISOFORM 1).\r\n",
      "RC   TISSUE=Brain;\r\n",
      "RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;\r\n",
      "RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,\r\n",
      "RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,\r\n",
      "RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,\r\n",
      "RA   Wiemann S., Schupp I.;\r\n",
      "RT   \"The full-ORF clone resource of the German cDNA consortium.\";\r\n",
      "RL   BMC Genomics 8:399-399(2007).\r\n",
      "RN   [10]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4709-5183 (ISOFORM 1), AND\r\n",
      "RP   VARIANT LEU-4867.\r\n",
      "RC   TISSUE=Brain;\r\n",
      "RA   Yu W., Gibbs R.A.;\r\n",
      "RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [11]\r\n",
      "RP   INTERACTION WITH HPV-16 E7; HPV-6B E7 AND HPV-11 E7 (MICROBIAL INFECTION),\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=16061792; DOI=10.1073/pnas.0505337102;\r\n",
      "RA   Huh K.-W., DeMasi J., Ogawa H., Nakatani Y., Howley P.M., Muenger K.;\r\n",
      "RT   \"Association of the human papillomavirus type 16 E7 oncoprotein with the\r\n",
      "RT   600-kDa retinoblastoma protein-associated factor, p600.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 102:11492-11497(2005).\r\n",
      "RN   [12]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;\r\n",
      "RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,\r\n",
      "RA   Greff Z., Keri G., Stemmann O., Mann M.;\r\n",
      "RT   \"Kinase-selective enrichment enables quantitative phosphoproteomics of the\r\n",
      "RT   kinome across the cell cycle.\";\r\n",
      "RL   Mol. Cell 31:438-448(2008).\r\n",
      "RN   [13]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178; SER-181 AND THR-2715,\r\n",
      "RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;\r\n",
      "RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,\r\n",
      "RA   Elledge S.J., Gygi S.P.;\r\n",
      "RT   \"A quantitative atlas of mitotic phosphorylation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).\r\n",
      "RN   [14]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19413330; DOI=10.1021/ac9004309;\r\n",
      "RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;\r\n",
      "RT   \"Lys-N and trypsin cover complementary parts of the phosphoproteome in a\r\n",
      "RT   refined SCX-based approach.\";\r\n",
      "RL   Anal. Chem. 81:4493-4501(2009).\r\n",
      "RN   [15]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [16]\r\n",
      "RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1084, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19608861; DOI=10.1126/science.1175371;\r\n",
      "RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,\r\n",
      "RA   Olsen J.V., Mann M.;\r\n",
      "RT   \"Lysine acetylation targets protein complexes and co-regulates major\r\n",
      "RT   cellular functions.\";\r\n",
      "RL   Science 325:834-840(2009).\r\n",
      "RN   [17]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178; SER-181 AND SER-1763,\r\n",
      "RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;\r\n",
      "RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,\r\n",
      "RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;\r\n",
      "RT   \"Quantitative phosphoproteomics reveals widespread full phosphorylation\r\n",
      "RT   site occupancy during mitosis.\";\r\n",
      "RL   Sci. Signal. 3:RA3-RA3(2010).\r\n",
      "RN   [18]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;\r\n",
      "RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,\r\n",
      "RA   Bennett K.L., Superti-Furga G., Colinge J.;\r\n",
      "RT   \"Initial characterization of the human central proteome.\";\r\n",
      "RL   BMC Syst. Biol. 5:17-17(2011).\r\n",
      "RN   [19]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2719, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;\r\n",
      "RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,\r\n",
      "RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;\r\n",
      "RT   \"System-wide temporal characterization of the proteome and phosphoproteome\r\n",
      "RT   of human embryonic stem cell differentiation.\";\r\n",
      "RL   Sci. Signal. 4:RS3-RS3(2011).\r\n",
      "RN   [20]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178; SER-181; THR-905;\r\n",
      "RP   SER-1747; SER-1878; SER-1904; THR-2715 AND SER-2719, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [21]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=23932781; DOI=10.1016/j.molcel.2013.07.002;\r\n",
      "RA   Lin R., Tao R., Gao X., Li T., Zhou X., Guan K.L., Xiong Y., Lei Q.Y.;\r\n",
      "RT   \"Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and\r\n",
      "RT   tumor growth.\";\r\n",
      "RL   Mol. Cell 51:506-518(2013).\r\n",
      "RN   [22]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1647; SER-1652; THR-2944 AND\r\n",
      "RP   SER-2952, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;\r\n",
      "RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,\r\n",
      "RA   Ye M., Zou H.;\r\n",
      "RT   \"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteomics 96:253-262(2014).\r\n",
      "RN   [23]\r\n",
      "RP   INTERACTION WITH RIFT VALLEY FEVER VIRUS GLYCOPROTEIN N (MICROBIAL\r\n",
      "RP   INFECTION).\r\n",
      "RX   PubMed=35032865; DOI=10.1016/j.virol.2021.12.010;\r\n",
      "RA   Bracci N., de la Fuente C., Saleem S., Pinkham C., Narayanan A.,\r\n",
      "RA   Garcia-Sastre A., Balaraman V., Richt J.A., Wilson W., Kehn-Hall K.;\r\n",
      "RT   \"Rift Valley fever virus Gn V5-epitope tagged virus enables identification\r\n",
      "RT   of UBR4 as a Gn interacting protein that facilitates Rift Valley fever\r\n",
      "RT   virus production.\";\r\n",
      "RL   Virology 567:65-76(2022).\r\n",
      "RN   [24]\r\n",
      "RP   VARIANT [LARGE SCALE ANALYSIS] HIS-1394.\r\n",
      "RX   PubMed=16959974; DOI=10.1126/science.1133427;\r\n",
      "RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,\r\n",
      "RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,\r\n",
      "RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,\r\n",
      "RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,\r\n",
      "RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,\r\n",
      "RA   Velculescu V.E.;\r\n",
      "RT   \"The consensus coding sequences of human breast and colorectal cancers.\";\r\n",
      "RL   Science 314:268-274(2006).\r\n",
      "CC   -!- FUNCTION: E3 ubiquitin-protein ligase which is a component of the N-end\r\n",
      "CC       rule pathway. Recognizes and binds to proteins bearing specific N-\r\n",
      "CC       terminal residues that are destabilizing according to the N-end rule,\r\n",
      "CC       leading to their ubiquitination and subsequent degradation. Together\r\n",
      "CC       with clathrin, forms meshwork structures involved in membrane\r\n",
      "CC       morphogenesis and cytoskeletal organization. Regulates integrin-\r\n",
      "CC       mediated signaling. May play a role in activation of FAK in response to\r\n",
      "CC       cell-matrix interactions. Mediates ubiquitination of ACLY, leading to\r\n",
      "CC       its subsequent degradation. {ECO:0000269|PubMed:16214886,\r\n",
      "CC       ECO:0000269|PubMed:23932781}.\r\n",
      "CC   -!- CATALYTIC ACTIVITY:\r\n",
      "CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +\r\n",
      "CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-\r\n",
      "CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;\r\n",
      "CC         EC=2.3.2.27;\r\n",
      "CC   -!- PATHWAY: Protein modification; protein ubiquitination.\r\n",
      "CC   -!- SUBUNIT: Interacts with RB1 and calmodulin.\r\n",
      "CC       {ECO:0000269|PubMed:16214886}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with protein E7 from papilloma\r\n",
      "CC       virus HPV-16, HPV-6B and HPV-11. {ECO:0000269|PubMed:16061792}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with Rift valley fever virus\r\n",
      "CC       glycoprotein N; this interaction is important for viral RNA production.\r\n",
      "CC       {ECO:0000269|PubMed:35032865}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q5T4S7; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-1995940, EBI-5235340;\r\n",
      "CC       Q5T4S7; Q93009: USP7; NbExp=2; IntAct=EBI-1995940, EBI-302474;\r\n",
      "CC       Q5T4S7; P03129: E7; Xeno; NbExp=5; IntAct=EBI-1995940, EBI-866453;\r\n",
      "CC       Q5T4S7; P04020: E7; Xeno; NbExp=2; IntAct=EBI-1995940, EBI-7005254;\r\n",
      "CC       Q5T4S7; P06464: E7; Xeno; NbExp=2; IntAct=EBI-1995940, EBI-6944797;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane\r\n",
      "CC       protein {ECO:0000305}. Cytoplasm. Cytoplasm, cytoskeleton. Nucleus.\r\n",
      "CC       Note=Concentrates at the leading edge of membrane structures involved\r\n",
      "CC       in actin motility.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=6;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=Q5T4S7-1; Sequence=Displayed;\r\n",
      "CC       Name=2;\r\n",
      "CC         IsoId=Q5T4S7-2; Sequence=VSP_025209;\r\n",
      "CC       Name=3;\r\n",
      "CC         IsoId=Q5T4S7-3; Sequence=VSP_025203, VSP_025206;\r\n",
      "CC       Name=4;\r\n",
      "CC         IsoId=Q5T4S7-4; Sequence=VSP_025205, VSP_025206;\r\n",
      "CC       Name=5;\r\n",
      "CC         IsoId=Q5T4S7-5; Sequence=VSP_025201, VSP_025202, VSP_025204;\r\n",
      "CC       Name=6;\r\n",
      "CC         IsoId=Q5T4S7-6; Sequence=VSP_025200, VSP_025207, VSP_025208;\r\n",
      "CC   -!- SIMILARITY: Belongs to the UBR4 family. {ECO:0000305}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=CAD43719.1; Type=Erroneous initiation; Evidence={ECO:0000305};\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AF348492; AAL83880.1; -; mRNA.\r\n",
      "DR   EMBL; AK022322; BAB14011.1; -; mRNA.\r\n",
      "DR   EMBL; AL137127; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AL357564; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AB037728; BAA92545.1; -; mRNA.\r\n",
      "DR   EMBL; AB007931; BAA32307.1; -; mRNA.\r\n",
      "DR   EMBL; BC018694; AAH18694.2; -; mRNA.\r\n",
      "DR   EMBL; BC063573; AAH63573.1; -; mRNA.\r\n",
      "DR   EMBL; BC073905; AAH73905.1; -; mRNA.\r\n",
      "DR   EMBL; BC096758; AAH96758.1; -; mRNA.\r\n",
      "DR   EMBL; AJ505016; CAD43719.1; ALT_INIT; mRNA.\r\n",
      "DR   EMBL; AL049972; CAB43227.1; -; mRNA.\r\n",
      "DR   EMBL; AF055010; AAC09360.1; -; mRNA.\r\n",
      "DR   CCDS; CCDS189.1; -. [Q5T4S7-1]\r\n",
      "DR   PIR; T00076; T00076.\r\n",
      "DR   RefSeq; NP_065816.2; NM_020765.2. [Q5T4S7-1]\r\n",
      "DR   BioGRID; 116934; 299.\r\n",
      "DR   CORUM; Q5T4S7; -.\r\n",
      "DR   IntAct; Q5T4S7; 121.\r\n",
      "DR   MINT; Q5T4S7; -.\r\n",
      "DR   STRING; 9606.ENSP00000364403; -.\r\n",
      "DR   ChEMBL; CHEMBL4295851; -.\r\n",
      "DR   DrugBank; DB05483; Picolinic acid.\r\n",
      "DR   DrugBank; DB04959; Verpasep caltespen.\r\n",
      "DR   CarbonylDB; Q5T4S7; -.\r\n",
      "DR   GlyCosmos; Q5T4S7; 2 sites, 2 glycans.\r\n",
      "DR   GlyGen; Q5T4S7; 4 sites, 2 O-linked glycans (4 sites).\r\n",
      "DR   iPTMnet; Q5T4S7; -.\r\n",
      "DR   MetOSite; Q5T4S7; -.\r\n",
      "DR   PhosphoSitePlus; Q5T4S7; -.\r\n",
      "DR   SwissPalm; Q5T4S7; -.\r\n",
      "DR   BioMuta; UBR4; -.\r\n",
      "DR   DMDM; 74744979; -.\r\n",
      "DR   EPD; Q5T4S7; -.\r\n",
      "DR   jPOST; Q5T4S7; -.\r\n",
      "DR   MassIVE; Q5T4S7; -.\r\n",
      "DR   MaxQB; Q5T4S7; -.\r\n",
      "DR   PaxDb; Q5T4S7; -.\r\n",
      "DR   PeptideAtlas; Q5T4S7; -.\r\n",
      "DR   ProteomicsDB; 64480; -. [Q5T4S7-1]\r\n",
      "DR   ProteomicsDB; 64481; -. [Q5T4S7-2]\r\n",
      "DR   ProteomicsDB; 64482; -. [Q5T4S7-3]\r\n",
      "DR   ProteomicsDB; 64483; -. [Q5T4S7-4]\r\n",
      "DR   ProteomicsDB; 64484; -. [Q5T4S7-5]\r\n",
      "DR   ProteomicsDB; 64485; -. [Q5T4S7-6]\r\n",
      "DR   Antibodypedia; 2856; 124 antibodies from 28 providers.\r\n",
      "DR   DNASU; 23352; -.\r\n",
      "DR   Ensembl; ENST00000375218.3; ENSP00000364366.3; ENSG00000127481.15. [Q5T4S7-6]\r\n",
      "DR   Ensembl; ENST00000375254.8; ENSP00000364403.3; ENSG00000127481.15. [Q5T4S7-1]\r\n",
      "DR   GeneID; 23352; -.\r\n",
      "DR   KEGG; hsa:23352; -.\r\n",
      "DR   MANE-Select; ENST00000375254.8; ENSP00000364403.3; NM_020765.3; NP_065816.2.\r\n",
      "DR   UCSC; uc001bbi.4; human. [Q5T4S7-1]\r\n",
      "DR   AGR; HGNC:30313; -.\r\n",
      "DR   CTD; 23352; -.\r\n",
      "DR   DisGeNET; 23352; -.\r\n",
      "DR   GeneCards; UBR4; -.\r\n",
      "DR   HGNC; HGNC:30313; UBR4.\r\n",
      "DR   HPA; ENSG00000127481; Low tissue specificity.\r\n",
      "DR   MIM; 609890; gene.\r\n",
      "DR   neXtProt; NX_Q5T4S7; -.\r\n",
      "DR   OpenTargets; ENSG00000127481; -.\r\n",
      "DR   PharmGKB; PA162407958; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000127481; -.\r\n",
      "DR   eggNOG; KOG1776; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00600000084471; -.\r\n",
      "DR   HOGENOM; CLU_000069_0_0_1; -.\r\n",
      "DR   InParanoid; Q5T4S7; -.\r\n",
      "DR   OMA; VHRMEEH; -.\r\n",
      "DR   OrthoDB; 10597at2759; -.\r\n",
      "DR   PhylomeDB; Q5T4S7; -.\r\n",
      "DR   TreeFam; TF314406; -.\r\n",
      "DR   PathwayCommons; Q5T4S7; -.\r\n",
      "DR   Reactome; R-HSA-6798695; Neutrophil degranulation.\r\n",
      "DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.\r\n",
      "DR   SignaLink; Q5T4S7; -.\r\n",
      "DR   UniPathway; UPA00143; -.\r\n",
      "DR   BioGRID-ORCS; 23352; 681 hits in 1220 CRISPR screens.\r\n",
      "DR   ChiTaRS; UBR4; human.\r\n",
      "DR   GeneWiki; UBR4; -.\r\n",
      "DR   GenomeRNAi; 23352; -.\r\n",
      "DR   Pharos; Q5T4S7; Tbio.\r\n",
      "DR   PRO; PR:Q5T4S7; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 1.\r\n",
      "DR   RNAct; Q5T4S7; protein.\r\n",
      "DR   Bgee; ENSG00000127481; Expressed in skin of leg and 101 other tissues.\r\n",
      "DR   ExpressionAtlas; Q5T4S7; baseline and differential.\r\n",
      "DR   Genevisible; Q5T4S7; HS.\r\n",
      "DR   GO; GO:0005813; C:centrosome; IDA:HPA.\r\n",
      "DR   GO; GO:0005829; C:cytosol; IDA:HPA.\r\n",
      "DR   GO; GO:0101003; C:ficolin-1-rich granule membrane; TAS:Reactome.\r\n",
      "DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.\r\n",
      "DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.\r\n",
      "DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.\r\n",
      "DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.\r\n",
      "DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IBA:GO_Central.\r\n",
      "DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.\r\n",
      "DR   GO; GO:0045717; P:negative regulation of fatty acid biosynthetic process; IDA:UniProt.\r\n",
      "DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.\r\n",
      "DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB.\r\n",
      "DR   CDD; cd19680; UBR-box_UBR4; 1.\r\n",
      "DR   InterPro; IPR016024; ARM-type_fold.\r\n",
      "DR   InterPro; IPR025704; E3_Ub_ligase_UBR4_C.\r\n",
      "DR   InterPro; IPR045841; E3_UBR4_N.\r\n",
      "DR   InterPro; IPR045189; UBR4-like.\r\n",
      "DR   InterPro; IPR047509; UBR4-like_UBR-box.\r\n",
      "DR   InterPro; IPR036322; WD40_repeat_dom_sf.\r\n",
      "DR   InterPro; IPR003126; Znf_UBR.\r\n",
      "DR   PANTHER; PTHR21725; E3 UBIQUITIN-PROTEIN LIGASE UBR4; 1.\r\n",
      "DR   PANTHER; PTHR21725:SF1; E3 UBIQUITIN-PROTEIN LIGASE UBR4; 1.\r\n",
      "DR   Pfam; PF13764; E3_UbLigase_R4; 1.\r\n",
      "DR   Pfam; PF19423; E3_UBR4_N; 1.\r\n",
      "DR   Pfam; PF02207; zf-UBR; 1.\r\n",
      "DR   SMART; SM00396; ZnF_UBR1; 1.\r\n",
      "DR   SUPFAM; SSF48371; ARM repeat; 2.\r\n",
      "DR   SUPFAM; SSF50978; WD40 repeat-like; 1.\r\n",
      "DR   PROSITE; PS51157; ZF_UBR; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Acetylation; Alternative splicing; Calmodulin-binding; Cytoplasm;\r\n",
      "KW   Cytoskeleton; Direct protein sequencing; Host-virus interaction; Membrane;\r\n",
      "KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Transferase;\r\n",
      "KW   Transmembrane; Transmembrane helix; Ubl conjugation pathway; Zinc;\r\n",
      "KW   Zinc-finger.\r\n",
      "FT   CHAIN           1..5183\r\n",
      "FT                   /note=\"E3 ubiquitin-protein ligase UBR4\"\r\n",
      "FT                   /id=\"PRO_0000286861\"\r\n",
      "FT   TRANSMEM        850..870\r\n",
      "FT                   /note=\"Helical\"\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   TRANSMEM        993..1013\r\n",
      "FT                   /note=\"Helical\"\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   ZN_FING         1656..1729\r\n",
      "FT                   /note=\"UBR-type\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00508\"\r\n",
      "FT   REGION          1..26\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          549..588\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          601..638\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1756..1778\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          2430..2469\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          2711..2764\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          2833..2967\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          3342..3385\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        549..571\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        572..586\r\n",
      "FT                   /note=\"Acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        604..621\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        2444..2469\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        2833..2891\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        2929..2949\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        2950..2967\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        3342..3365\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        3366..3385\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         178\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         181\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         212\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:A2AN08\"\r\n",
      "FT   MOD_RES         370\r\n",
      "FT                   /note=\"Phosphotyrosine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:A2AN08\"\r\n",
      "FT   MOD_RES         905\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1084\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19608861\"\r\n",
      "FT   MOD_RES         1402\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q2TL32\"\r\n",
      "FT   MOD_RES         1647\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         1652\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         1747\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1754\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q2TL32\"\r\n",
      "FT   MOD_RES         1763\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         1878\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1904\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         2715\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         2719\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|Ref.4, ECO:0007744|PubMed:21406692,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         2722\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:A2AN08\"\r\n",
      "FT   MOD_RES         2724\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:A2AN08\"\r\n",
      "FT   MOD_RES         2944\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         2952\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:24275569\"\r\n",
      "FT   VAR_SEQ         1..3585\r\n",
      "FT                   /note=\"Missing (in isoform 6)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:14702039\"\r\n",
      "FT                   /id=\"VSP_025200\"\r\n",
      "FT   VAR_SEQ         2100\r\n",
      "FT                   /note=\"K -> KQ (in isoform 5)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:10718198\"\r\n",
      "FT                   /id=\"VSP_025201\"\r\n",
      "FT   VAR_SEQ         2405..2486\r\n",
      "FT                   /note=\"IGASVDPAGVTMIDAVKIYGKTKEQFGWPDEPPEEFPSASVSNICPSNLNQS\r\n",
      "FT                   NGTGDSDSAAPTTTSGTVLERLVVSSLEAL -> SESPTPGADSVLIVTAKLGATGLWL\r\n",
      "FT                   SNILGSLHSADFSVLSSGNFELHLMY (in isoform 5)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:10718198\"\r\n",
      "FT                   /id=\"VSP_025202\"\r\n",
      "FT   VAR_SEQ         2476\r\n",
      "FT                   /note=\"E -> ESSETESLTKLD (in isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT                   /id=\"VSP_025203\"\r\n",
      "FT   VAR_SEQ         2487..5183\r\n",
      "FT                   /note=\"Missing (in isoform 5)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:10718198\"\r\n",
      "FT                   /id=\"VSP_025204\"\r\n",
      "FT   VAR_SEQ         2601\r\n",
      "FT                   /note=\"T -> TDCFFPRCACWSLGIVGILIGAPLETPSP (in isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT                   /id=\"VSP_025205\"\r\n",
      "FT   VAR_SEQ         2830..2864\r\n",
      "FT                   /note=\"Missing (in isoform 3 and isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT                   /id=\"VSP_025206\"\r\n",
      "FT   VAR_SEQ         3777..3797\r\n",
      "FT                   /note=\"DDSGTAGGISSTSASVNRYIL -> VVPRCKGHLDKGLGLDQKTAS (in\r\n",
      "FT                   isoform 6)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:14702039\"\r\n",
      "FT                   /id=\"VSP_025207\"\r\n",
      "FT   VAR_SEQ         3798..5183\r\n",
      "FT                   /note=\"Missing (in isoform 6)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:14702039\"\r\n",
      "FT                   /id=\"VSP_025208\"\r\n",
      "FT   VAR_SEQ         5108\r\n",
      "FT                   /note=\"K -> KKQTTPTVGGIDTGSLEPCVCE (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_025209\"\r\n",
      "FT   VARIANT         1107\r\n",
      "FT                   /note=\"T -> A (in dbSNP:rs16862578)\"\r\n",
      "FT                   /id=\"VAR_032193\"\r\n",
      "FT   VARIANT         1394\r\n",
      "FT                   /note=\"R -> H (in a breast cancer sample; somatic mutation;\r\n",
      "FT                   dbSNP:rs756549939)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16959974\"\r\n",
      "FT                   /id=\"VAR_035540\"\r\n",
      "FT   VARIANT         4867\r\n",
      "FT                   /note=\"M -> L (in dbSNP:rs12584)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:15489334,\r\n",
      "FT                   ECO:0000269|PubMed:16247014, ECO:0000269|Ref.10\"\r\n",
      "FT                   /id=\"VAR_032194\"\r\n",
      "FT   VARIANT         4924\r\n",
      "FT                   /note=\"G -> R (in a melanoma patient)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16247014\"\r\n",
      "FT                   /id=\"VAR_032195\"\r\n",
      "FT   VARIANT         5084\r\n",
      "FT                   /note=\"V -> M (in dbSNP:rs2274010)\"\r\n",
      "FT                   /id=\"VAR_032196\"\r\n",
      "FT   CONFLICT        2016\r\n",
      "FT                   /note=\"A -> S (in Ref. 1; AAL83880)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        2410\r\n",
      "FT                   /note=\"D -> E (in Ref. 1; AAL83880)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        3957\r\n",
      "FT                   /note=\"G -> S (in Ref. 1; AAL83880)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        4589\r\n",
      "FT                   /note=\"G -> V (in Ref. 7; AAH18694)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   5183 AA;  573841 MW;  5F6DD7B565E27609 CRC64;\r\n",
      "     MATSGGEEAA AAAPAPGTPA TGADTTPGWE VAVRPLLSAS YSAFEMKELP QLVASVIESE\r\n",
      "     SEILHHEKQY EPFYSSFVAL STHYITTVCS LIPRNQLQSV AAACKVLIEF SLLRLENPDE\r\n",
      "     ACAVSQKHLI LLIKGLCTGC SRLDRTEIIT FTAMMKSAKL PQTVKTLSDV EDQKELASPV\r\n",
      "     SPELRQKEVQ MNFLNQLTSV FNPRTVASQP ISTQTLVEGE NDEQSSTDQA SAIKTKNVFI\r\n",
      "     AQNVASLQEL GGSEKLLRVC LNLPYFLRYI NRFQDAVLAN SFFIMPATVA DATAVRNGFH\r\n",
      "     SLVIDVTMAL DTLSLPVLEP LNPSRLQDVT VLSLSCLYAG VSVATCMAIL HVGSAQQVRT\r\n",
      "     GSTSSKEDDY ESDAATIVQK CLEIYDMIGQ AISSSRRAGG EHYQNFQLLG AWCLLNSLFL\r\n",
      "     ILNLSPTALA DKGKEKDPLA ALRVRDILSR TKEGVGSPKL GPGKGHQGFG VLSVILANHA\r\n",
      "     IKLLTSLFQD LQVEALHKGW ETDGPPAALS IMAQSTSIQR IQRLIDSVPL MNLLLTLLST\r\n",
      "     SYRKACVLQR QRKGSMSSDA SASTDSNTYY EDDFSSTEED SSQDDDSEPI LGQWFEETIS\r\n",
      "     PSKEKAAPPP PPPPPPLESS PRVKSPSKQA PGEKGNILAS RKDPELFLGL ASNILNFITS\r\n",
      "     SMLNSRNNFI RNYLSVSLSE HHMATLASII KEVDKDGLKG SSDEEFAAAL YHFNHSLVTS\r\n",
      "     DLQSPNLQNT LLQQLGVAPF SEGPWPLYIH PQSLSVLSRL LLIWQHKASA QGDPDVPECL\r\n",
      "     KVWDRFLSTM KQNALQGVVP SETEDLNVEH LQMLLLIFHN FTETGRRAIL SLFVQIIQEL\r\n",
      "     SVNMDAQMRF VPLILARLLL IFDYLLHQYS KAPVYLFEQV QHNLLSPPFG WASGSQDSNS\r\n",
      "     RRATTPLYHG FKEVEENWSK HFSSDAVPHP RFYCVLSPEA SEDDLNRLDS VACDVLFSKL\r\n",
      "     VKYDELYAAL TALLAAGSQL DTVRRKENKN VTALEACALQ YYFLILWRIL GILPPSKTYI\r\n",
      "     NQLSMNSPEM SECDILHTLR WSSRLRISSY VNWIKDHLIK QGMKAEHASS LLELASTTKC\r\n",
      "     SSVKYDVEIV EEYFARQISS FCSIDCTTIL QLHEIPSLQS IYTLDAAISK VQVSLDEHFS\r\n",
      "     KMAAETDPHK SSEITKNLLP ATLQLIDTYA SFTRAYLLQN FNEEGTTEKP SKEKLQGFAA\r\n",
      "     VLAIGSSRCK ANTLGPTLVQ NLPSSVQTVC ESWNNINTNE FPNIGSWRNA FANDTIPSES\r\n",
      "     YISAVQAAHL GTLCSQSLPL AASLKHTLLS LVRLTGDLIV WSDEMNPPQV IRTLLPLLLE\r\n",
      "     SSTESVAEIS SNSLERILGP AESDEFLARV YEKLITGCYN ILANHADPNS GLDESILEEC\r\n",
      "     LQYLEKQLES SQARKAMEEF FSDSGELVQI MMATANENLS AKFCNRVLKF FTKLFQLTEK\r\n",
      "     SPNPSLLHLC GSLAQLACVE PVRLQAWLTR MTTSPPKDSD QLDVIQENRQ LLQLLTTYIV\r\n",
      "     RENSQVGEGV CAVLLGTLTP MATEMLANGD GTGFPELMVV MATLASAGQG AGHLQLHNAA\r\n",
      "     VDWLSRCKKY LSQKNVVEKL NANVMHGKHV MILECTCHIM SYLADVTNAL SQSNGQGPSH\r\n",
      "     LSVDGEERAI EVDSDWVEEL AVEEEDSQAE DSDEDSLCNK LCTFTITQKE FMNQHWYHCH\r\n",
      "     TCKMVDGVGV CTVCAKVCHK DHEISYAKYG SFFCDCGAKE DGSCLALVKR TPSSGMSSTM\r\n",
      "     KESAFQSEPR ISESLVRHAS TSSPADKAKV TISDGKVADE EKPKKSSLCR TVEGCREELQ\r\n",
      "     NQANFSFAPL VLDMLNFLMD AIQTNFQQAS AVGSSSRAQQ ALSELHTVEK AVEMTDQLMV\r\n",
      "     PTLGSQEGAF ENVRMNYSGD QGQTIRQLIS AHVLRRVAMC VLSSPHGRRQ HLAVSHEKGK\r\n",
      "     ITVLQLSALL KQADSSKRKL TLTRLASAPV PFTVLSLTGN PCKEDYLAVC GLKDCHVLTF\r\n",
      "     SSSGSVSDHL VLHPQLATGN FIIKAVWLPG SQTELAIVTA DFVKIYDLCV DALSPTFYFL\r\n",
      "     LPSSKIRDVT FLFNEEGKNI IVIMSSAGYI YTQLMEEASS AQQGPFYVTN VLEINHEDLK\r\n",
      "     DSNSQVAGGG VSVYYSHVLQ MLFFSYCQGK SFAATISRTT LEVLQLFPIN IKSSNGGSKT\r\n",
      "     SPALCQWSEV MNHPGLVCCV QQTTGVPLVV MVKPDTFLIQ EIKTLPAKAK IQDMVAIRHT\r\n",
      "     ACNEQQRTTM ILLCEDGSLR IYMANVENTS YWLQPSLQPS SVISIMKPVR KRKTATITTR\r\n",
      "     TSSQVTFPID FFEHNQQLTD VEFGGNDLLQ VYNAQQIKHR LNSTGMYVAN TKPGGFTIEI\r\n",
      "     SNNNSTMVMT GMRIQIGTQA IERAPSYIEI FGRTMQLNLS RSRWFDFPFT REEALQADKK\r\n",
      "     LNLFIGASVD PAGVTMIDAV KIYGKTKEQF GWPDEPPEEF PSASVSNICP SNLNQSNGTG\r\n",
      "     DSDSAAPTTT SGTVLERLVV SSLEALESCF AVGPIIEKER NKNAAQELAT LLLSLPAPAS\r\n",
      "     VQQQSKSLLA SLHTSRSAYH SHKDQALLSK AVQCLNTSSK EGKDLDPEVF QRLVITARSI\r\n",
      "     AIMRPNNLVH FTESKLPQME TEGMDEGKEP QKQLEGDCCS FITQLVNHFW KLHASKPKNA\r\n",
      "     FLAPACLPGL THIEATVNAL VDIIHGYCTC ELDCINTASK IYMQMLLCPD PAVSFSCKQA\r\n",
      "     LIRVLRPRNK RRHVTLPSSP RSNTPMGDKD DDDDDDADEK MQSSGIPNGG HIRQESQEQS\r\n",
      "     EVDHGDFEMV SESMVLETAE NVNNGNPSPL EALLAGAEGF PPMLDIPPDA DDETMVELAI\r\n",
      "     ALSLQQDQQG SSSSALGLQS LGLSGQAPSS SSLDAGTLSD TTASAPASDD EGSTAATDGS\r\n",
      "     TLRTSPADHG GSVGSESGGS AVDSVAGEHS VSGRSSAYGD ATAEGHPAGP GSVSSSTGAI\r\n",
      "     STTTGHQEGD GSEGEGEGET EGDVHTSNRL HMVRLMLLER LLQTLPQLRN VGGVRAIPYM\r\n",
      "     QVILMLTTDL DGEDEKDKGA LDNLLSQLIA ELGMDKKDVS KKNERSALNE VHLVVMRLLS\r\n",
      "     VFMSRTKSGS KSSICESSSL ISSATAAALL SSGAVDYCLH VLKSLLEYWK SQQNDEEPVA\r\n",
      "     TSQLLKPHTT SSPPDMSPFF LRQYVKGHAA DVFEAYTQLL TEMVLRLPYQ IKKITDTNSR\r\n",
      "     IPPPVFDHSW FYFLSEYLMI QQTPFVRRQV RKLLLFICGS KEKYRQLRDL HTLDSHVRGI\r\n",
      "     KKLLEEQGIF LRASVVTASS GSALQYDTLI SLMEHLKACA EIAAQRTINW QKFCIKDDSV\r\n",
      "     LYFLLQVSFL VDEGVSPVLL QLLSCALCGS KVLAALAASS GSSSASSSSA PVAASSGQAT\r\n",
      "     TQSKSSTKKS KKEEKEKEKD GETSGSQEDQ LCTALVNQLN KFADKETLIQ FLRCFLLESN\r\n",
      "     SSSVRWQAHC LTLHIYRNSS KSQQELLLDL MWSIWPELPA YGRKAAQFVD LLGYFSLKTP\r\n",
      "     QTEKKLKEYS QKAVEILRTQ NHILTNHPNS NIYNTLSGLV EFDGYYLESD PCLVCNNPEV\r\n",
      "     PFCYIKLSSI KVDTRYTTTQ QVVKLIGSHT ISKVTVKIGD LKRTKMVRTI NLYYNNRTVQ\r\n",
      "     AIVELKNKPA RWHKAKKVQL TPGQTEVKID LPLPIVASNL MIEFADFYEN YQASTETLQC\r\n",
      "     PRCSASVPAN PGVCGNCGEN VYQCHKCRSI NYDEKDPFLC NACGFCKYAR FDFMLYAKPC\r\n",
      "     CAVDPIENEE DRKKAVSNIN TLLDKADRVY HQLMGHRPQL ENLLCKVNEA APEKPQDDSG\r\n",
      "     TAGGISSTSA SVNRYILQLA QEYCGDCKNS FDELSKIIQK VFASRKELLE YDLQQREAAT\r\n",
      "     KSSRTSVQPT FTASQYRALS VLGCGHTSST KCYGCASAVT EHCITLLRAL ATNPALRHIL\r\n",
      "     VSQGLIRELF DYNLRRGAAA MREEVRQLMC LLTRDNPEAT QQMNDLIIGK VSTALKGHWA\r\n",
      "     NPDLASSLQY EMLLLTDSIS KEDSCWELRL RCALSLFLMA VNIKTPVVVE NITLMCLRIL\r\n",
      "     QKLIKPPAPT SKKNKDVPVE ALTTVKPYCN EIHAQAQLWL KRDPKASYDA WKKCLPIRGI\r\n",
      "     DGNGKAPSKS ELRHLYLTEK YVWRWKQFLS RRGKRTSPLD LKLGHNNWLR QVLFTPATQA\r\n",
      "     ARQAACTIVE ALATIPSRKQ QVLDLLTSYL DELSIAGECA AEYLALYQKL ITSAHWKVYL\r\n",
      "     AARGVLPYVG NLITKEIARL LALEEATLST DLQQGYALKS LTGLLSSFVE VESIKRHFKS\r\n",
      "     RLVGTVLNGY LCLRKLVVQR TKLIDETQDM LLEMLEDMTT GTESETKAFM AVCIETAKRY\r\n",
      "     NLDDYRTPVF IFERLCSIIY PEENEVTEFF VTLEKDPQQE DFLQGRMPGN PYSSNEPGIG\r\n",
      "     PLMRDIKNKI CQDCDLVALL EDDSGMELLV NNKIISLDLP VAEVYKKVWC TTNEGEPMRI\r\n",
      "     VYRMRGLLGD ATEEFIESLD STTDEEEDEE EVYKMAGVMA QCGGLECMLN RLAGIRDFKQ\r\n",
      "     GRHLLTVLLK LFSYCVKVKV NRQQLVKLEM NTLNVMLGTL NLALVAEQES KDSGGAAVAE\r\n",
      "     QVLSIMEIIL DESNAEPLSE DKGNLLLTGD KDQLVMLLDQ INSTFVRSNP SVLQGLLRII\r\n",
      "     PYLSFGEVEK MQILVERFKP YCNFDKYDED HSGDDKVFLD CFCKIAAGIK NNSNGHQLKD\r\n",
      "     LILQKGITQN ALDYMKKHIP SAKNLDADIW KKFLSRPALP FILRLLRGLA IQHPGTQVLI\r\n",
      "     GTDSIPNLHK LEQVSSDEGI GTLAENLLEA LREHPDVNKK IDAARRETRA EKKRMAMAMR\r\n",
      "     QKALGTLGMT TNEKGQVVTK TALLKQMEEL IEEPGLTCCI CREGYKFQPT KVLGIYTFTK\r\n",
      "     RVALEEMENK PRKQQGYSTV SHFNIVHYDC HLAAVRLARG REEWESAALQ NANTKCNGLL\r\n",
      "     PVWGPHVPES AFATCLARHN TYLQECTGQR EPTYQLNIHD IKLLFLRFAM EQSFSADTGG\r\n",
      "     GGRESNIHLI PYIIHTVLYV LNTTRATSRE EKNLQGFLEQ PKEKWVESAF EVDGPYYFTV\r\n",
      "     LALHILPPEQ WRATRVEILR RLLVTSQARA VAPGGATRLT DKAVKDYSAY RSSLLFWALV\r\n",
      "     DLIYNMFKKV PTSNTEGGWS CSLAEYIRHN DMPIYEAADK ALKTFQEEFM PVETFSEFLD\r\n",
      "     VAGLLSEITD PESFLKDLLN SVP\r\n",
      "//\r\n",
      "ID   NDC80_HUMAN             Reviewed;         642 AA.\r\n",
      "AC   O14777; Q6PJX2;\r\n",
      "DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   01-JAN-1998, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 188.\r\n",
      "DE   RecName: Full=Kinetochore protein NDC80 homolog;\r\n",
      "DE   AltName: Full=Highly expressed in cancer protein;\r\n",
      "DE   AltName: Full=Kinetochore protein Hec1;\r\n",
      "DE            Short=HsHec1;\r\n",
      "DE   AltName: Full=Kinetochore-associated protein 2;\r\n",
      "DE   AltName: Full=Retinoblastoma-associated protein HEC;\r\n",
      "GN   Name=NDC80; Synonyms=HEC, HEC1, KNTC2;\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND\r\n",
      "RP   DEVELOPMENTAL STAGE.\r\n",
      "RX   PubMed=9315664; DOI=10.1128/mcb.17.10.6049;\r\n",
      "RA   Chen Y., Riley D.J., Chen P.-L., Lee W.-H.;\r\n",
      "RT   \"HEC, a novel nuclear protein rich in leucine heptad repeats specifically\r\n",
      "RT   involved in mitosis.\";\r\n",
      "RL   Mol. Cell. Biol. 17:6049-6056(1997).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\r\n",
      "RC   TISSUE=Brain, and Lymph;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [3]\r\n",
      "RP   INTERACTION WITH NEK2; PSMC2; PSMC5 AND SMC1A, SUBCELLULAR LOCATION, AND\r\n",
      "RP   DEVELOPMENTAL STAGE.\r\n",
      "RX   PubMed=9295362; DOI=10.1074/jbc.272.38.24081;\r\n",
      "RA   Chen Y., Sharp Z.D., Lee W.-H.;\r\n",
      "RT   \"HEC binds to the seventh regulatory subunit of the 26 S proteasome and\r\n",
      "RT   modulates the proteolysis of mitotic cyclins.\";\r\n",
      "RL   J. Biol. Chem. 272:24081-24087(1997).\r\n",
      "RN   [4]\r\n",
      "RP   INTERACTION WITH NEK2; PSMC2; PSMC5; RB1 AND SMC1A.\r\n",
      "RX   PubMed=10409732; DOI=10.1128/mcb.19.8.5417;\r\n",
      "RA   Zheng L., Chen Y., Lee W.-H.;\r\n",
      "RT   \"Hec1p, an evolutionarily conserved coiled-coil protein, modulates\r\n",
      "RT   chromosome segregation through interaction with SMC proteins.\";\r\n",
      "RL   Mol. Cell. Biol. 19:5417-5428(1999).\r\n",
      "RN   [5]\r\n",
      "RP   INTERACTION WITH RB1 AND SMC1A, AND MUTAGENESIS OF GLU-234.\r\n",
      "RX   PubMed=10779342; DOI=10.1128/mcb.20.10.3529-3537.2000;\r\n",
      "RA   Zheng L., Chen Y., Riley D.J., Chen P.-L., Lee W.-H.;\r\n",
      "RT   \"Retinoblastoma protein enhances the fidelity of chromosome segregation\r\n",
      "RT   mediated by hsHec1p.\";\r\n",
      "RL   Mol. Cell. Biol. 20:3529-3537(2000).\r\n",
      "RN   [6]\r\n",
      "RP   INTERACTION WITH NEK2, AND PHOSPHORYLATION AT SER-165 BY NEK2.\r\n",
      "RX   PubMed=12386167; DOI=10.1074/jbc.m207069200;\r\n",
      "RA   Chen Y., Riley D.J., Zheng L., Chen P.-L., Lee W.-H.;\r\n",
      "RT   \"Phosphorylation of the mitotic regulator protein Hec1 by Nek2 kinase is\r\n",
      "RT   essential for faithful chromosome segregation.\";\r\n",
      "RL   J. Biol. Chem. 277:49408-49416(2002).\r\n",
      "RN   [7]\r\n",
      "RP   FUNCTION, AND SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=12351790; DOI=10.1126/science.1075596;\r\n",
      "RA   Martin-Lluesma S., Stucke V.M., Nigg E.A.;\r\n",
      "RT   \"Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment\r\n",
      "RT   of Mad1/Mad2.\";\r\n",
      "RL   Science 297:2267-2270(2002).\r\n",
      "RN   [8]\r\n",
      "RP   FUNCTION, AND SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=14654001; DOI=10.1016/j.cub.2003.10.056;\r\n",
      "RA   DeLuca J.G., Howell B.J., Canman J.C., Hickey J.M., Fang G., Salmon E.D.;\r\n",
      "RT   \"Nuf2 and Hec1 are required for retention of the checkpoint proteins Mad1\r\n",
      "RT   and Mad2 to kinetochores.\";\r\n",
      "RL   Curr. Biol. 13:2103-2109(2003).\r\n",
      "RN   [9]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=15235793; DOI=10.1007/s00412-004-0288-2;\r\n",
      "RA   Stucke V.M., Baumann C., Nigg E.A.;\r\n",
      "RT   \"Kinetochore localization and microtubule interaction of the human spindle\r\n",
      "RT   checkpoint kinase Mps1.\";\r\n",
      "RL   Chromosoma 113:1-15(2004).\r\n",
      "RN   [10]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=15062103; DOI=10.1016/j.cub.2004.03.031;\r\n",
      "RA   Joseph J., Liu S.-T., Jablonski S.A., Yen T.J., Dasso M.;\r\n",
      "RT   \"The RanGAP1-RanBP2 complex is essential for microtubule-kinetochore\r\n",
      "RT   interactions in vivo.\";\r\n",
      "RL   Curr. Biol. 14:611-617(2004).\r\n",
      "RN   [11]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=15239953; DOI=10.1016/j.devcel.2004.06.006;\r\n",
      "RA   Meraldi P., Draviam V.M., Sorger P.K.;\r\n",
      "RT   \"Timing and checkpoints in the regulation of mitotic progression.\";\r\n",
      "RL   Dev. Cell 7:45-60(2004).\r\n",
      "RN   [12]\r\n",
      "RP   SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=15133482; DOI=10.1038/sj.embor.7400154;\r\n",
      "RA   Steensgaard P., Garre M., Muradore I., Transidico P., Nigg E.A.,\r\n",
      "RA   Kitagawa K., Earnshaw W.C., Faretta M., Musacchio A.;\r\n",
      "RT   \"Sgt1 is required for human kinetochore assembly.\";\r\n",
      "RL   EMBO Rep. 5:626-631(2004).\r\n",
      "RN   [13]\r\n",
      "RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE\r\n",
      "RP   NDC80 COMPLEX.\r\n",
      "RX   PubMed=14699129; DOI=10.1074/jbc.m310224200;\r\n",
      "RA   Bharadwaj R., Qi W., Yu H.;\r\n",
      "RT   \"Identification of two novel components of the human NDC80 kinetochore\r\n",
      "RT   complex.\";\r\n",
      "RL   J. Biol. Chem. 279:13076-13085(2004).\r\n",
      "RN   [14]\r\n",
      "RP   SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=14978040; DOI=10.1074/jbc.m314205200;\r\n",
      "RA   Lou Y., Yao J., Zereshki A., Dou Z., Ahmed K., Wang H., Hu J., Wang Y.,\r\n",
      "RA   Yao X.;\r\n",
      "RT   \"NEK2A interacts with MAD1 and possibly functions as a novel integrator of\r\n",
      "RT   the spindle checkpoint signaling.\";\r\n",
      "RL   J. Biol. Chem. 279:20049-20057(2004).\r\n",
      "RN   [15]\r\n",
      "RP   INTERACTION WITH AURKB AND CDCA1, AND PHOSPHORYLATION BY AURKA AND AURKB.\r\n",
      "RX   PubMed=14602875; DOI=10.1074/mcp.m300072-mcp200;\r\n",
      "RA   Tien A.-C., Lin M.-H., Su L.-J., Hong Y.-R., Cheng T.-S., Lee Y.-C.G.,\r\n",
      "RA   Lin W.-J., Still I.H., Huang C.-Y.F.;\r\n",
      "RT   \"Identification of the substrates and interaction proteins of aurora\r\n",
      "RT   kinases from a protein-protein interaction model.\";\r\n",
      "RL   Mol. Cell. Proteomics 3:93-104(2004).\r\n",
      "RN   [16]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN A COMPLEX WITH\r\n",
      "RP   MIS12.\r\n",
      "RX   PubMed=15502821; DOI=10.1038/ncb1187;\r\n",
      "RA   Obuse C., Iwasaki O., Kiyomitsu T., Goshima G., Toyoda Y., Yanagida M.;\r\n",
      "RT   \"A conserved Mis12 centromere complex is linked to heterochromatic HP1 and\r\n",
      "RT   outer kinetochore protein Zwint-1.\";\r\n",
      "RL   Nat. Cell Biol. 6:1135-1141(2004).\r\n",
      "RN   [17]\r\n",
      "RP   SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=15964272; DOI=10.1016/j.cub.2005.05.026;\r\n",
      "RA   Ahonen L.J., Kallio M.J., Daum J.R., Bolton M., Manke I.A., Yaffe M.B.,\r\n",
      "RA   Stukenberg P.T., Gorbsky G.J.;\r\n",
      "RT   \"Polo-like kinase 1 creates the tension-sensing 3F3/2 phosphoepitope and\r\n",
      "RT   modulates the association of spindle-checkpoint proteins at kinetochores.\";\r\n",
      "RL   Curr. Biol. 15:1078-1089(2005).\r\n",
      "RN   [18]\r\n",
      "RP   CHARACTERIZATION OF THE NDC80 COMPLEX, AND SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=15961401; DOI=10.1074/jbc.m504070200;\r\n",
      "RA   Ciferri C., De Luca J., Monzani S., Ferrari K.J., Ristic D., Wyman C.,\r\n",
      "RA   Stark H., Kilmartin J., Salmon E.D., Musacchio A.;\r\n",
      "RT   \"Architecture of the human Ndc80-Hec1 complex, a critical constituent of\r\n",
      "RT   the outer kinetochore.\";\r\n",
      "RL   J. Biol. Chem. 280:29088-29095(2005).\r\n",
      "RN   [19]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN A COMPLEX WITH\r\n",
      "RP   ZWINT.\r\n",
      "RX   PubMed=15824131; DOI=10.1083/jcb.200411118;\r\n",
      "RA   Kops G.J.P.L., Kim Y., Weaver B.A.A., Mao Y., McLeod I., Yates J.R. III,\r\n",
      "RA   Tagaya M., Cleveland D.W.;\r\n",
      "RT   \"ZW10 links mitotic checkpoint signaling to the structural kinetochore.\";\r\n",
      "RL   J. Cell Biol. 169:49-60(2005).\r\n",
      "RN   [20]\r\n",
      "RP   FUNCTION, AND SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=15548592; DOI=10.1091/mbc.e04-09-0852;\r\n",
      "RA   DeLuca J.G., Dong Y., Hergert P., Strauss J., Hickey J.M., Salmon E.D.,\r\n",
      "RA   McEwen B.F.;\r\n",
      "RT   \"Hec1 and Nuf2 are core components of the kinetochore outer plate essential\r\n",
      "RT   for organizing microtubule attachment sites.\";\r\n",
      "RL   Mol. Biol. Cell 16:519-531(2005).\r\n",
      "RN   [21]\r\n",
      "RP   INTERACTION WITH CENPH.\r\n",
      "RX   PubMed=15713649; DOI=10.1128/mcb.25.5.1958-1970.2005;\r\n",
      "RA   Mikami Y., Hori T., Kimura H., Fukagawa T.;\r\n",
      "RT   \"The functional region of CENP-H interacts with the Nuf2 complex that\r\n",
      "RT   localizes to centromere during mitosis.\";\r\n",
      "RL   Mol. Cell. Biol. 25:1958-1970(2005).\r\n",
      "RN   [22]\r\n",
      "RP   FUNCTION, INTERACTION WITH ZWINT, SUBCELLULAR LOCATION, AND DEVELOPMENTAL\r\n",
      "RP   STAGE.\r\n",
      "RX   PubMed=16732327; DOI=10.1038/sj.onc.1209687;\r\n",
      "RA   Lin Y.-T., Chen Y., Wu G., Lee W.-H.;\r\n",
      "RT   \"Hec1 sequentially recruits Zwint-1 and ZW10 to kinetochores for faithful\r\n",
      "RT   chromosome segregation and spindle checkpoint control.\";\r\n",
      "RL   Oncogene 25:6901-6914(2006).\r\n",
      "RN   [23]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-69, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;\r\n",
      "RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,\r\n",
      "RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;\r\n",
      "RT   \"Quantitative phosphoproteomics reveals widespread full phosphorylation\r\n",
      "RT   site occupancy during mitosis.\";\r\n",
      "RL   Sci. Signal. 3:RA3-RA3(2010).\r\n",
      "RN   [24]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;\r\n",
      "RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,\r\n",
      "RA   Bennett K.L., Superti-Furga G., Colinge J.;\r\n",
      "RT   \"Initial characterization of the human central proteome.\";\r\n",
      "RL   BMC Syst. Biol. 5:17-17(2011).\r\n",
      "RN   [25]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=23085020; DOI=10.1016/j.devcel.2012.09.012;\r\n",
      "RA   Schmidt J.C., Arthanari H., Boeszoermenyi A., Dashkevich N.M.,\r\n",
      "RA   Wilson-Kubalek E.M., Monnier N., Markus M., Oberer M., Milligan R.A.,\r\n",
      "RA   Bathe M., Wagner G., Grishchuk E.L., Cheeseman I.M.;\r\n",
      "RT   \"The kinetochore-bound Ska1 complex tracks depolymerizing microtubules and\r\n",
      "RT   binds to curved protofilaments.\";\r\n",
      "RL   Dev. Cell 23:968-980(2012).\r\n",
      "RN   [26]\r\n",
      "RP   INTERACTION WITH CDT1.\r\n",
      "RX   PubMed=22581055; DOI=10.1038/ncb2489;\r\n",
      "RA   Varma D., Chandrasekaran S., Sundin L.J., Reidy K.T., Wan X., Chasse D.A.,\r\n",
      "RA   Nevis K.R., DeLuca J.G., Salmon E.D., Cook J.G.;\r\n",
      "RT   \"Recruitment of the human Cdt1 replication licensing protein by the loop\r\n",
      "RT   domain of Hec1 is required for stable kinetochore-microtubule attachment.\";\r\n",
      "RL   Nat. Cell Biol. 14:593-603(2012).\r\n",
      "RN   [27]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=23891108; DOI=10.1016/j.cub.2013.06.040;\r\n",
      "RA   Shrestha R.L., Draviam V.M.;\r\n",
      "RT   \"Lateral to end-on conversion of chromosome-microtubule attachment requires\r\n",
      "RT   kinesins CENP-E and MCAK.\";\r\n",
      "RL   Curr. Biol. 23:1514-1526(2013).\r\n",
      "RN   [28]\r\n",
      "RP   ERRATUM OF PUBMED:23891108.\r\n",
      "RA   Shrestha R.L., Draviam V.M.;\r\n",
      "RL   Curr. Biol. 23:2440-2441(2013).\r\n",
      "RN   [29]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND SER-69, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [30]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=25743205; DOI=10.1038/ncomms7447;\r\n",
      "RA   Iemura K., Tanaka K.;\r\n",
      "RT   \"Chromokinesin Kid and kinetochore kinesin CENP-E differentially support\r\n",
      "RT   chromosome congression without end-on attachment to microtubules.\";\r\n",
      "RL   Nat. Commun. 6:6447-6447(2015).\r\n",
      "RN   [31]\r\n",
      "RP   INTERACTION WITH CKAP5.\r\n",
      "RX   PubMed=27156448; DOI=10.1016/j.cell.2016.04.030;\r\n",
      "RA   Miller M.P., Asbury C.L., Biggins S.;\r\n",
      "RT   \"A TOG protein confers tension sensitivity to kinetochore-microtubule\r\n",
      "RT   attachments.\";\r\n",
      "RL   Cell 165:1428-1439(2016).\r\n",
      "RN   [32]\r\n",
      "RP   FUNCTION, PHOSPHORYLATION AT SER-55 AND SER-62, ACETYLATION AT LYS-53;\r\n",
      "RP   LYS-59 AND LYS-527, AND MUTAGENESIS OF LYS-53 AND LYS-59.\r\n",
      "RX   PubMed=30409912; DOI=10.1074/jbc.ra118.003844;\r\n",
      "RA   Zhao G., Cheng Y., Gui P., Cui M., Liu W., Wang W., Wang X., Ali M.,\r\n",
      "RA   Dou Z., Niu L., Liu H., Anderson L., Ruan K., Hong J., Yao X.;\r\n",
      "RT   \"Dynamic acetylation of the kinetochore-associated protein HEC1 ensures\r\n",
      "RT   accurate microtubule-kinetochore attachment.\";\r\n",
      "RL   J. Biol. Chem. 294:576-592(2019).\r\n",
      "CC   -!- FUNCTION: Acts as a component of the essential kinetochore-associated\r\n",
      "CC       NDC80 complex, which is required for chromosome segregation and spindle\r\n",
      "CC       checkpoint activity (PubMed:9315664, PubMed:12351790, PubMed:14654001,\r\n",
      "CC       PubMed:14699129, PubMed:15062103, PubMed:15235793, PubMed:15239953,\r\n",
      "CC       PubMed:15548592, PubMed:16732327, PubMed:30409912). Required for\r\n",
      "CC       kinetochore integrity and the organization of stable microtubule\r\n",
      "CC       binding sites in the outer plate of the kinetochore (PubMed:15548592,\r\n",
      "CC       PubMed:30409912). The NDC80 complex synergistically enhances the\r\n",
      "CC       affinity of the SKA1 complex for microtubules and may allow the NDC80\r\n",
      "CC       complex to track depolymerizing microtubules (PubMed:23085020). Plays a\r\n",
      "CC       role in chromosome congression and is essential for the end-on\r\n",
      "CC       attachment of the kinetochores to spindle microtubules\r\n",
      "CC       (PubMed:25743205, PubMed:23891108). {ECO:0000269|PubMed:12351790,\r\n",
      "CC       ECO:0000269|PubMed:14654001, ECO:0000269|PubMed:14699129,\r\n",
      "CC       ECO:0000269|PubMed:15062103, ECO:0000269|PubMed:15235793,\r\n",
      "CC       ECO:0000269|PubMed:15239953, ECO:0000269|PubMed:15548592,\r\n",
      "CC       ECO:0000269|PubMed:16732327, ECO:0000269|PubMed:23085020,\r\n",
      "CC       ECO:0000269|PubMed:23891108, ECO:0000269|PubMed:25743205,\r\n",
      "CC       ECO:0000269|PubMed:30409912, ECO:0000269|PubMed:9315664}.\r\n",
      "CC   -!- SUBUNIT: Component of the NDC80 complex, which consists of NDC80/HEC1,\r\n",
      "CC       CDCA1, SPBC24 and SPBC25. The NDC80 complex is formed by two\r\n",
      "CC       subcomplexes composed of NDC80/HEC1-CDCA1 and SPBC24-SPBC25. Each\r\n",
      "CC       subcomplex is formed by parallel interactions through the coiled-coil\r\n",
      "CC       domains of individual subunits. Formation of a tetrameric complex is\r\n",
      "CC       mediated by interactions between the C-terminal regions of both\r\n",
      "CC       subunits of the NDC80/HEC1-CDCA1 subcomplex and the N-terminal regions\r\n",
      "CC       of both subunits of the SPBC24-SPBC25 complex. The tetrameric NDC80\r\n",
      "CC       complex has an elongated rod-like structure with globular domains at\r\n",
      "CC       either end. Interacts with isoform 1 of NEK2 and ZWINT specifically\r\n",
      "CC       during mitosis. Interacts with CENPH and MIS12. May interact with\r\n",
      "CC       AURKB, PSMC2, PSMC5 and SMC1A. May interact with RB1 during G2 phase\r\n",
      "CC       and mitosis. Interacts with CKAP5 (PubMed:27156448). Interacts with\r\n",
      "CC       CDT1; leading to kinetochore localization of CDT1 (PubMed:22581055).\r\n",
      "CC       {ECO:0000269|PubMed:10409732, ECO:0000269|PubMed:10779342,\r\n",
      "CC       ECO:0000269|PubMed:12386167, ECO:0000269|PubMed:14602875,\r\n",
      "CC       ECO:0000269|PubMed:14699129, ECO:0000269|PubMed:15502821,\r\n",
      "CC       ECO:0000269|PubMed:15713649, ECO:0000269|PubMed:15824131,\r\n",
      "CC       ECO:0000269|PubMed:16732327, ECO:0000269|PubMed:22581055,\r\n",
      "CC       ECO:0000269|PubMed:27156448, ECO:0000269|PubMed:9295362}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       O14777; Q9Y2J4: AMOTL2; NbExp=3; IntAct=EBI-715849, EBI-746752;\r\n",
      "CC       O14777; P18848: ATF4; NbExp=8; IntAct=EBI-715849, EBI-492498;\r\n",
      "CC       O14777; P48047: ATP5PO; NbExp=3; IntAct=EBI-715849, EBI-355815;\r\n",
      "CC       O14777; Q9Y5K8: ATP6V1D; NbExp=3; IntAct=EBI-715849, EBI-2684998;\r\n",
      "CC       O14777; Q8TC20-4: CAGE1; NbExp=3; IntAct=EBI-715849, EBI-11522698;\r\n",
      "CC       O14777; Q9P1Z2: CALCOCO1; NbExp=4; IntAct=EBI-715849, EBI-749920;\r\n",
      "CC       O14777; Q8TD31-3: CCHCR1; NbExp=6; IntAct=EBI-715849, EBI-10175300;\r\n",
      "CC       O14777; P51946: CCNH; NbExp=3; IntAct=EBI-715849, EBI-741406;\r\n",
      "CC       O14777; O75909: CCNK; NbExp=3; IntAct=EBI-715849, EBI-739806;\r\n",
      "CC       O14777; Q9H211: CDT1; NbExp=7; IntAct=EBI-715849, EBI-456953;\r\n",
      "CC       O14777; Q9H3R5: CENPH; NbExp=6; IntAct=EBI-715849, EBI-1003700;\r\n",
      "CC       O14777; Q96MT8-3: CEP63; NbExp=3; IntAct=EBI-715849, EBI-11522539;\r\n",
      "CC       O14777; Q9UBC2-3: EPS15L1; NbExp=3; IntAct=EBI-715849, EBI-11958621;\r\n",
      "CC       O14777; Q8IYI6: EXOC8; NbExp=3; IntAct=EBI-715849, EBI-742102;\r\n",
      "CC       O14777; Q8IZT9: FAM9C; NbExp=3; IntAct=EBI-715849, EBI-2870039;\r\n",
      "CC       O14777; Q08379: GOLGA2; NbExp=3; IntAct=EBI-715849, EBI-618309;\r\n",
      "CC       O14777; Q96CS2: HAUS1; NbExp=3; IntAct=EBI-715849, EBI-2514791;\r\n",
      "CC       O14777; O14964: HGS; NbExp=6; IntAct=EBI-715849, EBI-740220;\r\n",
      "CC       O14777; O75146-2: HIP1R; NbExp=3; IntAct=EBI-715849, EBI-12292427;\r\n",
      "CC       O14777; Q8IY31: IFT20; NbExp=5; IntAct=EBI-715849, EBI-744203;\r\n",
      "CC       O14777; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-715849, EBI-14069005;\r\n",
      "CC       O14777; Q6P597: KLC3; NbExp=3; IntAct=EBI-715849, EBI-1643885;\r\n",
      "CC       O14777; Q7Z3Y8: KRT27; NbExp=3; IntAct=EBI-715849, EBI-3044087;\r\n",
      "CC       O14777; P04259: KRT6B; NbExp=3; IntAct=EBI-715849, EBI-740907;\r\n",
      "CC       O14777; O95678: KRT75; NbExp=3; IntAct=EBI-715849, EBI-2949715;\r\n",
      "CC       O14777; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-715849, EBI-739832;\r\n",
      "CC       O14777; Q9NPJ6: MED4; NbExp=4; IntAct=EBI-715849, EBI-394607;\r\n",
      "CC       O14777; P55081: MFAP1; NbExp=3; IntAct=EBI-715849, EBI-1048159;\r\n",
      "CC       O14777; O14777: NDC80; NbExp=2; IntAct=EBI-715849, EBI-715849;\r\n",
      "CC       O14777; Q9GZM8: NDEL1; NbExp=4; IntAct=EBI-715849, EBI-928842;\r\n",
      "CC       O14777; Q9BZD4: NUF2; NbExp=14; IntAct=EBI-715849, EBI-724102;\r\n",
      "CC       O14777; Q96KQ4: PPP1R13B; NbExp=3; IntAct=EBI-715849, EBI-1105153;\r\n",
      "CC       O14777; Q6ZNE9: RUFY4; NbExp=7; IntAct=EBI-715849, EBI-10181525;\r\n",
      "CC       O14777; Q86XK3: SFR1; NbExp=3; IntAct=EBI-715849, EBI-1104535;\r\n",
      "CC       O14777; Q96ES7: SGF29; NbExp=7; IntAct=EBI-715849, EBI-743117;\r\n",
      "CC       O14777; Q9HBM1: SPC25; NbExp=12; IntAct=EBI-715849, EBI-999909;\r\n",
      "CC       O14777; O75558: STX11; NbExp=3; IntAct=EBI-715849, EBI-714135;\r\n",
      "CC       O14777; Q9UBB9: TFIP11; NbExp=6; IntAct=EBI-715849, EBI-1105213;\r\n",
      "CC       O14777; Q6I9Y2: THOC7; NbExp=3; IntAct=EBI-715849, EBI-716286;\r\n",
      "CC       O14777; Q15025: TNIP1; NbExp=9; IntAct=EBI-715849, EBI-357849;\r\n",
      "CC       O14777; Q05BL1: TP53BP2; NbExp=3; IntAct=EBI-715849, EBI-11952721;\r\n",
      "CC       O14777; Q13625-3: TP53BP2; NbExp=3; IntAct=EBI-715849, EBI-10175039;\r\n",
      "CC       O14777; P33981-1: TTK; NbExp=4; IntAct=EBI-715849, EBI-15986834;\r\n",
      "CC       O14777; P40222: TXLNA; NbExp=7; IntAct=EBI-715849, EBI-359793;\r\n",
      "CC       O14777; Q8N6Y0: USHBP1; NbExp=4; IntAct=EBI-715849, EBI-739895;\r\n",
      "CC       O14777; Q8N1B4: VPS52; NbExp=3; IntAct=EBI-715849, EBI-2799833;\r\n",
      "CC       O14777; Q9Y3C0: WASHC3; NbExp=10; IntAct=EBI-715849, EBI-712969;\r\n",
      "CC       O14777; Q8N720: ZNF655; NbExp=3; IntAct=EBI-715849, EBI-625509;\r\n",
      "CC       O14777; O95229: ZWINT; NbExp=14; IntAct=EBI-715849, EBI-1001132;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9315664}. Chromosome,\r\n",
      "CC       centromere, kinetochore {ECO:0000269|PubMed:14699129}. Note=Localizes\r\n",
      "CC       to kinetochores from late prophase to anaphase (PubMed:14699129).\r\n",
      "CC       Localizes specifically to the outer plate of the kinetochore\r\n",
      "CC       (PubMed:14699129). {ECO:0000269|PubMed:14699129}.\r\n",
      "CC   -!- DEVELOPMENTAL STAGE: Expression peaks in mitosis.\r\n",
      "CC       {ECO:0000269|PubMed:16732327, ECO:0000269|PubMed:9295362,\r\n",
      "CC       ECO:0000269|PubMed:9315664}.\r\n",
      "CC   -!- PTM: Phosphorylation begins in S phase of the cell cycle and peaks in\r\n",
      "CC       mitosis. Phosphorylated by NEK2. Also phosphorylated by AURKA and\r\n",
      "CC       AURKB. {ECO:0000269|PubMed:12386167, ECO:0000269|PubMed:14602875,\r\n",
      "CC       ECO:0000269|PubMed:30409912}.\r\n",
      "CC   -!- PTM: Acetylated at Lys-53 and Lys-59 by KAT5 during mitosis, promoting\r\n",
      "CC       robust kinetochore-microtubule attachment (PubMed:30409912).\r\n",
      "CC       Deacetylated by SIRT1 (PubMed:30409912). {ECO:0000269|PubMed:30409912}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the NDC80/HEC1 family. {ECO:0000305}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AF017790; AAB80726.1; -; mRNA.\r\n",
      "DR   EMBL; BC010171; -; NOT_ANNOTATED_CDS; mRNA.\r\n",
      "DR   CCDS; CCDS11827.1; -.\r\n",
      "DR   RefSeq; NP_006092.1; NM_006101.2.\r\n",
      "DR   PDB; 2IGP; X-ray; 1.80 A; A=81-196.\r\n",
      "DR   PDB; 2VE7; X-ray; 2.88 A; A/B=80-286.\r\n",
      "DR   PDB; 3IZ0; EM; -; C/E=80-286.\r\n",
      "DR   PDBsum; 2IGP; -.\r\n",
      "DR   PDBsum; 2VE7; -.\r\n",
      "DR   PDBsum; 3IZ0; -.\r\n",
      "DR   AlphaFoldDB; O14777; -.\r\n",
      "DR   SMR; O14777; -.\r\n",
      "DR   BioGRID; 115675; 323.\r\n",
      "DR   ComplexPortal; CPX-550; Ndc80 complex.\r\n",
      "DR   CORUM; O14777; -.\r\n",
      "DR   DIP; DIP-35100N; -.\r\n",
      "DR   IntAct; O14777; 124.\r\n",
      "DR   MINT; O14777; -.\r\n",
      "DR   STRING; 9606.ENSP00000261597; -.\r\n",
      "DR   ChEMBL; CHEMBL5660; -.\r\n",
      "DR   GlyGen; O14777; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; O14777; -.\r\n",
      "DR   PhosphoSitePlus; O14777; -.\r\n",
      "DR   BioMuta; NDC80; -.\r\n",
      "DR   EPD; O14777; -.\r\n",
      "DR   jPOST; O14777; -.\r\n",
      "DR   MassIVE; O14777; -.\r\n",
      "DR   MaxQB; O14777; -.\r\n",
      "DR   PaxDb; O14777; -.\r\n",
      "DR   PeptideAtlas; O14777; -.\r\n",
      "DR   ProteomicsDB; 48231; -.\r\n",
      "DR   ABCD; O14777; 1 sequenced antibody.\r\n",
      "DR   Antibodypedia; 6039; 467 antibodies from 39 providers.\r\n",
      "DR   DNASU; 10403; -.\r\n",
      "DR   Ensembl; ENST00000261597.9; ENSP00000261597.4; ENSG00000080986.13.\r\n",
      "DR   GeneID; 10403; -.\r\n",
      "DR   KEGG; hsa:10403; -.\r\n",
      "DR   MANE-Select; ENST00000261597.9; ENSP00000261597.4; NM_006101.3; NP_006092.1.\r\n",
      "DR   UCSC; uc002kli.3; human.\r\n",
      "DR   AGR; HGNC:16909; -.\r\n",
      "DR   CTD; 10403; -.\r\n",
      "DR   DisGeNET; 10403; -.\r\n",
      "DR   GeneCards; NDC80; -.\r\n",
      "DR   HGNC; HGNC:16909; NDC80.\r\n",
      "DR   HPA; ENSG00000080986; Tissue enhanced (bone marrow, lymphoid tissue).\r\n",
      "DR   MIM; 607272; gene.\r\n",
      "DR   neXtProt; NX_O14777; -.\r\n",
      "DR   OpenTargets; ENSG00000080986; -.\r\n",
      "DR   PharmGKB; PA162397359; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000080986; -.\r\n",
      "DR   eggNOG; KOG0995; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00390000018386; -.\r\n",
      "DR   HOGENOM; CLU_012583_2_0_1; -.\r\n",
      "DR   InParanoid; O14777; -.\r\n",
      "DR   OMA; PSHKFQK; -.\r\n",
      "DR   OrthoDB; 25325at2759; -.\r\n",
      "DR   PhylomeDB; O14777; -.\r\n",
      "DR   TreeFam; TF101177; -.\r\n",
      "DR   PathwayCommons; O14777; -.\r\n",
      "DR   Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.\r\n",
      "DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.\r\n",
      "DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.\r\n",
      "DR   Reactome; R-HSA-68877; Mitotic Prometaphase.\r\n",
      "DR   Reactome; R-HSA-9648025; EML4 and NUDC in mitotic spindle formation.\r\n",
      "DR   SignaLink; O14777; -.\r\n",
      "DR   SIGNOR; O14777; -.\r\n",
      "DR   BioGRID-ORCS; 10403; 793 hits in 1162 CRISPR screens.\r\n",
      "DR   ChiTaRS; NDC80; human.\r\n",
      "DR   EvolutionaryTrace; O14777; -.\r\n",
      "DR   GeneWiki; NDC80; -.\r\n",
      "DR   GenomeRNAi; 10403; -.\r\n",
      "DR   Pharos; O14777; Tbio.\r\n",
      "DR   PRO; PR:O14777; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 18.\r\n",
      "DR   RNAct; O14777; protein.\r\n",
      "DR   Bgee; ENSG00000080986; Expressed in ventricular zone and 135 other tissues.\r\n",
      "DR   ExpressionAtlas; O14777; baseline and differential.\r\n",
      "DR   Genevisible; O14777; HS.\r\n",
      "DR   GO; GO:0005813; C:centrosome; IDA:HPA.\r\n",
      "DR   GO; GO:0000775; C:chromosome, centromeric region; TAS:ProtInc.\r\n",
      "DR   GO; GO:0005829; C:cytosol; TAS:Reactome.\r\n",
      "DR   GO; GO:0000776; C:kinetochore; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.\r\n",
      "DR   GO; GO:0031262; C:Ndc80 complex; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.\r\n",
      "DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.\r\n",
      "DR   GO; GO:0000940; C:outer kinetochore; IDA:BHF-UCL.\r\n",
      "DR   GO; GO:0030332; F:cyclin binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.\r\n",
      "DR   GO; GO:0140483; F:kinetochore adaptor activity; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0051315; P:attachment of mitotic spindle microtubules to kinetochore; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0008608; P:attachment of spindle microtubules to kinetochore; IDA:ComplexPortal.\r\n",
      "DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0051298; P:centrosome duplication; IDA:MGI.\r\n",
      "DR   GO; GO:0007059; P:chromosome segregation; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0000132; P:establishment of mitotic spindle orientation; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0008315; P:G2/MI transition of meiotic cell cycle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051383; P:kinetochore organization; IMP:CAFA.\r\n",
      "DR   GO; GO:0051310; P:metaphase plate congression; IDA:MGI.\r\n",
      "DR   GO; GO:0000278; P:mitotic cell cycle; TAS:ProtInc.\r\n",
      "DR   GO; GO:0000070; P:mitotic sister chromatid segregation; TAS:ProtInc.\r\n",
      "DR   GO; GO:0007094; P:mitotic spindle assembly checkpoint signaling; NAS:ComplexPortal.\r\n",
      "DR   GO; GO:0007052; P:mitotic spindle organization; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0090267; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; IMP:UniProtKB.\r\n",
      "DR   GO; GO:1905342; P:positive regulation of protein localization to kinetochore; IMP:CAFA.\r\n",
      "DR   GO; GO:0031647; P:regulation of protein stability; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007057; P:spindle assembly involved in female meiosis I; IEA:Ensembl.\r\n",
      "DR   DisProt; DP01576; -.\r\n",
      "DR   Gene3D; 6.10.250.1950; -; 1.\r\n",
      "DR   Gene3D; 1.10.418.30; Ncd80 complex, Ncd80 subunit; 1.\r\n",
      "DR   IDEAL; IID00184; -.\r\n",
      "DR   InterPro; IPR040967; DUF5595.\r\n",
      "DR   InterPro; IPR005550; Kinetochore_Ndc80.\r\n",
      "DR   InterPro; IPR038273; Ndc80_sf.\r\n",
      "DR   PANTHER; PTHR10643; KINETOCHORE PROTEIN NDC80; 1.\r\n",
      "DR   PANTHER; PTHR10643:SF2; KINETOCHORE PROTEIN NDC80 HOMOLOG; 1.\r\n",
      "DR   Pfam; PF18077; DUF5595; 1.\r\n",
      "DR   Pfam; PF03801; Ndc80_HEC; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Acetylation; Cell cycle; Cell division; Centromere;\r\n",
      "KW   Chromosome; Coiled coil; Kinetochore; Mitosis; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome.\r\n",
      "FT   CHAIN           1..642\r\n",
      "FT                   /note=\"Kinetochore protein NDC80 homolog\"\r\n",
      "FT                   /id=\"PRO_0000249550\"\r\n",
      "FT   REGION          1..445\r\n",
      "FT                   /note=\"Interaction with the N-terminus of CDCA1\"\r\n",
      "FT   REGION          1..250\r\n",
      "FT                   /note=\"Nuclear localization\"\r\n",
      "FT   REGION          1..74\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          128..251\r\n",
      "FT                   /note=\"Interaction with RB1\"\r\n",
      "FT   REGION          251..618\r\n",
      "FT                   /note=\"Interaction with NEK2 and ZWINT\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16732327\"\r\n",
      "FT   REGION          251..431\r\n",
      "FT                   /note=\"Interaction with SMC1A\"\r\n",
      "FT   REGION          361..547\r\n",
      "FT                   /note=\"Interaction with PSMC2 and SMC1A\"\r\n",
      "FT   REGION          446..642\r\n",
      "FT                   /note=\"Interaction with the C-terminus of CDCA1 and the\r\n",
      "FT                   SPBC24-SPBC25 subcomplex\"\r\n",
      "FT   COILED          261..403\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COILED          458..642\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COMPBIAS        1..51\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         44\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         53\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MOD_RES         55\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MOD_RES         59\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MOD_RES         62\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MOD_RES         69\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         165\r\n",
      "FT                   /note=\"Phosphoserine; by NEK2\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:12386167\"\r\n",
      "FT   MOD_RES         242\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q9D0F1\"\r\n",
      "FT   MOD_RES         527\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   VARIANT         66\r\n",
      "FT                   /note=\"S -> A (in dbSNP:rs16943490)\"\r\n",
      "FT                   /id=\"VAR_027436\"\r\n",
      "FT   VARIANT         348\r\n",
      "FT                   /note=\"E -> D (in dbSNP:rs12456560)\"\r\n",
      "FT                   /id=\"VAR_027437\"\r\n",
      "FT   VARIANT         605\r\n",
      "FT                   /note=\"A -> P (in dbSNP:rs9051)\"\r\n",
      "FT                   /id=\"VAR_027438\"\r\n",
      "FT   MUTAGEN         53\r\n",
      "FT                   /note=\"K->Q: Mimics acetylation, leading to increased\r\n",
      "FT                   kinetochore-microtubule attachment; when associated with\r\n",
      "FT                   Q-59.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MUTAGEN         53\r\n",
      "FT                   /note=\"K->R: Impaired acetylation, leading to reduced\r\n",
      "FT                   kinetochore-microtubule attachment; when associated with\r\n",
      "FT                   R-59.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MUTAGEN         59\r\n",
      "FT                   /note=\"K->Q: Mimics acetylation, leading to increased\r\n",
      "FT                   kinetochore-microtubule attachment; when associated with\r\n",
      "FT                   Q-53.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MUTAGEN         59\r\n",
      "FT                   /note=\"K->R: Impaired acetylation, leading to reduced\r\n",
      "FT                   kinetochore-microtubule attachment; when associated with\r\n",
      "FT                   R-53.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MUTAGEN         234\r\n",
      "FT                   /note=\"E->K: Abrogates binding to RB1.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10779342\"\r\n",
      "FT   HELIX           89..105\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   TURN            114..117\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   HELIX           122..133\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   TURN            134..136\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   HELIX           147..157\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   HELIX           166..170\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   TURN            171..173\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   TURN            175..177\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   HELIX           178..194\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   HELIX           222..238\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2VE7\"\r\n",
      "FT   HELIX           244..258\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2VE7\"\r\n",
      "FT   HELIX           264..286\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2VE7\"\r\n",
      "SQ   SEQUENCE   642 AA;  73913 MW;  6A82DA4D8B77ECDC CRC64;\r\n",
      "     MKRSSVSSGG AGRLSMQELR SQDVNKQGLY TPQTKEKPTF GKLSINKPTS ERKVSLFGKR\r\n",
      "     TSGHGSRNSQ LGIFSSSEKI KDPRPLNDKA FIQQCIRQLC EFLTENGYAH NVSMKSLQAP\r\n",
      "     SVKDFLKIFT FLYGFLCPSY ELPDTKFEEE VPRIFKDLGY PFALSKSSMY TVGAPHTWPH\r\n",
      "     IVAALVWLID CIKIHTAMKE SSPLFDDGQP WGEETEDGIM HNKLFLDYTI KCYESFMSGA\r\n",
      "     DSFDEMNAEL QSKLKDLFNV DAFKLESLEA KNRALNEQIA RLEQEREKEP NRLESLRKLK\r\n",
      "     ASLQGDVQKY QAYMSNLESH SAILDQKLNG LNEEIARVEL ECETIKQENT RLQNIIDNQK\r\n",
      "     YSVADIERIN HERNELQQTI NKLTKDLEAE QQKLWNEELK YARGKEAIET QLAEYHKLAR\r\n",
      "     KLKLIPKGAE NSKGYDFEIK FNPEAGANCL VKYRAQVYVP LKELLNETEE EINKALNKKM\r\n",
      "     GLEDTLEQLN AMITESKRSV RTLKEEVQKL DDLYQQKIKE AEEEDEKCAS ELESLEKHKH\r\n",
      "     LLESTVNQGL SEAMNELDAV QREYQLVVQT TTEERRKVGN NLQRLLEMVA THVGSVEKHL\r\n",
      "     EEQIAKVDRE YEECMSEDLS ENIKEIRDKY EKKATLIKSS EE\r\n",
      "//\r\n",
      "ID   RB_MOUSE                Reviewed;         921 AA.\r\n",
      "AC   P13405; Q4VA62;\r\n",
      "DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   27-JUL-2011, sequence version 2.\r\n",
      "DT   03-MAY-2023, entry version 226.\r\n",
      "DE   RecName: Full=Retinoblastoma-associated protein;\r\n",
      "DE   AltName: Full=p110-RB1 {ECO:0000303|PubMed:8336704};\r\n",
      "DE   AltName: Full=pRb;\r\n",
      "DE            Short=Rb;\r\n",
      "DE   AltName: Full=pp105;\r\n",
      "GN   Name=Rb1; Synonyms=Rb-1;\r\n",
      "OS   Mus musculus (Mouse).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Mus; Mus.\r\n",
      "OX   NCBI_TaxID=10090;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=2671991; DOI=10.1073/pnas.86.17.6474;\r\n",
      "RA   Bernards R., Schackleford G.M., Gerber M.R., Horowitz J.M., Friend S.H.,\r\n",
      "RA   Schartl M., Bogenmann E., Rapaport J., McGee T., Dryja T.P., Weinberg R.A.;\r\n",
      "RT   \"Structure and expression of the murine retinoblastoma gene and\r\n",
      "RT   characterization of its encoded protein.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 86:6474-6478(1989).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RA   Wu J., Liao J.D.;\r\n",
      "RT   \"Sequencing of the full-length cDNA sequence of the murine retinoblastoma\r\n",
      "RT   gene.\";\r\n",
      "RL   Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\r\n",
      "RC   STRAIN=C57BL/6J; TISSUE=Brain;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [4]\r\n",
      "RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION OF THE NUCLEAR LOCALIZATION\r\n",
      "RP   SIGNAL, MUTAGENESIS OF 733-LYS--PRO-769; 769-PRO--ILE-872; 853-LYS--ARG-869\r\n",
      "RP   AND 866-LYS--ARG-869, INTERACTION WITH ADENOVIRUS E1A PROTEIN AND SV40\r\n",
      "RP   LARGE T ANTIGEN (MICROBIAL INFECTION), INTERACTION WITH E2F1, AND\r\n",
      "RP   PHOSPHORYLATION.\r\n",
      "RX   PubMed=8336704; DOI=10.1128/mcb.13.8.4588-4599.1993;\r\n",
      "RA   Zacksenhaus E., Bremner R., Phillips R.A., Gallie B.L.;\r\n",
      "RT   \"A bipartite nuclear localization signal in the retinoblastoma gene product\r\n",
      "RT   and its importance for biological activity.\";\r\n",
      "RL   Mol. Cell. Biol. 13:4588-4599(1993).\r\n",
      "RN   [5]\r\n",
      "RP   INTERACTION WITH DNMT1.\r\n",
      "RX   PubMed=10888886; DOI=10.1038/77124;\r\n",
      "RA   Robertson K.D., Ait-Si-Ali S., Yokochi T., Wade P.A., Jones P.L.,\r\n",
      "RA   Wolffe A.P.;\r\n",
      "RT   \"DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription\r\n",
      "RT   from E2F-responsive promoters.\";\r\n",
      "RL   Nat. Genet. 25:338-342(2000).\r\n",
      "RN   [6]\r\n",
      "RP   INTERACTION WITH E4F1.\r\n",
      "RX   PubMed=10869426; DOI=10.1073/pnas.130198397;\r\n",
      "RA   Fajas L., Paul C., Zugasti O., Le Cam L., Polanowska J., Fabbrizio E.,\r\n",
      "RA   Medema R., Vignais M.-L., Sardet C.;\r\n",
      "RT   \"pRB binds to and modulates the transrepressing activity of the E1A-\r\n",
      "RT   regulated transcription factor p120E4F.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 97:7738-7743(2000).\r\n",
      "RN   [7]\r\n",
      "RP   INTERACTION WITH USP4.\r\n",
      "RX   PubMed=11571651; DOI=10.1038/sj.onc.1204823;\r\n",
      "RA   Blanchette P., Gilchrist C.A., Baker R.T., Gray D.A.;\r\n",
      "RT   \"Association of UNP, a ubiquitin-specific protease, with the pocket\r\n",
      "RT   proteins pRb, p107 and p130.\";\r\n",
      "RL   Oncogene 20:5533-5537(2001).\r\n",
      "RN   [8]\r\n",
      "RP   TISSUE SPECIFICITY.\r\n",
      "RC   STRAIN=C57BL/6J; TISSUE=Skeletal muscle;\r\n",
      "RX   PubMed=12095676; DOI=10.1016/s0378-1119(02)00585-1;\r\n",
      "RA   Chano T., Ikegawa S., Saito-Ohara F., Inazawa J., Mabuchi A., Saeki Y.,\r\n",
      "RA   Okabe H.;\r\n",
      "RT   \"Isolation, characterization and mapping of the mouse and human RB1CC1\r\n",
      "RT   genes.\";\r\n",
      "RL   Gene 291:29-34(2002).\r\n",
      "RN   [9]\r\n",
      "RP   FUNCTION, AND INTERACTION WITH KMT5B AND KMT5C.\r\n",
      "RX   PubMed=15750587; DOI=10.1038/ncb1235;\r\n",
      "RA   Gonzalo S., Garcia-Cao M., Fraga M.F., Schotta G., Peters A.H.F.M.,\r\n",
      "RA   Cotter S.E., Eguia R., Dean D.C., Esteller M., Jenuwein T., Blasco M.A.;\r\n",
      "RT   \"Role of the RB1 family in stabilizing histone methylation at constitutive\r\n",
      "RT   heterochromatin.\";\r\n",
      "RL   Nat. Cell Biol. 7:420-428(2005).\r\n",
      "RN   [10]\r\n",
      "RP   INTERACTION WITH ATAD5.\r\n",
      "RX   PubMed=15983387; DOI=10.1073/pnas.0504222102;\r\n",
      "RA   Ishii H., Inageta T., Mimori K., Saito T., Sasaki H., Isobe M., Mori M.,\r\n",
      "RA   Croce C.M., Huebner K., Ozawa K., Furukawa Y.;\r\n",
      "RT   \"Frag1, a homolog of alternative replication factor C subunits, links\r\n",
      "RT   replication stress surveillance with apoptosis.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 102:9655-9660(2005).\r\n",
      "RN   [11]\r\n",
      "RP   INTERACTION WITH PRMT2.\r\n",
      "RX   PubMed=16616919; DOI=10.1016/j.yexcr.2006.03.001;\r\n",
      "RA   Yoshimoto T., Boehm M., Olive M., Crook M.F., San H., Langenickel T.,\r\n",
      "RA   Nabel E.G.;\r\n",
      "RT   \"The arginine methyltransferase PRMT2 binds RB and regulates E2F\r\n",
      "RT   function.\";\r\n",
      "RL   Exp. Cell Res. 312:2040-2053(2006).\r\n",
      "RN   [12]\r\n",
      "RP   FUNCTION, INTERACTION WITH KMT5B AND KMT5C, AND MUTAGENESIS OF ILE-746;\r\n",
      "RP   ASN-750 AND MET-754.\r\n",
      "RX   PubMed=16612004; DOI=10.1128/mcb.26.9.3659-3671.2006;\r\n",
      "RA   Isaac C.E., Francis S.M., Martens A.L., Julian L.M., Seifried L.A.,\r\n",
      "RA   Erdmann N., Binne U.K., Harrington L., Sicinski P., Berube N.G.,\r\n",
      "RA   Dyson N.J., Dick F.A.;\r\n",
      "RT   \"The retinoblastoma protein regulates pericentric heterochromatin.\";\r\n",
      "RL   Mol. Cell. Biol. 26:3659-3671(2006).\r\n",
      "RN   [13]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31; SER-243; THR-246;\r\n",
      "RP   THR-364; THR-367; SER-601; SER-605; SER-773; SER-800; SER-804; THR-814;\r\n",
      "RP   THR-819 AND SER-848, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE\r\n",
      "RP   ANALYSIS].\r\n",
      "RC   TISSUE=Kidney, Lung, Spleen, and Testis;\r\n",
      "RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;\r\n",
      "RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,\r\n",
      "RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;\r\n",
      "RT   \"A tissue-specific atlas of mouse protein phosphorylation and expression.\";\r\n",
      "RL   Cell 143:1174-1189(2010).\r\n",
      "RN   [14]\r\n",
      "RP   TISSUE SPECIFICITY, ACETYLATION, AND INTERACTION WITH E2F1; EP300 AND\r\n",
      "RP   KAT2B.\r\n",
      "RX   PubMed=20940255; DOI=10.1242/jcs.068924;\r\n",
      "RA   Pickard A., Wong P.P., McCance D.J.;\r\n",
      "RT   \"Acetylation of Rb by PCAF is required for nuclear localization and\r\n",
      "RT   keratinocyte differentiation.\";\r\n",
      "RL   J. Cell Sci. 123:3718-3726(2010).\r\n",
      "RN   [15]\r\n",
      "RP   CLEAVAGE OF INITIATOR METHIONINE, AND METHYLATION AT PRO-2.\r\n",
      "RX   PubMed=20668449; DOI=10.1038/nature09343;\r\n",
      "RA   Tooley C.E., Petkowski J.J., Muratore-Schroeder T.L., Balsbaugh J.L.,\r\n",
      "RA   Shabanowitz J., Sabat M., Minor W., Hunt D.F., Macara I.G.;\r\n",
      "RT   \"NRMT is an alpha-N-methyltransferase that methylates RCC1 and\r\n",
      "RT   retinoblastoma protein.\";\r\n",
      "RL   Nature 466:1125-1128(2010).\r\n",
      "CC   -!- FUNCTION: Tumor suppressor that is a key regulator of the G1/S\r\n",
      "CC       transition of the cell cycle (PubMed:8336704). The hypophosphorylated\r\n",
      "CC       form binds transcription regulators of the E2F family, preventing\r\n",
      "CC       transcription of E2F-responsive genes. Both physically blocks E2Fs\r\n",
      "CC       transactivating domain and recruits chromatin-modifying enzymes that\r\n",
      "CC       actively repress transcription. Cyclin and CDK-dependent\r\n",
      "CC       phosphorylation of RB1 induces its dissociation from E2Fs, thereby\r\n",
      "CC       activating transcription of E2F responsive genes and triggering entry\r\n",
      "CC       into S phase. RB1 also promotes the G0-G1 transition upon\r\n",
      "CC       phosphorylation and activation by CDK3/cyclin-C. Directly involved in\r\n",
      "CC       heterochromatin formation by maintaining overall chromatin structure\r\n",
      "CC       and, in particular, that of constitutive heterochromatin by stabilizing\r\n",
      "CC       histone methylation (PubMed:15750587). Recruits and targets histone\r\n",
      "CC       methyltransferases SUV39H1, KMT5B and KMT5C, leading to epigenetic\r\n",
      "CC       transcriptional repression. Controls histone H4 'Lys-20' trimethylation\r\n",
      "CC       (PubMed:16612004). Inhibits the intrinsic kinase activity of TAF1.\r\n",
      "CC       Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a\r\n",
      "CC       histone deacetylase (HDAC) complex to the c-FOS promoter. In resting\r\n",
      "CC       neurons, transcription of the c-FOS promoter is inhibited by BRG1-\r\n",
      "CC       dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon\r\n",
      "CC       calcium influx, RB1 is dephosphorylated by calcineurin, which leads to\r\n",
      "CC       release of the repressor complex (By similarity) (PubMed:15750587,\r\n",
      "CC       PubMed:16612004, PubMed:8336704). {ECO:0000250|UniProtKB:P06400,\r\n",
      "CC       ECO:0000250|UniProtKB:P33568, ECO:0000269|PubMed:15750587,\r\n",
      "CC       ECO:0000269|PubMed:16612004, ECO:0000269|PubMed:8336704}.\r\n",
      "CC   -!- SUBUNIT: The hypophosphorylated form interacts with and sequesters the\r\n",
      "CC       E2F1 transcription factor. Interacts with heterodimeric E2F/DP\r\n",
      "CC       transcription factor complexes containing TFDP1 and either E2F1/E2F,\r\n",
      "CC       E2F3, E2F4 or E2F5, or TFDP2 and E2F4 (PubMed:8336704,\r\n",
      "CC       PubMed:20940255). The unphosphorylated form interacts with EID1,\r\n",
      "CC       ARID3B, KDM5A, SUV39H1, MJD2A/JHDM3A and THOC1. Interacts with the N-\r\n",
      "CC       terminal domain of TAF1. Interacts with SNW1, ATAD5, AATF, DNMT1, LIN9,\r\n",
      "CC       LMNA, KMT5B, KMT5C, PELP1, UHRF2, TMPO-alpha and USP4. May interact\r\n",
      "CC       with NDC80. Interacts with GRIP1 and UBR4. Interacts with ARID4A and\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CC       KDM5B. Interacts with E4F1 and LIMD1. Interacts with SMARCA4/BRG1 and\r\n",
      "CC       HDAC1. Interacts with USP4. Interacts (when methylated at Lys-853) with\r\n",
      "CC       L3MBTL1. Binds to CDK1 and CDK2. Interacts with CHEK2; phosphorylates\r\n",
      "CC       RB1 (By similarity). Interacts with PRMT2. Interacts with CEBPA. P-TEFB\r\n",
      "CC       complex interacts with RB1; promotes phosphorylation of RB1 (By\r\n",
      "CC       similarity). Interacts with RBBP9; the interaction disrupts RB1 binding\r\n",
      "CC       to E2F1 (By similarity). Interacts with KAT2B/PCAF and EP300/P300\r\n",
      "CC       (PubMed:20940255). Interacts with PAX5 (By similarity).\r\n",
      "CC       {ECO:0000250|UniProtKB:P06400, ECO:0000250|UniProtKB:P33568,\r\n",
      "CC       ECO:0000269|PubMed:10869426, ECO:0000269|PubMed:10888886,\r\n",
      "CC       ECO:0000269|PubMed:11571651, ECO:0000269|PubMed:15750587,\r\n",
      "CC       ECO:0000269|PubMed:15983387, ECO:0000269|PubMed:16612004,\r\n",
      "CC       ECO:0000269|PubMed:16616919, ECO:0000269|PubMed:20940255,\r\n",
      "CC       ECO:0000269|PubMed:8336704}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with adenovirus E1a protein.\r\n",
      "CC       {ECO:0000269|PubMed:8336704}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with SV40 large T antigen.\r\n",
      "CC       {ECO:0000269|PubMed:8336704}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       P13405; Q155P7: Cenpf; NbExp=4; IntAct=EBI-971782, EBI-2211248;\r\n",
      "CC       P13405; Q80UP3: Dgkz; NbExp=2; IntAct=EBI-971782, EBI-971774;\r\n",
      "CC       P13405; P17679: Gata1; NbExp=3; IntAct=EBI-971782, EBI-3903251;\r\n",
      "CC       P13405; Q9R002: Ifi202; NbExp=7; IntAct=EBI-971782, EBI-3043899;\r\n",
      "CC       P13405; P24610: Pax3; NbExp=3; IntAct=EBI-971782, EBI-1208116;\r\n",
      "CC       P13405; P52946: Pdx1; NbExp=2; IntAct=EBI-971782, EBI-7128945;\r\n",
      "CC       P13405; Q3TKT4: Smarca4; NbExp=3; IntAct=EBI-971782, EBI-1210244;\r\n",
      "CC       P13405; Q61412: Vsx2; NbExp=2; IntAct=EBI-971782, EBI-1208174;\r\n",
      "CC       P13405; P15976: GATA1; Xeno; NbExp=2; IntAct=EBI-971782, EBI-3909284;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8336704}. Note=During\r\n",
      "CC       keratinocyte differentiation, acetylation by KAT2B/PCAF is required for\r\n",
      "CC       nuclear localization. {ECO:0000250|UniProtKB:P06400}.\r\n",
      "CC   -!- TISSUE SPECIFICITY: Expressed in the cell nuclei of renal tubules,\r\n",
      "CC       hepatocytes and skeletal muscles. Expressed in skin (at protein level)\r\n",
      "CC       (PubMed:20940255). {ECO:0000269|PubMed:12095676,\r\n",
      "CC       ECO:0000269|PubMed:20940255}.\r\n",
      "CC   -!- PTM: Phosphorylated (PubMed:8336704). Phosphorylated by CDK6 and CDK4,\r\n",
      "CC       and subsequently by CDK2 at Ser-561 in G1, thereby releasing E2F1 which\r\n",
      "CC       is then able to activate cell growth. Dephosphorylated at the late M\r\n",
      "CC       phase. Phosphorylation of threonine residues in domain C promotes\r\n",
      "CC       interaction between the C-terminal domain C and the Pocket domain, and\r\n",
      "CC       thereby inhibits interactions with heterodimeric E2F/DP transcription\r\n",
      "CC       factor complexes. Dephosphorylated at Ser-788 by calcineruin upon\r\n",
      "CC       calcium stimulation. CDK3/cyclin-C-mediated phosphorylation at Ser-800\r\n",
      "CC       and Ser-804 is required for G0-G1 transition (By similarity).\r\n",
      "CC       Phosphorylated by CDK1 and CDK2 upon TGFB1-mediated apoptosis (By\r\n",
      "CC       similarity). {ECO:0000250, ECO:0000269|PubMed:8336704}.\r\n",
      "CC   -!- PTM: Monomethylation at Lys-803 by SMYD2 enhances phosphorylation at\r\n",
      "CC       Ser-800 and Ser-804, and promotes cell cycle progression.\r\n",
      "CC       Monomethylation at Lys-853 by SMYD2 promotes interaction with L3MBTL1\r\n",
      "CC       (By similarity). N-terminus is methylated by METTL11A/NTM1.\r\n",
      "CC       {ECO:0000250, ECO:0000269|PubMed:20668449}.\r\n",
      "CC   -!- PTM: Acetylated in the skin (PubMed:20940255). Acetylation at Lys-866\r\n",
      "CC       and Lys-867 regulates subcellular localization during keratinocytes\r\n",
      "CC       differentiation (By similarity). {ECO:0000250|UniProtKB:P06400,\r\n",
      "CC       ECO:0000269|PubMed:20940255}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Retinoblastoma protein entry;\r\n",
      "CC       URL=\"https://en.wikipedia.org/wiki/Retinoblastoma_protein\";\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; M26391; AAA39964.1; -; mRNA.\r\n",
      "DR   EMBL; DQ400415; ABD72475.1; -; mRNA.\r\n",
      "DR   EMBL; BC096525; AAH96525.1; -; mRNA.\r\n",
      "DR   CCDS; CCDS27267.1; -.\r\n",
      "DR   PIR; A33718; A33718.\r\n",
      "DR   RefSeq; NP_033055.2; NM_009029.2.\r\n",
      "DR   AlphaFoldDB; P13405; -.\r\n",
      "DR   SMR; P13405; -.\r\n",
      "DR   BioGRID; 202815; 61.\r\n",
      "DR   ComplexPortal; CPX-160; RB1-E2F1-TFDP1 transcription repressor complex.\r\n",
      "DR   ComplexPortal; CPX-177; RB1-E2F2-TFDP1 transcription repressor complex.\r\n",
      "DR   ComplexPortal; CPX-470; L3MBTL1 complex.\r\n",
      "DR   CORUM; P13405; -.\r\n",
      "DR   DIP; DIP-37637N; -.\r\n",
      "DR   IntAct; P13405; 26.\r\n",
      "DR   MINT; P13405; -.\r\n",
      "DR   STRING; 10090.ENSMUSP00000022701; -.\r\n",
      "DR   iPTMnet; P13405; -.\r\n",
      "DR   PhosphoSitePlus; P13405; -.\r\n",
      "DR   EPD; P13405; -.\r\n",
      "DR   jPOST; P13405; -.\r\n",
      "DR   MaxQB; P13405; -.\r\n",
      "DR   PaxDb; P13405; -.\r\n",
      "DR   PeptideAtlas; P13405; -.\r\n",
      "DR   ProteomicsDB; 255135; -.\r\n",
      "DR   Antibodypedia; 3758; 3544 antibodies from 52 providers.\r\n",
      "DR   DNASU; 19645; -.\r\n",
      "DR   Ensembl; ENSMUST00000022701.7; ENSMUSP00000022701.7; ENSMUSG00000022105.7.\r\n",
      "DR   GeneID; 19645; -.\r\n",
      "DR   KEGG; mmu:19645; -.\r\n",
      "DR   UCSC; uc007upp.2; mouse.\r\n",
      "DR   AGR; MGI:97874; -.\r\n",
      "DR   CTD; 5925; -.\r\n",
      "DR   MGI; MGI:97874; Rb1.\r\n",
      "DR   VEuPathDB; HostDB:ENSMUSG00000022105; -.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00950000183202; -.\r\n",
      "DR   HOGENOM; CLU_015754_0_0_1; -.\r\n",
      "DR   InParanoid; P13405; -.\r\n",
      "DR   OMA; VKDIGCI; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; P13405; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   Reactome; R-MMU-113501; Inhibition of replication initiation of damaged DNA by RB1/E2F1.\r\n",
      "DR   Reactome; R-MMU-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.\r\n",
      "DR   Reactome; R-MMU-2299718; Condensation of Prophase Chromosomes.\r\n",
      "DR   Reactome; R-MMU-2559584; Formation of Senescence-Associated Heterochromatin Foci (SAHF).\r\n",
      "DR   Reactome; R-MMU-69200; Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes.\r\n",
      "DR   Reactome; R-MMU-69202; Cyclin E associated events during G1/S transition.\r\n",
      "DR   Reactome; R-MMU-69231; Cyclin D associated events in G1.\r\n",
      "DR   Reactome; R-MMU-69656; Cyclin A:Cdk2-associated events at S phase entry.\r\n",
      "DR   BioGRID-ORCS; 19645; 4 hits in 84 CRISPR screens.\r\n",
      "DR   ChiTaRS; Rb1; mouse.\r\n",
      "DR   PRO; PR:P13405; -.\r\n",
      "DR   Proteomes; UP000000589; Chromosome 14.\r\n",
      "DR   RNAct; P13405; protein.\r\n",
      "DR   Bgee; ENSMUSG00000022105; Expressed in molar tooth and 267 other tissues.\r\n",
      "DR   ExpressionAtlas; P13405; baseline and differential.\r\n",
      "DR   Genevisible; P13405; MM.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0061793; C:chromatin lock complex; ISO:MGI.\r\n",
      "DR   GO; GO:0008024; C:cyclin/CDK positive transcription elongation factor complex; ISO:MGI.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0016605; C:PML body; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0005819; C:spindle; IDA:MGI.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; IDA:MGI.\r\n",
      "DR   GO; GO:0097718; F:disordered domain specific binding; ISO:MGI.\r\n",
      "DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.\r\n",
      "DR   GO; GO:0061676; F:importin-alpha family protein binding; ISO:MGI.\r\n",
      "DR   GO; GO:0019900; F:kinase binding; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0060090; F:molecular adaptor activity; ISO:MGI.\r\n",
      "DR   GO; GO:0051219; F:phosphoprotein binding; ISO:MGI.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IPI:BHF-UCL.\r\n",
      "DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:MGI.\r\n",
      "DR   GO; GO:0003180; P:aortic valve morphogenesis; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0006915; P:apoptotic process; IMP:MGI.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0051301; P:cell division; IMP:MGI.\r\n",
      "DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IMP:MGI.\r\n",
      "DR   GO; GO:0008283; P:cell population proliferation; IMP:MGI.\r\n",
      "DR   GO; GO:0032869; P:cellular response to insulin stimulus; IDA:MGI.\r\n",
      "DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IMP:MGI.\r\n",
      "DR   GO; GO:0002062; P:chondrocyte differentiation; IDA:MGI.\r\n",
      "DR   GO; GO:0051276; P:chromosome organization; ISO:MGI.\r\n",
      "DR   GO; GO:0048565; P:digestive tract development; IMP:MGI.\r\n",
      "DR   GO; GO:0043353; P:enucleate erythrocyte differentiation; IGI:MGI.\r\n",
      "DR   GO; GO:0050673; P:epithelial cell proliferation; IMP:MGI.\r\n",
      "DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:MGI.\r\n",
      "DR   GO; GO:0034349; P:glial cell apoptotic process; IMP:MGI.\r\n",
      "DR   GO; GO:0014009; P:glial cell proliferation; IGI:MGI.\r\n",
      "DR   GO; GO:0097284; P:hepatocyte apoptotic process; IMP:MGI.\r\n",
      "DR   GO; GO:0031507; P:heterochromatin formation; ISO:MGI.\r\n",
      "DR   GO; GO:0034088; P:maintenance of mitotic sister chromatid cohesion; ISO:MGI.\r\n",
      "DR   GO; GO:0045445; P:myoblast differentiation; ISS:UniProtKB.\r\n",
      "DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; ISO:MGI.\r\n",
      "DR   GO; GO:0045786; P:negative regulation of cell cycle; IMP:MGI.\r\n",
      "DR   GO; GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:MGI.\r\n",
      "DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; IMP:YuBioLab.\r\n",
      "DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; ISO:MGI.\r\n",
      "DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:MGI.\r\n",
      "DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:MGI.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IMP:MGI.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:MGI.\r\n",
      "DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IGI:MGI.\r\n",
      "DR   GO; GO:1903944; P:negative regulation of hepatocyte apoptotic process; ISO:MGI.\r\n",
      "DR   GO; GO:0050728; P:negative regulation of inflammatory response; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; IGI:MGI.\r\n",
      "DR   GO; GO:1904761; P:negative regulation of myofibroblast differentiation; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0006469; P:negative regulation of protein kinase activity; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0071901; P:negative regulation of protein serine/threonine kinase activity; ISO:MGI.\r\n",
      "DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; IMP:MGI.\r\n",
      "DR   GO; GO:1902948; P:negative regulation of tau-protein kinase activity; ISO:MGI.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:MGI.\r\n",
      "DR   GO; GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; IGI:BHF-UCL.\r\n",
      "DR   GO; GO:0051402; P:neuron apoptotic process; IMP:MGI.\r\n",
      "DR   GO; GO:0030182; P:neuron differentiation; IMP:MGI.\r\n",
      "DR   GO; GO:0042551; P:neuron maturation; IMP:MGI.\r\n",
      "DR   GO; GO:0031175; P:neuron projection development; IMP:MGI.\r\n",
      "DR   GO; GO:1904028; P:positive regulation of collagen fibril organization; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:1903055; P:positive regulation of extracellular matrix organization; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; IGI:MGI.\r\n",
      "DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; ISO:MGI.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:MGI.\r\n",
      "DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; ISO:MGI.\r\n",
      "DR   GO; GO:0071459; P:protein localization to chromosome, centromeric region; ISO:MGI.\r\n",
      "DR   GO; GO:0007265; P:Ras protein signal transduction; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051726; P:regulation of cell cycle; IMP:MGI.\r\n",
      "DR   GO; GO:0001558; P:regulation of cell growth; IGI:MGI.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0007346; P:regulation of mitotic cell cycle; IMP:MGI.\r\n",
      "DR   GO; GO:0031134; P:sister chromatid biorientation; ISO:MGI.\r\n",
      "DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IMP:MGI.\r\n",
      "DR   GO; GO:0007224; P:smoothened signaling pathway; IMP:MGI.\r\n",
      "DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051146; P:striated muscle cell differentiation; IGI:MGI.\r\n",
      "DR   GO; GO:0001894; P:tissue homeostasis; IGI:MGI.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; IGI:MGI.\r\n",
      "DR   CDD; cd20599; CYCLIN_RB; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 6.10.140.1380; -; 1.\r\n",
      "DR   Gene3D; 6.10.250.530; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 2.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Acetylation; Cell cycle; Chromatin regulator; DNA-binding; Methylation;\r\n",
      "KW   Nucleus; Phosphoprotein; Reference proteome; Repressor; Transcription;\r\n",
      "KW   Transcription regulation; Tumor suppressor.\r\n",
      "FT   INIT_MET        1\r\n",
      "FT                   /note=\"Removed\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20668449\"\r\n",
      "FT   CHAIN           2..921\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein\"\r\n",
      "FT                   /id=\"PRO_0000167837\"\r\n",
      "FT   REGION          1..36\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          341..360\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          367..764\r\n",
      "FT                   /note=\"Pocket; binds T and E1A\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          367..573\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          574..632\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          633..764\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          756..921\r\n",
      "FT                   /note=\"Interaction with LIMD1\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          764..921\r\n",
      "FT                   /note=\"Domain; mediates interaction with E4F1\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          872..921\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOTIF           853..869\r\n",
      "FT                   /note=\"Bipartite nuclear localization signal\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8336704\"\r\n",
      "FT   COMPBIAS        1..26\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        341..356\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        872..886\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        906..921\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         2\r\n",
      "FT                   /note=\"N,N-dimethylproline; by NTM1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20668449\"\r\n",
      "FT   MOD_RES         31\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         243\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         246\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         350\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         364\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         367\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         561\r\n",
      "FT                   /note=\"Phosphoserine; by CDK2\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         601\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         605\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         617\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         773\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         781\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         788\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         800\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         803\r\n",
      "FT                   /note=\"N6-methyllysine; by SMYD2\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         804\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         814\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         816\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         819\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         834\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         848\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         853\r\n",
      "FT                   /note=\"N6-methyllysine; by SMYD2\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         866\r\n",
      "FT                   /note=\"N6-acetyllysine; by PCAF\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         867\r\n",
      "FT                   /note=\"N6-acetyllysine; by PCAF\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MUTAGEN         733..769\r\n",
      "FT                   /note=\"Missing: Loss of exclusive nuclear localization.\r\n",
      "FT                   Complete loss of nuclear localization, loss of growth\r\n",
      "FT                   inhibition, when transfected in Saos-2 cells and loss of\r\n",
      "FT                   interaction with SV40 large T antigen, adenovirus E1a and\r\n",
      "FT                   E2F1; when associated with 866-N--Q-869.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8336704\"\r\n",
      "FT   MUTAGEN         746\r\n",
      "FT                   /note=\"I->A: Abolishes the interaction with many chromatin\r\n",
      "FT                   regulators but not that with KMT5B and KMT5C; when\r\n",
      "FT                   associated with A-750 and A-754.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16612004\"\r\n",
      "FT   MUTAGEN         750\r\n",
      "FT                   /note=\"N->A: Abolishes the interaction with many chromatin\r\n",
      "FT                   regulators but not that with KMT5B and KMT5C; when\r\n",
      "FT                   associated with A-746 and A-754.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16612004\"\r\n",
      "FT   MUTAGEN         754\r\n",
      "FT                   /note=\"M->A: Abolishes the interaction with many chromatin\r\n",
      "FT                   regulators but not that with KMT5B and KMT5C; when\r\n",
      "FT                   associated with A-746 and A-750.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16612004\"\r\n",
      "FT   MUTAGEN         769..872\r\n",
      "FT                   /note=\"Missing: Loss of exclusive nuclear localization and\r\n",
      "FT                   loss of growth inhibition, when transfected in Saos-2\r\n",
      "FT                   cells. No effect on the interaction with SV40 large T\r\n",
      "FT                   antigen.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8336704\"\r\n",
      "FT   MUTAGEN         853..869\r\n",
      "FT                   /note=\"Missing: Loss of exclusive nuclear localization.\r\n",
      "FT                   Decreased growth inhibition activity, when transfected in\r\n",
      "FT                   Saos-2 cells. No effect on the interaction with SV40 large\r\n",
      "FT                   T antigen, adenovirus E1a, nor E2F1.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8336704\"\r\n",
      "FT   MUTAGEN         866..869\r\n",
      "FT                   /note=\"KKLR->NKLQ: Loss of exclusive nuclear localization,\r\n",
      "FT                   no effect on the interaction with SV40 large T antigen,\r\n",
      "FT                   adenovirus E1a, nor E2F1. Decreased growth inhibition\r\n",
      "FT                   activity, when transfected in Saos-2 cells. Complete loss\r\n",
      "FT                   of nuclear localization, loss of growth inhibition, when\r\n",
      "FT                   transfected in Saos-2 cells and loss of interaction with\r\n",
      "FT                   SV40 large T antigen, adenovirus E1a and E2F1; when\r\n",
      "FT                   associated with 733-K--P-769.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8336704\"\r\n",
      "FT   CONFLICT        867..868\r\n",
      "FT                   /note=\"KL -> NV (in Ref. 1; AAA39964)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   921 AA;  105367 MW;  AE81D35A07ADB493 CRC64;\r\n",
      "     MPPKAPRRAA AAEPPPPPPP PPREDDPAQD SGPEELPLAR LEFEEIEEPE FIALCQKLKV\r\n",
      "     PDHVRERAWL TWEKVSSVDG ILEGYIQKKK ELWGICIFIA AVDLDEMPFT FTELQKSIET\r\n",
      "     SVYKFFDLLK EIDTSTKVDN AMSRLLKKYN VLCALYSKLE RTCELIYLTQ PSSALSTEIN\r\n",
      "     SMLVLKISWI TFLLAKGEVL QMEDDLVISF QLMLCVVDYF IKFSPPALLR EPYKTAAIPI\r\n",
      "     NGSPRTPRRG QNRSARIAKQ LENDTRIIEV LCKEHECNID EVKNVYFKNF IPFINSLGIV\r\n",
      "     SSNGLPEVES LSKRYEEVYL KNKDLDARLF LDHDKTLQTD PIDSFETERT PRKNNPDEEA\r\n",
      "     NVVTPHTPVR TVMNTIQQLM VILNSASDQP SENLISYFNN CTVNPKENIL KRVKDVGHIF\r\n",
      "     KEKFANAVGQ GCVDIGVQRY KLGVRLYYRV MESMLKSEEE RLSIQNFSKL LNDNIFHMSL\r\n",
      "     LACALEVVMA TYSRSTLQHL DSGTDLSFPW ILNVLNLKAF DFYKVIESFI KVEANLTREM\r\n",
      "     IKHLERCEHR IMESLAWLSD SPLFDLIKQS KDGEGPDNLE PACPLSLPLQ GNHTAADMYL\r\n",
      "     SPLRSPKKRT STTRVNSAAN TETQAASAFH TQKPLKSTSL ALFYKKVYRL AYLRLNTLCA\r\n",
      "     RLLSDHPELE HIIWTLFQHT LQNEYELMRD RHLDQIMMCS MYGICKVKNI DLKFKIIVTA\r\n",
      "     YKDLPHAAQE TFKRVLIREE EFDSIIVFYN SVFMQRLKTN ILQYASTRPP TLSPIPHIPR\r\n",
      "     SPYKFSSSPL RIPGGNIYIS PLKSPYKISE GLPTPTKMTP RSRILVSIGE SFGTSEKFQK\r\n",
      "     INQMVCNSDR VLKRSAEGGN PPKPLKKLRF DIEGADEADG SKHLPAESKF QQKLAEMTST\r\n",
      "     RTRMQKQRMN ESKDVSNKEE K\r\n",
      "//\r\n",
      "ID   RBBP6_HUMAN             Reviewed;        1792 AA.\r\n",
      "AC   Q7Z6E9; Q147T5; Q15290; Q6DKH4; Q6P4C2; Q6YNC9; Q7Z6E8; Q8N0V2; Q96PH3;\r\n",
      "AC   Q9H3I8; Q9H5M5; Q9NPX4;\r\n",
      "DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   01-OCT-2003, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 180.\r\n",
      "DE   RecName: Full=E3 ubiquitin-protein ligase RBBP6;\r\n",
      "DE            EC=2.3.2.27;\r\n",
      "DE   AltName: Full=Proliferation potential-related protein;\r\n",
      "DE   AltName: Full=Protein P2P-R;\r\n",
      "DE   AltName: Full=RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};\r\n",
      "DE   AltName: Full=Retinoblastoma-binding Q protein 1;\r\n",
      "DE            Short=RBQ-1;\r\n",
      "DE   AltName: Full=Retinoblastoma-binding protein 6;\r\n",
      "DE   AltName: Full=p53-associated cellular protein of testis;\r\n",
      "GN   Name=RBBP6; Synonyms=P2PR, PACT, RBQ1; ORFNames=My038;\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).\r\n",
      "RA   Kudo E., Itakura M.;\r\n",
      "RT   \"Retinoblastoma binding protein 6 (RBBP6), mRNA.\";\r\n",
      "RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,\r\n",
      "RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,\r\n",
      "RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,\r\n",
      "RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,\r\n",
      "RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,\r\n",
      "RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,\r\n",
      "RA   Hunkapiller M.W., Myers E.W., Venter J.C.;\r\n",
      "RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE\r\n",
      "RP   [LARGE SCALE MRNA] OF 1-1727 (ISOFORM 4), AND NUCLEOTIDE SEQUENCE [LARGE\r\n",
      "RP   SCALE MRNA] OF 1427-1792 (ISOFORMS 1/2/4).\r\n",
      "RC   TISSUE=Bone, and Kidney;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-55 (ISOFORMS 1/2/3/4).\r\n",
      "RC   TISSUE=Fetal brain;\r\n",
      "RA   Mao Y.M., Xie Y., Zheng Z.H.;\r\n",
      "RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 117-1792 (ISOFORM 2).\r\n",
      "RC   TISSUE=Spleen;\r\n",
      "RA   Ma X., Qu X., Sun L., Wu S., He F.;\r\n",
      "RT   \"The cDNA sequence for the human PACT gene.\";\r\n",
      "RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 150-1792 (ISOFORM 1).\r\n",
      "RA   Camargo A.A., Moreira E.S., Simpson A.J.G.;\r\n",
      "RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [7]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 150-1146 (ISOFORM 1).\r\n",
      "RC   TISSUE=Lung carcinoma;\r\n",
      "RX   PubMed=8595913; DOI=10.1006/geno.1995.0017;\r\n",
      "RA   Sakai Y., Saijo M., Coelho K., Kishino T., Niikawa N., Taya Y.;\r\n",
      "RT   \"cDNA sequence and chromosomal localization of a novel human protein, RBQ-1\r\n",
      "RT   (RBBP6), that binds to the retinoblastoma gene product.\";\r\n",
      "RL   Genomics 30:98-101(1995).\r\n",
      "RN   [8]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1165-1792 (ISOFORMS 1/2).\r\n",
      "RC   TISSUE=Hepatoma;\r\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\r\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\r\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\r\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\r\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\r\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\r\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\r\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\r\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\r\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\r\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\r\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\r\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\r\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\r\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\r\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\r\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\r\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\r\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\r\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\r\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\r\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\r\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\r\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\r\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\r\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\r\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\r\n",
      "RA   Isogai T., Sugano S.;\r\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\r\n",
      "RT   cDNAs.\";\r\n",
      "RL   Nat. Genet. 36:40-45(2004).\r\n",
      "RN   [9]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1264-1792 (ISOFORMS 1/2).\r\n",
      "RC   TISSUE=Amygdala;\r\n",
      "RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;\r\n",
      "RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,\r\n",
      "RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,\r\n",
      "RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,\r\n",
      "RA   Wiemann S., Schupp I.;\r\n",
      "RT   \"The full-ORF clone resource of the German cDNA consortium.\";\r\n",
      "RL   BMC Genomics 8:399-399(2007).\r\n",
      "RN   [10]\r\n",
      "RP   SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=12064457; DOI=10.1002/jcp.10084;\r\n",
      "RA   Gao S., Witte M.M., Scott R.E.;\r\n",
      "RT   \"P2P-R protein localizes to the nucleolus of interphase cells and the\r\n",
      "RT   periphery of chromosomes in mitotic cells which show maximum P2P-R\r\n",
      "RT   immunoreactivity.\";\r\n",
      "RL   J. Cell. Physiol. 191:145-154(2002).\r\n",
      "RN   [11]\r\n",
      "RP   ERRATUM OF PUBMED:12064457.\r\n",
      "RA   Gao S., Witte M.M., Scott R.E.;\r\n",
      "RL   J. Cell. Physiol. 192:359-360(2002).\r\n",
      "RN   [12]\r\n",
      "RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND OVEREXPRESSION IN ESOPHAGEAL\r\n",
      "RP   CANCER.\r\n",
      "RX   PubMed=15475430; DOI=10.1158/1078-0432.ccr-04-0841;\r\n",
      "RA   Yoshitake Y., Nakatsura T., Monji M., Senju S., Matsuyoshi H.,\r\n",
      "RA   Tsukamoto H., Hosaka S., Komori H., Fukuma D., Ikuta Y., Katagiri T.,\r\n",
      "RA   Furukawa Y., Ito H., Shinohara M., Nakamura Y., Nishimura Y.;\r\n",
      "RT   \"Proliferation potential-related protein, an ideal esophageal cancer\r\n",
      "RT   antigen for immunotherapy, identified using complementary DNA microarray\r\n",
      "RT   analysis.\";\r\n",
      "RL   Clin. Cancer Res. 10:6437-6448(2004).\r\n",
      "RN   [13]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244; SER-245; SER-246;\r\n",
      "RP   SER-247; SER-360; SER-770; SER-772; SER-861; SER-1179 AND SER-1328, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;\r\n",
      "RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;\r\n",
      "RT   \"Global, in vivo, and site-specific phosphorylation dynamics in signaling\r\n",
      "RT   networks.\";\r\n",
      "RL   Cell 127:635-648(2006).\r\n",
      "RN   [14]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-516, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=16964243; DOI=10.1038/nbt1240;\r\n",
      "RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;\r\n",
      "RT   \"A probability-based approach for high-throughput protein phosphorylation\r\n",
      "RT   analysis and site localization.\";\r\n",
      "RL   Nat. Biotechnol. 24:1285-1292(2006).\r\n",
      "RN   [15]\r\n",
      "RP   INTERACTION WITH MDM2.\r\n",
      "RX   PubMed=17470788; DOI=10.1073/pnas.0701916104;\r\n",
      "RA   Li L., Deng B., Xing G., Teng Y., Tian C., Cheng X., Yin X., Yang J.,\r\n",
      "RA   Gao X., Zhu Y., Sun Q., Zhang L., Yang X., He F.;\r\n",
      "RT   \"PACT is a negative regulator of p53 and essential for cell growth and\r\n",
      "RT   embryonic development.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 104:7951-7956(2007).\r\n",
      "RN   [16]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Embryonic kidney;\r\n",
      "RX   PubMed=17525332; DOI=10.1126/science.1140321;\r\n",
      "RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,\r\n",
      "RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,\r\n",
      "RA   Gygi S.P., Elledge S.J.;\r\n",
      "RT   \"ATM and ATR substrate analysis reveals extensive protein networks\r\n",
      "RT   responsive to DNA damage.\";\r\n",
      "RL   Science 316:1160-1166(2007).\r\n",
      "RN   [17]\r\n",
      "RP   FUNCTION, AND INTERACTION WITH YBX1.\r\n",
      "RX   PubMed=18851979; DOI=10.1016/j.jmb.2008.09.060;\r\n",
      "RA   Chibi M., Meyer M., Skepu A., Rees D.J.G., Moolman-Smook J.C., Pugh D.J.;\r\n",
      "RT   \"RBBP6 interacts with multifunctional protein YB-1 through its RING finger\r\n",
      "RT   domain, leading to ubiquitination and proteosomal degradation of YB-1.\";\r\n",
      "RL   J. Mol. Biol. 384:908-916(2008).\r\n",
      "RN   [18]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-516, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18220336; DOI=10.1021/pr0705441;\r\n",
      "RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;\r\n",
      "RT   \"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient\r\n",
      "RT   phosphoproteomic analysis.\";\r\n",
      "RL   J. Proteome Res. 7:1346-1351(2008).\r\n",
      "RN   [19]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-516; SER-1179;\r\n",
      "RP   THR-1468; SER-1646 AND SER-1648, AND IDENTIFICATION BY MASS SPECTROMETRY\r\n",
      "RP   [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;\r\n",
      "RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,\r\n",
      "RA   Elledge S.J., Gygi S.P.;\r\n",
      "RT   \"A quantitative atlas of mitotic phosphorylation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).\r\n",
      "RN   [20]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1328, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=18318008; DOI=10.1002/pmic.200700884;\r\n",
      "RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,\r\n",
      "RA   Zou H., Gu J.;\r\n",
      "RT   \"Large-scale phosphoproteome analysis of human liver tissue by enrichment\r\n",
      "RT   and fractionation of phosphopeptides with strong anion exchange\r\n",
      "RT   chromatography.\";\r\n",
      "RL   Proteomics 8:1346-1361(2008).\r\n",
      "RN   [21]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-516; SER-1179; SER-1277;\r\n",
      "RP   SER-1328 AND SER-1648, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE\r\n",
      "RP   ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [22]\r\n",
      "RP   SUBCELLULAR LOCATION, INTERACTION WITH NEK6, AND PHOSPHORYLATION.\r\n",
      "RX   PubMed=20873783; DOI=10.1021/pr100562w;\r\n",
      "RA   Vaz Meirelles G., Ferreira Lanza D.C., da Silva J.C., Santana Bernachi J.,\r\n",
      "RA   Paes Leme A.F., Kobarg J.;\r\n",
      "RT   \"Characterization of hNek6 interactome reveals an important role for its\r\n",
      "RT   short N-terminal domain and colocalization with proteins at the\r\n",
      "RT   centrosome.\";\r\n",
      "RL   J. Proteome Res. 9:6298-6316(2010).\r\n",
      "RN   [23]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244; SER-245; SER-246;\r\n",
      "RP   SER-247; SER-516; SER-861; SER-1179 AND SER-1328, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;\r\n",
      "RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,\r\n",
      "RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;\r\n",
      "RT   \"Quantitative phosphoproteomics reveals widespread full phosphorylation\r\n",
      "RT   site occupancy during mitosis.\";\r\n",
      "RL   Sci. Signal. 3:RA3-RA3(2010).\r\n",
      "RN   [24]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-780; SER-1179 AND SER-1328,\r\n",
      "RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;\r\n",
      "RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,\r\n",
      "RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;\r\n",
      "RT   \"System-wide temporal characterization of the proteome and phosphoproteome\r\n",
      "RT   of human embryonic stem cell differentiation.\";\r\n",
      "RL   Sci. Signal. 4:RS3-RS3(2011).\r\n",
      "RN   [25]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-516; SER-768;\r\n",
      "RP   SER-770; SER-772; SER-815; SER-861; SER-873; SER-957; THR-984; SER-1179;\r\n",
      "RP   SER-1221; SER-1277; SER-1328; SER-1341 AND SER-1347, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [26]\r\n",
      "RP   FUNCTION, AND INTERACTION WITH ZBTB38.\r\n",
      "RX   PubMed=24726359; DOI=10.1016/j.celrep.2014.03.030;\r\n",
      "RA   Miotto B., Chibi M., Xie P., Koundrioukoff S., Moolman-Smook H., Pugh D.,\r\n",
      "RA   Debatisse M., He F., Zhang L., Defossez P.A.;\r\n",
      "RT   \"The RBBP6/ZBTB38/MCM10 axis regulates DNA replication and common fragile\r\n",
      "RT   site stability.\";\r\n",
      "RL   Cell Rep. 7:575-587(2014).\r\n",
      "RN   [27]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-984 AND SER-1277, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;\r\n",
      "RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,\r\n",
      "RA   Ye M., Zou H.;\r\n",
      "RT   \"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteomics 96:253-262(2014).\r\n",
      "RN   [28]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1106 AND LYS-1169, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;\r\n",
      "RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,\r\n",
      "RA   Vertegaal A.C.;\r\n",
      "RT   \"System-wide analysis of SUMOylation dynamics in response to replication\r\n",
      "RT   stress reveals novel small ubiquitin-like modified target proteins and\r\n",
      "RT   acceptor lysines relevant for genome stability.\";\r\n",
      "RL   Mol. Cell. Proteomics 14:1419-1434(2015).\r\n",
      "RN   [29]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1169, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=28112733; DOI=10.1038/nsmb.3366;\r\n",
      "RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,\r\n",
      "RA   Nielsen M.L.;\r\n",
      "RT   \"Site-specific mapping of the human SUMO proteome reveals co-modification\r\n",
      "RT   with phosphorylation.\";\r\n",
      "RL   Nat. Struct. Mol. Biol. 24:325-336(2017).\r\n",
      "RN   [30]\r\n",
      "RP   STRUCTURE BY NMR OF 1-81.\r\n",
      "RX   PubMed=16396680; DOI=10.1186/1472-6807-6-1;\r\n",
      "RA   Pugh D.J.R., Ab E., Faro A., Lutya P.T., Hoffmann E., Rees D.J.G.;\r\n",
      "RT   \"DWNN, a novel ubiquitin-like domain, implicates RBBP6 in mRNA processing\r\n",
      "RT   and ubiquitin-like pathways.\";\r\n",
      "RL   BMC Struct. Biol. 6:1-1(2006).\r\n",
      "RN   [31]\r\n",
      "RP   STRUCTURE BY NMR OF 159-309.\r\n",
      "RG   RIKEN structural genomics initiative (RSGI);\r\n",
      "RT   \"Solution structure of the zinc finger CCHC domain and of the RING finger\r\n",
      "RT   from the human retinoblastoma-binding protein 6 (retinoblastoma-binding Q\r\n",
      "RT   protein 1, RBQ-1).\";\r\n",
      "RL   Submitted (APR-2008) to the PDB data bank.\r\n",
      "RN   [32] {ECO:0007744|PDB:3ZTG}\r\n",
      "RP   STRUCTURE BY NMR OF 249-335, AND DOMAIN.\r\n",
      "RX   PubMed=22130672; DOI=10.1074/jbc.m110.217059;\r\n",
      "RA   Kappo M.A., Ab E., Hassem F., Atkinson R.A., Faro A., Muleya V.,\r\n",
      "RA   Mulaudzi T., Poole J.O., McKenzie J.M., Chibi M., Moolman-Smook J.C.,\r\n",
      "RA   Rees D.J., Pugh D.J.;\r\n",
      "RT   \"Solution structure of RING finger-like domain of retinoblastoma-binding\r\n",
      "RT   protein-6 (RBBP6) suggests it functions as a U-box.\";\r\n",
      "RL   J. Biol. Chem. 287:7146-7158(2012).\r\n",
      "RN   [33] {ECO:0007744|PDB:6E5X}\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 554-568, INTERACTION WITH\r\n",
      "RP   EBOLAVIRUS VP30 (MICROBIAL INFECTION), AND FUNCTION (MICROBIAL INFECTION).\r\n",
      "RX   PubMed=30550789; DOI=10.1016/j.cell.2018.08.044;\r\n",
      "RA   Batra J., Hultquist J.F., Liu D., Shtanko O., Von Dollen J., Satkamp L.,\r\n",
      "RA   Jang G.M., Luthra P., Schwarz T.M., Small G.I., Arnett E., Anantpadma M.,\r\n",
      "RA   Reyes A., Leung D.W., Kaake R., Haas P., Schmidt C.B., Schlesinger L.S.,\r\n",
      "RA   LaCount D.J., Davey R.A., Amarasinghe G.K., Basler C.F., Krogan N.J.;\r\n",
      "RT   \"Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of\r\n",
      "RT   Ebola Virus Replication.\";\r\n",
      "RL   Cell 175:1917-1930.e13(2018).\r\n",
      "CC   -!- FUNCTION: E3 ubiquitin-protein ligase which promotes ubiquitination of\r\n",
      "CC       YBX1, leading to its degradation by the proteasome (PubMed:18851979).\r\n",
      "CC       May play a role as a scaffold protein to promote the assembly of the\r\n",
      "CC       p53/TP53-MDM2 complex, resulting in increase of MDM2-mediated\r\n",
      "CC       ubiquitination and degradation of p53/TP53; may function as negative\r\n",
      "CC       regulator of p53/TP53, leading to both apoptosis and cell growth (By\r\n",
      "CC       similarity). Regulates DNA-replication and the stability of chromosomal\r\n",
      "CC       common fragile sites (CFSs) in a ZBTB38- and MCM10-dependent manner.\r\n",
      "CC       Controls ZBTB38 protein stability and abundance via ubiquitination and\r\n",
      "CC       proteasomal degradation, and ZBTB38 in turn negatively regulates the\r\n",
      "CC       expression of MCM10 which plays an important role in DNA-replication\r\n",
      "CC       (PubMed:24726359). {ECO:0000250|UniProtKB:P97868,\r\n",
      "CC       ECO:0000269|PubMed:18851979, ECO:0000269|PubMed:24726359}.\r\n",
      "CC   -!- FUNCTION: (Microbial infection) [Isoform 1]: Restricts ebolavirus\r\n",
      "CC       replication probably by impairing the vp30-NP interaction, and thus\r\n",
      "CC       viral transcription. {ECO:0000269|PubMed:30550789}.\r\n",
      "CC   -!- CATALYTIC ACTIVITY:\r\n",
      "CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +\r\n",
      "CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-\r\n",
      "CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;\r\n",
      "CC         EC=2.3.2.27;\r\n",
      "CC   -!- PATHWAY: Protein modification; protein ubiquitination.\r\n",
      "CC   -!- SUBUNIT: Interacts with p53/TP53 and RB1 (By similarity). Interacts\r\n",
      "CC       also with MDM2 and YBX1 (PubMed:17470788). Interacts also with MDM2 and\r\n",
      "CC       YBX1 (PubMed:18851979). Interacts with NEK6 (PubMed:20873783).\r\n",
      "CC       Interacts with ZBTB38 (PubMed:24726359). {ECO:0000250|UniProtKB:P97868,\r\n",
      "CC       ECO:0000269|PubMed:17470788, ECO:0000269|PubMed:18851979,\r\n",
      "CC       ECO:0000269|PubMed:20873783, ECO:0000269|PubMed:24726359}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) [Isoform 1]: Interacts with ebolavirus\r\n",
      "CC       VP30. {ECO:0000269|PubMed:30550789}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q7Z6E9; Q16629: SRSF7; NbExp=3; IntAct=EBI-2117026, EBI-398885;\r\n",
      "CC       Q7Z6E9; P46937: YAP1; NbExp=2; IntAct=EBI-2117026, EBI-1044059;\r\n",
      "CC       Q7Z6E9-3; P49821: NDUFV1; NbExp=3; IntAct=EBI-11743772, EBI-748312;\r\n",
      "CC       Q7Z6E9-3; O76024: WFS1; NbExp=3; IntAct=EBI-11743772, EBI-720609;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus. Chromosome. Cytoplasm,\r\n",
      "CC       cytoskeleton, microtubule organizing center, centrosome.\r\n",
      "CC       Note=Colocalizes with mitotic chromosomes. Colocalizes with NEK6 in the\r\n",
      "CC       centrosome.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=4;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=Q7Z6E9-1; Sequence=Displayed;\r\n",
      "CC       Name=2;\r\n",
      "CC         IsoId=Q7Z6E9-2; Sequence=VSP_018284;\r\n",
      "CC       Name=3;\r\n",
      "CC         IsoId=Q7Z6E9-3; Sequence=VSP_018281, VSP_018282;\r\n",
      "CC       Name=4;\r\n",
      "CC         IsoId=Q7Z6E9-4; Sequence=VSP_018283;\r\n",
      "CC   -!- TISSUE SPECIFICITY: Highly expressed in the placenta and testis.\r\n",
      "CC       Expressed at lower levels in the brain, heart, kidney, liver and lung.\r\n",
      "CC       Overexpressed in esophageal cancer. {ECO:0000269|PubMed:15475430}.\r\n",
      "CC   -!- DOMAIN: Contains a N-terminus DWNN domain, a zinc-finger domain and a\r\n",
      "CC       C4C4 zinc-binding RING finger domain (PubMed:22130672). The ring finger\r\n",
      "CC       may indeed be a U-box domain (PubMed:22130672).\r\n",
      "CC       {ECO:0000269|PubMed:22130672}.\r\n",
      "CC   -!- PTM: Phosphorylated by NEK6. {ECO:0000269|PubMed:20873783}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=AAG43155.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=AAH63524.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=AAL05625.1; Type=Frameshift; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=AAL68925.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=CAA59445.1; Type=Frameshift; Evidence={ECO:0000305};\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AB112074; BAC77636.1; -; mRNA.\r\n",
      "DR   EMBL; AB112075; BAC77637.1; -; mRNA.\r\n",
      "DR   EMBL; CH471145; EAW55789.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; BC029352; AAH29352.1; -; mRNA.\r\n",
      "DR   EMBL; BC063524; AAH63524.1; ALT_SEQ; mRNA.\r\n",
      "DR   EMBL; BC073938; AAH73938.1; -; mRNA.\r\n",
      "DR   EMBL; BC101139; AAI01140.1; -; mRNA.\r\n",
      "DR   EMBL; BC101140; AAI01141.1; -; mRNA.\r\n",
      "DR   EMBL; BC101141; AAI01142.1; -; mRNA.\r\n",
      "DR   EMBL; BC101142; AAI01143.1; -; mRNA.\r\n",
      "DR   EMBL; BC114353; AAI14354.1; -; mRNA.\r\n",
      "DR   EMBL; BC114354; AAI14355.1; -; mRNA.\r\n",
      "DR   EMBL; BC118667; AAI18668.1; -; mRNA.\r\n",
      "DR   EMBL; BC139830; AAI39831.1; -; mRNA.\r\n",
      "DR   EMBL; AF063596; AAG43155.1; ALT_SEQ; mRNA.\r\n",
      "DR   EMBL; AY072922; AAL68925.1; ALT_SEQ; mRNA.\r\n",
      "DR   EMBL; AF352051; AAL05625.1; ALT_FRAME; mRNA.\r\n",
      "DR   EMBL; X85133; CAA59445.1; ALT_FRAME; mRNA.\r\n",
      "DR   EMBL; AK026954; BAB15600.1; -; mRNA.\r\n",
      "DR   EMBL; AL359564; CAB94869.1; -; mRNA.\r\n",
      "DR   CCDS; CCDS10621.1; -. [Q7Z6E9-1]\r\n",
      "DR   CCDS; CCDS10622.1; -. [Q7Z6E9-2]\r\n",
      "DR   CCDS; CCDS45444.1; -. [Q7Z6E9-3]\r\n",
      "DR   PIR; A57640; A57640.\r\n",
      "DR   PIR; T50609; T50609.\r\n",
      "DR   RefSeq; NP_008841.2; NM_006910.4. [Q7Z6E9-1]\r\n",
      "DR   RefSeq; NP_061173.1; NM_018703.3. [Q7Z6E9-2]\r\n",
      "DR   RefSeq; NP_116015.2; NM_032626.5. [Q7Z6E9-3]\r\n",
      "DR   PDB; 2C7H; NMR; -; A=1-81.\r\n",
      "DR   PDB; 2YSA; NMR; -; A=159-206.\r\n",
      "DR   PDB; 2YUR; NMR; -; A=249-309.\r\n",
      "DR   PDB; 3ZTG; NMR; -; A/B=249-335.\r\n",
      "DR   PDB; 6E5X; X-ray; 1.50 A; B=554-568.\r\n",
      "DR   PDBsum; 2C7H; -.\r\n",
      "DR   PDBsum; 2YSA; -.\r\n",
      "DR   PDBsum; 2YUR; -.\r\n",
      "DR   PDBsum; 3ZTG; -.\r\n",
      "DR   PDBsum; 6E5X; -.\r\n",
      "DR   AlphaFoldDB; Q7Z6E9; -.\r\n",
      "DR   BMRB; Q7Z6E9; -.\r\n",
      "DR   SMR; Q7Z6E9; -.\r\n",
      "DR   BioGRID; 111865; 227.\r\n",
      "DR   DIP; DIP-46897N; -.\r\n",
      "DR   IntAct; Q7Z6E9; 53.\r\n",
      "DR   MINT; Q7Z6E9; -.\r\n",
      "DR   STRING; 9606.ENSP00000317872; -.\r\n",
      "DR   GlyCosmos; Q7Z6E9; 3 sites, 1 glycan.\r\n",
      "DR   GlyGen; Q7Z6E9; 4 sites, 1 O-linked glycan (4 sites).\r\n",
      "DR   iPTMnet; Q7Z6E9; -.\r\n",
      "DR   MetOSite; Q7Z6E9; -.\r\n",
      "DR   PhosphoSitePlus; Q7Z6E9; -.\r\n",
      "DR   BioMuta; RBBP6; -.\r\n",
      "DR   DMDM; 74762440; -.\r\n",
      "DR   EPD; Q7Z6E9; -.\r\n",
      "DR   jPOST; Q7Z6E9; -.\r\n",
      "DR   MassIVE; Q7Z6E9; -.\r\n",
      "DR   MaxQB; Q7Z6E9; -.\r\n",
      "DR   PaxDb; Q7Z6E9; -.\r\n",
      "DR   PeptideAtlas; Q7Z6E9; -.\r\n",
      "DR   ProteomicsDB; 69396; -. [Q7Z6E9-1]\r\n",
      "DR   ProteomicsDB; 69397; -. [Q7Z6E9-2]\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DR   ProteomicsDB; 69398; -. [Q7Z6E9-3]\r\n",
      "DR   ProteomicsDB; 69399; -. [Q7Z6E9-4]\r\n",
      "DR   Antibodypedia; 26070; 364 antibodies from 30 providers.\r\n",
      "DR   DNASU; 5930; -.\r\n",
      "DR   Ensembl; ENST00000319715.10; ENSP00000317872.4; ENSG00000122257.20. [Q7Z6E9-1]\r\n",
      "DR   Ensembl; ENST00000348022.6; ENSP00000316291.4; ENSG00000122257.20. [Q7Z6E9-2]\r\n",
      "DR   Ensembl; ENST00000381039.7; ENSP00000370427.3; ENSG00000122257.20. [Q7Z6E9-4]\r\n",
      "DR   Ensembl; ENST00000452655.6; ENSP00000390537.2; ENSG00000122257.20. [Q7Z6E9-3]\r\n",
      "DR   GeneID; 5930; -.\r\n",
      "DR   KEGG; hsa:5930; -.\r\n",
      "DR   MANE-Select; ENST00000319715.10; ENSP00000317872.4; NM_006910.5; NP_008841.2.\r\n",
      "DR   UCSC; uc002dmg.4; human. [Q7Z6E9-1]\r\n",
      "DR   AGR; HGNC:9889; -.\r\n",
      "DR   CTD; 5930; -.\r\n",
      "DR   DisGeNET; 5930; -.\r\n",
      "DR   GeneCards; RBBP6; -.\r\n",
      "DR   HGNC; HGNC:9889; RBBP6.\r\n",
      "DR   HPA; ENSG00000122257; Tissue enhanced (bone).\r\n",
      "DR   MIM; 600938; gene.\r\n",
      "DR   neXtProt; NX_Q7Z6E9; -.\r\n",
      "DR   OpenTargets; ENSG00000122257; -.\r\n",
      "DR   PharmGKB; PA34253; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000122257; -.\r\n",
      "DR   eggNOG; KOG0314; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00940000157561; -.\r\n",
      "DR   HOGENOM; CLU_239162_0_0_1; -.\r\n",
      "DR   InParanoid; Q7Z6E9; -.\r\n",
      "DR   OMA; ECIRTFL; -.\r\n",
      "DR   OrthoDB; 150979at2759; -.\r\n",
      "DR   PhylomeDB; Q7Z6E9; -.\r\n",
      "DR   TreeFam; TF350543; -.\r\n",
      "DR   PathwayCommons; Q7Z6E9; -.\r\n",
      "DR   Reactome; R-HSA-9013422; RHOBTB1 GTPase cycle.\r\n",
      "DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.\r\n",
      "DR   SignaLink; Q7Z6E9; -.\r\n",
      "DR   SIGNOR; Q7Z6E9; -.\r\n",
      "DR   UniPathway; UPA00143; -.\r\n",
      "DR   BioGRID-ORCS; 5930; 802 hits in 1209 CRISPR screens.\r\n",
      "DR   ChiTaRS; RBBP6; human.\r\n",
      "DR   EvolutionaryTrace; Q7Z6E9; -.\r\n",
      "DR   GeneWiki; RBBP6; -.\r\n",
      "DR   GenomeRNAi; 5930; -.\r\n",
      "DR   Pharos; Q7Z6E9; Tbio.\r\n",
      "DR   PRO; PR:Q7Z6E9; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 16.\r\n",
      "DR   RNAct; Q7Z6E9; protein.\r\n",
      "DR   Bgee; ENSG00000122257; Expressed in buccal mucosa cell and 201 other tissues.\r\n",
      "DR   ExpressionAtlas; Q7Z6E9; baseline and differential.\r\n",
      "DR   Genevisible; Q7Z6E9; HS.\r\n",
      "DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.\r\n",
      "DR   GO; GO:0005829; C:cytosol; TAS:Reactome.\r\n",
      "DR   GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell.\r\n",
      "DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.\r\n",
      "DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.\r\n",
      "DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.\r\n",
      "DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.\r\n",
      "DR   GO; GO:0006974; P:DNA damage response; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0048568; P:embryonic organ development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006397; P:mRNA processing; IEA:InterPro.\r\n",
      "DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.\r\n",
      "DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006275; P:regulation of DNA replication; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0061053; P:somite development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB.\r\n",
      "DR   CDD; cd16620; vRING-HC-C4C4_RBBP6; 1.\r\n",
      "DR   Gene3D; 4.10.60.10; Zinc finger, CCHC-type; 1.\r\n",
      "DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.\r\n",
      "DR   InterPro; IPR014891; DWNN_domain.\r\n",
      "DR   InterPro; IPR033489; RBBP6.\r\n",
      "DR   InterPro; IPR003613; Ubox_domain.\r\n",
      "DR   InterPro; IPR025829; Zn_knuckle_CX2CX3GHX4C.\r\n",
      "DR   InterPro; IPR001878; Znf_CCHC.\r\n",
      "DR   InterPro; IPR036875; Znf_CCHC_sf.\r\n",
      "DR   InterPro; IPR001841; Znf_RING.\r\n",
      "DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.\r\n",
      "DR   PANTHER; PTHR15439:SF0; E3 UBIQUITIN-PROTEIN LIGASE RBBP6; 1.\r\n",
      "DR   PANTHER; PTHR15439; RETINOBLASTOMA-BINDING PROTEIN 6; 1.\r\n",
      "DR   Pfam; PF08783; DWNN; 1.\r\n",
      "DR   Pfam; PF04564; U-box; 1.\r\n",
      "DR   Pfam; PF13696; zf-CCHC_2; 1.\r\n",
      "DR   SMART; SM01180; DWNN; 1.\r\n",
      "DR   SMART; SM00184; RING; 1.\r\n",
      "DR   SMART; SM00343; ZnF_C2HC; 1.\r\n",
      "DR   SUPFAM; SSF57756; Retrovirus zinc finger-like domains; 1.\r\n",
      "DR   SUPFAM; SSF57850; RING/U-box; 1.\r\n",
      "DR   PROSITE; PS51282; DWNN; 1.\r\n",
      "DR   PROSITE; PS50158; ZF_CCHC; 1.\r\n",
      "DR   PROSITE; PS50089; ZF_RING_2; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Acetylation; Alternative splicing; Chromosome; Cytoplasm;\r\n",
      "KW   Cytoskeleton; DNA damage; DNA replication; Host-virus interaction;\r\n",
      "KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Transferase; Ubl conjugation; Ubl conjugation pathway;\r\n",
      "KW   Zinc; Zinc-finger.\r\n",
      "FT   CHAIN           1..1792\r\n",
      "FT                   /note=\"E3 ubiquitin-protein ligase RBBP6\"\r\n",
      "FT                   /id=\"PRO_0000234354\"\r\n",
      "FT   DOMAIN          4..76\r\n",
      "FT                   /note=\"DWNN\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00612\"\r\n",
      "FT   ZN_FING         159..176\r\n",
      "FT                   /note=\"CCHC-type\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00047\"\r\n",
      "FT   ZN_FING         259..300\r\n",
      "FT                   /note=\"RING-type; degenerate\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00175\"\r\n",
      "FT   REGION          326..347\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          371..410\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          532..601\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          549..571\r\n",
      "FT                   /note=\"(Microbial infection) Interaction with Ebolavirus\r\n",
      "FT                   VP30\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30550789\"\r\n",
      "FT   REGION          621..640\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          645..799\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          847..1290\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          982..1139\r\n",
      "FT                   /note=\"Interaction with RB1\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          1321..1348\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1360..1665\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1433..1544\r\n",
      "FT                   /note=\"Interaction with p53\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          1682..1792\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOTIF           560..565\r\n",
      "FT                   /note=\"PPxPxY\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30550789\"\r\n",
      "FT   COMPBIAS        553..601\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        645..685\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        686..729\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        735..766\r\n",
      "FT                   /note=\"Basic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        772..786\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        904..929\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        982..1029\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1036..1070\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1083..1165\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1175..1217\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1218..1233\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1234..1255\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1256..1279\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1361..1434\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1448..1579\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1597..1625\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1647..1665\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1683..1722\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1729..1750\r\n",
      "FT                   /note=\"Basic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1774..1792\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         130\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P97868\"\r\n",
      "FT   MOD_RES         244\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         245\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         246\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         247\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         360\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         516\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:16964243,\r\n",
      "FT                   ECO:0007744|PubMed:18220336, ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         768\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         770\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         772\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         780\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21406692\"\r\n",
      "FT   MOD_RES         815\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         861\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         873\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         957\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         984\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163,\r\n",
      "FT                   ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         1179\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1221\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1271\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P97868\"\r\n",
      "FT   MOD_RES         1277\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         1328\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:18318008, ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1341\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1347\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1468\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648\"\r\n",
      "FT   MOD_RES         1646\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648\"\r\n",
      "FT   MOD_RES         1648\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332\"\r\n",
      "FT   MOD_RES         1651\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P97868\"\r\n",
      "FT   CROSSLNK        1106\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:25755297\"\r\n",
      "FT   CROSSLNK        1169\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:25755297,\r\n",
      "FT                   ECO:0007744|PubMed:28112733\"\r\n",
      "FT   VAR_SEQ         102..117\r\n",
      "FT                   /note=\"IDDSSASISLAQLTKT -> VCKNTISHFFYTLLLPL (in isoform\r\n",
      "FT                   3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_018281\"\r\n",
      "FT   VAR_SEQ         118..1792\r\n",
      "FT                   /note=\"Missing (in isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_018282\"\r\n",
      "FT   VAR_SEQ         431..1270\r\n",
      "FT                   /note=\"Missing (in isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_018283\"\r\n",
      "FT   VAR_SEQ         652..685\r\n",
      "FT                   /note=\"Missing (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|Ref.1, ECO:0000303|Ref.5\"\r\n",
      "FT                   /id=\"VSP_018284\"\r\n",
      "FT   VARIANT         43\r\n",
      "FT                   /note=\"D -> H (in dbSNP:rs16973796)\"\r\n",
      "FT                   /id=\"VAR_051306\"\r\n",
      "FT   VARIANT         555\r\n",
      "FT                   /note=\"V -> A (in dbSNP:rs16973840)\"\r\n",
      "FT                   /id=\"VAR_026216\"\r\n",
      "FT   VARIANT         1208\r\n",
      "FT                   /note=\"K -> I (in dbSNP:rs3743968)\"\r\n",
      "FT                   /id=\"VAR_051307\"\r\n",
      "FT   CONFLICT        223\r\n",
      "FT                   /note=\"I -> T (in Ref. 5; AAL68925)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1633\r\n",
      "FT                   /note=\"D -> H (in Ref. 5; AAL68925)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   STRAND          1..8\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2C7H\"\r\n",
      "FT   STRAND          12..25\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2C7H\"\r\n",
      "FT   HELIX           26..37\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2C7H\"\r\n",
      "FT   TURN            41..43\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2C7H\"\r\n",
      "FT   STRAND          44..53\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2C7H\"\r\n",
      "FT   STRAND          63..65\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2C7H\"\r\n",
      "FT   STRAND          70..76\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2C7H\"\r\n",
      "FT   TURN            162..164\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YSA\"\r\n",
      "FT   HELIX           171..173\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YSA\"\r\n",
      "FT   HELIX           176..178\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YSA\"\r\n",
      "FT   STRAND          197..199\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YSA\"\r\n",
      "FT   HELIX           255..257\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YUR\"\r\n",
      "FT   STRAND          260..262\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YUR\"\r\n",
      "FT   STRAND          273..275\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YUR\"\r\n",
      "FT   HELIX           283..290\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YUR\"\r\n",
      "FT   STRAND          291..294\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YUR\"\r\n",
      "FT   STRAND          297..299\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YUR\"\r\n",
      "FT   TURN            306..309\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YUR\"\r\n",
      "FT   HELIX           313..326\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:3ZTG\"\r\n",
      "SQ   SEQUENCE   1792 AA;  201564 MW;  550F7BBA5125DA06 CRC64;\r\n",
      "     MSCVHYKFSS KLNYDTVTFD GLHISLCDLK KQIMGREKLK AADCDLQITN AQTKEEYTDD\r\n",
      "     NALIPKNSSV IVRRIPIGGV KSTSKTYVIS RTEPAMATTK AIDDSSASIS LAQLTKTANL\r\n",
      "     AEANASEEDK IKAMMSQSGH EYDPINYMKK PLGPPPPSYT CFRCGKPGHY IKNCPTNGDK\r\n",
      "     NFESGPRIKK STGIPRSFMM EVKDPNMKGA MLTNTGKYAI PTIDAEAYAI GKKEKPPFLP\r\n",
      "     EEPSSSSEED DPIPDELLCL ICKDIMTDAV VIPCCGNSYC DECIRTALLE SDEHTCPTCH\r\n",
      "     QNDVSPDALI ANKFLRQAVN NFKNETGYTK RLRKQLPPPP PPIPPPRPLI QRNLQPLMRS\r\n",
      "     PISRQQDPLM IPVTSSSTHP APSISSLTSN QSSLAPPVSG NPSSAPAPVP DITATVSISV\r\n",
      "     HSEKSDGPFR DSDNKILPAA ALASEHSKGT SSIAITALME EKGYQVPVLG TPSLLGQSLL\r\n",
      "     HGQLIPTTGP VRINTARPGG GRPGWEHSNK LGYLVSPPQQ IRRGERSCYR SINRGRHHSE\r\n",
      "     RSQRTQGPSL PATPVFVPVP PPPLYPPPPH TLPLPPGVPP PQFSPQFPPG QPPPAGYSVP\r\n",
      "     PPGFPPAPAN LSTPWVSSGV QTAHSNTIPT TQAPPLSREE FYREQRRLKE EEKKKSKLDE\r\n",
      "     FTNDFAKELM EYKKIQKERR RSFSRSKSPY SGSSYSRSSY TYSKSRSGST RSRSYSRSFS\r\n",
      "     RSHSRSYSRS PPYPRRGRGK SRNYRSRSRS HGYHRSRSRS PPYRRYHSRS RSPQAFRGQS\r\n",
      "     PNKRNVPQGE TEREYFNRYR EVPPPYDMKA YYGRSVDFRD PFEKERYREW ERKYREWYEK\r\n",
      "     YYKGYAAGAQ PRPSANRENF SPERFLPLNI RNSPFTRGRR EDYVGGQSHR SRNIGSNYPE\r\n",
      "     KLSARDGHNQ KDNTKSKEKE SENAPGDGKG NKHKKHRKRR KGEESEGFLN PELLETSRKS\r\n",
      "     REPTGVEENK TDSLFVLPSR DDATPVRDEP MDAESITFKS VSEKDKRERD KPKAKGDKTK\r\n",
      "     RKNDGSAVSK KENIVKPAKG PQEKVDGERE RSPRSEPPIK KAKEETPKTD NTKSSSSSQK\r\n",
      "     DEKITGTPRK AHSKSAKEHQ ETKPVKEEKV KKDYSKDVKS EKLTTKEEKA KKPNEKNKPL\r\n",
      "     DNKGEKRKRK TEEKGVDKDF ESSSMKISKL EVTEIVKPSP KRKMEPDTEK MDRTPEKDKI\r\n",
      "     SLSAPAKKIK LNRETGKKIG STENISNTKE PSEKLESTSS KVKQEKVKGK VRRKVTGTEG\r\n",
      "     SSSTLVDYTS TSSTGGSPVR KSEEKTDTKR TVIKTMEEYN NDNTAPAEDV IIMIQVPQSK\r\n",
      "     WDKDDFESEE EDVKSTQPIS SVGKPASVIK NVSTKPSNIV KYPEKESEPS EKIQKFTKDV\r\n",
      "     SHEIIQHEVK SSKNSASSEK GKTKDRDYSV LEKENPEKRK NSTQPEKESN LDRLNEQGNF\r\n",
      "     KSLSQSSKEA RTSDKHDSTR ASSNKDFTPN RDKKTDYDTR EYSSSKRRDE KNELTRRKDS\r\n",
      "     PSRNKDSASG QKNKPREERD LPKKGTGDSK KSNSSPSRDR KPHDHKATYD TKRPNEETKS\r\n",
      "     VDKNPCKDRE KHVLEARNNK ESSGNKLLYI LNPPETQVEK EQITGQIDKS TVKPKPQLSH\r\n",
      "     SSRLSSDLTR ETDEAAFEPD YNESDSESNV SVKEEESSGN ISKDLKDKIV EKAKESLDTA\r\n",
      "     AVVQVGISRN QSHSSPSVSP SRSHSPSGSQ TRSHSSSASS AESQDSKKKK KKKEKKKHKK\r\n",
      "     HKKHKKHKKH AGTEVELEKS QKHKHKKKKS KKNKDKEKEK EKDDQKVKSV TV\r\n",
      "//\r\n",
      "ID   BRE1B_HUMAN             Reviewed;        1001 AA.\r\n",
      "AC   O75150; A0A024QZG0; Q6AHZ6; Q6N005; Q7L3T6; Q8N615; Q96T18; Q9BSV9; Q9HC82;\r\n",
      "DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   12-SEP-2018, sequence version 5.\r\n",
      "DT   03-MAY-2023, entry version 189.\r\n",
      "DE   RecName: Full=E3 ubiquitin-protein ligase BRE1B;\r\n",
      "DE            Short=BRE1-B;\r\n",
      "DE            EC=2.3.2.27 {ECO:0000269|PubMed:16307923, ECO:0000269|PubMed:19410543};\r\n",
      "DE   AltName: Full=95 kDa retinoblastoma-associated protein;\r\n",
      "DE            Short=RBP95;\r\n",
      "DE   AltName: Full=RING finger protein 40;\r\n",
      "DE   AltName: Full=RING-type E3 ubiquitin transferase BRE1B {ECO:0000305};\r\n",
      "GN   Name=RNF40; Synonyms=BRE1B, KIAA0661;\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), SUBCELLULAR LOCATION, TISSUE\r\n",
      "RP   SPECIFICITY, SUBUNIT, INTERACTION WITH RB1, AND MUTAGENESIS OF LEU-109;\r\n",
      "RP   CYS-111 AND GLU-113.\r\n",
      "RC   TISSUE=Fetal brain;\r\n",
      "RX   PubMed=10944455; DOI=10.1006/bbrc.2000.3242;\r\n",
      "RA   Wen H., Ao S.;\r\n",
      "RT   \"RBP95, a novel leucine zipper protein, binds to the retinoblastoma\r\n",
      "RT   protein.\";\r\n",
      "RL   Biochem. Biophys. Res. Commun. 275:141-148(2000).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).\r\n",
      "RC   TISSUE=Brain;\r\n",
      "RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;\r\n",
      "RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,\r\n",
      "RA   Nomura N., Ohara O.;\r\n",
      "RT   \"Prediction of the coding sequences of unidentified human genes. X. The\r\n",
      "RT   complete sequences of 100 new cDNA clones from brain which can code for\r\n",
      "RT   large proteins in vitro.\";\r\n",
      "RL   DNA Res. 5:169-176(1998).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).\r\n",
      "RC   TISSUE=Teratocarcinoma;\r\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\r\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\r\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\r\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\r\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\r\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\r\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\r\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\r\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\r\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\r\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\r\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\r\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\r\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\r\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\r\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\r\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\r\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\r\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\r\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\r\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\r\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\r\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\r\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\r\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\r\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\r\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\r\n",
      "RA   Isogai T., Sugano S.;\r\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\r\n",
      "RT   cDNAs.\";\r\n",
      "RL   Nat. Genet. 36:40-45(2004).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).\r\n",
      "RC   TISSUE=Cervix, and Rectum tumor;\r\n",
      "RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;\r\n",
      "RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,\r\n",
      "RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,\r\n",
      "RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,\r\n",
      "RA   Wiemann S., Schupp I.;\r\n",
      "RT   \"The full-ORF clone resource of the German cDNA consortium.\";\r\n",
      "RL   BMC Genomics 8:399-399(2007).\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RX   PubMed=15616553; DOI=10.1038/nature03187;\r\n",
      "RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,\r\n",
      "RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,\r\n",
      "RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,\r\n",
      "RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,\r\n",
      "RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,\r\n",
      "RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,\r\n",
      "RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,\r\n",
      "RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,\r\n",
      "RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,\r\n",
      "RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,\r\n",
      "RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,\r\n",
      "RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,\r\n",
      "RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,\r\n",
      "RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,\r\n",
      "RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,\r\n",
      "RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,\r\n",
      "RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,\r\n",
      "RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,\r\n",
      "RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,\r\n",
      "RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,\r\n",
      "RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,\r\n",
      "RA   Myers R.M., Rubin E.M., Pennacchio L.A.;\r\n",
      "RT   \"The sequence and analysis of duplication-rich human chromosome 16.\";\r\n",
      "RL   Nature 432:988-994(2004).\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,\r\n",
      "RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,\r\n",
      "RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,\r\n",
      "RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,\r\n",
      "RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,\r\n",
      "RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,\r\n",
      "RA   Hunkapiller M.W., Myers E.W., Venter J.C.;\r\n",
      "RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [7]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).\r\n",
      "RC   TISSUE=Brain, Mammary gland, Skin, and Uterus;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [8]\r\n",
      "RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, AND IDENTIFICATION IN A COMPLEX WITH\r\n",
      "RP   RNF20 AND UBE2E1.\r\n",
      "RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;\r\n",
      "RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P.,\r\n",
      "RA   Reinberg D.;\r\n",
      "RT   \"Monoubiquitination of human histone H2B: the factors involved and their\r\n",
      "RT   roles in HOX gene regulation.\";\r\n",
      "RL   Mol. Cell 20:601-611(2005).\r\n",
      "RN   [9]\r\n",
      "RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBUNIT.\r\n",
      "RX   PubMed=19410543; DOI=10.1016/j.cell.2009.02.027;\r\n",
      "RA   Kim J., Guermah M., McGinty R.K., Lee J.S., Tang Z., Milne T.A.,\r\n",
      "RA   Shilatifard A., Muir T.W., Roeder R.G.;\r\n",
      "RT   \"RAD6-mediated transcription-coupled H2B ubiquitylation directly stimulates\r\n",
      "RT   H3K4 methylation in human cells.\";\r\n",
      "RL   Cell 137:459-471(2009).\r\n",
      "RN   [10]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;\r\n",
      "RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,\r\n",
      "RA   Bennett K.L., Superti-Furga G., Colinge J.;\r\n",
      "RT   \"Initial characterization of the human central proteome.\";\r\n",
      "RL   BMC Syst. Biol. 5:17-17(2011).\r\n",
      "RN   [11]\r\n",
      "RP   INTERACTION WITH WAC.\r\n",
      "RX   PubMed=21329877; DOI=10.1016/j.molcel.2011.01.024;\r\n",
      "RA   Zhang F., Yu X.;\r\n",
      "RT   \"WAC, a functional partner of RNF20/40, regulates histone H2B\r\n",
      "RT   ubiquitination and gene transcription.\";\r\n",
      "RL   Mol. Cell 41:384-397(2011).\r\n",
      "RN   [12]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [13]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;\r\n",
      "RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,\r\n",
      "RA   Ye M., Zou H.;\r\n",
      "RT   \"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteomics 96:253-262(2014).\r\n",
      "RN   [14]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-578 AND LYS-579, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=28112733; DOI=10.1038/nsmb.3366;\r\n",
      "RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,\r\n",
      "RA   Nielsen M.L.;\r\n",
      "RT   \"Site-specific mapping of the human SUMO proteome reveals co-modification\r\n",
      "RT   with phosphorylation.\";\r\n",
      "RL   Nat. Struct. Mol. Biol. 24:325-336(2017).\r\n",
      "CC   -!- FUNCTION: Component of the RNF20/40 E3 ubiquitin-protein ligase complex\r\n",
      "CC       that mediates monoubiquitination of 'Lys-120' of histone H2B\r\n",
      "CC       (H2BK120ub1). H2BK120ub1 gives a specific tag for epigenetic\r\n",
      "CC       transcriptional activation and is also prerequisite for histone H3\r\n",
      "CC       'Lys-4' and 'Lys-79' methylation (H3K4me and H3K79me, respectively). It\r\n",
      "CC       thereby plays a central role in histone code and gene regulation. The\r\n",
      "CC       RNF20/40 complex forms a H2B ubiquitin ligase complex in cooperation\r\n",
      "CC       with the E2 enzyme UBE2A or UBE2B; reports about the cooperation with\r\n",
      "CC       UBE2E1/UBCH are contradictory. Required for transcriptional activation\r\n",
      "CC       of Hox genes. {ECO:0000269|PubMed:16307923,\r\n",
      "CC       ECO:0000269|PubMed:19410543}.\r\n",
      "CC   -!- CATALYTIC ACTIVITY:\r\n",
      "CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +\r\n",
      "CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-\r\n",
      "CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;\r\n",
      "CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:16307923,\r\n",
      "CC         ECO:0000269|PubMed:19410543};\r\n",
      "CC   -!- PATHWAY: Protein modification; protein ubiquitination.\r\n",
      "CC   -!- SUBUNIT: Component of the RNF20/40 complex (also known as BRE1 complex)\r\n",
      "CC       probably composed of 2 copies of RNF20/BRE1A and 2 copies of\r\n",
      "CC       RNF40/BRE1B. Interacts with UBE2E1/UBCH6. Interacts with RB1 and WAC.\r\n",
      "CC       {ECO:0000269|PubMed:10944455, ECO:0000269|PubMed:16307923,\r\n",
      "CC       ECO:0000269|PubMed:19410543, ECO:0000269|PubMed:21329877}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       O75150; Q9Y2J4: AMOTL2; NbExp=3; IntAct=EBI-744408, EBI-746752;\r\n",
      "CC       O75150; Q9Y2J4-4: AMOTL2; NbExp=3; IntAct=EBI-744408, EBI-10187270;\r\n",
      "CC       O75150; Q8IYE0-2: CCDC146; NbExp=3; IntAct=EBI-744408, EBI-10247802;\r\n",
      "CC       O75150; Q9NRI5-2: DISC1; NbExp=3; IntAct=EBI-744408, EBI-11988027;\r\n",
      "CC       O75150; Q68J44: DUSP29; NbExp=3; IntAct=EBI-744408, EBI-1054321;\r\n",
      "CC       O75150; P42858: HTT; NbExp=12; IntAct=EBI-744408, EBI-466029;\r\n",
      "CC       O75150; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-744408, EBI-16439278;\r\n",
      "CC       O75150; Q09161: NCBP1; NbExp=4; IntAct=EBI-744408, EBI-464743;\r\n",
      "CC       O75150; P06400: RB1; NbExp=3; IntAct=EBI-744408, EBI-491274;\r\n",
      "CC       O75150; Q5VTR2: RNF20; NbExp=10; IntAct=EBI-744408, EBI-2372238;\r\n",
      "CC       O75150; Q86XK3: SFR1; NbExp=3; IntAct=EBI-744408, EBI-1104535;\r\n",
      "CC       O75150; Q7KZS0: UBE2I; NbExp=6; IntAct=EBI-744408, EBI-10180829;\r\n",
      "CC       O75150; Q6PEW1: ZCCHC12; NbExp=3; IntAct=EBI-744408, EBI-748373;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10944455}.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=3;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=O75150-1; Sequence=Displayed;\r\n",
      "CC       Name=3;\r\n",
      "CC         IsoId=O75150-3; Sequence=VSP_016682, VSP_016683;\r\n",
      "CC       Name=4;\r\n",
      "CC         IsoId=O75150-4; Sequence=VSP_016681;\r\n",
      "CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expressed at higher level\r\n",
      "CC       in testis, heart and pancreas, while it is only weakly expressed in\r\n",
      "CC       lung, skeletal muscle and small intestine.\r\n",
      "CC       {ECO:0000269|PubMed:10944455}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the BRE1 family. {ECO:0000305}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=BAA31636.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=CAE45869.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AF122819; AAG13723.1; -; mRNA.\r\n",
      "DR   EMBL; AB014561; BAA31636.2; ALT_INIT; mRNA.\r\n",
      "DR   EMBL; AK027406; BAB55092.1; -; mRNA.\r\n",
      "DR   EMBL; BX640763; CAE45869.1; ALT_SEQ; mRNA.\r\n",
      "DR   EMBL; CR627431; CAH10518.1; -; mRNA.\r\n",
      "DR   EMBL; AC106886; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; CH471192; EAW52197.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; CH471192; EAW52200.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; BC004527; AAH04527.2; -; mRNA.\r\n",
      "DR   EMBL; BC006133; AAH06133.1; -; mRNA.\r\n",
      "DR   EMBL; BC011769; AAH11769.1; -; mRNA.\r\n",
      "DR   EMBL; BC018647; AAH18647.1; -; mRNA.\r\n",
      "DR   EMBL; BC030802; AAH30802.2; -; mRNA.\r\n",
      "DR   CCDS; CCDS10691.1; -. [O75150-1]\r\n",
      "DR   CCDS; CCDS55994.1; -. [O75150-4]\r\n",
      "DR   PIR; JC7363; JC7363.\r\n",
      "DR   RefSeq; NP_001193962.1; NM_001207033.1.\r\n",
      "DR   RefSeq; NP_001193963.1; NM_001207034.1. [O75150-4]\r\n",
      "DR   RefSeq; NP_001273501.1; NM_001286572.2. [O75150-1]\r\n",
      "DR   RefSeq; NP_055586.1; NM_014771.3. [O75150-1]\r\n",
      "DR   AlphaFoldDB; O75150; -.\r\n",
      "DR   SMR; O75150; -.\r\n",
      "DR   BioGRID; 115149; 252.\r\n",
      "DR   CORUM; O75150; -.\r\n",
      "DR   IntAct; O75150; 64.\r\n",
      "DR   MINT; O75150; -.\r\n",
      "DR   STRING; 9606.ENSP00000325677; -.\r\n",
      "DR   GlyCosmos; O75150; 1 site, 1 glycan.\r\n",
      "DR   GlyGen; O75150; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; O75150; -.\r\n",
      "DR   MetOSite; O75150; -.\r\n",
      "DR   PhosphoSitePlus; O75150; -.\r\n",
      "DR   BioMuta; RNF40; -.\r\n",
      "DR   EPD; O75150; -.\r\n",
      "DR   jPOST; O75150; -.\r\n",
      "DR   MassIVE; O75150; -.\r\n",
      "DR   PaxDb; O75150; -.\r\n",
      "DR   PeptideAtlas; O75150; -.\r\n",
      "DR   ProteomicsDB; 49814; -. [O75150-1]\r\n",
      "DR   ProteomicsDB; 49815; -. [O75150-3]\r\n",
      "DR   ProteomicsDB; 49816; -. [O75150-4]\r\n",
      "DR   Antibodypedia; 13809; 277 antibodies from 32 providers.\r\n",
      "DR   DNASU; 9810; -.\r\n",
      "DR   Ensembl; ENST00000324685.11; ENSP00000325677.6; ENSG00000103549.22. [O75150-1]\r\n",
      "DR   Ensembl; ENST00000357890.9; ENSP00000350563.5; ENSG00000103549.22. [O75150-4]\r\n",
      "DR   GeneID; 9810; -.\r\n",
      "DR   KEGG; hsa:9810; -.\r\n",
      "DR   MANE-Select; ENST00000324685.11; ENSP00000325677.6; NM_014771.4; NP_055586.1.\r\n",
      "DR   UCSC; uc002dzq.4; human. [O75150-1]\r\n",
      "DR   AGR; HGNC:16867; -.\r\n",
      "DR   CTD; 9810; -.\r\n",
      "DR   DisGeNET; 9810; -.\r\n",
      "DR   GeneCards; RNF40; -.\r\n",
      "DR   HGNC; HGNC:16867; RNF40.\r\n",
      "DR   HPA; ENSG00000103549; Low tissue specificity.\r\n",
      "DR   MIM; 607700; gene.\r\n",
      "DR   neXtProt; NX_O75150; -.\r\n",
      "DR   OpenTargets; ENSG00000103549; -.\r\n",
      "DR   PharmGKB; PA34440; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000103549; -.\r\n",
      "DR   eggNOG; KOG0978; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00390000002866; -.\r\n",
      "DR   InParanoid; O75150; -.\r\n",
      "DR   OMA; THIEIMT; -.\r\n",
      "DR   OrthoDB; 53681at2759; -.\r\n",
      "DR   PhylomeDB; O75150; -.\r\n",
      "DR   TreeFam; TF323183; -.\r\n",
      "DR   PathwayCommons; O75150; -.\r\n",
      "DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.\r\n",
      "DR   SignaLink; O75150; -.\r\n",
      "DR   SIGNOR; O75150; -.\r\n",
      "DR   UniPathway; UPA00143; -.\r\n",
      "DR   BioGRID-ORCS; 9810; 396 hits in 1203 CRISPR screens.\r\n",
      "DR   ChiTaRS; RNF40; human.\r\n",
      "DR   GeneWiki; RNF40; -.\r\n",
      "DR   GenomeRNAi; 9810; -.\r\n",
      "DR   Pharos; O75150; Tbio.\r\n",
      "DR   PRO; PR:O75150; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 16.\r\n",
      "DR   RNAct; O75150; protein.\r\n",
      "DR   Bgee; ENSG00000103549; Expressed in ventricular zone and 149 other tissues.\r\n",
      "DR   ExpressionAtlas; O75150; baseline and differential.\r\n",
      "DR   Genevisible; O75150; HS.\r\n",
      "DR   GO; GO:0033503; C:HULC complex; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.\r\n",
      "DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0000151; C:ubiquitin ligase complex; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0017075; F:syntaxin-1 binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.\r\n",
      "DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0071894; P:histone H2B conserved C-terminal lysine ubiquitination; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010390; P:histone monoubiquitination; IBA:GO_Central.\r\n",
      "DR   GO; GO:1901800; P:positive regulation of proteasomal protein catabolic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:1902916; P:positive regulation of protein polyubiquitination; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB.\r\n",
      "DR   CDD; cd16815; RING-HC_RNF40; 1.\r\n",
      "DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.\r\n",
      "DR   InterPro; IPR013956; E3_ubiquit_lig_Bre1.\r\n",
      "DR   InterPro; IPR018957; Znf_C3HC4_RING-type.\r\n",
      "DR   InterPro; IPR001841; Znf_RING.\r\n",
      "DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.\r\n",
      "DR   InterPro; IPR017907; Znf_RING_CS.\r\n",
      "DR   PANTHER; PTHR23163:SF4; E3 UBIQUITIN-PROTEIN LIGASE BRE1B; 1.\r\n",
      "DR   PANTHER; PTHR23163; RING FINGER PROTEIN-RELATED; 1.\r\n",
      "DR   Pfam; PF00097; zf-C3HC4; 1.\r\n",
      "DR   SMART; SM00184; RING; 1.\r\n",
      "DR   SUPFAM; SSF57850; RING/U-box; 1.\r\n",
      "DR   PROSITE; PS00518; ZF_RING_1; 1.\r\n",
      "DR   PROSITE; PS50089; ZF_RING_2; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Acetylation; Alternative splicing; Chromatin regulator; Coiled coil;\r\n",
      "KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Transferase; Ubl conjugation; Ubl conjugation pathway;\r\n",
      "KW   Zinc; Zinc-finger.\r\n",
      "FT   CHAIN           1..1001\r\n",
      "FT                   /note=\"E3 ubiquitin-protein ligase BRE1B\"\r\n",
      "FT                   /id=\"PRO_0000055839\"\r\n",
      "FT   ZN_FING         948..987\r\n",
      "FT                   /note=\"RING-type\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00175\"\r\n",
      "FT   REGION          1..32\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          116..146\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          518..652\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COILED          44..91\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COILED          189..377\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COILED          437..525\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COILED          627..946\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COMPBIAS        604..619\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        633..652\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         20\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q3U319\"\r\n",
      "FT   MOD_RES         42\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q5VTR2\"\r\n",
      "FT   MOD_RES         355\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q5VTR2\"\r\n",
      "FT   MOD_RES         517\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q3U319\"\r\n",
      "FT   MOD_RES         528\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q5VTR2\"\r\n",
      "FT   MOD_RES         585\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q3U319\"\r\n",
      "FT   CROSSLNK        578\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        579\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   VAR_SEQ         332..431\r\n",
      "FT                   /note=\"Missing (in isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:14702039\"\r\n",
      "FT                   /id=\"VSP_016681\"\r\n",
      "FT   VAR_SEQ         822..838\r\n",
      "FT                   /note=\"DAQLLTVQKLEEKERAL -> WPPPACRLELERWGSWP (in isoform\r\n",
      "FT                   3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:10944455\"\r\n",
      "FT                   /id=\"VSP_016682\"\r\n",
      "FT   VAR_SEQ         839..1001\r\n",
      "FT                   /note=\"Missing (in isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:10944455\"\r\n",
      "FT                   /id=\"VSP_016683\"\r\n",
      "FT   VARIANT         463\r\n",
      "FT                   /note=\"R -> H (in dbSNP:rs11556801)\"\r\n",
      "FT                   /id=\"VAR_055021\"\r\n",
      "FT   VARIANT         615\r\n",
      "FT                   /note=\"R -> Q (in dbSNP:rs7195142)\"\r\n",
      "FT                   /id=\"VAR_055022\"\r\n",
      "FT   MUTAGEN         109\r\n",
      "FT                   /note=\"L->S: Abolishes interaction with RB1.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10944455\"\r\n",
      "FT   MUTAGEN         111\r\n",
      "FT                   /note=\"C->M: Abolishes interaction with RB1.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10944455\"\r\n",
      "FT   MUTAGEN         113\r\n",
      "FT                   /note=\"E->Q: Abolishes interaction with RB1.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10944455\"\r\n",
      "FT   CONFLICT        56\r\n",
      "FT                   /note=\"N -> D (in Ref. 3; BAB55092)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        96\r\n",
      "FT                   /note=\"R -> L (in Ref. 1; AAG13723)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        108\r\n",
      "FT                   /note=\"L -> P (in Ref. 3; BAB55092)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        172\r\n",
      "FT                   /note=\"S -> G (in Ref. 3; BAB55092)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        387\r\n",
      "FT                   /note=\"E -> K (in Ref. 4; CAH10518)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        562\r\n",
      "FT                   /note=\"K -> E (in Ref. 4; CAE45869)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        600\r\n",
      "FT                   /note=\"S -> F (in Ref. 4; CAE45869)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        714\r\n",
      "FT                   /note=\"D -> N (in Ref. 3; BAB55092)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   1001 AA;  113678 MW;  408A6E5A9CC25E41 CRC64;\r\n",
      "     MSGPGNKRAA GDGGSGPPEK KLSREEKTTT TLIEPIRLGG ISSTEEMDLK VLQFKNKKLA\r\n",
      "     ERLEQRQACE DELRERIEKL EKRQATDDAT LLIVNRYWAQ LDETVEALLR CHESQGELSS\r\n",
      "     APEAPGTQEG PTCDGTPLPE PGTSELRDPL LMQLRPPLSE PALAFVVALG ASSSEEVELE\r\n",
      "     LQGRMEFSKA AVSRVVEASD RLQRRVEELC QRVYSRGDSE PLSEAAQAHT RELGRENRRL\r\n",
      "     QDLATQLQEK HHRISLEYSE LQDKVTSAET KVLEMETTVE DLQWDIEKLR KREQKLNKHL\r\n",
      "     AEALEQLNSG YYVSGSSSGF QGGQITLSMQ KFEMLNAELE ENQELANSRM AELEKLQAEL\r\n",
      "     QGAVRTNERL KVALRSLPEE VVRETGEYRM LQAQFSLLYN ESLQVKTQLD EARGLLLATK\r\n",
      "     NSHLRHIEHM ESDELGLQKK LRTEVIQLED TLAQVRKEYE MLRIEFEQNL AANEQAGPIN\r\n",
      "     REMRHLISSL QNHNHQLKGD AQRYKRKLRE VQAEIGKLRA QASGSAHSTP NLGHPEDSGV\r\n",
      "     SAPAPGKEEG GPGPVSTPDN RKEMAPVPGT TTTTTSVKKE ELVPSEEDFQ GITPGAQGPS\r\n",
      "     SRGREPEARP KRELREREGP SLGPPPVASA LSRADREKAK VEETKRKESE LLKGLRAELK\r\n",
      "     KAQESQKEMK LLLDMYKSAP KEQRDKVQLM AAERKAKAEV DELRSRIREL EERDRRESKK\r\n",
      "     IADEDALRRI RQAEEQIEHL QRKLGATKQE EEALLSEMDV TGQAFEDMQE QNGRLLQQLR\r\n",
      "     EKDDANFKLM SERIKANQIH KLLREEKDEL GEQVLGLKSQ VDAQLLTVQK LEEKERALQG\r\n",
      "     SLGGVEKELT LRSQALELNK RKAVEAAQLA EDLKVQLEHV QTRLREIQPC LAESRAAREK\r\n",
      "     ESFNLKRAQE DISRLRRKLE KQRKVEVYAD ADEILQEEIK EYKARLTCPC CNTRKKDAVL\r\n",
      "     TKCFHVFCFE CVRGRYEARQ RKCPKCNAAF GAHDFHRIYI S\r\n",
      "//\r\n",
      "ID   ARI4B_HUMAN             Reviewed;        1312 AA.\r\n",
      "AC   Q4LE39; A1L465; Q3MHV4; Q5HY99; Q5T2C2; Q5T2C3; Q5T2C4; Q5T2C5; Q5T2C6;\r\n",
      "AC   Q6P600; Q86UX1; Q86WR4; Q9H915; Q9NYU3; Q9NZB6; Q9NZG4; Q9P2W4; Q9UF62;\r\n",
      "AC   Q9Y6E1;\r\n",
      "DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   03-APR-2007, sequence version 2.\r\n",
      "DT   03-MAY-2023, entry version 157.\r\n",
      "DE   RecName: Full=AT-rich interactive domain-containing protein 4B;\r\n",
      "DE            Short=ARID domain-containing protein 4B;\r\n",
      "DE   AltName: Full=180 kDa Sin3-associated polypeptide;\r\n",
      "DE            Short=Sin3-associated polypeptide p180;\r\n",
      "DE   AltName: Full=Breast cancer-associated antigen BRCAA1;\r\n",
      "DE   AltName: Full=Histone deacetylase complex subunit SAP180;\r\n",
      "DE   AltName: Full=Retinoblastoma-binding protein 1-like 1;\r\n",
      "GN   Name=ARID4B; Synonyms=BRCAA1, RBBP1L1, RBP1L1, SAP180;\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION, AND TISSUE\r\n",
      "RP   SPECIFICITY.\r\n",
      "RX   PubMed=11481388; DOI=10.1093/jnci/93.15.1159;\r\n",
      "RA   Cao J.-N., Gao T.-W., Stanbridge E.J., Irie R.;\r\n",
      "RT   \"RBP1L1, a retinoblastoma-binding protein-related gene encoding an\r\n",
      "RT   antigenic epitope abundantly expressed in human carcinomas and normal\r\n",
      "RT   testis.\";\r\n",
      "RL   J. Natl. Cancer Inst. 93:1159-1165(2001).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, DOMAIN, TISSUE\r\n",
      "RP   SPECIFICITY, AND IDENTIFICATION IN A MSIN3A COREPRESSOR COMPLEX WITH SIN3A;\r\n",
      "RP   SAP130; SUDS3; ARID4B; HDAC1 AND HDAC2.\r\n",
      "RX   PubMed=12724404; DOI=10.1128/mcb.23.10.3456-3467.2003;\r\n",
      "RA   Fleischer T.C., Yun U.J., Ayer D.E.;\r\n",
      "RT   \"Identification and characterization of three new components of the mSin3A\r\n",
      "RT   corepressor complex.\";\r\n",
      "RL   Mol. Cell. Biol. 23:3456-3467(2003).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION, AND TISSUE\r\n",
      "RP   SPECIFICITY.\r\n",
      "RX   PubMed=15247124; DOI=10.1158/1055-9965.1136.13.7;\r\n",
      "RA   Cui D., Jin G., Gao T.W., Sun T., Tian F., Estrada G.G., Gao H., Sarai A.;\r\n",
      "RT   \"Characterization of BRCAA1 and its novel antigen epitope identification.\";\r\n",
      "RL   Cancer Epidemiol. Biomarkers Prev. 13:1136-1145(2004).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).\r\n",
      "RC   TISSUE=Synovium;\r\n",
      "RA   Tanaka M.;\r\n",
      "RT   \"Rheumatoid arthritis antigenic protein similar to retinoblastoma binding\r\n",
      "RT   protein 1 (RBP1).\";\r\n",
      "RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).\r\n",
      "RC   TISSUE=Brain;\r\n",
      "RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M., Ohara R.,\r\n",
      "RA   Okazaki N., Koga H., Nagase T., Ohara O.;\r\n",
      "RT   \"Preparation of a set of expression-ready clones of mammalian long cDNAs\r\n",
      "RT   encoding large proteins by the ORF trap cloning method.\";\r\n",
      "RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RX   PubMed=16710414; DOI=10.1038/nature04727;\r\n",
      "RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,\r\n",
      "RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,\r\n",
      "RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,\r\n",
      "RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,\r\n",
      "RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,\r\n",
      "RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,\r\n",
      "RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,\r\n",
      "RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,\r\n",
      "RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,\r\n",
      "RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,\r\n",
      "RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,\r\n",
      "RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,\r\n",
      "RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,\r\n",
      "RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,\r\n",
      "RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,\r\n",
      "RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,\r\n",
      "RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,\r\n",
      "RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,\r\n",
      "RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,\r\n",
      "RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,\r\n",
      "RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,\r\n",
      "RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,\r\n",
      "RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,\r\n",
      "RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,\r\n",
      "RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,\r\n",
      "RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,\r\n",
      "RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,\r\n",
      "RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,\r\n",
      "RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;\r\n",
      "RT   \"The DNA sequence and biological annotation of human chromosome 1.\";\r\n",
      "RL   Nature 441:315-321(2006).\r\n",
      "RN   [7]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE\r\n",
      "RP   [LARGE SCALE MRNA] OF 1-651 (ISOFORM 2), AND NUCLEOTIDE SEQUENCE [LARGE\r\n",
      "RP   SCALE MRNA] OF 1-424.\r\n",
      "RC   TISSUE=Hippocampus, Kidney, and Lung;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [8]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1149 (ISOFORM 2), AND\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1147-1312.\r\n",
      "RC   TISSUE=Adipose tissue, and Testis;\r\n",
      "RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;\r\n",
      "RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,\r\n",
      "RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,\r\n",
      "RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,\r\n",
      "RA   Wiemann S., Schupp I.;\r\n",
      "RT   \"The full-ORF clone resource of the German cDNA consortium.\";\r\n",
      "RL   BMC Genomics 8:399-399(2007).\r\n",
      "RN   [9]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 440-1312 (ISOFORM 1).\r\n",
      "RA   Cao J., Irie R.F., Stanbridge E.J.;\r\n",
      "RT   \"Human breast carcinoma-associated antigen isoform I.\";\r\n",
      "RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [10]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 547-1312.\r\n",
      "RA   Liu T., Tao J., Zhang J., Li W., Ye M., Zhou J., Wu J., Shen Y., Yu M.,\r\n",
      "RA   Chen S., Mao M., Chen Z.;\r\n",
      "RT   \"Human Rb binding protein homolog gene, partial CDS.\";\r\n",
      "RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [11]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 828-1312.\r\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\r\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\r\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\r\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\r\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\r\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\r\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\r\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\r\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\r\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\r\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\r\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\r\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\r\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\r\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\r\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\r\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\r\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\r\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\r\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\r\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\r\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\r\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\r\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\r\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\r\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\r\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\r\n",
      "RA   Isogai T., Sugano S.;\r\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\r\n",
      "RT   cDNAs.\";\r\n",
      "RL   Nat. Genet. 36:40-45(2004).\r\n",
      "RN   [12]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-717, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;\r\n",
      "RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;\r\n",
      "RT   \"Global, in vivo, and site-specific phosphorylation dynamics in signaling\r\n",
      "RT   networks.\";\r\n",
      "RL   Cell 127:635-648(2006).\r\n",
      "RN   [13]\r\n",
      "RP   INTERACTION WITH ARID4A.\r\n",
      "RX   PubMed=17043311; DOI=10.1101/gad.1452206;\r\n",
      "RA   Wu M.Y., Tsai T.F., Beaudet A.L.;\r\n",
      "RT   \"Deficiency of Rbbp1/Arid4a and Rbbp1l1/Arid4b alters epigenetic\r\n",
      "RT   modifications and suppresses an imprinting defect in the PWS/AS domain.\";\r\n",
      "RL   Genes Dev. 20:2859-2870(2006).\r\n",
      "RN   [14]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-666; SER-675; SER-790;\r\n",
      "RP   THR-793; THR-1150; SER-1152; SER-1153; SER-1155 AND SER-1159, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;\r\n",
      "RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,\r\n",
      "RA   Elledge S.J., Gygi S.P.;\r\n",
      "RT   \"A quantitative atlas of mitotic phosphorylation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).\r\n",
      "RN   [15]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19413330; DOI=10.1021/ac9004309;\r\n",
      "RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;\r\n",
      "RT   \"Lys-N and trypsin cover complementary parts of the phosphoproteome in a\r\n",
      "RT   refined SCX-based approach.\";\r\n",
      "RL   Anal. Chem. 81:4493-4501(2009).\r\n",
      "RN   [16]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-790; THR-793; SER-1014 AND\r\n",
      "RP   THR-1026, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [17]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-675; SER-778; SER-790 AND\r\n",
      "RP   THR-793, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;\r\n",
      "RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,\r\n",
      "RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;\r\n",
      "RT   \"Quantitative phosphoproteomics reveals widespread full phosphorylation\r\n",
      "RT   site occupancy during mitosis.\";\r\n",
      "RL   Sci. Signal. 3:RA3-RA3(2010).\r\n",
      "RN   [18]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;\r\n",
      "RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,\r\n",
      "RA   Bennett K.L., Superti-Furga G., Colinge J.;\r\n",
      "RT   \"Initial characterization of the human central proteome.\";\r\n",
      "RL   BMC Syst. Biol. 5:17-17(2011).\r\n",
      "RN   [19]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-276; SER-778; SER-790 AND\r\n",
      "RP   THR-793, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;\r\n",
      "RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,\r\n",
      "RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;\r\n",
      "RT   \"System-wide temporal characterization of the proteome and phosphoproteome\r\n",
      "RT   of human embryonic stem cell differentiation.\";\r\n",
      "RL   Sci. Signal. 4:RS3-RS3(2011).\r\n",
      "RN   [20]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483; SER-666; SER-675;\r\n",
      "RP   SER-778; SER-1029 AND SER-1153, AND IDENTIFICATION BY MASS SPECTROMETRY\r\n",
      "RP   [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [21]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-429, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=25218447; DOI=10.1038/nsmb.2890;\r\n",
      "RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,\r\n",
      "RA   Vertegaal A.C.;\r\n",
      "RT   \"Uncovering global SUMOylation signaling networks in a site-specific\r\n",
      "RT   manner.\";\r\n",
      "RL   Nat. Struct. Mol. Biol. 21:927-936(2014).\r\n",
      "RN   [22]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-429, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;\r\n",
      "RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,\r\n",
      "RA   Vertegaal A.C.;\r\n",
      "RT   \"SUMO-2 orchestrates chromatin modifiers in response to DNA damage.\";\r\n",
      "RL   Cell Rep. 10:1778-1791(2015).\r\n",
      "RN   [23]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-429 AND LYS-440, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;\r\n",
      "RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,\r\n",
      "RA   Vertegaal A.C.;\r\n",
      "RT   \"System-wide analysis of SUMOylation dynamics in response to replication\r\n",
      "RT   stress reveals novel small ubiquitin-like modified target proteins and\r\n",
      "RT   acceptor lysines relevant for genome stability.\";\r\n",
      "RL   Mol. Cell. Proteomics 14:1419-1434(2015).\r\n",
      "RN   [24]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-429; LYS-440; LYS-462; LYS-517\r\n",
      "RP   AND LYS-751, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE\r\n",
      "RP   ANALYSIS].\r\n",
      "RX   PubMed=28112733; DOI=10.1038/nsmb.3366;\r\n",
      "RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,\r\n",
      "RA   Nielsen M.L.;\r\n",
      "RT   \"Site-specific mapping of the human SUMO proteome reveals co-modification\r\n",
      "RT   with phosphorylation.\";\r\n",
      "RL   Nat. Struct. Mol. Biol. 24:325-336(2017).\r\n",
      "CC   -!- FUNCTION: Acts as a transcriptional repressor (PubMed:12724404). May\r\n",
      "CC       function in the assembly and/or enzymatic activity of the Sin3A\r\n",
      "CC       corepressor complex or in mediating interactions between the complex\r\n",
      "CC       and other regulatory complexes (PubMed:12724404). Plays a role in the\r\n",
      "CC       regulation of epigenetic modifications at the PWS/AS imprinting center\r\n",
      "CC       near the SNRPN promoter, where it might function as part of a complex\r\n",
      "CC       with RB1 and ARID4A. Involved in spermatogenesis, together with ARID4A,\r\n",
      "CC       where it functions as a transcriptional coactivator for AR (androgen\r\n",
      "CC       receptor) and enhances expression of genes required for sperm\r\n",
      "CC       maturation. Regulates expression of the tight junction protein CLDN3 in\r\n",
      "CC       the testis, which is important for integrity of the blood-testis\r\n",
      "CC       barrier. Plays a role in myeloid homeostasis where it regulates the\r\n",
      "CC       histone methylation state of bone marrow cells and expression of\r\n",
      "CC       various genes involved in hematopoiesis. May function as a leukemia\r\n",
      "CC       suppressor (By similarity). {ECO:0000250|UniProtKB:A2CG63,\r\n",
      "CC       ECO:0000269|PubMed:12724404}.\r\n",
      "CC   -!- SUBUNIT: Component of a Sin3A corepressor complex consisting of SIN3A,\r\n",
      "CC       SAP130, SUDS3/SAP45, SAP180, HDAC1 and HDAC2 (PubMed:12724404).\r\n",
      "CC       Interacts with ARID4A (PubMed:17043311). Interacts with AR (By\r\n",
      "CC       similarity). {ECO:0000250|UniProtKB:A2CG63,\r\n",
      "CC       ECO:0000269|PubMed:12724404, ECO:0000269|PubMed:17043311}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q4LE39; P14921: ETS1; NbExp=2; IntAct=EBI-2680990, EBI-913209;\r\n",
      "CC       Q4LE39-3; Q9BTE6-2: AARSD1; NbExp=3; IntAct=EBI-11957452, EBI-9357295;\r\n",
      "CC       Q4LE39-3; Q9NQM4: DNAAF6; NbExp=3; IntAct=EBI-11957452, EBI-10239299;\r\n",
      "CC       Q4LE39-3; P63172: DYNLT1; NbExp=3; IntAct=EBI-11957452, EBI-1176455;\r\n",
      "CC       Q4LE39-3; Q96JC9: EAF1; NbExp=3; IntAct=EBI-11957452, EBI-769261;\r\n",
      "CC       Q4LE39-3; I6L957: HNRNPA2B1; NbExp=3; IntAct=EBI-11957452, EBI-1642515;\r\n",
      "CC       Q4LE39-3; Q5HYW2: NHSL2; NbExp=3; IntAct=EBI-11957452, EBI-2859639;\r\n",
      "CC       Q4LE39-3; Q96HA8: NTAQ1; NbExp=3; IntAct=EBI-11957452, EBI-741158;\r\n",
      "CC       Q4LE39-3; Q92569: PIK3R3; NbExp=3; IntAct=EBI-11957452, EBI-79893;\r\n",
      "CC       Q4LE39-3; Q9H8W4: PLEKHF2; NbExp=3; IntAct=EBI-11957452, EBI-742388;\r\n",
      "CC       Q4LE39-3; Q6ZRT6: PRR23B; NbExp=3; IntAct=EBI-11957452, EBI-12845180;\r\n",
      "CC       Q4LE39-3; Q9NS25: SPANXB1; NbExp=3; IntAct=EBI-11957452, EBI-17197485;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355}.\r\n",
      "CC       Cytoplasm {ECO:0000269|PubMed:11481388, ECO:0000269|PubMed:15247124}.\r\n",
      "CC       Note=Cytoplasmic in breast cancer cells. {ECO:0000269|PubMed:15247124}.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=4;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=Q4LE39-1; Sequence=Displayed;\r\n",
      "CC       Name=2;\r\n",
      "CC         IsoId=Q4LE39-2; Sequence=VSP_024231;\r\n",
      "CC       Name=3;\r\n",
      "CC         IsoId=Q4LE39-3; Sequence=VSP_024234, VSP_024235;\r\n",
      "CC       Name=4;\r\n",
      "CC         IsoId=Q4LE39-4; Sequence=VSP_024230, VSP_024232, VSP_024233;\r\n",
      "CC   -!- TISSUE SPECIFICITY: Highly expressed in the testis and in breast, lung,\r\n",
      "CC       colon, pancreatic and ovarian cancers. Expressed at low levels in the\r\n",
      "CC       thymus, prostate and ovary. {ECO:0000269|PubMed:11481388,\r\n",
      "CC       ECO:0000269|PubMed:12724404, ECO:0000269|PubMed:15247124}.\r\n",
      "CC   -!- DOMAIN: The C-terminus mediates interaction with mSin3A corepressor\r\n",
      "CC       complex. {ECO:0000269|PubMed:12724404}.\r\n",
      "CC   -!- DOMAIN: The N-terminus is involved in transcriptional repression by\r\n",
      "CC       HDAC-independent mechanisms. {ECO:0000269|PubMed:12724404}.\r\n",
      "CC   -!- DOMAIN: The ARID domain is involved in stabilizing the mSin3A\r\n",
      "CC       corepressor complex on DNA. {ECO:0000269|PubMed:12724404}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=AAD41239.1; Type=Frameshift; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=AAF23433.3; Type=Frameshift; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=BAB14428.1; Type=Erroneous initiation; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=BAE06114.1; Type=Erroneous initiation; Evidence={ECO:0000305};\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AF214114; AAF28341.2; -; mRNA.\r\n",
      "DR   EMBL; AY220790; AAO63590.1; -; mRNA.\r\n",
      "DR   EMBL; AF208045; AAF23433.3; ALT_FRAME; mRNA.\r\n",
      "DR   EMBL; AB030181; BAA89794.1; -; mRNA.\r\n",
      "DR   EMBL; AB210032; BAE06114.1; ALT_INIT; mRNA.\r\n",
      "DR   EMBL; AL133418; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AL391994; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; BC048959; AAH48959.1; ALT_TERM; mRNA.\r\n",
      "DR   EMBL; BC062536; AAH62536.1; ALT_TERM; mRNA.\r\n",
      "DR   EMBL; BC104632; AAI04633.1; ALT_TERM; mRNA.\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DR   EMBL; BC130418; AAI30419.1; -; mRNA.\r\n",
      "DR   EMBL; BX648820; CAI46047.1; -; mRNA.\r\n",
      "DR   EMBL; AL133594; CAB63731.1; -; mRNA.\r\n",
      "DR   EMBL; AF227899; AAF36964.1; -; mRNA.\r\n",
      "DR   EMBL; AF083249; AAD41239.1; ALT_FRAME; mRNA.\r\n",
      "DR   EMBL; AK023144; BAB14428.1; ALT_INIT; mRNA.\r\n",
      "DR   CCDS; CCDS31060.1; -. [Q4LE39-2]\r\n",
      "DR   CCDS; CCDS31061.1; -. [Q4LE39-1]\r\n",
      "DR   PIR; T43497; T43497.\r\n",
      "DR   RefSeq; NP_001193723.1; NM_001206794.1. [Q4LE39-1]\r\n",
      "DR   RefSeq; NP_057458.4; NM_016374.5. [Q4LE39-1]\r\n",
      "DR   RefSeq; NP_112739.2; NM_031371.3. [Q4LE39-2]\r\n",
      "DR   RefSeq; XP_011542514.1; XM_011544212.2. [Q4LE39-1]\r\n",
      "DR   PDB; 7DM4; NMR; -; A=1-151.\r\n",
      "DR   PDBsum; 7DM4; -.\r\n",
      "DR   AlphaFoldDB; Q4LE39; -.\r\n",
      "DR   SMR; Q4LE39; -.\r\n",
      "DR   BioGRID; 119708; 188.\r\n",
      "DR   ComplexPortal; CPX-3321; SIN3A histone deacetylase complex.\r\n",
      "DR   ComplexPortal; CPX-3322; SIN3B histone deacetylase complex.\r\n",
      "DR   ComplexPortal; CPX-3323; SIN3A histone deacetylase complex, ES cell-specific variant.\r\n",
      "DR   CORUM; Q4LE39; -.\r\n",
      "DR   IntAct; Q4LE39; 95.\r\n",
      "DR   MINT; Q4LE39; -.\r\n",
      "DR   STRING; 9606.ENSP00000264183; -.\r\n",
      "DR   GlyGen; Q4LE39; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; Q4LE39; -.\r\n",
      "DR   PhosphoSitePlus; Q4LE39; -.\r\n",
      "DR   BioMuta; ARID4B; -.\r\n",
      "DR   DMDM; 143955276; -.\r\n",
      "DR   CPTAC; CPTAC-1754; -.\r\n",
      "DR   EPD; Q4LE39; -.\r\n",
      "DR   jPOST; Q4LE39; -.\r\n",
      "DR   MassIVE; Q4LE39; -.\r\n",
      "DR   MaxQB; Q4LE39; -.\r\n",
      "DR   PaxDb; Q4LE39; -.\r\n",
      "DR   PeptideAtlas; Q4LE39; -.\r\n",
      "DR   ProteomicsDB; 62238; -. [Q4LE39-1]\r\n",
      "DR   ProteomicsDB; 62239; -. [Q4LE39-2]\r\n",
      "DR   ProteomicsDB; 62240; -. [Q4LE39-3]\r\n",
      "DR   ProteomicsDB; 62241; -. [Q4LE39-4]\r\n",
      "DR   ABCD; Q4LE39; 1 sequenced antibody.\r\n",
      "DR   Antibodypedia; 20807; 170 antibodies from 31 providers.\r\n",
      "DR   DNASU; 51742; -.\r\n",
      "DR   Ensembl; ENST00000264183.9; ENSP00000264183.3; ENSG00000054267.22. [Q4LE39-1]\r\n",
      "DR   Ensembl; ENST00000349213.7; ENSP00000264184.4; ENSG00000054267.22. [Q4LE39-2]\r\n",
      "DR   Ensembl; ENST00000366603.6; ENSP00000355562.2; ENSG00000054267.22. [Q4LE39-1]\r\n",
      "DR   Ensembl; ENST00000421364.5; ENSP00000394663.1; ENSG00000054267.22. [Q4LE39-3]\r\n",
      "DR   GeneID; 51742; -.\r\n",
      "DR   KEGG; hsa:51742; -.\r\n",
      "DR   MANE-Select; ENST00000264183.9; ENSP00000264183.3; NM_016374.6; NP_057458.4.\r\n",
      "DR   UCSC; uc001hwq.3; human. [Q4LE39-1]\r\n",
      "DR   AGR; HGNC:15550; -.\r\n",
      "DR   CTD; 51742; -.\r\n",
      "DR   DisGeNET; 51742; -.\r\n",
      "DR   GeneCards; ARID4B; -.\r\n",
      "DR   HGNC; HGNC:15550; ARID4B.\r\n",
      "DR   HPA; ENSG00000054267; Low tissue specificity.\r\n",
      "DR   MIM; 609696; gene.\r\n",
      "DR   neXtProt; NX_Q4LE39; -.\r\n",
      "DR   OpenTargets; ENSG00000054267; -.\r\n",
      "DR   PharmGKB; PA134940494; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000054267; -.\r\n",
      "DR   eggNOG; KOG2744; Eukaryota.\r\n",
      "DR   eggNOG; KOG3001; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00940000158149; -.\r\n",
      "DR   HOGENOM; CLU_007419_0_0_1; -.\r\n",
      "DR   InParanoid; Q4LE39; -.\r\n",
      "DR   OMA; XCTGQKR; -.\r\n",
      "DR   OrthoDB; 445024at2759; -.\r\n",
      "DR   PhylomeDB; Q4LE39; -.\r\n",
      "DR   TreeFam; TF106427; -.\r\n",
      "DR   PathwayCommons; Q4LE39; -.\r\n",
      "DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.\r\n",
      "DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.\r\n",
      "DR   Reactome; R-HSA-9679191; Potential therapeutics for SARS.\r\n",
      "DR   SignaLink; Q4LE39; -.\r\n",
      "DR   BioGRID-ORCS; 51742; 96 hits in 1172 CRISPR screens.\r\n",
      "DR   ChiTaRS; ARID4B; human.\r\n",
      "DR   GeneWiki; ARID4B; -.\r\n",
      "DR   GenomeRNAi; 51742; -.\r\n",
      "DR   Pharos; Q4LE39; Tbio.\r\n",
      "DR   PRO; PR:Q4LE39; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 1.\r\n",
      "DR   RNAct; Q4LE39; protein.\r\n",
      "DR   Bgee; ENSG00000054267; Expressed in choroid plexus epithelium and 198 other tissues.\r\n",
      "DR   ExpressionAtlas; Q4LE39; baseline and differential.\r\n",
      "DR   Genevisible; Q4LE39; HS.\r\n",
      "DR   GO; GO:0005829; C:cytosol; IDA:HPA.\r\n",
      "DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.\r\n",
      "DR   GO; GO:0016580; C:Sin3 complex; NAS:ComplexPortal.\r\n",
      "DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0097368; P:establishment of Sertoli cell barrier; IEA:Ensembl.\r\n",
      "DR   GO; GO:0036124; P:histone H3-K9 trimethylation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0034773; P:histone H4-K20 trimethylation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0030336; P:negative regulation of cell migration; NAS:ComplexPortal.\r\n",
      "DR   GO; GO:1902455; P:negative regulation of stem cell population maintenance; NAS:ComplexPortal.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; NAS:ComplexPortal.\r\n",
      "DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; NAS:ComplexPortal.\r\n",
      "DR   GO; GO:1902459; P:positive regulation of stem cell population maintenance; NAS:ComplexPortal.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006349; P:regulation of gene expression by genomic imprinting; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   CDD; cd16883; ARID_ARID4B; 1.\r\n",
      "DR   CDD; cd20460; Tudor_ARID4B_rpt1; 1.\r\n",
      "DR   CDD; cd20462; Tudor_ARID4B_rpt2; 1.\r\n",
      "DR   Gene3D; 2.30.30.140; -; 3.\r\n",
      "DR   Gene3D; 1.10.150.60; ARID DNA-binding domain; 1.\r\n",
      "DR   InterPro; IPR012603; ARID4A/B_PWWP.\r\n",
      "DR   InterPro; IPR028853; ARID4B_ARID/BRIGHT.\r\n",
      "DR   InterPro; IPR001606; ARID_dom.\r\n",
      "DR   InterPro; IPR036431; ARID_dom_sf.\r\n",
      "DR   InterPro; IPR016197; Chromo-like_dom_sf.\r\n",
      "DR   InterPro; IPR002999; Tudor.\r\n",
      "DR   InterPro; IPR025995; Tudor-knot.\r\n",
      "DR   InterPro; IPR047476; Tudor_ARID4B_rpt1.\r\n",
      "DR   InterPro; IPR047474; Tudor_ARID4B_rpt2.\r\n",
      "DR   PANTHER; PTHR13964:SF24; AT-RICH INTERACTIVE DOMAIN-CONTAINING PROTEIN 4B; 1.\r\n",
      "DR   PANTHER; PTHR13964; RBP-RELATED; 1.\r\n",
      "DR   Pfam; PF01388; ARID; 1.\r\n",
      "DR   Pfam; PF08169; RBB1NT; 1.\r\n",
      "DR   Pfam; PF11717; Tudor-knot; 1.\r\n",
      "DR   SMART; SM01014; ARID; 1.\r\n",
      "DR   SMART; SM00501; BRIGHT; 1.\r\n",
      "DR   SMART; SM00333; TUDOR; 2.\r\n",
      "DR   SUPFAM; SSF46774; ARID-like; 1.\r\n",
      "DR   SUPFAM; SSF54160; Chromo domain-like; 1.\r\n",
      "DR   SUPFAM; SSF63748; Tudor/PWWP/MBT; 2.\r\n",
      "DR   PROSITE; PS51011; ARID; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Alternative splicing; Chromatin regulator; Coiled coil;\r\n",
      "KW   Cytoplasm; DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Transcription; Transcription regulation;\r\n",
      "KW   Ubl conjugation.\r\n",
      "FT   CHAIN           1..1312\r\n",
      "FT                   /note=\"AT-rich interactive domain-containing protein 4B\"\r\n",
      "FT                   /id=\"PRO_0000282863\"\r\n",
      "FT   DOMAIN          306..398\r\n",
      "FT                   /note=\"ARID\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00355\"\r\n",
      "FT   DOMAIN          572..624\r\n",
      "FT                   /note=\"Tudor-knot\"\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   REGION          124..166\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          266..306\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          458..577\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          465..473\r\n",
      "FT                   /note=\"Antigenic epitope\"\r\n",
      "FT   REGION          635..680\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          708..894\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          909..1212\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1130..1137\r\n",
      "FT                   /note=\"Antigenic epitope\"\r\n",
      "FT   REGION          1252..1288\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COILED          728..754\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COILED          1231..1270\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COMPBIAS        144..166\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        274..306\r\n",
      "FT                   /note=\"Acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        479..531\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        532..566\r\n",
      "FT                   /note=\"Acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        645..660\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        724..747\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        748..762\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        777..851\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        863..890\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        909..927\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        992..1007\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1010..1053\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1079..1107\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1144..1191\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1194..1210\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1273..1288\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         276\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21406692\"\r\n",
      "FT   MOD_RES         295\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q9JKB5\"\r\n",
      "FT   MOD_RES         296\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q9JKB5\"\r\n",
      "FT   MOD_RES         483\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         666\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         675\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         717\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983\"\r\n",
      "FT   MOD_RES         778\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         790\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:21406692\"\r\n",
      "FT   MOD_RES         793\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:21406692\"\r\n",
      "FT   MOD_RES         1014\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332\"\r\n",
      "FT   MOD_RES         1026\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332\"\r\n",
      "FT   MOD_RES         1029\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1150\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648\"\r\n",
      "FT   MOD_RES         1152\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648\"\r\n",
      "FT   MOD_RES         1153\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1155\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648\"\r\n",
      "FT   MOD_RES         1159\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648\"\r\n",
      "FT   CROSSLNK        429\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:25218447,\r\n",
      "FT                   ECO:0007744|PubMed:25755297, ECO:0007744|PubMed:25772364,\r\n",
      "FT                   ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        440\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:25755297,\r\n",
      "FT                   ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        462\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        517\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        751\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   VAR_SEQ         1..319\r\n",
      "FT                   /note=\"Missing (in isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|Ref.4\"\r\n",
      "FT                   /id=\"VSP_024230\"\r\n",
      "FT   VAR_SEQ         529..614\r\n",
      "FT                   /note=\"Missing (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:11481388,\r\n",
      "FT                   ECO:0000303|PubMed:15247124, ECO:0000303|PubMed:15489334,\r\n",
      "FT                   ECO:0000303|PubMed:17974005\"\r\n",
      "FT                   /id=\"VSP_024231\"\r\n",
      "FT   VAR_SEQ         1112..1122\r\n",
      "FT                   /note=\"ACTGQKRVKDA -> GEKENVYVDLF (in isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|Ref.4\"\r\n",
      "FT                   /id=\"VSP_024232\"\r\n",
      "FT   VAR_SEQ         1123..1312\r\n",
      "FT                   /note=\"Missing (in isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|Ref.4\"\r\n",
      "FT                   /id=\"VSP_024233\"\r\n",
      "FT   VAR_SEQ         1150..1153\r\n",
      "FT                   /note=\"TNSS -> SAPH (in isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_024234\"\r\n",
      "FT   VAR_SEQ         1154..1312\r\n",
      "FT                   /note=\"Missing (in isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_024235\"\r\n",
      "FT   CONFLICT        15\r\n",
      "FT                   /note=\"D -> G (in Ref. 2; AAO63590)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        79\r\n",
      "FT                   /note=\"V -> A (in Ref. 2; AAO63590)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        330\r\n",
      "FT                   /note=\"R -> Q (in Ref. 1; AAF28341 and 3; AAF23433)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        400\r\n",
      "FT                   /note=\"A -> P (in Ref. 4; BAA89794)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        436\r\n",
      "FT                   /note=\"I -> IEFCGR (in Ref. 3; AAF23433)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        437\r\n",
      "FT                   /note=\"K -> Q (in Ref. 4; BAA89794)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        559..561\r\n",
      "FT                   /note=\"DNN -> ATI (in Ref. 4; BAA89794)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        568\r\n",
      "FT                   /note=\"C -> S (in Ref. 4; BAA89794)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        575\r\n",
      "FT                   /note=\"V -> A (in Ref. 4; BAA89794)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        584\r\n",
      "FT                   /note=\"N -> H (in Ref. 4; BAA89794)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        605\r\n",
      "FT                   /note=\"L -> S (in Ref. 9; AAF36964)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        616\r\n",
      "FT                   /note=\"D -> G (in Ref. 9; AAF36964)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        813\r\n",
      "FT                   /note=\"D -> G (in Ref. 2; AAO63590)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        915..917\r\n",
      "FT                   /note=\"RLQ -> LP (in Ref. 3; AAF23433)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        940\r\n",
      "FT                   /note=\"L -> R (in Ref. 3; AAF23433)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1000\r\n",
      "FT                   /note=\"K -> E (in Ref. 1; AAF28341 and 9; AAF36964)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1001\r\n",
      "FT                   /note=\"T -> Q (in Ref. 3; AAF23433)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1032\r\n",
      "FT                   /note=\"S -> P (in Ref. 2; AAO63590)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1087\r\n",
      "FT                   /note=\"S -> N (in Ref. 2; AAO63590)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1118\r\n",
      "FT                   /note=\"R -> G (in Ref. 8; CAI46047)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1144\r\n",
      "FT                   /note=\"K -> T (in Ref. 3; AAF23433 and 10; AAD41239)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1243..1244\r\n",
      "FT                   /note=\"IR -> NQ (in Ref. 3; AAF23433 and 10; AAD41239)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1290\r\n",
      "FT                   /note=\"V -> A (in Ref. 1; AAF28341 and 9; AAF36964)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   STRAND          15..20\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          23..42\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   TURN            43..45\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          48..52\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   HELIX           53..55\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          56..58\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          65..69\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          75..92\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          98..102\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   HELIX           103..105\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          106..111\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          133..136\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   TURN            146..148\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "SQ   SEQUENCE   1312 AA;  147809 MW;  E4175FF80F5217EE CRC64;\r\n",
      "     MKALDEPPYL TVGTDVSAKY RGAFCEAKIK TAKRLVKVKV TFRHDSSTVE VQDDHIKGPL\r\n",
      "     KVGAIVEVKN LDGAYQEAVI NKLTDASWYT VVFDDGDEKT LRRSSLCLKG ERHFAESETL\r\n",
      "     DQLPLTNPEH FGTPVIGKKT NRGRRSNHIP EEESSSSSSD EDEDDRKQID ELLGKVVCVD\r\n",
      "     YISLDKKKAL WFPALVVCPD CSDEIAVKKD NILVRSFKDG KFTSVPRKDV HEITSDTAPK\r\n",
      "     PDAVLKQAFE QALEFHKSRT IPANWKTELK EDSSSSEAEE EEEEEDDEKE KEDNSSEEEE\r\n",
      "     EIEPFPEERE NFLQQLYKFM EDRGTPINKR PVLGYRNLNL FKLFRLVHKL GGFDNIESGA\r\n",
      "     VWKQVYQDLG IPVLNSAAGY NVKCAYKKYL YGFEEYCRSA NIEFQMALPE KVVNKQCKEC\r\n",
      "     ENVKEIKVKE ENETEIKEIK MEEERNIIPR EEKPIEDEIE RKENIKPSLG SKKNLLESIP\r\n",
      "     THSDQEKEVN IKKPEDNENL DDKDDDTTRV DESLNIKVEA EEEKAKSGDE TNKEEDEDDE\r\n",
      "     EAEEEEEEEE EEEDEDDDDN NEEEEFECYP PGMKVQVRYG RGKNQKMYEA SIKDSDVEGG\r\n",
      "     EVLYLVHYCG WNVRYDEWIK ADKIVRPADK NVPKIKHRKK IKNKLDKEKD KDEKYSPKNC\r\n",
      "     KLRRLSKPPF QTNPSPEMVS KLDLTDAKNS DTAHIKSIEI TSILNGLQAS ESSAEDSEQE\r\n",
      "     DERGAQDMDN NGKEESKIDH LTNNRNDLIS KEEQNSSSLL EENKVHADLV ISKPVSKSPE\r\n",
      "     RLRKDIEVLS EDTDYEEDEV TKKRKDVKKD TTDKSSKPQI KRGKRRYCNT EECLKTGSPG\r\n",
      "     KKEEKAKNKE SLCMENSSNS SSDEDEEETK AKMTPTKKYN GLEEKRKSLR TTGFYSGFSE\r\n",
      "     VAEKRIKLLN NSDERLQNSR AKDRKDVWSS IQGQWPKKTL KELFSDSDTE AAASPPHPAP\r\n",
      "     EEGVAEESLQ TVAEEESCSP SVELEKPPPV NVDSKPIEEK TVEVNDRKAE FPSSGSNSVL\r\n",
      "     NTPPTTPESP SSVTVTEGSR QQSSVTVSEP LAPNQEEVRS IKSETDSTIE VDSVAGELQD\r\n",
      "     LQSEGNSSPA GFDASVSSSS SNQPEPEHPE KACTGQKRVK DAQGGGSSSK KQKRSHKATV\r\n",
      "     VNNKKKGKGT NSSDSEELSA GESITKSQPV KSVSTGMKSH STKSPARTQS PGKCGKNGDK\r\n",
      "     DPDLKEPSNR LPKVYKWSFQ MSDLENMTSA ERITILQEKL QEIRKHYLSL KSEVASIDRR\r\n",
      "     RKRLKKKERE SAATSSSSSS PSSSSITAAV MLTLAEPSMS SASQNGMSVE CR\r\n",
      "//\r\n",
      "ID   RBBP6_MOUSE             Reviewed;        1790 AA.\r\n",
      "AC   P97868; P70287; Q3TTR9; Q3TUM7; Q3UMP7; Q4U217; Q7TT06; Q8BNY8; Q8R399;\r\n",
      "DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   16-MAY-2006, sequence version 5.\r\n",
      "DT   03-MAY-2023, entry version 175.\r\n",
      "DE   RecName: Full=E3 ubiquitin-protein ligase RBBP6;\r\n",
      "DE            EC=2.3.2.27;\r\n",
      "DE   AltName: Full=Proliferation potential-related protein;\r\n",
      "DE   AltName: Full=Protein P2P-R;\r\n",
      "DE   AltName: Full=RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};\r\n",
      "DE   AltName: Full=Retinoblastoma-binding protein 6;\r\n",
      "DE   AltName: Full=p53-associated cellular protein of testis;\r\n",
      "GN   Name=Rbbp6; Synonyms=P2pr, Pact;\r\n",
      "OS   Mus musculus (Mouse).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Mus; Mus.\r\n",
      "OX   NCBI_TaxID=10090;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE\r\n",
      "RP   [LARGE SCALE MRNA] OF 546-1148 (ISOFORM 2), AND NUCLEOTIDE SEQUENCE [LARGE\r\n",
      "RP   SCALE MRNA] OF 1356-1790 (ISOFORMS 1/2).\r\n",
      "RC   STRAIN=C57BL/6J;\r\n",
      "RC   TISSUE=Corpora quadrigemina, Corpus striatum, Embryo, Head, and Lung;\r\n",
      "RX   PubMed=16141072; DOI=10.1126/science.1112014;\r\n",
      "RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,\r\n",
      "RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,\r\n",
      "RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,\r\n",
      "RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,\r\n",
      "RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,\r\n",
      "RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,\r\n",
      "RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,\r\n",
      "RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,\r\n",
      "RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,\r\n",
      "RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,\r\n",
      "RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,\r\n",
      "RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,\r\n",
      "RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,\r\n",
      "RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,\r\n",
      "RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,\r\n",
      "RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,\r\n",
      "RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,\r\n",
      "RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,\r\n",
      "RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,\r\n",
      "RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,\r\n",
      "RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,\r\n",
      "RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,\r\n",
      "RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,\r\n",
      "RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,\r\n",
      "RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,\r\n",
      "RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,\r\n",
      "RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,\r\n",
      "RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,\r\n",
      "RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,\r\n",
      "RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,\r\n",
      "RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,\r\n",
      "RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,\r\n",
      "RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,\r\n",
      "RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;\r\n",
      "RT   \"The transcriptional landscape of the mammalian genome.\";\r\n",
      "RL   Science 309:1559-1563(2005).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RC   STRAIN=C57BL/6J;\r\n",
      "RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;\r\n",
      "RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,\r\n",
      "RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,\r\n",
      "RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,\r\n",
      "RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,\r\n",
      "RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,\r\n",
      "RA   Eichler E.E., Ponting C.P.;\r\n",
      "RT   \"Lineage-specific biology revealed by a finished genome assembly of the\r\n",
      "RT   mouse.\";\r\n",
      "RL   PLoS Biol. 7:E1000112-E1000112(2009).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).\r\n",
      "RC   STRAIN=FVB/N-3; TISSUE=Mammary tumor;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 154-1790 (ISOFORM 2), INTERACTION WITH RB1,\r\n",
      "RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.\r\n",
      "RC   STRAIN=BALB/cJ;\r\n",
      "RX   PubMed=9037032; DOI=10.1073/pnas.94.4.1212;\r\n",
      "RA   Witte M.M., Scott R.E.;\r\n",
      "RT   \"The proliferation potential protein-related (P2P-R) gene with domains\r\n",
      "RT   encoding heterogeneous nuclear ribonucleoprotein association and Rb1\r\n",
      "RT   binding shows repressed expression during terminal differentiation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 94:1212-1217(1997).\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 204-1790 (ISOFORM 1), INTERACTION WITH TP53\r\n",
      "RP   AND RB1, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.\r\n",
      "RC   STRAIN=BALB/cJ; TISSUE=Testis;\r\n",
      "RX   PubMed=9010216; DOI=10.1038/sj.onc.1200825;\r\n",
      "RA   Simons A., Melamed-Bessudo C., Wolkowicz R., Sperling J., Sperling R.,\r\n",
      "RA   Eisenbach L., Rotter V.;\r\n",
      "RT   \"PACT: cloning and characterization of a cellular p53 binding protein that\r\n",
      "RT   interacts with Rb.\";\r\n",
      "RL   Oncogene 14:145-155(1997).\r\n",
      "RN   [6]\r\n",
      "RP   SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.\r\n",
      "RX   PubMed=12064457; DOI=10.1002/jcp.10084;\r\n",
      "RA   Gao S., Witte M.M., Scott R.E.;\r\n",
      "RT   \"P2P-R protein localizes to the nucleolus of interphase cells and the\r\n",
      "RT   periphery of chromosomes in mitotic cells which show maximum P2P-R\r\n",
      "RT   immunoreactivity.\";\r\n",
      "RL   J. Cell. Physiol. 191:145-154(2002).\r\n",
      "RN   [7]\r\n",
      "RP   ERRATUM OF PUBMED:12064457.\r\n",
      "RA   Gao S., Witte M.M., Scott R.E.;\r\n",
      "RL   J. Cell. Physiol. 192:359-360(2002).\r\n",
      "RN   [8]\r\n",
      "RP   SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=12384997; DOI=10.1002/jcp.10163;\r\n",
      "RA   Gao S., Scott R.E.;\r\n",
      "RT   \"P2P-R protein overexpression restricts mitotic progression at prometaphase\r\n",
      "RT   and promotes mitotic apoptosis.\";\r\n",
      "RL   J. Cell. Physiol. 193:199-207(2002).\r\n",
      "RN   [9]\r\n",
      "RP   INTERACTION WITH TP53.\r\n",
      "RX   PubMed=14566974; DOI=10.1002/jcp.10381;\r\n",
      "RA   Gao S., Scott R.E.;\r\n",
      "RT   \"Stable overexpression of specific segments of the P2P-R protein in human\r\n",
      "RT   MCF-7 cells promotes camptothecin-induced apoptosis.\";\r\n",
      "RL   J. Cell. Physiol. 197:445-452(2003).\r\n",
      "RN   [10]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-985; SER-1179; THR-1272 AND\r\n",
      "RP   SER-1329, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;\r\n",
      "RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;\r\n",
      "RT   \"Large-scale phosphorylation analysis of mouse liver.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).\r\n",
      "RN   [11]\r\n",
      "RP   DISRUPTION PHENOTYPE, AND FUNCTION.\r\n",
      "RX   PubMed=17470788; DOI=10.1073/pnas.0701916104;\r\n",
      "RA   Li L., Deng B., Xing G., Teng Y., Tian C., Cheng X., Yin X., Yang J.,\r\n",
      "RA   Gao X., Zhu Y., Sun Q., Zhang L., Yang X., He F.;\r\n",
      "RT   \"PACT is a negative regulator of p53 and essential for cell growth and\r\n",
      "RT   embryonic development.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 104:7951-7956(2007).\r\n",
      "RN   [12]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1179 AND SER-1329, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;\r\n",
      "RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,\r\n",
      "RA   Thibault P.;\r\n",
      "RT   \"The phagosomal proteome in interferon-gamma-activated macrophages.\";\r\n",
      "RL   Immunity 30:143-154(2009).\r\n",
      "RN   [13]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-361; THR-985; SER-1179;\r\n",
      "RP   SER-1278; SER-1329; SER-1648 AND SER-1651, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Lung, Pancreas,\r\n",
      "RC   Spleen, and Testis;\r\n",
      "RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;\r\n",
      "RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,\r\n",
      "RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;\r\n",
      "RT   \"A tissue-specific atlas of mouse protein phosphorylation and expression.\";\r\n",
      "RL   Cell 143:1174-1189(2010).\r\n",
      "RN   [14]\r\n",
      "RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-130, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Embryonic fibroblast;\r\n",
      "RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;\r\n",
      "RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,\r\n",
      "RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;\r\n",
      "RT   \"SIRT5-mediated lysine desuccinylation impacts diverse metabolic\r\n",
      "RT   pathways.\";\r\n",
      "RL   Mol. Cell 50:919-930(2013).\r\n",
      "RN   [15]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=24726359; DOI=10.1016/j.celrep.2014.03.030;\r\n",
      "RA   Miotto B., Chibi M., Xie P., Koundrioukoff S., Moolman-Smook H., Pugh D.,\r\n",
      "RA   Debatisse M., He F., Zhang L., Defossez P.A.;\r\n",
      "RT   \"The RBBP6/ZBTB38/MCM10 axis regulates DNA replication and common fragile\r\n",
      "RT   site stability.\";\r\n",
      "RL   Cell Rep. 7:575-587(2014).\r\n",
      "CC   -!- FUNCTION: E3 ubiquitin-protein ligase which promotes ubiquitination of\r\n",
      "CC       YBX1, leading to its degradation by the proteasome (By similarity). May\r\n",
      "CC       play a role as a scaffold protein to promote the assembly of the\r\n",
      "CC       p53/TP53-MDM2 complex, resulting in increase of MDM2-mediated\r\n",
      "CC       ubiquitination and degradation of p53/TP53; may function as negative\r\n",
      "CC       regulator of p53/TP53, leading to both apoptosis and cell growth\r\n",
      "CC       retardation (PubMed:17470788). Regulates DNA-replication and common\r\n",
      "CC       fragile sites (CFS) stability in a ZBTB38- and MCM10-dependent manner.\r\n",
      "CC       Controls ZBTB38 protein stability and abundance via ubiquitination and\r\n",
      "CC       proteasomal degradation, and ZBTB38 in turn negatively regulates the\r\n",
      "CC       expression of MCM10 which plays an important role in DNA-replication\r\n",
      "CC       (PubMed:24726359). {ECO:0000250|UniProtKB:Q7Z6E9,\r\n",
      "CC       ECO:0000269|PubMed:17470788, ECO:0000269|PubMed:24726359}.\r\n",
      "CC   -!- CATALYTIC ACTIVITY:\r\n",
      "CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +\r\n",
      "CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-\r\n",
      "CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;\r\n",
      "CC         EC=2.3.2.27;\r\n",
      "CC   -!- PATHWAY: Protein modification; protein ubiquitination.\r\n",
      "CC   -!- SUBUNIT: Interacts with MDM2 and YBX1 (By similarity). Interacts also\r\n",
      "CC       with p53/TP53 and RB1. Interacts with NEK6 (By similarity). Interacts\r\n",
      "CC       with ZBTB38 (By similarity). {ECO:0000250|UniProtKB:Q7Z6E9,\r\n",
      "CC       ECO:0000269|PubMed:14566974, ECO:0000269|PubMed:9010216,\r\n",
      "CC       ECO:0000269|PubMed:9037032}.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus. Chromosome. Cytoplasm,\r\n",
      "CC       cytoskeleton, microtubule organizing center, centrosome {ECO:0000250}.\r\n",
      "CC       Note=Colocalizes with mitotic chromosomes. Co-localizes with NEK6 in\r\n",
      "CC       the centrosome (By similarity). {ECO:0000250}.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=3;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=P97868-1; Sequence=Displayed;\r\n",
      "CC       Name=2;\r\n",
      "CC         IsoId=P97868-2; Sequence=VSP_018287;\r\n",
      "CC       Name=3;\r\n",
      "CC         IsoId=P97868-3; Sequence=VSP_018285, VSP_018286;\r\n",
      "CC   -!- TISSUE SPECIFICITY: Highly expressed in testis. Expressed at lower\r\n",
      "CC       levels in brain, heart, kidney, liver, lung, skeletal muscle, spleen,\r\n",
      "CC       thymus and tongue. {ECO:0000269|PubMed:9010216,\r\n",
      "CC       ECO:0000269|PubMed:9037032}.\r\n",
      "CC   -!- DEVELOPMENTAL STAGE: Expression is reduced during terminal\r\n",
      "CC       differentiation. Expression is induced in the G2/M phase of the cell\r\n",
      "CC       cycle (at protein level). {ECO:0000269|PubMed:12064457,\r\n",
      "CC       ECO:0000269|PubMed:9037032}.\r\n",
      "CC   -!- DOMAIN: Contains a N-terminus DWNN domain, a zinc-finger domain and a\r\n",
      "CC       C4C4 zinc-binding RING finger domain (By similarity). The ring finger\r\n",
      "CC       may indeed be a U-box domain (By similarity).\r\n",
      "CC       {ECO:0000250|UniProtKB:Q7Z6E9}.\r\n",
      "CC   -!- PTM: Phosphorylated by NEK6. {ECO:0000250}.\r\n",
      "CC   -!- DISRUPTION PHENOTYPE: Early embryonic lethality before 7.5 dpc,\r\n",
      "CC       accompanied by accumulation of p53 and widespread apoptosis.\r\n",
      "CC       {ECO:0000269|PubMed:17470788}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=AAC72432.1; Type=Frameshift; Evidence={ECO:0000305};\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AK045635; BAC32441.1; -; mRNA.\r\n",
      "DR   EMBL; AK079129; BAC37553.1; -; mRNA.\r\n",
      "DR   EMBL; AK081261; BAC38179.1; -; mRNA.\r\n",
      "DR   EMBL; AK144758; BAE26051.1; -; mRNA.\r\n",
      "DR   EMBL; AK160656; BAE35944.1; -; mRNA.\r\n",
      "DR   EMBL; AK161231; BAE36255.1; -; mRNA.\r\n",
      "DR   EMBL; AC125221; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; BC025874; AAH25874.1; -; mRNA.\r\n",
      "DR   EMBL; U83913; AAC72432.1; ALT_FRAME; mRNA.\r\n",
      "DR   EMBL; U28789; AAB49620.1; -; mRNA.\r\n",
      "DR   CCDS; CCDS52387.1; -. [P97868-1]\r\n",
      "DR   PIR; T42727; T42727.\r\n",
      "DR   RefSeq; NP_035377.2; NM_011247.2. [P97868-1]\r\n",
      "DR   RefSeq; NP_778188.1; NM_175023.3.\r\n",
      "DR   RefSeq; XP_006507533.1; XM_006507470.3. [P97868-2]\r\n",
      "DR   AlphaFoldDB; P97868; -.\r\n",
      "DR   BMRB; P97868; -.\r\n",
      "DR   SMR; P97868; -.\r\n",
      "DR   BioGRID; 202817; 7.\r\n",
      "DR   IntAct; P97868; 2.\r\n",
      "DR   MINT; P97868; -.\r\n",
      "DR   STRING; 10090.ENSMUSP00000049528; -.\r\n",
      "DR   GlyGen; P97868; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; P97868; -.\r\n",
      "DR   PhosphoSitePlus; P97868; -.\r\n",
      "DR   EPD; P97868; -.\r\n",
      "DR   jPOST; P97868; -.\r\n",
      "DR   MaxQB; P97868; -.\r\n",
      "DR   PaxDb; P97868; -.\r\n",
      "DR   PeptideAtlas; P97868; -.\r\n",
      "DR   ProteomicsDB; 255114; -. [P97868-1]\r\n",
      "DR   ProteomicsDB; 255115; -. [P97868-2]\r\n",
      "DR   ProteomicsDB; 255116; -. [P97868-3]\r\n",
      "DR   Antibodypedia; 26070; 364 antibodies from 30 providers.\r\n",
      "DR   DNASU; 19647; -.\r\n",
      "DR   Ensembl; ENSMUST00000052135.14; ENSMUSP00000049528.8; ENSMUSG00000030779.17.\r\n",
      "DR   Ensembl; ENSMUST00000071590.6; ENSMUSP00000071519.6; ENSMUSG00000030779.17. [P97868-2]\r\n",
      "DR   GeneID; 19647; -.\r\n",
      "DR   KEGG; mmu:19647; -.\r\n",
      "DR   UCSC; uc009jow.2; mouse. [P97868-3]\r\n",
      "DR   UCSC; uc009joy.2; mouse. [P97868-1]\r\n",
      "DR   AGR; MGI:894835; -.\r\n",
      "DR   CTD; 5930; -.\r\n",
      "DR   MGI; MGI:894835; Rbbp6.\r\n",
      "DR   VEuPathDB; HostDB:ENSMUSG00000030779; -.\r\n",
      "DR   eggNOG; KOG0314; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00940000157561; -.\r\n",
      "DR   HOGENOM; CLU_239162_0_0_1; -.\r\n",
      "DR   InParanoid; P97868; -.\r\n",
      "DR   OMA; ECIRTFL; -.\r\n",
      "DR   OrthoDB; 150979at2759; -.\r\n",
      "DR   PhylomeDB; P97868; -.\r\n",
      "DR   TreeFam; TF350543; -.\r\n",
      "DR   Reactome; R-MMU-9013422; RHOBTB1 GTPase cycle.\r\n",
      "DR   Reactome; R-MMU-983168; Antigen processing: Ubiquitination & Proteasome degradation.\r\n",
      "DR   UniPathway; UPA00143; -.\r\n",
      "DR   BioGRID-ORCS; 19647; 27 hits in 76 CRISPR screens.\r\n",
      "DR   ChiTaRS; Rbbp6; mouse.\r\n",
      "DR   PRO; PR:P97868; -.\r\n",
      "DR   Proteomes; UP000000589; Chromosome 7.\r\n",
      "DR   RNAct; P97868; protein.\r\n",
      "DR   Bgee; ENSMUSG00000030779; Expressed in embryonic post-anal tail and 255 other tissues.\r\n",
      "DR   ExpressionAtlas; P97868; baseline and differential.\r\n",
      "DR   Genevisible; P97868; MM.\r\n",
      "DR   GO; GO:0005813; C:centrosome; ISO:MGI.\r\n",
      "DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.\r\n",
      "DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0016607; C:nuclear speck; ISO:MGI.\r\n",
      "DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.\r\n",
      "DR   GO; GO:0032991; C:protein-containing complex; ISO:MGI.\r\n",
      "DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.\r\n",
      "DR   GO; GO:0019901; F:protein kinase binding; ISO:MGI.\r\n",
      "DR   GO; GO:0061630; F:ubiquitin protein ligase activity; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.\r\n",
      "DR   GO; GO:0006974; P:DNA damage response; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0048568; P:embryonic organ development; IGI:MGI.\r\n",
      "DR   GO; GO:0001701; P:in utero embryonic development; IMP:MGI.\r\n",
      "DR   GO; GO:0006397; P:mRNA processing; IEA:InterPro.\r\n",
      "DR   GO; GO:0035264; P:multicellular organism growth; IMP:MGI.\r\n",
      "DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006275; P:regulation of DNA replication; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0061053; P:somite development; IMP:MGI.\r\n",
      "DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB.\r\n",
      "DR   CDD; cd16620; vRING-HC-C4C4_RBBP6; 1.\r\n",
      "DR   Gene3D; 4.10.60.10; Zinc finger, CCHC-type; 1.\r\n",
      "DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.\r\n",
      "DR   InterPro; IPR014891; DWNN_domain.\r\n",
      "DR   InterPro; IPR033489; RBBP6.\r\n",
      "DR   InterPro; IPR003613; Ubox_domain.\r\n",
      "DR   InterPro; IPR025829; Zn_knuckle_CX2CX3GHX4C.\r\n",
      "DR   InterPro; IPR001878; Znf_CCHC.\r\n",
      "DR   InterPro; IPR036875; Znf_CCHC_sf.\r\n",
      "DR   InterPro; IPR001841; Znf_RING.\r\n",
      "DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.\r\n",
      "DR   PANTHER; PTHR15439:SF0; E3 UBIQUITIN-PROTEIN LIGASE RBBP6; 1.\r\n",
      "DR   PANTHER; PTHR15439; RETINOBLASTOMA-BINDING PROTEIN 6; 1.\r\n",
      "DR   Pfam; PF08783; DWNN; 1.\r\n",
      "DR   Pfam; PF04564; U-box; 1.\r\n",
      "DR   Pfam; PF13696; zf-CCHC_2; 1.\r\n",
      "DR   SMART; SM01180; DWNN; 1.\r\n",
      "DR   SMART; SM00184; RING; 1.\r\n",
      "DR   SMART; SM00343; ZnF_C2HC; 1.\r\n",
      "DR   SUPFAM; SSF57756; Retrovirus zinc finger-like domains; 1.\r\n",
      "DR   SUPFAM; SSF57850; RING/U-box; 1.\r\n",
      "DR   PROSITE; PS51282; DWNN; 1.\r\n",
      "DR   PROSITE; PS50158; ZF_CCHC; 1.\r\n",
      "DR   PROSITE; PS50089; ZF_RING_2; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Acetylation; Alternative splicing; Chromosome; Cytoplasm; Cytoskeleton;\r\n",
      "KW   DNA damage; DNA replication; Isopeptide bond; Metal-binding; Nucleus;\r\n",
      "KW   Phosphoprotein; Reference proteome; Transferase; Ubl conjugation;\r\n",
      "KW   Ubl conjugation pathway; Zinc; Zinc-finger.\r\n",
      "FT   CHAIN           1..1790\r\n",
      "FT                   /note=\"E3 ubiquitin-protein ligase RBBP6\"\r\n",
      "FT                   /id=\"PRO_0000234355\"\r\n",
      "FT   DOMAIN          4..76\r\n",
      "FT                   /note=\"DWNN\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00612\"\r\n",
      "FT   ZN_FING         160..177\r\n",
      "FT                   /note=\"CCHC-type\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00047\"\r\n",
      "FT   ZN_FING         260..301\r\n",
      "FT                   /note=\"RING-type; degenerate\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00175\"\r\n",
      "FT   REGION          329..353\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          374..408\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          533..599\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          622..641\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          648..667\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          675..797\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          850..1292\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          983..1139\r\n",
      "FT                   /note=\"Interaction with RB1\"\r\n",
      "FT   REGION          1322..1790\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1434..1544\r\n",
      "FT                   /note=\"Interaction with p53\"\r\n",
      "FT   COMPBIAS        335..352\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        554..599\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        687..730\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        736..767\r\n",
      "FT                   /note=\"Basic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        773..787\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        905..930\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        983..1030\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1037..1071\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1084..1165\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1175..1204\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1220..1234\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1235..1256\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1258..1280\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1336..1361\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1362..1436\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1449..1579\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1647..1674\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1675..1723\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1726..1750\r\n",
      "FT                   /note=\"Basic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1774..1790\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         130\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23806337\"\r\n",
      "FT   MOD_RES         245\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         246\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         247\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         248\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         361\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         517\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         769\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         771\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         773\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         781\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         816\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         862\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         874\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         958\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         985\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355,\r\n",
      "FT                   ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         1179\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355,\r\n",
      "FT                   ECO:0007744|PubMed:19144319, ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         1272\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355\"\r\n",
      "FT   MOD_RES         1278\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         1329\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355,\r\n",
      "FT                   ECO:0007744|PubMed:19144319, ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         1342\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         1348\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         1469\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         1646\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         1648\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         1651\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   CROSSLNK        1107\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   CROSSLNK        1169\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   VAR_SEQ         102..123\r\n",
      "FT                   /note=\"IDDASASISLAQLTKTANLAEA -> VCKNTITLFLHNCFYLYNVSVT (in\r\n",
      "FT                   isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334,\r\n",
      "FT                   ECO:0000303|PubMed:16141072\"\r\n",
      "FT                   /id=\"VSP_018285\"\r\n",
      "FT   VAR_SEQ         124..1756\r\n",
      "FT                   /note=\"Missing (in isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334,\r\n",
      "FT                   ECO:0000303|PubMed:16141072\"\r\n",
      "FT                   /id=\"VSP_018286\"\r\n",
      "FT   VAR_SEQ         653..686\r\n",
      "FT                   /note=\"Missing (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:16141072,\r\n",
      "FT                   ECO:0000303|PubMed:9037032\"\r\n",
      "FT                   /id=\"VSP_018287\"\r\n",
      "FT   CONFLICT        254\r\n",
      "FT                   /note=\"I -> F (in Ref. 5; AAB49620)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        317..318\r\n",
      "FT                   /note=\"RQ -> GR (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        341\r\n",
      "FT                   /note=\"P -> H (in Ref. 5; AAB49620)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        418\r\n",
      "FT                   /note=\"S -> F (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        421\r\n",
      "FT                   /note=\"V -> S (in Ref. 5; AAB49620)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        580\r\n",
      "FT                   /note=\"P -> L (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        595\r\n",
      "FT                   /note=\"P -> T (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        615..622\r\n",
      "FT                   /note=\"PWVSSGVQ -> ACFSPGVP (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        629\r\n",
      "FT                   /note=\"I -> M (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        636\r\n",
      "FT                   /note=\"P -> L (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        647\r\n",
      "FT                   /note=\"R -> K (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        689\r\n",
      "FT                   /note=\"S -> F (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        703\r\n",
      "FT                   /note=\"Y -> D (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        789\r\n",
      "FT                   /note=\"Q -> R (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        940\r\n",
      "FT                   /note=\"R -> Q (in Ref. 1; BAE36255)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        941\r\n",
      "FT                   /note=\"R -> RNEE (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        956..958\r\n",
      "FT                   /note=\"ETS -> GKF (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        963\r\n",
      "FT                   /note=\"E -> G (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        978\r\n",
      "FT                   /note=\"L -> F (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        982\r\n",
      "FT                   /note=\"D -> E (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1012\r\n",
      "FT                   /note=\"K -> N (in Ref. 5; AAB49620)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1290\r\n",
      "FT                   /note=\"K -> T (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1316\r\n",
      "FT                   /note=\"Q -> H (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1564\r\n",
      "FT                   /note=\"N -> I (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1581\r\n",
      "FT                   /note=\"E -> D (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1591\r\n",
      "FT                   /note=\"P -> L (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1596\r\n",
      "FT                   /note=\"P -> L (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1604\r\n",
      "FT                   /note=\"A -> V (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   1790 AA;  199587 MW;  3909C30EB9DD2CE3 CRC64;\r\n",
      "     MSCVHYKFSS KLNYDTVTFD GLHISLCDLK KQIMGREKLK AADSDLQITN AQTKEEYTDD\r\n",
      "     NALIPKNSSV IVRRIPIGGV KSTSKTYVIS RTEPVMGTTK AIDDASASIS LAQLTKTANL\r\n",
      "     AEANASEEDK IKAMMSQSGH EYDPINYMKK TLVGPPPPSY TCFRCGKPGH YIKNCPTNGD\r\n",
      "     KNFESGPRIK KSTGIPRSFM MEVKDPNMKG AMLTNTGKYA IPTIDAEAYA IGKKEKPPFL\r\n",
      "     PEEPSSSSEE DDPIPDELLC LICKDIMTDA VVIPCCGNSY CDECIRTALL ESDEHTCPTC\r\n",
      "     HQNDVSPDAL IANKFLRQAV NNFKNETGYT KRLRKQLPPP PPPVPPPRPL MQRNLQPLMR\r\n",
      "     SPISRQQDPL MIPVTSSSAH SAPSISSLTS NPSALAPSVS GNPSSAPAPV PDITATVSIS\r\n",
      "     VHSEKSDGPF RDSDNKLLPA AALTSEHSKG ASSIAITALM EEKGYQVPVL GTPSLLGQSL\r\n",
      "     LHGQLIPTTG PVRINAARPG GGRPGWEHSN KLGYLVSPPQ QIRRGERSCY RSINRGRHHS\r\n",
      "     ERSQRTQGPS LPATPVFVPV PPPPLYPPPP HTLPLPPGVP PPQFSPQFPP GQPPPAGYSV\r\n",
      "     PPPGFPPAPA NISTPWVSSG VQTAHSNTIP TTQAPPLSRE EFYREQRRLK EEEKKKSKLD\r\n",
      "     EFTNDFAKEL MEYKKIQKER RRSFSRSKSP YSGSSYSRSS YTYSKSRSGS TRSRSYSRSF\r\n",
      "     SRSHSRSYSR SPPYPRRGRG KSRNYRSRSR SHGYHRSRSR SPPYRRYHSR SRSPQAFRGQ\r\n",
      "     SPTKRNVPQG ETEREYFNRY REVPPPYDIK AYYGRSVDFR DPFEKERYRE WERKYREWYE\r\n",
      "     KYYKGYAVGA QPRPSANRED FSPERLLPLN IRNSPFTRGR REDYAAGQSH RNRNLGGNYP\r\n",
      "     EKLSTRDSHN AKDNPKSKEK ESENVPGDGK GNKHKKHRKR RKGEESESFL NPELLETSRK\r\n",
      "     CRESSGIDET KTDTLFVLPS RDDATPVRDE PMDAESITFK SVSDKDKREK DKPKVKSDKT\r\n",
      "     KRKSDGSATA KKDNVLKPSK GPQEKVDGDR EKSPRSEPPL KKAKEEATKI DSVKPSSSSQ\r\n",
      "     KDEKVTGTPR KAHSKSAKEH QEAKPAKDEK VKKDCSKDIK SEKPASKDEK AKKPEKNKLL\r\n",
      "     DSKGEKRKRK TEEKSVDKDF ESSSMKISKV EGTEIVKPSP KRKMEGDVEK LERTPEKDKI\r\n",
      "     ASSTTPAKKI KLNRETGKKI GNAENASTTK EPSEKLESTS SKIKQEKVKG KAKRKVAGSE\r\n",
      "     GSSSTLVDYT STSSTGGSPV RKSEEKTDTK RTVIKTMEEY NNDNTAPAED VIIMIQVPQS\r\n",
      "     KWDKDDFESE EEDVKTTQPI QSVGKPSSII KNVTTKPSAT AKYTEKESEQ PEKLQKLPKE\r\n",
      "     ASHELMQHEL RSSKGSASSE KGRAKDREHS GSEKDNPDKR KSGAQPDKES TVDRLSEQGH\r\n",
      "     FKTLSQSSKE TRTSEKHESV RGSSNKDFTP GRDKKVDYDS RDYSSSKRRD ERGELARRKD\r\n",
      "     SPPRGKESLS GQKSKLREER DLPKKGAESK KSNSSPPRDK KPHDHKAPYE TKRPCEETKP\r\n",
      "     VDKNSGKERE KHAAEARNGK ESSGGKLPCI PNPPDPPMEK ELAAGQVEKS AVKPKPQLSH\r\n",
      "     SSRLSSDLTR ETDEAAFEPD YNESDSESNV SVKEEEAVAS ISKDLKEKTT EKAKESLTVA\r\n",
      "     TASQPGADRS QSQSSPSVSP SRSHSPSGSQ TRSHSSSASS AGSQDSKKKK KKKEKKKHKK\r\n",
      "     HKKHKKHKKH AGADGDVEKS QKHKHKKKKA KKNKDKEKEK DDQKVRSVTV\r\n",
      "//\r\n",
      "ID   RBL1_RAT                Reviewed;        1049 AA.\r\n",
      "AC   D3ZS28;\r\n",
      "DT   31-JUL-2019, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   31-JUL-2019, sequence version 4.\r\n",
      "DT   03-MAY-2023, entry version 91.\r\n",
      "DE   RecName: Full=Retinoblastoma-like protein 1 {ECO:0000305};\r\n",
      "DE   AltName: Full=107 kDa retinoblastoma-associated protein {ECO:0000305};\r\n",
      "DE            Short=p107 {ECO:0000305};\r\n",
      "DE   AltName: Full=pRb1 {ECO:0000305};\r\n",
      "GN   Name=Rbl1 {ECO:0000312|RGD:1595511};\r\n",
      "OS   Rattus norvegicus (Rat).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Rattus.\r\n",
      "OX   NCBI_TaxID=10116 {ECO:0000312|Proteomes:UP000002494};\r\n",
      "RN   [1] {ECO:0000312|Proteomes:UP000002494}\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RC   STRAIN=Brown Norway {ECO:0000312|Proteomes:UP000002494};\r\n",
      "RX   PubMed=15057822; DOI=10.1038/nature02426;\r\n",
      "RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,\r\n",
      "RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,\r\n",
      "RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,\r\n",
      "RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,\r\n",
      "RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,\r\n",
      "RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,\r\n",
      "RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,\r\n",
      "RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,\r\n",
      "RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,\r\n",
      "RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,\r\n",
      "RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,\r\n",
      "RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,\r\n",
      "RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,\r\n",
      "RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,\r\n",
      "RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,\r\n",
      "RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,\r\n",
      "RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,\r\n",
      "RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,\r\n",
      "RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,\r\n",
      "RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,\r\n",
      "RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,\r\n",
      "RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,\r\n",
      "RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,\r\n",
      "RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,\r\n",
      "RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,\r\n",
      "RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,\r\n",
      "RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,\r\n",
      "RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,\r\n",
      "RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,\r\n",
      "RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,\r\n",
      "RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,\r\n",
      "RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,\r\n",
      "RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,\r\n",
      "RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,\r\n",
      "RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,\r\n",
      "RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,\r\n",
      "RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,\r\n",
      "RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,\r\n",
      "RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,\r\n",
      "RA   Mockrin S., Collins F.S.;\r\n",
      "RT   \"Genome sequence of the Brown Norway rat yields insights into mammalian\r\n",
      "RT   evolution.\";\r\n",
      "RL   Nature 428:493-521(2004).\r\n",
      "RN   [2] {ECO:0000305}\r\n",
      "RP   INTERACTION WITH RBBP9.\r\n",
      "RX   PubMed=9697699; DOI=10.1038/1258;\r\n",
      "RA   Woitach J.T., Zhang M., Niu C.-H., Thorgeirsson S.S.;\r\n",
      "RT   \"A retinoblastoma-binding protein that affects cell-cycle control and\r\n",
      "RT   confers transforming ability.\";\r\n",
      "RL   Nat. Genet. 19:371-374(1998).\r\n",
      "RN   [3] {ECO:0007744|PubMed:22673903}\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=22673903; DOI=10.1038/ncomms1871;\r\n",
      "RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,\r\n",
      "RA   Olsen J.V.;\r\n",
      "RT   \"Quantitative maps of protein phosphorylation sites across 14 different rat\r\n",
      "RT   organs and tissues.\";\r\n",
      "RL   Nat. Commun. 3:876-876(2012).\r\n",
      "CC   -!- FUNCTION: Key regulator of entry into cell division (By similarity).\r\n",
      "CC       Directly involved in heterochromatin formation by maintaining overall\r\n",
      "CC       chromatin structure and, in particular, that of constitutive\r\n",
      "CC       heterochromatin by stabilizing histone methylation. Recruits and\r\n",
      "CC       targets histone methyltransferases KMT5B and KMT5C, leading to\r\n",
      "CC       epigenetic transcriptional repression. Controls histone H4 'Lys-20'\r\n",
      "CC       trimethylation. Probably acts as a transcription repressor by\r\n",
      "CC       recruiting chromatin-modifying enzymes to promoters (By similarity).\r\n",
      "CC       Potent inhibitor of E2F-mediated trans-activation. May act as a tumor\r\n",
      "CC       suppressor (By similarity). {ECO:0000250|UniProtKB:P28749,\r\n",
      "CC       ECO:0000250|UniProtKB:Q64701}.\r\n",
      "CC   -!- SUBUNIT: Component of the DREAM complex (also named LINC complex) at\r\n",
      "CC       least composed of E2F4, E2F5, LIN9, LIN37, LIN52, LIN54, MYBL1, MYBL2,\r\n",
      "CC       RBL1, RBL2, RBBP4, TFDP1 and TFDP2. The complex exists in quiescent\r\n",
      "CC       cells where it represses cell cycle-dependent genes. It dissociates in\r\n",
      "CC       S phase when LIN9, LIN37, LIN52 and LIN54 form a subcomplex that binds\r\n",
      "CC       to MYBL2. Interacts with AATF. Interacts with KDM5A (By similarity).\r\n",
      "CC       Interacts with KMT5B and KMT5C. Interacts with USP4 (By similarity).\r\n",
      "CC       Interacts with RBBP9 (PubMed:9697699). {ECO:0000250|UniProtKB:P28749,\r\n",
      "CC       ECO:0000250|UniProtKB:Q64701, ECO:0000269|PubMed:9697699}.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.\r\n",
      "CC   -!- PTM: Cell-cycle arrest properties are inactivated by phosphorylation on\r\n",
      "CC       Thr-332, Ser-640, Ser-959 and Ser-970 by CDK4.\r\n",
      "CC       {ECO:0000250|UniProtKB:P28749}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AABR07054428; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AABR07054429; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   RefSeq; NP_001177995.1; NM_001191066.1.\r\n",
      "DR   AlphaFoldDB; D3ZS28; -.\r\n",
      "DR   SMR; D3ZS28; -.\r\n",
      "DR   MINT; D3ZS28; -.\r\n",
      "DR   STRING; 10116.ENSRNOP00000063017; -.\r\n",
      "DR   PaxDb; D3ZS28; -.\r\n",
      "DR   GeneID; 680111; -.\r\n",
      "DR   KEGG; rno:680111; -.\r\n",
      "DR   AGR; RGD:1595511; -.\r\n",
      "DR   CTD; 5933; -.\r\n",
      "DR   RGD; 1595511; Rbl1.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   HOGENOM; CLU_008943_0_1_1; -.\r\n",
      "DR   InParanoid; D3ZS28; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   Reactome; R-RNO-1538133; G0 and Early G1.\r\n",
      "DR   Reactome; R-RNO-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.\r\n",
      "DR   Reactome; R-RNO-69231; Cyclin D associated events in G1.\r\n",
      "DR   PRO; PR:D3ZS28; -.\r\n",
      "DR   Proteomes; UP000002494; Unplaced.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0005634; C:nucleus; ISO:RGD.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.\r\n",
      "DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:RGD.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:2000773; P:negative regulation of cellular senescence; ISO:RGD.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; ISO:RGD.\r\n",
      "DR   CDD; cd20605; CYCLIN_RBL1; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 3.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   PANTHER; PTHR13742:SF20; RETINOBLASTOMA-LIKE PROTEIN 1; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Cell cycle; Chromatin regulator; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Repressor; Transcription; Transcription regulation;\r\n",
      "KW   Tumor suppressor.\r\n",
      "FT   CHAIN           1..1049\r\n",
      "FT                   /note=\"Retinoblastoma-like protein 1\"\r\n",
      "FT                   /id=\"PRO_0000447676\"\r\n",
      "FT   REGION          385..944\r\n",
      "FT                   /note=\"Pocket; binds T and E1A\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   REGION          385..584\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   REGION          585..779\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   REGION          780..944\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   MOD_RES         332\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         369\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         385\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         640\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         650\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         748\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         761\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         959\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         970\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         983\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         992\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         1004\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         1022\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "SQ   SEQUENCE   1049 AA;  117818 MW;  68F2C046818BB277 CRC64;\r\n",
      "     MFEDEPHAEG AAAVAAAREA LQALCQELNL DEGSAAEALD DFTAIRGNYS LEGEVIHWLA\r\n",
      "     CSLYVACRKS IIPTVGKGVM EGNCVSLTRI LRSAKLSLIQ FFSKMKKWMD MSNLPQEFRE\r\n",
      "     RIERLERNFE VSTVIFKKFE PIFLDIFQNP YEELPKLPRS RKQRRIPCSV KDLFNFCWTL\r\n",
      "     FVYTKGNFRM IGDDLVNSYH LLLCCLDLIF ANAIMCPNRR DLLNPSFKGL PSDFHAVNFK\r\n",
      "     AAEEPPCIIA VLCDLHDGLL VEAKGIKEHY FKPYISKLFD KKILKGECLL DLSSFTDNSK\r\n",
      "     AVNKEYEEYV LTVGDFDERI FLGADAEEEI GTPRKFAADT QFGKLTSQAS VDCNLQQHFE\r\n",
      "     KKRSFAPSTP LTGRRYLQEK EAVTTPVASA TQSVSRLQSI VAGLKSAPSE QLLTIFESCM\r\n",
      "     RNPMGNIVKI VKGIGETFCQ HYTQSTDKQP GSHIDFAVNR LKLAEILYYK ILETIMVQET\r\n",
      "     RRLHGMDMSV LLEQDIFHRS LLACCLEIVL FAYSSPRTFP WIIDVLGLQP FYFYKVIEVV\r\n",
      "     IRSEEGLSRD MVKHLNSIEE QILESLAWTN NSALWEALRA SANKVPSCEE VIFPNNFEIG\r\n",
      "     NGGSVQGHLP MMPMSPIIHP RVKEVRTDSG SLRKDMQPLS PISVHERYSS PAAGSAKRRL\r\n",
      "     FGDDPPKETL MEKIMAEGTQ LKIAPSSVTA ESLSISPGQA LLTMATTTVT GTTGRKVTVP\r\n",
      "     LHGIANDAGE ITLVPISMNT TQDSTAESLV SLTAQSLIGA SPKQTHLTKT QDAPLTGISK\r\n",
      "     PKRTGSLALF YRKVYHLASV RLRDLCLKLD VSNELRRKIW TCFEFTLVHC PDLMKDRHLD\r\n",
      "     QLLLCAFYIM AKVTKEERTF QEIMKSYRNQ PQANSHVYRS VLLKSIPGEV VAYNGDYEMT\r\n",
      "     DGDIEDATKT PNCSSEPVKE ERGDLIKFYN AIYVGRVKSF ALKYDLSNQD HIMDAPPLSP\r\n",
      "     FPHIKQQPGS PRRISQQHSI YVSPHKNASG LTPRSALLYK FNGSPSKKAK KRVIAISGDA\r\n",
      "     ESPAKRLCQE NDDVLLKRLQ DVVSERANH\r\n",
      "//\r\n",
      "ID   RBL2_RAT                Reviewed;        1135 AA.\r\n",
      "AC   O55081;\r\n",
      "DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   01-JUN-1998, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 157.\r\n",
      "DE   RecName: Full=Retinoblastoma-like protein 2;\r\n",
      "DE   AltName: Full=130 kDa retinoblastoma-associated protein;\r\n",
      "DE            Short=p130;\r\n",
      "DE   AltName: Full=PPAR-alpha-interacting complex protein 128;\r\n",
      "DE            Short=PRIC128;\r\n",
      "DE   AltName: Full=Retinoblastoma-related protein 2;\r\n",
      "DE            Short=RBR-2;\r\n",
      "DE   AltName: Full=pRb2;\r\n",
      "GN   Name=Rbl2;\r\n",
      "OS   Rattus norvegicus (Rat).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Rattus.\r\n",
      "OX   NCBI_TaxID=10116;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RC   STRAIN=Sprague-Dawley; TISSUE=Spleen;\r\n",
      "RX   PubMed=9247086; DOI=10.1016/s0925-4439(97)00037-9;\r\n",
      "RA   Sawada Y., Nomura H., Endo Y., Umeki K., Fujita T., Ohtaki S., Fujinaga K.;\r\n",
      "RT   \"Cloning and characterization of the rat p130, a member of the\r\n",
      "RT   retinoblastoma gene family.\";\r\n",
      "RL   Biochim. Biophys. Acta 1361:20-27(1997).\r\n",
      "RN   [2]\r\n",
      "RP   PROTEIN SEQUENCE OF 276-288 AND 829-838, AND SUBUNIT.\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=12189208; DOI=10.1073/pnas.182426699;\r\n",
      "RA   Surapureddi S., Yu S., Bu H., Hashimoto T., Yeldandi A.V., Kashireddy P.,\r\n",
      "RA   Cherkaoui-Malki M., Qi C., Zhu Y.-J., Rao M.S., Reddy J.K.;\r\n",
      "RT   \"Identification of a transcriptionally active peroxisome proliferator-\r\n",
      "RT   activated receptor alpha-interacting cofactor complex in rat liver and\r\n",
      "RT   characterization of PRIC285 as a coactivator.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 99:11836-11841(2002).\r\n",
      "RN   [3]\r\n",
      "RP   INTERACTION WITH RBBP9.\r\n",
      "RX   PubMed=9697699; DOI=10.1038/1258;\r\n",
      "RA   Woitach J.T., Zhang M., Niu C.-H., Thorgeirsson S.S.;\r\n",
      "RT   \"A retinoblastoma-binding protein that affects cell-cycle control and\r\n",
      "RT   confers transforming ability.\";\r\n",
      "RL   Nat. Genet. 19:371-374(1998).\r\n",
      "RN   [4]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-636; THR-639; SER-946;\r\n",
      "RP   SER-1064 AND SER-1108, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE\r\n",
      "RP   ANALYSIS].\r\n",
      "RX   PubMed=22673903; DOI=10.1038/ncomms1871;\r\n",
      "RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,\r\n",
      "RA   Olsen J.V.;\r\n",
      "RT   \"Quantitative maps of protein phosphorylation sites across 14 different rat\r\n",
      "RT   organs and tissues.\";\r\n",
      "RL   Nat. Commun. 3:876-876(2012).\r\n",
      "CC   -!- FUNCTION: Key regulator of entry into cell division. Directly involved\r\n",
      "CC       in heterochromatin formation by maintaining overall chromatin structure\r\n",
      "CC       and, in particular, that of constitutive heterochromatin by stabilizing\r\n",
      "CC       histone methylation. Recruits and targets histone methyltransferases\r\n",
      "CC       KMT5B and KMT5C, leading to epigenetic transcriptional repression.\r\n",
      "CC       Controls histone H4 'Lys-20' trimethylation. Probably acts as a\r\n",
      "CC       transcription repressor by recruiting chromatin-modifying enzymes to\r\n",
      "CC       promoters. Potent inhibitor of E2F-mediated trans-activation,\r\n",
      "CC       associates preferentially with E2F5. Binds to cyclins A and E. Binds to\r\n",
      "CC       and may be involved in the transforming capacity of the adenovirus E1A\r\n",
      "CC       protein. May act as a tumor suppressor (By similarity). {ECO:0000250}.\r\n",
      "CC   -!- SUBUNIT: Interacts with AATF, KMT5B and KMT5C. Component of the DREAM\r\n",
      "CC       complex (also named LINC complex) at least composed of E2F4, E2F5,\r\n",
      "CC       LIN9, LIN37, LIN52, LIN54, MYBL1, MYBL2, RBL1, RBL2, RBBP4, TFDP1 and\r\n",
      "CC       TFDP2. The complex exists in quiescent cells where it represses cell\r\n",
      "CC       cycle-dependent genes. It dissociates in S phase when LIN9, LIN37,\r\n",
      "CC       LIN52 and LIN54 form a subcomplex that binds to MYBL2. Interacts with\r\n",
      "CC       USP4 (By similarity). Part of the peroxisome proliferator activated\r\n",
      "CC       receptor alpha (PPAR-alpha) interacting complex (PRIC). Interacts with\r\n",
      "CC       RINT1 (By similarity). Interacts with PML (By similarity). Interacts\r\n",
      "CC       with RBBP9 (PubMed:9697699). {ECO:0000250, ECO:0000269|PubMed:9697699}.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus.\r\n",
      "CC   -!- PTM: During G0 and early G1 phase of the cell cycle, phosphorylated on\r\n",
      "CC       Ser-636 and on 5 sites within the domain B. Phosphorylation on Ser-669\r\n",
      "CC       in G1 leads to its ubiquitin-dependent proteolysis (By similarity).\r\n",
      "CC       {ECO:0000250}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; D55627; BAA24196.1; -; mRNA.\r\n",
      "DR   RefSeq; NP_112356.1; NM_031094.1.\r\n",
      "DR   AlphaFoldDB; O55081; -.\r\n",
      "DR   SMR; O55081; -.\r\n",
      "DR   BioGRID; 249630; 5.\r\n",
      "DR   IntAct; O55081; 1.\r\n",
      "DR   STRING; 10116.ENSRNOP00000017361; -.\r\n",
      "DR   iPTMnet; O55081; -.\r\n",
      "DR   PhosphoSitePlus; O55081; -.\r\n",
      "DR   PaxDb; O55081; -.\r\n",
      "DR   GeneID; 81758; -.\r\n",
      "DR   KEGG; rno:81758; -.\r\n",
      "DR   AGR; RGD:3541; -.\r\n",
      "DR   CTD; 5934; -.\r\n",
      "DR   RGD; 3541; Rbl2.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   InParanoid; O55081; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; O55081; -.\r\n",
      "DR   Reactome; R-RNO-1538133; G0 and Early G1.\r\n",
      "DR   Reactome; R-RNO-69231; Cyclin D associated events in G1.\r\n",
      "DR   PRO; PR:O55081; -.\r\n",
      "DR   Proteomes; UP000002494; Unplaced.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IDA:RGD.\r\n",
      "DR   GO; GO:0005634; C:nucleus; ISO:RGD.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.\r\n",
      "DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:RGD.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; ISO:RGD.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:InterPro.\r\n",
      "DR   CDD; cd20606; CYCLIN_RBL2; 1.\r\n",
      "DR   CDD; cd00043; CYCLIN_SF; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 3.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   PANTHER; PTHR13742:SF8; RETINOBLASTOMA-LIKE PROTEIN 2; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 2.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 3.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Cell cycle; Chromatin regulator; Direct protein sequencing; DNA-binding;\r\n",
      "KW   Nucleus; Phosphoprotein; Reference proteome; Repressor; Transcription;\r\n",
      "KW   Transcription regulation; Tumor suppressor.\r\n",
      "FT   CHAIN           1..1135\r\n",
      "FT                   /note=\"Retinoblastoma-like protein 2\"\r\n",
      "FT                   /id=\"PRO_0000167843\"\r\n",
      "FT   REGION          1..43\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          414..1021\r\n",
      "FT                   /note=\"Pocket; binds E1A\"\r\n",
      "FT   REGION          414..613\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT   REGION          614..824\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT   REGION          649..698\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          806..825\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          825..1021\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT   REGION          932..995\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        654..691\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        939..971\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         410\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         414\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q64700\"\r\n",
      "FT   MOD_RES         636\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         639\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         659\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         669\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         684\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         942\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q64700\"\r\n",
      "FT   MOD_RES         946\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         960\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         965\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         967\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         968\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         975\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         976\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         980\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         1031\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         1064\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         1076\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         1108\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "SQ   SEQUENCE   1135 AA;  127818 MW;  6C42A87E163B4298 CRC64;\r\n",
      "     MASGGNQSSP PPPAAAASSE EEEEDGDTAD RAQPAGSPSH QIQQRFEELC SRLNMDEAAR\r\n",
      "     AEAWSSYRSM SESYTLEGND LHWLACALYV ACRKSVPTVS KGTAEGNYVS LTRILRCSEQ\r\n",
      "     SLIEFFNKMK KWEDMANLPP HFRERTERLE RNFTVSAVIF KKYEPIFQDI FKYPQEEQPR\r\n",
      "     QQRGRKQRRQ PCTTSEIFHF CWVLFIYAKG NFPMISDDLV NSYHLLLCAL DLVYGNALQC\r\n",
      "     SNRKELVNPN FKGVSEDGHP RDSHPSSDPP CVIEKLCSLH DGLVLEAKGI KQHFWKPYIR\r\n",
      "     KLFEKKLLRG KEENLTGFLE PGNFAESFKA VNKAYEEYVL ATGSLDERIF LGEDAEEEVG\r\n",
      "     TFSRCVSAAS GTESAERTQM RDILQQHLDK SKTLRVCNPL TGVRYVQENS PCVTPVSTAT\r\n",
      "     HSLNRLHTML AGLRNAPSEK LEQILRSCSR DPTRAIADRL REMYEIYSQH FQPDENVSNC\r\n",
      "     AKEMANKHFR FAEMLYYKVL ESVIEQEQKR LGDMDLSGVL EQDAFHKSLL ACCLEVVAFS\r\n",
      "     YKPPGNFPFI AEIFDVPHYH FYKVIEVFIR AEDGLCREVV KHLNQIEEQI LDHLAWKTKS\r\n",
      "     PLWDRIRDNE NRVPTCEEVT PPHNLERTDE IYIAGSPLTP RRVGEVRTDA GGLGRSVTSP\r\n",
      "     TTLYDRYSSP TVSTTRRRLF ESDSPSEGST AGRIPPQPLV NAVPVQNVSG ETVSVTPVPG\r\n",
      "     QTLVTMATAT VTANNGQTVT IPVQGIANEN GGITFFPVQV NVGGQAQAVT GSIQPLSAQA\r\n",
      "     LAGSLSSQQV TGTTLQVPGP VAIQQISPGG QQQNQGQPLT SSSIRPRKTS SLSLFFRKVY\r\n",
      "     YLAGVRLRDL CTKLDISDEL RKKIWTCFEF SIVQCPELMM DRHLDQLLMC AIYVMAKVTK\r\n",
      "     EDKSFQNIMR CYRTQPQARS QVYRSVLIKG KRRNSGSCEN RSHQNSPTEL NTDRASRDSS\r\n",
      "     PVMRSNSTLP VPQPSSAPPT PTRLTGANSD IEEEERGDLI QFYNNIYRKQ IQTFAMKYSQ\r\n",
      "     ANSQMDTPPL SPYPFVRTGS PRRVQLSQSH PIYISPHKNE AMLSPREKIF YYFSNSPSKR\r\n",
      "     LREINSMIRT GETPTKKRGI LLDDGSESPA KRICPENHSA LLRRLQDVAN DRGSH\r\n",
      "//\r\n",
      "ID   RB_CHICK                Reviewed;         921 AA.\r\n",
      "AC   Q90600; Q788Q6; Q90599; Q91016;\r\n",
      "DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   01-NOV-1996, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 123.\r\n",
      "DE   RecName: Full=Retinoblastoma-associated protein;\r\n",
      "DE   AltName: Full=p104;\r\n",
      "DE   AltName: Full=pRb;\r\n",
      "DE            Short=Rb;\r\n",
      "GN   Name=RB1;\r\n",
      "OS   Gallus gallus (Chicken).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\r\n",
      "OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;\r\n",
      "OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae;\r\n",
      "OC   Phasianinae; Gallus.\r\n",
      "OX   NCBI_TaxID=9031;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA], AND NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-72.\r\n",
      "RC   STRAIN=SPAFAS;\r\n",
      "RX   PubMed=8180136;\r\n",
      "RA   Boehmelt G., Ulrich E., Kurzbauer R., Mellitzer G., Bird A., Zenke M.;\r\n",
      "RT   \"Structure and expression of the chicken retinoblastoma gene.\";\r\n",
      "RL   Cell Growth Differ. 5:221-230(1994).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=8193168; DOI=10.1016/0167-4781(94)90103-1;\r\n",
      "RA   Feinstein R., Bolton W.K., Quinones J.N., Mosialos G., Sif S., Huff J.L.,\r\n",
      "RA   Capobianco A.J., Gilmore T.D.;\r\n",
      "RT   \"Characterization of a chicken cDNA encoding the retinoblastoma gene\r\n",
      "RT   product.\";\r\n",
      "RL   Biochim. Biophys. Acta 1218:82-86(1994).\r\n",
      "RN   [3]\r\n",
      "RP   INTERACTION WITH FOWL ADENOVIRUS 1 PROTEIN GAM-1 (MICROBIAL INFECTION).\r\n",
      "RX   PubMed=10400747; DOI=10.1128/jvi.73.8.6517-6525.1999;\r\n",
      "RA   Lehrmann H., Cotten M.;\r\n",
      "RT   \"Characterization of CELO virus proteins that modulate the pRb/E2F\r\n",
      "RT   pathway.\";\r\n",
      "RL   J. Virol. 73:6517-6525(1999).\r\n",
      "CC   -!- FUNCTION: Tumor suppressor that is a key regulator of the G1/S\r\n",
      "CC       transition of the cell cycle. The hypophosphorylated form binds\r\n",
      "CC       transcription regulators of the E2F family, preventing transcription of\r\n",
      "CC       E2F-responsive genes. Both physically blocks E2Fs transactivating\r\n",
      "CC       domain and recruits chromatin-modifying enzymes that actively repress\r\n",
      "CC       transcription. Cyclin and CDK-dependent phosphorylation of RB1 induces\r\n",
      "CC       its dissociation from E2Fs, thereby activating transcription of E2F\r\n",
      "CC       responsive genes and triggering entry into S phase. RB1 also promotes\r\n",
      "CC       the G0-G1 transition upon phosphorylation and activation by\r\n",
      "CC       CDK3/cyclin-C. {ECO:0000250|UniProtKB:P06400,\r\n",
      "CC       ECO:0000250|UniProtKB:P13405, ECO:0000250|UniProtKB:P33568}.\r\n",
      "CC   -!- SUBUNIT: Interacts with and sequesters the E2F1 transcription factor.\r\n",
      "CC       Interacts with SUV39H1, KMT5B and KMT5C (By similarity). {ECO:0000250}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with, and is inhibited by fowl\r\n",
      "CC       adenovirus 1 protein GAM-1. {ECO:0000269|PubMed:10400747}.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P13405}.\r\n",
      "CC   -!- PTM: Phosphorylated in G1, thereby releasing E2F1 which is then able to\r\n",
      "CC       activate cell growth. Dephosphorylated at the late M phase.\r\n",
      "CC       Phosphorylation of domain C promotes interaction between the C-terminal\r\n",
      "CC       domain C and the Pocket domain, and thereby inhibits interactions with\r\n",
      "CC       heterodimeric E2F/DP transcription factor complexes (By similarity).\r\n",
      "CC       {ECO:0000250}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=AAA19644.1; Type=Frameshift; Evidence={ECO:0000305};\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; X72218; CAA51019.1; -; mRNA.\r\n",
      "DR   EMBL; U00113; AAA19644.1; ALT_FRAME; mRNA.\r\n",
      "DR   EMBL; X72217; CAA51018.1; -; Genomic_DNA.\r\n",
      "DR   PIR; S45298; S45298.\r\n",
      "DR   RefSeq; NP_989750.1; NM_204419.1.\r\n",
      "DR   AlphaFoldDB; Q90600; -.\r\n",
      "DR   SMR; Q90600; -.\r\n",
      "DR   STRING; 9031.ENSGALP00000027407; -.\r\n",
      "DR   PaxDb; Q90600; -.\r\n",
      "DR   GeneID; 386582; -.\r\n",
      "DR   KEGG; gga:386582; -.\r\n",
      "DR   CTD; 5925; -.\r\n",
      "DR   VEuPathDB; HostDB:geneid_386582; -.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   InParanoid; Q90600; -.\r\n",
      "DR   PhylomeDB; Q90600; -.\r\n",
      "DR   PRO; PR:Q90600; -.\r\n",
      "DR   Proteomes; UP000000539; Unassembled WGS sequence.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030308; P:negative regulation of cell growth; ISS:UniProtKB.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0031175; P:neuron projection development; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:InterPro.\r\n",
      "DR   CDD; cd20599; CYCLIN_RB; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 6.10.140.1380; -; 1.\r\n",
      "DR   Gene3D; 6.10.250.530; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 2.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Cell cycle; Chromatin regulator; DNA-binding; Host-virus interaction;\r\n",
      "KW   Nucleus; Phosphoprotein; Reference proteome; Repressor; Transcription;\r\n",
      "KW   Transcription regulation; Tumor suppressor.\r\n",
      "FT   CHAIN           1..921\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein\"\r\n",
      "FT                   /id=\"PRO_0000331619\"\r\n",
      "FT   REGION          1..31\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          603..634\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          873..921\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOTIF           853..869\r\n",
      "FT                   /note=\"Bipartite nuclear localization signal\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   COMPBIAS        610..634\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        891..912\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   CONFLICT        63\r\n",
      "FT                   /note=\"Q -> E (in Ref. 2; AAA19644)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        163\r\n",
      "FT                   /note=\"E -> S (in Ref. 2; AAA19644)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        411\r\n",
      "FT                   /note=\"S -> C (in Ref. 2; AAA19644)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        619\r\n",
      "FT                   /note=\"N -> G (in Ref. 2; AAA19644)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        791..792\r\n",
      "FT                   /note=\"VP -> A (in Ref. 2; AAA19644)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   921 AA;  104436 MW;  8527B7B4ACB12F36 CRC64;\r\n",
      "     MPPKPLRRAG AARSQRTSPE GGAGTASPPG GTRLEVGEAE FVALCDALKA PDSVREKAWM\r\n",
      "     TYQSLAAADG ASAYNKKKKE TWGVCIFIVA IDLDEMTFTF TELLKSLSIS VCTFFQFLKE\r\n",
      "     VDVNMDTVST KVDSTVSRLK KKYDVLLALY HKFERTCGLI YLEQPSSEIS AELSSVLVLK\r\n",
      "     NYWITFLLAK GKVLQMEDDL VISFQLLLCV LDYFIKLSPP AMLKEPYKSA VTALTVNGST\r\n",
      "     RTPRRGQNRN ARASKQIDTD TKVIEILCKE HDCNLDEVKN VYFTSFIPFL NSLGVVASNG\r\n",
      "     LPEVDVLSKQ YDELYLKNKD IDARLFLDHD ETLQPDVIAC SQLERTPRKN NPDEEVNHVL\r\n",
      "     PQTPVRAAMN TIQQLMMILN SATDKPSDTL IAYFNNCTVN PEDSILKRVE SLGHIFKKKF\r\n",
      "     AEAVGQGCAE IGSQRYQLGV RLYYRVMESM LKSEEERLSV HNFSKLLNDN IFHTSLLACA\r\n",
      "     LEIVMATYGR TASQSDGTSA ETDLSFPWIL NVFDLKAFDF YKVIESFIKV EPSLTRDMIK\r\n",
      "     HLERCEHRIM ESLAWQSDSP LFDLIKQSKE REGQTDQPEP TSTLNLPLQH NHTAADLYLS\r\n",
      "     PVRSPKKKAS GHPQSGTSNP DAQPSATSQT QKPQKSTSLS LFYKKVFRLA YLRLHTLFFR\r\n",
      "     LLSEHPDLEP LIWTLFQHTL QNESELMRDR HLDQIMMCSM YGICKVKNVD LRFKTIVSAY\r\n",
      "     KELPNTNQET FKRVLIREEQ YDSIIVFYNL VFMQKLKTNI LQYASNRPPT LSPIPHIPRS\r\n",
      "     PYQFSNSPRR VPAGNNIYIS PLKSPYKFSD GFHSPTKMTP RSRILVSIGE TFGTSEKFQK\r\n",
      "     INQMVCNSES HVKRSAEPSD APKPLKRLRF DIEGQDEADG GKHLPQESKF QQKLAEMTST\r\n",
      "     RTRMQKQKLN DGNDTSANEE K\r\n",
      "//\r\n",
      "ID   ARI4B_RAT               Reviewed;        1228 AA.\r\n",
      "AC   Q9JKB5;\r\n",
      "DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   01-OCT-2000, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 114.\r\n",
      "DE   RecName: Full=AT-rich interactive domain-containing protein 4B;\r\n",
      "DE            Short=ARID domain-containing protein 4B;\r\n",
      "DE   AltName: Full=180 kDa Sin3-associated polypeptide;\r\n",
      "DE            Short=Sin3-associated polypeptide p180;\r\n",
      "DE   AltName: Full=Histone deacetylase complex subunit SAP180;\r\n",
      "DE   AltName: Full=Retinoblastoma-binding protein 1-like 1;\r\n",
      "GN   Name=Arid4b; Synonyms=Rbbp1l1, Sap180;\r\n",
      "OS   Rattus norvegicus (Rat).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Rattus.\r\n",
      "OX   NCBI_TaxID=10116;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RA   Kholodilov N.G., Neystat M., Burke R.E.;\r\n",
      "RT   \"Upregulation of rat homolog of human retinoblastoma-binding protein\r\n",
      "RT   (RBBP1) in substantia nigra following developmental striatal target\r\n",
      "RT   injury.\";\r\n",
      "RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [2]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-295; SER-296; SER-581;\r\n",
      "RP   SER-588; SER-703 AND THR-706, AND IDENTIFICATION BY MASS SPECTROMETRY\r\n",
      "RP   [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=22673903; DOI=10.1038/ncomms1871;\r\n",
      "RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,\r\n",
      "RA   Olsen J.V.;\r\n",
      "RT   \"Quantitative maps of protein phosphorylation sites across 14 different rat\r\n",
      "RT   organs and tissues.\";\r\n",
      "RL   Nat. Commun. 3:876-876(2012).\r\n",
      "CC   -!- FUNCTION: Acts as a transcriptional repressor. May function in the\r\n",
      "CC       assembly and/or enzymatic activity of the Sin3A corepressor complex or\r\n",
      "CC       in mediating interactions between the complex and other regulatory\r\n",
      "CC       complexes.Plays a role in the regulation of epigenetic modifications at\r\n",
      "CC       the PWS/AS imprinting center near the SNRPN promoter, where it might\r\n",
      "CC       function as part of a complex with RB1 and ARID4A. Involved in\r\n",
      "CC       spermatogenesis, together with ARID4A, where it functions as a\r\n",
      "CC       transcriptional coactivator for AR (androgen receptor) and enhances\r\n",
      "CC       expression of genes required for sperm maturation. Regulates expression\r\n",
      "CC       of the tight junction protein CLDN3 in the testis, which is important\r\n",
      "CC       for integrity of the blood-testis barrier. Plays a role in myeloid\r\n",
      "CC       homeostasis where it regulates the histone methylation state of bone\r\n",
      "CC       marrow cells and expression of various genes involved in hematopoiesis.\r\n",
      "CC       May function as a leukemia suppressor. {ECO:0000250|UniProtKB:A2CG63,\r\n",
      "CC       ECO:0000250|UniProtKB:Q4LE39}.\r\n",
      "CC   -!- SUBUNIT: Component of a Sin3A corepressor complex consisting of SIN3A,\r\n",
      "CC       SAP130, SUDS3/SAP45, SAP180, HDAC1 and HDAC2. Interacts with ARID4A (By\r\n",
      "CC       similarity). Interacts with AR (By similarity).\r\n",
      "CC       {ECO:0000250|UniProtKB:A2CG63, ECO:0000250|UniProtKB:Q4LE39}.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355}.\r\n",
      "CC   -!- DOMAIN: The C-terminus mediates interaction with mSin3A corepressor\r\n",
      "CC       complex. {ECO:0000250|UniProtKB:Q4LE39}.\r\n",
      "CC   -!- DOMAIN: The N-terminus is involved in transcriptional repression by\r\n",
      "CC       HDAC-independent mechanisms. {ECO:0000250|UniProtKB:Q4LE39}.\r\n",
      "CC   -!- DOMAIN: The ARID domain is involved in stabilizing the mSin3A\r\n",
      "CC       corepressor complex on DNA. {ECO:0000250|UniProtKB:Q4LE39}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AF245512; AAF61271.1; -; mRNA.\r\n",
      "DR   RefSeq; NP_445873.1; NM_053421.1.\r\n",
      "DR   AlphaFoldDB; Q9JKB5; -.\r\n",
      "DR   SMR; Q9JKB5; -.\r\n",
      "DR   STRING; 10116.ENSRNOP00000010836; -.\r\n",
      "DR   iPTMnet; Q9JKB5; -.\r\n",
      "DR   PhosphoSitePlus; Q9JKB5; -.\r\n",
      "DR   PaxDb; Q9JKB5; -.\r\n",
      "DR   GeneID; 84481; -.\r\n",
      "DR   KEGG; rno:84481; -.\r\n",
      "DR   UCSC; RGD:619919; rat.\r\n",
      "DR   AGR; RGD:619919; -.\r\n",
      "DR   CTD; 51742; -.\r\n",
      "DR   RGD; 619919; Arid4b.\r\n",
      "DR   eggNOG; KOG2744; Eukaryota.\r\n",
      "DR   eggNOG; KOG3001; Eukaryota.\r\n",
      "DR   InParanoid; Q9JKB5; -.\r\n",
      "DR   OrthoDB; 445024at2759; -.\r\n",
      "DR   PhylomeDB; Q9JKB5; -.\r\n",
      "DR   Reactome; R-RNO-3214815; HDACs deacetylate histones.\r\n",
      "DR   PRO; PR:Q9JKB5; -.\r\n",
      "DR   Proteomes; UP000002494; Unplaced.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.\r\n",
      "DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0097368; P:establishment of Sertoli cell barrier; ISO:RGD.\r\n",
      "DR   GO; GO:0036124; P:histone H3-K9 trimethylation; ISO:RGD.\r\n",
      "DR   GO; GO:0034773; P:histone H4-K20 trimethylation; ISO:RGD.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.\r\n",
      "DR   GO; GO:0006349; P:regulation of gene expression by genomic imprinting; ISO:RGD.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007283; P:spermatogenesis; ISO:RGD.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.\r\n",
      "DR   CDD; cd16883; ARID_ARID4B; 1.\r\n",
      "DR   CDD; cd20460; Tudor_ARID4B_rpt1; 1.\r\n",
      "DR   CDD; cd20462; Tudor_ARID4B_rpt2; 1.\r\n",
      "DR   Gene3D; 2.30.30.140; -; 2.\r\n",
      "DR   Gene3D; 1.10.150.60; ARID DNA-binding domain; 1.\r\n",
      "DR   InterPro; IPR012603; ARID4A/B_PWWP.\r\n",
      "DR   InterPro; IPR028853; ARID4B_ARID/BRIGHT.\r\n",
      "DR   InterPro; IPR001606; ARID_dom.\r\n",
      "DR   InterPro; IPR036431; ARID_dom_sf.\r\n",
      "DR   InterPro; IPR002999; Tudor.\r\n",
      "DR   InterPro; IPR047476; Tudor_ARID4B_rpt1.\r\n",
      "DR   InterPro; IPR047474; Tudor_ARID4B_rpt2.\r\n",
      "DR   PANTHER; PTHR13964:SF24; AT-RICH INTERACTIVE DOMAIN-CONTAINING PROTEIN 4B; 1.\r\n",
      "DR   PANTHER; PTHR13964; RBP-RELATED; 1.\r\n",
      "DR   Pfam; PF01388; ARID; 1.\r\n",
      "DR   Pfam; PF08169; RBB1NT; 1.\r\n",
      "DR   SMART; SM01014; ARID; 1.\r\n",
      "DR   SMART; SM00501; BRIGHT; 1.\r\n",
      "DR   SMART; SM00333; TUDOR; 1.\r\n",
      "DR   SUPFAM; SSF46774; ARID-like; 1.\r\n",
      "DR   SUPFAM; SSF63748; Tudor/PWWP/MBT; 1.\r\n",
      "DR   PROSITE; PS51011; ARID; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Chromatin regulator; Coiled coil; DNA-binding; Isopeptide bond; Nucleus;\r\n",
      "KW   Phosphoprotein; Reference proteome; Transcription;\r\n",
      "KW   Transcription regulation; Ubl conjugation.\r\n",
      "FT   CHAIN           1..1228\r\n",
      "FT                   /note=\"AT-rich interactive domain-containing protein 4B\"\r\n",
      "FT                   /id=\"PRO_0000282865\"\r\n",
      "FT   DOMAIN          306..398\r\n",
      "FT                   /note=\"ARID\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00355\"\r\n",
      "FT   REGION          123..167\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          266..307\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          437..466\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          479..525\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          539..606\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          620..802\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          825..1129\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1168..1204\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COILED          1141..1186\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COMPBIAS        144..167\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        274..306\r\n",
      "FT                   /note=\"Acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        487..509\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        558..573\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        637..663\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        711..735\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        739..754\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        777..802\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        825..843\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        908..923\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        925..969\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        995..1023\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1060..1104\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1110..1126\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1189..1204\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         276\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         295\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         296\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         482\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         579\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         581\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         588\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         630\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         691\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         703\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         706\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         930\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         942\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         945\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         1066\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         1068\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         1069\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         1071\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         1075\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   CROSSLNK        428\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   CROSSLNK        461\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   CROSSLNK        664\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "SQ   SEQUENCE   1228 AA;  137080 MW;  DE50F198D9E46C6C CRC64;\r\n",
      "     MKALDEPPYL TVGTDVSAKY RGAFCEAKIK TAKRLVKVKV TFRHDSSTVE VQDDHIKGPL\r\n",
      "     KVGAIVEVKN LDGAYQEAVI NKLTDASWYT VVFDDGDEKT LRRSSLCLKG ERHFAESETL\r\n",
      "     DQLPLTNPEH FGTPVIGKKT NRGRRSNHIP EEESSSSSSD DDEDDRKQTD ELLGKVVCVD\r\n",
      "     YISLDKKKAL WFPALVVCPD CSDEIAVKKD NILVRSFKDG KFTSVPRKDV HEITSDTAPK\r\n",
      "     PDAVLKQAFD QALEFHKSRT IPANWKTELK EDSSSSEAEE EEEEEDDEKE KEDNSSEEEE\r\n",
      "     EIEPFPEERE NFLQQLYKFM EDRGTPINKR PVLGYRNLNL FKLFRLVHKL GGFDNIESGA\r\n",
      "     VWKQVYQDLG IPVLNSAAGY NVKCAYKKYL YGFEEYCRSA NIDFQMALPE KVLNKPCKDC\r\n",
      "     ENKEIKVKEE SDAEIKEVNV EDSKNMIPKE ETPAEDESER KENIKPSLGS KKGLLECIPA\r\n",
      "     QSDQEKEANI TKLEEKESLE DKDGATARAE EALSTEVDAE EEQARSGYDE WIKADKIVRP\r\n",
      "     ADKNVPKIKH RKKIKNKLDK EKDRDEKYSP KNCKLRRLSK SPFQSNPSPE MVSKLDLADA\r\n",
      "     KNSDTGHIKS IEITSILNGL QASESSAEDS EQEEERCAQD PESSSKDESK VEHSAHSRSE\r\n",
      "     LISKEELSSP SLLEENKVHP DLVIAKTVSK SPERLRKDVE AISEDTDFEE EDEITKKRKD\r\n",
      "     VKKDTTDKAL KPQTKTWGKD RYCIQTNCLQ SGSPGKKEDR TKSKEPLCTG NSSNSSSDED\r\n",
      "     EEEKSKAKMT PTKKYNGLEE KRKSLRTTSF YSGFSEVAEK RIKLLNNSDE RLQNNRAKDR\r\n",
      "     KDVWSSIQGQ WPKKTLKELF SDSDTEAAAS PPHAAPDEGT VEESLQTVAE EESCSPNMEL\r\n",
      "     EKPLPTSVDS KPVEEKPLEV SDRKTEFPSS GSNSVLNTPP TTPESPSSVT VTETSQQQSS\r\n",
      "     VTVSVPLPPN QEEVRSIKSE TDSTIEVDSV VGELQDLQSE GNSSPAGFNA SVSSSSSNQP\r\n",
      "     EPEHPEKACT GQKRVKDTQG VGSSSKKQKR SHKATVVNNK KKGKGTNSSD SEDLSAGESV\r\n",
      "     TKTQAIKSVP TGMKTHNSKS PARIQSPGKC GKNGDKDPDL KEPSNRLPKV YKWSFQMSDL\r\n",
      "     ENMTSAERIS ILQEKLQEIR KHYLSLKSEV ASIDRRRKRL KKKERESAAT SSSSSSPSSS\r\n",
      "     SITAAVMLTL AEPSMSSASQ NGMSVECR\r\n",
      "//\r\n",
      "ID   R9PXV5_RAT              Unreviewed;       892 AA.\r\n",
      "AC   R9PXV5;\r\n",
      "DT   24-JUL-2013, integrated into UniProtKB/TrEMBL.\r\n",
      "DT   22-JUL-2015, sequence version 2.\r\n",
      "DT   03-MAY-2023, entry version 64.\r\n",
      "DE   SubName: Full=Retinoblastoma-associated protein {ECO:0000313|Ensembl:ENSRNOP00000021752};\r\n",
      "GN   Name=Rb1 {ECO:0000313|Ensembl:ENSRNOP00000021752,\r\n",
      "GN   ECO:0000313|RGD:3540};\r\n",
      "OS   Rattus norvegicus (Rat).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Rattus.\r\n",
      "OX   NCBI_TaxID=10116 {ECO:0000313|Ensembl:ENSRNOP00000021752, ECO:0000313|Proteomes:UP000002494};\r\n",
      "RN   [1] {ECO:0000313|Ensembl:ENSRNOP00000021752, ECO:0000313|Proteomes:UP000002494}\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RC   STRAIN=Brown Norway {ECO:0000313|Ensembl:ENSRNOP00000021752,\r\n",
      "RC   ECO:0000313|Proteomes:UP000002494};\r\n",
      "RX   PubMed=15057822; DOI=10.1038/nature02426;\r\n",
      "RG   Rat Genome Sequencing Project Consortium;\r\n",
      "RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,\r\n",
      "RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,\r\n",
      "RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,\r\n",
      "RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,\r\n",
      "RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,\r\n",
      "RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,\r\n",
      "RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,\r\n",
      "RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,\r\n",
      "RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,\r\n",
      "RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,\r\n",
      "RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,\r\n",
      "RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,\r\n",
      "RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,\r\n",
      "RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,\r\n",
      "RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,\r\n",
      "RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,\r\n",
      "RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,\r\n",
      "RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,\r\n",
      "RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,\r\n",
      "RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,\r\n",
      "RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,\r\n",
      "RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,\r\n",
      "RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,\r\n",
      "RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,\r\n",
      "RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,\r\n",
      "RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,\r\n",
      "RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,\r\n",
      "RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,\r\n",
      "RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,\r\n",
      "RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,\r\n",
      "RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,\r\n",
      "RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,\r\n",
      "RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,\r\n",
      "RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,\r\n",
      "RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,\r\n",
      "RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,\r\n",
      "RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,\r\n",
      "RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,\r\n",
      "RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,\r\n",
      "RA   Mockrin S., Collins F.S.;\r\n",
      "RT   \"Genome sequence of the Brown Norway rat yields insights into mammalian\r\n",
      "RT   evolution.\";\r\n",
      "RL   Nature 428:493-521(2004).\r\n",
      "RN   [2] {ECO:0007829|PubMed:22673903}\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=22673903;\r\n",
      "RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,\r\n",
      "RA   Olsen J.V.;\r\n",
      "RT   \"Quantitative maps of protein phosphorylation sites across 14 different rat\r\n",
      "RT   organs and tissues.\";\r\n",
      "RL   Nat. Commun. 3:876-876(2012).\r\n",
      "RN   [3] {ECO:0000313|Ensembl:ENSRNOP00000021752}\r\n",
      "RP   IDENTIFICATION.\r\n",
      "RC   STRAIN=Brown Norway {ECO:0000313|Ensembl:ENSRNOP00000021752};\r\n",
      "RG   Ensembl;\r\n",
      "RL   Submitted (JUN-2013) to the EMBL/GenBank/DDBJ databases.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|ARBA:ARBA00004123}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000256|ARBA:ARBA00009475}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AABR07018385; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AABR07018386; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   AlphaFoldDB; R9PXV5; -.\r\n",
      "DR   SMR; R9PXV5; -.\r\n",
      "DR   Ensembl; ENSRNOT00000021752; ENSRNOP00000021752; ENSRNOG00000016029.\r\n",
      "DR   RGD; 3540; Rb1.\r\n",
      "DR   VEuPathDB; HostDB:ENSRNOG00000016029; -.\r\n",
      "DR   GeneTree; ENSGT00950000183202; -.\r\n",
      "DR   HOGENOM; CLU_015754_0_0_1; -.\r\n",
      "DR   Proteomes; UP000002494; Chromosome 15.\r\n",
      "DR   Bgee; ENSRNOG00000016029; Expressed in thymus and 20 other tissues.\r\n",
      "DR   GO; GO:0061793; C:chromatin lock complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0008024; C:cyclin/CDK positive transcription elongation factor complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0016605; C:PML body; IEA:Ensembl.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0005819; C:spindle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0097718; F:disordered domain specific binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0061676; F:importin-alpha family protein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0019900; F:kinase binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051219; F:phosphoprotein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0003180; P:aortic valve morphogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051301; P:cell division; IEA:Ensembl.\r\n",
      "DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0002062; P:chondrocyte differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0048565; P:digestive tract development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043353; P:enucleate erythrocyte differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050673; P:epithelial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0034349; P:glial cell apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0014009; P:glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031507; P:heterochromatin formation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0034088; P:maintenance of mitotic sister chromatid cohesion; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045445; P:myoblast differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0030308; P:negative regulation of cell growth; IEA:Ensembl.\r\n",
      "DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.\r\n",
      "DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.\r\n",
      "DR   GO; GO:1904761; P:negative regulation of myofibroblast differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0042551; P:neuron maturation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031175; P:neuron projection development; IEA:Ensembl.\r\n",
      "DR   GO; GO:1904028; P:positive regulation of collagen fibril organization; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071459; P:protein localization to chromosome, centromeric region; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007265; P:Ras protein signal transduction; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031134; P:sister chromatid biorientation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0001894; P:tissue homeostasis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   CDD; cd20599; CYCLIN_RB; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 6.10.140.1380; -; 1.\r\n",
      "DR   Gene3D; 6.10.250.530; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 2.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Cell cycle {ECO:0000256|ARBA:ARBA00023306};\r\n",
      "KW   Chromatin regulator {ECO:0000256|ARBA:ARBA00022853};\r\n",
      "KW   Nucleus {ECO:0000256|ARBA:ARBA00023242};\r\n",
      "KW   Phosphoprotein {ECO:0000256|ARBA:ARBA00022553};\r\n",
      "KW   Reference proteome {ECO:0000313|Proteomes:UP000002494};\r\n",
      "KW   Repressor {ECO:0000256|ARBA:ARBA00022491};\r\n",
      "KW   Transcription {ECO:0000256|ARBA:ARBA00023163};\r\n",
      "KW   Transcription regulation {ECO:0000256|ARBA:ARBA00023015}.\r\n",
      "FT   DOMAIN          68..194\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein N-terminal\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01367\"\r\n",
      "FT   DOMAIN          338..538\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein A-box\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01368\"\r\n",
      "FT   DOMAIN          624..711\r\n",
      "FT                   /note=\"Cyclin-like\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM00385\"\r\n",
      "FT   DOMAIN          732..891\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein C-terminal\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01369\"\r\n",
      "FT   REGION          312..334\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          867..892\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        312..327\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        867..882\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "SQ   SEQUENCE   892 AA;  102272 MW;  0CB0791882F3A867 CRC64;\r\n",
      "     MYQFCNFLIC RLEFEKIEEP EFIALCQKLK VPDHVRERAW LTWEKVSSVD GILEGYIQKK\r\n",
      "     KELWGICIFI AAVDLDEMPF TFTELQKSIE TSVYKFFDLL KEIDTSTKVD NAVSRLLKKY\r\n",
      "     NVLCALYSKL ERTCGLIYLT QPSSGLSTEI NSMLVLKVSW ITFLLAKGEV VQMEDDLVIS\r\n",
      "     FQLMLCVLDY FIKLSPPALL REPYKTAATP INGSPRTPRR GQNRSARIAK QLESDTRTIE\r\n",
      "     VLCKEHECNV DEVKNVYFKN FIPFISSLGI VSSNGLPELE SLSKRYEEVY LKSKDLDARL\r\n",
      "     FLDHDKTLQT DTIDSFETER TPRKSNPDEE ANMVTPHTPV RTVMNTIQQL MVILNSASDQ\r\n",
      "     PSENLISYFS NCTVNPKENI LKRVKDVGHI FKEKFASAVG QGCIDIGAQR YKLGVRLYYR\r\n",
      "     VMESMLKSEE ERLSIQNFSK LLNDNIFHMS LLACALEVVM ATYSRSMLQN LDSGTDLSFP\r\n",
      "     WILNVLNLKA FDFYKVIESF IKVEANLTRE MIKHLERCEH RIMESLAWLS DSPLFDLIKQ\r\n",
      "     SKDGEGPDHL ESACSLSLPL QSNHTAADMY LSPIRSPKKR TSTTRVNSAA NTETQAASAF\r\n",
      "     HTQKPLKSTS LSLFYKKVYR LAYLRLNTLC ARLLSDHPEL EHIIWTLFQH TLENEYELMK\r\n",
      "     DRHLDQIMMC SMYGICKVKN IDLKFKIIVT AYKDLPHAAQ ETFKRVLIRE EEFDSIIVFY\r\n",
      "     NSVFMQRLKT NILQYASTRP PTLSPIPHIP RSPYKFSSSP LRIPGGNIYI SPLKSPYKIS\r\n",
      "     EGLPTPTKMT PRSRILVSIG ESFGTSEKFQ KINQMVCNSD RVLKRSAEGG NPPKPLKKLR\r\n",
      "     FDIEGSDEAD GSKHLPAESK FQQKLAEMTS TRTRMQKQKL NDSMEISNKE EK\r\n",
      "//\r\n",
      "ID   A0A0P6JI57_HETGA        Unreviewed;       924 AA.\r\n",
      "AC   A0A0P6JI57;\r\n",
      "DT   20-JAN-2016, integrated into UniProtKB/TrEMBL.\r\n",
      "DT   20-JAN-2016, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 38.\r\n",
      "DE   SubName: Full=Retinoblastoma-associated protein {ECO:0000313|EMBL:JAO01125.1};\r\n",
      "GN   Name=RB1 {ECO:0000313|EMBL:JAO01125.1};\r\n",
      "OS   Heterocephalus glaber (Naked mole rat).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Hystricomorpha; Bathyergidae;\r\n",
      "OC   Heterocephalus.\r\n",
      "OX   NCBI_TaxID=10181 {ECO:0000313|EMBL:JAO01125.1};\r\n",
      "RN   [1] {ECO:0000313|EMBL:JAO01125.1}\r\n",
      "RP   NUCLEOTIDE SEQUENCE.\r\n",
      "RC   TISSUE=Kidney {ECO:0000313|EMBL:JAO01125.1};\r\n",
      "RA   Bens M., Sahm A., Jahn N., Morhart M., Holtze S., Hildebrandt T.B.,\r\n",
      "RA   Platzer M., Szafranski K.;\r\n",
      "RT   \"FRAMA: From RNA-seq data to annotated mRNA assemblies.\";\r\n",
      "RL   Submitted (OCT-2015) to the EMBL/GenBank/DDBJ databases.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|ARBA:ARBA00004123}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000256|ARBA:ARBA00009475}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; GEBF01002508; JAO01125.1; -; Transcribed_RNA.\r\n",
      "DR   RefSeq; XP_004844243.1; XM_004844186.2.\r\n",
      "DR   AlphaFoldDB; A0A0P6JI57; -.\r\n",
      "DR   Ensembl; ENSHGLT00000004941; ENSHGLP00000004877; ENSHGLG00000003581.\r\n",
      "DR   GeneID; 101703701; -.\r\n",
      "DR   KEGG; hgl:101703701; -.\r\n",
      "DR   CTD; 5925; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   Bgee; ENSHGLG00000003581; Expressed in zone of skin and 10 other tissues.\r\n",
      "DR   GO; GO:0061793; C:chromatin lock complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0008024; C:cyclin/CDK positive transcription elongation factor complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0016605; C:PML body; IEA:Ensembl.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0005819; C:spindle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0097718; F:disordered domain specific binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0061676; F:importin-alpha family protein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0019900; F:kinase binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051219; F:phosphoprotein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0003180; P:aortic valve morphogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051301; P:cell division; IEA:Ensembl.\r\n",
      "DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0002062; P:chondrocyte differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0048565; P:digestive tract development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043353; P:enucleate erythrocyte differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050673; P:epithelial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0034349; P:glial cell apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0014009; P:glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031507; P:heterochromatin formation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0034088; P:maintenance of mitotic sister chromatid cohesion; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045445; P:myoblast differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0030308; P:negative regulation of cell growth; IEA:Ensembl.\r\n",
      "DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.\r\n",
      "DR   GO; GO:1904761; P:negative regulation of myofibroblast differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0042551; P:neuron maturation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031175; P:neuron projection development; IEA:Ensembl.\r\n",
      "DR   GO; GO:1904028; P:positive regulation of collagen fibril organization; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071459; P:protein localization to chromosome, centromeric region; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007265; P:Ras protein signal transduction; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031134; P:sister chromatid biorientation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0001894; P:tissue homeostasis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   CDD; cd20599; CYCLIN_RB; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 6.10.140.1380; -; 1.\r\n",
      "DR   Gene3D; 6.10.250.530; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 2.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "DR   SUPFAM; SSF101447; Formin homology 2 domain (FH2 domain); 1.\r\n",
      "PE   3: Inferred from homology;\r\n",
      "KW   Cell cycle {ECO:0000256|ARBA:ARBA00023306};\r\n",
      "KW   Chromatin regulator {ECO:0000256|ARBA:ARBA00022853};\r\n",
      "KW   Nucleus {ECO:0000256|ARBA:ARBA00023242};\r\n",
      "KW   Phosphoprotein {ECO:0000256|ARBA:ARBA00022553};\r\n",
      "KW   Repressor {ECO:0000256|ARBA:ARBA00022491};\r\n",
      "KW   Transcription {ECO:0000256|ARBA:ARBA00023163};\r\n",
      "KW   Transcription regulation {ECO:0000256|ARBA:ARBA00023015}.\r\n",
      "FT   DOMAIN          99..225\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein N-terminal\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01367\"\r\n",
      "FT   DOMAIN          369..569\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein A-box\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01368\"\r\n",
      "FT   DOMAIN          656..757\r\n",
      "FT                   /note=\"Cyclin-like\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM00385\"\r\n",
      "FT   DOMAIN          764..923\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein C-terminal\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01369\"\r\n",
      "FT   REGION          1..39\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          603..633\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          856..924\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1..28\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        609..633\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        867..889\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        895..914\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "SQ   SEQUENCE   924 AA;  105526 MW;  A975097D799F1A1D CRC64;\r\n",
      "     MPPKTPRRAA ATAVEPPPPP PPPPPEEDPE QDSGPEDLPL ARFEFEEAEE PDFTALCQKL\r\n",
      "     KIADCVRERA WLTWEKVSSV DGVLKGYIQK KMELWGICIF IAAVDLDEMP FTFTELQKNI\r\n",
      "     ETSVYKFFDL VKEIDTSTKV DNAMSRLLKK YNVLCALYSK LERTCELIYL TPPSSSISAE\r\n",
      "     ISSALVLKVS WITFLLAKGE VLQMEDDLVI SFQLMLCVLD YFIKLSPAAL LKEPYKTAVI\r\n",
      "     PINGSPRTPR RGQNRSARIA KQLENDTRII EVLCKEHECN IDEVKNVYFK NFIPFMNSLG\r\n",
      "     IVTSNGLPEV ESLSKQYEEI YLKNKDIDAR LFLDHDKTLQ TDPIDSFEMQ RTPQKSNPDE\r\n",
      "     EVNVIPPHTP VRTVMNTIQQ LMMILNSSSD QPSEILISYF NNCTVNPKEN ILKRVKDIGH\r\n",
      "     IFKEKFANAV GQGCVEIGSQ RYKLGVRLYY RVMESMLKSE EERLSIQNFS KLLNDNVFHM\r\n",
      "     SLLACALEVV MATYSRSTSQ NLDSGTDLSF PWILNVLNLK AFDFYKVIES FIKAEANLTR\r\n",
      "     EMIKHLERCE HRIMESLAWL SDSPLFDLIK QSKDQEGPAE HLESTCPLNL PLQNNHTAAD\r\n",
      "     MYLSPIRSPK RKGSTTRGNS TANAETQATS AFQTQKPLKS TSLSLFYKKV YRLAYLRLNT\r\n",
      "     LCARLLSDHP ELEHIIWTLF QHTLQNEYEL MKDRHLDQIM MCSMYGICKV KNIDLKFKII\r\n",
      "     VTAYKDLPHA VQETFKRVLI REEEYDSIIV FYNSVFMQRL KTNILQYAST RPPTLSPIPH\r\n",
      "     IPRSPYKFSS SPLRIPGGNI YISPLKSPYK ISEGLPTPTK MTPRSRILVS IGESFGTSEK\r\n",
      "     FQKINQMVGN SDRVLKRSAE GSNPPKPLKK LRFDIEGSDE ADGSKHLPGE SKFQQKLAEM\r\n",
      "     TSTRTRMQKQ KMNDSMDTSN KEEK\r\n",
      "//\r\n",
      "ID   A0A1S3ELD5_DIPOR        Unreviewed;       926 AA.\r\n",
      "AC   A0A1S3ELD5;\r\n",
      "DT   12-APR-2017, integrated into UniProtKB/TrEMBL.\r\n",
      "DT   12-APR-2017, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 35.\r\n",
      "DE   SubName: Full=Retinoblastoma-associated protein isoform X1 {ECO:0000313|RefSeq:XP_012864764.1};\r\n",
      "GN   Name=Rb1 {ECO:0000313|RefSeq:XP_012864764.1};\r\n",
      "OS   Dipodomys ordii (Ord's kangaroo rat).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Castorimorpha; Heteromyidae;\r\n",
      "OC   Dipodomyinae; Dipodomys.\r\n",
      "OX   NCBI_TaxID=10020 {ECO:0000313|Proteomes:UP000081671, ECO:0000313|RefSeq:XP_012864764.1};\r\n",
      "RN   [1] {ECO:0000313|RefSeq:XP_012864764.1}\r\n",
      "RP   IDENTIFICATION.\r\n",
      "RC   TISSUE=Kidney {ECO:0000313|RefSeq:XP_012864764.1};\r\n",
      "RG   RefSeq;\r\n",
      "RL   Submitted (JAN-2023) to UniProtKB.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|ARBA:ARBA00004123}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000256|ARBA:ARBA00009475}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   RefSeq; XP_012864764.1; XM_013009310.1.\r\n",
      "DR   AlphaFoldDB; A0A1S3ELD5; -.\r\n",
      "DR   STRING; 10020.ENSDORP00000019227; -.\r\n",
      "DR   GeneID; 105980484; -.\r\n",
      "DR   KEGG; dord:105980484; -.\r\n",
      "DR   CTD; 5925; -.\r\n",
      "DR   OMA; VKDIGCI; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   Proteomes; UP000081671; Unplaced.\r\n",
      "DR   GO; GO:0061793; C:chromatin lock complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0008024; C:cyclin/CDK positive transcription elongation factor complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0016605; C:PML body; IEA:Ensembl.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0005819; C:spindle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0097718; F:disordered domain specific binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0061676; F:importin-alpha family protein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0019900; F:kinase binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051219; F:phosphoprotein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0003180; P:aortic valve morphogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051301; P:cell division; IEA:Ensembl.\r\n",
      "DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0002062; P:chondrocyte differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0048565; P:digestive tract development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043353; P:enucleate erythrocyte differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050673; P:epithelial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0034349; P:glial cell apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0014009; P:glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031507; P:heterochromatin formation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0034088; P:maintenance of mitotic sister chromatid cohesion; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045445; P:myoblast differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0030308; P:negative regulation of cell growth; IEA:Ensembl.\r\n",
      "DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.\r\n",
      "DR   GO; GO:1904761; P:negative regulation of myofibroblast differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0042551; P:neuron maturation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031175; P:neuron projection development; IEA:Ensembl.\r\n",
      "DR   GO; GO:1904028; P:positive regulation of collagen fibril organization; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071459; P:protein localization to chromosome, centromeric region; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007265; P:Ras protein signal transduction; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031134; P:sister chromatid biorientation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0001894; P:tissue homeostasis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   CDD; cd20599; CYCLIN_RB; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 6.10.140.1380; -; 1.\r\n",
      "DR   Gene3D; 6.10.250.530; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 2.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   3: Inferred from homology;\r\n",
      "KW   Cell cycle {ECO:0000256|ARBA:ARBA00023306};\r\n",
      "KW   Chromatin regulator {ECO:0000256|ARBA:ARBA00022853};\r\n",
      "KW   Nucleus {ECO:0000256|ARBA:ARBA00023242};\r\n",
      "KW   Phosphoprotein {ECO:0000256|ARBA:ARBA00022553};\r\n",
      "KW   Reference proteome {ECO:0000313|Proteomes:UP000081671};\r\n",
      "KW   Repressor {ECO:0000256|ARBA:ARBA00022491};\r\n",
      "KW   Transcription {ECO:0000256|ARBA:ARBA00023163};\r\n",
      "KW   Transcription regulation {ECO:0000256|ARBA:ARBA00023015}.\r\n",
      "FT   DOMAIN          101..227\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein N-terminal\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01367\"\r\n",
      "FT   DOMAIN          371..571\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein A-box\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01368\"\r\n",
      "FT   DOMAIN          658..759\r\n",
      "FT                   /note=\"Cyclin-like\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM00385\"\r\n",
      "FT   DOMAIN          766..925\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein C-terminal\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01369\"\r\n",
      "FT   REGION          1..41\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          858..926\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        13..31\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        869..891\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        897..911\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        912..926\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "SQ   SEQUENCE   926 AA;  106229 MW;  EB90DB4EE0C750B0 CRC64;\r\n",
      "     MPPKHPRRAA VTAVEPPTPP LPPPPPPAED PEPDSGPEDL PLARLEFEET EEPDFTALCQ\r\n",
      "     KLKIPDHVRE RAWLTWEKVS SVDGVLEGYI QKKKEFWGIC IFIAAVDLDE MPFTFTELQK\r\n",
      "     NIETSVYKFF DLLKEIDTST KVDNAMSRLM KKYNVLCALY SKLERTCELI YLTQPSNSLS\r\n",
      "     TEISSLLVLK VSWITFLLAK GEVLQMEDDL VISFQLMLCV LDYFIKLSPP ALLKEPYKTA\r\n",
      "     VIPTNGSPRT PRRGQNRSAR VARQLENDTR IIEVLCKEHE CNIDEVKNVY FKNFIPFMNS\r\n",
      "     LGIITSNGLP EVESLSKRYE EIYLKNKDLD ARLFLDHDQT LQTDPIDSFE MQRTPRKCNP\r\n",
      "     DEEVNVIPPH TPVRTVMNTI QQLMMILNSA NDQPSENLIA YFNNCTVNPR ENILKRVQNI\r\n",
      "     GHIFKEKFAK AVGQGCAEIG SQRYKLGVRL YYRVMESMLK SEEERLSIQN FSKLLNDNIF\r\n",
      "     HMSLLACALE VVMATYSRST SQNLDSGTDL SFPWILNVLE LKAFDFYKVI ESFIKAEANL\r\n",
      "     TREMIKHLER CEHRIMESLA WLSDSPLFDL IKQSKDREGP VDHLESACPL NLPLQNNHTA\r\n",
      "     ADMYLSPLRS PKKKGSTTRV NATANVETQA TSALQTQKPS KSTSLSLFYK KVYRLAYLRL\r\n",
      "     NTLCARLLSD HPELEHIIWT LFQHTLQNEY ELMRDRHLDQ IMMCSMYGIC KVKNIDLKFK\r\n",
      "     IIVTAYKDLP HAVQETFKRV LIREEEYDSI IVFYNSVFMQ RLKTNILQYA STRPPTLSPI\r\n",
      "     PHIPRSPYKF PSSPLRVPGG NIYISPLKSP YKISEGLPTP TKMTPRSRIL VSIGESFGTS\r\n",
      "     EKFHKINQMV CNSDRVLKRS AEGSNPPKPL KKLRFDIEGS DEADGSKHLP GESKFQQKLA\r\n",
      "     EMTSTRTRMQ KQKMNESMDT LKKEEK\r\n",
      "//\r\n",
      "ID   A0A455BVS4_PHYMC        Unreviewed;       929 AA.\r\n",
      "AC   A0A455BVS4;\r\n",
      "DT   05-JUN-2019, integrated into UniProtKB/TrEMBL.\r\n",
      "DT   05-JUN-2019, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 18.\r\n",
      "DE   SubName: Full=Retinoblastoma-associated protein isoform X2 {ECO:0000313|RefSeq:XP_028353104.1, ECO:0000313|RefSeq:XP_028353105.1};\r\n",
      "GN   Name=RB1 {ECO:0000313|RefSeq:XP_028353104.1,\r\n",
      "GN   ECO:0000313|RefSeq:XP_028353105.1};\r\n",
      "OS   Physeter macrocephalus (Sperm whale) (Physeter catodon).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Laurasiatheria; Artiodactyla; Whippomorpha; Cetacea; Odontoceti;\r\n",
      "OC   Physeteridae; Physeter.\r\n",
      "OX   NCBI_TaxID=9755 {ECO:0000313|Proteomes:UP000248484, ECO:0000313|RefSeq:XP_028353105.1};\r\n",
      "RN   [1] {ECO:0000313|RefSeq:XP_028353104.1, ECO:0000313|RefSeq:XP_028353105.1}\r\n",
      "RP   IDENTIFICATION.\r\n",
      "RC   TISSUE=Muscle {ECO:0000313|RefSeq:XP_028353104.1,\r\n",
      "RC   ECO:0000313|RefSeq:XP_028353105.1};\r\n",
      "RG   RefSeq;\r\n",
      "RL   Submitted (JAN-2023) to UniProtKB.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|ARBA:ARBA00004123}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000256|ARBA:ARBA00009475}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   RefSeq; XP_028353104.1; XM_028497303.1.\r\n",
      "DR   RefSeq; XP_028353105.1; XM_028497304.1.\r\n",
      "DR   STRING; 9755.ENSPCTP00005024702; -.\r\n",
      "DR   Ensembl; ENSPCTT00005027218; ENSPCTP00005024702; ENSPCTG00005017710.\r\n",
      "DR   Proteomes; UP000248484; Chromosome 13.\r\n",
      "DR   GO; GO:0061793; C:chromatin lock complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0008024; C:cyclin/CDK positive transcription elongation factor complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0016605; C:PML body; IEA:Ensembl.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0005819; C:spindle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0097718; F:disordered domain specific binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0061676; F:importin-alpha family protein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0019900; F:kinase binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051219; F:phosphoprotein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0003180; P:aortic valve morphogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051301; P:cell division; IEA:Ensembl.\r\n",
      "DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0002062; P:chondrocyte differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0048565; P:digestive tract development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043353; P:enucleate erythrocyte differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050673; P:epithelial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0034349; P:glial cell apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0014009; P:glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031507; P:heterochromatin formation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0034088; P:maintenance of mitotic sister chromatid cohesion; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045445; P:myoblast differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0030308; P:negative regulation of cell growth; IEA:Ensembl.\r\n",
      "DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.\r\n",
      "DR   GO; GO:1904761; P:negative regulation of myofibroblast differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0042551; P:neuron maturation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031175; P:neuron projection development; IEA:Ensembl.\r\n",
      "DR   GO; GO:1904028; P:positive regulation of collagen fibril organization; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071459; P:protein localization to chromosome, centromeric region; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007265; P:Ras protein signal transduction; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031134; P:sister chromatid biorientation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0001894; P:tissue homeostasis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   CDD; cd20599; CYCLIN_RB; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 6.10.140.1380; -; 1.\r\n",
      "DR   Gene3D; 6.10.250.530; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 2.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "DR   SUPFAM; SSF101447; Formin homology 2 domain (FH2 domain); 1.\r\n",
      "PE   3: Inferred from homology;\r\n",
      "KW   Cell cycle {ECO:0000256|ARBA:ARBA00023306};\r\n",
      "KW   Chromatin regulator {ECO:0000256|ARBA:ARBA00022853};\r\n",
      "KW   Nucleus {ECO:0000256|ARBA:ARBA00023242};\r\n",
      "KW   Phosphoprotein {ECO:0000256|ARBA:ARBA00022553};\r\n",
      "KW   Reference proteome {ECO:0000313|Proteomes:UP000248484};\r\n",
      "KW   Repressor {ECO:0000256|ARBA:ARBA00022491};\r\n",
      "KW   Transcription {ECO:0000256|ARBA:ARBA00023163};\r\n",
      "KW   Transcription regulation {ECO:0000256|ARBA:ARBA00023015}.\r\n",
      "FT   DOMAIN          104..230\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein N-terminal\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01367\"\r\n",
      "FT   DOMAIN          374..574\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein A-box\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01368\"\r\n",
      "FT   DOMAIN          661..762\r\n",
      "FT                   /note=\"Cyclin-like\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM00385\"\r\n",
      "FT   DOMAIN          769..928\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein C-terminal\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01369\"\r\n",
      "FT   REGION          1..44\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          611..636\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          861..929\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        18..33\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        614..636\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        872..894\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        900..919\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "SQ   SEQUENCE   929 AA;  106124 MW;  A7DB6A8148E50032 CRC64;\r\n",
      "     MPPKTPRRAA AAAAAAAAAE PPPPPPPPPP EEDPEQDSGP EDLPLARLEF EETEEPDFTA\r\n",
      "     LCQKLKIPDH VRERAWLTWE KVSSVDGVLE GYVQKKKELW GICIFTAAVD LDEMPFTFTE\r\n",
      "     LQKNIETSVY KFFDLLKEID TSTKVDNVMS RLLKKYNVLC ALYSKLERTC ELIYLSQPSS\r\n",
      "     SISTEINSML VLKVSWLTFL LAKGQVLQME DDLVISFQLM LCVLDYFIKL SPPALLKEPY\r\n",
      "     KTAVIPINGS PRTPRRGQNR SARIAKQLEN DTRIIEVLCK EHECNIDEVK NVYFKNFIPF\r\n",
      "     MNSLGIVASN GLPEVESLSK QYEEIYLKNK DIDARLFLDH DKTLQADPTD SFEMQRTPRK\r\n",
      "     SNPDEEVNVI LPQTPVRTVM NTIQQLMMIL NSASDQPSEN LISYFNNCTV NPKESILKRV\r\n",
      "     KDIGYIFKEK FAKAVGQGCM EIGSQRYKLG VRLYYRVMES MLKSEEERLS IQNFSKLLND\r\n",
      "     NIFHMSLLAC ALEVVMATYS RSTSQNLDTG TDLSFPWILN VLNLKAFDFY KVIESFIKAE\r\n",
      "     ANLTREMIKH LERCEHRIME SLAWLSDSPL FDLIKQAKDR EGPADHLEPA CTLNLPLQNN\r\n",
      "     HTAADMYLSP VRSPKKKGST TRVNSTANSE AQATSAFQTQ KPLKSTSLSL FYKKVYRLAY\r\n",
      "     LRLNTLCARL LSDHPELEHI IWTLFQHTLQ NEYELMRDRH LDQIMMCSMY GICKVKNIDL\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "     KFKIIVTAYK DLPHAVQETF KRVLIREEEY DSIIVFYNSV FMQRLKTNIL QYASTRPPTL\r\n",
      "     SPIPHIPRSP YKFSSSPLRV PGGNIYISPL KNPYKISEGL PVPTKMTPRS RILVSIGESF\r\n",
      "     GTSEKFQKIN QMVCNSDRVL KRSAEGSNPP KPLKKLRFDI EGSDEADGSK HLPGESKFQQ\r\n",
      "     KLAEMTSTRT RMQKQKMNDS TDTSNREEK\r\n",
      "//\r\n",
      "ID   I2CVJ1_MACMU            Unreviewed;       928 AA.\r\n",
      "AC   I2CVJ1; A0A1D5QLD3;\r\n",
      "DT   30-NOV-2016, integrated into UniProtKB/TrEMBL.\r\n",
      "DT   30-NOV-2016, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 39.\r\n",
      "DE   SubName: Full=RB transcriptional corepressor 1 {ECO:0000313|Ensembl:ENSMMUP00000048858.2};\r\n",
      "DE   SubName: Full=Retinoblastoma-associated protein {ECO:0000313|EMBL:AFJ70976.1};\r\n",
      "GN   Name=RB1 {ECO:0000313|EMBL:AFJ70976.1,\r\n",
      "GN   ECO:0000313|Ensembl:ENSMMUP00000048858.2,\r\n",
      "GN   ECO:0000313|VGNC:VGNC:76675};\r\n",
      "OS   Macaca mulatta (Rhesus macaque).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini;\r\n",
      "OC   Cercopithecidae; Cercopithecinae; Macaca.\r\n",
      "OX   NCBI_TaxID=9544 {ECO:0000313|EMBL:AFJ70976.1};\r\n",
      "RN   [1] {ECO:0000313|Ensembl:ENSMMUP00000048858.2, ECO:0000313|Proteomes:UP000006718}\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RC   STRAIN=17573 {ECO:0000313|Ensembl:ENSMMUP00000048858.2,\r\n",
      "RC   ECO:0000313|Proteomes:UP000006718};\r\n",
      "RX   PubMed=17431167; DOI=10.1126/science.1139247;\r\n",
      "RA   Gibbs R.A., Rogers J., Katze M.G., Bumgarner R., Weinstock G.M.,\r\n",
      "RA   Mardis E.R., Remington K.A., Strausberg R.L., Venter J.C., Wilson R.K.,\r\n",
      "RA   Batzer M.A., Bustamante C.D., Eichler E.E., Hahn M.W., Hardison R.C.,\r\n",
      "RA   Makova K.D., Miller W., Milosavljevic A., Palermo R.E., Siepel A.,\r\n",
      "RA   Sikela J.M., Attaway T., Bell S., Bernard K.E., Buhay C.J.,\r\n",
      "RA   Chandrabose M.N., Dao M., Davis C., Delehaunty K.D., Ding Y., Dinh H.H.,\r\n",
      "RA   Dugan-Rocha S., Fulton L.A., Gabisi R.A., Garner T.T., Godfrey J.,\r\n",
      "RA   Hawes A.C., Hernandez J., Hines S., Holder M., Hume J., Jhangiani S.N.,\r\n",
      "RA   Joshi V., Khan Z.M., Kirkness E.F., Cree A., Fowler R.G., Lee S.,\r\n",
      "RA   Lewis L.R., Li Z., Liu Y.-S., Moore S.M., Muzny D., Nazareth L.V.,\r\n",
      "RA   Ngo D.N., Okwuonu G.O., Pai G., Parker D., Paul H.A., Pfannkoch C.,\r\n",
      "RA   Pohl C.S., Rogers Y.-H.C., Ruiz S.J., Sabo A., Santibanez J.,\r\n",
      "RA   Schneider B.W., Smith S.M., Sodergren E., Svatek A.F., Utterback T.R.,\r\n",
      "RA   Vattathil S., Warren W., White C.S., Chinwalla A.T., Feng Y., Halpern A.L.,\r\n",
      "RA   Hillier L.W., Huang X., Minx P., Nelson J.O., Pepin K.H., Qin X.,\r\n",
      "RA   Sutton G.G., Venter E., Walenz B.P., Wallis J.W., Worley K.C., Yang S.-P.,\r\n",
      "RA   Jones S.M., Marra M.A., Rocchi M., Schein J.E., Baertsch R., Clarke L.,\r\n",
      "RA   Csuros M., Glasscock J., Harris R.A., Havlak P., Jackson A.R., Jiang H.,\r\n",
      "RA   Liu Y., Messina D.N., Shen Y., Song H.X.-Z., Wylie T., Zhang L., Birney E.,\r\n",
      "RA   Han K., Konkel M.K., Lee J., Smit A.F.A., Ullmer B., Wang H., Xing J.,\r\n",
      "RA   Burhans R., Cheng Z., Karro J.E., Ma J., Raney B., She X., Cox M.J.,\r\n",
      "RA   Demuth J.P., Dumas L.J., Han S.-G., Hopkins J., Karimpour-Fard A.,\r\n",
      "RA   Kim Y.H., Pollack J.R., Vinar T., Addo-Quaye C., Degenhardt J., Denby A.,\r\n",
      "RA   Hubisz M.J., Indap A., Kosiol C., Lahn B.T., Lawson H.A., Marklein A.,\r\n",
      "RA   Nielsen R., Vallender E.J., Clark A.G., Ferguson B., Hernandez R.D.,\r\n",
      "RA   Hirani K., Kehrer-Sawatzki H., Kolb J., Patil S., Pu L.-L., Ren Y.,\r\n",
      "RA   Smith D.G., Wheeler D.A., Schenck I., Ball E.V., Chen R., Cooper D.N.,\r\n",
      "RA   Giardine B., Hsu F., Kent W.J., Lesk A., Nelson D.L., O'brien W.E.,\r\n",
      "RA   Pruefer K., Stenson P.D., Wallace J.C., Ke H., Liu X.-M., Wang P.,\r\n",
      "RA   Xiang A.P., Yang F., Barber G.P., Haussler D., Karolchik D., Kern A.D.,\r\n",
      "RA   Kuhn R.M., Smith K.E., Zwieg A.S.;\r\n",
      "RT   \"Evolutionary and biomedical insights from the rhesus macaque genome.\";\r\n",
      "RL   Science 316:222-234(2007).\r\n",
      "RN   [2] {ECO:0000313|EMBL:AFJ70976.1}\r\n",
      "RP   NUCLEOTIDE SEQUENCE.\r\n",
      "RC   TISSUE=Orbital {ECO:0000313|EMBL:AFJ70976.1}, and Thymus\r\n",
      "RC   {ECO:0000313|EMBL:AFH28439.1};\r\n",
      "RX   PubMed=25319552; DOI=10.1186/1745-6150-9-20;\r\n",
      "RA   Zimin A.V., Cornish A.S., Maudhoo M.D., Gibbs R.M., Zhang X., Pandey S.,\r\n",
      "RA   Meehan D.T., Wipfler K., Bosinger S.E., Johnson Z.P., Tharp G.K.,\r\n",
      "RA   Marcais G., Roberts M., Ferguson B., Fox H.S., Treangen T., Salzberg S.L.,\r\n",
      "RA   Yorke J.A., Norgren R.B.Jr.;\r\n",
      "RT   \"A new rhesus macaque assembly and annotation for next-generation\r\n",
      "RT   sequencing analyses.\";\r\n",
      "RL   Biol. Direct 9:20-20(2014).\r\n",
      "RN   [3] {ECO:0000313|Ensembl:ENSMMUP00000048858.2}\r\n",
      "RP   IDENTIFICATION.\r\n",
      "RC   STRAIN=17573 {ECO:0000313|Ensembl:ENSMMUP00000048858.2};\r\n",
      "RG   Ensembl;\r\n",
      "RL   Submitted (JAN-2023) to UniProtKB.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|ARBA:ARBA00004123}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000256|ARBA:ARBA00009475}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; JU471635; AFH28439.1; -; mRNA.\r\n",
      "DR   EMBL; JU471636; AFH28440.1; -; mRNA.\r\n",
      "DR   EMBL; JV635636; AFJ70976.1; -; mRNA.\r\n",
      "DR   RefSeq; NP_001247976.1; NM_001261047.1.\r\n",
      "DR   STRING; 9544.ENSMMUP00000010362; -.\r\n",
      "DR   Ensembl; ENSMMUT00000055616.2; ENSMMUP00000048858.2; ENSMMUG00000007891.4.\r\n",
      "DR   GeneID; 704871; -.\r\n",
      "DR   KEGG; mcc:704871; -.\r\n",
      "DR   CTD; 5925; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSMMUG00000007891; -.\r\n",
      "DR   VGNC; VGNC:76675; RB1.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00950000183202; -.\r\n",
      "DR   OMA; VKDIGCI; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   Proteomes; UP000006718; Chromosome 17.\r\n",
      "DR   Bgee; ENSMMUG00000007891; Expressed in colon and 23 other tissues.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0061793; C:chromatin lock complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0008024; C:cyclin/CDK positive transcription elongation factor complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0016605; C:PML body; IEA:Ensembl.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; IBA:GO_Central.\r\n",
      "DR   GO; GO:0005819; C:spindle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0097718; F:disordered domain specific binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0061676; F:importin-alpha family protein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0019900; F:kinase binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051219; F:phosphoprotein binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0003180; P:aortic valve morphogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0051301; P:cell division; IEA:Ensembl.\r\n",
      "DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0002062; P:chondrocyte differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0048565; P:digestive tract development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043353; P:enucleate erythrocyte differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050673; P:epithelial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0034349; P:glial cell apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0014009; P:glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031507; P:heterochromatin formation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0034088; P:maintenance of mitotic sister chromatid cohesion; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045445; P:myoblast differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0030308; P:negative regulation of cell growth; IEA:Ensembl.\r\n",
      "DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.\r\n",
      "DR   GO; GO:1904761; P:negative regulation of myofibroblast differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0042551; P:neuron maturation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031175; P:neuron projection development; IBA:GO_Central.\r\n",
      "DR   GO; GO:1904028; P:positive regulation of collagen fibril organization; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071459; P:protein localization to chromosome, centromeric region; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007265; P:Ras protein signal transduction; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031134; P:sister chromatid biorientation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0001894; P:tissue homeostasis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   CDD; cd20599; CYCLIN_RB; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 6.10.140.1380; -; 1.\r\n",
      "DR   Gene3D; 6.10.250.530; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 2.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   2: Evidence at transcript level;\r\n",
      "KW   Cell cycle {ECO:0000256|ARBA:ARBA00023306};\r\n",
      "KW   Chromatin regulator {ECO:0000256|ARBA:ARBA00022853};\r\n",
      "KW   Nucleus {ECO:0000256|ARBA:ARBA00023242};\r\n",
      "KW   Phosphoprotein {ECO:0000256|ARBA:ARBA00022553};\r\n",
      "KW   Reference proteome {ECO:0000313|Proteomes:UP000006718};\r\n",
      "KW   Repressor {ECO:0000256|ARBA:ARBA00022491};\r\n",
      "KW   Transcription {ECO:0000256|ARBA:ARBA00023163};\r\n",
      "KW   Transcription regulation {ECO:0000256|ARBA:ARBA00023015}.\r\n",
      "FT   DOMAIN          103..229\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein N-terminal\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01367\"\r\n",
      "FT   DOMAIN          373..573\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein A-box\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01368\"\r\n",
      "FT   DOMAIN          660..761\r\n",
      "FT                   /note=\"Cyclin-like\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM00385\"\r\n",
      "FT   DOMAIN          768..927\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein C-terminal\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01369\"\r\n",
      "FT   REGION          1..42\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          610..632\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          860..928\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        18..32\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        613..632\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        871..893\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        899..918\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "SQ   SEQUENCE   928 AA;  106144 MW;  BAF9942974A34F42 CRC64;\r\n",
      "     MPPKTPRKTA AAAAAAAAEP PAPPPPPPPE EDPEQDSGPE DLPLVRLEFE ETEEPDFTAL\r\n",
      "     CQKLKIPDHV RERAWLTWEK VSSVDGVLGG YIQKKKELWG ICIFIAAVDL DEMPFTFTEL\r\n",
      "     QKNIEISVHK FFNLLKEIDT STKVDNAMSR LLKKYDVLFA LFSKLERTCE LIYLTQPSSS\r\n",
      "     ISTEINSTLV LKVSWITFLL AKGEVLQMED DLVISFQLML CVLDYFIKLS PPVLLKEPYK\r\n",
      "     TAVIPINGSP RTPRRGQNRS ARIAKQLEND TRIIEVLCKE HECNIDEVKN VYFKNFIPFM\r\n",
      "     NSLGLVTSNG LPEVESLSKR YEEIYLKNKD LDARLFLDHD KTLQTDSIDS FETQRTPRKS\r\n",
      "     NLDEEVNVIP PHTPVRTVMN TIQQLMMILN SASDQPSENL ISYFNNCTVN PKESILKRVK\r\n",
      "     DIGYIFKEKF AKAVGQGCVE IGSQRYKLGV RLYYRVMESM LKSEEERLSI QNFSKLLNDN\r\n",
      "     IFHMSLLACA LEVVMATYSR STSQNLDSGT DLSFPWILNV LNLKAFDFYK VIESFIKAEG\r\n",
      "     NLTREMIKHL ERCEHRIMES LAWLSDSPLF DLIKQSKDRE GPTDHFESAC PLNLPLQNNH\r\n",
      "     TAADMYLSPV RSPKKKGSTT RVNSTANAET QATSAFQTQK PLKSTSLSLF YKKVYRLAYL\r\n",
      "     RLNTLCERLL SEHPELEHII WTLFQHTLQN EYELMRDRHL DQIMMCSMYG ICKVKNIDLK\r\n",
      "     FKIIVTAYKD LPHAVQETFK RVLIKEEEYD SIIVFYNSVF MQRLKTNILQ YASTRPPTLS\r\n",
      "     PIPHIPRSPY KFPSSPLRIP GGNIYISPLK SPYKISEGLP TPTKMTPRSR ILVSIGESFG\r\n",
      "     TSEKFQKINQ MVCNSDRVLK RSAEGSNPPK PLKKLRFDIE GSDEADGSKH LPGESKFQQK\r\n",
      "     LAEMTSTRTR MQKQKMNDSM DTSNKEEK\r\n",
      "//\r\n",
      "ID   A0JMQ4_DANRE            Unreviewed;       903 AA.\r\n",
      "AC   A0JMQ4;\r\n",
      "DT   12-DEC-2006, integrated into UniProtKB/TrEMBL.\r\n",
      "DT   12-DEC-2006, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 91.\r\n",
      "DE   SubName: Full=Retinoblastoma 1 {ECO:0000313|EMBL:AAI25967.1};\r\n",
      "DE   SubName: Full=Retinoblastoma-associated protein {ECO:0000313|RefSeq:NP_001071248.1};\r\n",
      "GN   Name=zgc:154147 {ECO:0000313|RefSeq:NP_001071248.1};\r\n",
      "GN   OrderedLocusNames=rb1 {ECO:0000313|EMBL:AAI25967.1,\r\n",
      "GN   ECO:0000313|RefSeq:NP_001071248.1,\r\n",
      "GN   ECO:0000313|ZFIN:ZDB-GENE-040428-1};\r\n",
      "OS   Danio rerio (Zebrafish) (Brachydanio rerio).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\r\n",
      "OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;\r\n",
      "OC   Danionidae; Danioninae; Danio.\r\n",
      "OX   NCBI_TaxID=7955 {ECO:0000313|EMBL:AAI25967.1};\r\n",
      "RN   [1] {ECO:0000313|EMBL:AAI25967.1}\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\r\n",
      "RC   TISSUE=Whole {ECO:0000313|EMBL:AAI25967.1};\r\n",
      "RG   NIH - Zebrafish Gene Collection (ZGC) project;\r\n",
      "RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [2] {ECO:0000313|RefSeq:NP_001071248.1}\r\n",
      "RP   NUCLEOTIDE SEQUENCE.\r\n",
      "RX   PubMed=19014929; DOI=10.1016/j.ydbio.2008.09.032;\r\n",
      "RA   Kizil C., Otto G.W., Geisler R., Nusslein-Volhard C., Antos C.L.;\r\n",
      "RT   \"Simplet controls cell proliferation and gene transcription during\r\n",
      "RT   zebrafish caudal fin regeneration.\";\r\n",
      "RL   Dev. Biol. 325:329-340(2009).\r\n",
      "RN   [3] {ECO:0000313|RefSeq:NP_001071248.1}\r\n",
      "RP   NUCLEOTIDE SEQUENCE.\r\n",
      "RX   PubMed=21888654;\r\n",
      "RA   Schuck J.B., Sun H., Penberthy W.T., Cooper N.G., Li X., Smith M.E.;\r\n",
      "RT   \"Transcriptomic analysis of the zebrafish inner ear points to growth\r\n",
      "RT   hormone mediated regeneration following acoustic trauma.\";\r\n",
      "RL   BMC Neurosci. 12:88-88(2011).\r\n",
      "RN   [4] {ECO:0000313|RefSeq:NP_001071248.1}\r\n",
      "RP   NUCLEOTIDE SEQUENCE.\r\n",
      "RX   PubMed=21249182;\r\n",
      "RA   Rios Y., Melmed S., Lin S., Liu N.A.;\r\n",
      "RT   \"Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and pituitary\r\n",
      "RT   lineage expansion.\";\r\n",
      "RL   PLoS Genet. 7:e1001271-e1001271(2011).\r\n",
      "RN   [5] {ECO:0000313|RefSeq:NP_001071248.1}\r\n",
      "RP   NUCLEOTIDE SEQUENCE.\r\n",
      "RX   PubMed=23209449;\r\n",
      "RA   Gyda M., Wolman M., Lorent K., Granato M.;\r\n",
      "RT   \"The tumor suppressor gene retinoblastoma-1 is required for retinotectal\r\n",
      "RT   development and visual function in zebrafish.\";\r\n",
      "RL   PLoS Genet. 8:e1003106-e1003106(2012).\r\n",
      "RN   [6] {ECO:0000313|RefSeq:NP_001071248.1}\r\n",
      "RP   NUCLEOTIDE SEQUENCE.\r\n",
      "RX   PubMed=23381351;\r\n",
      "RA   Lin Q., Li W., Chen Y., Sun S., Li H.;\r\n",
      "RT   \"Disrupting Rb-Raf-1 interaction inhibits hair cell regeneration in\r\n",
      "RT   zebrafish lateral line neuromasts.\";\r\n",
      "RL   NeuroReport 24:190-195(2013).\r\n",
      "RN   [7] {ECO:0000313|RefSeq:NP_001071248.1}\r\n",
      "RP   NUCLEOTIDE SEQUENCE.\r\n",
      "RX   PubMed=29229770; DOI=10.1242/dev.158139;\r\n",
      "RA   Zhang Z., Liu W., Zhao L., Huang Z., Chen X., Ma N., Xu J., Xu J.,\r\n",
      "RA   Zhang W., Zhang Y.;\r\n",
      "RT   \"Retinoblastoma 1 protects T cell maturation from premature apoptosis by\r\n",
      "RT   inhibiting E2F1. .\";\r\n",
      "RL   Development 145:dev158139-dev158139(2018).\r\n",
      "RN   [8] {ECO:0000313|RefSeq:NP_001071248.1}\r\n",
      "RP   NUCLEOTIDE SEQUENCE.\r\n",
      "RX   PubMed=29914980; DOI=10.1242/dmm.034124;\r\n",
      "RA   Schultz L.E., Haltom J.A., Almeida M.P., Wierson W.A., Solin S.L.,\r\n",
      "RA   Weiss T.J., Helmer J.A., Sandquist E.J., Shive H.R., McGrail M.;\r\n",
      "RT   \"Epigenetic regulators Rbbp4 and Hdac1 are overexpressed in a zebrafish\r\n",
      "RT   model of RB1 embryonal brain tumor, and are required for neural progenitor\r\n",
      "RT   survival and proliferation. .\";\r\n",
      "RL   Dis. Model. Mech. 11:dmm034124-dmm034124(2018).\r\n",
      "RN   [9] {ECO:0000313|RefSeq:NP_001071248.1}\r\n",
      "RP   NUCLEOTIDE SEQUENCE.\r\n",
      "RX   PubMed=30061297; DOI=10.1242/dmm.034561;\r\n",
      "RA   Callahan S.J., Tepan S., Zhang Y.M., Lindsay H., Burger A., Campbell N.R.,\r\n",
      "RA   Kim I.S., Hollmann T.J., Studer L., Mosimann C., White R.M.;\r\n",
      "RT   \"Cancer modeling by Transgene Electroporation in Adult Zebrafish (TEAZ).\r\n",
      "RT   .\";\r\n",
      "RL   Dis. Model. Mech. 11:dmm034561-dmm034561(2018).\r\n",
      "RN   [10] {ECO:0000313|RefSeq:NP_001071248.1}\r\n",
      "RP   NUCLEOTIDE SEQUENCE.\r\n",
      "RX   PubMed=30530669;\r\n",
      "RA   Vera-Chang M.N., St-Jacques A.D., Gagne R., Martyniuk C.J., Yauk C.L.,\r\n",
      "RA   Moon T.W., Trudeau V.L.;\r\n",
      "RT   \"Transgenerational hypocortisolism and behavioral disruption are induced by\r\n",
      "RT   the antidepressant fluoxetine in male zebrafish Danio rerio.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 115:E12435-E12442(2018).\r\n",
      "RN   [11] {ECO:0000313|RefSeq:NP_001071248.1}\r\n",
      "RP   NUCLEOTIDE SEQUENCE.\r\n",
      "RX   PubMed=30763280;\r\n",
      "RA   Webster K.A., Henke K., Ingalls D.M., Nahrin A., Harris M.P.,\r\n",
      "RA   Siegfried K.R.;\r\n",
      "RT   \"Cyclin-dependent kinase 21 is a novel regulator of proliferation and\r\n",
      "RT   meiosis in the male germline of zebrafish.\";\r\n",
      "RL   Reproduction 157:383-398(2018).\r\n",
      "RN   [12] {ECO:0000313|RefSeq:NP_001071248.1}\r\n",
      "RP   IDENTIFICATION.\r\n",
      "RG   RefSeq;\r\n",
      "RL   Submitted (JAN-2023) to UniProtKB.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|ARBA:ARBA00004123}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000256|ARBA:ARBA00009475}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; BC125966; AAI25967.1; -; mRNA.\r\n",
      "DR   RefSeq; NP_001071248.1; NM_001077780.1.\r\n",
      "DR   GeneID; 777733; -.\r\n",
      "DR   KEGG; dre:777733; -.\r\n",
      "DR   CTD; 5925; -.\r\n",
      "DR   ZFIN; ZDB-GENE-040428-1; rb1.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   Proteomes; UP000000437; Chromosome 21.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; IBA:GO_Central.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:ZFIN.\r\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0048469; P:cell maturation; IMP:ZFIN.\r\n",
      "DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0031175; P:neuron projection development; IBA:GO_Central.\r\n",
      "DR   GO; GO:0021554; P:optic nerve development; IMP:ZFIN.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:InterPro.\r\n",
      "DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; IMP:ZFIN.\r\n",
      "DR   GO; GO:0007601; P:visual perception; IMP:ZFIN.\r\n",
      "DR   CDD; cd20599; CYCLIN_RB; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 6.10.140.1380; -; 1.\r\n",
      "DR   Gene3D; 6.10.250.530; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 2.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Cell cycle {ECO:0000256|ARBA:ARBA00023306};\r\n",
      "KW   Chromatin regulator {ECO:0000256|ARBA:ARBA00022853};\r\n",
      "KW   Nucleus {ECO:0000256|ARBA:ARBA00023242};\r\n",
      "KW   Proteomics identification {ECO:0007829|PeptideAtlas:A0JMQ4};\r\n",
      "KW   Reference proteome {ECO:0000313|Proteomes:UP000000437};\r\n",
      "KW   Repressor {ECO:0000256|ARBA:ARBA00022491};\r\n",
      "KW   Transcription {ECO:0000256|ARBA:ARBA00023163};\r\n",
      "KW   Transcription regulation {ECO:0000256|ARBA:ARBA00023015}.\r\n",
      "FT   DOMAIN          90..215\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein N-terminal\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01367\"\r\n",
      "FT   DOMAIN          359..569\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein A-box\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01368\"\r\n",
      "FT   DOMAIN          752..903\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein C-terminal\"\r\n",
      "FT                   /evidence=\"ECO:0000259|SMART:SM01369\"\r\n",
      "FT   REGION          1..38\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          224..252\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          856..903\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        8..22\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        224..243\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        865..885\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        886..903\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "SQ   SEQUENCE   903 AA;  102358 MW;  46968B55B44942ED CRC64;\r\n",
      "     MPPKKRSSGT PQKKELKGSL KSRSPDSGDN AVLSPERHKD KDPEFVFLSE ELQSTNSICD\r\n",
      "     HAWRIWEREI RSMDKTNMPY SNRQQWGACL FIAGMELEGI NLTFTQFLKA VGLSVKQFIS\r\n",
      "     LVRKMDVNVD TISPKVNSAV TRLENKYDVT LALYQRFVKT CEKIFAEPDN AKRKELWESS\r\n",
      "     WTMFLLAKGT FLQMEDDLVI SFQLLLCVLE FFAKRLSPSL LQSPYNSVVS SSTLSPPTRT\r\n",
      "     SRRNQGKSKP RPAEMDMQLL ETLCKEGDCS VDEVKNVYQS TFCAFLDSVG LLGLQGLPPM\r\n",
      "     EALSKQYEEL YHKSKDFDAR LFLSDDETLS PNKIEVSKVE VTPRKNLFAE DIAIPVPQTP\r\n",
      "     IRAAMTSIQQ LRGDLTSGSD QPSSNLLVYY KNCTVDPSGE IKKRVEELGE VFIQRFAQAV\r\n",
      "     GQHCEGLGRK RFYLGAQLYY KVMESMLKSE EKRLSVQNFS KLLNNAAFHT SLLACALEVV\r\n",
      "     IATYVGSSLK NGGFGRSSGA SDSVESDLCF PWILSVFQLP AFDFYKVIES FIKAEPTLKH\r\n",
      "     DMVKHLEQCE HVIMESLAWR TDSPLFDLLK QSREEGPGEQ AEPPATLNQP LHHNHTAADL\r\n",
      "     YLSPVRPCRQ PPVMEAEPPT PGTRAPRSNS LSLFYKKLYR MAYLRLKMLF SNLLTSHPEM\r\n",
      "     EPIIWTLLQH TLQNEYELMR DRHLDQLIMS AMYAICKVKN VDLRFKTIVT AYKELPNTNQ\r\n",
      "     ETFKRVLIRE GQYDSIIVFY NLVFMQKLKT NILQYSSPRP PPLSPIPHIP CSPYKNSPLR\r\n",
      "     VPGSNNVYVS PLKSSRVSPL VMTPRSRILI SIGESFGSAD KFQKINQMLS SSDWSLKRSL\r\n",
      "     DGGSAPKPLK RLRFDMDGQD EADGSKSSGE SALIQKLAEM SSTRSRMQEQ KLKEESDKDH\r\n",
      "     PEP\r\n",
      "//\r\n"
     ]
    }
   ],
   "source": [
    "!curl -H \"Accept: text/plain; format=flatfile\" \"https://rest.uniprot.org/uniprotkb/search?query=(protein_name:Retinoblastoma-associated)\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "7bc42515",
   "metadata": {},
   "outputs": [],
   "source": [
    "!curl -H \"Accept: text/plain; format=flatfile\" \"https://rest.uniprot.org/uniprotkb/search?query=(reviewed:true)%20AND%20(protein_name:Retinoblastoma-associated%20protein)?fields=(accession)\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "b97b8588",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ID   RBL1_HUMAN              Reviewed;        1068 AA.\n",
      "AC   P28749; A8K2W5; Q4VXA0; Q8N5K6; Q9H1L5; Q9H1M1;\n",
      "DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.\n",
      "DT   07-MAR-2006, sequence version 3.\n",
      "DT   03-MAY-2023, entry version 223.\n",
      "DE   RecName: Full=Retinoblastoma-like protein 1;\n",
      "DE   AltName: Full=107 kDa retinoblastoma-associated protein;\n",
      "DE            Short=p107;\n",
      "DE   AltName: Full=pRb1;\n",
      "GN   Name=RBL1;\n",
      "OS   Homo sapiens (Human).\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\n",
      "OC   Homo.\n",
      "OX   NCBI_TaxID=9606;\n",
      "RN   [1]\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.\n",
      "RX   PubMed=8319904; DOI=10.1101/gad.7.7a.1111;\n",
      "RA   Zhu L., van den Heuvel S., Helin K., Fattaey A., Ewen M., Livingston D.,\n",
      "RA   Dyson N., Harlow E.;\n",
      "RT   \"Inhibition of cell proliferation by p107, a relative of the retinoblastoma\n",
      "RT   protein.\";\n",
      "RL   Genes Dev. 7:1111-1125(1993).\n",
      "RN   [2]\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).\n",
      "RC   TISSUE=Tongue;\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\n",
      "RA   Isogai T., Sugano S.;\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\n",
      "RT   cDNAs.\";\n",
      "RL   Nat. Genet. 36:40-45(2004).\n",
      "RN   [3]\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\n",
      "RX   PubMed=11780052; DOI=10.1038/414865a;\n",
      "RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,\n",
      "RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,\n",
      "RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,\n",
      "RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,\n",
      "RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,\n",
      "RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,\n",
      "RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,\n",
      "RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,\n",
      "RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,\n",
      "RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,\n",
      "RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,\n",
      "RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,\n",
      "RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,\n",
      "RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,\n",
      "RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,\n",
      "RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,\n",
      "RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,\n",
      "RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,\n",
      "RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,\n",
      "RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,\n",
      "RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,\n",
      "RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,\n",
      "RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;\n",
      "RT   \"The DNA sequence and comparative analysis of human chromosome 20.\";\n",
      "RL   Nature 414:865-871(2001).\n",
      "RN   [4]\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\n",
      "RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,\n",
      "RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,\n",
      "RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,\n",
      "RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,\n",
      "RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,\n",
      "RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,\n",
      "RA   Hunkapiller M.W., Myers E.W., Venter J.C.;\n",
      "RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.\n",
      "RN   [5]\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).\n",
      "RC   TISSUE=Testis;\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\n",
      "RG   The MGC Project Team;\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\n",
      "RT   the Mammalian Gene Collection (MGC).\";\n",
      "RL   Genome Res. 14:2121-2127(2004).\n",
      "RN   [6]\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 134-1068 (ISOFORM 1), AND PARTIAL PROTEIN\n",
      "RP   SEQUENCE.\n",
      "RX   PubMed=1833063; DOI=10.1016/0092-8674(91)90038-z;\n",
      "RA   Ewen M.E., Xing Y., Lawrence J.B., Livingston D.M.;\n",
      "RT   \"Molecular cloning, chromosomal mapping, and expression of the cDNA for\n",
      "RT   p107, a retinoblastoma gene product-related protein.\";\n",
      "RL   Cell 66:1155-1164(1991).\n",
      "RN   [7]\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-52.\n",
      "RX   PubMed=7791762; DOI=10.1128/mcb.15.7.3552;\n",
      "RA   Zhu L., Zhu L., Xie E., Chang L.S.;\n",
      "RT   \"Differential roles of two tandem E2F sites in repression of the human p107\n",
      "RT   promoter by retinoblastoma and p107 proteins.\";\n",
      "RL   Mol. Cell. Biol. 15:3552-3562(1995).\n",
      "RN   [8]\n",
      "RP   PROTEIN SEQUENCE OF 320-334; 364-374; 635-657; 949-977 AND 1006-1012,\n",
      "RP   PHOSPHORYLATION AT THR-332; THR-369; THR-385; SER-640; SER-762; SER-964;\n",
      "RP   SER-975; SER-988; THR-997 AND SER-1009, MUTAGENESIS OF SER-640; SER-643;\n",
      "RP   SER-650 AND 657-LYS--LEU-660, AND IDENTIFICATION BY MASS SPECTROMETRY.\n",
      "RX   PubMed=11884610; DOI=10.1128/mcb.22.7.2242-2254.2002;\n",
      "RA   Leng X., Noble M., Adams P.D., Qin J., Harper J.W.;\n",
      "RT   \"Reversal of growth suppression by p107 via direct phosphorylation by\n",
      "RT   cyclin D1/cyclin-dependent kinase 4.\";\n",
      "RL   Mol. Cell. Biol. 22:2242-2254(2002).\n",
      "RN   [9]\n",
      "RP   INTERACTION WITH SV40 AND JC VIRUS LARGE T ANTIGEN (MICROBIAL INFECTION).\n",
      "RX   PubMed=2546678; DOI=10.1016/0092-8674(89)90839-8;\n",
      "RA   Dyson N., Buchkovich K., Whyte P., Harlow E.;\n",
      "RT   \"The cellular 107K protein that binds to adenovirus E1A also associates\n",
      "RT   with the large T antigens of SV40 and JC virus.\";\n",
      "RL   Cell 58:249-255(1989).\n",
      "RN   [10]\n",
      "RP   INTERACTION WITH KDM5A.\n",
      "RX   PubMed=7935440; DOI=10.1128/mcb.14.11.7256-7264.1994;\n",
      "RA   Kim Y.W., Otterson G.A., Kratzke R.A., Coxon A.B., Kaye F.J.;\n",
      "RT   \"Differential specificity for binding of retinoblastoma binding protein 2\n",
      "RT   to RB, p107, and TATA-binding protein.\";\n",
      "RL   Mol. Cell. Biol. 14:7256-7264(1994).\n",
      "RN   [11]\n",
      "RP   INTERACTION WITH AATF.\n",
      "RX   PubMed=12450794; DOI=10.1016/s1535-6108(02)00182-4;\n",
      "RA   Bruno T., De Angelis R., De Nicola F., Barbato C., Di Padova M., Corbi N.,\n",
      "RA   Libri V., Benassi B., Mattei E., Chersi A., Soddu S., Floridi A.,\n",
      "RA   Passananti C., Fanciulli M.;\n",
      "RT   \"Che-1 affects cell growth by interfering with the recruitment of HDAC1 by\n",
      "RT   Rb.\";\n",
      "RL   Cancer Cell 2:387-399(2002).\n",
      "RN   [12]\n",
      "RP   PHOSPHORYLATION AT THR-369 AND SER-650.\n",
      "RX   PubMed=12006580; DOI=10.1074/jbc.m200381200;\n",
      "RA   Farkas T., Hansen K., Holm K., Lukas J., Bartek J.;\n",
      "RT   \"Distinct phosphorylation events regulate p130- and p107-mediated\n",
      "RT   repression of E2F-4.\";\n",
      "RL   J. Biol. Chem. 277:26741-26752(2002).\n",
      "RN   [13]\n",
      "RP   INTERACTION WITH E2F4 AND TFDP1.\n",
      "RX   PubMed=16360038; DOI=10.1016/j.cell.2005.09.044;\n",
      "RA   Rubin S.M., Gall A.-L., Zheng N., Pavletich N.P.;\n",
      "RT   \"Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for\n",
      "RT   phosphorylation-induced E2F release.\";\n",
      "RL   Cell 123:1093-1106(2005).\n",
      "RN   [14]\n",
      "RP   FUNCTION, AND IDENTIFICATION IN THE DREAM COMPLEX.\n",
      "RX   PubMed=17671431; DOI=10.4161/cc.6.15.4512;\n",
      "RA   Schmit F., Korenjak M., Mannefeld M., Schmitt K., Franke C., von Eyss B.,\n",
      "RA   Gagrica S., Haenel F., Brehm A., Gaubatz S.;\n",
      "RT   \"LINC, a human complex that is related to pRB-containing complexes in\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RT   invertebrates regulates the expression of G2/M genes.\";\n",
      "RL   Cell Cycle 6:1903-1913(2007).\n",
      "RN   [15]\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-385; SER-749 AND SER-762, AND\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\n",
      "RC   TISSUE=Leukemic T-cell;\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\n",
      "RA   Rodionov V., Han D.K.;\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\n",
      "RN   [16]\n",
      "RP   INTERACTION WITH JC VIRUS SMALL T ANTIGEN (MICROBIAL INFECTION).\n",
      "RX   PubMed=20485545; DOI=10.1371/journal.pone.0010606;\n",
      "RA   Bollag B., Hofstetter C.A., Reviriego-Mendoza M.M., Frisque R.J.;\n",
      "RT   \"JC virus small T antigen binds phosphatase PP2A and Rb family proteins and\n",
      "RT   is required for efficient viral DNA replication activity.\";\n",
      "RL   PLoS ONE 5:e10606-e10606(2010).\n",
      "RN   [17]\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-332; THR-369; THR-385;\n",
      "RP   SER-640; SER-749; SER-762; SER-988 AND SER-1041, AND IDENTIFICATION BY MASS\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\n",
      "RA   Mohammed S.;\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\n",
      "RT   phosphoproteome.\";\n",
      "RL   J. Proteome Res. 12:260-271(2013).\n",
      "CC   -!- FUNCTION: Key regulator of entry into cell division (PubMed:17671431).\n",
      "CC       Directly involved in heterochromatin formation by maintaining overall\n",
      "CC       chromatin structure and, in particular, that of constitutive\n",
      "CC       heterochromatin by stabilizing histone methylation (By similarity).\n",
      "CC       Recruits and targets histone methyltransferases KMT5B and KMT5C,\n",
      "CC       leading to epigenetic transcriptional repression (By similarity).\n",
      "CC       Controls histone H4 'Lys-20' trimethylation (By similarity). Probably\n",
      "CC       acts as a transcription repressor by recruiting chromatin-modifying\n",
      "CC       enzymes to promoters (By similarity). Potent inhibitor of E2F-mediated\n",
      "CC       trans-activation (PubMed:8319904). May act as a tumor suppressor\n",
      "CC       (PubMed:8319904). {ECO:0000250|UniProtKB:Q64701,\n",
      "CC       ECO:0000269|PubMed:17671431, ECO:0000269|PubMed:8319904}.\n",
      "CC   -!- SUBUNIT: Component of the DREAM complex (also named LINC complex) at\n",
      "CC       least composed of E2F4, E2F5, LIN9, LIN37, LIN52, LIN54, MYBL1, MYBL2,\n",
      "CC       RBL1, RBL2, RBBP4, TFDP1 and TFDP2 (PubMed:17671431, PubMed:16360038).\n",
      "CC       The complex exists in quiescent cells where it represses cell cycle-\n",
      "CC       dependent genes (PubMed:17671431). It dissociates in S phase when LIN9,\n",
      "CC       LIN37, LIN52 and LIN54 form a subcomplex that binds to MYBL2\n",
      "CC       (PubMed:17671431). Interacts with AATF (PubMed:12450794). Interacts\n",
      "CC       with KDM5A (PubMed:7935440). Interacts with KMT5B and KMT5C (By\n",
      "CC       similarity). Interacts with USP4 (By similarity). Interacts with RBBP9\n",
      "CC       (By similarity). {ECO:0000250|UniProtKB:D3ZS28,\n",
      "CC       ECO:0000250|UniProtKB:Q64701, ECO:0000269|PubMed:12450794,\n",
      "CC       ECO:0000269|PubMed:16360038, ECO:0000269|PubMed:17671431,\n",
      "CC       ECO:0000269|PubMed:7935440}.\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with SV40 and JC virus large T\n",
      "CC       antigens. Large T antigen, but not E1A, binds only to the\n",
      "CC       unphosphorylated form. {ECO:0000269|PubMed:2546678}.\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with JC virus small t antigen.\n",
      "CC       {ECO:0000269|PubMed:20485545}.\n",
      "CC   -!- INTERACTION:\n",
      "CC       P28749; Q9BUH8: BEGAIN; NbExp=2; IntAct=EBI-971402, EBI-742722;\n",
      "CC       P28749; P11802: CDK4; NbExp=2; IntAct=EBI-971402, EBI-295644;\n",
      "CC       P28749; Q13574-2: DGKZ; NbExp=2; IntAct=EBI-971402, EBI-715527;\n",
      "CC       P28749; Q13627: DYRK1A; NbExp=4; IntAct=EBI-971402, EBI-1053596;\n",
      "CC       P28749; Q9Y463: DYRK1B; NbExp=4; IntAct=EBI-971402, EBI-634187;\n",
      "CC       P28749; O43524: FOXO3; NbExp=3; IntAct=EBI-971402, EBI-1644164;\n",
      "CC       P28749; Q14653: IRF3; NbExp=2; IntAct=EBI-971402, EBI-2650369;\n",
      "CC       P28749; P67775: PPP2CA; NbExp=2; IntAct=EBI-971402, EBI-712311;\n",
      "CC       P28749; P03129: E7; Xeno; NbExp=4; IntAct=EBI-971402, EBI-866453;\n",
      "CC       P28749; P24610: Pax3; Xeno; NbExp=3; IntAct=EBI-971402, EBI-1208116;\n",
      "CC       P28749; Q923E4: Sirt1; Xeno; NbExp=2; IntAct=EBI-971402, EBI-1802585;\n",
      "CC       P28749; P03255; Xeno; NbExp=3; IntAct=EBI-971402, EBI-2603114;\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\n",
      "CC       Event=Alternative splicing; Named isoforms=2;\n",
      "CC       Name=1;\n",
      "CC         IsoId=P28749-1; Sequence=Displayed;\n",
      "CC       Name=2;\n",
      "CC         IsoId=P28749-2; Sequence=VSP_017496;\n",
      "CC   -!- PTM: Cell-cycle arrest properties are inactivated by phosphorylation on\n",
      "CC       Thr-332, Ser-640, Ser-964 and Ser-975 by CDK4.\n",
      "CC       {ECO:0000269|PubMed:11884610, ECO:0000269|PubMed:12006580}.\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\n",
      "CC       {ECO:0000305}.\n",
      "CC   ---------------------------------------------------------------------------\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\n",
      "CC   ---------------------------------------------------------------------------\n",
      "DR   EMBL; L14812; AAA02489.1; -; mRNA.\n",
      "DR   EMBL; AK290380; BAF83069.1; -; mRNA.\n",
      "DR   EMBL; AL136172; -; NOT_ANNOTATED_CDS; Genomic_DNA.\n",
      "DR   EMBL; AL365505; -; NOT_ANNOTATED_CDS; Genomic_DNA.\n",
      "DR   EMBL; AL391114; -; NOT_ANNOTATED_CDS; Genomic_DNA.\n",
      "DR   EMBL; CH471077; EAW76088.1; -; Genomic_DNA.\n",
      "DR   EMBL; BC032247; AAH32247.1; -; mRNA.\n",
      "DR   EMBL; M74547; AAA36397.1; -; mRNA.\n",
      "DR   EMBL; S78664; AAD14290.1; -; Genomic_DNA.\n",
      "DR   CCDS; CCDS13289.1; -. [P28749-1]\n",
      "DR   CCDS; CCDS13290.1; -. [P28749-2]\n",
      "DR   PIR; A47319; A40265.\n",
      "DR   RefSeq; NP_002886.2; NM_002895.4. [P28749-1]\n",
      "DR   RefSeq; NP_899662.1; NM_183404.3. [P28749-2]\n",
      "DR   PDB; 1H28; X-ray; 2.80 A; E/F=653-663.\n",
      "DR   PDB; 4YOO; X-ray; 2.40 A; A=391-600, A=781-972.\n",
      "DR   PDB; 4YOS; X-ray; 2.30 A; A=391-599.\n",
      "DR   PDB; 4YOZ; X-ray; 2.25 A; A=391-593, A=777-972.\n",
      "DR   PDB; 5TUV; X-ray; 2.90 A; C/F=994-1031.\n",
      "DR   PDB; 7SMC; X-ray; 2.70 A; A/C=391-972.\n",
      "DR   PDB; 7SMD; X-ray; 2.15 A; A=391-972.\n",
      "DR   PDB; 7SME; X-ray; 2.64 A; A=391-972.\n",
      "DR   PDB; 7SMF; X-ray; 3.00 A; A/C=391-972.\n",
      "DR   PDBsum; 1H28; -.\n",
      "DR   PDBsum; 4YOO; -.\n",
      "DR   PDBsum; 4YOS; -.\n",
      "DR   PDBsum; 4YOZ; -.\n",
      "DR   PDBsum; 5TUV; -.\n",
      "DR   PDBsum; 7SMC; -.\n",
      "DR   PDBsum; 7SMD; -.\n",
      "DR   PDBsum; 7SME; -.\n",
      "DR   PDBsum; 7SMF; -.\n",
      "DR   AlphaFoldDB; P28749; -.\n",
      "DR   SMR; P28749; -.\n",
      "DR   BioGRID; 111868; 97.\n",
      "DR   CORUM; P28749; -.\n",
      "DR   DIP; DIP-148N; -.\n",
      "DR   ELM; P28749; -.\n",
      "DR   IntAct; P28749; 56.\n",
      "DR   MINT; P28749; -.\n",
      "DR   STRING; 9606.ENSP00000362768; -.\n",
      "DR   GlyGen; P28749; 1 site, 1 O-linked glycan (1 site).\n",
      "DR   iPTMnet; P28749; -.\n",
      "DR   PhosphoSitePlus; P28749; -.\n",
      "DR   BioMuta; RBL1; -.\n",
      "DR   DMDM; 90103515; -.\n",
      "DR   EPD; P28749; -.\n",
      "DR   jPOST; P28749; -.\n",
      "DR   MassIVE; P28749; -.\n",
      "DR   MaxQB; P28749; -.\n",
      "DR   PaxDb; P28749; -.\n",
      "DR   PeptideAtlas; P28749; -.\n",
      "DR   ProteomicsDB; 54497; -. [P28749-1]\n",
      "DR   ProteomicsDB; 54498; -. [P28749-2]\n",
      "DR   Antibodypedia; 11876; 440 antibodies from 35 providers.\n",
      "DR   CPTC; P28749; 1 antibody.\n",
      "DR   DNASU; 5933; -.\n",
      "DR   Ensembl; ENST00000344359.7; ENSP00000343646.3; ENSG00000080839.12. [P28749-2]\n",
      "DR   Ensembl; ENST00000373664.8; ENSP00000362768.3; ENSG00000080839.12. [P28749-1]\n",
      "DR   GeneID; 5933; -.\n",
      "DR   KEGG; hsa:5933; -.\n",
      "DR   MANE-Select; ENST00000373664.8; ENSP00000362768.3; NM_002895.5; NP_002886.2.\n",
      "DR   UCSC; uc002xgi.5; human. [P28749-1]\n",
      "DR   AGR; HGNC:9893; -.\n",
      "DR   CTD; 5933; -.\n",
      "DR   DisGeNET; 5933; -.\n",
      "DR   GeneCards; RBL1; -.\n",
      "DR   HGNC; HGNC:9893; RBL1.\n",
      "DR   HPA; ENSG00000080839; Tissue enhanced (bone).\n",
      "DR   MIM; 116957; gene.\n",
      "DR   neXtProt; NX_P28749; -.\n",
      "DR   OpenTargets; ENSG00000080839; -.\n",
      "DR   PharmGKB; PA34257; -.\n",
      "DR   VEuPathDB; HostDB:ENSG00000080839; -.\n",
      "DR   eggNOG; KOG1010; Eukaryota.\n",
      "DR   GeneTree; ENSGT00950000183202; -.\n",
      "DR   HOGENOM; CLU_008943_0_1_1; -.\n",
      "DR   InParanoid; P28749; -.\n",
      "DR   OMA; AILCELH; -.\n",
      "DR   OrthoDB; 519973at2759; -.\n",
      "DR   PhylomeDB; P28749; -.\n",
      "DR   TreeFam; TF105568; -.\n",
      "DR   PathwayCommons; P28749; -.\n",
      "DR   Reactome; R-HSA-1362277; Transcription of E2F targets under negative control by DREAM complex.\n",
      "DR   Reactome; R-HSA-1362300; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1.\n",
      "DR   Reactome; R-HSA-1538133; G0 and Early G1.\n",
      "DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.\n",
      "DR   Reactome; R-HSA-6804114; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest.\n",
      "DR   Reactome; R-HSA-69205; G1/S-Specific Transcription.\n",
      "DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.\n",
      "DR   SignaLink; P28749; -.\n",
      "DR   SIGNOR; P28749; -.\n",
      "DR   BioGRID-ORCS; 5933; 27 hits in 1165 CRISPR screens.\n",
      "DR   ChiTaRS; RBL1; human.\n",
      "DR   EvolutionaryTrace; P28749; -.\n",
      "DR   GeneWiki; Retinoblastoma-like_protein_1; -.\n",
      "DR   GenomeRNAi; 5933; -.\n",
      "DR   Pharos; P28749; Tbio.\n",
      "DR   PRO; PR:P28749; -.\n",
      "DR   Proteomes; UP000005640; Chromosome 20.\n",
      "DR   RNAct; P28749; protein.\n",
      "DR   Bgee; ENSG00000080839; Expressed in buccal mucosa cell and 154 other tissues.\n",
      "DR   ExpressionAtlas; P28749; baseline and differential.\n",
      "DR   Genevisible; P28749; HS.\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:CAFA.\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; IBA:GO_Central.\n",
      "DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:MGI.\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\n",
      "DR   GO; GO:2000773; P:negative regulation of cellular senescence; IMP:BHF-UCL.\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:MGI.\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; IDA:UniProtKB.\n",
      "DR   CDD; cd20605; CYCLIN_RBL1; 1.\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 3.\n",
      "DR   IDEAL; IID00130; -.\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\n",
      "DR   InterPro; IPR002720; RB_A.\n",
      "DR   InterPro; IPR002719; RB_B.\n",
      "DR   InterPro; IPR015030; RB_C.\n",
      "DR   InterPro; IPR028309; RB_fam.\n",
      "DR   InterPro; IPR024599; RB_N.\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\n",
      "DR   PANTHER; PTHR13742:SF20; RETINOBLASTOMA-LIKE PROTEIN 1; 1.\n",
      "DR   Pfam; PF11934; DUF3452; 1.\n",
      "DR   Pfam; PF01858; RB_A; 1.\n",
      "DR   Pfam; PF01857; RB_B; 1.\n",
      "DR   Pfam; PF08934; Rb_C; 1.\n",
      "DR   SMART; SM00385; CYCLIN; 1.\n",
      "DR   SMART; SM01367; DUF3452; 1.\n",
      "DR   SMART; SM01368; RB_A; 1.\n",
      "DR   SMART; SM01369; Rb_C; 1.\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\n",
      "PE   1: Evidence at protein level;\n",
      "KW   3D-structure; Alternative splicing; Cell cycle; Chromatin regulator;\n",
      "KW   Direct protein sequencing; Host-virus interaction; Nucleus; Phosphoprotein;\n",
      "KW   Reference proteome; Repressor; Transcription; Transcription regulation;\n",
      "KW   Tumor suppressor.\n",
      "FT   CHAIN           1..1068\n",
      "FT                   /note=\"Retinoblastoma-like protein 1\"\n",
      "FT                   /id=\"PRO_0000167839\"\n",
      "FT   REGION          385..949\n",
      "FT                   /note=\"Pocket; binds T and E1A\"\n",
      "FT                   /evidence=\"ECO:0000305|PubMed:7935440\"\n",
      "FT   REGION          385..584\n",
      "FT                   /note=\"Domain A\"\n",
      "FT                   /evidence=\"ECO:0000305\"\n",
      "FT   REGION          585..780\n",
      "FT                   /note=\"Spacer\"\n",
      "FT                   /evidence=\"ECO:0000305\"\n",
      "FT   REGION          781..949\n",
      "FT                   /note=\"Domain B\"\n",
      "FT                   /evidence=\"ECO:0000305\"\n",
      "FT   MOD_RES         332\n",
      "FT                   /note=\"Phosphothreonine; by CDK2\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610,\n",
      "FT                   ECO:0007744|PubMed:23186163\"\n",
      "FT   MOD_RES         369\n",
      "FT                   /note=\"Phosphothreonine; by CDK4\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610,\n",
      "FT                   ECO:0000269|PubMed:12006580, ECO:0007744|PubMed:23186163\"\n",
      "FT   MOD_RES         385\n",
      "FT                   /note=\"Phosphothreonine; by CDK2\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610,\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163\"\n",
      "FT   MOD_RES         640\n",
      "FT                   /note=\"Phosphoserine; by CDK2 and CDK4\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610,\n",
      "FT                   ECO:0007744|PubMed:23186163\"\n",
      "FT   MOD_RES         650\n",
      "FT                   /note=\"Phosphoserine\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:12006580\"\n",
      "FT   MOD_RES         749\n",
      "FT                   /note=\"Phosphoserine\"\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332,\n",
      "FT                   ECO:0007744|PubMed:23186163\"\n",
      "FT   MOD_RES         762\n",
      "FT                   /note=\"Phosphoserine; by CDK2\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610,\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163\"\n",
      "FT   MOD_RES         964\n",
      "FT                   /note=\"Phosphoserine; by CDK2 and CDK4\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\n",
      "FT   MOD_RES         975\n",
      "FT                   /note=\"Phosphoserine; by CDK2 and CDK4\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\n",
      "FT   MOD_RES         988\n",
      "FT                   /note=\"Phosphoserine; by CDK2\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610,\n",
      "FT                   ECO:0007744|PubMed:23186163\"\n",
      "FT   MOD_RES         997\n",
      "FT                   /note=\"Phosphothreonine; by CDK2\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\n",
      "FT   MOD_RES         1009\n",
      "FT                   /note=\"Phosphoserine; by CDK2\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\n",
      "FT   MOD_RES         1041\n",
      "FT                   /note=\"Phosphoserine\"\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\n",
      "FT   VAR_SEQ         1013..1068\n",
      "FT                   /note=\"SLKDINNMIRQGEQRTKKRVIAIDSDAESPAKRVCQENDDVLLKRLQDVVSE\n",
      "FT                   RANH -> VR (in isoform 2)\"\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\n",
      "FT                   /id=\"VSP_017496\"\n",
      "FT   VARIANT         1035\n",
      "FT                   /note=\"I -> M (in dbSNP:rs8114297)\"\n",
      "FT                   /id=\"VAR_034443\"\n",
      "FT   MUTAGEN         640\n",
      "FT                   /note=\"S->A: Strongly reduces phosphorylation by CDK2 and\n",
      "FT                   CDK4.\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\n",
      "FT   MUTAGEN         643\n",
      "FT                   /note=\"S->R: No effect on S-640 phosphorylation, but\n",
      "FT                   strongly increases S-640 phosphorylation; when associated\n",
      "FT                   with 657-A--A-660.\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\n",
      "FT   MUTAGEN         650\n",
      "FT                   /note=\"S->A: No effect on phosphorylation by CDK2.\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\n",
      "FT   MUTAGEN         657..660\n",
      "FT                   /note=\"KRRL->AAAA: Reduces S-640 phosphorylation by CDK2\n",
      "FT                   and CDK4.\"\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11884610\"\n",
      "FT   CONFLICT        326\n",
      "FT                   /note=\"Missing (in Ref. 8; AA sequence)\"\n",
      "FT                   /evidence=\"ECO:0000305\"\n",
      "FT   CONFLICT        928\n",
      "FT                   /note=\"G -> S (in Ref. 1 and 6)\"\n",
      "FT                   /evidence=\"ECO:0000305\"\n",
      "FT   HELIX           392..400\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   TURN            401..403\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           410..417\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   STRAND          419..421\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           424..442\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   STRAND          447..449\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           454..477\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           480..483\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           489..492\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           495..512\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           521..525\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           530..533\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           535..543\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           549..564\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           566..568\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           573..580\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   TURN            581..583\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           588..591\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           785..809\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           814..830\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           832..835\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           840..854\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   STRAND          855..857\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOS\"\n",
      "FT   HELIX           861..868\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           877..880\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   STRAND          881..883\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           930..936\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   HELIX           938..946\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4YOZ\"\n",
      "FT   STRAND          1001..1005\n",
      "FT                   /evidence=\"ECO:0007829|PDB:5TUV\"\n",
      "FT   TURN            1006..1008\n",
      "FT                   /evidence=\"ECO:0007829|PDB:5TUV\"\n",
      "FT   HELIX           1011..1023\n",
      "FT                   /evidence=\"ECO:0007829|PDB:5TUV\"\n",
      "SQ   SEQUENCE   1068 AA;  120847 MW;  2BC4876EA04BDB31 CRC64;\n",
      "     MFEDKPHAEG AAVVAAAGEA LQALCQELNL DEGSAAEALD DFTAIRGNYS LEGEVTHWLA\n",
      "     CSLYVACRKS IIPTVGKGIM EGNCVSLTRI LRSAKLSLIQ FFSKMKKWMD MSNLPQEFRE\n",
      "     RIERLERNFE VSTVIFKKYE PIFLDIFQNP YEEPPKLPRS RKQRRIPCSV KDLFNFCWTL\n",
      "     FVYTKGNFRM IGDDLVNSYH LLLCCLDLIF ANAIMCPNRQ DLLNPSFKGL PSDFHTADFT\n",
      "     ASEEPPCIIA VLCELHDGLL VEAKGIKEHY FKPYISKLFD RKILKGECLL DLSSFTDNSK\n",
      "     AVNKEYEEYV LTVGDFDERI FLGADAEEEI GTPRKFTRDT PLGKLTAQAN VEYNLQQHFE\n",
      "     KKRSFAPSTP LTGRRYLREK EAVITPVASA TQSVSRLQSI VAGLKNAPSD QLINIFESCV\n",
      "     RNPVENIMKI LKGIGETFCQ HYTQSTDEQP GSHIDFAVNR LKLAEILYYK ILETVMVQET\n",
      "     RRLHGMDMSV LLEQDIFHRS LMACCLEIVL FAYSSPRTFP WIIEVLNLQP FYFYKVIEVV\n",
      "     IRSEEGLSRD MVKHLNSIEE QILESLAWSH DSALWEALQV SANKVPTCEE VIFPNNFETG\n",
      "     NGGNVQGHLP LMPMSPLMHP RVKEVRTDSG SLRRDMQPLS PISVHERYSS PTAGSAKRRL\n",
      "     FGEDPPKEML MDKIITEGTK LKIAPSSSIT AENVSILPGQ TLLTMATAPV TGTTGHKVTI\n",
      "     PLHGVANDAG EITLIPLSMN TNQESKVKSP VSLTAHSLIG ASPKQTNLTK AQEVHSTGIN\n",
      "     RPKRTGSLAL FYRKVYHLAS VRLRDLCLKL DVSNELRRKI WTCFEFTLVH CPDLMKDRHL\n",
      "     DQLLLCAFYI MAKVTKEERT FQEIMKSYRN QPQANSHVYR SVLLKSIPRE VVAYNKNIND\n",
      "     DFEMIDCDLE DATKTPDCSS GPVKEERGDL IKFYNTIYVG RVKSFALKYD LANQDHMMDA\n",
      "     PPLSPFPHIK QQPGSPRRIS QQHSIYISPH KNGSGLTPRS ALLYKFNGSP SKSLKDINNM\n",
      "     IRQGEQRTKK RVIAIDSDAE SPAKRVCQEN DDVLLKRLQD VVSERANH\n",
      "//\n",
      "ID   RB_HUMAN                Reviewed;         928 AA.\n",
      "AC   P06400; A8K5E3; P78499; Q5VW46; Q8IZL4;\n",
      "DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.\n",
      "DT   01-JAN-1990, sequence version 2.\n",
      "DT   03-MAY-2023, entry version 273.\n",
      "DE   RecName: Full=Retinoblastoma-associated protein;\n",
      "DE   AltName: Full=p105-Rb;\n",
      "DE   AltName: Full=p110-RB1 {ECO:0000303|PubMed:8336704};\n",
      "DE   AltName: Full=pRb;\n",
      "DE            Short=Rb;\n",
      "DE   AltName: Full=pp110;\n",
      "GN   Name=RB1;\n",
      "OS   Homo sapiens (Human).\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\n",
      "OC   Homo.\n",
      "OX   NCBI_TaxID=9606;\n",
      "RN   [1]\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\n",
      "RX   PubMed=3657987; DOI=10.1038/329642a0;\n",
      "RA   Lee W.-H., Shew J.-Y., Hong F.D., Sery T.W., Donoso L.A., Young L.-J.S.,\n",
      "RA   Bookstein R., Lee E.Y.-H.P.;\n",
      "RT   \"The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein\n",
      "RT   associated with DNA binding activity.\";\n",
      "RL   Nature 329:642-645(1987).\n",
      "RN   [2]\n",
      "RP   SEQUENCE REVISION.\n",
      "RX   PubMed=3823889; DOI=10.1126/science.3823889;\n",
      "RA   Lee W.-H., Bookstein R., Hong F.D., Young L.-J., Shew J.-Y., Lee E.Y.-H.P.;\n",
      "RT   \"Human retinoblastoma susceptibility gene: cloning, identification, and\n",
      "RT   sequence.\";\n",
      "RL   Science 235:1394-1399(1987).\n",
      "RN   [3]\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\n",
      "RX   PubMed=3480530; DOI=10.1073/pnas.84.24.9059;\n",
      "RA   Friend S.H., Horowitz J.M., Gerber M.R., Wang X.-F., Bogenmann E., Li F.P.,\n",
      "RA   Weinberg R.A.;\n",
      "RT   \"Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors:\n",
      "RT   organization of the sequence and its encoded protein.\";\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 84:9059-9063(1987).\n",
      "RN   [4]\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].\n",
      "RX   PubMed=2701949; DOI=10.1016/0378-1119(89)90256-4;\n",
      "RA   McGee T.L., Yandell D.W., Dryja T.P.;\n",
      "RT   \"Structure and partial genomic sequence of the human retinoblastoma\n",
      "RT   susceptibility gene.\";\n",
      "RL   Gene 80:119-128(1989).\n",
      "RN   [5]\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].\n",
      "RC   TISSUE=Carcinoma;\n",
      "RX   PubMed=1352398;\n",
      "RA   Hogg A., Onadim Z., Baird P.N., Cowell J.K.;\n",
      "RT   \"Detection of heterozygous mutations in the RB1 gene in retinoblastoma\n",
      "RT   patients using single-strand conformation polymorphism analysis and\n",
      "RT   polymerase chain reaction sequencing.\";\n",
      "RL   Oncogene 7:1445-1451(1992).\n",
      "RN   [6]\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].\n",
      "RX   PubMed=7902321; DOI=10.1006/geno.1993.1368;\n",
      "RA   Toguchida J., McGee T.L., Paterson J.C., Eagle J.R., Tucker S.,\n",
      "RA   Yandell D.W., Dryja T.P.;\n",
      "RT   \"Complete genomic sequence of the human retinoblastoma susceptibility\n",
      "RT   gene.\";\n",
      "RL   Genomics 17:535-543(1993).\n",
      "RN   [7]\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LYS-436 AND GLY-525.\n",
      "RG   NIEHS SNPs program;\n",
      "RL   Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases.\n",
      "RN   [8]\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\n",
      "RA   Isogai T., Sugano S.;\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\n",
      "RT   cDNAs.\";\n",
      "RL   Nat. Genet. 36:40-45(2004).\n",
      "RN   [9]\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\n",
      "RX   PubMed=15057823; DOI=10.1038/nature02379;\n",
      "RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,\n",
      "RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,\n",
      "RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,\n",
      "RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,\n",
      "RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,\n",
      "RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,\n",
      "RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,\n",
      "RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,\n",
      "RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,\n",
      "RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,\n",
      "RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,\n",
      "RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,\n",
      "RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,\n",
      "RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,\n",
      "RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,\n",
      "RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,\n",
      "RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,\n",
      "RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,\n",
      "RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,\n",
      "RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,\n",
      "RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,\n",
      "RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,\n",
      "RA   Rogers J., Ross M.T.;\n",
      "RT   \"The DNA sequence and analysis of human chromosome 13.\";\n",
      "RL   Nature 428:522-528(2004).\n",
      "RN   [10]\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\n",
      "RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,\n",
      "RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,\n",
      "RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,\n",
      "RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,\n",
      "RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,\n",
      "RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,\n",
      "RA   Hunkapiller M.W., Myers E.W., Venter J.C.;\n",
      "RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.\n",
      "RN   [11]\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\n",
      "RC   TISSUE=Cervix, and Testis;\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\n",
      "RG   The MGC Project Team;\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\n",
      "RT   the Mammalian Gene Collection (MGC).\";\n",
      "RL   Genome Res. 14:2121-2127(2004).\n",
      "RN   [12]\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-45.\n",
      "RX   PubMed=2717184;\n",
      "RA   T'Ang A., Wu K.J., Hashimoto T., Liu W.Y., Takahashi R., Shi X.H.,\n",
      "RA   Mihara K., Zhang F.H., Chen Y.Y., Du C., Qian J., Lin Y.G., Murphree A.L.,\n",
      "RA   Qiu W.R., Thompson T., Benedict W.F., Fung Y.K.T.;\n",
      "RT   \"Genomic organization of the human retinoblastoma gene.\";\n",
      "RL   Oncogene 4:401-407(1989).\n",
      "RN   [13]\n",
      "RP   PROTEIN SEQUENCE OF 47-65, AND INVOLVEMENT IN RETINOBLASTOMA.\n",
      "RX   PubMed=7881418; DOI=10.1093/hmg/3.12.2187;\n",
      "RA   Lohmann D.R., Brandt B., Hopping W., Passarge E., Horsthemke B.;\n",
      "RT   \"Spectrum of small length germline mutations in the RB1 gene.\";\n",
      "RL   Hum. Mol. Genet. 3:2187-2193(1994).\n",
      "RN   [14]\n",
      "RP   INTERACTION WITH SV40 LARGE T ANTIGEN AND HPV E7 PROTEIN (MICROBIAL\n",
      "RP   INFECTION).\n",
      "RX   PubMed=1316611; DOI=10.1073/pnas.89.10.4549;\n",
      "RA   Chellappan S., Kraus V.B., Kroger B., Munger K., Howley P.M., Phelps W.C.,\n",
      "RA   Nevins J.R.;\n",
      "RT   \"Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7\n",
      "RT   protein share the capacity to disrupt the interaction between transcription\n",
      "RT   factor E2F and the retinoblastoma gene product.\";\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 89:4549-4553(1992).\n",
      "RN   [15]\n",
      "RP   INTERACTION WITH E2F1.\n",
      "RX   PubMed=8336704; DOI=10.1128/mcb.13.8.4588-4599.1993;\n",
      "RA   Zacksenhaus E., Bremner R., Phillips R.A., Gallie B.L.;\n",
      "RT   \"A bipartite nuclear localization signal in the retinoblastoma gene product\n",
      "RT   and its importance for biological activity.\";\n",
      "RL   Mol. Cell. Biol. 13:4588-4599(1993).\n",
      "RN   [16]\n",
      "RP   PHOSPHORYLATION BY CDK6.\n",
      "RX   PubMed=8114739; DOI=10.1128/mcb.14.3.2077-2086.1994;\n",
      "RA   Meyerson M., Harlow E.;\n",
      "RT   \"Identification of G1 kinase activity for cdk6, a novel cyclin D partner.\";\n",
      "RL   Mol. Cell. Biol. 14:2077-2086(1994).\n",
      "RN   [17]\n",
      "RP   INTERACTION WITH SV40 LARGE T ANTIGEN (MICROBIAL INFECTION).\n",
      "RX   PubMed=2839300; DOI=10.1016/0092-8674(88)90559-4;\n",
      "RA   Decaprio J.A., Ludlow J.W., Figge J., Shew J.-Y., Huang C.-M., Lee W.-H.,\n",
      "RA   Marsilio E., Paucha E., Livingston D.M.;\n",
      "RT   \"SV40 large tumor antigen forms a specific complex with the product of the\n",
      "RT   retinoblastoma susceptibility gene.\";\n",
      "RL   Cell 54:275-283(1988).\n",
      "RN   [18]\n",
      "RP   INVOLVEMENT IN RETINOBLASTOMA.\n",
      "RX   PubMed=3413073; DOI=10.1073/pnas.85.16.6017;\n",
      "RA   Lee E.Y.-H.P., Bookstein R., Young L.-J., Lin C.-J., Rosenfeld M.G.,\n",
      "RA   Lee W.-H.;\n",
      "RT   \"Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma\n",
      "RT   cell line Y79.\";\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 85:6017-6021(1988).\n",
      "RN   [19]\n",
      "RP   PHOSPHORYLATION AT SER-249; THR-252; THR-373; SER-807 AND SER-811.\n",
      "RX   PubMed=1756735; DOI=10.1002/j.1460-2075.1991.tb05006.x;\n",
      "RA   Lees J.A., Buchkovich K.J., Marshak D.R., Anderson C.W., Harlow E.;\n",
      "RT   \"The retinoblastoma protein is phosphorylated on multiple sites by human\n",
      "RT   cdc2.\";\n",
      "RL   EMBO J. 10:4279-4290(1991).\n",
      "RN   [20]\n",
      "RP   INTERACTION WITH KDM5A AND ARID4A.\n",
      "RX   PubMed=8414517;\n",
      "RA   Fattaey A.R., Helin K., Dembski M.S., Dyson N., Harlow E., Vuocolo G.A.,\n",
      "RA   Hanobik M.G., Haskell K.M., Oliff A., Defeo-Jones D., Jones R.E.;\n",
      "RT   \"Characterization of the retinoblastoma binding proteins RBP1 and RBP2.\";\n",
      "RL   Oncogene 8:3149-3156(1993).\n",
      "RN   [21]\n",
      "RP   INTERACTION WITH THOC1.\n",
      "RX   PubMed=7525595; DOI=10.1083/jcb.127.3.609;\n",
      "RA   Durfee T., Mancini M.A., Jones D., Elledge S.J., Lee W.H.;\n",
      "RT   \"The amino-terminal region of the retinoblastoma gene product binds a novel\n",
      "RT   nuclear matrix protein that co-localizes to centers for RNA processing.\";\n",
      "RL   J. Cell Biol. 127:609-622(1994).\n",
      "RN   [22]\n",
      "RP   INTERACTION WITH KDM5A.\n",
      "RX   PubMed=7935440; DOI=10.1128/mcb.14.11.7256-7264.1994;\n",
      "RA   Kim Y.W., Otterson G.A., Kratzke R.A., Coxon A.B., Kaye F.J.;\n",
      "RT   \"Differential specificity for binding of retinoblastoma binding protein 2\n",
      "RT   to RB, p107, and TATA-binding protein.\";\n",
      "RL   Mol. Cell. Biol. 14:7256-7264(1994).\n",
      "RN   [23]\n",
      "RP   INTERACTION WITH HHV-5 PROTEIN UL123 (MICROBIAL INFECTION).\n",
      "RX   PubMed=8892909; DOI=10.1128/jvi.70.11.7867-7877.1996;\n",
      "RA   Poma E.E., Kowalik T.F., Zhu L., Sinclair J.H., Huang E.S.;\n",
      "RT   \"The human cytomegalovirus IE1-72 protein interacts with the cellular p107\n",
      "RT   protein and relieves p107-mediated transcriptional repression of an E2F-\n",
      "RT   responsive promoter.\";\n",
      "RL   J. Virol. 70:7867-7877(1996).\n",
      "RN   [24]\n",
      "RP   INTERACTION WITH ARID3B.\n",
      "RX   PubMed=10446990;\n",
      "RA   Numata S., Claudio P.P., Dean C., Giordano A., Croce C.M.;\n",
      "RT   \"Bdp, a new member of a family of DNA-binding proteins, associates with the\n",
      "RT   retinoblastoma gene product.\";\n",
      "RL   Cancer Res. 59:3741-3747(1999).\n",
      "RN   [25]\n",
      "RP   FUNCTION, PHOSPHORYLATION AT SER-567 BY CDK2, AND PHOSPHORYLATION BY CDK4\n",
      "RP   AND CDK6.\n",
      "RX   PubMed=10499802; DOI=10.1016/s0092-8674(00)81519-6;\n",
      "RA   Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., Dean D.C.;\n",
      "RT   \"Cdk phosphorylation triggers sequential intramolecular interactions that\n",
      "RT   progressively block Rb functions as cells move through G1.\";\n",
      "RL   Cell 98:859-869(1999).\n",
      "RN   [26]\n",
      "RP   INTERACTION WITH NDC80.\n",
      "RX   PubMed=10409732; DOI=10.1128/mcb.19.8.5417;\n",
      "RA   Zheng L., Chen Y., Lee W.-H.;\n",
      "RT   \"Hec1p, an evolutionarily conserved coiled-coil protein, modulates\n",
      "RT   chromosome segregation through interaction with SMC proteins.\";\n",
      "RL   Mol. Cell. Biol. 19:5417-5428(1999).\n",
      "RN   [27]\n",
      "RP   INTERACTION WITH NDC80.\n",
      "RX   PubMed=10779342; DOI=10.1128/mcb.20.10.3529-3537.2000;\n",
      "RA   Zheng L., Chen Y., Riley D.J., Chen P.-L., Lee W.-H.;\n",
      "RT   \"Retinoblastoma protein enhances the fidelity of chromosome segregation\n",
      "RT   mediated by hsHec1p.\";\n",
      "RL   Mol. Cell. Biol. 20:3529-3537(2000).\n",
      "RN   [28]\n",
      "RP   INTERACTION WITH TAF1.\n",
      "RX   PubMed=9858607; DOI=10.1128/mcb.19.1.846;\n",
      "RA   Siegert J.L., Robbins P.D.;\n",
      "RT   \"Rb inhibits the intrinsic kinase activity of TATA-binding protein-\n",
      "RT   associated factor TAFII250.\";\n",
      "RL   Mol. Cell. Biol. 19:846-854(1999).\n",
      "RN   [29]\n",
      "RP   INTERACTION WITH PAX5.\n",
      "RX   PubMed=10197586;\n",
      "RA   Eberhard D., Busslinger M.;\n",
      "RT   \"The partial homeodomain of the transcription factor Pax-5 (BSAP) is an\n",
      "RT   interaction motif for the retinoblastoma and TATA-binding proteins.\";\n",
      "RL   Cancer Res. 59:1716-1724(1999).\n",
      "RN   [30]\n",
      "RP   INTERACTION WITH E4F1.\n",
      "RX   PubMed=10869426; DOI=10.1073/pnas.130198397;\n",
      "RA   Fajas L., Paul C., Zugasti O., Le Cam L., Polanowska J., Fabbrizio E.,\n",
      "RA   Medema R., Vignais M.-L., Sardet C.;\n",
      "RT   \"pRB binds to and modulates the transrepressing activity of the E1A-\n",
      "RT   regulated transcription factor p120E4F.\";\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 97:7738-7743(2000).\n",
      "RN   [31]\n",
      "RP   INTERACTION WITH EID1.\n",
      "RX   PubMed=11223246; DOI=10.1016/s0378-1119(00)00585-0;\n",
      "RA   Wen H., Ao S.;\n",
      "RT   \"Identification and characterization of a novel human cDNA encoding a 21\n",
      "RT   kDa pRb-associated protein.\";\n",
      "RL   Gene 263:85-92(2001).\n",
      "RN   [32]\n",
      "RP   INTERACTION WITH DNMT1.\n",
      "RX   PubMed=10888886; DOI=10.1038/77124;\n",
      "RA   Robertson K.D., Ait-Si-Ali S., Yokochi T., Wade P.A., Jones P.L.,\n",
      "RA   Wolffe A.P.;\n",
      "RT   \"DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription\n",
      "RT   from E2F-responsive promoters.\";\n",
      "RL   Nat. Genet. 25:338-342(2000).\n",
      "RN   [33]\n",
      "RP   INTERACTION WITH SUV39H1.\n",
      "RX   PubMed=11484059; DOI=10.1038/35087620;\n",
      "RA   Nielsen S.J., Schneider R., Bauer U.-M., Bannister A.J., Morrison A.,\n",
      "RA   O'Carroll D., Firestein R., Cleary M.L., Jenuwein T., Herrera R.E.,\n",
      "RA   Kouzarides T.;\n",
      "RT   \"Rb targets histone H3 methylation and HP1 to promoters.\";\n",
      "RL   Nature 412:561-565(2001).\n",
      "RN   [34]\n",
      "RP   INTERACTION WITH USP4.\n",
      "RX   PubMed=11571652; DOI=10.1038/sj.onc.1204824;\n",
      "RA   DeSalle L.M., Latres E., Lin D., Graner E., Montagnoli A., Baker R.T.,\n",
      "RA   Pagano M., Loda M.;\n",
      "RT   \"The de-ubiquitinating enzyme Unp interacts with the retinoblastoma\n",
      "RT   protein.\";\n",
      "RL   Oncogene 20:5538-5542(2001).\n",
      "RN   [35]\n",
      "RP   INTERACTION WITH AATF.\n",
      "RX   PubMed=12450794; DOI=10.1016/s1535-6108(02)00182-4;\n",
      "RA   Bruno T., De Angelis R., De Nicola F., Barbato C., Di Padova M., Corbi N.,\n",
      "RA   Libri V., Benassi B., Mattei E., Chersi A., Soddu S., Floridi A.,\n",
      "RA   Passananti C., Fanciulli M.;\n",
      "RT   \"Che-1 affects cell growth by interfering with the recruitment of HDAC1 by\n",
      "RT   Rb.\";\n",
      "RL   Cancer Cell 2:387-399(2002).\n",
      "RN   [36]\n",
      "RP   INTERACTION WITH TMPO-ALPHA AND LMNA.\n",
      "RX   PubMed=12475961; DOI=10.1091/mbc.e02-07-0450;\n",
      "RA   Markiewicz E., Dechat T., Foisner R., Quinlan R.A., Hutchison C.J.;\n",
      "RT   \"Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of\n",
      "RT   retinoblastoma protein.\";\n",
      "RL   Mol. Biol. Cell 13:4401-4413(2002).\n",
      "RN   [37]\n",
      "RP   INTERACTION WITH SNW1.\n",
      "RX   PubMed=12466551; DOI=10.1093/nar/gkf658;\n",
      "RA   Prathapam T., Kuhne C., Banks L.;\n",
      "RT   \"Skip interacts with the retinoblastoma tumor suppressor and inhibits its\n",
      "RT   transcriptional repression activity.\";\n",
      "RL   Nucleic Acids Res. 30:5261-5268(2002).\n",
      "RN   [38]\n",
      "RP   INTERACTION WITH P-TEFB COMPLEX.\n",
      "RX   PubMed=12037672; DOI=10.1038/sj.onc.1205511;\n",
      "RA   Simone C., Bagella L., Bellan C., Giordano A.;\n",
      "RT   \"Physical interaction between pRb and cdk9/cyclinT2 complex.\";\n",
      "RL   Oncogene 21:4158-4165(2002).\n",
      "RN   [39]\n",
      "RP   INTERACTION WITH PELP1.\n",
      "RX   PubMed=12682072; DOI=10.1074/jbc.m212822200;\n",
      "RA   Balasenthil S., Vadlamudi R.K.;\n",
      "RT   \"Functional interactions between the estrogen receptor coactivator\n",
      "RT   PELP1/MNAR and retinoblastoma protein.\";\n",
      "RL   J. Biol. Chem. 278:22119-22127(2003).\n",
      "RN   [40]\n",
      "RP   INTERACTION WITH HUMAN CYTOMEGALOVIRUS PROTEIN UL82 (MICROBIAL INFECTION).\n",
      "RX   PubMed=12626766; DOI=10.1073/pnas.0538058100;\n",
      "RA   Kalejta R.F., Shenk T.;\n",
      "RT   \"Proteasome-dependent, ubiquitin-independent degradation of the Rb family\n",
      "RT   of tumor suppressors by the human cytomegalovirus pp71 protein.\";\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 100:3263-3268(2003).\n",
      "RN   [41]\n",
      "RP   FUNCTION IN G0-G1 TRANSITION, AND PHOSPHORYLATION AT SER-807 AND SER-811 BY\n",
      "RP   CDK3.\n",
      "RX   PubMed=15084261; DOI=10.1016/s0092-8674(04)00300-9;\n",
      "RA   Ren S., Rollins B.J.;\n",
      "RT   \"Cyclin C/cdk3 promotes Rb-dependent G0 exit.\";\n",
      "RL   Cell 117:239-251(2004).\n",
      "RN   [42]\n",
      "RP   INTERACTION WITH LIN9.\n",
      "RX   PubMed=15538385; DOI=10.1038/sj.emboj.7600470;\n",
      "RA   Gagrica S., Hauser S., Kolfschoten I., Osterloh L., Agami R., Gaubatz S.;\n",
      "RT   \"Inhibition of oncogenic transformation by mammalian Lin-9, a pRB-\n",
      "RT   associated protein.\";\n",
      "RL   EMBO J. 23:4627-4638(2004).\n",
      "RN   [43]\n",
      "RP   INTERACTION WITH CEBPA.\n",
      "RX   PubMed=15107404; DOI=10.1101/gad.1183304;\n",
      "RA   Wang G.L., Iakova P., Wilde M., Awad S., Timchenko N.A.;\n",
      "RT   \"Liver tumors escape negative control of proliferation via PI3K/Akt-\n",
      "RT   mediated block of C/EBP alpha growth inhibitory activity.\";\n",
      "RL   Genes Dev. 18:912-925(2004).\n",
      "RN   [44]\n",
      "RP   INTERACTION WITH LIMD1.\n",
      "RX   PubMed=15542589; DOI=10.1073/pnas.0407123101;\n",
      "RA   Sharp T.V., Munoz F., Bourboulia D., Presneau N., Darai E., Wang H.-W.,\n",
      "RA   Cannon M., Butcher D.N., Nicholson A.G., Klein G., Imreh S., Boshoff C.;\n",
      "RT   \"LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at\n",
      "RT   chromosome 3p21.3, binds pRB and represses E2F-driven transcription.\";\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 101:16531-16536(2004).\n",
      "RN   [45]\n",
      "RP   PHOSPHORYLATION AT THR-821 AND THR-826.\n",
      "RX   PubMed=15809340; DOI=10.1093/jb/mvi050;\n",
      "RA   Takaki T., Fukasawa K., Suzuki-Takahashi I., Semba K., Kitagawa M.,\n",
      "RA   Taya Y., Hirai H.;\n",
      "RT   \"Preferences for phosphorylation sites in the retinoblastoma protein of D-\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RT   type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.\";\r\n",
      "RL   J. Biochem. 137:381-386(2005).\r\n",
      "RN   [46]\r\n",
      "RP   INTERACTION WITH KDM4A.\r\n",
      "RX   PubMed=15927959; DOI=10.1074/jbc.m413687200;\r\n",
      "RA   Gray S.G., Iglesias A.H., Lizcano F., Villanueva R., Camelo S., Jingu H.,\r\n",
      "RA   Teh B.T., Koibuchi N., Chin W.W., Kokkotou E., Dangond F.;\r\n",
      "RT   \"Functional characterization of JMJD2A, a histone deacetylase- and\r\n",
      "RT   retinoblastoma-binding protein.\";\r\n",
      "RL   J. Biol. Chem. 280:28507-28518(2005).\r\n",
      "RN   [47]\r\n",
      "RP   INTERACTION WITH KDM5B.\r\n",
      "RX   PubMed=15803180; DOI=10.1038/modpathol.3800413;\r\n",
      "RA   Roesch A., Becker B., Meyer S., Wild P., Hafner C., Landthaler M., Vogt T.;\r\n",
      "RT   \"Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding\r\n",
      "RT   protein downregulated in malignant melanomas.\";\r\n",
      "RL   Mod. Pathol. 18:1249-1257(2005).\r\n",
      "RN   [48]\r\n",
      "RP   INTERACTION WITH KDM5A.\r\n",
      "RX   PubMed=15949438; DOI=10.1016/j.molcel.2005.05.012;\r\n",
      "RA   Benevolenskaya E.V., Murray H.L., Branton P., Young R.A., Kaelin W.G. Jr.;\r\n",
      "RT   \"Binding of pRB to the PHD protein RBP2 promotes cellular\r\n",
      "RT   differentiation.\";\r\n",
      "RL   Mol. Cell 18:623-635(2005).\r\n",
      "RN   [49]\r\n",
      "RP   INTERACTION WITH PSMA3.\r\n",
      "RX   PubMed=16337594; DOI=10.1016/j.molcel.2005.10.017;\r\n",
      "RA   Sdek P., Ying H., Chang D.L., Qiu W., Zheng H., Touitou R., Allday M.J.,\r\n",
      "RA   Xiao Z.X.;\r\n",
      "RT   \"MDM2 promotes proteasome-dependent ubiquitin-independent degradation of\r\n",
      "RT   retinoblastoma protein.\";\r\n",
      "RL   Mol. Cell 20:699-708(2005).\r\n",
      "RN   [50]\r\n",
      "RP   INTERACTION WITH ZUBR1.\r\n",
      "RX   PubMed=16214886; DOI=10.1073/pnas.0507458102;\r\n",
      "RA   Nakatani Y., Konishi H., Vassilev A., Kurooka H., Ishiguro K., Sawada J.,\r\n",
      "RA   Ikura T., Korsmeyer S.J., Qin J., Herlitz A.M.;\r\n",
      "RT   \"p600, a unique protein required for membrane morphogenesis and cell\r\n",
      "RT   survival.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 102:15093-15098(2005).\r\n",
      "RN   [51]\r\n",
      "RP   INTERACTION WITH KDM5B.\r\n",
      "RX   PubMed=16645588; DOI=10.1038/sj.jid.5700324;\r\n",
      "RA   Roesch A., Becker B., Schneider-Brachert W., Hagen I., Landthaler M.,\r\n",
      "RA   Vogt T.;\r\n",
      "RT   \"Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals\r\n",
      "RT   tumor-suppressive functions in highly metastatic melanoma cells.\";\r\n",
      "RL   J. Invest. Dermatol. 126:1850-1859(2006).\r\n",
      "RN   [52]\r\n",
      "RP   PHOSPHORYLATION AT SER-612 BY CHEK2, AND INTERACTION WITH CHEK2.\r\n",
      "RX   PubMed=17380128; DOI=10.1038/sj.emboj.7601652;\r\n",
      "RA   Inoue Y., Kitagawa M., Taya Y.;\r\n",
      "RT   \"Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB\r\n",
      "RT   and E2F-1 after DNA damage.\";\r\n",
      "RL   EMBO J. 26:2083-2093(2007).\r\n",
      "RN   [53]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249; THR-252 AND THR-356, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18220336; DOI=10.1021/pr0705441;\r\n",
      "RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;\r\n",
      "RT   \"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient\r\n",
      "RT   phosphoproteomic analysis.\";\r\n",
      "RL   J. Proteome Res. 7:1346-1351(2008).\r\n",
      "RN   [54]\r\n",
      "RP   INTERACTION WITH MOLLUSCUM CONTAGIOSUM VIRUS PROTEIN MC007 (MICROBIAL\r\n",
      "RP   FUNCTION).\r\n",
      "RX   PubMed=18701596; DOI=10.1128/jvi.01187-08;\r\n",
      "RA   Mohr S., Grandemange S., Massimi P., Darai G., Banks L., Martinou J.C.,\r\n",
      "RA   Zeier M., Muranyi W.;\r\n",
      "RT   \"Targeting the retinoblastoma protein by MC007L, gene product of the\r\n",
      "RT   molluscum contagiosum virus: detection of a novel virus-cell interaction by\r\n",
      "RT   a member of the poxviruses.\";\r\n",
      "RL   J. Virol. 82:10625-10633(2008).\r\n",
      "RN   [55]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; SER-249; THR-252;\r\n",
      "RP   SER-612; SER-807; SER-811; THR-823 AND THR-826, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;\r\n",
      "RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,\r\n",
      "RA   Elledge S.J., Gygi S.P.;\r\n",
      "RT   \"A quantitative atlas of mitotic phosphorylation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).\r\n",
      "RN   [56]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19413330; DOI=10.1021/ac9004309;\r\n",
      "RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;\r\n",
      "RT   \"Lys-N and trypsin cover complementary parts of the phosphoproteome in a\r\n",
      "RT   refined SCX-based approach.\";\r\n",
      "RL   Anal. Chem. 81:4493-4501(2009).\r\n",
      "RN   [57]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; SER-249; THR-373; SER-807\r\n",
      "RP   AND THR-841, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE\r\n",
      "RP   ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [58]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19608861; DOI=10.1126/science.1175371;\r\n",
      "RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,\r\n",
      "RA   Olsen J.V., Mann M.;\r\n",
      "RT   \"Lysine acetylation targets protein complexes and co-regulates major\r\n",
      "RT   cellular functions.\";\r\n",
      "RL   Science 325:834-840(2009).\r\n",
      "RN   [59]\r\n",
      "RP   METHYLATION AT LYS-860, INTERACTION WITH L3MBTL1, AND MUTAGENESIS OF\r\n",
      "RP   LYS-860; LYS-870 AND 873-LYS-LYS-874.\r\n",
      "RX   PubMed=20870719; DOI=10.1074/jbc.m110.137612;\r\n",
      "RA   Saddic L.A., West L.E., Aslanian A., Yates J.R. III, Rubin S.M., Gozani O.,\r\n",
      "RA   Sage J.;\r\n",
      "RT   \"Methylation of the retinoblastoma tumor suppressor by SMYD2.\";\r\n",
      "RL   J. Biol. Chem. 285:37733-37740(2010).\r\n",
      "RN   [60]\r\n",
      "RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, ACETYLATION AT LYS-873 AND\r\n",
      "RP   LYS-874, AND MUTAGENESIS OF 873-LYS--LYS-874.\r\n",
      "RX   PubMed=20940255; DOI=10.1242/jcs.068924;\r\n",
      "RA   Pickard A., Wong P.P., McCance D.J.;\r\n",
      "RT   \"Acetylation of Rb by PCAF is required for nuclear localization and\r\n",
      "RT   keratinocyte differentiation.\";\r\n",
      "RL   J. Cell Sci. 123:3718-3726(2010).\r\n",
      "RN   [61]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-821 AND THR-826, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;\r\n",
      "RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,\r\n",
      "RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;\r\n",
      "RT   \"Quantitative phosphoproteomics reveals widespread full phosphorylation\r\n",
      "RT   site occupancy during mitosis.\";\r\n",
      "RL   Sci. Signal. 3:RA3-RA3(2010).\r\n",
      "RN   [62]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;\r\n",
      "RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,\r\n",
      "RA   Bennett K.L., Superti-Furga G., Colinge J.;\r\n",
      "RT   \"Initial characterization of the human central proteome.\";\r\n",
      "RL   BMC Syst. Biol. 5:17-17(2011).\r\n",
      "RN   [63]\r\n",
      "RP   INTERACTION WITH UHRF2.\r\n",
      "RX   PubMed=21952639; DOI=10.4161/cc.10.19.17176;\r\n",
      "RA   Mori T., Ikeda D.D., Fukushima T., Takenoshita S., Kochi H.;\r\n",
      "RT   \"NIRF constitutes a nodal point in the cell cycle network and is a\r\n",
      "RT   candidate tumor suppressor.\";\r\n",
      "RL   Cell Cycle 10:3284-3299(2011).\r\n",
      "RN   [64]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;\r\n",
      "RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,\r\n",
      "RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;\r\n",
      "RT   \"System-wide temporal characterization of the proteome and phosphoproteome\r\n",
      "RT   of human embryonic stem cell differentiation.\";\r\n",
      "RL   Sci. Signal. 4:RS3-RS3(2011).\r\n",
      "RN   [65]\r\n",
      "RP   METHYLATION AT LYS-810 BY SMYD2.\r\n",
      "RX   PubMed=22787429; DOI=10.1593/neo.12656;\r\n",
      "RA   Cho H.S., Hayami S., Toyokawa G., Maejima K., Yamane Y., Suzuki T.,\r\n",
      "RA   Dohmae N., Kogure M., Kang D., Neal D.E., Ponder B.A., Yamaue H.,\r\n",
      "RA   Nakamura Y., Hamamoto R.;\r\n",
      "RT   \"RB1 methylation by SMYD2 enhances cell cycle progression through an\r\n",
      "RT   increase of RB1 phosphorylation.\";\r\n",
      "RL   Neoplasia 14:476-486(2012).\r\n",
      "RN   [66]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249; THR-252; THR-356;\r\n",
      "RP   THR-373; SER-624; SER-780; SER-788; SER-795; SER-807; SER-811; THR-821;\r\n",
      "RP   THR-823; THR-826 AND SER-855, AND IDENTIFICATION BY MASS SPECTROMETRY\r\n",
      "RP   [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [67]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;\r\n",
      "RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,\r\n",
      "RA   Ye M., Zou H.;\r\n",
      "RT   \"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteomics 96:253-262(2014).\r\n",
      "RN   [68]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 378-562.\r\n",
      "RX   PubMed=9145110; DOI=10.1038/nsb0597-390;\r\n",
      "RA   Kim H.Y., Cho Y.;\r\n",
      "RT   \"Structural similarity between the pocket region of retinoblastoma tumour\r\n",
      "RT   suppressor and the cyclin-box.\";\r\n",
      "RL   Nat. Struct. Biol. 4:390-395(1997).\r\n",
      "RN   [69]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 380-785.\r\n",
      "RX   PubMed=9495340; DOI=10.1038/36038;\r\n",
      "RA   Lee J.O., Russo A.A., Pavletich N.P.;\r\n",
      "RT   \"Structure of the retinoblastoma tumour-suppressor pocket domain bound to a\r\n",
      "RT   peptide from HPV E7.\";\r\n",
      "RL   Nature 391:859-865(1998).\r\n",
      "RN   [70]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 860-876 IN COMPLEX WITH KPNA2.\r\n",
      "RX   PubMed=12695505; DOI=10.1074/jbc.m303275200;\r\n",
      "RA   Fontes M.R.M., Teh T., Jans D., Brinkworth R.I., Kobe B.;\r\n",
      "RT   \"Structural basis for the specificity of bipartite nuclear localization\r\n",
      "RT   sequence binding by importin-alpha.\";\r\n",
      "RL   J. Biol. Chem. 278:27981-27987(2003).\r\n",
      "RN   [71]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 829-874 IN COMPLEX WITH E2F1 AND\r\n",
      "RP   TFDP1, INTERACTION WITH HETERODIMERIC COMPLEXES CONTAINING TFDP1 AND EITHER\r\n",
      "RP   E2F1; E2F3; E2F4 OR E2F5, MUTAGENESIS OF THR-821 AND THR-826, AND\r\n",
      "RP   PHOSPHORYLATION AT THR-821 AND THR-826.\r\n",
      "RX   PubMed=16360038; DOI=10.1016/j.cell.2005.09.044;\r\n",
      "RA   Rubin S.M., Gall A.-L., Zheng N., Pavletich N.P.;\r\n",
      "RT   \"Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for\r\n",
      "RT   phosphorylation-induced E2F release.\";\r\n",
      "RL   Cell 123:1093-1106(2005).\r\n",
      "RN   [72]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (1.67 ANGSTROMS) OF 380-787 IN COMPLEX WITH HUMAN\r\n",
      "RP   ADENOVIRUS E1A PROTEIN (MICROBIAL INFECTION).\r\n",
      "RX   PubMed=17974914; DOI=10.1101/gad.1590607;\r\n",
      "RA   Liu X., Marmorstein R.;\r\n",
      "RT   \"Structure of the retinoblastoma protein bound to adenovirus E1A reveals\r\n",
      "RT   the molecular basis for viral oncoprotein inactivation of a tumor\r\n",
      "RT   suppressor.\";\r\n",
      "RL   Genes Dev. 21:2711-2716(2007).\r\n",
      "RN   [73]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 52-355, PARTIAL PROTEIN SEQUENCE,\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH THOC1 AND GRIP1, AND\r\n",
      "RP   INTERACTION OF THE UNPHOSPHORYLATED PROTEIN WITH EID1.\r\n",
      "RX   PubMed=17996702; DOI=10.1016/j.molcel.2007.08.023;\r\n",
      "RA   Hassler M., Singh S., Yue W.W., Luczynski M., Lakbir R.,\r\n",
      "RA   Sanchez-Sanchez F., Bader T., Pearl L.H., Mittnacht S.;\r\n",
      "RT   \"Crystal structure of the retinoblastoma protein N domain provides insight\r\n",
      "RT   into tumor suppression, ligand interaction, and holoprotein architecture.\";\r\n",
      "RL   Mol. Cell 28:371-385(2007).\r\n",
      "RN   [74]\r\n",
      "RP   VARIANT RB LEU-567.\r\n",
      "RX   PubMed=2594029; DOI=10.1056/nejm198912213212501;\r\n",
      "RA   Yandell D.W., Campbell T.A., Dayton S.H., Petersen R., Walton D.,\r\n",
      "RA   Little J.B., McConkie-Rosell A., Buckley E., Dryja T.P.;\r\n",
      "RT   \"Oncogenic point mutations in the human retinoblastoma gene: their\r\n",
      "RT   application to genetic counseling.\";\r\n",
      "RL   N. Engl. J. Med. 321:1689-1695(1989).\r\n",
      "RN   [75]\r\n",
      "RP   VARIANT RB TRP-661.\r\n",
      "RX   PubMed=1352883; DOI=10.1073/pnas.89.13.6177;\r\n",
      "RA   Onadim Z., Hogg A., Baird P.N., Cowell J.K.;\r\n",
      "RT   \"Oncogenic point mutations in exon 20 of the RB1 gene in families showing\r\n",
      "RT   incomplete penetrance and mild expression of the retinoblastoma\r\n",
      "RT   phenotype.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 89:6177-6181(1992).\r\n",
      "RN   [76]\r\n",
      "RP   VARIANT RB ARG-457.\r\n",
      "RX   PubMed=8346255; DOI=10.1073/pnas.90.15.7351;\r\n",
      "RA   Hogg A., Bia B., Onadim Z., Cowell J.K.;\r\n",
      "RT   \"Molecular mechanisms of oncogenic mutations in tumors from patients with\r\n",
      "RT   bilateral and unilateral retinoblastoma.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 90:7351-7355(1993).\r\n",
      "RN   [77]\r\n",
      "RP   VARIANT RB ARG-530.\r\n",
      "RX   PubMed=7704558; DOI=10.1159/000472372;\r\n",
      "RA   Cowell J.K., Smith T., Bia B.;\r\n",
      "RT   \"Frequent constitutional C to T mutations in CGA-arginine codons in the RB1\r\n",
      "RT   gene produce premature stop codons in patients with bilateral (hereditary)\r\n",
      "RT   retinoblastoma.\";\r\n",
      "RL   Eur. J. Hum. Genet. 2:281-290(1994).\r\n",
      "RN   [78]\r\n",
      "RP   VARIANTS RB ASN-480 DEL AND TRP-661.\r\n",
      "RX   PubMed=7927327; DOI=10.1007/bf00201591;\r\n",
      "RA   Lohmann D.R., Brandt B., Hoepping W., Passarge E., Horsthemke B.;\r\n",
      "RT   \"Distinct RB1 gene mutations with low penetrance in hereditary\r\n",
      "RT   retinoblastoma.\";\r\n",
      "RL   Hum. Genet. 94:349-354(1994).\r\n",
      "RN   [79]\r\n",
      "RP   VARIANTS RB GLN-72; TYR-549 AND LYS-803.\r\n",
      "RX   PubMed=8605116; DOI=10.1002/gcc.2870140406;\r\n",
      "RA   Liu Z., Song Y., Bia B., Cowell J.K.;\r\n",
      "RT   \"Germline mutations in the RB1 gene in patients with hereditary\r\n",
      "RT   retinoblastoma.\";\r\n",
      "RL   Genes Chromosomes Cancer 14:277-284(1995).\r\n",
      "RN   [80]\r\n",
      "RP   VARIANTS RB THR-185; PRO-635; GLU-654 AND PRO-685.\r\n",
      "RX   PubMed=7795591; DOI=10.1093/hmg/4.3.383;\r\n",
      "RA   Blanquet V., Turleau C., Gross-Morand M.S., Senamaud-Beaufort C., Doz F.,\r\n",
      "RA   Besmond C.;\r\n",
      "RT   \"Spectrum of germline mutations in the RB1 gene: a study of 232 patients\r\n",
      "RT   with hereditary and non hereditary retinoblastoma.\";\r\n",
      "RL   Hum. Mol. Genet. 4:383-388(1995).\r\n",
      "RN   [81]\r\n",
      "RP   VARIANTS RB GLY-358; PRO-657 AND TRP-661.\r\n",
      "RX   PubMed=8776589; DOI=10.1093/hmg/5.6.755;\r\n",
      "RA   Van Orsouw N.J., Li D., van der Vlies P., Scheffer H., Eng C.,\r\n",
      "RA   Buys C.H.C.M., Li F.P., Vijg J.;\r\n",
      "RT   \"Mutational scanning of large genes by extensive PCR multiplexing and two-\r\n",
      "RT   dimensional electrophoresis: application to the RB1 gene.\";\r\n",
      "RL   Hum. Mol. Genet. 5:755-761(1996).\r\n",
      "RN   [82]\r\n",
      "RP   VARIANTS RB ASP-137 AND TRP-661.\r\n",
      "RX   PubMed=9311732; DOI=10.1086/514845;\r\n",
      "RA   Lohmann D.R., Gerick M., Brandt B., Oelschlaeger U., Lorenz B.,\r\n",
      "RA   Passarge E., Horsthemke B.;\r\n",
      "RT   \"Constitutional RB1-gene mutations in patients with isolated unilateral\r\n",
      "RT   retinoblastoma.\";\r\n",
      "RL   Am. J. Hum. Genet. 61:282-294(1997).\r\n",
      "RN   [83]\r\n",
      "RP   VARIANT RB GLN-447.\r\n",
      "RX   PubMed=9140452; DOI=10.1016/s0165-4608(96)00387-1;\r\n",
      "RA   Mateu E., Sanchez F., Najera C., Beneyto M., Castell V., Hernandez M.,\r\n",
      "RA   Serra I., Prieto F.;\r\n",
      "RT   \"Genetics of retinoblastoma: a study.\";\r\n",
      "RL   Cancer Genet. Cytogenet. 95:40-50(1997).\r\n",
      "RN   [84]\r\n",
      "RP   VARIANTS RB LEU-567; PRO-662 AND ARG-712.\r\n",
      "RX   PubMed=10671068;\r\n",
      "RA   Yilmaz S., Horsthemke B., Lohmann D.R.;\r\n",
      "RT   \"Twelve novel RB1 gene mutations in patients with hereditary\r\n",
      "RT   retinoblastoma.\";\r\n",
      "RL   Hum. Mutat. 12:434-434(1998).\r\n",
      "RN   [85]\r\n",
      "RP   VARIANT RB GLU-310.\r\n",
      "RX   PubMed=9973307; DOI=10.1086/302254;\r\n",
      "RA   Klutz M., Horsthemke B., Lohmann D.R.;\r\n",
      "RT   \"RB1 gene mutations in peripheral blood DNA of patients with isolated\r\n",
      "RT   unilateral retinoblastoma.\";\r\n",
      "RL   Am. J. Hum. Genet. 64:667-668(1999).\r\n",
      "RN   [86]\r\n",
      "RP   VARIANTS RB GLY-500 AND GLU-616.\r\n",
      "RX   PubMed=11524739; DOI=10.1002/humu.1184;\r\n",
      "RA   Yu Y.S., Kim I.-J., Ku J.-L., Park J.-G.;\r\n",
      "RT   \"Identification of four novel RB1 germline mutations in Korean\r\n",
      "RT   retinoblastoma patients.\";\r\n",
      "RL   Hum. Mutat. 18:252-252(2001).\r\n",
      "RN   [87]\r\n",
      "RP   VARIANT HIS-173.\r\n",
      "RX   PubMed=23033978; DOI=10.1056/nejmoa1206524;\r\n",
      "RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,\r\n",
      "RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P., Gilissen C.,\r\n",
      "RA   del Rosario M., Hoischen A., Scheffer H., de Vries B.B., Brunner H.G.,\r\n",
      "RA   Veltman J.A., Vissers L.E.;\r\n",
      "RT   \"Diagnostic exome sequencing in persons with severe intellectual\r\n",
      "RT   disability.\";\r\n",
      "RL   N. Engl. J. Med. 367:1921-1929(2012).\r\n",
      "CC   -!- FUNCTION: Tumor suppressor that is a key regulator of the G1/S\r\n",
      "CC       transition of the cell cycle (PubMed:10499802). The hypophosphorylated\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CC       form binds transcription regulators of the E2F family, preventing\r\n",
      "CC       transcription of E2F-responsive genes (PubMed:10499802). Both\r\n",
      "CC       physically blocks E2Fs transactivating domain and recruits chromatin-\r\n",
      "CC       modifying enzymes that actively repress transcription\r\n",
      "CC       (PubMed:10499802). Cyclin and CDK-dependent phosphorylation of RB1\r\n",
      "CC       induces its dissociation from E2Fs, thereby activating transcription of\r\n",
      "CC       E2F responsive genes and triggering entry into S phase\r\n",
      "CC       (PubMed:10499802). RB1 also promotes the G0-G1 transition upon\r\n",
      "CC       phosphorylation and activation by CDK3/cyclin-C (PubMed:15084261).\r\n",
      "CC       Directly involved in heterochromatin formation by maintaining overall\r\n",
      "CC       chromatin structure and, in particular, that of constitutive\r\n",
      "CC       heterochromatin by stabilizing histone methylation. Recruits and\r\n",
      "CC       targets histone methyltransferases SUV39H1, KMT5B and KMT5C, leading to\r\n",
      "CC       epigenetic transcriptional repression. Controls histone H4 'Lys-20'\r\n",
      "CC       trimethylation. Inhibits the intrinsic kinase activity of TAF1.\r\n",
      "CC       Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a\r\n",
      "CC       histone deacetylase (HDAC) complex to the c-FOS promoter. In resting\r\n",
      "CC       neurons, transcription of the c-FOS promoter is inhibited by BRG1-\r\n",
      "CC       dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon\r\n",
      "CC       calcium influx, RB1 is dephosphorylated by calcineurin, which leads to\r\n",
      "CC       release of the repressor complex (By similarity).\r\n",
      "CC       {ECO:0000250|UniProtKB:P13405, ECO:0000250|UniProtKB:P33568,\r\n",
      "CC       ECO:0000269|PubMed:10499802, ECO:0000269|PubMed:15084261}.\r\n",
      "CC   -!- FUNCTION: (Microbial infection) In case of viral infections,\r\n",
      "CC       interactions with SV40 large T antigen, HPV E7 protein or adenovirus\r\n",
      "CC       E1A protein induce the disassembly of RB1-E2F1 complex thereby\r\n",
      "CC       disrupting RB1's activity. {ECO:0000269|PubMed:1316611,\r\n",
      "CC       ECO:0000269|PubMed:17974914, ECO:0000269|PubMed:18701596,\r\n",
      "CC       ECO:0000269|PubMed:2839300, ECO:0000269|PubMed:8892909}.\r\n",
      "CC   -!- SUBUNIT: Interacts with ATAD5. Interacts with PRMT2, CDK1 and CDK2 (By\r\n",
      "CC       similarity). The hypophosphorylated form interacts with and sequesters\r\n",
      "CC       the E2F1 transcription factor (PubMed:8336704, PubMed:20940255).\r\n",
      "CC       Interacts with heterodimeric E2F/DP transcription factor complexes\r\n",
      "CC       containing TFDP1 and either E2F1, E2F3, E2F4 or E2F5, or TFDP2 and\r\n",
      "CC       E2F4. The unphosphorylated form interacts with EID1, ARID3B, KDM5A,\r\n",
      "CC       SUV39H1, MJD2A/JHDM3A and THOC1. Interacts with the N-terminal domain\r\n",
      "CC       of TAF1. Interacts with SNW1, AATF, DNMT1, LIN9, LMNA, KMT5B, KMT5C,\r\n",
      "CC       PELP1, UHRF2 and TMPO-alpha. May interact with NDC80. Interacts with\r\n",
      "CC       GRIP1 and UBR4. Interacts with ARID4A and KDM5B. Interacts with E4F1\r\n",
      "CC       and LIMD1. Interacts with SMARCA4/BRG1 and HDAC1 (By similarity).\r\n",
      "CC       Interacts with PSMA3 and USP4. Interacts (when methylated at Lys-860)\r\n",
      "CC       with L3MBTL1. Interacts with CHEK2; phosphorylates RB1. Interacts with\r\n",
      "CC       CEBPA (PubMed:15107404). P-TEFB complex interacts with RB1; promotes\r\n",
      "CC       phosphorylation of RB1 (PubMed:12037672). Interacts with RBBP9; the\r\n",
      "CC       interaction disrupts RB1 binding to E2F1 (By similarity). Interacts\r\n",
      "CC       with KAT2B/PCAF and EP300/P300 (By similarity). Interacts with PAX5\r\n",
      "CC       (PubMed:10197586). {ECO:0000250|UniProtKB:P13405,\r\n",
      "CC       ECO:0000250|UniProtKB:P33568, ECO:0000269|PubMed:10197586,\r\n",
      "CC       ECO:0000269|PubMed:10409732, ECO:0000269|PubMed:10446990,\r\n",
      "CC       ECO:0000269|PubMed:10779342, ECO:0000269|PubMed:10869426,\r\n",
      "CC       ECO:0000269|PubMed:10888886, ECO:0000269|PubMed:11223246,\r\n",
      "CC       ECO:0000269|PubMed:11484059, ECO:0000269|PubMed:11571652,\r\n",
      "CC       ECO:0000269|PubMed:12037672, ECO:0000269|PubMed:12450794,\r\n",
      "CC       ECO:0000269|PubMed:12466551, ECO:0000269|PubMed:12475961,\r\n",
      "CC       ECO:0000269|PubMed:12682072, ECO:0000269|PubMed:12695505,\r\n",
      "CC       ECO:0000269|PubMed:15107404, ECO:0000269|PubMed:15538385,\r\n",
      "CC       ECO:0000269|PubMed:15542589, ECO:0000269|PubMed:15803180,\r\n",
      "CC       ECO:0000269|PubMed:15927959, ECO:0000269|PubMed:15949438,\r\n",
      "CC       ECO:0000269|PubMed:16214886, ECO:0000269|PubMed:16337594,\r\n",
      "CC       ECO:0000269|PubMed:16360038, ECO:0000269|PubMed:16645588,\r\n",
      "CC       ECO:0000269|PubMed:17380128, ECO:0000269|PubMed:17996702,\r\n",
      "CC       ECO:0000269|PubMed:20870719, ECO:0000269|PubMed:20940255,\r\n",
      "CC       ECO:0000269|PubMed:21952639, ECO:0000269|PubMed:7525595,\r\n",
      "CC       ECO:0000269|PubMed:7935440, ECO:0000269|PubMed:8336704,\r\n",
      "CC       ECO:0000269|PubMed:8414517, ECO:0000269|PubMed:9858607}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with adenovirus E1A protein.\r\n",
      "CC       {ECO:0000269|PubMed:17974914}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with HPV E7 protein.\r\n",
      "CC       {ECO:0000269|PubMed:1316611}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with SV40 large T antigen.\r\n",
      "CC       {ECO:0000269|PubMed:1316611, ECO:0000269|PubMed:2839300}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with human\r\n",
      "CC       cytomegalovirus/HHV-5 proteins UL82 and UL123.\r\n",
      "CC       {ECO:0000269|PubMed:12626766, ECO:0000269|PubMed:8892909}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with molluscum contagiosum\r\n",
      "CC       virus protein MC007. {ECO:0000269|PubMed:18701596}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       P06400; Q9UKV8: AGO2; NbExp=3; IntAct=EBI-491274, EBI-528269;\r\n",
      "CC       P06400; P24863: CCNC; NbExp=4; IntAct=EBI-491274, EBI-395261;\r\n",
      "CC       P06400; P24941: CDK2; NbExp=3; IntAct=EBI-491274, EBI-375096;\r\n",
      "CC       P06400; O14757: CHEK1; NbExp=3; IntAct=EBI-491274, EBI-974488;\r\n",
      "CC       P06400; O96017: CHEK2; NbExp=3; IntAct=EBI-491274, EBI-1180783;\r\n",
      "CC       P06400; Q13574-2: DGKZ; NbExp=6; IntAct=EBI-491274, EBI-715527;\r\n",
      "CC       P06400; Q13627: DYRK1A; NbExp=4; IntAct=EBI-491274, EBI-1053596;\r\n",
      "CC       P06400; Q9Y463: DYRK1B; NbExp=4; IntAct=EBI-491274, EBI-634187;\r\n",
      "CC       P06400; Q01094: E2F1; NbExp=26; IntAct=EBI-491274, EBI-448924;\r\n",
      "CC       P06400; Q14209: E2F2; NbExp=5; IntAct=EBI-491274, EBI-718476;\r\n",
      "CC       P06400; O00716: E2F3; NbExp=5; IntAct=EBI-491274, EBI-765551;\r\n",
      "CC       P06400; Q15329: E2F5; NbExp=2; IntAct=EBI-491274, EBI-1389773;\r\n",
      "CC       P06400; O43524: FOXO3; NbExp=2; IntAct=EBI-491274, EBI-1644164;\r\n",
      "CC       P06400; P42685: FRK; NbExp=3; IntAct=EBI-491274, EBI-1383583;\r\n",
      "CC       P06400; P15976: GATA1; NbExp=2; IntAct=EBI-491274, EBI-3909284;\r\n",
      "CC       P06400; P62993: GRB2; NbExp=4; IntAct=EBI-491274, EBI-401755;\r\n",
      "CC       P06400; O60381: HBP1; NbExp=2; IntAct=EBI-491274, EBI-954175;\r\n",
      "CC       P06400; Q13547: HDAC1; NbExp=16; IntAct=EBI-491274, EBI-301834;\r\n",
      "CC       P06400; Q14653: IRF3; NbExp=2; IntAct=EBI-491274, EBI-2650369;\r\n",
      "CC       P06400; P29375: KDM5A; NbExp=2; IntAct=EBI-491274, EBI-1560836;\r\n",
      "CC       P06400; Q16539: MAPK14; NbExp=4; IntAct=EBI-491274, EBI-73946;\r\n",
      "CC       P06400; Q00987: MDM2; NbExp=5; IntAct=EBI-491274, EBI-389668;\r\n",
      "CC       P06400; O15151: MDM4; NbExp=4; IntAct=EBI-491274, EBI-398437;\r\n",
      "CC       P06400; Q9Y676: MRPS18B; NbExp=2; IntAct=EBI-491274, EBI-750085;\r\n",
      "CC       P06400; Q14686: NCOA6; NbExp=3; IntAct=EBI-491274, EBI-78670;\r\n",
      "CC       P06400; P07197: NEFM; NbExp=2; IntAct=EBI-491274, EBI-1105035;\r\n",
      "CC       P06400; Q9UQ80: PA2G4; NbExp=4; IntAct=EBI-491274, EBI-924893;\r\n",
      "CC       P06400; P62136: PPP1CA; NbExp=2; IntAct=EBI-491274, EBI-357253;\r\n",
      "CC       P06400; P55345: PRMT2; NbExp=3; IntAct=EBI-491274, EBI-78458;\r\n",
      "CC       P06400; Q00577: PURA; NbExp=6; IntAct=EBI-491274, EBI-1045860;\r\n",
      "CC       P06400; P04049: RAF1; NbExp=3; IntAct=EBI-491274, EBI-365996;\r\n",
      "CC       P06400; P06400: RB1; NbExp=3; IntAct=EBI-491274, EBI-491274;\r\n",
      "CC       P06400; Q99708: RBBP8; NbExp=2; IntAct=EBI-491274, EBI-745715;\r\n",
      "CC       P06400; O75150: RNF40; NbExp=3; IntAct=EBI-491274, EBI-744408;\r\n",
      "CC       P06400; Q8WTS6: SETD7; NbExp=4; IntAct=EBI-491274, EBI-1268586;\r\n",
      "CC       P06400; Q96PU4: UHRF2; NbExp=4; IntAct=EBI-491274, EBI-625304;\r\n",
      "CC       P06400; Q93009: USP7; NbExp=8; IntAct=EBI-491274, EBI-302474;\r\n",
      "CC       P06400; P30285: Cdk4; Xeno; NbExp=2; IntAct=EBI-491274, EBI-847225;\r\n",
      "CC       P06400; Q155P7: Cenpf; Xeno; NbExp=4; IntAct=EBI-491274, EBI-2211248;\r\n",
      "CC       P06400; A0MPS7: E7; Xeno; NbExp=2; IntAct=EBI-491274, EBI-7014709;\r\n",
      "CC       P06400; P03129: E7; Xeno; NbExp=23; IntAct=EBI-491274, EBI-866453;\r\n",
      "CC       P06400; P04020: E7; Xeno; NbExp=3; IntAct=EBI-491274, EBI-7005254;\r\n",
      "CC       P06400; P06464: E7; Xeno; NbExp=3; IntAct=EBI-491274, EBI-6944797;\r\n",
      "CC       P06400; P06465: E7; Xeno; NbExp=3; IntAct=EBI-491274, EBI-963841;\r\n",
      "CC       P06400; P06788: E7; Xeno; NbExp=4; IntAct=EBI-491274, EBI-1776887;\r\n",
      "CC       P06400; P52927: Hmga2; Xeno; NbExp=5; IntAct=EBI-491274, EBI-912574;\r\n",
      "CC       P06400; Q9R002: Ifi202; Xeno; NbExp=5; IntAct=EBI-491274, EBI-3043899;\r\n",
      "CC       P06400; Q8VSP9: ospF; Xeno; NbExp=2; IntAct=EBI-491274, EBI-6506625;\r\n",
      "CC       P06400; Q9Z2X2: Psmd10; Xeno; NbExp=3; IntAct=EBI-491274, EBI-8377084;\r\n",
      "CC       P06400; PRO_0000037321 [P0C6X7]: rep; Xeno; NbExp=3; IntAct=EBI-491274, EBI-25487301;\r\n",
      "CC       P06400; Q923E4: Sirt1; Xeno; NbExp=4; IntAct=EBI-491274, EBI-1802585;\r\n",
      "CC       P06400; Q3TKT4: Smarca4; Xeno; NbExp=4; IntAct=EBI-491274, EBI-1210244;\r\n",
      "CC       P06400; P03070; Xeno; NbExp=6; IntAct=EBI-491274, EBI-617698;\r\n",
      "CC       P06400; P03254; Xeno; NbExp=3; IntAct=EBI-491274, EBI-8599077;\r\n",
      "CC       P06400; P03255; Xeno; NbExp=10; IntAct=EBI-491274, EBI-2603114;\r\n",
      "CC       P06400; P03255-1; Xeno; NbExp=2; IntAct=EBI-491274, EBI-6692439;\r\n",
      "CC       P06400; P03255-2; Xeno; NbExp=3; IntAct=EBI-491274, EBI-6859460;\r\n",
      "CC       P06400; PRO_0000041225 [Q86500]; Xeno; NbExp=3; IntAct=EBI-491274, EBI-2568719;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20940255}.\r\n",
      "CC       Note=During keratinocyte differentiation, acetylation by KAT2B/PCAF is\r\n",
      "CC       required for nuclear localization. {ECO:0000269|PubMed:20940255}.\r\n",
      "CC   -!- TISSUE SPECIFICITY: Expressed in the retina. Expressed in foreskin\r\n",
      "CC       keratinocytes (at protein level) (PubMed:20940255).\r\n",
      "CC       {ECO:0000269|PubMed:20940255}.\r\n",
      "CC   -!- DOMAIN: The Pocket domain binds to the threonine-phosphorylated domain\r\n",
      "CC       C, thereby preventing interaction with heterodimeric E2F/DP\r\n",
      "CC       transcription factor complexes.\r\n",
      "CC   -!- PTM: Phosphorylated by CDK6 and CDK4, and subsequently by CDK2 at Ser-\r\n",
      "CC       567 in G1, thereby releasing E2F1 which is then able to activate cell\r\n",
      "CC       growth. Dephosphorylated at the late M phase. SV40 large T antigen, HPV\r\n",
      "CC       E7 and adenovirus E1A bind to the underphosphorylated, active form of\r\n",
      "CC       pRb. Phosphorylation at Thr-821 and Thr-826 promotes interaction\r\n",
      "CC       between the C-terminal domain C and the Pocket domain, and thereby\r\n",
      "CC       inhibits interactions with heterodimeric E2F/DP transcription factor\r\n",
      "CC       complexes. Dephosphorylated at Ser-795 by calcineruin upon calcium\r\n",
      "CC       stimulation. CDK3/cyclin-C-mediated phosphorylation at Ser-807 and Ser-\r\n",
      "CC       811 is required for G0-G1 transition. Phosphorylated by CDK1 and CDK2\r\n",
      "CC       upon TGFB1-mediated apoptosis. {ECO:0000269|PubMed:10499802,\r\n",
      "CC       ECO:0000269|PubMed:8114739}.\r\n",
      "CC   -!- PTM: N-terminus is methylated by METTL11A/NTM1 (By similarity).\r\n",
      "CC       Monomethylation at Lys-810 by SMYD2 enhances phosphorylation at Ser-807\r\n",
      "CC       and Ser-811, and promotes cell cycle progression. Monomethylation at\r\n",
      "CC       Lys-860 by SMYD2 promotes interaction with L3MBTL1. {ECO:0000250,\r\n",
      "CC       ECO:0000269|PubMed:15084261, ECO:0000269|PubMed:15809340,\r\n",
      "CC       ECO:0000269|PubMed:16360038, ECO:0000269|PubMed:17380128,\r\n",
      "CC       ECO:0000269|PubMed:1756735, ECO:0000269|PubMed:20870719,\r\n",
      "CC       ECO:0000269|PubMed:22787429}.\r\n",
      "CC   -!- PTM: Acetylated during keratinocyte differentiation. Acetylation at\r\n",
      "CC       Lys-873 and Lys-874 regulates subcellular localization. Can be\r\n",
      "CC       deacetylated by SIRT1. {ECO:0000269|PubMed:20940255}.\r\n",
      "CC   -!- DISEASE: Childhood cancer retinoblastoma (RB) [MIM:180200]: Congenital\r\n",
      "CC       malignant tumor that arises from the nuclear layers of the retina. It\r\n",
      "CC       occurs in about 1:20'000 live births and represents about 2% of\r\n",
      "CC       childhood malignancies. It is bilateral in about 30% of cases. Although\r\n",
      "CC       most RB appear sporadically, about 20% are transmitted as an autosomal\r\n",
      "CC       dominant trait with incomplete penetrance. The diagnosis is usually\r\n",
      "CC       made before the age of 2 years when strabismus or a gray to yellow\r\n",
      "CC       reflex from pupil ('cat eye') is investigated.\r\n",
      "CC       {ECO:0000269|PubMed:10671068, ECO:0000269|PubMed:11524739,\r\n",
      "CC       ECO:0000269|PubMed:1352883, ECO:0000269|PubMed:2594029,\r\n",
      "CC       ECO:0000269|PubMed:7704558, ECO:0000269|PubMed:7795591,\r\n",
      "CC       ECO:0000269|PubMed:7927327, ECO:0000269|PubMed:8346255,\r\n",
      "CC       ECO:0000269|PubMed:8605116, ECO:0000269|PubMed:8776589,\r\n",
      "CC       ECO:0000269|PubMed:9140452, ECO:0000269|PubMed:9311732,\r\n",
      "CC       ECO:0000269|PubMed:9973307}. Note=The disease is caused by variants\r\n",
      "CC       affecting the gene represented in this entry.\r\n",
      "CC   -!- DISEASE: Bladder cancer (BLC) [MIM:109800]: A malignancy originating in\r\n",
      "CC       tissues of the urinary bladder. It often presents with multiple tumors\r\n",
      "CC       appearing at different times and at different sites in the bladder.\r\n",
      "CC       Most bladder cancers are transitional cell carcinomas that begin in\r\n",
      "CC       cells that normally make up the inner lining of the bladder. Other\r\n",
      "CC       types of bladder cancer include squamous cell carcinoma (cancer that\r\n",
      "CC       begins in thin, flat cells) and adenocarcinoma (cancer that begins in\r\n",
      "CC       cells that make and release mucus and other fluids). Bladder cancer is\r\n",
      "CC       a complex disorder with both genetic and environmental influences.\r\n",
      "CC       Note=Disease susceptibility is associated with variants affecting the\r\n",
      "CC       gene represented in this entry.\r\n",
      "CC   -!- DISEASE: Osteogenic sarcoma (OSRC) [MIM:259500]: A sarcoma originating\r\n",
      "CC       in bone-forming cells, affecting the ends of long bones. Note=The\r\n",
      "CC       disease is caused by variants affecting the gene represented in this\r\n",
      "CC       entry.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   -!- WEB RESOURCE: Name=RB1base; Note=RB1 mutation db;\r\n",
      "CC       URL=\"http://rb1-lsdb.d-lohmann.de/\";\r\n",
      "CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and\r\n",
      "CC       Haematology;\r\n",
      "CC       URL=\"https://atlasgeneticsoncology.org/gene/90/RB1\";\r\n",
      "CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;\r\n",
      "CC       URL=\"http://egp.gs.washington.edu/data/rb1/\";\r\n",
      "CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Retinoblastoma protein entry;\r\n",
      "CC       URL=\"https://en.wikipedia.org/wiki/Retinoblastoma_protein\";\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; M15400; AAA69807.1; ALT_SEQ; mRNA.\r\n",
      "DR   EMBL; M28419; AAA69808.1; -; mRNA.\r\n",
      "DR   EMBL; M33647; AAA69806.1; -; mRNA.\r\n",
      "DR   EMBL; L41870; AAB59465.1; -; mRNA.\r\n",
      "DR   EMBL; M27866; AAA53484.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; M27845; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27846; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27847; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27849; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27850; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27851; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; L35146; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27852; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27853; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27854; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27855; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27856; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27857; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27858; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27859; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27860; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; L35147; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27862; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27863; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27864; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; M27865; AAA53484.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; L41889; AAB59467.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41890; AAA65735.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41891; AAA65736.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41893; AAA65737.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41894; AAA65738.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41895; AAA65739.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41896; AAA65740.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41897; AAA65741.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41898; AAB59471.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41899; AAB59473.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; L41997; AAB59482.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; X16439; CAA34462.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; AF551763; AAN64133.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; AK291258; BAF83947.1; -; mRNA.\r\n",
      "DR   EMBL; AL136960; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AL392048; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; CH471075; EAX08793.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; BC039060; AAH39060.1; -; mRNA.\r\n",
      "DR   EMBL; BC040540; AAH40540.1; -; mRNA.\r\n",
      "DR   EMBL; L11910; AAA53483.1; -; Genomic_DNA.\r\n",
      "DR   CCDS; CCDS31973.1; -.\r\n",
      "DR   PIR; JS0276; RBHU.\r\n",
      "DR   RefSeq; NP_000312.2; NM_000321.2.\r\n",
      "DR   PDB; 1AD6; X-ray; 2.30 A; A=378-562.\r\n",
      "DR   PDB; 1GH6; X-ray; 3.20 A; B=379-577, B=645-772.\r\n",
      "DR   PDB; 1GUX; X-ray; 1.85 A; A=372-589, B=636-787.\r\n",
      "DR   PDB; 1H25; X-ray; 2.50 A; E=868-878.\r\n",
      "DR   PDB; 1N4M; X-ray; 2.20 A; A/B=380-785.\r\n",
      "DR   PDB; 1O9K; X-ray; 2.60 A; A/C/E/G=372-589, B/D/F/H=636-787.\r\n",
      "DR   PDB; 1PJM; X-ray; 2.50 A; A=858-881.\r\n",
      "DR   PDB; 2AZE; X-ray; 2.55 A; C=829-874.\r\n",
      "DR   PDB; 2QDJ; X-ray; 2.00 A; A=52-355.\r\n",
      "DR   PDB; 2R7G; X-ray; 1.67 A; A/C=380-787.\r\n",
      "DR   PDB; 3N5U; X-ray; 3.20 A; C=870-882.\r\n",
      "DR   PDB; 3POM; X-ray; 2.50 A; A/B=380-577, A/B=643-783.\r\n",
      "DR   PDB; 4CRI; X-ray; 2.35 A; C/D=802-817.\r\n",
      "DR   PDB; 4ELJ; X-ray; 2.70 A; A=53-787.\r\n",
      "DR   PDB; 4ELL; X-ray; 1.98 A; A/B=380-787.\r\n",
      "DR   PDBsum; 1AD6; -.\r\n",
      "DR   PDBsum; 1GH6; -.\r\n",
      "DR   PDBsum; 1GUX; -.\r\n",
      "DR   PDBsum; 1H25; -.\r\n",
      "DR   PDBsum; 1N4M; -.\r\n",
      "DR   PDBsum; 1O9K; -.\r\n",
      "DR   PDBsum; 1PJM; -.\r\n",
      "DR   PDBsum; 2AZE; -.\r\n",
      "DR   PDBsum; 2QDJ; -.\r\n",
      "DR   PDBsum; 2R7G; -.\r\n",
      "DR   PDBsum; 3N5U; -.\r\n",
      "DR   PDBsum; 3POM; -.\r\n",
      "DR   PDBsum; 4CRI; -.\r\n",
      "DR   PDBsum; 4ELJ; -.\r\n",
      "DR   PDBsum; 4ELL; -.\r\n",
      "DR   AlphaFoldDB; P06400; -.\r\n",
      "DR   SMR; P06400; -.\r\n",
      "DR   BioGRID; 111860; 358.\r\n",
      "DR   ComplexPortal; CPX-155; RB1-E2F1-TFDP1 transcription repressor complex.\r\n",
      "DR   ComplexPortal; CPX-175; RB1-E2F2-TFDP1 transcription repressor complex.\r\n",
      "DR   ComplexPortal; CPX-469; L3MBTL1 complex.\r\n",
      "DR   CORUM; P06400; -.\r\n",
      "DR   DIP; DIP-582N; -.\r\n",
      "DR   IntAct; P06400; 160.\r\n",
      "DR   MINT; P06400; -.\r\n",
      "DR   STRING; 9606.ENSP00000267163; -.\r\n",
      "DR   BindingDB; P06400; -.\r\n",
      "DR   ChEMBL; CHEMBL5288; -.\r\n",
      "DR   GlyGen; P06400; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; P06400; -.\r\n",
      "DR   PhosphoSitePlus; P06400; -.\r\n",
      "DR   BioMuta; RB1; -.\r\n",
      "DR   DMDM; 132164; -.\r\n",
      "DR   CPTAC; CPTAC-1328; -.\r\n",
      "DR   CPTAC; CPTAC-3251; -.\r\n",
      "DR   CPTAC; CPTAC-3288; -.\r\n",
      "DR   CPTAC; CPTAC-898; -.\r\n",
      "DR   CPTAC; CPTAC-941; -.\r\n",
      "DR   CPTAC; CPTAC-942; -.\r\n",
      "DR   EPD; P06400; -.\r\n",
      "DR   jPOST; P06400; -.\r\n",
      "DR   MassIVE; P06400; -.\r\n",
      "DR   MaxQB; P06400; -.\r\n",
      "DR   PaxDb; P06400; -.\r\n",
      "DR   PeptideAtlas; P06400; -.\r\n",
      "DR   ProteomicsDB; 51900; -.\r\n",
      "DR   Antibodypedia; 3758; 3544 antibodies from 52 providers.\r\n",
      "DR   CPTC; P06400; 6 antibodies.\r\n",
      "DR   DNASU; 5925; -.\r\n",
      "DR   Ensembl; ENST00000267163.6; ENSP00000267163.4; ENSG00000139687.16.\r\n",
      "DR   GeneID; 5925; -.\r\n",
      "DR   KEGG; hsa:5925; -.\r\n",
      "DR   MANE-Select; ENST00000267163.6; ENSP00000267163.4; NM_000321.3; NP_000312.2.\r\n",
      "DR   UCSC; uc001vcb.4; human.\r\n",
      "DR   AGR; HGNC:9884; -.\r\n",
      "DR   CTD; 5925; -.\r\n",
      "DR   DisGeNET; 5925; -.\r\n",
      "DR   GeneCards; RB1; -.\r\n",
      "DR   GeneReviews; RB1; -.\r\n",
      "DR   HGNC; HGNC:9884; RB1.\r\n",
      "DR   HPA; ENSG00000139687; Low tissue specificity.\r\n",
      "DR   MalaCards; RB1; -.\r\n",
      "DR   MIM; 109800; phenotype.\r\n",
      "DR   MIM; 180200; phenotype.\r\n",
      "DR   MIM; 259500; phenotype.\r\n",
      "DR   MIM; 614041; gene.\r\n",
      "DR   neXtProt; NX_P06400; -.\r\n",
      "DR   OpenTargets; ENSG00000139687; -.\r\n",
      "DR   Orphanet; 357027; Hereditary retinoblastoma.\r\n",
      "DR   Orphanet; 1587; Monosomy 13q14.\r\n",
      "DR   Orphanet; 357034; Non-hereditary retinoblastoma.\r\n",
      "DR   Orphanet; 668; Osteosarcoma.\r\n",
      "DR   Orphanet; 70573; Small cell lung cancer.\r\n",
      "DR   PharmGKB; PA295; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000139687; -.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00950000183202; -.\r\n",
      "DR   HOGENOM; CLU_015754_0_0_1; -.\r\n",
      "DR   InParanoid; P06400; -.\r\n",
      "DR   OMA; VKDIGCI; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; P06400; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   PathwayCommons; P06400; -.\r\n",
      "DR   Reactome; R-HSA-113501; Inhibition of replication initiation of damaged DNA by RB1/E2F1.\r\n",
      "DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.\r\n",
      "DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.\r\n",
      "DR   Reactome; R-HSA-2559584; Formation of Senescence-Associated Heterochromatin Foci (SAHF).\r\n",
      "DR   Reactome; R-HSA-2559585; Oncogene Induced Senescence.\r\n",
      "DR   Reactome; R-HSA-69200; Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes.\r\n",
      "DR   Reactome; R-HSA-69202; Cyclin E associated events during G1/S transition.\r\n",
      "DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.\r\n",
      "DR   Reactome; R-HSA-69656; Cyclin A:Cdk2-associated events at S phase entry.\r\n",
      "DR   Reactome; R-HSA-8940973; RUNX2 regulates osteoblast differentiation.\r\n",
      "DR   Reactome; R-HSA-9661069; Defective binding of RB1 mutants to E2F1,(E2F2, E2F3).\r\n",
      "DR   Reactome; R-HSA-9661070; Defective translocation of RB1 mutants to the nucleus.\r\n",
      "DR   Reactome; R-HSA-9682706; Replication of the SARS-CoV-1 genome.\r\n",
      "DR   Reactome; R-HSA-9687136; Aberrant regulation of mitotic exit in cancer due to RB1 defects.\r\n",
      "DR   Reactome; R-HSA-9694686; Replication of the SARS-CoV-2 genome.\r\n",
      "DR   SignaLink; P06400; -.\r\n",
      "DR   SIGNOR; P06400; -.\r\n",
      "DR   BioGRID-ORCS; 5925; 32 hits in 1194 CRISPR screens.\r\n",
      "DR   ChiTaRS; RB1; human.\r\n",
      "DR   EvolutionaryTrace; P06400; -.\r\n",
      "DR   GeneWiki; Retinoblastoma_protein; -.\r\n",
      "DR   GenomeRNAi; 5925; -.\r\n",
      "DR   Pharos; P06400; Tchem.\r\n",
      "DR   PRO; PR:P06400; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 13.\r\n",
      "DR   RNAct; P06400; protein.\r\n",
      "DR   Bgee; ENSG00000139687; Expressed in epithelium of nasopharynx and 198 other tissues.\r\n",
      "DR   ExpressionAtlas; P06400; baseline and differential.\r\n",
      "DR   Genevisible; P06400; HS.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0061793; C:chromatin lock complex; IPI:ComplexPortal.\r\n",
      "DR   GO; GO:0005829; C:cytosol; TAS:Reactome.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:CAFA.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; IDA:CAFA.\r\n",
      "DR   GO; GO:0005819; C:spindle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0016514; C:SWI/SNF complex; TAS:BHF-UCL.\r\n",
      "DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.\r\n",
      "DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.\r\n",
      "DR   GO; GO:0061676; F:importin-alpha family protein binding; IPI:CAFA.\r\n",
      "DR   GO; GO:0019900; F:kinase binding; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0060090; F:molecular adaptor activity; EXP:DisProt.\r\n",
      "DR   GO; GO:0051219; F:phosphoprotein binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ARUK-UCL.\r\n",
      "DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0003180; P:aortic valve morphogenesis; ISS:BHF-UCL.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0051301; P:cell division; IEA:Ensembl.\r\n",
      "DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0002062; P:chondrocyte differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006338; P:chromatin remodeling; TAS:BHF-UCL.\r\n",
      "DR   GO; GO:0051276; P:chromosome organization; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0048565; P:digestive tract development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0043353; P:enucleate erythrocyte differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050673; P:epithelial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0034349; P:glial cell apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0014009; P:glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031507; P:heterochromatin formation; IDA:ComplexPortal.\r\n",
      "DR   GO; GO:0034088; P:maintenance of mitotic sister chromatid cohesion; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0045445; P:myoblast differentiation; IMP:UniProtKB.\r\n",
      "DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; ISS:ARUK-UCL.\r\n",
      "DR   GO; GO:0045786; P:negative regulation of cell cycle; ISS:ARUK-UCL.\r\n",
      "DR   GO; GO:0030308; P:negative regulation of cell growth; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.\r\n",
      "DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IDA:ComplexPortal.\r\n",
      "DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:MGI.\r\n",
      "DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:1903944; P:negative regulation of hepatocyte apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISS:BHF-UCL.\r\n",
      "DR   GO; GO:1904761; P:negative regulation of myofibroblast differentiation; ISS:BHF-UCL.\r\n",
      "DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0071901; P:negative regulation of protein serine/threonine kinase activity; ISS:ARUK-UCL.\r\n",
      "DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl.\r\n",
      "DR   GO; GO:1902948; P:negative regulation of tau-protein kinase activity; ISS:ARUK-UCL.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; TAS:BHF-UCL.\r\n",
      "DR   GO; GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:BHF-UCL.\r\n",
      "DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0042551; P:neuron maturation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031175; P:neuron projection development; IBA:GO_Central.\r\n",
      "DR   GO; GO:1904028; P:positive regulation of collagen fibril organization; ISS:BHF-UCL.\r\n",
      "DR   GO; GO:1903055; P:positive regulation of extracellular matrix organization; ISS:BHF-UCL.\r\n",
      "DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IDA:MGI.\r\n",
      "DR   GO; GO:0071459; P:protein localization to chromosome, centromeric region; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0007265; P:Ras protein signal transduction; IEP:BHF-UCL.\r\n",
      "DR   GO; GO:0051726; P:regulation of cell cycle; TAS:BHF-UCL.\r\n",
      "DR   GO; GO:0090230; P:regulation of centromere complex assembly; TAS:BHF-UCL.\r\n",
      "DR   GO; GO:0006355; P:regulation of DNA-templated transcription; NAS:UniProtKB.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0007346; P:regulation of mitotic cell cycle; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0031134; P:sister chromatid biorientation; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0001894; P:tissue homeostasis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   CDD; cd20599; CYCLIN_RB; 1.\r\n",
      "DR   DisProt; DP01426; -.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 6.10.140.1380; -; 1.\r\n",
      "DR   Gene3D; 6.10.250.530; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 2.\r\n",
      "DR   IDEAL; IID00017; -.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Acetylation; Cell cycle; Chromatin regulator;\r\n",
      "KW   Direct protein sequencing; Disease variant; DNA-binding;\r\n",
      "KW   Host-virus interaction; Methylation; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Repressor; Transcription; Transcription regulation;\r\n",
      "KW   Tumor suppressor.\r\n",
      "FT   INIT_MET        1\r\n",
      "FT                   /note=\"Removed\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   CHAIN           2..928\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein\"\r\n",
      "FT                   /id=\"PRO_0000167836\"\r\n",
      "FT   REGION          1..42\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          373..771\r\n",
      "FT                   /note=\"Pocket; binds T and E1A\"\r\n",
      "FT   REGION          373..579\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT   REGION          580..639\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT   REGION          610..632\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          640..771\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT   REGION          763..928\r\n",
      "FT                   /note=\"Interaction with LIMD1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:15542589\"\r\n",
      "FT   REGION          771..928\r\n",
      "FT                   /note=\"Domain C; mediates interaction with E4F1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10869426\"\r\n",
      "FT   REGION          860..928\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOTIF           860..876\r\n",
      "FT                   /note=\"Bipartite nuclear localization signal\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   COMPBIAS        18..32\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        613..632\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        871..893\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        899..918\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         2\r\n",
      "FT                   /note=\"N,N-dimethylproline\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   MOD_RES         37\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         249\r\n",
      "FT                   /note=\"Phosphoserine; by CDK1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:1756735,\r\n",
      "FT                   ECO:0007744|PubMed:18220336, ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:21406692,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         252\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:1756735,\r\n",
      "FT                   ECO:0007744|PubMed:18220336, ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         356\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18220336,\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         373\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:1756735,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         567\r\n",
      "FT                   /note=\"Phosphoserine; by CDK2\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10499802\"\r\n",
      "FT   MOD_RES         608\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   MOD_RES         612\r\n",
      "FT                   /note=\"Phosphoserine; by CHEK2 and CHEK1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:17380128,\r\n",
      "FT                   ECO:0007744|PubMed:18669648\"\r\n",
      "FT   MOD_RES         624\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         780\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         788\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         795\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         807\r\n",
      "FT                   /note=\"Phosphoserine; by CDK1 and CDK3\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:15084261,\r\n",
      "FT                   ECO:0000269|PubMed:1756735, ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         810\r\n",
      "FT                   /note=\"N6-methyllysine; by SMYD2\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:22787429\"\r\n",
      "FT   MOD_RES         811\r\n",
      "FT                   /note=\"Phosphoserine; by CDK1 and CDK3\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:15084261,\r\n",
      "FT                   ECO:0000269|PubMed:1756735, ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         821\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK6\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:15809340,\r\n",
      "FT                   ECO:0000269|PubMed:16360038, ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         823\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         826\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK4\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:15809340,\r\n",
      "FT                   ECO:0000269|PubMed:16360038, ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         841\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332\"\r\n",
      "FT   MOD_RES         855\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         860\r\n",
      "FT                   /note=\"N6-methyllysine; by SMYD2\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20870719\"\r\n",
      "FT   MOD_RES         873\r\n",
      "FT                   /note=\"N6-acetyllysine; by PCAF\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20940255\"\r\n",
      "FT   MOD_RES         874\r\n",
      "FT                   /note=\"N6-acetyllysine; by PCAF\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20940255\"\r\n",
      "FT   VARIANT         72\r\n",
      "FT                   /note=\"E -> Q (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8605116\"\r\n",
      "FT                   /id=\"VAR_005572\"\r\n",
      "FT   VARIANT         133\r\n",
      "FT                   /note=\"N -> H (in dbSNP:rs3092900)\"\r\n",
      "FT                   /id=\"VAR_051909\"\r\n",
      "FT   VARIANT         137\r\n",
      "FT                   /note=\"E -> D (in RB; unilateral form; dbSNP:rs3092902)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:9311732\"\r\n",
      "FT                   /id=\"VAR_005573\"\r\n",
      "FT   VARIANT         173\r\n",
      "FT                   /note=\"Y -> H\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:23033978\"\r\n",
      "FT                   /id=\"VAR_069376\"\r\n",
      "FT   VARIANT         185\r\n",
      "FT                   /note=\"I -> T (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:7795591\"\r\n",
      "FT                   /id=\"VAR_005574\"\r\n",
      "FT   VARIANT         310\r\n",
      "FT                   /note=\"G -> E (in RB; unknown pathological significance;\r\n",
      "FT                   dbSNP:rs200844292)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:9973307\"\r\n",
      "FT                   /id=\"VAR_010045\"\r\n",
      "FT   VARIANT         358\r\n",
      "FT                   /note=\"R -> G (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8776589\"\r\n",
      "FT                   /id=\"VAR_010046\"\r\n",
      "FT   VARIANT         358\r\n",
      "FT                   /note=\"R -> Q (in RB; dbSNP:rs767011440)\"\r\n",
      "FT                   /id=\"VAR_005575\"\r\n",
      "FT   VARIANT         436\r\n",
      "FT                   /note=\"Q -> K (in dbSNP:rs4151534)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|Ref.7\"\r\n",
      "FT                   /id=\"VAR_019379\"\r\n",
      "FT   VARIANT         447\r\n",
      "FT                   /note=\"K -> Q (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:9140452\"\r\n",
      "FT                   /id=\"VAR_010048\"\r\n",
      "FT   VARIANT         457\r\n",
      "FT                   /note=\"M -> R (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8346255\"\r\n",
      "FT                   /id=\"VAR_005576\"\r\n",
      "FT   VARIANT         480\r\n",
      "FT                   /note=\"Missing (in RB; mild form)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:7927327\"\r\n",
      "FT                   /id=\"VAR_005577\"\r\n",
      "FT   VARIANT         500\r\n",
      "FT                   /note=\"R -> G (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11524739\"\r\n",
      "FT                   /id=\"VAR_011580\"\r\n",
      "FT   VARIANT         525\r\n",
      "FT                   /note=\"A -> G (in dbSNP:rs4151539)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|Ref.7\"\r\n",
      "FT                   /id=\"VAR_019380\"\r\n",
      "FT   VARIANT         530\r\n",
      "FT                   /note=\"K -> R (in RB; dbSNP:rs1948534047)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:7704558\"\r\n",
      "FT                   /id=\"VAR_010049\"\r\n",
      "FT   VARIANT         549\r\n",
      "FT                   /note=\"H -> Y (in RB; dbSNP:rs1050717570)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8605116\"\r\n",
      "FT                   /id=\"VAR_005578\"\r\n",
      "FT   VARIANT         567\r\n",
      "FT                   /note=\"S -> L (in RB; dbSNP:rs137853292)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10671068,\r\n",
      "FT                   ECO:0000269|PubMed:2594029\"\r\n",
      "FT                   /id=\"VAR_005579\"\r\n",
      "FT   VARIANT         569\r\n",
      "FT                   /note=\"L -> F (in dbSNP:rs3092895)\"\r\n",
      "FT                   /id=\"VAR_051910\"\r\n",
      "FT   VARIANT         616\r\n",
      "FT                   /note=\"K -> E (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11524739\"\r\n",
      "FT                   /id=\"VAR_011581\"\r\n",
      "FT   VARIANT         635\r\n",
      "FT                   /note=\"A -> P (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:7795591\"\r\n",
      "FT                   /id=\"VAR_005580\"\r\n",
      "FT   VARIANT         654\r\n",
      "FT                   /note=\"V -> E (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:7795591\"\r\n",
      "FT                   /id=\"VAR_005581\"\r\n",
      "FT   VARIANT         657\r\n",
      "FT                   /note=\"L -> P (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8776589\"\r\n",
      "FT                   /id=\"VAR_010050\"\r\n",
      "FT   VARIANT         661\r\n",
      "FT                   /note=\"R -> W (in RB; mild form; dbSNP:rs137853294)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:1352883,\r\n",
      "FT                   ECO:0000269|PubMed:7927327, ECO:0000269|PubMed:8776589,\r\n",
      "FT                   ECO:0000269|PubMed:9311732\"\r\n",
      "FT                   /id=\"VAR_005582\"\r\n",
      "FT   VARIANT         662\r\n",
      "FT                   /note=\"L -> P (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10671068\"\r\n",
      "FT                   /id=\"VAR_005583\"\r\n",
      "FT   VARIANT         673\r\n",
      "FT                   /note=\"H -> P (in RB)\"\r\n",
      "FT                   /id=\"VAR_005584\"\r\n",
      "FT   VARIANT         685\r\n",
      "FT                   /note=\"Q -> P (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:7795591\"\r\n",
      "FT                   /id=\"VAR_005585\"\r\n",
      "FT   VARIANT         697\r\n",
      "FT                   /note=\"D -> E (in dbSNP:rs3092903)\"\r\n",
      "FT                   /id=\"VAR_051911\"\r\n",
      "FT   VARIANT         706\r\n",
      "FT                   /note=\"C -> Y (in RB)\"\r\n",
      "FT                   /id=\"VAR_005586\"\r\n",
      "FT   VARIANT         712\r\n",
      "FT                   /note=\"C -> R (in RB; dbSNP:rs137853296)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10671068\"\r\n",
      "FT                   /id=\"VAR_005587\"\r\n",
      "FT   VARIANT         746\r\n",
      "FT                   /note=\"E -> G (in dbSNP:rs3092905)\"\r\n",
      "FT                   /id=\"VAR_034442\"\r\n",
      "FT   VARIANT         803\r\n",
      "FT                   /note=\"N -> K (in RB)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8605116\"\r\n",
      "FT                   /id=\"VAR_005588\"\r\n",
      "FT   MUTAGEN         821\r\n",
      "FT                   /note=\"T->A: Abolishes interaction with Pocket domain; when\r\n",
      "FT                   associated with A-826.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16360038\"\r\n",
      "FT   MUTAGEN         826\r\n",
      "FT                   /note=\"T->A: Abolishes interaction with Pocket domain; when\r\n",
      "FT                   associated with A-821.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16360038\"\r\n",
      "FT   MUTAGEN         860\r\n",
      "FT                   /note=\"K->R: Abolishes monomethylation by SMYD2 and\r\n",
      "FT                   subsequent interaction with L3MBTL1.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20870719\"\r\n",
      "FT   MUTAGEN         870\r\n",
      "FT                   /note=\"K->R: Does not affect the ability to be methylated\r\n",
      "FT                   by SMYD2; when associated with 873-R-R-874.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20870719\"\r\n",
      "FT   MUTAGEN         873..874\r\n",
      "FT                   /note=\"KK->R: Does not affect the ability to be methylated\r\n",
      "FT                   by SMYD2; when associated with 873-R-R-874.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20870719,\r\n",
      "FT                   ECO:0000269|PubMed:20940255\"\r\n",
      "FT   MUTAGEN         873..874\r\n",
      "FT                   /note=\"KK->RR: Does not alter Rb localization in cycling\r\n",
      "FT                   cells, but mislocalizes to the cytoplasm during\r\n",
      "FT                   keratinocyte differentiation. Does not affect the ability\r\n",
      "FT                   to arrest cell growth. Probable loss of acetylation by\r\n",
      "FT                   PCAF.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20870719,\r\n",
      "FT                   ECO:0000269|PubMed:20940255\"\r\n",
      "FT   CONFLICT        500..501\r\n",
      "FT                   /note=\"RS -> SN (in Ref. 7; AAN64133)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   HELIX           55..63\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           68..82\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           95..110\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           117..124\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           128..135\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           142..172\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   STRAND          180..182\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           188..204\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   STRAND          207..209\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4ELJ\"\r\n",
      "FT   HELIX           212..228\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           232..234\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   TURN            237..240\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           241..243\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           272..281\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           285..294\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           296..299\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           302..306\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4ELJ\"\r\n",
      "FT   HELIX           314..328\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           333..338\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           341..343\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           347..353\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2QDJ\"\r\n",
      "FT   HELIX           382..391\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           398..405\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          407..409\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           412..434\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           436..438\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           439..468\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           474..477\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           480..501\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   TURN            504..506\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:1N4M\"\r\n",
      "FT   STRAND          511..513\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4ELJ\"\r\n",
      "FT   HELIX           516..521\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           525..529\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           532..538\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           544..559\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           561..563\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          564..566\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4ELJ\"\r\n",
      "FT   HELIX           569..577\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           582..586\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4ELL\"\r\n",
      "FT   HELIX           602..607\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4ELL\"\r\n",
      "FT   HELIX           645..669\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           676..690\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           692..695\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           700..714\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           721..728\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          731..733\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:1N4M\"\r\n",
      "FT   HELIX           737..740\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          741..743\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          745..747\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          748..750\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:4ELJ\"\r\n",
      "FT   HELIX           752..758\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   HELIX           760..770\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          773..775\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2R7G\"\r\n",
      "FT   STRAND          830..836\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   TURN            838..840\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   HELIX           841..853\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "SQ   SEQUENCE   928 AA;  106159 MW;  C8E746111E19CC32 CRC64;\r\n",
      "     MPPKTPRKTA ATAAAAAAEP PAPPPPPPPE EDPEQDSGPE DLPLVRLEFE ETEEPDFTAL\r\n",
      "     CQKLKIPDHV RERAWLTWEK VSSVDGVLGG YIQKKKELWG ICIFIAAVDL DEMSFTFTEL\r\n",
      "     QKNIEISVHK FFNLLKEIDT STKVDNAMSR LLKKYDVLFA LFSKLERTCE LIYLTQPSSS\r\n",
      "     ISTEINSALV LKVSWITFLL AKGEVLQMED DLVISFQLML CVLDYFIKLS PPMLLKEPYK\r\n",
      "     TAVIPINGSP RTPRRGQNRS ARIAKQLEND TRIIEVLCKE HECNIDEVKN VYFKNFIPFM\r\n",
      "     NSLGLVTSNG LPEVENLSKR YEEIYLKNKD LDARLFLDHD KTLQTDSIDS FETQRTPRKS\r\n",
      "     NLDEEVNVIP PHTPVRTVMN TIQQLMMILN SASDQPSENL ISYFNNCTVN PKESILKRVK\r\n",
      "     DIGYIFKEKF AKAVGQGCVE IGSQRYKLGV RLYYRVMESM LKSEEERLSI QNFSKLLNDN\r\n",
      "     IFHMSLLACA LEVVMATYSR STSQNLDSGT DLSFPWILNV LNLKAFDFYK VIESFIKAEG\r\n",
      "     NLTREMIKHL ERCEHRIMES LAWLSDSPLF DLIKQSKDRE GPTDHLESAC PLNLPLQNNH\r\n",
      "     TAADMYLSPV RSPKKKGSTT RVNSTANAET QATSAFQTQK PLKSTSLSLF YKKVYRLAYL\r\n",
      "     RLNTLCERLL SEHPELEHII WTLFQHTLQN EYELMRDRHL DQIMMCSMYG ICKVKNIDLK\r\n",
      "     FKIIVTAYKD LPHAVQETFK RVLIKEEEYD SIIVFYNSVF MQRLKTNILQ YASTRPPTLS\r\n",
      "     PIPHIPRSPY KFPSSPLRIP GGNIYISPLK SPYKISEGLP TPTKMTPRSR ILVSIGESFG\r\n",
      "     TSEKFQKINQ MVCNSDRVLK RSAEGSNPPK PLKKLRFDIE GSDEADGSKH LPGESKFQQK\r\n",
      "     LAEMTSTRTR MQKQKMNDSM DTSNKEEK\r\n",
      "//\r\n",
      "ID   E2F1_HUMAN              Reviewed;         437 AA.\r\n",
      "AC   Q01094; Q13143; Q92768;\r\n",
      "DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   01-JUL-1993, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 243.\r\n",
      "DE   RecName: Full=Transcription factor E2F1 {ECO:0000303|PubMed:8964493};\r\n",
      "DE            Short=E2F-1 {ECO:0000303|PubMed:8964493};\r\n",
      "DE   AltName: Full=PBR3;\r\n",
      "DE   AltName: Full=Retinoblastoma-associated protein 1 {ECO:0000303|PubMed:1638635};\r\n",
      "DE            Short=RBAP-1 {ECO:0000303|PubMed:1638635};\r\n",
      "DE   AltName: Full=Retinoblastoma-binding protein 3 {ECO:0000303|PubMed:1638634};\r\n",
      "DE            Short=RBBP-3 {ECO:0000303|PubMed:1638634};\r\n",
      "DE   AltName: Full=pRB-binding protein E2F-1;\r\n",
      "GN   Name=E2F1 {ECO:0000303|PubMed:8964493, ECO:0000312|HGNC:HGNC:3113};\r\n",
      "GN   Synonyms=RBBP3 {ECO:0000303|PubMed:1638634};\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=1638634; DOI=10.1016/0092-8674(92)90107-n;\r\n",
      "RA   Helin K., Lees J.A., Vidal M., Dyson N.J., Harlow E., Fattaey A.;\r\n",
      "RT   \"A cDNA encoding a pRB-binding protein with properties of the transcription\r\n",
      "RT   factor E2F.\";\r\n",
      "RL   Cell 70:337-350(1992).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=1638635; DOI=10.1016/0092-8674(92)90108-o;\r\n",
      "RA   Kaelin W.G. Jr., Krek W., Sellers W.R., Decaprio J.A., Ajchenbaum F.,\r\n",
      "RA   Fuchs C.S., Chittenden T., Li Y., Farnham P.J., Blanar M.A.,\r\n",
      "RA   Livingston D.M., Flemington E.K.;\r\n",
      "RT   \"Expression cloning of a cDNA encoding a retinoblastoma-binding protein\r\n",
      "RT   with E2F-like properties.\";\r\n",
      "RL   Cell 70:351-364(1992).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=1448092; DOI=10.1128/mcb.12.12.5620-5631.1992;\r\n",
      "RA   Shan B., Zhu X., Chen P.L., Durfee T., Yang Y., Sharp D., Lee W.H.;\r\n",
      "RT   \"Molecular cloning of cellular genes encoding retinoblastoma-associated\r\n",
      "RT   proteins: identification of a gene with properties of the transcription\r\n",
      "RT   factor E2F.\";\r\n",
      "RL   Mol. Cell. Biol. 12:5620-5631(1992).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].\r\n",
      "RX   PubMed=8964493; DOI=10.1016/0378-1119(96)00184-9;\r\n",
      "RA   Neuman E., Sellers W.R.S., McNeil J.A., Lawrence J.B., Kaelin W.G. Jr.;\r\n",
      "RT   \"Structure and partial genomic sequence of the human E2F1 gene.\";\r\n",
      "RL   Gene 173:163-169(1996).\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-252; MET-276; ASN-311\r\n",
      "RP   AND SER-393.\r\n",
      "RG   NIEHS SNPs program;\r\n",
      "RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RX   PubMed=11780052; DOI=10.1038/414865a;\r\n",
      "RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,\r\n",
      "RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,\r\n",
      "RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,\r\n",
      "RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,\r\n",
      "RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,\r\n",
      "RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,\r\n",
      "RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,\r\n",
      "RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,\r\n",
      "RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,\r\n",
      "RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,\r\n",
      "RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,\r\n",
      "RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,\r\n",
      "RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,\r\n",
      "RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,\r\n",
      "RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,\r\n",
      "RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,\r\n",
      "RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,\r\n",
      "RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,\r\n",
      "RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,\r\n",
      "RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,\r\n",
      "RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,\r\n",
      "RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,\r\n",
      "RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;\r\n",
      "RT   \"The DNA sequence and comparative analysis of human chromosome 20.\";\r\n",
      "RL   Nature 414:865-871(2001).\r\n",
      "RN   [7]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\r\n",
      "RC   TISSUE=Pancreas, and Skin;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [8]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-111.\r\n",
      "RX   PubMed=7958836; DOI=10.1101/gad.8.13.1514;\r\n",
      "RA   Johnson D.G., Ohtani K., Nevins J.R.;\r\n",
      "RT   \"Autoregulatory control of E2F1 expression in response to positive and\r\n",
      "RT   negative regulators of cell cycle progression.\";\r\n",
      "RL   Genes Dev. 8:1514-1525(1994).\r\n",
      "RN   [9]\r\n",
      "RP   INTERACTION WITH RB1.\r\n",
      "RX   PubMed=8336704; DOI=10.1128/mcb.13.8.4588-4599.1993;\r\n",
      "RA   Zacksenhaus E., Bremner R., Phillips R.A., Gallie B.L.;\r\n",
      "RT   \"A bipartite nuclear localization signal in the retinoblastoma gene product\r\n",
      "RT   and its importance for biological activity.\";\r\n",
      "RL   Mol. Cell. Biol. 13:4588-4599(1993).\r\n",
      "RN   [10]\r\n",
      "RP   TRANSACTIVATION INHIBITION, AND MUTAGENESIS OF TYR-411.\r\n",
      "RX   PubMed=8413249; DOI=10.1128/mcb.13.10.6501-6508.1993;\r\n",
      "RA   Helin K., Harlow E., Fattaey A.;\r\n",
      "RT   \"Inhibition of E2F-1 transactivation by direct binding of the\r\n",
      "RT   retinoblastoma protein.\";\r\n",
      "RL   Mol. Cell. Biol. 13:6501-6508(1993).\r\n",
      "RN   [11]\r\n",
      "RP   DOMAIN CYCLIN A:CDK2 BINDING.\r\n",
      "RX   PubMed=8033208; DOI=10.1016/0092-8674(94)90582-7;\r\n",
      "RA   Krek W., Ewen M.E., Shirodkar S., Arany Z., Kaelin W.G. Jr.,\r\n",
      "RA   Livingston D.M.;\r\n",
      "RT   \"Negative regulation of the growth-promoting transcription factor E2F-1 by\r\n",
      "RT   a stably bound cyclin A-dependent protein kinase.\";\r\n",
      "RL   Cell 78:161-172(1994).\r\n",
      "RN   [12]\r\n",
      "RP   DIFFERENTIAL REGULATION BY CYCLIN/CDK2 KINASES.\r\n",
      "RX   PubMed=7958856; DOI=10.1101/gad.8.15.1772;\r\n",
      "RA   Dynlacht B.D., Flores O., Lees J.A., Harlow E.;\r\n",
      "RT   \"Differential regulation of E2F transactivation by cyclin/cdk2 complexes.\";\r\n",
      "RL   Genes Dev. 8:1772-1786(1994).\r\n",
      "RN   [13]\r\n",
      "RP   INHIBITION OF DNA-BINDING.\r\n",
      "RX   PubMed=7969176; DOI=10.1128/mcb.14.12.8420-8431.1994;\r\n",
      "RA   Xu M., Sheppard K.-A., Peng C.-Y., Yee A.S., Piwnica-Worms H.;\r\n",
      "RT   \"Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding\r\n",
      "RT   activity of E2F-1/DP-1 by phosphorylation.\";\r\n",
      "RL   Mol. Cell. Biol. 14:8420-8431(1994).\r\n",
      "RN   [14]\r\n",
      "RP   FUNCTION IN APOPTOSIS.\r\n",
      "RX   PubMed=8170954; DOI=10.1073/pnas.91.9.3602;\r\n",
      "RA   Wu X., Levine A.J.;\r\n",
      "RT   \"P53 and E2F-1 cooperate to mediate apoptosis.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 91:3602-3606(1994).\r\n",
      "RN   [15]\r\n",
      "RP   INTERACTION WITH HHV-5 PROTEIN UL123.\r\n",
      "RX   PubMed=7494286; DOI=10.1128/jvi.69.12.7759-7767.1995;\r\n",
      "RA   Margolis M.J., Pajovic S., Wong E.L., Wade M., Jupp R., Nelson J.A.,\r\n",
      "RA   Azizkhan J.C.;\r\n",
      "RT   \"Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product\r\n",
      "RT   with E2F1 coincides with E2F-dependent activation of dihydrofolate\r\n",
      "RT   reductase transcription.\";\r\n",
      "RL   J. Virol. 69:7759-7767(1995).\r\n",
      "RN   [16]\r\n",
      "RP   PHOSPHORYLATION.\r\n",
      "RX   PubMed=7838523;\r\n",
      "RA   Kitagawa M., Higashi H., Suzuki-Takahashi I., Segawa K., Hanks S.K.,\r\n",
      "RA   Taya Y., Nishimura S., Okuyama A.;\r\n",
      "RT   \"Phosphorylation of E2F-1 by cyclin A-cdk2.\";\r\n",
      "RL   Oncogene 10:229-236(1995).\r\n",
      "RN   [17]\r\n",
      "RP   REGULATION BY CYCLIN-DEPENDENT KINASES.\r\n",
      "RX   PubMed=9199321; DOI=10.1128/mcb.17.7.3867;\r\n",
      "RA   Dynlacht B.D., Moberg K., Lees J.A., Harlow E., Zhu L.;\r\n",
      "RT   \"Specific regulation of E2F family members by cyclin-dependent kinases.\";\r\n",
      "RL   Mol. Cell. Biol. 17:3867-3875(1997).\r\n",
      "RN   [18]\r\n",
      "RP   INTERACTION WITH ARID3A.\r\n",
      "RX   PubMed=9780002; DOI=10.1038/sj.onc.1202163;\r\n",
      "RA   Suzuki M., Okuyama S., Okamoto S., Shirasuna K., Nakajima T., Hachiya T.,\r\n",
      "RA   Nojima H., Sekiya S., Oda K.;\r\n",
      "RT   \"A novel E2F binding protein with Myc-type HLH motif stimulates E2F-\r\n",
      "RT   dependent transcription by forming a heterodimer.\";\r\n",
      "RL   Oncogene 17:853-865(1998).\r\n",
      "RN   [19]\r\n",
      "RP   ACETYLATION AT LYS-117; LYS-120 AND LYS-125, DNA-BINDING, INTERACTION WITH\r\n",
      "RP   KAT2B, FUNCTION, AND MUTAGENESIS OF LYS-117; LYS-120 AND LYS-125.\r\n",
      "RX   PubMed=10675335; DOI=10.1093/emboj/19.4.662;\r\n",
      "RA   Martinez-Balbas M.A., Bauer U.M., Nielsen S.J., Brehm A., Kouzarides T.;\r\n",
      "RT   \"Regulation of E2F1 activity by acetylation.\";\r\n",
      "RL   EMBO J. 19:662-671(2000).\r\n",
      "RN   [20]\r\n",
      "RP   INTERACTION WITH TRRAP.\r\n",
      "RX   PubMed=11418595; DOI=10.1074/jbc.m102067200;\r\n",
      "RA   Lang S.E., McMahon S.B., Cole M.D., Hearing P.;\r\n",
      "RT   \"E2F transcriptional activation requires TRRAP and GCN5 cofactors.\";\r\n",
      "RL   J. Biol. Chem. 276:32627-32634(2001).\r\n",
      "RN   [21]\r\n",
      "RP   INTERACTION WITH TOPBP1.\r\n",
      "RX   PubMed=12697828; DOI=10.1128/mcb.23.9.3287-3304.2003;\r\n",
      "RA   Liu K., Lin F.-T., Ruppert J.M., Lin W.-C.;\r\n",
      "RT   \"Regulation of E2F1 by BRCT domain-containing protein TopBP1.\";\r\n",
      "RL   Mol. Cell. Biol. 23:3287-3304(2003).\r\n",
      "RN   [22]\r\n",
      "RP   FUNCTION IN TRANSCRIPTION REGULATION, FUNCTION IN APOPTOSIS,\r\n",
      "RP   PHOSPHORYLATION AT SER-364 BY CHEK2, AND MUTAGENESIS OF SER-364.\r\n",
      "RX   PubMed=12717439; DOI=10.1038/ncb974;\r\n",
      "RA   Stevens C., Smith L., La Thangue N.B.;\r\n",
      "RT   \"Chk2 activates E2F-1 in response to DNA damage.\";\r\n",
      "RL   Nat. Cell Biol. 5:401-409(2003).\r\n",
      "RN   [23]\r\n",
      "RP   INTERACTION WITH RB1 AND TFDP1.\r\n",
      "RX   PubMed=16360038; DOI=10.1016/j.cell.2005.09.044;\r\n",
      "RA   Rubin S.M., Gall A.-L., Zheng N., Pavletich N.P.;\r\n",
      "RT   \"Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for\r\n",
      "RT   phosphorylation-induced E2F release.\";\r\n",
      "RL   Cell 123:1093-1106(2005).\r\n",
      "RN   [24]\r\n",
      "RP   INTERACTION WITH EAPP.\r\n",
      "RX   PubMed=15716352; DOI=10.1091/mbc.e04-11-0975;\r\n",
      "RA   Novy M., Pohn R., Andorfer P., Novy-Weiland T., Galos B., Schwarzmayr L.,\r\n",
      "RA   Rotheneder H.;\r\n",
      "RT   \"EAPP, a novel E2F binding protein that modulates E2F-dependent\r\n",
      "RT   transcription.\";\r\n",
      "RL   Mol. Biol. Cell 16:2181-2190(2005).\r\n",
      "RN   [25]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;\r\n",
      "RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;\r\n",
      "RT   \"Global, in vivo, and site-specific phosphorylation dynamics in signaling\r\n",
      "RT   networks.\";\r\n",
      "RL   Cell 127:635-648(2006).\r\n",
      "RN   [26]\r\n",
      "RP   FUNCTION, PHOSPHORYLATION AT SER-403 AND THR-433, AND MUTAGENESIS OF\r\n",
      "RP   SER-403 AND THR-433.\r\n",
      "RX   PubMed=17050006; DOI=10.1016/j.bbamcr.2006.09.015;\r\n",
      "RA   Garcia-Alvarez G., Ventura V., Ros O., Aligue R., Gil J., Tauler A.;\r\n",
      "RT   \"Glycogen synthase kinase-3beta binds to E2F1 and regulates its\r\n",
      "RT   transcriptional activity.\";\r\n",
      "RL   Biochim. Biophys. Acta 1773:375-382(2007).\r\n",
      "RN   [27]\r\n",
      "RP   INTERACTION WITH HDAC1 AND TRIM28, FUNCTION, ACETYLATION, AND\r\n",
      "RP   DEACETYLATION.\r\n",
      "RX   PubMed=17704056; DOI=10.1074/jbc.m704757200;\r\n",
      "RA   Wang C., Rauscher F.J. III, Cress W.D., Chen J.;\r\n",
      "RT   \"Regulation of E2F1 function by the nuclear corepressor KAP1.\";\r\n",
      "RL   J. Biol. Chem. 282:29902-29909(2007).\r\n",
      "RN   [28]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=18625225; DOI=10.1016/j.febslet.2008.07.009;\r\n",
      "RA   Wang C., Xiao Y., Hu Z., Chen Y., Liu N., Hu G.;\r\n",
      "RT   \"PEG10 directly regulated by E2Fs might have a role in the development of\r\n",
      "RT   hepatocellular carcinoma.\";\r\n",
      "RL   FEBS Lett. 582:2793-2798(2008).\r\n",
      "RN   [29]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;\r\n",
      "RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,\r\n",
      "RA   Elledge S.J., Gygi S.P.;\r\n",
      "RT   \"A quantitative atlas of mitotic phosphorylation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).\r\n",
      "RN   [30]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [31]\r\n",
      "RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH RRP1B.\r\n",
      "RX   PubMed=20040599; DOI=10.1074/jbc.m109.072074;\r\n",
      "RA   Paik J.C., Wang B., Liu K., Lue J.K., Lin W.C.;\r\n",
      "RT   \"Regulation of E2F1-induced apoptosis by the nucleolar protein RRP1B.\";\r\n",
      "RL   J. Biol. Chem. 285:6348-6363(2010).\r\n",
      "RN   [32]\r\n",
      "RP   FUNCTION, INTERACTION WITH CEBPA, AND MUTAGENESIS OF LEU-132 AND TYR-411.\r\n",
      "RX   PubMed=20176812; DOI=10.1128/mcb.01619-09;\r\n",
      "RA   Zaragoza K., Begay V., Schuetz A., Heinemann U., Leutz A.;\r\n",
      "RT   \"Repression of transcriptional activity of C/EBPalpha by E2F-dimerization\r\n",
      "RT   partner complexes.\";\r\n",
      "RL   Mol. Cell. Biol. 30:2293-2304(2010).\r\n",
      "RN   [33]\r\n",
      "RP   METHYLATION AT LYS-185, AND MUTAGENESIS OF LYS-185.\r\n",
      "RX   PubMed=20603083; DOI=10.1016/j.molcel.2010.06.006;\r\n",
      "RA   Kontaki H., Talianidis I.;\r\n",
      "RT   \"Lysine methylation regulates E2F1-induced cell death.\";\r\n",
      "RL   Mol. Cell 39:152-160(2010).\r\n",
      "RN   [34]\r\n",
      "RP   INTERACTION WITH BIRC2, AND ACTIVITY REGULATION.\r\n",
      "RX   PubMed=21653699; DOI=10.1074/jbc.m110.191239;\r\n",
      "RA   Cartier J., Berthelet J., Marivin A., Gemble S., Edmond V., Plenchette S.,\r\n",
      "RA   Lagrange B., Hammann A., Dupoux A., Delva L., Eymin B., Solary E.,\r\n",
      "RA   Dubrez L.;\r\n",
      "RT   \"Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1\r\n",
      "RT   transcription factor-mediated control of cyclin transcription.\";\r\n",
      "RL   J. Biol. Chem. 286:26406-26417(2011).\r\n",
      "RN   [35]\r\n",
      "RP   INTERACTION WITH KMT2E AND HCFC1.\r\n",
      "RX   PubMed=23629655; DOI=10.1074/jbc.m112.439729;\r\n",
      "RA   Zhou P., Wang Z., Yuan X., Zhou C., Liu L., Wan X., Zhang F., Ding X.,\r\n",
      "RA   Wang C., Xiong S., Wang Z., Yuan J., Li Q., Zhang Y.;\r\n",
      "RT   \"Mixed lineage leukemia 5 (MLL5) protein regulates cell cycle progression\r\n",
      "RT   and E2F1-responsive gene expression via association with host cell factor-1\r\n",
      "RT   (HCF-1).\";\r\n",
      "RL   J. Biol. Chem. 288:17532-17543(2013).\r\n",
      "RN   [36]\r\n",
      "RP   FUNCTION, SUBCELLULAR LOCATION, UBIQUITINATION, DEUBIQUITINATION,\r\n",
      "RP   PHOSPHORYLATION AT SER-403, AND MUTAGENESIS OF SER-403.\r\n",
      "RX   PubMed=28992046; DOI=10.1093/jmcb/mjx034;\r\n",
      "RA   Wang D., Zhao J., Li S., Wei J., Nan L., Mallampalli R.K.,\r\n",
      "RA   Weathington N.M., Ma H., Zhao Y.;\r\n",
      "RT   \"Phosphorylated E2F1 is stabilized by nuclear USP11 to drive Peg10 gene\r\n",
      "RT   expression and activate lung epithelial cells.\";\r\n",
      "RL   J. Mol. Cell Biol. 10:60-73(2018).\r\n",
      "RN   [37]\r\n",
      "RP   INTERACTION WITH DCAF5 AND L3MBTL3, AND MUTAGENESIS OF LYS-185.\r\n",
      "RX   PubMed=29691401; DOI=10.1038/s41467-018-04019-9;\r\n",
      "RA   Leng F., Yu J., Zhang C., Alejo S., Hoang N., Sun H., Lu F., Zhang H.;\r\n",
      "RT   \"Methylated DNMT1 and E2F1 are targeted for proteolysis by L3MBTL3 and\r\n",
      "RT   CRL4-DCAF5 ubiquitin ligase.\";\r\n",
      "RL   Nat. Commun. 9:1641-1641(2018).\r\n",
      "RN   [38]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 87-95.\r\n",
      "RX   PubMed=12501191; DOI=10.1021/bi0268910;\r\n",
      "RA   Lowe E.D., Tews I., Cheng K.Y., Brown N.R., Gul S., Noble M.E.M.,\r\n",
      "RA   Gamblin S.J., Johnson L.N.;\r\n",
      "RT   \"Specificity determinants of recruitment peptides bound to phospho-\r\n",
      "RT   CDK2/cyclin A.\";\r\n",
      "RL   Biochemistry 41:15625-15634(2002).\r\n",
      "RN   [39]\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 409-426 IN COMPLEX WITH RB1.\r\n",
      "RX   PubMed=12598654; DOI=10.1073/pnas.0436813100;\r\n",
      "RA   Xiao B., Spencer J., Clements A., Ali-Khan N., Mittnacht S., Broceno C.,\r\n",
      "RA   Burghammer M., Perrakis A., Marmorstein R., Gamblin S.J.;\r\n",
      "RT   \"Crystal structure of the retinoblastoma tumor suppressor protein bound to\r\n",
      "RT   E2F and the molecular basis of its regulation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 100:2363-2368(2003).\r\n",
      "CC   -!- FUNCTION: Transcription activator that binds DNA cooperatively with DP\r\n",
      "CC       proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in\r\n",
      "CC       the promoter region of a number of genes whose products are involved in\r\n",
      "CC       cell cycle regulation or in DNA replication (PubMed:10675335,\r\n",
      "CC       PubMed:12717439, PubMed:17704056, PubMed:17050006, PubMed:18625225,\r\n",
      "CC       PubMed:28992046). The DRTF1/E2F complex functions in the control of\r\n",
      "CC       cell-cycle progression from G1 to S phase (PubMed:10675335,\r\n",
      "CC       PubMed:12717439, PubMed:17704056). E2F1 binds preferentially RB1 in a\r\n",
      "CC       cell-cycle dependent manner (PubMed:10675335, PubMed:12717439,\r\n",
      "CC       PubMed:17704056). It can mediate both cell proliferation and TP53/p53-\r\n",
      "CC       dependent apoptosis (PubMed:8170954). Blocks adipocyte differentiation\r\n",
      "CC       by binding to specific promoters repressing CEBPA binding to its target\r\n",
      "CC       gene promoters (PubMed:20176812). Directly activates transcription of\r\n",
      "CC       PEG10 (PubMed:17050006, PubMed:18625225, PubMed:28992046). Positively\r\n",
      "CC       regulates transcription of RRP1B (PubMed:20040599).\r\n",
      "CC       {ECO:0000269|PubMed:10675335, ECO:0000269|PubMed:12717439,\r\n",
      "CC       ECO:0000269|PubMed:17050006, ECO:0000269|PubMed:17704056,\r\n",
      "CC       ECO:0000269|PubMed:18625225, ECO:0000269|PubMed:20040599,\r\n",
      "CC       ECO:0000269|PubMed:20176812, ECO:0000269|PubMed:28992046,\r\n",
      "CC       ECO:0000269|PubMed:8170954}.\r\n",
      "CC   -!- ACTIVITY REGULATION: BIRC2/c-IAP1 stimulates its transcriptional\r\n",
      "CC       activity. {ECO:0000269|PubMed:21653699}.\r\n",
      "CC   -!- SUBUNIT: Component of the DRTF1/E2F transcription factor complex. Forms\r\n",
      "CC       heterodimers with DP family members. The E2F1 complex binds\r\n",
      "CC       specifically hypophosphorylated retinoblastoma protein RB1\r\n",
      "CC       (PubMed:8336704). During the cell cycle, RB1 becomes phosphorylated in\r\n",
      "CC       mid-to-late G1 phase, detaches from the DRTF1/E2F complex, rendering\r\n",
      "CC       E2F transcriptionally active. Viral oncoproteins, notably E1A, T-\r\n",
      "CC       antigen and HPV E7, are capable of sequestering RB1, thus releasing the\r\n",
      "CC       active complex. Interacts with TRRAP, which probably mediates its\r\n",
      "CC       interaction with histone acetyltransferase complexes, leading to\r\n",
      "CC       transcription activation. Binds TOPBP1 and EAPP. Interacts with ARID3A.\r\n",
      "CC       Interacts with TRIM28; the interaction inhibits E2F1 acetylation\r\n",
      "CC       through recruiting HDAC1 and represses its transcriptional activity.\r\n",
      "CC       Interaction with KAT2B; the interaction acetylates E2F1 enhancing its\r\n",
      "CC       DNA-binding and transcriptional activity. Interacts with BIRC2/c-IAP1\r\n",
      "CC       (via BIR domains). The complex TFDP1:E2F1 interacts with CEBPA; the\r\n",
      "CC       interaction prevents CEBPA binding to target genes promoters and\r\n",
      "CC       represses its transcriptional activity (PubMed:20176812). Interacts\r\n",
      "CC       with RRP1B (PubMed:20040599). Interacts with HCFC1 (PubMed:23629655).\r\n",
      "CC       Interacts with KMT2E; the interaction is probably indirect and is\r\n",
      "CC       mediated via HCFC1 (PubMed:23629655). Interacts with DCAF5 and L3MBTL3;\r\n",
      "CC       the interaction requires methylation at Lys-185 and is necessary to\r\n",
      "CC       target E2F1 for ubiquitination by the CRL4-DCAF5 E3 ubiquitin ligase\r\n",
      "CC       complex (PubMed:29691401). {ECO:0000250|UniProtKB:Q61501,\r\n",
      "CC       ECO:0000269|PubMed:10675335, ECO:0000269|PubMed:11418595,\r\n",
      "CC       ECO:0000269|PubMed:12598654, ECO:0000269|PubMed:12697828,\r\n",
      "CC       ECO:0000269|PubMed:15716352, ECO:0000269|PubMed:16360038,\r\n",
      "CC       ECO:0000269|PubMed:17704056, ECO:0000269|PubMed:20040599,\r\n",
      "CC       ECO:0000269|PubMed:20176812, ECO:0000269|PubMed:21653699,\r\n",
      "CC       ECO:0000269|PubMed:23629655, ECO:0000269|PubMed:29691401,\r\n",
      "CC       ECO:0000269|PubMed:8336704, ECO:0000269|PubMed:9780002}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with human\r\n",
      "CC       cytomegalovirus/HHV-5 protein UL123. {ECO:0000269|PubMed:7494286}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q01094; P05067: APP; NbExp=3; IntAct=EBI-448924, EBI-77613;\r\n",
      "CC       Q01094; Q14201: BTG3; NbExp=3; IntAct=EBI-448924, EBI-948192;\r\n",
      "CC       Q01094; P49336: CDK8; NbExp=3; IntAct=EBI-448924, EBI-394377;\r\n",
      "CC       Q01094; Q92466: DDB2; NbExp=2; IntAct=EBI-448924, EBI-1176171;\r\n",
      "CC       Q01094; Q13547: HDAC1; NbExp=2; IntAct=EBI-448924, EBI-301834;\r\n",
      "CC       Q01094; Q92830: KAT2A; NbExp=3; IntAct=EBI-448924, EBI-477622;\r\n",
      "CC       Q01094; Q96JM7: L3MBTL3; NbExp=2; IntAct=EBI-448924, EBI-2686809;\r\n",
      "CC       Q01094; Q8NEM0: MCPH1; NbExp=6; IntAct=EBI-448924, EBI-1565483;\r\n",
      "CC       Q01094; Q9Y618: NCOR2; NbExp=2; IntAct=EBI-448924, EBI-80830;\r\n",
      "CC       Q01094; P09874: PARP1; NbExp=3; IntAct=EBI-448924, EBI-355676;\r\n",
      "CC       Q01094; Q96IZ0: PAWR; NbExp=2; IntAct=EBI-448924, EBI-595869;\r\n",
      "CC       Q01094; O14744: PRMT5; NbExp=8; IntAct=EBI-448924, EBI-351098;\r\n",
      "CC       Q01094; P06400: RB1; NbExp=26; IntAct=EBI-448924, EBI-491274;\r\n",
      "CC       Q01094; Q14684: RRP1B; NbExp=10; IntAct=EBI-448924, EBI-372051;\r\n",
      "CC       Q01094; Q96EB6: SIRT1; NbExp=3; IntAct=EBI-448924, EBI-1802965;\r\n",
      "CC       Q01094; P08047: SP1; NbExp=2; IntAct=EBI-448924, EBI-298336;\r\n",
      "CC       Q01094; P42224: STAT1; NbExp=2; IntAct=EBI-448924, EBI-1057697;\r\n",
      "CC       Q01094; Q14186: TFDP1; NbExp=14; IntAct=EBI-448924, EBI-749713;\r\n",
      "CC       Q01094; Q92547: TOPBP1; NbExp=3; IntAct=EBI-448924, EBI-308302;\r\n",
      "CC       Q01094; O95361: TRIM16; NbExp=2; IntAct=EBI-448924, EBI-727384;\r\n",
      "CC       Q01094; P03129: E7; Xeno; NbExp=2; IntAct=EBI-448924, EBI-866453;\r\n",
      "CC       Q01094; Q923E4: Sirt1; Xeno; NbExp=3; IntAct=EBI-448924, EBI-1802585;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20040599,\r\n",
      "CC       ECO:0000269|PubMed:28992046}.\r\n",
      "CC   -!- PTM: Phosphorylated by CDK2 and cyclin A-CDK2 in the S-phase\r\n",
      "CC       (PubMed:12717439, PubMed:7838523). Phosphorylation at Ser-364 by CHEK2\r\n",
      "CC       stabilizes E2F1 upon DNA damage and regulates its effect on\r\n",
      "CC       transcription and apoptosis (PubMed:12717439). Phosphorylation at Ser-\r\n",
      "CC       403 by GSK3B promotes interaction with USP11, leading to its\r\n",
      "CC       deubiquitination and stabilization (PubMed:28992046).\r\n",
      "CC       {ECO:0000269|PubMed:12717439, ECO:0000269|PubMed:28992046,\r\n",
      "CC       ECO:0000269|PubMed:7838523}.\r\n",
      "CC   -!- PTM: Ubiquitinated via 'Lys-63'-linked ubiquitin, leading to its\r\n",
      "CC       degradation (PubMed:28992046). Deubiquitinated by USP11 follwong\r\n",
      "CC       phosphorylation by GSK3B, promoting its stability (PubMed:28992046).\r\n",
      "CC       {ECO:0000269|PubMed:28992046}.\r\n",
      "CC   -!- PTM: Acetylation stimulates DNA-binding. Enhanced under stress\r\n",
      "CC       conditions such as DNA damage and inhibited by retinoblastoma protein\r\n",
      "CC       RB1. Regulated by KAP1/TRIM28 which recruits HDAC1 to E2F1 resulting in\r\n",
      "CC       deacetylation. Acetylated by P/CAF/KAT2B. {ECO:0000269|PubMed:10675335,\r\n",
      "CC       ECO:0000269|PubMed:17704056}.\r\n",
      "CC   -!- PTM: Methylation at Lys-185 by SETD7 promotes E2F1 ubiquitin-dependent\r\n",
      "CC       proteasomal degradation. {ECO:0000269|PubMed:20603083,\r\n",
      "CC       ECO:0000269|PubMed:29691401}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the E2F/DP family. {ECO:0000305}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=AAB24289.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};\r\n",
      "CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and\r\n",
      "CC       Haematology;\r\n",
      "CC       URL=\"https://atlasgeneticsoncology.org/gene/40382/E2F1\";\r\n",
      "CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;\r\n",
      "CC       URL=\"http://egp.gs.washington.edu/data/e2f1/\";\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; M96577; AAA35782.1; -; mRNA.\r\n",
      "DR   EMBL; U47677; AAC50719.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; U47675; AAC50719.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; U47676; AAC50719.1; JOINED; Genomic_DNA.\r\n",
      "DR   EMBL; S49592; AAB24289.1; ALT_INIT; mRNA.\r\n",
      "DR   EMBL; AF516106; AAM47604.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; AL121906; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; BC050369; AAH50369.1; -; mRNA.\r\n",
      "DR   EMBL; BC058902; AAH58902.1; -; mRNA.\r\n",
      "DR   EMBL; S74230; AAD14150.1; -; Genomic_DNA.\r\n",
      "DR   CCDS; CCDS13224.1; -.\r\n",
      "DR   PIR; JC4929; JC4929.\r\n",
      "DR   RefSeq; NP_005216.1; NM_005225.2.\r\n",
      "DR   PDB; 1H24; X-ray; 2.50 A; E=87-95.\r\n",
      "DR   PDB; 1O9K; X-ray; 2.60 A; P/Q/R/S=409-426.\r\n",
      "DR   PDB; 2AZE; X-ray; 2.55 A; B=200-301.\r\n",
      "DR   PDB; 5M9N; X-ray; 1.95 A; C=104-120.\r\n",
      "DR   PDB; 5M9O; X-ray; 1.45 A; B=108-116.\r\n",
      "DR   PDB; 6G0P; X-ray; 1.30 A; B=114-129.\r\n",
      "DR   PDB; 6ULS; X-ray; 1.50 A; B=114-123.\r\n",
      "DR   PDBsum; 1H24; -.\r\n",
      "DR   PDBsum; 1O9K; -.\r\n",
      "DR   PDBsum; 2AZE; -.\r\n",
      "DR   PDBsum; 5M9N; -.\r\n",
      "DR   PDBsum; 5M9O; -.\r\n",
      "DR   PDBsum; 6G0P; -.\r\n",
      "DR   PDBsum; 6ULS; -.\r\n",
      "DR   AlphaFoldDB; Q01094; -.\r\n",
      "DR   SASBDB; Q01094; -.\r\n",
      "DR   SMR; Q01094; -.\r\n",
      "DR   BioGRID; 108201; 170.\r\n",
      "DR   ComplexPortal; CPX-155; RB1-E2F1-TFDP1 transcription repressor complex.\r\n",
      "DR   ComplexPortal; CPX-1971; E2F1-DP1 transcription factor complex.\r\n",
      "DR   CORUM; Q01094; -.\r\n",
      "DR   DIP; DIP-24227N; -.\r\n",
      "DR   ELM; Q01094; -.\r\n",
      "DR   IntAct; Q01094; 65.\r\n",
      "DR   MINT; Q01094; -.\r\n",
      "DR   STRING; 9606.ENSP00000345571; -.\r\n",
      "DR   ChEMBL; CHEMBL4382; -.\r\n",
      "DR   iPTMnet; Q01094; -.\r\n",
      "DR   PhosphoSitePlus; Q01094; -.\r\n",
      "DR   BioMuta; E2F1; -.\r\n",
      "DR   DMDM; 400928; -.\r\n",
      "DR   MassIVE; Q01094; -.\r\n",
      "DR   MaxQB; Q01094; -.\r\n",
      "DR   PaxDb; Q01094; -.\r\n",
      "DR   PeptideAtlas; Q01094; -.\r\n",
      "DR   ProteomicsDB; 57915; -.\r\n",
      "DR   Antibodypedia; 3771; 1472 antibodies from 48 providers.\r\n",
      "DR   DNASU; 1869; -.\r\n",
      "DR   Ensembl; ENST00000343380.6; ENSP00000345571.5; ENSG00000101412.13.\r\n",
      "DR   GeneID; 1869; -.\r\n",
      "DR   KEGG; hsa:1869; -.\r\n",
      "DR   MANE-Select; ENST00000343380.6; ENSP00000345571.5; NM_005225.3; NP_005216.1.\r\n",
      "DR   UCSC; uc002wzu.5; human.\r\n",
      "DR   AGR; HGNC:3113; -.\r\n",
      "DR   CTD; 1869; -.\r\n",
      "DR   DisGeNET; 1869; -.\r\n",
      "DR   GeneCards; E2F1; -.\r\n",
      "DR   HGNC; HGNC:3113; E2F1.\r\n",
      "DR   HPA; ENSG00000101412; Tissue enhanced (bone).\r\n",
      "DR   MIM; 189971; gene.\r\n",
      "DR   neXtProt; NX_Q01094; -.\r\n",
      "DR   OpenTargets; ENSG00000101412; -.\r\n",
      "DR   PharmGKB; PA152; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000101412; -.\r\n",
      "DR   eggNOG; KOG2577; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00940000159472; -.\r\n",
      "DR   HOGENOM; CLU_032091_0_1_1; -.\r\n",
      "DR   InParanoid; Q01094; -.\r\n",
      "DR   OMA; HVMEQQI; -.\r\n",
      "DR   OrthoDB; 1761at2759; -.\r\n",
      "DR   PhylomeDB; Q01094; -.\r\n",
      "DR   TreeFam; TF105566; -.\r\n",
      "DR   PathwayCommons; Q01094; -.\r\n",
      "DR   Reactome; R-HSA-111448; Activation of NOXA and translocation to mitochondria.\r\n",
      "DR   Reactome; R-HSA-113501; Inhibition of replication initiation of damaged DNA by RB1/E2F1.\r\n",
      "DR   Reactome; R-HSA-1362277; Transcription of E2F targets under negative control by DREAM complex.\r\n",
      "DR   Reactome; R-HSA-1362300; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1.\r\n",
      "DR   Reactome; R-HSA-139915; Activation of PUMA and translocation to mitochondria.\r\n",
      "DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.\r\n",
      "DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.\r\n",
      "DR   Reactome; R-HSA-2559585; Oncogene Induced Senescence.\r\n",
      "DR   Reactome; R-HSA-6804116; TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest.\r\n",
      "DR   Reactome; R-HSA-68911; G2 Phase.\r\n",
      "DR   Reactome; R-HSA-69202; Cyclin E associated events during G1/S transition.\r\n",
      "DR   Reactome; R-HSA-69205; G1/S-Specific Transcription.\r\n",
      "DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.\r\n",
      "DR   Reactome; R-HSA-69656; Cyclin A:Cdk2-associated events at S phase entry.\r\n",
      "DR   Reactome; R-HSA-8953750; Transcriptional Regulation by E2F6.\r\n",
      "DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.\r\n",
      "DR   Reactome; R-HSA-9661069; Defective binding of RB1 mutants to E2F1,(E2F2, E2F3).\r\n",
      "DR   SignaLink; Q01094; -.\r\n",
      "DR   SIGNOR; Q01094; -.\r\n",
      "DR   BioGRID-ORCS; 1869; 91 hits in 1191 CRISPR screens.\r\n",
      "DR   ChiTaRS; E2F1; human.\r\n",
      "DR   EvolutionaryTrace; Q01094; -.\r\n",
      "DR   GeneWiki; E2F1; -.\r\n",
      "DR   GenomeRNAi; 1869; -.\r\n",
      "DR   Pharos; Q01094; Tbio.\r\n",
      "DR   PRO; PR:Q01094; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 20.\r\n",
      "DR   RNAct; Q01094; protein.\r\n",
      "DR   Bgee; ENSG00000101412; Expressed in ganglionic eminence and 150 other tissues.\r\n",
      "DR   Genevisible; Q01094; HS.\r\n",
      "DR   GO; GO:0005813; C:centrosome; IDA:HPA.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IDA:BHF-UCL.\r\n",
      "DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.\r\n",
      "DR   GO; GO:0000228; C:nuclear chromosome; IEA:Ensembl.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; IDA:BHF-UCL.\r\n",
      "DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; IPI:ComplexPortal.\r\n",
      "DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0001216; F:DNA-binding transcription activator activity; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0060090; F:molecular adaptor activity; EXP:DisProt.\r\n",
      "DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.\r\n",
      "DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.\r\n",
      "DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.\r\n",
      "DR   GO; GO:0043276; P:anoikis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071398; P:cellular response to fatty acid; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.\r\n",
      "DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEA:Ensembl.\r\n",
      "DR   GO; GO:0000077; P:DNA damage checkpoint signaling; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0006351; P:DNA-templated transcription; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IEA:Ensembl.\r\n",
      "DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IMP:UniProtKB.\r\n",
      "DR   GO; GO:1990086; P:lens fiber cell apoptotic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:0048255; P:mRNA stabilization; IDA:BHF-UCL.\r\n",
      "DR   GO; GO:0043392; P:negative regulation of DNA binding; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IDA:ComplexPortal.\r\n",
      "DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0070345; P:negative regulation of fat cell proliferation; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:BHF-UCL.\r\n",
      "DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:BHF-UCL.\r\n",
      "DR   GO; GO:0060252; P:positive regulation of glial cell proliferation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IDA:UniProtKB.\r\n",
      "DR   GO; GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.\r\n",
      "DR   GO; GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; IDA:ComplexPortal.\r\n",
      "DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.\r\n",
      "DR   CDD; cd14660; E2F_DD; 1.\r\n",
      "DR   DisProt; DP01427; -.\r\n",
      "DR   Gene3D; 6.10.250.540; -; 1.\r\n",
      "DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.\r\n",
      "DR   IDEAL; IID00064; -.\r\n",
      "DR   InterPro; IPR015633; E2F.\r\n",
      "DR   InterPro; IPR037241; E2F-DP_heterodim.\r\n",
      "DR   InterPro; IPR032198; E2F_CC-MB.\r\n",
      "DR   InterPro; IPR003316; E2F_WHTH_DNA-bd_dom.\r\n",
      "DR   InterPro; IPR036388; WH-like_DNA-bd_sf.\r\n",
      "DR   InterPro; IPR036390; WH_DNA-bd_sf.\r\n",
      "DR   PANTHER; PTHR12081; TRANSCRIPTION FACTOR E2F; 1.\r\n",
      "DR   PANTHER; PTHR12081:SF43; TRANSCRIPTION FACTOR E2F1; 1.\r\n",
      "DR   Pfam; PF16421; E2F_CC-MB; 1.\r\n",
      "DR   Pfam; PF02319; E2F_TDP; 1.\r\n",
      "DR   SMART; SM01372; E2F_TDP; 1.\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DR   SUPFAM; SSF144074; E2F-DP heterodimerization region; 1.\r\n",
      "DR   SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Acetylation; Activator; Apoptosis; Cell cycle; DNA-binding;\r\n",
      "KW   Host-virus interaction; Methylation; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Transcription; Transcription regulation;\r\n",
      "KW   Ubl conjugation.\r\n",
      "FT   CHAIN           1..437\r\n",
      "FT                   /note=\"Transcription factor E2F1\"\r\n",
      "FT                   /id=\"PRO_0000219461\"\r\n",
      "FT   DNA_BIND        110..194\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   REGION          42..87\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          67..108\r\n",
      "FT                   /note=\"Cyclin A:CDK2 binding\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8033208\"\r\n",
      "FT   REGION          89..191\r\n",
      "FT                   /note=\"Interaction with BIRC2/c-IAP1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:21653699\"\r\n",
      "FT   REGION          101..128\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          153..174\r\n",
      "FT                   /note=\"Leucine-zipper\"\r\n",
      "FT   REGION          192..382\r\n",
      "FT                   /note=\"Required for interaction with TRIM28\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:17704056\"\r\n",
      "FT   REGION          195..284\r\n",
      "FT                   /note=\"Dimerization\"\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   REGION          300..349\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          368..437\r\n",
      "FT                   /note=\"Transactivation\"\r\n",
      "FT   REGION          409..426\r\n",
      "FT                   /note=\"RB1 binding\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:12598654\"\r\n",
      "FT   MOTIF           158..194\r\n",
      "FT                   /note=\"DEF box\"\r\n",
      "FT   MOD_RES         117\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10675335\"\r\n",
      "FT   MOD_RES         120\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10675335\"\r\n",
      "FT   MOD_RES         125\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10675335\"\r\n",
      "FT   MOD_RES         185\r\n",
      "FT                   /note=\"N6-methyllysine; by SETD7\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20603083\"\r\n",
      "FT   MOD_RES         364\r\n",
      "FT                   /note=\"Phosphoserine; by CHEK2\"\r\n",
      "FT                   /evidence=\"ECO:0000305|PubMed:12717439\"\r\n",
      "FT   MOD_RES         375\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332\"\r\n",
      "FT   MOD_RES         403\r\n",
      "FT                   /note=\"Phosphoserine; by GSK3-beta\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:17050006,\r\n",
      "FT                   ECO:0000269|PubMed:28992046\"\r\n",
      "FT   MOD_RES         433\r\n",
      "FT                   /note=\"Phosphothreonine; by GSK3-beta\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:17050006\"\r\n",
      "FT   VARIANT         200\r\n",
      "FT                   /note=\"G -> S (in dbSNP:rs35385772)\"\r\n",
      "FT                   /id=\"VAR_048907\"\r\n",
      "FT   VARIANT         252\r\n",
      "FT                   /note=\"R -> H (in dbSNP:rs3213172)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|Ref.5\"\r\n",
      "FT                   /id=\"VAR_013607\"\r\n",
      "FT   VARIANT         276\r\n",
      "FT                   /note=\"V -> M (in dbSNP:rs3213173)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|Ref.5\"\r\n",
      "FT                   /id=\"VAR_013608\"\r\n",
      "FT   VARIANT         311\r\n",
      "FT                   /note=\"T -> N (in dbSNP:rs3213174)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|Ref.5\"\r\n",
      "FT                   /id=\"VAR_013609\"\r\n",
      "FT   VARIANT         393\r\n",
      "FT                   /note=\"G -> S (in dbSNP:rs3213176)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|Ref.5\"\r\n",
      "FT                   /id=\"VAR_013610\"\r\n",
      "FT   MUTAGEN         117\r\n",
      "FT                   /note=\"K->R: Abolishes acetylation; when associated with\r\n",
      "FT                   R-120 and R-125.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10675335\"\r\n",
      "FT   MUTAGEN         120\r\n",
      "FT                   /note=\"K->R: Abolishes acetylation; when associated with\r\n",
      "FT                   R-117 and R-125.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10675335\"\r\n",
      "FT   MUTAGEN         125\r\n",
      "FT                   /note=\"K->R: Abolishes acetylation; when associated with\r\n",
      "FT                   R-117 and R-120.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10675335\"\r\n",
      "FT   MUTAGEN         132\r\n",
      "FT                   /note=\"L->E: Abolishes interaction with and repression of\r\n",
      "FT                   CEBPA and inhibition of adipogenesis.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20176812\"\r\n",
      "FT   MUTAGEN         185\r\n",
      "FT                   /note=\"K->R: Abrogates methylation by SETD7. Loss of\r\n",
      "FT                   interaction with L3MBTL3. Loss of ubiquitination by the\r\n",
      "FT                   CRL4-DCAF5 E3 ubiquitin ligase complex.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20603083,\r\n",
      "FT                   ECO:0000269|PubMed:29691401\"\r\n",
      "FT   MUTAGEN         364\r\n",
      "FT                   /note=\"S->A: Abrogates in vitro phosphorylation by CHEK2\r\n",
      "FT                   and CHEK2-dependent stabilization of E2F1 upon DNA damage.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:12717439\"\r\n",
      "FT   MUTAGEN         403\r\n",
      "FT                   /note=\"S->A: Decreased phosphorylation by GSK3B, leading to\r\n",
      "FT                   abolished interaction with USP11 and subsequent\r\n",
      "FT                   deubiquitination.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:17050006,\r\n",
      "FT                   ECO:0000269|PubMed:28992046\"\r\n",
      "FT   MUTAGEN         411\r\n",
      "FT                   /note=\"Y->C: No retinoblastoma protein binding. No effect\r\n",
      "FT                   on interaction with and repression of CEBPA.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20176812,\r\n",
      "FT                   ECO:0000269|PubMed:8413249\"\r\n",
      "FT   MUTAGEN         433\r\n",
      "FT                   /note=\"T->A: Decreased phosphorylation by GSK3B.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:17050006\"\r\n",
      "FT   CONFLICT        89..111\r\n",
      "FT                   /note=\"KRRLDLETDHQYLAESSGPARGR -> RTPGTPRRQRRLCPPRRPGRAPC\r\n",
      "FT                   (in Ref. 8; AAD14150)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        313\r\n",
      "FT                   /note=\"S -> Y (in Ref. 4; AAC50719)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        322\r\n",
      "FT                   /note=\"N -> T (in Ref. 4; AAC50719)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        329\r\n",
      "FT                   /note=\"T -> N (in Ref. 4; AAC50719)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   HELIX           202..236\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   HELIX           238..243\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   STRAND          245..247\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   HELIX           248..252\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   TURN            257..259\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   STRAND          260..266\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   STRAND          272..277\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   STRAND          282..287\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   STRAND          289..291\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   STRAND          294..296\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2AZE\"\r\n",
      "FT   HELIX           421..424\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:1O9K\"\r\n",
      "SQ   SEQUENCE   437 AA;  46920 MW;  003B3F654F0C60DF CRC64;\r\n",
      "     MALAGAPAGG PCAPALEALL GAGALRLLDS SQIVIISAAQ DASAPPAPTG PAAPAAGPCD\r\n",
      "     PDLLLFATPQ APRPTPSAPR PALGRPPVKR RLDLETDHQY LAESSGPARG RGRHPGKGVK\r\n",
      "     SPGEKSRYET SLNLTTKRFL ELLSHSADGV VDLNWAAEVL KVQKRRIYDI TNVLEGIQLI\r\n",
      "     AKKSKNHIQW LGSHTTVGVG GRLEGLTQDL RQLQESEQQL DHLMNICTTQ LRLLSEDTDS\r\n",
      "     QRLAYVTCQD LRSIADPAEQ MVMVIKAPPE TQLQAVDSSE NFQISLKSKQ GPIDVFLCPE\r\n",
      "     ETVGGISPGK TPSQEVTSEE ENRATDSATI VSPPPSSPPS SLTTDPSQSL LSLEQEPLLS\r\n",
      "     RMGSLRAPVD EDRLSPLVAA DSLLEHVRED FSGLLPEEFI SLSPPHEALD YHFGLEEGEG\r\n",
      "     IRDLFDCDFG DLTPLDF\r\n",
      "//\r\n",
      "ID   UBR4_HUMAN              Reviewed;        5183 AA.\r\n",
      "AC   Q5T4S7; A8MPT2; A8MQ33; A8MQB1; O60646; O75050; Q4QRK5; Q5T4S8; Q5T4S9;\r\n",
      "AC   Q5TBN8; Q5TBP2; Q6DKH8; Q6P4A4; Q7L8P7; Q8IXJ4; Q8TDN5; Q8WV67; Q9HA46;\r\n",
      "AC   Q9P2N9; Q9UG82;\r\n",
      "DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   21-DEC-2004, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 172.\r\n",
      "DE   RecName: Full=E3 ubiquitin-protein ligase UBR4;\r\n",
      "DE            EC=2.3.2.27;\r\n",
      "DE   AltName: Full=600 kDa retinoblastoma protein-associated factor;\r\n",
      "DE   AltName: Full=N-recognin-4;\r\n",
      "DE   AltName: Full=RING-type E3 ubiquitin transferase UBR4;\r\n",
      "DE   AltName: Full=Retinoblastoma-associated factor of 600 kDa;\r\n",
      "DE            Short=RBAF600;\r\n",
      "DE            Short=p600;\r\n",
      "DE   AltName: Full=Zinc finger UBR1-type protein 1;\r\n",
      "GN   Name=UBR4; Synonyms=KIAA0462, KIAA1307, RBAF600, ZUBR1;\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH RB1 AND CALM,\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND FUNCTION.\r\n",
      "RX   PubMed=16214886; DOI=10.1073/pnas.0507458102;\r\n",
      "RA   Nakatani Y., Konishi H., Vassilev A., Kurooka H., Ishiguro K., Sawada J.,\r\n",
      "RA   Ikura T., Korsmeyer S.J., Qin J., Herlitz A.M.;\r\n",
      "RT   \"p600, a unique protein required for membrane morphogenesis and cell\r\n",
      "RT   survival.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 102:15093-15098(2005).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).\r\n",
      "RC   TISSUE=Mammary gland;\r\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\r\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\r\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\r\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\r\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\r\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\r\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\r\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\r\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\r\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\r\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\r\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\r\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\r\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\r\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\r\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\r\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\r\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\r\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\r\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\r\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\r\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\r\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\r\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\r\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\r\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\r\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\r\n",
      "RA   Isogai T., Sugano S.;\r\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\r\n",
      "RT   cDNAs.\";\r\n",
      "RL   Nat. Genet. 36:40-45(2004).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RX   PubMed=16710414; DOI=10.1038/nature04727;\r\n",
      "RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,\r\n",
      "RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,\r\n",
      "RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,\r\n",
      "RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,\r\n",
      "RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,\r\n",
      "RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,\r\n",
      "RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,\r\n",
      "RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,\r\n",
      "RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,\r\n",
      "RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,\r\n",
      "RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,\r\n",
      "RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,\r\n",
      "RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,\r\n",
      "RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,\r\n",
      "RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,\r\n",
      "RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,\r\n",
      "RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,\r\n",
      "RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,\r\n",
      "RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,\r\n",
      "RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,\r\n",
      "RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,\r\n",
      "RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,\r\n",
      "RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,\r\n",
      "RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,\r\n",
      "RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,\r\n",
      "RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,\r\n",
      "RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,\r\n",
      "RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,\r\n",
      "RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;\r\n",
      "RT   \"The DNA sequence and biological annotation of human chromosome 1.\";\r\n",
      "RL   Nature 441:315-321(2006).\r\n",
      "RN   [4]\r\n",
      "RP   PROTEIN SEQUENCE OF 166-185; 435-443; 850-857; 921-931; 1065-1079;\r\n",
      "RP   1131-1141; 1175-1192; 1195-1208; 1286-1293; 1337-1349; 1434-1440;\r\n",
      "RP   1464-1470; 1478-1489; 1731-1757; 1838-1850; 1875-1886; 1909-1918;\r\n",
      "RP   1921-1931; 2048-2058; 2131-2138; 2211-2218; 2354-2381; 2527-2536;\r\n",
      "RP   2564-2572; 2713-2721; 2981-2989; 3046-3065; 3229-3238; 3243-3252;\r\n",
      "RP   3589-3606; 3618-3628; 3735-3745; 3809-3816; 3827-3836; 3845-3857;\r\n",
      "RP   3889-3915; 4131-4142; 4204-4215; 4320-4334; 4414-4426; 4608-4637;\r\n",
      "RP   4686-4696; 4717-4724; 4803-4814; 4852-4860; 5013-5022 AND 5062-5069,\r\n",
      "RP   PHOSPHORYLATION AT SER-2719, AND IDENTIFICATION BY MASS SPECTROMETRY.\r\n",
      "RC   TISSUE=Hepatoma;\r\n",
      "RA   Bienvenut W.V., Boldt K., von Kriegsheim A.F., Kolch W.;\r\n",
      "RL   Submitted (JUL-2007) to UniProtKB.\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 779-5183 (ISOFORM 5).\r\n",
      "RC   TISSUE=Brain;\r\n",
      "RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;\r\n",
      "RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;\r\n",
      "RT   \"Prediction of the coding sequences of unidentified human genes. XVI. The\r\n",
      "RT   complete sequences of 150 new cDNA clones from brain which code for large\r\n",
      "RT   proteins in vitro.\";\r\n",
      "RL   DNA Res. 7:65-73(2000).\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2908-5183 (ISOFORM 1).\r\n",
      "RC   TISSUE=Brain;\r\n",
      "RX   PubMed=9455484; DOI=10.1093/dnares/4.5.345;\r\n",
      "RA   Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D.,\r\n",
      "RA   Nomura N., Ohara O.;\r\n",
      "RT   \"Characterization of cDNA clones in size-fractionated cDNA libraries from\r\n",
      "RT   human brain.\";\r\n",
      "RL   DNA Res. 4:345-349(1997).\r\n",
      "RN   [7]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4385-5183 (ISOFORMS 1 AND 2), AND\r\n",
      "RP   VARIANT LEU-4867.\r\n",
      "RC   TISSUE=Kidney, Liver, Lung, and Spleen;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [8]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4583-5183 (ISOFORM 1), AND VARIANTS LEU-4867\r\n",
      "RP   AND ARG-4924.\r\n",
      "RX   PubMed=16247014; DOI=10.1073/pnas.0500090102;\r\n",
      "RA   Lennerz V., Fatho M., Gentilini C., Frye R.A., Lifke A., Ferel D.,\r\n",
      "RA   Woelfel C., Huber C., Woelfel T.;\r\n",
      "RT   \"The response of autologous T cells to a human melanoma is dominated by\r\n",
      "RT   mutated neoantigens.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 102:16013-16018(2005).\r\n",
      "RN   [9]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4686-5183 (ISOFORM 1).\r\n",
      "RC   TISSUE=Brain;\r\n",
      "RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;\r\n",
      "RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,\r\n",
      "RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,\r\n",
      "RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,\r\n",
      "RA   Wiemann S., Schupp I.;\r\n",
      "RT   \"The full-ORF clone resource of the German cDNA consortium.\";\r\n",
      "RL   BMC Genomics 8:399-399(2007).\r\n",
      "RN   [10]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4709-5183 (ISOFORM 1), AND\r\n",
      "RP   VARIANT LEU-4867.\r\n",
      "RC   TISSUE=Brain;\r\n",
      "RA   Yu W., Gibbs R.A.;\r\n",
      "RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [11]\r\n",
      "RP   INTERACTION WITH HPV-16 E7; HPV-6B E7 AND HPV-11 E7 (MICROBIAL INFECTION),\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=16061792; DOI=10.1073/pnas.0505337102;\r\n",
      "RA   Huh K.-W., DeMasi J., Ogawa H., Nakatani Y., Howley P.M., Muenger K.;\r\n",
      "RT   \"Association of the human papillomavirus type 16 E7 oncoprotein with the\r\n",
      "RT   600-kDa retinoblastoma protein-associated factor, p600.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 102:11492-11497(2005).\r\n",
      "RN   [12]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;\r\n",
      "RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,\r\n",
      "RA   Greff Z., Keri G., Stemmann O., Mann M.;\r\n",
      "RT   \"Kinase-selective enrichment enables quantitative phosphoproteomics of the\r\n",
      "RT   kinome across the cell cycle.\";\r\n",
      "RL   Mol. Cell 31:438-448(2008).\r\n",
      "RN   [13]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178; SER-181 AND THR-2715,\r\n",
      "RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;\r\n",
      "RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,\r\n",
      "RA   Elledge S.J., Gygi S.P.;\r\n",
      "RT   \"A quantitative atlas of mitotic phosphorylation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).\r\n",
      "RN   [14]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19413330; DOI=10.1021/ac9004309;\r\n",
      "RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;\r\n",
      "RT   \"Lys-N and trypsin cover complementary parts of the phosphoproteome in a\r\n",
      "RT   refined SCX-based approach.\";\r\n",
      "RL   Anal. Chem. 81:4493-4501(2009).\r\n",
      "RN   [15]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [16]\r\n",
      "RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1084, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19608861; DOI=10.1126/science.1175371;\r\n",
      "RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,\r\n",
      "RA   Olsen J.V., Mann M.;\r\n",
      "RT   \"Lysine acetylation targets protein complexes and co-regulates major\r\n",
      "RT   cellular functions.\";\r\n",
      "RL   Science 325:834-840(2009).\r\n",
      "RN   [17]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178; SER-181 AND SER-1763,\r\n",
      "RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;\r\n",
      "RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,\r\n",
      "RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;\r\n",
      "RT   \"Quantitative phosphoproteomics reveals widespread full phosphorylation\r\n",
      "RT   site occupancy during mitosis.\";\r\n",
      "RL   Sci. Signal. 3:RA3-RA3(2010).\r\n",
      "RN   [18]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;\r\n",
      "RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,\r\n",
      "RA   Bennett K.L., Superti-Furga G., Colinge J.;\r\n",
      "RT   \"Initial characterization of the human central proteome.\";\r\n",
      "RL   BMC Syst. Biol. 5:17-17(2011).\r\n",
      "RN   [19]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2719, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;\r\n",
      "RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,\r\n",
      "RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;\r\n",
      "RT   \"System-wide temporal characterization of the proteome and phosphoproteome\r\n",
      "RT   of human embryonic stem cell differentiation.\";\r\n",
      "RL   Sci. Signal. 4:RS3-RS3(2011).\r\n",
      "RN   [20]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178; SER-181; THR-905;\r\n",
      "RP   SER-1747; SER-1878; SER-1904; THR-2715 AND SER-2719, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [21]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=23932781; DOI=10.1016/j.molcel.2013.07.002;\r\n",
      "RA   Lin R., Tao R., Gao X., Li T., Zhou X., Guan K.L., Xiong Y., Lei Q.Y.;\r\n",
      "RT   \"Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and\r\n",
      "RT   tumor growth.\";\r\n",
      "RL   Mol. Cell 51:506-518(2013).\r\n",
      "RN   [22]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1647; SER-1652; THR-2944 AND\r\n",
      "RP   SER-2952, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;\r\n",
      "RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,\r\n",
      "RA   Ye M., Zou H.;\r\n",
      "RT   \"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteomics 96:253-262(2014).\r\n",
      "RN   [23]\r\n",
      "RP   INTERACTION WITH RIFT VALLEY FEVER VIRUS GLYCOPROTEIN N (MICROBIAL\r\n",
      "RP   INFECTION).\r\n",
      "RX   PubMed=35032865; DOI=10.1016/j.virol.2021.12.010;\r\n",
      "RA   Bracci N., de la Fuente C., Saleem S., Pinkham C., Narayanan A.,\r\n",
      "RA   Garcia-Sastre A., Balaraman V., Richt J.A., Wilson W., Kehn-Hall K.;\r\n",
      "RT   \"Rift Valley fever virus Gn V5-epitope tagged virus enables identification\r\n",
      "RT   of UBR4 as a Gn interacting protein that facilitates Rift Valley fever\r\n",
      "RT   virus production.\";\r\n",
      "RL   Virology 567:65-76(2022).\r\n",
      "RN   [24]\r\n",
      "RP   VARIANT [LARGE SCALE ANALYSIS] HIS-1394.\r\n",
      "RX   PubMed=16959974; DOI=10.1126/science.1133427;\r\n",
      "RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,\r\n",
      "RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,\r\n",
      "RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,\r\n",
      "RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,\r\n",
      "RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,\r\n",
      "RA   Velculescu V.E.;\r\n",
      "RT   \"The consensus coding sequences of human breast and colorectal cancers.\";\r\n",
      "RL   Science 314:268-274(2006).\r\n",
      "CC   -!- FUNCTION: E3 ubiquitin-protein ligase which is a component of the N-end\r\n",
      "CC       rule pathway. Recognizes and binds to proteins bearing specific N-\r\n",
      "CC       terminal residues that are destabilizing according to the N-end rule,\r\n",
      "CC       leading to their ubiquitination and subsequent degradation. Together\r\n",
      "CC       with clathrin, forms meshwork structures involved in membrane\r\n",
      "CC       morphogenesis and cytoskeletal organization. Regulates integrin-\r\n",
      "CC       mediated signaling. May play a role in activation of FAK in response to\r\n",
      "CC       cell-matrix interactions. Mediates ubiquitination of ACLY, leading to\r\n",
      "CC       its subsequent degradation. {ECO:0000269|PubMed:16214886,\r\n",
      "CC       ECO:0000269|PubMed:23932781}.\r\n",
      "CC   -!- CATALYTIC ACTIVITY:\r\n",
      "CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +\r\n",
      "CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-\r\n",
      "CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;\r\n",
      "CC         EC=2.3.2.27;\r\n",
      "CC   -!- PATHWAY: Protein modification; protein ubiquitination.\r\n",
      "CC   -!- SUBUNIT: Interacts with RB1 and calmodulin.\r\n",
      "CC       {ECO:0000269|PubMed:16214886}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with protein E7 from papilloma\r\n",
      "CC       virus HPV-16, HPV-6B and HPV-11. {ECO:0000269|PubMed:16061792}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with Rift valley fever virus\r\n",
      "CC       glycoprotein N; this interaction is important for viral RNA production.\r\n",
      "CC       {ECO:0000269|PubMed:35032865}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q5T4S7; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-1995940, EBI-5235340;\r\n",
      "CC       Q5T4S7; Q93009: USP7; NbExp=2; IntAct=EBI-1995940, EBI-302474;\r\n",
      "CC       Q5T4S7; P03129: E7; Xeno; NbExp=5; IntAct=EBI-1995940, EBI-866453;\r\n",
      "CC       Q5T4S7; P04020: E7; Xeno; NbExp=2; IntAct=EBI-1995940, EBI-7005254;\r\n",
      "CC       Q5T4S7; P06464: E7; Xeno; NbExp=2; IntAct=EBI-1995940, EBI-6944797;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane\r\n",
      "CC       protein {ECO:0000305}. Cytoplasm. Cytoplasm, cytoskeleton. Nucleus.\r\n",
      "CC       Note=Concentrates at the leading edge of membrane structures involved\r\n",
      "CC       in actin motility.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=6;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=Q5T4S7-1; Sequence=Displayed;\r\n",
      "CC       Name=2;\r\n",
      "CC         IsoId=Q5T4S7-2; Sequence=VSP_025209;\r\n",
      "CC       Name=3;\r\n",
      "CC         IsoId=Q5T4S7-3; Sequence=VSP_025203, VSP_025206;\r\n",
      "CC       Name=4;\r\n",
      "CC         IsoId=Q5T4S7-4; Sequence=VSP_025205, VSP_025206;\r\n",
      "CC       Name=5;\r\n",
      "CC         IsoId=Q5T4S7-5; Sequence=VSP_025201, VSP_025202, VSP_025204;\r\n",
      "CC       Name=6;\r\n",
      "CC         IsoId=Q5T4S7-6; Sequence=VSP_025200, VSP_025207, VSP_025208;\r\n",
      "CC   -!- SIMILARITY: Belongs to the UBR4 family. {ECO:0000305}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=CAD43719.1; Type=Erroneous initiation; Evidence={ECO:0000305};\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AF348492; AAL83880.1; -; mRNA.\r\n",
      "DR   EMBL; AK022322; BAB14011.1; -; mRNA.\r\n",
      "DR   EMBL; AL137127; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AL357564; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AB037728; BAA92545.1; -; mRNA.\r\n",
      "DR   EMBL; AB007931; BAA32307.1; -; mRNA.\r\n",
      "DR   EMBL; BC018694; AAH18694.2; -; mRNA.\r\n",
      "DR   EMBL; BC063573; AAH63573.1; -; mRNA.\r\n",
      "DR   EMBL; BC073905; AAH73905.1; -; mRNA.\r\n",
      "DR   EMBL; BC096758; AAH96758.1; -; mRNA.\r\n",
      "DR   EMBL; AJ505016; CAD43719.1; ALT_INIT; mRNA.\r\n",
      "DR   EMBL; AL049972; CAB43227.1; -; mRNA.\r\n",
      "DR   EMBL; AF055010; AAC09360.1; -; mRNA.\r\n",
      "DR   CCDS; CCDS189.1; -. [Q5T4S7-1]\r\n",
      "DR   PIR; T00076; T00076.\r\n",
      "DR   RefSeq; NP_065816.2; NM_020765.2. [Q5T4S7-1]\r\n",
      "DR   BioGRID; 116934; 299.\r\n",
      "DR   CORUM; Q5T4S7; -.\r\n",
      "DR   IntAct; Q5T4S7; 121.\r\n",
      "DR   MINT; Q5T4S7; -.\r\n",
      "DR   STRING; 9606.ENSP00000364403; -.\r\n",
      "DR   ChEMBL; CHEMBL4295851; -.\r\n",
      "DR   DrugBank; DB05483; Picolinic acid.\r\n",
      "DR   DrugBank; DB04959; Verpasep caltespen.\r\n",
      "DR   CarbonylDB; Q5T4S7; -.\r\n",
      "DR   GlyCosmos; Q5T4S7; 2 sites, 2 glycans.\r\n",
      "DR   GlyGen; Q5T4S7; 4 sites, 2 O-linked glycans (4 sites).\r\n",
      "DR   iPTMnet; Q5T4S7; -.\r\n",
      "DR   MetOSite; Q5T4S7; -.\r\n",
      "DR   PhosphoSitePlus; Q5T4S7; -.\r\n",
      "DR   SwissPalm; Q5T4S7; -.\r\n",
      "DR   BioMuta; UBR4; -.\r\n",
      "DR   DMDM; 74744979; -.\r\n",
      "DR   EPD; Q5T4S7; -.\r\n",
      "DR   jPOST; Q5T4S7; -.\r\n",
      "DR   MassIVE; Q5T4S7; -.\r\n",
      "DR   MaxQB; Q5T4S7; -.\r\n",
      "DR   PaxDb; Q5T4S7; -.\r\n",
      "DR   PeptideAtlas; Q5T4S7; -.\r\n",
      "DR   ProteomicsDB; 64480; -. [Q5T4S7-1]\r\n",
      "DR   ProteomicsDB; 64481; -. [Q5T4S7-2]\r\n",
      "DR   ProteomicsDB; 64482; -. [Q5T4S7-3]\r\n",
      "DR   ProteomicsDB; 64483; -. [Q5T4S7-4]\r\n",
      "DR   ProteomicsDB; 64484; -. [Q5T4S7-5]\r\n",
      "DR   ProteomicsDB; 64485; -. [Q5T4S7-6]\r\n",
      "DR   Antibodypedia; 2856; 124 antibodies from 28 providers.\r\n",
      "DR   DNASU; 23352; -.\r\n",
      "DR   Ensembl; ENST00000375218.3; ENSP00000364366.3; ENSG00000127481.15. [Q5T4S7-6]\r\n",
      "DR   Ensembl; ENST00000375254.8; ENSP00000364403.3; ENSG00000127481.15. [Q5T4S7-1]\r\n",
      "DR   GeneID; 23352; -.\r\n",
      "DR   KEGG; hsa:23352; -.\r\n",
      "DR   MANE-Select; ENST00000375254.8; ENSP00000364403.3; NM_020765.3; NP_065816.2.\r\n",
      "DR   UCSC; uc001bbi.4; human. [Q5T4S7-1]\r\n",
      "DR   AGR; HGNC:30313; -.\r\n",
      "DR   CTD; 23352; -.\r\n",
      "DR   DisGeNET; 23352; -.\r\n",
      "DR   GeneCards; UBR4; -.\r\n",
      "DR   HGNC; HGNC:30313; UBR4.\r\n",
      "DR   HPA; ENSG00000127481; Low tissue specificity.\r\n",
      "DR   MIM; 609890; gene.\r\n",
      "DR   neXtProt; NX_Q5T4S7; -.\r\n",
      "DR   OpenTargets; ENSG00000127481; -.\r\n",
      "DR   PharmGKB; PA162407958; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000127481; -.\r\n",
      "DR   eggNOG; KOG1776; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00600000084471; -.\r\n",
      "DR   HOGENOM; CLU_000069_0_0_1; -.\r\n",
      "DR   InParanoid; Q5T4S7; -.\r\n",
      "DR   OMA; VHRMEEH; -.\r\n",
      "DR   OrthoDB; 10597at2759; -.\r\n",
      "DR   PhylomeDB; Q5T4S7; -.\r\n",
      "DR   TreeFam; TF314406; -.\r\n",
      "DR   PathwayCommons; Q5T4S7; -.\r\n",
      "DR   Reactome; R-HSA-6798695; Neutrophil degranulation.\r\n",
      "DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.\r\n",
      "DR   SignaLink; Q5T4S7; -.\r\n",
      "DR   UniPathway; UPA00143; -.\r\n",
      "DR   BioGRID-ORCS; 23352; 681 hits in 1220 CRISPR screens.\r\n",
      "DR   ChiTaRS; UBR4; human.\r\n",
      "DR   GeneWiki; UBR4; -.\r\n",
      "DR   GenomeRNAi; 23352; -.\r\n",
      "DR   Pharos; Q5T4S7; Tbio.\r\n",
      "DR   PRO; PR:Q5T4S7; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 1.\r\n",
      "DR   RNAct; Q5T4S7; protein.\r\n",
      "DR   Bgee; ENSG00000127481; Expressed in skin of leg and 101 other tissues.\r\n",
      "DR   ExpressionAtlas; Q5T4S7; baseline and differential.\r\n",
      "DR   Genevisible; Q5T4S7; HS.\r\n",
      "DR   GO; GO:0005813; C:centrosome; IDA:HPA.\r\n",
      "DR   GO; GO:0005829; C:cytosol; IDA:HPA.\r\n",
      "DR   GO; GO:0101003; C:ficolin-1-rich granule membrane; TAS:Reactome.\r\n",
      "DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.\r\n",
      "DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.\r\n",
      "DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.\r\n",
      "DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.\r\n",
      "DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IBA:GO_Central.\r\n",
      "DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.\r\n",
      "DR   GO; GO:0045717; P:negative regulation of fatty acid biosynthetic process; IDA:UniProt.\r\n",
      "DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.\r\n",
      "DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB.\r\n",
      "DR   CDD; cd19680; UBR-box_UBR4; 1.\r\n",
      "DR   InterPro; IPR016024; ARM-type_fold.\r\n",
      "DR   InterPro; IPR025704; E3_Ub_ligase_UBR4_C.\r\n",
      "DR   InterPro; IPR045841; E3_UBR4_N.\r\n",
      "DR   InterPro; IPR045189; UBR4-like.\r\n",
      "DR   InterPro; IPR047509; UBR4-like_UBR-box.\r\n",
      "DR   InterPro; IPR036322; WD40_repeat_dom_sf.\r\n",
      "DR   InterPro; IPR003126; Znf_UBR.\r\n",
      "DR   PANTHER; PTHR21725; E3 UBIQUITIN-PROTEIN LIGASE UBR4; 1.\r\n",
      "DR   PANTHER; PTHR21725:SF1; E3 UBIQUITIN-PROTEIN LIGASE UBR4; 1.\r\n",
      "DR   Pfam; PF13764; E3_UbLigase_R4; 1.\r\n",
      "DR   Pfam; PF19423; E3_UBR4_N; 1.\r\n",
      "DR   Pfam; PF02207; zf-UBR; 1.\r\n",
      "DR   SMART; SM00396; ZnF_UBR1; 1.\r\n",
      "DR   SUPFAM; SSF48371; ARM repeat; 2.\r\n",
      "DR   SUPFAM; SSF50978; WD40 repeat-like; 1.\r\n",
      "DR   PROSITE; PS51157; ZF_UBR; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Acetylation; Alternative splicing; Calmodulin-binding; Cytoplasm;\r\n",
      "KW   Cytoskeleton; Direct protein sequencing; Host-virus interaction; Membrane;\r\n",
      "KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Transferase;\r\n",
      "KW   Transmembrane; Transmembrane helix; Ubl conjugation pathway; Zinc;\r\n",
      "KW   Zinc-finger.\r\n",
      "FT   CHAIN           1..5183\r\n",
      "FT                   /note=\"E3 ubiquitin-protein ligase UBR4\"\r\n",
      "FT                   /id=\"PRO_0000286861\"\r\n",
      "FT   TRANSMEM        850..870\r\n",
      "FT                   /note=\"Helical\"\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   TRANSMEM        993..1013\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "FT                   /note=\"Helical\"\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   ZN_FING         1656..1729\r\n",
      "FT                   /note=\"UBR-type\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00508\"\r\n",
      "FT   REGION          1..26\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          549..588\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          601..638\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1756..1778\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          2430..2469\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          2711..2764\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          2833..2967\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          3342..3385\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        549..571\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        572..586\r\n",
      "FT                   /note=\"Acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        604..621\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        2444..2469\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        2833..2891\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        2929..2949\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        2950..2967\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        3342..3365\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        3366..3385\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         178\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         181\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         212\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:A2AN08\"\r\n",
      "FT   MOD_RES         370\r\n",
      "FT                   /note=\"Phosphotyrosine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:A2AN08\"\r\n",
      "FT   MOD_RES         905\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1084\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19608861\"\r\n",
      "FT   MOD_RES         1402\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q2TL32\"\r\n",
      "FT   MOD_RES         1647\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         1652\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         1747\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1754\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q2TL32\"\r\n",
      "FT   MOD_RES         1763\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         1878\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1904\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         2715\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         2719\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|Ref.4, ECO:0007744|PubMed:21406692,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         2722\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:A2AN08\"\r\n",
      "FT   MOD_RES         2724\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:A2AN08\"\r\n",
      "FT   MOD_RES         2944\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         2952\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:24275569\"\r\n",
      "FT   VAR_SEQ         1..3585\r\n",
      "FT                   /note=\"Missing (in isoform 6)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:14702039\"\r\n",
      "FT                   /id=\"VSP_025200\"\r\n",
      "FT   VAR_SEQ         2100\r\n",
      "FT                   /note=\"K -> KQ (in isoform 5)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:10718198\"\r\n",
      "FT                   /id=\"VSP_025201\"\r\n",
      "FT   VAR_SEQ         2405..2486\r\n",
      "FT                   /note=\"IGASVDPAGVTMIDAVKIYGKTKEQFGWPDEPPEEFPSASVSNICPSNLNQS\r\n",
      "FT                   NGTGDSDSAAPTTTSGTVLERLVVSSLEAL -> SESPTPGADSVLIVTAKLGATGLWL\r\n",
      "FT                   SNILGSLHSADFSVLSSGNFELHLMY (in isoform 5)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:10718198\"\r\n",
      "FT                   /id=\"VSP_025202\"\r\n",
      "FT   VAR_SEQ         2476\r\n",
      "FT                   /note=\"E -> ESSETESLTKLD (in isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT                   /id=\"VSP_025203\"\r\n",
      "FT   VAR_SEQ         2487..5183\r\n",
      "FT                   /note=\"Missing (in isoform 5)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:10718198\"\r\n",
      "FT                   /id=\"VSP_025204\"\r\n",
      "FT   VAR_SEQ         2601\r\n",
      "FT                   /note=\"T -> TDCFFPRCACWSLGIVGILIGAPLETPSP (in isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT                   /id=\"VSP_025205\"\r\n",
      "FT   VAR_SEQ         2830..2864\r\n",
      "FT                   /note=\"Missing (in isoform 3 and isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT                   /id=\"VSP_025206\"\r\n",
      "FT   VAR_SEQ         3777..3797\r\n",
      "FT                   /note=\"DDSGTAGGISSTSASVNRYIL -> VVPRCKGHLDKGLGLDQKTAS (in\r\n",
      "FT                   isoform 6)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:14702039\"\r\n",
      "FT                   /id=\"VSP_025207\"\r\n",
      "FT   VAR_SEQ         3798..5183\r\n",
      "FT                   /note=\"Missing (in isoform 6)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:14702039\"\r\n",
      "FT                   /id=\"VSP_025208\"\r\n",
      "FT   VAR_SEQ         5108\r\n",
      "FT                   /note=\"K -> KKQTTPTVGGIDTGSLEPCVCE (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_025209\"\r\n",
      "FT   VARIANT         1107\r\n",
      "FT                   /note=\"T -> A (in dbSNP:rs16862578)\"\r\n",
      "FT                   /id=\"VAR_032193\"\r\n",
      "FT   VARIANT         1394\r\n",
      "FT                   /note=\"R -> H (in a breast cancer sample; somatic mutation;\r\n",
      "FT                   dbSNP:rs756549939)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16959974\"\r\n",
      "FT                   /id=\"VAR_035540\"\r\n",
      "FT   VARIANT         4867\r\n",
      "FT                   /note=\"M -> L (in dbSNP:rs12584)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:15489334,\r\n",
      "FT                   ECO:0000269|PubMed:16247014, ECO:0000269|Ref.10\"\r\n",
      "FT                   /id=\"VAR_032194\"\r\n",
      "FT   VARIANT         4924\r\n",
      "FT                   /note=\"G -> R (in a melanoma patient)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16247014\"\r\n",
      "FT                   /id=\"VAR_032195\"\r\n",
      "FT   VARIANT         5084\r\n",
      "FT                   /note=\"V -> M (in dbSNP:rs2274010)\"\r\n",
      "FT                   /id=\"VAR_032196\"\r\n",
      "FT   CONFLICT        2016\r\n",
      "FT                   /note=\"A -> S (in Ref. 1; AAL83880)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        2410\r\n",
      "FT                   /note=\"D -> E (in Ref. 1; AAL83880)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        3957\r\n",
      "FT                   /note=\"G -> S (in Ref. 1; AAL83880)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        4589\r\n",
      "FT                   /note=\"G -> V (in Ref. 7; AAH18694)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   5183 AA;  573841 MW;  5F6DD7B565E27609 CRC64;\r\n",
      "     MATSGGEEAA AAAPAPGTPA TGADTTPGWE VAVRPLLSAS YSAFEMKELP QLVASVIESE\r\n",
      "     SEILHHEKQY EPFYSSFVAL STHYITTVCS LIPRNQLQSV AAACKVLIEF SLLRLENPDE\r\n",
      "     ACAVSQKHLI LLIKGLCTGC SRLDRTEIIT FTAMMKSAKL PQTVKTLSDV EDQKELASPV\r\n",
      "     SPELRQKEVQ MNFLNQLTSV FNPRTVASQP ISTQTLVEGE NDEQSSTDQA SAIKTKNVFI\r\n",
      "     AQNVASLQEL GGSEKLLRVC LNLPYFLRYI NRFQDAVLAN SFFIMPATVA DATAVRNGFH\r\n",
      "     SLVIDVTMAL DTLSLPVLEP LNPSRLQDVT VLSLSCLYAG VSVATCMAIL HVGSAQQVRT\r\n",
      "     GSTSSKEDDY ESDAATIVQK CLEIYDMIGQ AISSSRRAGG EHYQNFQLLG AWCLLNSLFL\r\n",
      "     ILNLSPTALA DKGKEKDPLA ALRVRDILSR TKEGVGSPKL GPGKGHQGFG VLSVILANHA\r\n",
      "     IKLLTSLFQD LQVEALHKGW ETDGPPAALS IMAQSTSIQR IQRLIDSVPL MNLLLTLLST\r\n",
      "     SYRKACVLQR QRKGSMSSDA SASTDSNTYY EDDFSSTEED SSQDDDSEPI LGQWFEETIS\r\n",
      "     PSKEKAAPPP PPPPPPLESS PRVKSPSKQA PGEKGNILAS RKDPELFLGL ASNILNFITS\r\n",
      "     SMLNSRNNFI RNYLSVSLSE HHMATLASII KEVDKDGLKG SSDEEFAAAL YHFNHSLVTS\r\n",
      "     DLQSPNLQNT LLQQLGVAPF SEGPWPLYIH PQSLSVLSRL LLIWQHKASA QGDPDVPECL\r\n",
      "     KVWDRFLSTM KQNALQGVVP SETEDLNVEH LQMLLLIFHN FTETGRRAIL SLFVQIIQEL\r\n",
      "     SVNMDAQMRF VPLILARLLL IFDYLLHQYS KAPVYLFEQV QHNLLSPPFG WASGSQDSNS\r\n",
      "     RRATTPLYHG FKEVEENWSK HFSSDAVPHP RFYCVLSPEA SEDDLNRLDS VACDVLFSKL\r\n",
      "     VKYDELYAAL TALLAAGSQL DTVRRKENKN VTALEACALQ YYFLILWRIL GILPPSKTYI\r\n",
      "     NQLSMNSPEM SECDILHTLR WSSRLRISSY VNWIKDHLIK QGMKAEHASS LLELASTTKC\r\n",
      "     SSVKYDVEIV EEYFARQISS FCSIDCTTIL QLHEIPSLQS IYTLDAAISK VQVSLDEHFS\r\n",
      "     KMAAETDPHK SSEITKNLLP ATLQLIDTYA SFTRAYLLQN FNEEGTTEKP SKEKLQGFAA\r\n",
      "     VLAIGSSRCK ANTLGPTLVQ NLPSSVQTVC ESWNNINTNE FPNIGSWRNA FANDTIPSES\r\n",
      "     YISAVQAAHL GTLCSQSLPL AASLKHTLLS LVRLTGDLIV WSDEMNPPQV IRTLLPLLLE\r\n",
      "     SSTESVAEIS SNSLERILGP AESDEFLARV YEKLITGCYN ILANHADPNS GLDESILEEC\r\n",
      "     LQYLEKQLES SQARKAMEEF FSDSGELVQI MMATANENLS AKFCNRVLKF FTKLFQLTEK\r\n",
      "     SPNPSLLHLC GSLAQLACVE PVRLQAWLTR MTTSPPKDSD QLDVIQENRQ LLQLLTTYIV\r\n",
      "     RENSQVGEGV CAVLLGTLTP MATEMLANGD GTGFPELMVV MATLASAGQG AGHLQLHNAA\r\n",
      "     VDWLSRCKKY LSQKNVVEKL NANVMHGKHV MILECTCHIM SYLADVTNAL SQSNGQGPSH\r\n",
      "     LSVDGEERAI EVDSDWVEEL AVEEEDSQAE DSDEDSLCNK LCTFTITQKE FMNQHWYHCH\r\n",
      "     TCKMVDGVGV CTVCAKVCHK DHEISYAKYG SFFCDCGAKE DGSCLALVKR TPSSGMSSTM\r\n",
      "     KESAFQSEPR ISESLVRHAS TSSPADKAKV TISDGKVADE EKPKKSSLCR TVEGCREELQ\r\n",
      "     NQANFSFAPL VLDMLNFLMD AIQTNFQQAS AVGSSSRAQQ ALSELHTVEK AVEMTDQLMV\r\n",
      "     PTLGSQEGAF ENVRMNYSGD QGQTIRQLIS AHVLRRVAMC VLSSPHGRRQ HLAVSHEKGK\r\n",
      "     ITVLQLSALL KQADSSKRKL TLTRLASAPV PFTVLSLTGN PCKEDYLAVC GLKDCHVLTF\r\n",
      "     SSSGSVSDHL VLHPQLATGN FIIKAVWLPG SQTELAIVTA DFVKIYDLCV DALSPTFYFL\r\n",
      "     LPSSKIRDVT FLFNEEGKNI IVIMSSAGYI YTQLMEEASS AQQGPFYVTN VLEINHEDLK\r\n",
      "     DSNSQVAGGG VSVYYSHVLQ MLFFSYCQGK SFAATISRTT LEVLQLFPIN IKSSNGGSKT\r\n",
      "     SPALCQWSEV MNHPGLVCCV QQTTGVPLVV MVKPDTFLIQ EIKTLPAKAK IQDMVAIRHT\r\n",
      "     ACNEQQRTTM ILLCEDGSLR IYMANVENTS YWLQPSLQPS SVISIMKPVR KRKTATITTR\r\n",
      "     TSSQVTFPID FFEHNQQLTD VEFGGNDLLQ VYNAQQIKHR LNSTGMYVAN TKPGGFTIEI\r\n",
      "     SNNNSTMVMT GMRIQIGTQA IERAPSYIEI FGRTMQLNLS RSRWFDFPFT REEALQADKK\r\n",
      "     LNLFIGASVD PAGVTMIDAV KIYGKTKEQF GWPDEPPEEF PSASVSNICP SNLNQSNGTG\r\n",
      "     DSDSAAPTTT SGTVLERLVV SSLEALESCF AVGPIIEKER NKNAAQELAT LLLSLPAPAS\r\n",
      "     VQQQSKSLLA SLHTSRSAYH SHKDQALLSK AVQCLNTSSK EGKDLDPEVF QRLVITARSI\r\n",
      "     AIMRPNNLVH FTESKLPQME TEGMDEGKEP QKQLEGDCCS FITQLVNHFW KLHASKPKNA\r\n",
      "     FLAPACLPGL THIEATVNAL VDIIHGYCTC ELDCINTASK IYMQMLLCPD PAVSFSCKQA\r\n",
      "     LIRVLRPRNK RRHVTLPSSP RSNTPMGDKD DDDDDDADEK MQSSGIPNGG HIRQESQEQS\r\n",
      "     EVDHGDFEMV SESMVLETAE NVNNGNPSPL EALLAGAEGF PPMLDIPPDA DDETMVELAI\r\n",
      "     ALSLQQDQQG SSSSALGLQS LGLSGQAPSS SSLDAGTLSD TTASAPASDD EGSTAATDGS\r\n",
      "     TLRTSPADHG GSVGSESGGS AVDSVAGEHS VSGRSSAYGD ATAEGHPAGP GSVSSSTGAI\r\n",
      "     STTTGHQEGD GSEGEGEGET EGDVHTSNRL HMVRLMLLER LLQTLPQLRN VGGVRAIPYM\r\n",
      "     QVILMLTTDL DGEDEKDKGA LDNLLSQLIA ELGMDKKDVS KKNERSALNE VHLVVMRLLS\r\n",
      "     VFMSRTKSGS KSSICESSSL ISSATAAALL SSGAVDYCLH VLKSLLEYWK SQQNDEEPVA\r\n",
      "     TSQLLKPHTT SSPPDMSPFF LRQYVKGHAA DVFEAYTQLL TEMVLRLPYQ IKKITDTNSR\r\n",
      "     IPPPVFDHSW FYFLSEYLMI QQTPFVRRQV RKLLLFICGS KEKYRQLRDL HTLDSHVRGI\r\n",
      "     KKLLEEQGIF LRASVVTASS GSALQYDTLI SLMEHLKACA EIAAQRTINW QKFCIKDDSV\r\n",
      "     LYFLLQVSFL VDEGVSPVLL QLLSCALCGS KVLAALAASS GSSSASSSSA PVAASSGQAT\r\n",
      "     TQSKSSTKKS KKEEKEKEKD GETSGSQEDQ LCTALVNQLN KFADKETLIQ FLRCFLLESN\r\n",
      "     SSSVRWQAHC LTLHIYRNSS KSQQELLLDL MWSIWPELPA YGRKAAQFVD LLGYFSLKTP\r\n",
      "     QTEKKLKEYS QKAVEILRTQ NHILTNHPNS NIYNTLSGLV EFDGYYLESD PCLVCNNPEV\r\n",
      "     PFCYIKLSSI KVDTRYTTTQ QVVKLIGSHT ISKVTVKIGD LKRTKMVRTI NLYYNNRTVQ\r\n",
      "     AIVELKNKPA RWHKAKKVQL TPGQTEVKID LPLPIVASNL MIEFADFYEN YQASTETLQC\r\n",
      "     PRCSASVPAN PGVCGNCGEN VYQCHKCRSI NYDEKDPFLC NACGFCKYAR FDFMLYAKPC\r\n",
      "     CAVDPIENEE DRKKAVSNIN TLLDKADRVY HQLMGHRPQL ENLLCKVNEA APEKPQDDSG\r\n",
      "     TAGGISSTSA SVNRYILQLA QEYCGDCKNS FDELSKIIQK VFASRKELLE YDLQQREAAT\r\n",
      "     KSSRTSVQPT FTASQYRALS VLGCGHTSST KCYGCASAVT EHCITLLRAL ATNPALRHIL\r\n",
      "     VSQGLIRELF DYNLRRGAAA MREEVRQLMC LLTRDNPEAT QQMNDLIIGK VSTALKGHWA\r\n",
      "     NPDLASSLQY EMLLLTDSIS KEDSCWELRL RCALSLFLMA VNIKTPVVVE NITLMCLRIL\r\n",
      "     QKLIKPPAPT SKKNKDVPVE ALTTVKPYCN EIHAQAQLWL KRDPKASYDA WKKCLPIRGI\r\n",
      "     DGNGKAPSKS ELRHLYLTEK YVWRWKQFLS RRGKRTSPLD LKLGHNNWLR QVLFTPATQA\r\n",
      "     ARQAACTIVE ALATIPSRKQ QVLDLLTSYL DELSIAGECA AEYLALYQKL ITSAHWKVYL\r\n",
      "     AARGVLPYVG NLITKEIARL LALEEATLST DLQQGYALKS LTGLLSSFVE VESIKRHFKS\r\n",
      "     RLVGTVLNGY LCLRKLVVQR TKLIDETQDM LLEMLEDMTT GTESETKAFM AVCIETAKRY\r\n",
      "     NLDDYRTPVF IFERLCSIIY PEENEVTEFF VTLEKDPQQE DFLQGRMPGN PYSSNEPGIG\r\n",
      "     PLMRDIKNKI CQDCDLVALL EDDSGMELLV NNKIISLDLP VAEVYKKVWC TTNEGEPMRI\r\n",
      "     VYRMRGLLGD ATEEFIESLD STTDEEEDEE EVYKMAGVMA QCGGLECMLN RLAGIRDFKQ\r\n",
      "     GRHLLTVLLK LFSYCVKVKV NRQQLVKLEM NTLNVMLGTL NLALVAEQES KDSGGAAVAE\r\n",
      "     QVLSIMEIIL DESNAEPLSE DKGNLLLTGD KDQLVMLLDQ INSTFVRSNP SVLQGLLRII\r\n",
      "     PYLSFGEVEK MQILVERFKP YCNFDKYDED HSGDDKVFLD CFCKIAAGIK NNSNGHQLKD\r\n",
      "     LILQKGITQN ALDYMKKHIP SAKNLDADIW KKFLSRPALP FILRLLRGLA IQHPGTQVLI\r\n",
      "     GTDSIPNLHK LEQVSSDEGI GTLAENLLEA LREHPDVNKK IDAARRETRA EKKRMAMAMR\r\n",
      "     QKALGTLGMT TNEKGQVVTK TALLKQMEEL IEEPGLTCCI CREGYKFQPT KVLGIYTFTK\r\n",
      "     RVALEEMENK PRKQQGYSTV SHFNIVHYDC HLAAVRLARG REEWESAALQ NANTKCNGLL\r\n",
      "     PVWGPHVPES AFATCLARHN TYLQECTGQR EPTYQLNIHD IKLLFLRFAM EQSFSADTGG\r\n",
      "     GGRESNIHLI PYIIHTVLYV LNTTRATSRE EKNLQGFLEQ PKEKWVESAF EVDGPYYFTV\r\n",
      "     LALHILPPEQ WRATRVEILR RLLVTSQARA VAPGGATRLT DKAVKDYSAY RSSLLFWALV\r\n",
      "     DLIYNMFKKV PTSNTEGGWS CSLAEYIRHN DMPIYEAADK ALKTFQEEFM PVETFSEFLD\r\n",
      "     VAGLLSEITD PESFLKDLLN SVP\r\n",
      "//\r\n",
      "ID   RB_MOUSE                Reviewed;         921 AA.\r\n",
      "AC   P13405; Q4VA62;\r\n",
      "DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   27-JUL-2011, sequence version 2.\r\n",
      "DT   03-MAY-2023, entry version 226.\r\n",
      "DE   RecName: Full=Retinoblastoma-associated protein;\r\n",
      "DE   AltName: Full=p110-RB1 {ECO:0000303|PubMed:8336704};\r\n",
      "DE   AltName: Full=pRb;\r\n",
      "DE            Short=Rb;\r\n",
      "DE   AltName: Full=pp105;\r\n",
      "GN   Name=Rb1; Synonyms=Rb-1;\r\n",
      "OS   Mus musculus (Mouse).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Mus; Mus.\r\n",
      "OX   NCBI_TaxID=10090;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=2671991; DOI=10.1073/pnas.86.17.6474;\r\n",
      "RA   Bernards R., Schackleford G.M., Gerber M.R., Horowitz J.M., Friend S.H.,\r\n",
      "RA   Schartl M., Bogenmann E., Rapaport J., McGee T., Dryja T.P., Weinberg R.A.;\r\n",
      "RT   \"Structure and expression of the murine retinoblastoma gene and\r\n",
      "RT   characterization of its encoded protein.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 86:6474-6478(1989).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RA   Wu J., Liao J.D.;\r\n",
      "RT   \"Sequencing of the full-length cDNA sequence of the murine retinoblastoma\r\n",
      "RT   gene.\";\r\n",
      "RL   Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\r\n",
      "RC   STRAIN=C57BL/6J; TISSUE=Brain;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [4]\r\n",
      "RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION OF THE NUCLEAR LOCALIZATION\r\n",
      "RP   SIGNAL, MUTAGENESIS OF 733-LYS--PRO-769; 769-PRO--ILE-872; 853-LYS--ARG-869\r\n",
      "RP   AND 866-LYS--ARG-869, INTERACTION WITH ADENOVIRUS E1A PROTEIN AND SV40\r\n",
      "RP   LARGE T ANTIGEN (MICROBIAL INFECTION), INTERACTION WITH E2F1, AND\r\n",
      "RP   PHOSPHORYLATION.\r\n",
      "RX   PubMed=8336704; DOI=10.1128/mcb.13.8.4588-4599.1993;\r\n",
      "RA   Zacksenhaus E., Bremner R., Phillips R.A., Gallie B.L.;\r\n",
      "RT   \"A bipartite nuclear localization signal in the retinoblastoma gene product\r\n",
      "RT   and its importance for biological activity.\";\r\n",
      "RL   Mol. Cell. Biol. 13:4588-4599(1993).\r\n",
      "RN   [5]\r\n",
      "RP   INTERACTION WITH DNMT1.\r\n",
      "RX   PubMed=10888886; DOI=10.1038/77124;\r\n",
      "RA   Robertson K.D., Ait-Si-Ali S., Yokochi T., Wade P.A., Jones P.L.,\r\n",
      "RA   Wolffe A.P.;\r\n",
      "RT   \"DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription\r\n",
      "RT   from E2F-responsive promoters.\";\r\n",
      "RL   Nat. Genet. 25:338-342(2000).\r\n",
      "RN   [6]\r\n",
      "RP   INTERACTION WITH E4F1.\r\n",
      "RX   PubMed=10869426; DOI=10.1073/pnas.130198397;\r\n",
      "RA   Fajas L., Paul C., Zugasti O., Le Cam L., Polanowska J., Fabbrizio E.,\r\n",
      "RA   Medema R., Vignais M.-L., Sardet C.;\r\n",
      "RT   \"pRB binds to and modulates the transrepressing activity of the E1A-\r\n",
      "RT   regulated transcription factor p120E4F.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 97:7738-7743(2000).\r\n",
      "RN   [7]\r\n",
      "RP   INTERACTION WITH USP4.\r\n",
      "RX   PubMed=11571651; DOI=10.1038/sj.onc.1204823;\r\n",
      "RA   Blanchette P., Gilchrist C.A., Baker R.T., Gray D.A.;\r\n",
      "RT   \"Association of UNP, a ubiquitin-specific protease, with the pocket\r\n",
      "RT   proteins pRb, p107 and p130.\";\r\n",
      "RL   Oncogene 20:5533-5537(2001).\r\n",
      "RN   [8]\r\n",
      "RP   TISSUE SPECIFICITY.\r\n",
      "RC   STRAIN=C57BL/6J; TISSUE=Skeletal muscle;\r\n",
      "RX   PubMed=12095676; DOI=10.1016/s0378-1119(02)00585-1;\r\n",
      "RA   Chano T., Ikegawa S., Saito-Ohara F., Inazawa J., Mabuchi A., Saeki Y.,\r\n",
      "RA   Okabe H.;\r\n",
      "RT   \"Isolation, characterization and mapping of the mouse and human RB1CC1\r\n",
      "RT   genes.\";\r\n",
      "RL   Gene 291:29-34(2002).\r\n",
      "RN   [9]\r\n",
      "RP   FUNCTION, AND INTERACTION WITH KMT5B AND KMT5C.\r\n",
      "RX   PubMed=15750587; DOI=10.1038/ncb1235;\r\n",
      "RA   Gonzalo S., Garcia-Cao M., Fraga M.F., Schotta G., Peters A.H.F.M.,\r\n",
      "RA   Cotter S.E., Eguia R., Dean D.C., Esteller M., Jenuwein T., Blasco M.A.;\r\n",
      "RT   \"Role of the RB1 family in stabilizing histone methylation at constitutive\r\n",
      "RT   heterochromatin.\";\r\n",
      "RL   Nat. Cell Biol. 7:420-428(2005).\r\n",
      "RN   [10]\r\n",
      "RP   INTERACTION WITH ATAD5.\r\n",
      "RX   PubMed=15983387; DOI=10.1073/pnas.0504222102;\r\n",
      "RA   Ishii H., Inageta T., Mimori K., Saito T., Sasaki H., Isobe M., Mori M.,\r\n",
      "RA   Croce C.M., Huebner K., Ozawa K., Furukawa Y.;\r\n",
      "RT   \"Frag1, a homolog of alternative replication factor C subunits, links\r\n",
      "RT   replication stress surveillance with apoptosis.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 102:9655-9660(2005).\r\n",
      "RN   [11]\r\n",
      "RP   INTERACTION WITH PRMT2.\r\n",
      "RX   PubMed=16616919; DOI=10.1016/j.yexcr.2006.03.001;\r\n",
      "RA   Yoshimoto T., Boehm M., Olive M., Crook M.F., San H., Langenickel T.,\r\n",
      "RA   Nabel E.G.;\r\n",
      "RT   \"The arginine methyltransferase PRMT2 binds RB and regulates E2F\r\n",
      "RT   function.\";\r\n",
      "RL   Exp. Cell Res. 312:2040-2053(2006).\r\n",
      "RN   [12]\r\n",
      "RP   FUNCTION, INTERACTION WITH KMT5B AND KMT5C, AND MUTAGENESIS OF ILE-746;\r\n",
      "RP   ASN-750 AND MET-754.\r\n",
      "RX   PubMed=16612004; DOI=10.1128/mcb.26.9.3659-3671.2006;\r\n",
      "RA   Isaac C.E., Francis S.M., Martens A.L., Julian L.M., Seifried L.A.,\r\n",
      "RA   Erdmann N., Binne U.K., Harrington L., Sicinski P., Berube N.G.,\r\n",
      "RA   Dyson N.J., Dick F.A.;\r\n",
      "RT   \"The retinoblastoma protein regulates pericentric heterochromatin.\";\r\n",
      "RL   Mol. Cell. Biol. 26:3659-3671(2006).\r\n",
      "RN   [13]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31; SER-243; THR-246;\r\n",
      "RP   THR-364; THR-367; SER-601; SER-605; SER-773; SER-800; SER-804; THR-814;\r\n",
      "RP   THR-819 AND SER-848, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE\r\n",
      "RP   ANALYSIS].\r\n",
      "RC   TISSUE=Kidney, Lung, Spleen, and Testis;\r\n",
      "RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;\r\n",
      "RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,\r\n",
      "RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;\r\n",
      "RT   \"A tissue-specific atlas of mouse protein phosphorylation and expression.\";\r\n",
      "RL   Cell 143:1174-1189(2010).\r\n",
      "RN   [14]\r\n",
      "RP   TISSUE SPECIFICITY, ACETYLATION, AND INTERACTION WITH E2F1; EP300 AND\r\n",
      "RP   KAT2B.\r\n",
      "RX   PubMed=20940255; DOI=10.1242/jcs.068924;\r\n",
      "RA   Pickard A., Wong P.P., McCance D.J.;\r\n",
      "RT   \"Acetylation of Rb by PCAF is required for nuclear localization and\r\n",
      "RT   keratinocyte differentiation.\";\r\n",
      "RL   J. Cell Sci. 123:3718-3726(2010).\r\n",
      "RN   [15]\r\n",
      "RP   CLEAVAGE OF INITIATOR METHIONINE, AND METHYLATION AT PRO-2.\r\n",
      "RX   PubMed=20668449; DOI=10.1038/nature09343;\r\n",
      "RA   Tooley C.E., Petkowski J.J., Muratore-Schroeder T.L., Balsbaugh J.L.,\r\n",
      "RA   Shabanowitz J., Sabat M., Minor W., Hunt D.F., Macara I.G.;\r\n",
      "RT   \"NRMT is an alpha-N-methyltransferase that methylates RCC1 and\r\n",
      "RT   retinoblastoma protein.\";\r\n",
      "RL   Nature 466:1125-1128(2010).\r\n",
      "CC   -!- FUNCTION: Tumor suppressor that is a key regulator of the G1/S\r\n",
      "CC       transition of the cell cycle (PubMed:8336704). The hypophosphorylated\r\n",
      "CC       form binds transcription regulators of the E2F family, preventing\r\n",
      "CC       transcription of E2F-responsive genes. Both physically blocks E2Fs\r\n",
      "CC       transactivating domain and recruits chromatin-modifying enzymes that\r\n",
      "CC       actively repress transcription. Cyclin and CDK-dependent\r\n",
      "CC       phosphorylation of RB1 induces its dissociation from E2Fs, thereby\r\n",
      "CC       activating transcription of E2F responsive genes and triggering entry\r\n",
      "CC       into S phase. RB1 also promotes the G0-G1 transition upon\r\n",
      "CC       phosphorylation and activation by CDK3/cyclin-C. Directly involved in\r\n",
      "CC       heterochromatin formation by maintaining overall chromatin structure\r\n",
      "CC       and, in particular, that of constitutive heterochromatin by stabilizing\r\n",
      "CC       histone methylation (PubMed:15750587). Recruits and targets histone\r\n",
      "CC       methyltransferases SUV39H1, KMT5B and KMT5C, leading to epigenetic\r\n",
      "CC       transcriptional repression. Controls histone H4 'Lys-20' trimethylation\r\n",
      "CC       (PubMed:16612004). Inhibits the intrinsic kinase activity of TAF1.\r\n",
      "CC       Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a\r\n",
      "CC       histone deacetylase (HDAC) complex to the c-FOS promoter. In resting\r\n",
      "CC       neurons, transcription of the c-FOS promoter is inhibited by BRG1-\r\n",
      "CC       dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon\r\n",
      "CC       calcium influx, RB1 is dephosphorylated by calcineurin, which leads to\r\n",
      "CC       release of the repressor complex (By similarity) (PubMed:15750587,\r\n",
      "CC       PubMed:16612004, PubMed:8336704). {ECO:0000250|UniProtKB:P06400,\r\n",
      "CC       ECO:0000250|UniProtKB:P33568, ECO:0000269|PubMed:15750587,\r\n",
      "CC       ECO:0000269|PubMed:16612004, ECO:0000269|PubMed:8336704}.\r\n",
      "CC   -!- SUBUNIT: The hypophosphorylated form interacts with and sequesters the\r\n",
      "CC       E2F1 transcription factor. Interacts with heterodimeric E2F/DP\r\n",
      "CC       transcription factor complexes containing TFDP1 and either E2F1/E2F,\r\n",
      "CC       E2F3, E2F4 or E2F5, or TFDP2 and E2F4 (PubMed:8336704,\r\n",
      "CC       PubMed:20940255). The unphosphorylated form interacts with EID1,\r\n",
      "CC       ARID3B, KDM5A, SUV39H1, MJD2A/JHDM3A and THOC1. Interacts with the N-\r\n",
      "CC       terminal domain of TAF1. Interacts with SNW1, ATAD5, AATF, DNMT1, LIN9,\r\n",
      "CC       LMNA, KMT5B, KMT5C, PELP1, UHRF2, TMPO-alpha and USP4. May interact\r\n",
      "CC       with NDC80. Interacts with GRIP1 and UBR4. Interacts with ARID4A and\r\n",
      "CC       KDM5B. Interacts with E4F1 and LIMD1. Interacts with SMARCA4/BRG1 and\r\n",
      "CC       HDAC1. Interacts with USP4. Interacts (when methylated at Lys-853) with\r\n",
      "CC       L3MBTL1. Binds to CDK1 and CDK2. Interacts with CHEK2; phosphorylates\r\n",
      "CC       RB1 (By similarity). Interacts with PRMT2. Interacts with CEBPA. P-TEFB\r\n",
      "CC       complex interacts with RB1; promotes phosphorylation of RB1 (By\r\n",
      "CC       similarity). Interacts with RBBP9; the interaction disrupts RB1 binding\r\n",
      "CC       to E2F1 (By similarity). Interacts with KAT2B/PCAF and EP300/P300\r\n",
      "CC       (PubMed:20940255). Interacts with PAX5 (By similarity).\r\n",
      "CC       {ECO:0000250|UniProtKB:P06400, ECO:0000250|UniProtKB:P33568,\r\n",
      "CC       ECO:0000269|PubMed:10869426, ECO:0000269|PubMed:10888886,\r\n",
      "CC       ECO:0000269|PubMed:11571651, ECO:0000269|PubMed:15750587,\r\n",
      "CC       ECO:0000269|PubMed:15983387, ECO:0000269|PubMed:16612004,\r\n",
      "CC       ECO:0000269|PubMed:16616919, ECO:0000269|PubMed:20940255,\r\n",
      "CC       ECO:0000269|PubMed:8336704}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with adenovirus E1a protein.\r\n",
      "CC       {ECO:0000269|PubMed:8336704}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with SV40 large T antigen.\r\n",
      "CC       {ECO:0000269|PubMed:8336704}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       P13405; Q155P7: Cenpf; NbExp=4; IntAct=EBI-971782, EBI-2211248;\r\n",
      "CC       P13405; Q80UP3: Dgkz; NbExp=2; IntAct=EBI-971782, EBI-971774;\r\n",
      "CC       P13405; P17679: Gata1; NbExp=3; IntAct=EBI-971782, EBI-3903251;\r\n",
      "CC       P13405; Q9R002: Ifi202; NbExp=7; IntAct=EBI-971782, EBI-3043899;\r\n",
      "CC       P13405; P24610: Pax3; NbExp=3; IntAct=EBI-971782, EBI-1208116;\r\n",
      "CC       P13405; P52946: Pdx1; NbExp=2; IntAct=EBI-971782, EBI-7128945;\r\n",
      "CC       P13405; Q3TKT4: Smarca4; NbExp=3; IntAct=EBI-971782, EBI-1210244;\r\n",
      "CC       P13405; Q61412: Vsx2; NbExp=2; IntAct=EBI-971782, EBI-1208174;\r\n",
      "CC       P13405; P15976: GATA1; Xeno; NbExp=2; IntAct=EBI-971782, EBI-3909284;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8336704}. Note=During\r\n",
      "CC       keratinocyte differentiation, acetylation by KAT2B/PCAF is required for\r\n",
      "CC       nuclear localization. {ECO:0000250|UniProtKB:P06400}.\r\n",
      "CC   -!- TISSUE SPECIFICITY: Expressed in the cell nuclei of renal tubules,\r\n",
      "CC       hepatocytes and skeletal muscles. Expressed in skin (at protein level)\r\n",
      "CC       (PubMed:20940255). {ECO:0000269|PubMed:12095676,\r\n",
      "CC       ECO:0000269|PubMed:20940255}.\r\n",
      "CC   -!- PTM: Phosphorylated (PubMed:8336704). Phosphorylated by CDK6 and CDK4,\r\n",
      "CC       and subsequently by CDK2 at Ser-561 in G1, thereby releasing E2F1 which\r\n",
      "CC       is then able to activate cell growth. Dephosphorylated at the late M\r\n",
      "CC       phase. Phosphorylation of threonine residues in domain C promotes\r\n",
      "CC       interaction between the C-terminal domain C and the Pocket domain, and\r\n",
      "CC       thereby inhibits interactions with heterodimeric E2F/DP transcription\r\n",
      "CC       factor complexes. Dephosphorylated at Ser-788 by calcineruin upon\r\n",
      "CC       calcium stimulation. CDK3/cyclin-C-mediated phosphorylation at Ser-800\r\n",
      "CC       and Ser-804 is required for G0-G1 transition (By similarity).\r\n",
      "CC       Phosphorylated by CDK1 and CDK2 upon TGFB1-mediated apoptosis (By\r\n",
      "CC       similarity). {ECO:0000250, ECO:0000269|PubMed:8336704}.\r\n",
      "CC   -!- PTM: Monomethylation at Lys-803 by SMYD2 enhances phosphorylation at\r\n",
      "CC       Ser-800 and Ser-804, and promotes cell cycle progression.\r\n",
      "CC       Monomethylation at Lys-853 by SMYD2 promotes interaction with L3MBTL1\r\n",
      "CC       (By similarity). N-terminus is methylated by METTL11A/NTM1.\r\n",
      "CC       {ECO:0000250, ECO:0000269|PubMed:20668449}.\r\n",
      "CC   -!- PTM: Acetylated in the skin (PubMed:20940255). Acetylation at Lys-866\r\n",
      "CC       and Lys-867 regulates subcellular localization during keratinocytes\r\n",
      "CC       differentiation (By similarity). {ECO:0000250|UniProtKB:P06400,\r\n",
      "CC       ECO:0000269|PubMed:20940255}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Retinoblastoma protein entry;\r\n",
      "CC       URL=\"https://en.wikipedia.org/wiki/Retinoblastoma_protein\";\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; M26391; AAA39964.1; -; mRNA.\r\n",
      "DR   EMBL; DQ400415; ABD72475.1; -; mRNA.\r\n",
      "DR   EMBL; BC096525; AAH96525.1; -; mRNA.\r\n",
      "DR   CCDS; CCDS27267.1; -.\r\n",
      "DR   PIR; A33718; A33718.\r\n",
      "DR   RefSeq; NP_033055.2; NM_009029.2.\r\n",
      "DR   AlphaFoldDB; P13405; -.\r\n",
      "DR   SMR; P13405; -.\r\n",
      "DR   BioGRID; 202815; 61.\r\n",
      "DR   ComplexPortal; CPX-160; RB1-E2F1-TFDP1 transcription repressor complex.\r\n",
      "DR   ComplexPortal; CPX-177; RB1-E2F2-TFDP1 transcription repressor complex.\r\n",
      "DR   ComplexPortal; CPX-470; L3MBTL1 complex.\r\n",
      "DR   CORUM; P13405; -.\r\n",
      "DR   DIP; DIP-37637N; -.\r\n",
      "DR   IntAct; P13405; 26.\r\n",
      "DR   MINT; P13405; -.\r\n",
      "DR   STRING; 10090.ENSMUSP00000022701; -.\r\n",
      "DR   iPTMnet; P13405; -.\r\n",
      "DR   PhosphoSitePlus; P13405; -.\r\n",
      "DR   EPD; P13405; -.\r\n",
      "DR   jPOST; P13405; -.\r\n",
      "DR   MaxQB; P13405; -.\r\n",
      "DR   PaxDb; P13405; -.\r\n",
      "DR   PeptideAtlas; P13405; -.\r\n",
      "DR   ProteomicsDB; 255135; -.\r\n",
      "DR   Antibodypedia; 3758; 3544 antibodies from 52 providers.\r\n",
      "DR   DNASU; 19645; -.\r\n",
      "DR   Ensembl; ENSMUST00000022701.7; ENSMUSP00000022701.7; ENSMUSG00000022105.7.\r\n",
      "DR   GeneID; 19645; -.\r\n",
      "DR   KEGG; mmu:19645; -.\r\n",
      "DR   UCSC; uc007upp.2; mouse.\r\n",
      "DR   AGR; MGI:97874; -.\r\n",
      "DR   CTD; 5925; -.\r\n",
      "DR   MGI; MGI:97874; Rb1.\r\n",
      "DR   VEuPathDB; HostDB:ENSMUSG00000022105; -.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00950000183202; -.\r\n",
      "DR   HOGENOM; CLU_015754_0_0_1; -.\r\n",
      "DR   InParanoid; P13405; -.\r\n",
      "DR   OMA; VKDIGCI; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; P13405; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   Reactome; R-MMU-113501; Inhibition of replication initiation of damaged DNA by RB1/E2F1.\r\n",
      "DR   Reactome; R-MMU-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.\r\n",
      "DR   Reactome; R-MMU-2299718; Condensation of Prophase Chromosomes.\r\n",
      "DR   Reactome; R-MMU-2559584; Formation of Senescence-Associated Heterochromatin Foci (SAHF).\r\n",
      "DR   Reactome; R-MMU-69200; Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes.\r\n",
      "DR   Reactome; R-MMU-69202; Cyclin E associated events during G1/S transition.\r\n",
      "DR   Reactome; R-MMU-69231; Cyclin D associated events in G1.\r\n",
      "DR   Reactome; R-MMU-69656; Cyclin A:Cdk2-associated events at S phase entry.\r\n",
      "DR   BioGRID-ORCS; 19645; 4 hits in 84 CRISPR screens.\r\n",
      "DR   ChiTaRS; Rb1; mouse.\r\n",
      "DR   PRO; PR:P13405; -.\r\n",
      "DR   Proteomes; UP000000589; Chromosome 14.\r\n",
      "DR   RNAct; P13405; protein.\r\n",
      "DR   Bgee; ENSMUSG00000022105; Expressed in molar tooth and 267 other tissues.\r\n",
      "DR   ExpressionAtlas; P13405; baseline and differential.\r\n",
      "DR   Genevisible; P13405; MM.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0061793; C:chromatin lock complex; ISO:MGI.\r\n",
      "DR   GO; GO:0008024; C:cyclin/CDK positive transcription elongation factor complex; ISO:MGI.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0016605; C:PML body; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0005819; C:spindle; IDA:MGI.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; IDA:MGI.\r\n",
      "DR   GO; GO:0097718; F:disordered domain specific binding; ISO:MGI.\r\n",
      "DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.\r\n",
      "DR   GO; GO:0061676; F:importin-alpha family protein binding; ISO:MGI.\r\n",
      "DR   GO; GO:0019900; F:kinase binding; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0060090; F:molecular adaptor activity; ISO:MGI.\r\n",
      "DR   GO; GO:0051219; F:phosphoprotein binding; ISO:MGI.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IPI:BHF-UCL.\r\n",
      "DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:MGI.\r\n",
      "DR   GO; GO:0003180; P:aortic valve morphogenesis; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0006915; P:apoptotic process; IMP:MGI.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0051301; P:cell division; IMP:MGI.\r\n",
      "DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IMP:MGI.\r\n",
      "DR   GO; GO:0008283; P:cell population proliferation; IMP:MGI.\r\n",
      "DR   GO; GO:0032869; P:cellular response to insulin stimulus; IDA:MGI.\r\n",
      "DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IMP:MGI.\r\n",
      "DR   GO; GO:0002062; P:chondrocyte differentiation; IDA:MGI.\r\n",
      "DR   GO; GO:0051276; P:chromosome organization; ISO:MGI.\r\n",
      "DR   GO; GO:0048565; P:digestive tract development; IMP:MGI.\r\n",
      "DR   GO; GO:0043353; P:enucleate erythrocyte differentiation; IGI:MGI.\r\n",
      "DR   GO; GO:0050673; P:epithelial cell proliferation; IMP:MGI.\r\n",
      "DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:MGI.\r\n",
      "DR   GO; GO:0034349; P:glial cell apoptotic process; IMP:MGI.\r\n",
      "DR   GO; GO:0014009; P:glial cell proliferation; IGI:MGI.\r\n",
      "DR   GO; GO:0097284; P:hepatocyte apoptotic process; IMP:MGI.\r\n",
      "DR   GO; GO:0031507; P:heterochromatin formation; ISO:MGI.\r\n",
      "DR   GO; GO:0034088; P:maintenance of mitotic sister chromatid cohesion; ISO:MGI.\r\n",
      "DR   GO; GO:0045445; P:myoblast differentiation; ISS:UniProtKB.\r\n",
      "DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; ISO:MGI.\r\n",
      "DR   GO; GO:0045786; P:negative regulation of cell cycle; IMP:MGI.\r\n",
      "DR   GO; GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:MGI.\r\n",
      "DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; IMP:YuBioLab.\r\n",
      "DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; ISO:MGI.\r\n",
      "DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:MGI.\r\n",
      "DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:MGI.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IMP:MGI.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:MGI.\r\n",
      "DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IGI:MGI.\r\n",
      "DR   GO; GO:1903944; P:negative regulation of hepatocyte apoptotic process; ISO:MGI.\r\n",
      "DR   GO; GO:0050728; P:negative regulation of inflammatory response; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; IGI:MGI.\r\n",
      "DR   GO; GO:1904761; P:negative regulation of myofibroblast differentiation; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0006469; P:negative regulation of protein kinase activity; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0071901; P:negative regulation of protein serine/threonine kinase activity; ISO:MGI.\r\n",
      "DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; IMP:MGI.\r\n",
      "DR   GO; GO:1902948; P:negative regulation of tau-protein kinase activity; ISO:MGI.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:MGI.\r\n",
      "DR   GO; GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; IGI:BHF-UCL.\r\n",
      "DR   GO; GO:0051402; P:neuron apoptotic process; IMP:MGI.\r\n",
      "DR   GO; GO:0030182; P:neuron differentiation; IMP:MGI.\r\n",
      "DR   GO; GO:0042551; P:neuron maturation; IMP:MGI.\r\n",
      "DR   GO; GO:0031175; P:neuron projection development; IMP:MGI.\r\n",
      "DR   GO; GO:1904028; P:positive regulation of collagen fibril organization; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:1903055; P:positive regulation of extracellular matrix organization; IMP:BHF-UCL.\r\n",
      "DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; IGI:MGI.\r\n",
      "DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; ISO:MGI.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:MGI.\r\n",
      "DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; ISO:MGI.\r\n",
      "DR   GO; GO:0071459; P:protein localization to chromosome, centromeric region; ISO:MGI.\r\n",
      "DR   GO; GO:0007265; P:Ras protein signal transduction; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051726; P:regulation of cell cycle; IMP:MGI.\r\n",
      "DR   GO; GO:0001558; P:regulation of cell growth; IGI:MGI.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0007346; P:regulation of mitotic cell cycle; IMP:MGI.\r\n",
      "DR   GO; GO:0031134; P:sister chromatid biorientation; ISO:MGI.\r\n",
      "DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IMP:MGI.\r\n",
      "DR   GO; GO:0007224; P:smoothened signaling pathway; IMP:MGI.\r\n",
      "DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051146; P:striated muscle cell differentiation; IGI:MGI.\r\n",
      "DR   GO; GO:0001894; P:tissue homeostasis; IGI:MGI.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; IGI:MGI.\r\n",
      "DR   CDD; cd20599; CYCLIN_RB; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 6.10.140.1380; -; 1.\r\n",
      "DR   Gene3D; 6.10.250.530; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 2.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Acetylation; Cell cycle; Chromatin regulator; DNA-binding; Methylation;\r\n",
      "KW   Nucleus; Phosphoprotein; Reference proteome; Repressor; Transcription;\r\n",
      "KW   Transcription regulation; Tumor suppressor.\r\n",
      "FT   INIT_MET        1\r\n",
      "FT                   /note=\"Removed\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20668449\"\r\n",
      "FT   CHAIN           2..921\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein\"\r\n",
      "FT                   /id=\"PRO_0000167837\"\r\n",
      "FT   REGION          1..36\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          341..360\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          367..764\r\n",
      "FT                   /note=\"Pocket; binds T and E1A\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          367..573\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          574..632\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          633..764\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          756..921\r\n",
      "FT                   /note=\"Interaction with LIMD1\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          764..921\r\n",
      "FT                   /note=\"Domain; mediates interaction with E4F1\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          872..921\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOTIF           853..869\r\n",
      "FT                   /note=\"Bipartite nuclear localization signal\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8336704\"\r\n",
      "FT   COMPBIAS        1..26\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        341..356\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        872..886\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        906..921\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         2\r\n",
      "FT                   /note=\"N,N-dimethylproline; by NTM1\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:20668449\"\r\n",
      "FT   MOD_RES         31\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         243\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         246\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         350\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         364\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         367\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         561\r\n",
      "FT                   /note=\"Phosphoserine; by CDK2\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         601\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         605\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         617\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         773\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         781\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         788\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         800\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         803\r\n",
      "FT                   /note=\"N6-methyllysine; by SMYD2\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         804\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         814\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         816\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         819\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         834\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         848\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         853\r\n",
      "FT                   /note=\"N6-methyllysine; by SMYD2\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         866\r\n",
      "FT                   /note=\"N6-acetyllysine; by PCAF\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         867\r\n",
      "FT                   /note=\"N6-acetyllysine; by PCAF\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MUTAGEN         733..769\r\n",
      "FT                   /note=\"Missing: Loss of exclusive nuclear localization.\r\n",
      "FT                   Complete loss of nuclear localization, loss of growth\r\n",
      "FT                   inhibition, when transfected in Saos-2 cells and loss of\r\n",
      "FT                   interaction with SV40 large T antigen, adenovirus E1a and\r\n",
      "FT                   E2F1; when associated with 866-N--Q-869.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8336704\"\r\n",
      "FT   MUTAGEN         746\r\n",
      "FT                   /note=\"I->A: Abolishes the interaction with many chromatin\r\n",
      "FT                   regulators but not that with KMT5B and KMT5C; when\r\n",
      "FT                   associated with A-750 and A-754.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16612004\"\r\n",
      "FT   MUTAGEN         750\r\n",
      "FT                   /note=\"N->A: Abolishes the interaction with many chromatin\r\n",
      "FT                   regulators but not that with KMT5B and KMT5C; when\r\n",
      "FT                   associated with A-746 and A-754.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16612004\"\r\n",
      "FT   MUTAGEN         754\r\n",
      "FT                   /note=\"M->A: Abolishes the interaction with many chromatin\r\n",
      "FT                   regulators but not that with KMT5B and KMT5C; when\r\n",
      "FT                   associated with A-746 and A-750.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16612004\"\r\n",
      "FT   MUTAGEN         769..872\r\n",
      "FT                   /note=\"Missing: Loss of exclusive nuclear localization and\r\n",
      "FT                   loss of growth inhibition, when transfected in Saos-2\r\n",
      "FT                   cells. No effect on the interaction with SV40 large T\r\n",
      "FT                   antigen.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8336704\"\r\n",
      "FT   MUTAGEN         853..869\r\n",
      "FT                   /note=\"Missing: Loss of exclusive nuclear localization.\r\n",
      "FT                   Decreased growth inhibition activity, when transfected in\r\n",
      "FT                   Saos-2 cells. No effect on the interaction with SV40 large\r\n",
      "FT                   T antigen, adenovirus E1a, nor E2F1.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8336704\"\r\n",
      "FT   MUTAGEN         866..869\r\n",
      "FT                   /note=\"KKLR->NKLQ: Loss of exclusive nuclear localization,\r\n",
      "FT                   no effect on the interaction with SV40 large T antigen,\r\n",
      "FT                   adenovirus E1a, nor E2F1. Decreased growth inhibition\r\n",
      "FT                   activity, when transfected in Saos-2 cells. Complete loss\r\n",
      "FT                   of nuclear localization, loss of growth inhibition, when\r\n",
      "FT                   transfected in Saos-2 cells and loss of interaction with\r\n",
      "FT                   SV40 large T antigen, adenovirus E1a and E2F1; when\r\n",
      "FT                   associated with 733-K--P-769.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:8336704\"\r\n",
      "FT   CONFLICT        867..868\r\n",
      "FT                   /note=\"KL -> NV (in Ref. 1; AAA39964)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   921 AA;  105367 MW;  AE81D35A07ADB493 CRC64;\r\n",
      "     MPPKAPRRAA AAEPPPPPPP PPREDDPAQD SGPEELPLAR LEFEEIEEPE FIALCQKLKV\r\n",
      "     PDHVRERAWL TWEKVSSVDG ILEGYIQKKK ELWGICIFIA AVDLDEMPFT FTELQKSIET\r\n",
      "     SVYKFFDLLK EIDTSTKVDN AMSRLLKKYN VLCALYSKLE RTCELIYLTQ PSSALSTEIN\r\n",
      "     SMLVLKISWI TFLLAKGEVL QMEDDLVISF QLMLCVVDYF IKFSPPALLR EPYKTAAIPI\r\n",
      "     NGSPRTPRRG QNRSARIAKQ LENDTRIIEV LCKEHECNID EVKNVYFKNF IPFINSLGIV\r\n",
      "     SSNGLPEVES LSKRYEEVYL KNKDLDARLF LDHDKTLQTD PIDSFETERT PRKNNPDEEA\r\n",
      "     NVVTPHTPVR TVMNTIQQLM VILNSASDQP SENLISYFNN CTVNPKENIL KRVKDVGHIF\r\n",
      "     KEKFANAVGQ GCVDIGVQRY KLGVRLYYRV MESMLKSEEE RLSIQNFSKL LNDNIFHMSL\r\n",
      "     LACALEVVMA TYSRSTLQHL DSGTDLSFPW ILNVLNLKAF DFYKVIESFI KVEANLTREM\r\n",
      "     IKHLERCEHR IMESLAWLSD SPLFDLIKQS KDGEGPDNLE PACPLSLPLQ GNHTAADMYL\r\n",
      "     SPLRSPKKRT STTRVNSAAN TETQAASAFH TQKPLKSTSL ALFYKKVYRL AYLRLNTLCA\r\n",
      "     RLLSDHPELE HIIWTLFQHT LQNEYELMRD RHLDQIMMCS MYGICKVKNI DLKFKIIVTA\r\n",
      "     YKDLPHAAQE TFKRVLIREE EFDSIIVFYN SVFMQRLKTN ILQYASTRPP TLSPIPHIPR\r\n",
      "     SPYKFSSSPL RIPGGNIYIS PLKSPYKISE GLPTPTKMTP RSRILVSIGE SFGTSEKFQK\r\n",
      "     INQMVCNSDR VLKRSAEGGN PPKPLKKLRF DIEGADEADG SKHLPAESKF QQKLAEMTST\r\n",
      "     RTRMQKQRMN ESKDVSNKEE K\r\n",
      "//\r\n",
      "ID   RBL2_HUMAN              Reviewed;        1139 AA.\r\n",
      "AC   Q08999; B7Z913; Q15073; Q16084; Q8NE70; Q92812;\r\n",
      "DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   17-OCT-2006, sequence version 3.\r\n",
      "DT   03-MAY-2023, entry version 206.\r\n",
      "DE   RecName: Full=Retinoblastoma-like protein 2;\r\n",
      "DE   AltName: Full=130 kDa retinoblastoma-associated protein;\r\n",
      "DE            Short=p130;\r\n",
      "DE   AltName: Full=Retinoblastoma-related protein 2;\r\n",
      "DE            Short=RBR-2;\r\n",
      "DE   AltName: Full=pRb2;\r\n",
      "GN   Name=RBL2; Synonyms=RB2;\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).\r\n",
      "RC   TISSUE=Placenta, and Spleen;\r\n",
      "RX   PubMed=8253383; DOI=10.1101/gad.7.12a.2366;\r\n",
      "RA   Li Y., Graham C., Lacy S., Duncan A.M.V., Whyte P.;\r\n",
      "RT   \"The adenovirus E1A-associated 130-kD protein is encoded by a member of the\r\n",
      "RT   retinoblastoma gene family and physically interacts with cyclins A and E.\";\r\n",
      "RL   Genes Dev. 7:2366-2377(1993).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).\r\n",
      "RX   PubMed=8253384; DOI=10.1101/gad.7.12a.2378;\r\n",
      "RA   Hannon G.J., Demetrick D., Beach D.;\r\n",
      "RT   \"Isolation of the Rb-related p130 through its interaction with CDK2 and\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RT   cyclins.\";\r\n",
      "RL   Genes Dev. 7:2378-2391(1993).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).\r\n",
      "RC   TISSUE=Trachea;\r\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\r\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\r\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\r\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\r\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\r\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\r\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\r\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\r\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\r\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\r\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\r\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\r\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\r\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\r\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\r\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\r\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\r\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\r\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\r\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\r\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\r\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\r\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\r\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\r\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\r\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\r\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\r\n",
      "RA   Isogai T., Sugano S.;\r\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\r\n",
      "RT   cDNAs.\";\r\n",
      "RL   Nat. Genet. 36:40-45(2004).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RX   PubMed=15616553; DOI=10.1038/nature03187;\r\n",
      "RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,\r\n",
      "RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,\r\n",
      "RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,\r\n",
      "RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,\r\n",
      "RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,\r\n",
      "RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,\r\n",
      "RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,\r\n",
      "RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,\r\n",
      "RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,\r\n",
      "RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,\r\n",
      "RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,\r\n",
      "RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,\r\n",
      "RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,\r\n",
      "RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,\r\n",
      "RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,\r\n",
      "RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,\r\n",
      "RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,\r\n",
      "RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,\r\n",
      "RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,\r\n",
      "RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,\r\n",
      "RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,\r\n",
      "RA   Myers R.M., Rubin E.M., Pennacchio L.A.;\r\n",
      "RT   \"The sequence and analysis of duplication-rich human chromosome 16.\";\r\n",
      "RL   Nature 432:988-994(2004).\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).\r\n",
      "RC   TISSUE=Testis;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 58-1139 (ISOFORM 1).\r\n",
      "RX   PubMed=8361765;\r\n",
      "RA   Mayol X., Grana X., Baldi A., Sang N., Hu Q., Giordano A.;\r\n",
      "RT   \"Cloning of a new member of the retinoblastoma gene family (pRb2) which\r\n",
      "RT   binds to the E1A transforming domain.\";\r\n",
      "RL   Oncogene 8:2561-2566(1993).\r\n",
      "RN   [7]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-80.\r\n",
      "RC   TISSUE=Placenta;\r\n",
      "RX   PubMed=8643454; DOI=10.1073/pnas.93.10.4629;\r\n",
      "RA   Baldi A., Boccia V., Claudio P.P., de Luca A., Giordano A.;\r\n",
      "RT   \"Genomic structure of the human retinoblastoma-related Rb2/p130 gene.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 93:4629-4632(1996).\r\n",
      "RN   [8]\r\n",
      "RP   PHOSPHORYLATION AT SER-639; SER-952; SER-966; SER-971; SER-972; SER-973;\r\n",
      "RP   THR-974; SER-981; SER-982 AND THR-986, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY.\r\n",
      "RX   PubMed=11042701; DOI=10.1038/sj.onc.1203893;\r\n",
      "RA   Canhoto A.J., Chestukhin A., Litovchick L., DeCaprio J.A.;\r\n",
      "RT   \"Phosphorylation of the retinoblastoma-related protein p130 in growth-\r\n",
      "RT   arrested cells.\";\r\n",
      "RL   Oncogene 19:5116-5122(2000).\r\n",
      "RN   [9]\r\n",
      "RP   INTERACTION WITH AATF.\r\n",
      "RX   PubMed=12450794; DOI=10.1016/s1535-6108(02)00182-4;\r\n",
      "RA   Bruno T., De Angelis R., De Nicola F., Barbato C., Di Padova M., Corbi N.,\r\n",
      "RA   Libri V., Benassi B., Mattei E., Chersi A., Soddu S., Floridi A.,\r\n",
      "RA   Passananti C., Fanciulli M.;\r\n",
      "RT   \"Che-1 affects cell growth by interfering with the recruitment of HDAC1 by\r\n",
      "RT   Rb.\";\r\n",
      "RL   Cancer Cell 2:387-399(2002).\r\n",
      "RN   [10]\r\n",
      "RP   PHOSPHORYLATION AT SER-672.\r\n",
      "RX   PubMed=12435635; DOI=10.1101/gad.1011202;\r\n",
      "RA   Tedesco D., Lukas J., Reed S.I.;\r\n",
      "RT   \"The pRb-related protein p130 is regulated by phosphorylation-dependent\r\n",
      "RT   proteolysis via the protein-ubiquitin ligase SCF(Skp2).\";\r\n",
      "RL   Genes Dev. 16:2946-2957(2002).\r\n",
      "RN   [11]\r\n",
      "RP   INTERACTION WITH RINT1.\r\n",
      "RX   PubMed=16600870; DOI=10.1016/j.molcel.2006.02.016;\r\n",
      "RA   Kong L.-J., Meloni A.R., Nevins J.R.;\r\n",
      "RT   \"The Rb-related p130 protein controls telomere lengthening through an\r\n",
      "RT   interaction with a Rad50-interacting protein, RINT-1.\";\r\n",
      "RL   Mol. Cell 22:63-71(2006).\r\n",
      "RN   [12]\r\n",
      "RP   IDENTIFICATION IN THE DREAM COMPLEX.\r\n",
      "RX   PubMed=17671431; DOI=10.4161/cc.6.15.4512;\r\n",
      "RA   Schmit F., Korenjak M., Mannefeld M., Schmitt K., Franke C., von Eyss B.,\r\n",
      "RA   Gagrica S., Haenel F., Brehm A., Gaubatz S.;\r\n",
      "RT   \"LINC, a human complex that is related to pRB-containing complexes in\r\n",
      "RT   invertebrates regulates the expression of G2/M genes.\";\r\n",
      "RL   Cell Cycle 6:1903-1913(2007).\r\n",
      "RN   [13]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19413330; DOI=10.1021/ac9004309;\r\n",
      "RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;\r\n",
      "RT   \"Lys-N and trypsin cover complementary parts of the phosphoproteome in a\r\n",
      "RT   refined SCX-based approach.\";\r\n",
      "RL   Anal. Chem. 81:4493-4501(2009).\r\n",
      "RN   [14]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;\r\n",
      "RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,\r\n",
      "RA   Mann M., Daub H.;\r\n",
      "RT   \"Large-scale proteomics analysis of the human kinome.\";\r\n",
      "RL   Mol. Cell. Proteomics 8:1751-1764(2009).\r\n",
      "RN   [15]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-662; SER-672 AND SER-1035,\r\n",
      "RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [16]\r\n",
      "RP   INTERACTION WITH JC VIRUS SMALL T ANTIGEN (MICROBIAL INFECTION).\r\n",
      "RX   PubMed=20485545; DOI=10.1371/journal.pone.0010606;\r\n",
      "RA   Bollag B., Hofstetter C.A., Reviriego-Mendoza M.M., Frisque R.J.;\r\n",
      "RT   \"JC virus small T antigen binds phosphatase PP2A and Rb family proteins and\r\n",
      "RT   is required for efficient viral DNA replication activity.\";\r\n",
      "RL   PLoS ONE 5:e10606-e10606(2010).\r\n",
      "RN   [17]\r\n",
      "RP   INTERACTION WITH PML.\r\n",
      "RX   PubMed=22002537; DOI=10.1038/emboj.2011.370;\r\n",
      "RA   Martin N., Benhamed M., Nacerddine K., Demarque M.D., van Lohuizen M.,\r\n",
      "RA   Dejean A., Bischof O.;\r\n",
      "RT   \"Physical and functional interaction between PML and TBX2 in the\r\n",
      "RT   establishment of cellular senescence.\";\r\n",
      "RL   EMBO J. 31:95-109(2012).\r\n",
      "RN   [18]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-413; SER-662; SER-688;\r\n",
      "RP   SER-1068; SER-1080 AND SER-1112, AND IDENTIFICATION BY MASS SPECTROMETRY\r\n",
      "RP   [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [19]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;\r\n",
      "RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,\r\n",
      "RA   Ye M., Zou H.;\r\n",
      "RT   \"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteomics 96:253-262(2014).\r\n",
      "RN   [20]\r\n",
      "RP   VARIANT PHE-99.\r\n",
      "RX   PubMed=23033978; DOI=10.1056/nejmoa1206524;\r\n",
      "RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,\r\n",
      "RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P., Gilissen C.,\r\n",
      "RA   del Rosario M., Hoischen A., Scheffer H., de Vries B.B., Brunner H.G.,\r\n",
      "RA   Veltman J.A., Vissers L.E.;\r\n",
      "RT   \"Diagnostic exome sequencing in persons with severe intellectual\r\n",
      "RT   disability.\";\r\n",
      "RL   N. Engl. J. Med. 367:1921-1929(2012).\r\n",
      "RN   [21]\r\n",
      "RP   VARIANT BRUWAG 186-ARG--HIS-1139 DEL, AND INVOLVEMENT IN BRUWAG.\r\n",
      "RX   PubMed=32105419; DOI=10.1002/acn3.50992;\r\n",
      "RA   Brunet T., Radivojkov-Blagojevic M., Lichtner P., Kraus V., Meitinger T.,\r\n",
      "RA   Wagner M.;\r\n",
      "RT   \"Biallelic loss-of-function variants in RBL2 in siblings with a\r\n",
      "RT   neurodevelopmental disorder.\";\r\n",
      "RL   Ann. Clin. Transl. Neurol. 7:390-396(2020).\r\n",
      "RN   [22]\r\n",
      "RP   INVOLVEMENT IN BRUWAG.\r\n",
      "RX   PubMed=33980986; DOI=10.1038/s10038-021-00931-z;\r\n",
      "RA   Samra N., Toubiana S., Yttervik H., Tzur-Gilat A., Morani I., Itzkovich C.,\r\n",
      "RA   Giladi L., Abu Jabal K., Cao J.Z., Godley L.A., Mory A., Baris Feldman H.,\r\n",
      "RA   Tveten K., Selig S., Weiss K.;\r\n",
      "RT   \"RBL2 bi-allelic truncating variants cause severe motor and cognitive\r\n",
      "RT   impairment without evidence for abnormalities in DNA methylation or\r\n",
      "RT   telomeric function.\";\r\n",
      "RL   J. Hum. Genet. 66:1101-1112(2021).\r\n",
      "CC   -!- FUNCTION: Key regulator of entry into cell division. Directly involved\r\n",
      "CC       in heterochromatin formation by maintaining overall chromatin structure\r\n",
      "CC       and, in particular, that of constitutive heterochromatin by stabilizing\r\n",
      "CC       histone methylation. Recruits and targets histone methyltransferases\r\n",
      "CC       KMT5B and KMT5C, leading to epigenetic transcriptional repression.\r\n",
      "CC       Controls histone H4 'Lys-20' trimethylation. Probably acts as a\r\n",
      "CC       transcription repressor by recruiting chromatin-modifying enzymes to\r\n",
      "CC       promoters. Potent inhibitor of E2F-mediated trans-activation,\r\n",
      "CC       associates preferentially with E2F5. Binds to cyclins A and E. Binds to\r\n",
      "CC       and may be involved in the transforming capacity of the adenovirus E1A\r\n",
      "CC       protein. May act as a tumor suppressor.\r\n",
      "CC   -!- SUBUNIT: Interacts with AATF. Interacts with KMT5B, KMT5C and USP4 (By\r\n",
      "CC       similarity). Component of the DREAM complex (also named LINC complex)\r\n",
      "CC       at least composed of E2F4, E2F5, LIN9, LIN37, LIN52, LIN54, MYBL1,\r\n",
      "CC       MYBL2, RBL1, RBL2, RBBP4, TFDP1 and TFDP2. The complex exists in\r\n",
      "CC       quiescent cells where it represses cell cycle-dependent genes. It\r\n",
      "CC       dissociates in S phase when LIN9, LIN37, LIN52 and LIN54 form a\r\n",
      "CC       subcomplex that binds to MYBL2. Interacts with RINT1. Interacts with\r\n",
      "CC       PML (isoform PML-1, isoform PML-2, isoform PML-3, isoform PML-4 and\r\n",
      "CC       isoform PML-5). Interacts with RBBP9 (By similarity). {ECO:0000250,\r\n",
      "CC       ECO:0000250|UniProtKB:O55081, ECO:0000269|PubMed:12450794,\r\n",
      "CC       ECO:0000269|PubMed:16600870, ECO:0000269|PubMed:17671431,\r\n",
      "CC       ECO:0000269|PubMed:22002537}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with JC virus small t antigen.\r\n",
      "CC       {ECO:0000269|PubMed:20485545}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q08999; Q13574-2: DGKZ; NbExp=2; IntAct=EBI-971439, EBI-715527;\r\n",
      "CC       Q08999; Q16254: E2F4; NbExp=7; IntAct=EBI-971439, EBI-448943;\r\n",
      "CC       Q08999; Q6MZP7: LIN54; NbExp=10; IntAct=EBI-971439, EBI-1389411;\r\n",
      "CC       Q08999; P67775: PPP2CA; NbExp=2; IntAct=EBI-971439, EBI-712311;\r\n",
      "CC       Q08999; I6L8A6: RBBP8; NbExp=3; IntAct=EBI-971439, EBI-11525639;\r\n",
      "CC       Q08999; Q99708-2: RBBP8; NbExp=3; IntAct=EBI-971439, EBI-10203615;\r\n",
      "CC       Q08999; P24610: Pax3; Xeno; NbExp=3; IntAct=EBI-971439, EBI-1208116;\r\n",
      "CC       Q08999; Q923E4: Sirt1; Xeno; NbExp=2; IntAct=EBI-971439, EBI-1802585;\r\n",
      "CC       Q08999; Q61412: Vsx2; Xeno; NbExp=4; IntAct=EBI-971439, EBI-1208174;\r\n",
      "CC       Q08999; P03255; Xeno; NbExp=2; IntAct=EBI-971439, EBI-2603114;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=2;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=Q08999-1; Sequence=Displayed;\r\n",
      "CC       Name=2;\r\n",
      "CC         IsoId=Q08999-2; Sequence=VSP_054328, VSP_054329;\r\n",
      "CC   -!- DEVELOPMENTAL STAGE: G0-restricted expression.\r\n",
      "CC   -!- PTM: During G0 and early G1 phase of the cell cycle, phosphorylated on\r\n",
      "CC       Ser-639 and on 5 sites within the domain B. Phosphorylation on Ser-672\r\n",
      "CC       in G1 leads to its ubiquitin-dependent proteolysis.\r\n",
      "CC       {ECO:0000269|PubMed:11042701, ECO:0000269|PubMed:12435635}.\r\n",
      "CC   -!- DISEASE: Brunet-Wagner neurodevelopmental syndrome (BRUWAG)\r\n",
      "CC       [MIM:619690]: An autosomal recessive disorder characterized by severe\r\n",
      "CC       developmental delay, intellectual disability, poor or absent speech,\r\n",
      "CC       infantile hypotonia, inability to walk, behavioral abnormalities, and\r\n",
      "CC       dysmorphic features. {ECO:0000269|PubMed:32105419,\r\n",
      "CC       ECO:0000269|PubMed:33980986}. Note=The disease is caused by variants\r\n",
      "CC       affecting the gene represented in this entry.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and\r\n",
      "CC       Haematology;\r\n",
      "CC       URL=\"https://atlasgeneticsoncology.org/gene/443/RBL2\";\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; X76061; CAA53661.1; -; mRNA.\r\n",
      "DR   EMBL; S67171; AAB29227.1; -; mRNA.\r\n",
      "DR   EMBL; AK304283; BAH14149.1; -; mRNA.\r\n",
      "DR   EMBL; AC007342; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; BC034490; AAH34490.1; -; mRNA.\r\n",
      "DR   EMBL; X74594; CAA52671.1; -; mRNA.\r\n",
      "DR   EMBL; U53220; AAC50479.1; -; Genomic_DNA.\r\n",
      "DR   CCDS; CCDS10748.1; -. [Q08999-1]\r\n",
      "DR   PIR; A49370; A49370.\r\n",
      "DR   RefSeq; NP_001310537.1; NM_001323608.1. [Q08999-1]\r\n",
      "DR   RefSeq; NP_005602.3; NM_005611.3. [Q08999-1]\r\n",
      "DR   PDB; 4XI9; X-ray; 3.10 A; E/F/G/H=416-422.\r\n",
      "DR   PDB; 5C1D; X-ray; 2.05 A; C=416-422.\r\n",
      "DR   PDBsum; 4XI9; -.\r\n",
      "DR   PDBsum; 5C1D; -.\r\n",
      "DR   AlphaFoldDB; Q08999; -.\r\n",
      "DR   SMR; Q08999; -.\r\n",
      "DR   BioGRID; 111869; 77.\r\n",
      "DR   CORUM; Q08999; -.\r\n",
      "DR   DIP; DIP-425N; -.\r\n",
      "DR   ELM; Q08999; -.\r\n",
      "DR   IntAct; Q08999; 48.\r\n",
      "DR   MINT; Q08999; -.\r\n",
      "DR   STRING; 9606.ENSP00000262133; -.\r\n",
      "DR   GlyCosmos; Q08999; 1 site, 1 glycan.\r\n",
      "DR   GlyGen; Q08999; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; Q08999; -.\r\n",
      "DR   PhosphoSitePlus; Q08999; -.\r\n",
      "DR   BioMuta; RBL2; -.\r\n",
      "DR   DMDM; 116242746; -.\r\n",
      "DR   EPD; Q08999; -.\r\n",
      "DR   jPOST; Q08999; -.\r\n",
      "DR   MassIVE; Q08999; -.\r\n",
      "DR   MaxQB; Q08999; -.\r\n",
      "DR   PaxDb; Q08999; -.\r\n",
      "DR   PeptideAtlas; Q08999; -.\r\n",
      "DR   ProteomicsDB; 58652; -. [Q08999-1]\r\n",
      "DR   ProteomicsDB; 6997; -.\r\n",
      "DR   Antibodypedia; 4299; 476 antibodies from 39 providers.\r\n",
      "DR   DNASU; 5934; -.\r\n",
      "DR   Ensembl; ENST00000262133.11; ENSP00000262133.6; ENSG00000103479.17. [Q08999-1]\r\n",
      "DR   GeneID; 5934; -.\r\n",
      "DR   KEGG; hsa:5934; -.\r\n",
      "DR   MANE-Select; ENST00000262133.11; ENSP00000262133.6; NM_005611.4; NP_005602.3.\r\n",
      "DR   UCSC; uc002ehi.5; human. [Q08999-1]\r\n",
      "DR   AGR; HGNC:9894; -.\r\n",
      "DR   CTD; 5934; -.\r\n",
      "DR   DisGeNET; 5934; -.\r\n",
      "DR   GeneCards; RBL2; -.\r\n",
      "DR   HGNC; HGNC:9894; RBL2.\r\n",
      "DR   HPA; ENSG00000103479; Low tissue specificity.\r\n",
      "DR   MalaCards; RBL2; -.\r\n",
      "DR   MIM; 180203; gene.\r\n",
      "DR   MIM; 619690; phenotype.\r\n",
      "DR   neXtProt; NX_Q08999; -.\r\n",
      "DR   OpenTargets; ENSG00000103479; -.\r\n",
      "DR   PharmGKB; PA34258; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000103479; -.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00950000183202; -.\r\n",
      "DR   HOGENOM; CLU_008943_0_0_1; -.\r\n",
      "DR   InParanoid; Q08999; -.\r\n",
      "DR   OMA; MHWLACA; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; Q08999; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   PathwayCommons; Q08999; -.\r\n",
      "DR   Reactome; R-HSA-1362277; Transcription of E2F targets under negative control by DREAM complex.\r\n",
      "DR   Reactome; R-HSA-1362300; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1.\r\n",
      "DR   Reactome; R-HSA-1538133; G0 and Early G1.\r\n",
      "DR   Reactome; R-HSA-6804114; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest.\r\n",
      "DR   Reactome; R-HSA-69202; Cyclin E associated events during G1/S transition.\r\n",
      "DR   Reactome; R-HSA-69205; G1/S-Specific Transcription.\r\n",
      "DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.\r\n",
      "DR   Reactome; R-HSA-69656; Cyclin A:Cdk2-associated events at S phase entry.\r\n",
      "DR   Reactome; R-HSA-9617828; FOXO-mediated transcription of cell cycle genes.\r\n",
      "DR   SignaLink; Q08999; -.\r\n",
      "DR   SIGNOR; Q08999; -.\r\n",
      "DR   BioGRID-ORCS; 5934; 15 hits in 1157 CRISPR screens.\r\n",
      "DR   ChiTaRS; RBL2; human.\r\n",
      "DR   GeneWiki; Retinoblastoma-like_protein_2; -.\r\n",
      "DR   GenomeRNAi; 5934; -.\r\n",
      "DR   Pharos; Q08999; Tbio.\r\n",
      "DR   PRO; PR:Q08999; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 16.\r\n",
      "DR   RNAct; Q08999; protein.\r\n",
      "DR   Bgee; ENSG00000103479; Expressed in germinal epithelium of ovary and 203 other tissues.\r\n",
      "DR   ExpressionAtlas; Q08999; baseline and differential.\r\n",
      "DR   Genevisible; Q08999; HS.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0005694; C:chromosome; IDA:HPA.\r\n",
      "DR   GO; GO:0005829; C:cytosol; IDA:HPA.\r\n",
      "DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.\r\n",
      "DR   GO; GO:0005730; C:nucleolus; IDA:HPA.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; IBA:GO_Central.\r\n",
      "DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:MGI.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:MGI.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:InterPro.\r\n",
      "DR   CDD; cd20606; CYCLIN_RBL2; 1.\r\n",
      "DR   CDD; cd00043; CYCLIN_SF; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 3.\r\n",
      "DR   IDEAL; IID00663; -.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   PANTHER; PTHR13742:SF8; RETINOBLASTOMA-LIKE PROTEIN 2; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 2.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 3.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Alternative splicing; Cell cycle; Chromatin regulator;\r\n",
      "KW   Disease variant; DNA-binding; Host-virus interaction;\r\n",
      "KW   Intellectual disability; Nucleus; Phosphoprotein; Reference proteome;\r\n",
      "KW   Repressor; Transcription; Transcription regulation; Tumor suppressor.\r\n",
      "FT   CHAIN           1..1139\r\n",
      "FT                   /note=\"Retinoblastoma-like protein 2\"\r\n",
      "FT                   /id=\"PRO_0000167841\"\r\n",
      "FT   REGION          1..45\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          417..1024\r\n",
      "FT                   /note=\"Pocket; binds E1A\"\r\n",
      "FT   REGION          417..616\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT   REGION          617..827\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT   REGION          654..678\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          810..832\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          828..1024\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT   REGION          933..999\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1..19\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        20..34\r\n",
      "FT                   /note=\"Acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        657..678\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         413\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         417\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q64700\"\r\n",
      "FT   MOD_RES         639\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11042701\"\r\n",
      "FT   MOD_RES         642\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q64700\"\r\n",
      "FT   MOD_RES         662\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         672\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:12435635,\r\n",
      "FT                   ECO:0007744|PubMed:19690332\"\r\n",
      "FT   MOD_RES         688\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         948\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q64700\"\r\n",
      "FT   MOD_RES         952\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11042701\"\r\n",
      "FT   MOD_RES         966\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11042701\"\r\n",
      "FT   MOD_RES         971\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000305|PubMed:11042701\"\r\n",
      "FT   MOD_RES         972\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000305|PubMed:11042701\"\r\n",
      "FT   MOD_RES         973\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000305|PubMed:11042701\"\r\n",
      "FT   MOD_RES         974\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000305|PubMed:11042701\"\r\n",
      "FT   MOD_RES         981\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000305|PubMed:11042701\"\r\n",
      "FT   MOD_RES         982\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11042701\"\r\n",
      "FT   MOD_RES         986\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11042701\"\r\n",
      "FT   MOD_RES         1035\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332\"\r\n",
      "FT   MOD_RES         1068\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1080\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1112\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   VAR_SEQ         1..216\r\n",
      "FT                   /note=\"Missing (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:14702039\"\r\n",
      "FT                   /id=\"VSP_054328\"\r\n",
      "FT   VAR_SEQ         638..1042\r\n",
      "FT                   /note=\"Missing (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:14702039\"\r\n",
      "FT                   /id=\"VSP_054329\"\r\n",
      "FT   VARIANT         99\r\n",
      "FT                   /note=\"V -> F\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:23033978\"\r\n",
      "FT                   /id=\"VAR_069377\"\r\n",
      "FT   VARIANT         186..1139\r\n",
      "FT                   /note=\"Missing (in BRUWAG)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:32105419\"\r\n",
      "FT                   /id=\"VAR_086722\"\r\n",
      "FT   VARIANT         210\r\n",
      "FT                   /note=\"Y -> C (in dbSNP:rs17800727)\"\r\n",
      "FT                   /id=\"VAR_028437\"\r\n",
      "FT   CONFLICT        37\r\n",
      "FT                   /note=\"P -> S (in Ref. 1; CAA53661 and 7; AAC50479)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        64\r\n",
      "FT                   /note=\"A -> P (in Ref. 1 and 7)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        206\r\n",
      "FT                   /note=\"V -> M (in Ref. 6; CAA52671)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1093\r\n",
      "FT                   /note=\"R -> H (in Ref. 5; AAH34490)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   1139 AA;  128367 MW;  D129032FB1F383D4 CRC64;\r\n",
      "     MPSGGDQSPP PPPPPPAAAA SDEEEEDDGE AEDAAPPAES PTPQIQQRFD ELCSRLNMDE\r\n",
      "     AARAEAWDSY RSMSESYTLE GNDLHWLACA LYVACRKSVP TVSKGTVEGN YVSLTRILKC\r\n",
      "     SEQSLIEFFN KMKKWEDMAN LPPHFRERTE RLERNFTVSA VIFKKYEPIF QDIFKYPQEE\r\n",
      "     QPRQQRGRKQ RRQPCTVSEI FHFCWVLFIY AKGNFPMISD DLVNSYHLLL CALDLVYGNA\r\n",
      "     LQCSNRKELV NPNFKGLSED FHAKDSKPSS DPPCIIEKLC SLHDGLVLEA KGIKEHFWKP\r\n",
      "     YIRKLYEKKL LKGKEENLTG FLEPGNFGES FKAINKAYEE YVLSVGNLDE RIFLGEDAEE\r\n",
      "     EIGTLSRCLN AGSGTETAER VQMKNILQQH FDKSKALRIS TPLTGVRYIK ENSPCVTPVS\r\n",
      "     TATHSLSRLH TMLTGLRNAP SEKLEQILRT CSRDPTQAIA NRLKEMFEIY SQHFQPDEDF\r\n",
      "     SNCAKEIASK HFRFAEMLYY KVLESVIEQE QKRLGDMDLS GILEQDAFHR SLLACCLEVV\r\n",
      "     TFSYKPPGNF PFITEIFDVP LYHFYKVIEV FIRAEDGLCR EVVKHLNQIE EQILDHLAWK\r\n",
      "     PESPLWEKIR DNENRVPTCE EVMPPQNLER ADEICIAGSP LTPRRVTEVR ADTGGLGRSI\r\n",
      "     TSPTTLYDRY SSPPASTTRR RLFVENDSPS DGGTPGRMPP QPLVNAVPVQ NVSGETVSVT\r\n",
      "     PVPGQTLVTM ATATVTANNG QTVTIPVQGI ANENGGITFF PVQVNVGGQA QAVTGSIQPL\r\n",
      "     SAQALAGSLS SQQVTGTTLQ VPGQVAIQQI SPGGQQQKQG QSVTSSSNRP RKTSSLSLFF\r\n",
      "     RKVYHLAAVR LRDLCAKLDI SDELRKKIWT CFEFSIIQCP ELMMDRHLDQ LLMCAIYVMA\r\n",
      "     KVTKEDKSFQ NIMRCYRTQP QARSQVYRSV LIKGKRKRRN SGSSDSRSHQ NSPTELNKDR\r\n",
      "     TSRDSSPVMR SSSTLPVPQP SSAPPTPTRL TGANSDMEEE ERGDLIQFYN NIYIKQIKTF\r\n",
      "     AMKYSQANMD APPLSPYPFV RTGSPRRIQL SQNHPVYISP HKNETMLSPR EKIFYYFSNS\r\n",
      "     PSKRLREINS MIRTGETPTK KRGILLEDGS ESPAKRICPE NHSALLRRLQ DVANDRGSH\r\n",
      "//\r\n",
      "ID   RB_RAT                  Reviewed;         920 AA.\r\n",
      "AC   P33568; Q63527;\r\n",
      "DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   09-FEB-2010, sequence version 3.\r\n",
      "DT   03-MAY-2023, entry version 191.\r\n",
      "DE   RecName: Full=Retinoblastoma-associated protein;\r\n",
      "DE   AltName: Full=pRb;\r\n",
      "DE            Short=Rb;\r\n",
      "DE   AltName: Full=pp105;\r\n",
      "GN   Name=Rb1; Synonyms=Rb-1;\r\n",
      "OS   Rattus norvegicus (Rat).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Rattus.\r\n",
      "OX   NCBI_TaxID=10116;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RC   STRAIN=Brown Norway;\r\n",
      "RX   PubMed=15057822; DOI=10.1038/nature02426;\r\n",
      "RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,\r\n",
      "RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,\r\n",
      "RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,\r\n",
      "RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,\r\n",
      "RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,\r\n",
      "RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,\r\n",
      "RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,\r\n",
      "RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,\r\n",
      "RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,\r\n",
      "RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,\r\n",
      "RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,\r\n",
      "RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,\r\n",
      "RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,\r\n",
      "RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,\r\n",
      "RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,\r\n",
      "RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,\r\n",
      "RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,\r\n",
      "RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,\r\n",
      "RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,\r\n",
      "RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,\r\n",
      "RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,\r\n",
      "RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,\r\n",
      "RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,\r\n",
      "RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,\r\n",
      "RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,\r\n",
      "RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,\r\n",
      "RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,\r\n",
      "RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,\r\n",
      "RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,\r\n",
      "RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,\r\n",
      "RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,\r\n",
      "RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,\r\n",
      "RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,\r\n",
      "RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,\r\n",
      "RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,\r\n",
      "RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,\r\n",
      "RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,\r\n",
      "RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,\r\n",
      "RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,\r\n",
      "RA   Mockrin S., Collins F.S.;\r\n",
      "RT   \"Genome sequence of the Brown Norway rat yields insights into mammalian\r\n",
      "RT   evolution.\";\r\n",
      "RL   Nature 428:493-521(2004).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 22-920.\r\n",
      "RC   STRAIN=Sprague-Dawley; TISSUE=Liver;\r\n",
      "RX   PubMed=7665085; DOI=10.1016/0378-1119(95)00154-x;\r\n",
      "RA   Esumi M., Idutsu T., Kinugasa S., Ohno M., Nakabayashi H., Ikeda T.,\r\n",
      "RA   Shikata T.;\r\n",
      "RT   \"Isolation and sequence polymorphism of a rat retinoblastoma (RB) cDNA.\";\r\n",
      "RL   Gene 161:231-235(1995).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 806-920.\r\n",
      "RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;\r\n",
      "RX   PubMed=8441612; DOI=10.1093/nar/21.1.170;\r\n",
      "RA   Roy N.K., Ballesteros A., Garte S.J.;\r\n",
      "RT   \"Cloning and sequence of the rat retinoblastoma (Rb) gene cDNA.\";\r\n",
      "RL   Nucleic Acids Res. 21:170-170(1993).\r\n",
      "RN   [4]\r\n",
      "RP   INTERACTION WITH RBBP9.\r\n",
      "RX   PubMed=9697699; DOI=10.1038/1258;\r\n",
      "RA   Woitach J.T., Zhang M., Niu C.-H., Thorgeirsson S.S.;\r\n",
      "RT   \"A retinoblastoma-binding protein that affects cell-cycle control and\r\n",
      "RT   confers transforming ability.\";\r\n",
      "RL   Nat. Genet. 19:371-374(1998).\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RN   [5]\r\n",
      "RP   PHOSPHORYLATION BY CDK1 AND CDK2, AND INTERACTION WITH CDK1 AND CDK2.\r\n",
      "RX   PubMed=10542199; DOI=10.1074/jbc.274.45.31775;\r\n",
      "RA   Choi K.S., Eom Y.W., Kang Y., Ha M.J., Rhee H., Yoon J.-W., Kim S.-J.;\r\n",
      "RT   \"Cdc2 and Cdk2 kinase activated by transforming growth factor-beta1 trigger\r\n",
      "RT   apoptosis through the phosphorylation of retinoblastoma protein in FaO\r\n",
      "RT   hepatoma cells.\";\r\n",
      "RL   J. Biol. Chem. 274:31775-31783(1999).\r\n",
      "RN   [6]\r\n",
      "RP   INTERACTION WITH DNMT1.\r\n",
      "RX   PubMed=10888886; DOI=10.1038/77124;\r\n",
      "RA   Robertson K.D., Ait-Si-Ali S., Yokochi T., Wade P.A., Jones P.L.,\r\n",
      "RA   Wolffe A.P.;\r\n",
      "RT   \"DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription\r\n",
      "RT   from E2F-responsive promoters.\";\r\n",
      "RL   Nat. Genet. 25:338-342(2000).\r\n",
      "RN   [7]\r\n",
      "RP   FUNCTION, INTERACTION WITH SMARCA4 AND HDAC1, PHOSPHORYLATION AT SER-787,\r\n",
      "RP   DEPHOSPHORYLATION, AND MUTAGENESIS OF SER-772; SER-780 AND SER-787.\r\n",
      "RX   PubMed=19081374; DOI=10.1016/j.neuron.2008.09.040;\r\n",
      "RA   Qiu Z., Ghosh A.;\r\n",
      "RT   \"A calcium-dependent switch in a CREST-BRG1 complex regulates activity-\r\n",
      "RT   dependent gene expression.\";\r\n",
      "RL   Neuron 60:775-787(2008).\r\n",
      "RN   [8]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; THR-363; THR-366 AND\r\n",
      "RP   SER-799, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=22673903; DOI=10.1038/ncomms1871;\r\n",
      "RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,\r\n",
      "RA   Olsen J.V.;\r\n",
      "RT   \"Quantitative maps of protein phosphorylation sites across 14 different rat\r\n",
      "RT   organs and tissues.\";\r\n",
      "RL   Nat. Commun. 3:876-876(2012).\r\n",
      "CC   -!- FUNCTION: Tumor suppressor that is a key regulator of the G1/S\r\n",
      "CC       transition of the cell cycle. The hypophosphorylated form binds\r\n",
      "CC       transcription regulators of the E2F family, preventing transcription of\r\n",
      "CC       E2F-responsive genes. Both physically blocks E2Fs transactivating\r\n",
      "CC       domain and recruits chromatin-modifying enzymes that actively repress\r\n",
      "CC       transcription. Cyclin and CDK-dependent phosphorylation of RB1 induces\r\n",
      "CC       its dissociation from E2Fs, thereby activating transcription of E2F\r\n",
      "CC       responsive genes and triggering entry into S phase. RB1 also promotes\r\n",
      "CC       the G0-G1 transition upon phosphorylation and activation by\r\n",
      "CC       CDK3/cyclin-C. Directly involved in heterochromatin formation by\r\n",
      "CC       maintaining overall chromatin structure and, in particular, that of\r\n",
      "CC       constitutive heterochromatin by stabilizing histone methylation.\r\n",
      "CC       Recruits and targets histone methyltransferases SUV39H1, KMT5B and\r\n",
      "CC       KMT5C, leading to epigenetic transcriptional repression. Controls\r\n",
      "CC       histone H4 'Lys-20' trimethylation. Inhibits the intrinsic kinase\r\n",
      "CC       activity of TAF1. Mediates transcriptional repression by SMARCA4/BRG1\r\n",
      "CC       by recruiting a histone deacetylase (HDAC) complex to the c-FOS\r\n",
      "CC       promoter (PubMed:19081374). In resting neurons, transcription of the c-\r\n",
      "CC       FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-\r\n",
      "CC       RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is\r\n",
      "CC       dephosphorylated by calcineurin, which leads to release of the\r\n",
      "CC       repressor complex (By similarity). {ECO:0000250|UniProtKB:P06400,\r\n",
      "CC       ECO:0000250|UniProtKB:P13405, ECO:0000269|PubMed:19081374}.\r\n",
      "CC   -!- SUBUNIT: The hypophosphorylated form interacts with and sequesters the\r\n",
      "CC       E2F1 transcription factor. Interacts with heterodimeric E2F/DP\r\n",
      "CC       transcription factor complexes containing TFDP1 and either E2F1, E2F3,\r\n",
      "CC       E2F4 or E2F5, or TFDP2 and E2F4. The unphosphorylated form interacts\r\n",
      "CC       with EID1, ARID3B, KDM5A, SUV39H1, MJD2A/JHDM3A and THOC1. Interacts\r\n",
      "CC       with the N-terminal domain of TAF1. Interacts with SNW1, ATAD5, AATF,\r\n",
      "CC       DNMT1, LIN9, LMNA, KMT5B, KMT5C, PELP1, UHRF2 and TMPO-alpha. May\r\n",
      "CC       interact with NDC80. Interacts with GRIP1 and UBR4. Interacts with\r\n",
      "CC       ARID4A and KDM5B. Interacts with E4F1, LIMD1 and USP4. Interacts with\r\n",
      "CC       PRMT2. Interacts (when methylated at Lys-852) with L3MBTL. Interacts\r\n",
      "CC       with CHEK2; phosphorylates RB1 (By similarity). Interacts with\r\n",
      "CC       SMARCA4/BRG1 and HDAC1. Binds to CDK1 and CDK2. P-TEFB complex\r\n",
      "CC       interacts with RB1; promotes phosphorylation of RB1 (By similarity).\r\n",
      "CC       Interacts with RBBP9; the interaction disrupts RB1 binding to E2F1\r\n",
      "CC       (PubMed:9697699). Interacts with KAT2B/PCAF and EP300/P300 (By\r\n",
      "CC       similarity). Interacts with PAX5 (By similarity).\r\n",
      "CC       {ECO:0000250|UniProtKB:P06400, ECO:0000250|UniProtKB:P13405,\r\n",
      "CC       ECO:0000269|PubMed:10542199, ECO:0000269|PubMed:10888886,\r\n",
      "CC       ECO:0000269|PubMed:19081374, ECO:0000269|PubMed:9697699}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       P33568; O09139: E2f1; NbExp=2; IntAct=EBI-1162932, EBI-1211101;\r\n",
      "CC       P33568; O88350: Rbbp9; NbExp=4; IntAct=EBI-1162932, EBI-1211014;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P13405}.\r\n",
      "CC   -!- PTM: Phosphorylated by CDK6 and CDK4, and subsequently by CDK2 at Ser-\r\n",
      "CC       560 in G1, thereby releasing E2F1 which is then able to activate cell\r\n",
      "CC       growth. Dephosphorylated at the late M phase. Phosphorylation of\r\n",
      "CC       threonine residues in domain C promotes interaction between the C-\r\n",
      "CC       terminal domain C and the Pocket domain, and thereby inhibits\r\n",
      "CC       interactions with heterodimeric E2F/DP transcription factor complexes.\r\n",
      "CC       CDK3/cyclin-C-mediated phosphorylation at Ser-799 and Ser-803 is\r\n",
      "CC       required for G0-G1 transition (By similarity). Dephosphorylated at Ser-\r\n",
      "CC       787 by calcineruin upon calcium stimulation. {ECO:0000250,\r\n",
      "CC       ECO:0000269|PubMed:10542199, ECO:0000269|PubMed:19081374}.\r\n",
      "CC   -!- PTM: N-terminus is methylated by METTL11A/NTM1. Monomethylation at Lys-\r\n",
      "CC       802 by SMYD2 enhances phosphorylation at Ser-799 and Ser-803, and\r\n",
      "CC       promotes cell cycle progression. Monomethylation at Lys-852 by SMYD2\r\n",
      "CC       promotes interaction with L3MBTL1 (By similarity). {ECO:0000250}.\r\n",
      "CC   -!- PTM: Acetylated during keratinocyte differentiation. Acetylation at\r\n",
      "CC       Ser-799 and Ser-803 regulates subcellular localization. Can be\r\n",
      "CC       deacetylated by SIRT1. {ECO:0000250|UniProtKB:P06400}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; D25233; BAA04958.1; -; mRNA.\r\n",
      "DR   EMBL; L07126; AAA42090.1; -; mRNA.\r\n",
      "DR   PIR; S35544; S35544.\r\n",
      "DR   RefSeq; NP_058741.1; NM_017045.1.\r\n",
      "DR   AlphaFoldDB; P33568; -.\r\n",
      "DR   SMR; P33568; -.\r\n",
      "DR   BioGRID; 246837; 5.\r\n",
      "DR   IntAct; P33568; 3.\r\n",
      "DR   STRING; 10116.ENSRNOP00000021752; -.\r\n",
      "DR   iPTMnet; P33568; -.\r\n",
      "DR   PhosphoSitePlus; P33568; -.\r\n",
      "DR   PaxDb; P33568; -.\r\n",
      "DR   DNASU; 24708; -.\r\n",
      "DR   Ensembl; ENSRNOT00000021752.6; ENSRNOP00000021752.6; ENSRNOG00000016029.6.\r\n",
      "DR   GeneID; 24708; -.\r\n",
      "DR   KEGG; rno:24708; -.\r\n",
      "DR   UCSC; RGD:3540; rat.\r\n",
      "DR   AGR; RGD:3540; -.\r\n",
      "DR   CTD; 5925; -.\r\n",
      "DR   RGD; 3540; Rb1.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   InParanoid; P33568; -.\r\n",
      "DR   OMA; VKDIGCI; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; P33568; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   Reactome; R-RNO-113501; Inhibition of replication initiation of damaged DNA by RB1/E2F1.\r\n",
      "DR   Reactome; R-RNO-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.\r\n",
      "DR   Reactome; R-RNO-2299718; Condensation of Prophase Chromosomes.\r\n",
      "DR   Reactome; R-RNO-2559584; Formation of Senescence-Associated Heterochromatin Foci (SAHF).\r\n",
      "DR   Reactome; R-RNO-69200; Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes.\r\n",
      "DR   Reactome; R-RNO-69202; Cyclin E associated events during G1/S transition.\r\n",
      "DR   Reactome; R-RNO-69231; Cyclin D associated events in G1.\r\n",
      "DR   Reactome; R-RNO-69656; Cyclin A:Cdk2-associated events at S phase entry.\r\n",
      "DR   PRO; PR:P33568; -.\r\n",
      "DR   Proteomes; UP000002494; Chromosome 15.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0061793; C:chromatin lock complex; ISO:RGD.\r\n",
      "DR   GO; GO:0008024; C:cyclin/CDK positive transcription elongation factor complex; IEA:Ensembl.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; ISO:RGD.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IDA:RGD.\r\n",
      "DR   GO; GO:0016605; C:PML body; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0005819; C:spindle; ISO:RGD.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.\r\n",
      "DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.\r\n",
      "DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.\r\n",
      "DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.\r\n",
      "DR   GO; GO:0061676; F:importin-alpha family protein binding; ISO:RGD.\r\n",
      "DR   GO; GO:0019900; F:kinase binding; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.\r\n",
      "DR   GO; GO:0051219; F:phosphoprotein binding; ISO:RGD.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.\r\n",
      "DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.\r\n",
      "DR   GO; GO:0003180; P:aortic valve morphogenesis; ISO:RGD.\r\n",
      "DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0051301; P:cell division; ISO:RGD.\r\n",
      "DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.\r\n",
      "DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISO:RGD.\r\n",
      "DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; ISO:RGD.\r\n",
      "DR   GO; GO:0002062; P:chondrocyte differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0051276; P:chromosome organization; ISO:RGD.\r\n",
      "DR   GO; GO:0048565; P:digestive tract development; ISO:RGD.\r\n",
      "DR   GO; GO:0043353; P:enucleate erythrocyte differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.\r\n",
      "DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; ISO:RGD.\r\n",
      "DR   GO; GO:0034349; P:glial cell apoptotic process; ISO:RGD.\r\n",
      "DR   GO; GO:0014009; P:glial cell proliferation; ISO:RGD.\r\n",
      "DR   GO; GO:0097284; P:hepatocyte apoptotic process; ISO:RGD.\r\n",
      "DR   GO; GO:0031507; P:heterochromatin formation; ISO:RGD.\r\n",
      "DR   GO; GO:0034088; P:maintenance of mitotic sister chromatid cohesion; ISO:RGD.\r\n",
      "DR   GO; GO:0045445; P:myoblast differentiation; ISS:UniProtKB.\r\n",
      "DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IMP:ARUK-UCL.\r\n",
      "DR   GO; GO:0045786; P:negative regulation of cell cycle; IMP:ARUK-UCL.\r\n",
      "DR   GO; GO:0030308; P:negative regulation of cell growth; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.\r\n",
      "DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.\r\n",
      "DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; ISO:RGD.\r\n",
      "DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.\r\n",
      "DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; ISO:RGD.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; ISO:RGD.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.\r\n",
      "DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; ISO:RGD.\r\n",
      "DR   GO; GO:1903944; P:negative regulation of hepatocyte apoptotic process; IMP:RGD.\r\n",
      "DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.\r\n",
      "DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; ISO:RGD.\r\n",
      "DR   GO; GO:1904761; P:negative regulation of myofibroblast differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0006469; P:negative regulation of protein kinase activity; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IMP:ARUK-UCL.\r\n",
      "DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; ISO:RGD.\r\n",
      "DR   GO; GO:1902948; P:negative regulation of tau-protein kinase activity; IMP:ARUK-UCL.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.\r\n",
      "DR   GO; GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; ISO:RGD.\r\n",
      "DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.\r\n",
      "DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0042551; P:neuron maturation; ISO:RGD.\r\n",
      "DR   GO; GO:0031175; P:neuron projection development; ISO:RGD.\r\n",
      "DR   GO; GO:1904028; P:positive regulation of collagen fibril organization; ISO:RGD.\r\n",
      "DR   GO; GO:1903055; P:positive regulation of extracellular matrix organization; ISO:RGD.\r\n",
      "DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; ISO:RGD.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.\r\n",
      "DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; ISO:RGD.\r\n",
      "DR   GO; GO:0071459; P:protein localization to chromosome, centromeric region; ISO:RGD.\r\n",
      "DR   GO; GO:0007265; P:Ras protein signal transduction; ISO:RGD.\r\n",
      "DR   GO; GO:0051726; P:regulation of cell cycle; ISO:RGD.\r\n",
      "DR   GO; GO:0001558; P:regulation of cell growth; ISO:RGD.\r\n",
      "DR   GO; GO:0071922; P:regulation of cohesin loading; ISO:RGD.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0007346; P:regulation of mitotic cell cycle; ISO:RGD.\r\n",
      "DR   GO; GO:0031134; P:sister chromatid biorientation; ISO:RGD.\r\n",
      "DR   GO; GO:0035914; P:skeletal muscle cell differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0007224; P:smoothened signaling pathway; ISO:RGD.\r\n",
      "DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.\r\n",
      "DR   GO; GO:0051146; P:striated muscle cell differentiation; ISO:RGD.\r\n",
      "DR   GO; GO:0001894; P:tissue homeostasis; ISO:RGD.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.\r\n",
      "DR   CDD; cd20599; CYCLIN_RB; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 6.10.140.1380; -; 1.\r\n",
      "DR   Gene3D; 6.10.250.530; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 2.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Acetylation; Cell cycle; Chromatin regulator; DNA-binding; Methylation;\r\n",
      "KW   Nucleus; Phosphoprotein; Reference proteome; Repressor; Transcription;\r\n",
      "KW   Transcription regulation; Tumor suppressor.\r\n",
      "FT   INIT_MET        1\r\n",
      "FT                   /note=\"Removed\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   CHAIN           2..920\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein\"\r\n",
      "FT                   /id=\"PRO_0000167838\"\r\n",
      "FT   REGION          1..34\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          340..362\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          366..763\r\n",
      "FT                   /note=\"Pocket; binds T and E1A\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          366..572\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          573..631\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          632..763\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          755..920\r\n",
      "FT                   /note=\"Interaction with LIMD1\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          763..920\r\n",
      "FT                   /note=\"Domain C; mediates interaction with E4F1\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          895..920\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOTIF           852..868\r\n",
      "FT                   /note=\"Bipartite nuclear localization signal\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   COMPBIAS        1..25\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        340..355\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        895..910\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         2\r\n",
      "FT                   /note=\"N,N-dimethylproline\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   MOD_RES         30\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         242\r\n",
      "FT                   /note=\"Phosphoserine; by CDK1\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         245\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK1\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         349\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         363\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         366\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         560\r\n",
      "FT                   /note=\"Phosphoserine; by CDK2\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         600\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   MOD_RES         604\r\n",
      "FT                   /note=\"Phosphoserine; by CHEK2 and CHEK1\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         616\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         772\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400, ECO:0000255\"\r\n",
      "FT   MOD_RES         780\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400, ECO:0000255\"\r\n",
      "FT   MOD_RES         787\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:19081374\"\r\n",
      "FT   MOD_RES         799\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         802\r\n",
      "FT                   /note=\"N6-methyllysine; by SMYD2\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         803\r\n",
      "FT                   /note=\"Phosphoserine; by CDK1 and CDK3\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         813\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK6\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         815\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         818\r\n",
      "FT                   /note=\"Phosphothreonine; by CDK4\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         833\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         847\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         852\r\n",
      "FT                   /note=\"N6-methyllysine; by SMYD2\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         865\r\n",
      "FT                   /note=\"N6-acetyllysine; by PCAF\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MOD_RES         866\r\n",
      "FT                   /note=\"N6-acetyllysine; by PCAF\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P06400\"\r\n",
      "FT   MUTAGEN         772\r\n",
      "FT                   /note=\"S->A: Decreased association with HDAC1; when\r\n",
      "FT                   associated with A-780 and A-787.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:19081374\"\r\n",
      "FT   MUTAGEN         780\r\n",
      "FT                   /note=\"S->A: Decreased association with HDAC1; when\r\n",
      "FT                   associated with A-772 and A-787.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:19081374\"\r\n",
      "FT   MUTAGEN         787\r\n",
      "FT                   /note=\"S->A: Decreased association with HDAC1; when\r\n",
      "FT                   associated with A-772 and A-780.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:19081374\"\r\n",
      "FT   CONFLICT        668\r\n",
      "FT                   /note=\"L -> P (in Ref. 2; BAA04958)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        798\r\n",
      "FT                   /note=\"I -> M (in Ref. 2; BAA04958)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        866..867\r\n",
      "FT                   /note=\"KL -> TW (in Ref. 3; AAA42090)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   920 AA;  105025 MW;  3BA735EA59927301 CRC64;\r\n",
      "     MPPKAPRRTA AAEPPPPPPP PPEDDPAQDS DPEELPLIRL EFEKIEEPEF IALCQKLKVP\r\n",
      "     DHVRERAWLT WEKVSSVDGI LEGYIQKKKE LWGICIFIAA VDLDEMPFTF TELQKSIETS\r\n",
      "     VYKFFDLLKE IDTSTKVDNA VSRLLKKYNV LCALYSKLER TCGLIYLTQP SSGLSTEINS\r\n",
      "     MLVLKVSWIT FLLAKGEVVQ MEDDLVISFQ LMLCVLDYFI KLSPPALLRE PYKTAATPIN\r\n",
      "     GSPRTPRRGQ NRSARIAKQL ESDTRTIEVL CKEHECNVDE VKNVYFKNFI PFISSLGIVS\r\n",
      "     SNGLPELESL SKRYEEVYLK SKDLDARLFL DHDKTLQTDT IDSFETERTP RKSNPDEEAN\r\n",
      "     MVTPHTPVRT VMNTIQQLMV ILNSASDQPS ENLISYFSNC TVNPKENILK RVKDVGHIFK\r\n",
      "     EKFASAVGQG CIDIGAQRYK LGVRLYYRVM ESMLKSEEER LSIQNFSKLL NDNIFHMSLL\r\n",
      "     ACALEVVMAT YSRSMLQNLD SGTDLSFPWI LNVLNLKAFD FYKVIESFIK VEANLTREMI\r\n",
      "     KHLERCEHRI MESLAWLSDS PLFDLIKQSK DGEGPDHLES ACSLSLPLQS NHTAADMYLS\r\n",
      "     PIRSPKKRTS TTRVNSAANT ETQAASAFHT QKPLKSTSLS LFYKKVYRLA YLRLNTLCAR\r\n",
      "     LLSDHPELEH IIWTLFQHTL ENEYELMKDR HLDQIMMCSM YGICKVKNID LKFKIIVTAY\r\n",
      "     KDLPHAAQET FKRVLIREEE FDSIIVFYNS VFMQRLKTNI LQYASTRPPT LSPIPHIPRS\r\n",
      "     PYKFSSSPLR IPGGNIYISP LKSPYKISEG LPTPTKMTPR SRILVSIGES FGTSEKFQKI\r\n",
      "     NQMVCNSDRV LKRSAEGGNP PKPLKKLRFD IEGSDEADGS KHLPAESKFQ QKLAEMTSTR\r\n",
      "     TRMQKQKLND SMEISNKEEK\r\n",
      "//\r\n",
      "ID   RBL1_MOUSE              Reviewed;        1063 AA.\r\n",
      "AC   Q64701; Q3U1D4;\r\n",
      "DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   27-JUL-2011, sequence version 3.\r\n",
      "DT   03-MAY-2023, entry version 188.\r\n",
      "DE   RecName: Full=Retinoblastoma-like protein 1;\r\n",
      "DE   AltName: Full=107 kDa retinoblastoma-associated protein;\r\n",
      "DE            Short=p107;\r\n",
      "DE   AltName: Full=pRb1;\r\n",
      "GN   Name=Rbl1;\r\n",
      "OS   Mus musculus (Mouse).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Mus; Mus.\r\n",
      "OX   NCBI_TaxID=10090;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RC   STRAIN=BALB/cJ;\r\n",
      "RX   PubMed=8661722; DOI=10.1007/s003359900102;\r\n",
      "RA   Huppi K., Siwarski D., Mock B.A., Dosik J., Hamel P.A.;\r\n",
      "RT   \"Molecular cloning, chromosomal mapping, and expression of the mouse p107\r\n",
      "RT   gene.\";\r\n",
      "RL   Mamm. Genome 7:353-355(1996).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT).\r\n",
      "RX   PubMed=7490090; DOI=10.1006/geno.1995.1184;\r\n",
      "RA   Kim K.K., Soonpaa M.H., Wang H., Field L.J.;\r\n",
      "RT   \"Developmental expression of p107 mRNA and evidence for alternative\r\n",
      "RT   splicing of the p107 (RBL1) gene product.\";\r\n",
      "RL   Genomics 28:520-529(1995).\r\n",
      "RN   [3]\r\n",
      "RP   SEQUENCE REVISION.\r\n",
      "RA   Kim K.K., Soonpaa M.H., Wang H., Field L.J.;\r\n",
      "RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\r\n",
      "RC   STRAIN=NOD; TISSUE=Spleen;\r\n",
      "RX   PubMed=16141072; DOI=10.1126/science.1112014;\r\n",
      "RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,\r\n",
      "RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,\r\n",
      "RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,\r\n",
      "RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,\r\n",
      "RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,\r\n",
      "RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,\r\n",
      "RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,\r\n",
      "RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,\r\n",
      "RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,\r\n",
      "RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,\r\n",
      "RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,\r\n",
      "RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,\r\n",
      "RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,\r\n",
      "RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,\r\n",
      "RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,\r\n",
      "RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,\r\n",
      "RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,\r\n",
      "RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,\r\n",
      "RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,\r\n",
      "RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,\r\n",
      "RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,\r\n",
      "RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,\r\n",
      "RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,\r\n",
      "RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,\r\n",
      "RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,\r\n",
      "RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,\r\n",
      "RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,\r\n",
      "RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,\r\n",
      "RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,\r\n",
      "RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,\r\n",
      "RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,\r\n",
      "RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,\r\n",
      "RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,\r\n",
      "RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;\r\n",
      "RT   \"The transcriptional landscape of the mammalian genome.\";\r\n",
      "RL   Science 309:1559-1563(2005).\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RC   STRAIN=C57BL/6J;\r\n",
      "RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;\r\n",
      "RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,\r\n",
      "RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,\r\n",
      "RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,\r\n",
      "RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,\r\n",
      "RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,\r\n",
      "RA   Eichler E.E., Ponting C.P.;\r\n",
      "RT   \"Lineage-specific biology revealed by a finished genome assembly of the\r\n",
      "RT   mouse.\";\r\n",
      "RL   PLoS Biol. 7:E1000112-E1000112(2009).\r\n",
      "RN   [6]\r\n",
      "RP   INTERACTION WITH USP4.\r\n",
      "RX   PubMed=11571651; DOI=10.1038/sj.onc.1204823;\r\n",
      "RA   Blanchette P., Gilchrist C.A., Baker R.T., Gray D.A.;\r\n",
      "RT   \"Association of UNP, a ubiquitin-specific protease, with the pocket\r\n",
      "RT   proteins pRb, p107 and p130.\";\r\n",
      "RL   Oncogene 20:5533-5537(2001).\r\n",
      "RN   [7]\r\n",
      "RP   FUNCTION, AND INTERACTION WITH KMT5B AND KMT5C.\r\n",
      "RX   PubMed=15750587; DOI=10.1038/ncb1235;\r\n",
      "RA   Gonzalo S., Garcia-Cao M., Fraga M.F., Schotta G., Peters A.H.F.M.,\r\n",
      "RA   Cotter S.E., Eguia R., Dean D.C., Esteller M., Jenuwein T., Blasco M.A.;\r\n",
      "RT   \"Role of the RB1 family in stabilizing histone methylation at constitutive\r\n",
      "RT   heterochromatin.\";\r\n",
      "RL   Nat. Cell Biol. 7:420-428(2005).\r\n",
      "RN   [8]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1036, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;\r\n",
      "RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;\r\n",
      "RT   \"Large-scale phosphorylation analysis of mouse liver.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).\r\n",
      "RN   [9]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-332; SER-959 AND SER-1036,\r\n",
      "RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Kidney, Lung, Spleen, and Testis;\r\n",
      "RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;\r\n",
      "RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,\r\n",
      "RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;\r\n",
      "RT   \"A tissue-specific atlas of mouse protein phosphorylation and expression.\";\r\n",
      "RL   Cell 143:1174-1189(2010).\r\n",
      "CC   -!- FUNCTION: Key regulator of entry into cell division (By similarity).\r\n",
      "CC       Directly involved in heterochromatin formation by maintaining overall\r\n",
      "CC       chromatin structure and, in particular, that of constitutive\r\n",
      "CC       heterochromatin by stabilizing histone methylation (PubMed:15750587).\r\n",
      "CC       Recruits and targets histone methyltransferases KMT5B and KMT5C,\r\n",
      "CC       leading to epigenetic transcriptional repression (PubMed:15750587).\r\n",
      "CC       Controls histone H4 'Lys-20' trimethylation (PubMed:15750587). Probably\r\n",
      "CC       acts as a transcription repressor by recruiting chromatin-modifying\r\n",
      "CC       enzymes to promoters (PubMed:15750587). Potent inhibitor of E2F-\r\n",
      "CC       mediated trans-activation (By similarity). May act as a tumor\r\n",
      "CC       suppressor (By similarity). {ECO:0000250|UniProtKB:P28749,\r\n",
      "CC       ECO:0000269|PubMed:15750587}.\r\n",
      "CC   -!- SUBUNIT: Component of the DREAM complex (also named LINC complex) at\r\n",
      "CC       least composed of E2F4, E2F5, LIN9, LIN37, LIN52, LIN54, MYBL1, MYBL2,\r\n",
      "CC       RBL1, RBL2, RBBP4, TFDP1 and TFDP2 (By similarity). The complex exists\r\n",
      "CC       in quiescent cells where it represses cell cycle-dependent genes (By\r\n",
      "CC       similarity). It dissociates in S phase when LIN9, LIN37, LIN52 and\r\n",
      "CC       LIN54 form a subcomplex that binds to MYBL2 (By similarity). Interacts\r\n",
      "CC       with AATF (By similarity). Interacts with KDM5A (By similarity).\r\n",
      "CC       Interacts with KMT5B and KMT5C (PubMed:11571651). Interacts with USP4\r\n",
      "CC       (PubMed:15750587). Interacts with RBBP9 (By similarity).\r\n",
      "CC       {ECO:0000250|UniProtKB:D3ZS28, ECO:0000250|UniProtKB:P28749,\r\n",
      "CC       ECO:0000269|PubMed:11571651, ECO:0000269|PubMed:15750587}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q64701; Q155P7: Cenpf; NbExp=3; IntAct=EBI-1213109, EBI-2211248;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=2;\r\n",
      "CC       Name=Long;\r\n",
      "CC         IsoId=Q64701-1; Sequence=Displayed;\r\n",
      "CC       Name=Short;\r\n",
      "CC         IsoId=Q64701-2; Sequence=VSP_005537, VSP_005538;\r\n",
      "CC   -!- TISSUE SPECIFICITY: Highly expressed in fetal heart and liver.\r\n",
      "CC       Expressed at low levels in all other fetal tissues except skeletal\r\n",
      "CC       muscle. High levels in neonatal spleen and thymus with low levels in\r\n",
      "CC       other tissues. In adult, highly expressed in testis. Barely detectable\r\n",
      "CC       in other tissues.\r\n",
      "CC   -!- DEVELOPMENTAL STAGE: Highly expressed in fetal tissues. Expression\r\n",
      "CC       markedly decreased in adult.\r\n",
      "CC   -!- PTM: Cell-cycle arrest properties are inactivated by phosphorylation on\r\n",
      "CC       Thr-332, Ser-640, Ser-959 and Ser-970 by CDK4.\r\n",
      "CC       {ECO:0000250|UniProtKB:P28749}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; U33320; AAB18279.1; -; mRNA.\r\n",
      "DR   EMBL; U27177; AAB53235.1; -; mRNA.\r\n",
      "DR   EMBL; U27178; AAB53236.1; -; mRNA.\r\n",
      "DR   EMBL; AK156055; BAE33564.1; -; mRNA.\r\n",
      "DR   EMBL; AL669828; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DR   CCDS; CCDS16974.1; -. [Q64701-1]\r\n",
      "DR   PIR; I49328; I49328.\r\n",
      "DR   RefSeq; NP_001132988.1; NM_001139516.1. [Q64701-2]\r\n",
      "DR   RefSeq; NP_035379.2; NM_011249.2. [Q64701-1]\r\n",
      "DR   AlphaFoldDB; Q64701; -.\r\n",
      "DR   SMR; Q64701; -.\r\n",
      "DR   BioGRID; 202819; 28.\r\n",
      "DR   CORUM; Q64701; -.\r\n",
      "DR   IntAct; Q64701; 4.\r\n",
      "DR   STRING; 10090.ENSMUSP00000029170; -.\r\n",
      "DR   GlyGen; Q64701; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; Q64701; -.\r\n",
      "DR   PhosphoSitePlus; Q64701; -.\r\n",
      "DR   EPD; Q64701; -.\r\n",
      "DR   jPOST; Q64701; -.\r\n",
      "DR   MaxQB; Q64701; -.\r\n",
      "DR   PaxDb; Q64701; -.\r\n",
      "DR   PeptideAtlas; Q64701; -.\r\n",
      "DR   ProteomicsDB; 300314; -. [Q64701-1]\r\n",
      "DR   ProteomicsDB; 300315; -. [Q64701-2]\r\n",
      "DR   Antibodypedia; 11876; 440 antibodies from 35 providers.\r\n",
      "DR   DNASU; 19650; -.\r\n",
      "DR   Ensembl; ENSMUST00000029170.8; ENSMUSP00000029170.8; ENSMUSG00000027641.14.\r\n",
      "DR   GeneID; 19650; -.\r\n",
      "DR   KEGG; mmu:19650; -.\r\n",
      "DR   UCSC; uc008noq.2; mouse. [Q64701-1]\r\n",
      "DR   UCSC; uc008nos.2; mouse. [Q64701-2]\r\n",
      "DR   AGR; MGI:103300; -.\r\n",
      "DR   CTD; 5933; -.\r\n",
      "DR   MGI; MGI:103300; Rbl1.\r\n",
      "DR   VEuPathDB; HostDB:ENSMUSG00000027641; -.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00950000183202; -.\r\n",
      "DR   HOGENOM; CLU_008943_0_1_1; -.\r\n",
      "DR   InParanoid; Q64701; -.\r\n",
      "DR   OMA; AILCELH; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; Q64701; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   Reactome; R-MMU-1538133; G0 and Early G1.\r\n",
      "DR   Reactome; R-MMU-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.\r\n",
      "DR   Reactome; R-MMU-69231; Cyclin D associated events in G1.\r\n",
      "DR   BioGRID-ORCS; 19650; 6 hits in 80 CRISPR screens.\r\n",
      "DR   ChiTaRS; Rbl1; mouse.\r\n",
      "DR   PRO; PR:Q64701; -.\r\n",
      "DR   Proteomes; UP000000589; Chromosome 2.\r\n",
      "DR   RNAct; Q64701; protein.\r\n",
      "DR   Bgee; ENSMUSG00000027641; Expressed in paneth cell and 199 other tissues.\r\n",
      "DR   Genevisible; Q64701; MM.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IDA:MGI.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; IDA:MGI.\r\n",
      "DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:MGI.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:2000773; P:negative regulation of cellular senescence; ISO:MGI.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:MGI.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:MGI.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; ISO:MGI.\r\n",
      "DR   CDD; cd20605; CYCLIN_RBL1; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 3.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   PANTHER; PTHR13742:SF20; RETINOBLASTOMA-LIKE PROTEIN 1; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Alternative splicing; Cell cycle; Chromatin regulator; Nucleus;\r\n",
      "KW   Phosphoprotein; Reference proteome; Repressor; Transcription;\r\n",
      "KW   Transcription regulation; Tumor suppressor.\r\n",
      "FT   CHAIN           1..1063\r\n",
      "FT                   /note=\"Retinoblastoma-like protein 1\"\r\n",
      "FT                   /id=\"PRO_0000167840\"\r\n",
      "FT   REGION          383..944\r\n",
      "FT                   /note=\"Pocket; binds T and E1A\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   REGION          383..584\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   REGION          585..779\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   REGION          780..944\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   MOD_RES         332\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         369\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         385\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         640\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         650\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         748\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         761\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         959\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         970\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         983\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         992\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         1004\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         1036\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355,\r\n",
      "FT                   ECO:0007744|PubMed:21183079\"\r\n",
      "FT   VAR_SEQ         592..594\r\n",
      "FT                   /note=\"IFP -> SQG (in isoform Short)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:7490090\"\r\n",
      "FT                   /id=\"VSP_005537\"\r\n",
      "FT   VAR_SEQ         595..1063\r\n",
      "FT                   /note=\"Missing (in isoform Short)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:7490090\"\r\n",
      "FT                   /id=\"VSP_005538\"\r\n",
      "FT   CONFLICT        26\r\n",
      "FT                   /note=\"Q -> P (in Ref. 1; AAB18279)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        430\r\n",
      "FT                   /note=\"I -> T (in Ref. 1; AAB18279)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        863\r\n",
      "FT                   /note=\"I -> R (in Ref. 2; AAB53235)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        989\r\n",
      "FT                   /note=\"A -> C (in Ref. 1; AAB18279)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   1063 AA;  119456 MW;  85BEA8EC064EC06E CRC64;\r\n",
      "     MFEDEPHAEG AAAVAAAREA LQALCQELNL DEGSAAEALD DFTAIRGNYS LEGEVIHWLA\r\n",
      "     CSLYVACRKS IIPTVGKGVM EGNCVSLTRI LRSAKLSLIQ FFSKMKKWMD MSNLPQEFRE\r\n",
      "     RIERLERNFE VSTVIFKKFE PIFLDIFQNP YEEPPKLPRS RKQRRIPCSV KDLFNFCWTL\r\n",
      "     FVYTKGNFRM IGDDLVNSYH LLLCCLDLIF ANAIMCPNRR DLLNPSFKGL PSDFHAPDFK\r\n",
      "     AAEEPPCIIA VLCDLHDGLL VEAKGIKEHY FKPYISKLFD KKILKGECLL DLSSFTDNSK\r\n",
      "     AVNKEYEEYV LTVGDFDERI FLGADAEEEI GTPRKFTADT PFGKLTSQAS VECNLQQHFE\r\n",
      "     KKRSFAPSTP LTGRRYLQEK EAVTTPVASA TQSVSRLQSI VAGLKSAPSE QLLNIFESCM\r\n",
      "     RNPMGNIIKI VKGIGETFCQ HYTQSTDKQP GSHIDFAVNR LKLAEILYYK ILETIMVQET\r\n",
      "     RRLHGMDMSV LLEQDIFHKS LMACCLEIVL FAYSSPRTFP WIIEVLDLQP FYFYKVIEVV\r\n",
      "     IRSEEGLSRD MVKHLNSIEE QILESLAWTN NSALWEALHA SANRVPSCEE VIFPNNFEIG\r\n",
      "     NGGNVQGHLP MMPMSPIIHP RVKEVRTDSG SLRQDMQPLS PISVHERYSS PAAGSAKRRL\r\n",
      "     FGDDPPKDTL MDKIMAEGTK LKIAPSSVTA ESLSISPGQA LLTMATTTVT GTTGRKVTVP\r\n",
      "     LHGIANDAGE ITLVPISMNP TQESTAESPV SLTAQSLIGT SPKQTHLTKA QDAHLTGVSK\r\n",
      "     PKRTGSLALF YRKVYHLASV RLRDLCLKLD VSNELRRKIW TCFEFTLVHC PDLMKDRHLD\r\n",
      "     QLLLCAFYIM AKVTKEERTF QEIMKSYRNQ PQANSHVYRS VLLKSIPGGV VVYNGDCEMT\r\n",
      "     DGDIEDATKT PNCSSEPVKE ERGDLIKFYN TVYVGRVKSF ALKYDLSNQD HIMDAPPLSP\r\n",
      "     FPHIKQQPGS PRRISQQHSL YVSPHKNGAG LTPRSALLYK FNGSPSKSLK DINNMIRQGE\r\n",
      "     QKTKKRVIAI SGDADSPAKR LCQENDDVLL KRLQDVVSER ANH\r\n",
      "//\r\n",
      "ID   NDC80_HUMAN             Reviewed;         642 AA.\r\n",
      "AC   O14777; Q6PJX2;\r\n",
      "DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   01-JAN-1998, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 188.\r\n",
      "DE   RecName: Full=Kinetochore protein NDC80 homolog;\r\n",
      "DE   AltName: Full=Highly expressed in cancer protein;\r\n",
      "DE   AltName: Full=Kinetochore protein Hec1;\r\n",
      "DE            Short=HsHec1;\r\n",
      "DE   AltName: Full=Kinetochore-associated protein 2;\r\n",
      "DE   AltName: Full=Retinoblastoma-associated protein HEC;\r\n",
      "GN   Name=NDC80; Synonyms=HEC, HEC1, KNTC2;\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND\r\n",
      "RP   DEVELOPMENTAL STAGE.\r\n",
      "RX   PubMed=9315664; DOI=10.1128/mcb.17.10.6049;\r\n",
      "RA   Chen Y., Riley D.J., Chen P.-L., Lee W.-H.;\r\n",
      "RT   \"HEC, a novel nuclear protein rich in leucine heptad repeats specifically\r\n",
      "RT   involved in mitosis.\";\r\n",
      "RL   Mol. Cell. Biol. 17:6049-6056(1997).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\r\n",
      "RC   TISSUE=Brain, and Lymph;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [3]\r\n",
      "RP   INTERACTION WITH NEK2; PSMC2; PSMC5 AND SMC1A, SUBCELLULAR LOCATION, AND\r\n",
      "RP   DEVELOPMENTAL STAGE.\r\n",
      "RX   PubMed=9295362; DOI=10.1074/jbc.272.38.24081;\r\n",
      "RA   Chen Y., Sharp Z.D., Lee W.-H.;\r\n",
      "RT   \"HEC binds to the seventh regulatory subunit of the 26 S proteasome and\r\n",
      "RT   modulates the proteolysis of mitotic cyclins.\";\r\n",
      "RL   J. Biol. Chem. 272:24081-24087(1997).\r\n",
      "RN   [4]\r\n",
      "RP   INTERACTION WITH NEK2; PSMC2; PSMC5; RB1 AND SMC1A.\r\n",
      "RX   PubMed=10409732; DOI=10.1128/mcb.19.8.5417;\r\n",
      "RA   Zheng L., Chen Y., Lee W.-H.;\r\n",
      "RT   \"Hec1p, an evolutionarily conserved coiled-coil protein, modulates\r\n",
      "RT   chromosome segregation through interaction with SMC proteins.\";\r\n",
      "RL   Mol. Cell. Biol. 19:5417-5428(1999).\r\n",
      "RN   [5]\r\n",
      "RP   INTERACTION WITH RB1 AND SMC1A, AND MUTAGENESIS OF GLU-234.\r\n",
      "RX   PubMed=10779342; DOI=10.1128/mcb.20.10.3529-3537.2000;\r\n",
      "RA   Zheng L., Chen Y., Riley D.J., Chen P.-L., Lee W.-H.;\r\n",
      "RT   \"Retinoblastoma protein enhances the fidelity of chromosome segregation\r\n",
      "RT   mediated by hsHec1p.\";\r\n",
      "RL   Mol. Cell. Biol. 20:3529-3537(2000).\r\n",
      "RN   [6]\r\n",
      "RP   INTERACTION WITH NEK2, AND PHOSPHORYLATION AT SER-165 BY NEK2.\r\n",
      "RX   PubMed=12386167; DOI=10.1074/jbc.m207069200;\r\n",
      "RA   Chen Y., Riley D.J., Zheng L., Chen P.-L., Lee W.-H.;\r\n",
      "RT   \"Phosphorylation of the mitotic regulator protein Hec1 by Nek2 kinase is\r\n",
      "RT   essential for faithful chromosome segregation.\";\r\n",
      "RL   J. Biol. Chem. 277:49408-49416(2002).\r\n",
      "RN   [7]\r\n",
      "RP   FUNCTION, AND SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=12351790; DOI=10.1126/science.1075596;\r\n",
      "RA   Martin-Lluesma S., Stucke V.M., Nigg E.A.;\r\n",
      "RT   \"Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment\r\n",
      "RT   of Mad1/Mad2.\";\r\n",
      "RL   Science 297:2267-2270(2002).\r\n",
      "RN   [8]\r\n",
      "RP   FUNCTION, AND SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=14654001; DOI=10.1016/j.cub.2003.10.056;\r\n",
      "RA   DeLuca J.G., Howell B.J., Canman J.C., Hickey J.M., Fang G., Salmon E.D.;\r\n",
      "RT   \"Nuf2 and Hec1 are required for retention of the checkpoint proteins Mad1\r\n",
      "RT   and Mad2 to kinetochores.\";\r\n",
      "RL   Curr. Biol. 13:2103-2109(2003).\r\n",
      "RN   [9]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=15235793; DOI=10.1007/s00412-004-0288-2;\r\n",
      "RA   Stucke V.M., Baumann C., Nigg E.A.;\r\n",
      "RT   \"Kinetochore localization and microtubule interaction of the human spindle\r\n",
      "RT   checkpoint kinase Mps1.\";\r\n",
      "RL   Chromosoma 113:1-15(2004).\r\n",
      "RN   [10]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=15062103; DOI=10.1016/j.cub.2004.03.031;\r\n",
      "RA   Joseph J., Liu S.-T., Jablonski S.A., Yen T.J., Dasso M.;\r\n",
      "RT   \"The RanGAP1-RanBP2 complex is essential for microtubule-kinetochore\r\n",
      "RT   interactions in vivo.\";\r\n",
      "RL   Curr. Biol. 14:611-617(2004).\r\n",
      "RN   [11]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=15239953; DOI=10.1016/j.devcel.2004.06.006;\r\n",
      "RA   Meraldi P., Draviam V.M., Sorger P.K.;\r\n",
      "RT   \"Timing and checkpoints in the regulation of mitotic progression.\";\r\n",
      "RL   Dev. Cell 7:45-60(2004).\r\n",
      "RN   [12]\r\n",
      "RP   SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=15133482; DOI=10.1038/sj.embor.7400154;\r\n",
      "RA   Steensgaard P., Garre M., Muradore I., Transidico P., Nigg E.A.,\r\n",
      "RA   Kitagawa K., Earnshaw W.C., Faretta M., Musacchio A.;\r\n",
      "RT   \"Sgt1 is required for human kinetochore assembly.\";\r\n",
      "RL   EMBO Rep. 5:626-631(2004).\r\n",
      "RN   [13]\r\n",
      "RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE\r\n",
      "RP   NDC80 COMPLEX.\r\n",
      "RX   PubMed=14699129; DOI=10.1074/jbc.m310224200;\r\n",
      "RA   Bharadwaj R., Qi W., Yu H.;\r\n",
      "RT   \"Identification of two novel components of the human NDC80 kinetochore\r\n",
      "RT   complex.\";\r\n",
      "RL   J. Biol. Chem. 279:13076-13085(2004).\r\n",
      "RN   [14]\r\n",
      "RP   SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=14978040; DOI=10.1074/jbc.m314205200;\r\n",
      "RA   Lou Y., Yao J., Zereshki A., Dou Z., Ahmed K., Wang H., Hu J., Wang Y.,\r\n",
      "RA   Yao X.;\r\n",
      "RT   \"NEK2A interacts with MAD1 and possibly functions as a novel integrator of\r\n",
      "RT   the spindle checkpoint signaling.\";\r\n",
      "RL   J. Biol. Chem. 279:20049-20057(2004).\r\n",
      "RN   [15]\r\n",
      "RP   INTERACTION WITH AURKB AND CDCA1, AND PHOSPHORYLATION BY AURKA AND AURKB.\r\n",
      "RX   PubMed=14602875; DOI=10.1074/mcp.m300072-mcp200;\r\n",
      "RA   Tien A.-C., Lin M.-H., Su L.-J., Hong Y.-R., Cheng T.-S., Lee Y.-C.G.,\r\n",
      "RA   Lin W.-J., Still I.H., Huang C.-Y.F.;\r\n",
      "RT   \"Identification of the substrates and interaction proteins of aurora\r\n",
      "RT   kinases from a protein-protein interaction model.\";\r\n",
      "RL   Mol. Cell. Proteomics 3:93-104(2004).\r\n",
      "RN   [16]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN A COMPLEX WITH\r\n",
      "RP   MIS12.\r\n",
      "RX   PubMed=15502821; DOI=10.1038/ncb1187;\r\n",
      "RA   Obuse C., Iwasaki O., Kiyomitsu T., Goshima G., Toyoda Y., Yanagida M.;\r\n",
      "RT   \"A conserved Mis12 centromere complex is linked to heterochromatic HP1 and\r\n",
      "RT   outer kinetochore protein Zwint-1.\";\r\n",
      "RL   Nat. Cell Biol. 6:1135-1141(2004).\r\n",
      "RN   [17]\r\n",
      "RP   SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=15964272; DOI=10.1016/j.cub.2005.05.026;\r\n",
      "RA   Ahonen L.J., Kallio M.J., Daum J.R., Bolton M., Manke I.A., Yaffe M.B.,\r\n",
      "RA   Stukenberg P.T., Gorbsky G.J.;\r\n",
      "RT   \"Polo-like kinase 1 creates the tension-sensing 3F3/2 phosphoepitope and\r\n",
      "RT   modulates the association of spindle-checkpoint proteins at kinetochores.\";\r\n",
      "RL   Curr. Biol. 15:1078-1089(2005).\r\n",
      "RN   [18]\r\n",
      "RP   CHARACTERIZATION OF THE NDC80 COMPLEX, AND SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=15961401; DOI=10.1074/jbc.m504070200;\r\n",
      "RA   Ciferri C., De Luca J., Monzani S., Ferrari K.J., Ristic D., Wyman C.,\r\n",
      "RA   Stark H., Kilmartin J., Salmon E.D., Musacchio A.;\r\n",
      "RT   \"Architecture of the human Ndc80-Hec1 complex, a critical constituent of\r\n",
      "RT   the outer kinetochore.\";\r\n",
      "RL   J. Biol. Chem. 280:29088-29095(2005).\r\n",
      "RN   [19]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN A COMPLEX WITH\r\n",
      "RP   ZWINT.\r\n",
      "RX   PubMed=15824131; DOI=10.1083/jcb.200411118;\r\n",
      "RA   Kops G.J.P.L., Kim Y., Weaver B.A.A., Mao Y., McLeod I., Yates J.R. III,\r\n",
      "RA   Tagaya M., Cleveland D.W.;\r\n",
      "RT   \"ZW10 links mitotic checkpoint signaling to the structural kinetochore.\";\r\n",
      "RL   J. Cell Biol. 169:49-60(2005).\r\n",
      "RN   [20]\r\n",
      "RP   FUNCTION, AND SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=15548592; DOI=10.1091/mbc.e04-09-0852;\r\n",
      "RA   DeLuca J.G., Dong Y., Hergert P., Strauss J., Hickey J.M., Salmon E.D.,\r\n",
      "RA   McEwen B.F.;\r\n",
      "RT   \"Hec1 and Nuf2 are core components of the kinetochore outer plate essential\r\n",
      "RT   for organizing microtubule attachment sites.\";\r\n",
      "RL   Mol. Biol. Cell 16:519-531(2005).\r\n",
      "RN   [21]\r\n",
      "RP   INTERACTION WITH CENPH.\r\n",
      "RX   PubMed=15713649; DOI=10.1128/mcb.25.5.1958-1970.2005;\r\n",
      "RA   Mikami Y., Hori T., Kimura H., Fukagawa T.;\r\n",
      "RT   \"The functional region of CENP-H interacts with the Nuf2 complex that\r\n",
      "RT   localizes to centromere during mitosis.\";\r\n",
      "RL   Mol. Cell. Biol. 25:1958-1970(2005).\r\n",
      "RN   [22]\r\n",
      "RP   FUNCTION, INTERACTION WITH ZWINT, SUBCELLULAR LOCATION, AND DEVELOPMENTAL\r\n",
      "RP   STAGE.\r\n",
      "RX   PubMed=16732327; DOI=10.1038/sj.onc.1209687;\r\n",
      "RA   Lin Y.-T., Chen Y., Wu G., Lee W.-H.;\r\n",
      "RT   \"Hec1 sequentially recruits Zwint-1 and ZW10 to kinetochores for faithful\r\n",
      "RT   chromosome segregation and spindle checkpoint control.\";\r\n",
      "RL   Oncogene 25:6901-6914(2006).\r\n",
      "RN   [23]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-69, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;\r\n",
      "RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,\r\n",
      "RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;\r\n",
      "RT   \"Quantitative phosphoproteomics reveals widespread full phosphorylation\r\n",
      "RT   site occupancy during mitosis.\";\r\n",
      "RL   Sci. Signal. 3:RA3-RA3(2010).\r\n",
      "RN   [24]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;\r\n",
      "RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,\r\n",
      "RA   Bennett K.L., Superti-Furga G., Colinge J.;\r\n",
      "RT   \"Initial characterization of the human central proteome.\";\r\n",
      "RL   BMC Syst. Biol. 5:17-17(2011).\r\n",
      "RN   [25]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=23085020; DOI=10.1016/j.devcel.2012.09.012;\r\n",
      "RA   Schmidt J.C., Arthanari H., Boeszoermenyi A., Dashkevich N.M.,\r\n",
      "RA   Wilson-Kubalek E.M., Monnier N., Markus M., Oberer M., Milligan R.A.,\r\n",
      "RA   Bathe M., Wagner G., Grishchuk E.L., Cheeseman I.M.;\r\n",
      "RT   \"The kinetochore-bound Ska1 complex tracks depolymerizing microtubules and\r\n",
      "RT   binds to curved protofilaments.\";\r\n",
      "RL   Dev. Cell 23:968-980(2012).\r\n",
      "RN   [26]\r\n",
      "RP   INTERACTION WITH CDT1.\r\n",
      "RX   PubMed=22581055; DOI=10.1038/ncb2489;\r\n",
      "RA   Varma D., Chandrasekaran S., Sundin L.J., Reidy K.T., Wan X., Chasse D.A.,\r\n",
      "RA   Nevis K.R., DeLuca J.G., Salmon E.D., Cook J.G.;\r\n",
      "RT   \"Recruitment of the human Cdt1 replication licensing protein by the loop\r\n",
      "RT   domain of Hec1 is required for stable kinetochore-microtubule attachment.\";\r\n",
      "RL   Nat. Cell Biol. 14:593-603(2012).\r\n",
      "RN   [27]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=23891108; DOI=10.1016/j.cub.2013.06.040;\r\n",
      "RA   Shrestha R.L., Draviam V.M.;\r\n",
      "RT   \"Lateral to end-on conversion of chromosome-microtubule attachment requires\r\n",
      "RT   kinesins CENP-E and MCAK.\";\r\n",
      "RL   Curr. Biol. 23:1514-1526(2013).\r\n",
      "RN   [28]\r\n",
      "RP   ERRATUM OF PUBMED:23891108.\r\n",
      "RA   Shrestha R.L., Draviam V.M.;\r\n",
      "RL   Curr. Biol. 23:2440-2441(2013).\r\n",
      "RN   [29]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND SER-69, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [30]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=25743205; DOI=10.1038/ncomms7447;\r\n",
      "RA   Iemura K., Tanaka K.;\r\n",
      "RT   \"Chromokinesin Kid and kinetochore kinesin CENP-E differentially support\r\n",
      "RT   chromosome congression without end-on attachment to microtubules.\";\r\n",
      "RL   Nat. Commun. 6:6447-6447(2015).\r\n",
      "RN   [31]\r\n",
      "RP   INTERACTION WITH CKAP5.\r\n",
      "RX   PubMed=27156448; DOI=10.1016/j.cell.2016.04.030;\r\n",
      "RA   Miller M.P., Asbury C.L., Biggins S.;\r\n",
      "RT   \"A TOG protein confers tension sensitivity to kinetochore-microtubule\r\n",
      "RT   attachments.\";\r\n",
      "RL   Cell 165:1428-1439(2016).\r\n",
      "RN   [32]\r\n",
      "RP   FUNCTION, PHOSPHORYLATION AT SER-55 AND SER-62, ACETYLATION AT LYS-53;\r\n",
      "RP   LYS-59 AND LYS-527, AND MUTAGENESIS OF LYS-53 AND LYS-59.\r\n",
      "RX   PubMed=30409912; DOI=10.1074/jbc.ra118.003844;\r\n",
      "RA   Zhao G., Cheng Y., Gui P., Cui M., Liu W., Wang W., Wang X., Ali M.,\r\n",
      "RA   Dou Z., Niu L., Liu H., Anderson L., Ruan K., Hong J., Yao X.;\r\n",
      "RT   \"Dynamic acetylation of the kinetochore-associated protein HEC1 ensures\r\n",
      "RT   accurate microtubule-kinetochore attachment.\";\r\n",
      "RL   J. Biol. Chem. 294:576-592(2019).\r\n",
      "CC   -!- FUNCTION: Acts as a component of the essential kinetochore-associated\r\n",
      "CC       NDC80 complex, which is required for chromosome segregation and spindle\r\n",
      "CC       checkpoint activity (PubMed:9315664, PubMed:12351790, PubMed:14654001,\r\n",
      "CC       PubMed:14699129, PubMed:15062103, PubMed:15235793, PubMed:15239953,\r\n",
      "CC       PubMed:15548592, PubMed:16732327, PubMed:30409912). Required for\r\n",
      "CC       kinetochore integrity and the organization of stable microtubule\r\n",
      "CC       binding sites in the outer plate of the kinetochore (PubMed:15548592,\r\n",
      "CC       PubMed:30409912). The NDC80 complex synergistically enhances the\r\n",
      "CC       affinity of the SKA1 complex for microtubules and may allow the NDC80\r\n",
      "CC       complex to track depolymerizing microtubules (PubMed:23085020). Plays a\r\n",
      "CC       role in chromosome congression and is essential for the end-on\r\n",
      "CC       attachment of the kinetochores to spindle microtubules\r\n",
      "CC       (PubMed:25743205, PubMed:23891108). {ECO:0000269|PubMed:12351790,\r\n",
      "CC       ECO:0000269|PubMed:14654001, ECO:0000269|PubMed:14699129,\r\n",
      "CC       ECO:0000269|PubMed:15062103, ECO:0000269|PubMed:15235793,\r\n",
      "CC       ECO:0000269|PubMed:15239953, ECO:0000269|PubMed:15548592,\r\n",
      "CC       ECO:0000269|PubMed:16732327, ECO:0000269|PubMed:23085020,\r\n",
      "CC       ECO:0000269|PubMed:23891108, ECO:0000269|PubMed:25743205,\r\n",
      "CC       ECO:0000269|PubMed:30409912, ECO:0000269|PubMed:9315664}.\r\n",
      "CC   -!- SUBUNIT: Component of the NDC80 complex, which consists of NDC80/HEC1,\r\n",
      "CC       CDCA1, SPBC24 and SPBC25. The NDC80 complex is formed by two\r\n",
      "CC       subcomplexes composed of NDC80/HEC1-CDCA1 and SPBC24-SPBC25. Each\r\n",
      "CC       subcomplex is formed by parallel interactions through the coiled-coil\r\n",
      "CC       domains of individual subunits. Formation of a tetrameric complex is\r\n",
      "CC       mediated by interactions between the C-terminal regions of both\r\n",
      "CC       subunits of the NDC80/HEC1-CDCA1 subcomplex and the N-terminal regions\r\n",
      "CC       of both subunits of the SPBC24-SPBC25 complex. The tetrameric NDC80\r\n",
      "CC       complex has an elongated rod-like structure with globular domains at\r\n",
      "CC       either end. Interacts with isoform 1 of NEK2 and ZWINT specifically\r\n",
      "CC       during mitosis. Interacts with CENPH and MIS12. May interact with\r\n",
      "CC       AURKB, PSMC2, PSMC5 and SMC1A. May interact with RB1 during G2 phase\r\n",
      "CC       and mitosis. Interacts with CKAP5 (PubMed:27156448). Interacts with\r\n",
      "CC       CDT1; leading to kinetochore localization of CDT1 (PubMed:22581055).\r\n",
      "CC       {ECO:0000269|PubMed:10409732, ECO:0000269|PubMed:10779342,\r\n",
      "CC       ECO:0000269|PubMed:12386167, ECO:0000269|PubMed:14602875,\r\n",
      "CC       ECO:0000269|PubMed:14699129, ECO:0000269|PubMed:15502821,\r\n",
      "CC       ECO:0000269|PubMed:15713649, ECO:0000269|PubMed:15824131,\r\n",
      "CC       ECO:0000269|PubMed:16732327, ECO:0000269|PubMed:22581055,\r\n",
      "CC       ECO:0000269|PubMed:27156448, ECO:0000269|PubMed:9295362}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       O14777; Q9Y2J4: AMOTL2; NbExp=3; IntAct=EBI-715849, EBI-746752;\r\n",
      "CC       O14777; P18848: ATF4; NbExp=8; IntAct=EBI-715849, EBI-492498;\r\n",
      "CC       O14777; P48047: ATP5PO; NbExp=3; IntAct=EBI-715849, EBI-355815;\r\n",
      "CC       O14777; Q9Y5K8: ATP6V1D; NbExp=3; IntAct=EBI-715849, EBI-2684998;\r\n",
      "CC       O14777; Q8TC20-4: CAGE1; NbExp=3; IntAct=EBI-715849, EBI-11522698;\r\n",
      "CC       O14777; Q9P1Z2: CALCOCO1; NbExp=4; IntAct=EBI-715849, EBI-749920;\r\n",
      "CC       O14777; Q8TD31-3: CCHCR1; NbExp=6; IntAct=EBI-715849, EBI-10175300;\r\n",
      "CC       O14777; P51946: CCNH; NbExp=3; IntAct=EBI-715849, EBI-741406;\r\n",
      "CC       O14777; O75909: CCNK; NbExp=3; IntAct=EBI-715849, EBI-739806;\r\n",
      "CC       O14777; Q9H211: CDT1; NbExp=7; IntAct=EBI-715849, EBI-456953;\r\n",
      "CC       O14777; Q9H3R5: CENPH; NbExp=6; IntAct=EBI-715849, EBI-1003700;\r\n",
      "CC       O14777; Q96MT8-3: CEP63; NbExp=3; IntAct=EBI-715849, EBI-11522539;\r\n",
      "CC       O14777; Q9UBC2-3: EPS15L1; NbExp=3; IntAct=EBI-715849, EBI-11958621;\r\n",
      "CC       O14777; Q8IYI6: EXOC8; NbExp=3; IntAct=EBI-715849, EBI-742102;\r\n",
      "CC       O14777; Q8IZT9: FAM9C; NbExp=3; IntAct=EBI-715849, EBI-2870039;\r\n",
      "CC       O14777; Q08379: GOLGA2; NbExp=3; IntAct=EBI-715849, EBI-618309;\r\n",
      "CC       O14777; Q96CS2: HAUS1; NbExp=3; IntAct=EBI-715849, EBI-2514791;\r\n",
      "CC       O14777; O14964: HGS; NbExp=6; IntAct=EBI-715849, EBI-740220;\r\n",
      "CC       O14777; O75146-2: HIP1R; NbExp=3; IntAct=EBI-715849, EBI-12292427;\r\n",
      "CC       O14777; Q8IY31: IFT20; NbExp=5; IntAct=EBI-715849, EBI-744203;\r\n",
      "CC       O14777; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-715849, EBI-14069005;\r\n",
      "CC       O14777; Q6P597: KLC3; NbExp=3; IntAct=EBI-715849, EBI-1643885;\r\n",
      "CC       O14777; Q7Z3Y8: KRT27; NbExp=3; IntAct=EBI-715849, EBI-3044087;\r\n",
      "CC       O14777; P04259: KRT6B; NbExp=3; IntAct=EBI-715849, EBI-740907;\r\n",
      "CC       O14777; O95678: KRT75; NbExp=3; IntAct=EBI-715849, EBI-2949715;\r\n",
      "CC       O14777; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-715849, EBI-739832;\r\n",
      "CC       O14777; Q9NPJ6: MED4; NbExp=4; IntAct=EBI-715849, EBI-394607;\r\n",
      "CC       O14777; P55081: MFAP1; NbExp=3; IntAct=EBI-715849, EBI-1048159;\r\n",
      "CC       O14777; O14777: NDC80; NbExp=2; IntAct=EBI-715849, EBI-715849;\r\n",
      "CC       O14777; Q9GZM8: NDEL1; NbExp=4; IntAct=EBI-715849, EBI-928842;\r\n",
      "CC       O14777; Q9BZD4: NUF2; NbExp=14; IntAct=EBI-715849, EBI-724102;\r\n",
      "CC       O14777; Q96KQ4: PPP1R13B; NbExp=3; IntAct=EBI-715849, EBI-1105153;\r\n",
      "CC       O14777; Q6ZNE9: RUFY4; NbExp=7; IntAct=EBI-715849, EBI-10181525;\r\n",
      "CC       O14777; Q86XK3: SFR1; NbExp=3; IntAct=EBI-715849, EBI-1104535;\r\n",
      "CC       O14777; Q96ES7: SGF29; NbExp=7; IntAct=EBI-715849, EBI-743117;\r\n",
      "CC       O14777; Q9HBM1: SPC25; NbExp=12; IntAct=EBI-715849, EBI-999909;\r\n",
      "CC       O14777; O75558: STX11; NbExp=3; IntAct=EBI-715849, EBI-714135;\r\n",
      "CC       O14777; Q9UBB9: TFIP11; NbExp=6; IntAct=EBI-715849, EBI-1105213;\r\n",
      "CC       O14777; Q6I9Y2: THOC7; NbExp=3; IntAct=EBI-715849, EBI-716286;\r\n",
      "CC       O14777; Q15025: TNIP1; NbExp=9; IntAct=EBI-715849, EBI-357849;\r\n",
      "CC       O14777; Q05BL1: TP53BP2; NbExp=3; IntAct=EBI-715849, EBI-11952721;\r\n",
      "CC       O14777; Q13625-3: TP53BP2; NbExp=3; IntAct=EBI-715849, EBI-10175039;\r\n",
      "CC       O14777; P33981-1: TTK; NbExp=4; IntAct=EBI-715849, EBI-15986834;\r\n",
      "CC       O14777; P40222: TXLNA; NbExp=7; IntAct=EBI-715849, EBI-359793;\r\n",
      "CC       O14777; Q8N6Y0: USHBP1; NbExp=4; IntAct=EBI-715849, EBI-739895;\r\n",
      "CC       O14777; Q8N1B4: VPS52; NbExp=3; IntAct=EBI-715849, EBI-2799833;\r\n",
      "CC       O14777; Q9Y3C0: WASHC3; NbExp=10; IntAct=EBI-715849, EBI-712969;\r\n",
      "CC       O14777; Q8N720: ZNF655; NbExp=3; IntAct=EBI-715849, EBI-625509;\r\n",
      "CC       O14777; O95229: ZWINT; NbExp=14; IntAct=EBI-715849, EBI-1001132;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9315664}. Chromosome,\r\n",
      "CC       centromere, kinetochore {ECO:0000269|PubMed:14699129}. Note=Localizes\r\n",
      "CC       to kinetochores from late prophase to anaphase (PubMed:14699129).\r\n",
      "CC       Localizes specifically to the outer plate of the kinetochore\r\n",
      "CC       (PubMed:14699129). {ECO:0000269|PubMed:14699129}.\r\n",
      "CC   -!- DEVELOPMENTAL STAGE: Expression peaks in mitosis.\r\n",
      "CC       {ECO:0000269|PubMed:16732327, ECO:0000269|PubMed:9295362,\r\n",
      "CC       ECO:0000269|PubMed:9315664}.\r\n",
      "CC   -!- PTM: Phosphorylation begins in S phase of the cell cycle and peaks in\r\n",
      "CC       mitosis. Phosphorylated by NEK2. Also phosphorylated by AURKA and\r\n",
      "CC       AURKB. {ECO:0000269|PubMed:12386167, ECO:0000269|PubMed:14602875,\r\n",
      "CC       ECO:0000269|PubMed:30409912}.\r\n",
      "CC   -!- PTM: Acetylated at Lys-53 and Lys-59 by KAT5 during mitosis, promoting\r\n",
      "CC       robust kinetochore-microtubule attachment (PubMed:30409912).\r\n",
      "CC       Deacetylated by SIRT1 (PubMed:30409912). {ECO:0000269|PubMed:30409912}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the NDC80/HEC1 family. {ECO:0000305}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AF017790; AAB80726.1; -; mRNA.\r\n",
      "DR   EMBL; BC010171; -; NOT_ANNOTATED_CDS; mRNA.\r\n",
      "DR   CCDS; CCDS11827.1; -.\r\n",
      "DR   RefSeq; NP_006092.1; NM_006101.2.\r\n",
      "DR   PDB; 2IGP; X-ray; 1.80 A; A=81-196.\r\n",
      "DR   PDB; 2VE7; X-ray; 2.88 A; A/B=80-286.\r\n",
      "DR   PDB; 3IZ0; EM; -; C/E=80-286.\r\n",
      "DR   PDBsum; 2IGP; -.\r\n",
      "DR   PDBsum; 2VE7; -.\r\n",
      "DR   PDBsum; 3IZ0; -.\r\n",
      "DR   AlphaFoldDB; O14777; -.\r\n",
      "DR   SMR; O14777; -.\r\n",
      "DR   BioGRID; 115675; 323.\r\n",
      "DR   ComplexPortal; CPX-550; Ndc80 complex.\r\n",
      "DR   CORUM; O14777; -.\r\n",
      "DR   DIP; DIP-35100N; -.\r\n",
      "DR   IntAct; O14777; 124.\r\n",
      "DR   MINT; O14777; -.\r\n",
      "DR   STRING; 9606.ENSP00000261597; -.\r\n",
      "DR   ChEMBL; CHEMBL5660; -.\r\n",
      "DR   GlyGen; O14777; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; O14777; -.\r\n",
      "DR   PhosphoSitePlus; O14777; -.\r\n",
      "DR   BioMuta; NDC80; -.\r\n",
      "DR   EPD; O14777; -.\r\n",
      "DR   jPOST; O14777; -.\r\n",
      "DR   MassIVE; O14777; -.\r\n",
      "DR   MaxQB; O14777; -.\r\n",
      "DR   PaxDb; O14777; -.\r\n",
      "DR   PeptideAtlas; O14777; -.\r\n",
      "DR   ProteomicsDB; 48231; -.\r\n",
      "DR   ABCD; O14777; 1 sequenced antibody.\r\n",
      "DR   Antibodypedia; 6039; 467 antibodies from 39 providers.\r\n",
      "DR   DNASU; 10403; -.\r\n",
      "DR   Ensembl; ENST00000261597.9; ENSP00000261597.4; ENSG00000080986.13.\r\n",
      "DR   GeneID; 10403; -.\r\n",
      "DR   KEGG; hsa:10403; -.\r\n",
      "DR   MANE-Select; ENST00000261597.9; ENSP00000261597.4; NM_006101.3; NP_006092.1.\r\n",
      "DR   UCSC; uc002kli.3; human.\r\n",
      "DR   AGR; HGNC:16909; -.\r\n",
      "DR   CTD; 10403; -.\r\n",
      "DR   DisGeNET; 10403; -.\r\n",
      "DR   GeneCards; NDC80; -.\r\n",
      "DR   HGNC; HGNC:16909; NDC80.\r\n",
      "DR   HPA; ENSG00000080986; Tissue enhanced (bone marrow, lymphoid tissue).\r\n",
      "DR   MIM; 607272; gene.\r\n",
      "DR   neXtProt; NX_O14777; -.\r\n",
      "DR   OpenTargets; ENSG00000080986; -.\r\n",
      "DR   PharmGKB; PA162397359; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000080986; -.\r\n",
      "DR   eggNOG; KOG0995; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00390000018386; -.\r\n",
      "DR   HOGENOM; CLU_012583_2_0_1; -.\r\n",
      "DR   InParanoid; O14777; -.\r\n",
      "DR   OMA; PSHKFQK; -.\r\n",
      "DR   OrthoDB; 25325at2759; -.\r\n",
      "DR   PhylomeDB; O14777; -.\r\n",
      "DR   TreeFam; TF101177; -.\r\n",
      "DR   PathwayCommons; O14777; -.\r\n",
      "DR   Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.\r\n",
      "DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.\r\n",
      "DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.\r\n",
      "DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.\r\n",
      "DR   Reactome; R-HSA-68877; Mitotic Prometaphase.\r\n",
      "DR   Reactome; R-HSA-9648025; EML4 and NUDC in mitotic spindle formation.\r\n",
      "DR   SignaLink; O14777; -.\r\n",
      "DR   SIGNOR; O14777; -.\r\n",
      "DR   BioGRID-ORCS; 10403; 793 hits in 1162 CRISPR screens.\r\n",
      "DR   ChiTaRS; NDC80; human.\r\n",
      "DR   EvolutionaryTrace; O14777; -.\r\n",
      "DR   GeneWiki; NDC80; -.\r\n",
      "DR   GenomeRNAi; 10403; -.\r\n",
      "DR   Pharos; O14777; Tbio.\r\n",
      "DR   PRO; PR:O14777; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 18.\r\n",
      "DR   RNAct; O14777; protein.\r\n",
      "DR   Bgee; ENSG00000080986; Expressed in ventricular zone and 135 other tissues.\r\n",
      "DR   ExpressionAtlas; O14777; baseline and differential.\r\n",
      "DR   Genevisible; O14777; HS.\r\n",
      "DR   GO; GO:0005813; C:centrosome; IDA:HPA.\r\n",
      "DR   GO; GO:0000775; C:chromosome, centromeric region; TAS:ProtInc.\r\n",
      "DR   GO; GO:0005829; C:cytosol; TAS:Reactome.\r\n",
      "DR   GO; GO:0000776; C:kinetochore; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.\r\n",
      "DR   GO; GO:0031262; C:Ndc80 complex; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.\r\n",
      "DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.\r\n",
      "DR   GO; GO:0000940; C:outer kinetochore; IDA:BHF-UCL.\r\n",
      "DR   GO; GO:0030332; F:cyclin binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.\r\n",
      "DR   GO; GO:0140483; F:kinetochore adaptor activity; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0051315; P:attachment of mitotic spindle microtubules to kinetochore; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0008608; P:attachment of spindle microtubules to kinetochore; IDA:ComplexPortal.\r\n",
      "DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0051298; P:centrosome duplication; IDA:MGI.\r\n",
      "DR   GO; GO:0007059; P:chromosome segregation; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0000132; P:establishment of mitotic spindle orientation; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0008315; P:G2/MI transition of meiotic cell cycle; IEA:Ensembl.\r\n",
      "DR   GO; GO:0051383; P:kinetochore organization; IMP:CAFA.\r\n",
      "DR   GO; GO:0051310; P:metaphase plate congression; IDA:MGI.\r\n",
      "DR   GO; GO:0000278; P:mitotic cell cycle; TAS:ProtInc.\r\n",
      "DR   GO; GO:0000070; P:mitotic sister chromatid segregation; TAS:ProtInc.\r\n",
      "DR   GO; GO:0007094; P:mitotic spindle assembly checkpoint signaling; NAS:ComplexPortal.\r\n",
      "DR   GO; GO:0007052; P:mitotic spindle organization; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0090267; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; IMP:UniProtKB.\r\n",
      "DR   GO; GO:1905342; P:positive regulation of protein localization to kinetochore; IMP:CAFA.\r\n",
      "DR   GO; GO:0031647; P:regulation of protein stability; IEA:Ensembl.\r\n",
      "DR   GO; GO:0007057; P:spindle assembly involved in female meiosis I; IEA:Ensembl.\r\n",
      "DR   DisProt; DP01576; -.\r\n",
      "DR   Gene3D; 6.10.250.1950; -; 1.\r\n",
      "DR   Gene3D; 1.10.418.30; Ncd80 complex, Ncd80 subunit; 1.\r\n",
      "DR   IDEAL; IID00184; -.\r\n",
      "DR   InterPro; IPR040967; DUF5595.\r\n",
      "DR   InterPro; IPR005550; Kinetochore_Ndc80.\r\n",
      "DR   InterPro; IPR038273; Ndc80_sf.\r\n",
      "DR   PANTHER; PTHR10643; KINETOCHORE PROTEIN NDC80; 1.\r\n",
      "DR   PANTHER; PTHR10643:SF2; KINETOCHORE PROTEIN NDC80 HOMOLOG; 1.\r\n",
      "DR   Pfam; PF18077; DUF5595; 1.\r\n",
      "DR   Pfam; PF03801; Ndc80_HEC; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Acetylation; Cell cycle; Cell division; Centromere;\r\n",
      "KW   Chromosome; Coiled coil; Kinetochore; Mitosis; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome.\r\n",
      "FT   CHAIN           1..642\r\n",
      "FT                   /note=\"Kinetochore protein NDC80 homolog\"\r\n",
      "FT                   /id=\"PRO_0000249550\"\r\n",
      "FT   REGION          1..445\r\n",
      "FT                   /note=\"Interaction with the N-terminus of CDCA1\"\r\n",
      "FT   REGION          1..250\r\n",
      "FT                   /note=\"Nuclear localization\"\r\n",
      "FT   REGION          1..74\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          128..251\r\n",
      "FT                   /note=\"Interaction with RB1\"\r\n",
      "FT   REGION          251..618\r\n",
      "FT                   /note=\"Interaction with NEK2 and ZWINT\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:16732327\"\r\n",
      "FT   REGION          251..431\r\n",
      "FT                   /note=\"Interaction with SMC1A\"\r\n",
      "FT   REGION          361..547\r\n",
      "FT                   /note=\"Interaction with PSMC2 and SMC1A\"\r\n",
      "FT   REGION          446..642\r\n",
      "FT                   /note=\"Interaction with the C-terminus of CDCA1 and the\r\n",
      "FT                   SPBC24-SPBC25 subcomplex\"\r\n",
      "FT   COILED          261..403\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COILED          458..642\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COMPBIAS        1..51\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         44\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         53\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MOD_RES         55\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MOD_RES         59\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MOD_RES         62\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MOD_RES         69\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         165\r\n",
      "FT                   /note=\"Phosphoserine; by NEK2\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:12386167\"\r\n",
      "FT   MOD_RES         242\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q9D0F1\"\r\n",
      "FT   MOD_RES         527\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   VARIANT         66\r\n",
      "FT                   /note=\"S -> A (in dbSNP:rs16943490)\"\r\n",
      "FT                   /id=\"VAR_027436\"\r\n",
      "FT   VARIANT         348\r\n",
      "FT                   /note=\"E -> D (in dbSNP:rs12456560)\"\r\n",
      "FT                   /id=\"VAR_027437\"\r\n",
      "FT   VARIANT         605\r\n",
      "FT                   /note=\"A -> P (in dbSNP:rs9051)\"\r\n",
      "FT                   /id=\"VAR_027438\"\r\n",
      "FT   MUTAGEN         53\r\n",
      "FT                   /note=\"K->Q: Mimics acetylation, leading to increased\r\n",
      "FT                   kinetochore-microtubule attachment; when associated with\r\n",
      "FT                   Q-59.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MUTAGEN         53\r\n",
      "FT                   /note=\"K->R: Impaired acetylation, leading to reduced\r\n",
      "FT                   kinetochore-microtubule attachment; when associated with\r\n",
      "FT                   R-59.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MUTAGEN         59\r\n",
      "FT                   /note=\"K->Q: Mimics acetylation, leading to increased\r\n",
      "FT                   kinetochore-microtubule attachment; when associated with\r\n",
      "FT                   Q-53.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MUTAGEN         59\r\n",
      "FT                   /note=\"K->R: Impaired acetylation, leading to reduced\r\n",
      "FT                   kinetochore-microtubule attachment; when associated with\r\n",
      "FT                   R-53.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30409912\"\r\n",
      "FT   MUTAGEN         234\r\n",
      "FT                   /note=\"E->K: Abrogates binding to RB1.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10779342\"\r\n",
      "FT   HELIX           89..105\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   TURN            114..117\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   HELIX           122..133\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   TURN            134..136\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   HELIX           147..157\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   HELIX           166..170\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   TURN            171..173\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   TURN            175..177\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   HELIX           178..194\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2IGP\"\r\n",
      "FT   HELIX           222..238\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2VE7\"\r\n",
      "FT   HELIX           244..258\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2VE7\"\r\n",
      "FT   HELIX           264..286\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2VE7\"\r\n",
      "SQ   SEQUENCE   642 AA;  73913 MW;  6A82DA4D8B77ECDC CRC64;\r\n",
      "     MKRSSVSSGG AGRLSMQELR SQDVNKQGLY TPQTKEKPTF GKLSINKPTS ERKVSLFGKR\r\n",
      "     TSGHGSRNSQ LGIFSSSEKI KDPRPLNDKA FIQQCIRQLC EFLTENGYAH NVSMKSLQAP\r\n",
      "     SVKDFLKIFT FLYGFLCPSY ELPDTKFEEE VPRIFKDLGY PFALSKSSMY TVGAPHTWPH\r\n",
      "     IVAALVWLID CIKIHTAMKE SSPLFDDGQP WGEETEDGIM HNKLFLDYTI KCYESFMSGA\r\n",
      "     DSFDEMNAEL QSKLKDLFNV DAFKLESLEA KNRALNEQIA RLEQEREKEP NRLESLRKLK\r\n",
      "     ASLQGDVQKY QAYMSNLESH SAILDQKLNG LNEEIARVEL ECETIKQENT RLQNIIDNQK\r\n",
      "     YSVADIERIN HERNELQQTI NKLTKDLEAE QQKLWNEELK YARGKEAIET QLAEYHKLAR\r\n",
      "     KLKLIPKGAE NSKGYDFEIK FNPEAGANCL VKYRAQVYVP LKELLNETEE EINKALNKKM\r\n",
      "     GLEDTLEQLN AMITESKRSV RTLKEEVQKL DDLYQQKIKE AEEEDEKCAS ELESLEKHKH\r\n",
      "     LLESTVNQGL SEAMNELDAV QREYQLVVQT TTEERRKVGN NLQRLLEMVA THVGSVEKHL\r\n",
      "     EEQIAKVDRE YEECMSEDLS ENIKEIRDKY EKKATLIKSS EE\r\n",
      "//\r\n",
      "ID   RBL2_MOUSE              Reviewed;        1135 AA.\r\n",
      "AC   Q64700; Q3TVP8;\r\n",
      "DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   27-JUL-2011, sequence version 3.\r\n",
      "DT   03-MAY-2023, entry version 181.\r\n",
      "DE   RecName: Full=Retinoblastoma-like protein 2;\r\n",
      "DE   AltName: Full=130 kDa retinoblastoma-associated protein;\r\n",
      "DE            Short=p130;\r\n",
      "DE   AltName: Full=Retinoblastoma-related protein 2;\r\n",
      "DE            Short=RBR-2;\r\n",
      "DE   AltName: Full=pRb2;\r\n",
      "GN   Name=Rbl2;\r\n",
      "OS   Mus musculus (Mouse).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Mus; Mus.\r\n",
      "OX   NCBI_TaxID=10090;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=8621630; DOI=10.1074/jbc.271.16.9567;\r\n",
      "RA   Chen G., Guy C.T., Chen H.W., Hu N., Lee E.Y.H.P., Lee W.H.;\r\n",
      "RT   \"Molecular cloning and developmental expression of mouse p130, a member of\r\n",
      "RT   the retinoblastoma gene family.\";\r\n",
      "RL   J. Biol. Chem. 271:9567-9572(1996).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=9019172;\r\n",
      "RA   Pertile P., Baldi A., de Luca A., Virgilio L., Pisano M.M., Giordano A.;\r\n",
      "RT   \"Molecular cloning, expression, and developmental characterization of the\r\n",
      "RT   murine retinoblastoma-related gene Rb2/p130.\";\r\n",
      "RL   Cell Growth Differ. 6:1659-1664(1995).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=8622859;\r\n",
      "RA   Lecouter J.E., Whyte P.F.M., Rudnicki M.A.;\r\n",
      "RT   \"Cloning and expression of the Rb-related mouse p130 mRNA.\";\r\n",
      "RL   Oncogene 12:1433-1440(1996).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\r\n",
      "RC   STRAIN=C57BL/6J;\r\n",
      "RX   PubMed=16141072; DOI=10.1126/science.1112014;\r\n",
      "RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,\r\n",
      "RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,\r\n",
      "RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,\r\n",
      "RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,\r\n",
      "RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,\r\n",
      "RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,\r\n",
      "RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,\r\n",
      "RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,\r\n",
      "RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,\r\n",
      "RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,\r\n",
      "RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,\r\n",
      "RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,\r\n",
      "RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,\r\n",
      "RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,\r\n",
      "RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,\r\n",
      "RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,\r\n",
      "RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,\r\n",
      "RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,\r\n",
      "RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,\r\n",
      "RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,\r\n",
      "RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,\r\n",
      "RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,\r\n",
      "RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,\r\n",
      "RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,\r\n",
      "RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,\r\n",
      "RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,\r\n",
      "RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,\r\n",
      "RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,\r\n",
      "RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,\r\n",
      "RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,\r\n",
      "RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,\r\n",
      "RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,\r\n",
      "RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,\r\n",
      "RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;\r\n",
      "RT   \"The transcriptional landscape of the mammalian genome.\";\r\n",
      "RL   Science 309:1559-1563(2005).\r\n",
      "RN   [5]\r\n",
      "RP   INTERACTION WITH USP4.\r\n",
      "RX   PubMed=11571651; DOI=10.1038/sj.onc.1204823;\r\n",
      "RA   Blanchette P., Gilchrist C.A., Baker R.T., Gray D.A.;\r\n",
      "RT   \"Association of UNP, a ubiquitin-specific protease, with the pocket\r\n",
      "RT   proteins pRb, p107 and p130.\";\r\n",
      "RL   Oncogene 20:5533-5537(2001).\r\n",
      "RN   [6]\r\n",
      "RP   FUNCTION, AND INTERACTION WITH KMT5B AND KMT5C.\r\n",
      "RX   PubMed=15750587; DOI=10.1038/ncb1235;\r\n",
      "RA   Gonzalo S., Garcia-Cao M., Fraga M.F., Schotta G., Peters A.H.F.M.,\r\n",
      "RA   Cotter S.E., Eguia R., Dean D.C., Esteller M., Jenuwein T., Blasco M.A.;\r\n",
      "RT   \"Role of the RB1 family in stabilizing histone methylation at constitutive\r\n",
      "RT   heterochromatin.\";\r\n",
      "RL   Nat. Cell Biol. 7:420-428(2005).\r\n",
      "RN   [7]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-636; THR-639 AND SER-942, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;\r\n",
      "RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;\r\n",
      "RT   \"Large-scale phosphorylation analysis of mouse liver.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).\r\n",
      "RN   [8]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-410; THR-414; SER-636;\r\n",
      "RP   THR-639; SER-942; SER-965; SER-976 AND THR-980, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Brown adipose tissue, Kidney, Liver, Lung, Pancreas, and\r\n",
      "RC   Spleen;\r\n",
      "RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;\r\n",
      "RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,\r\n",
      "RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;\r\n",
      "RT   \"A tissue-specific atlas of mouse protein phosphorylation and expression.\";\r\n",
      "RL   Cell 143:1174-1189(2010).\r\n",
      "CC   -!- FUNCTION: Key regulator of entry into cell division. Directly involved\r\n",
      "CC       in heterochromatin formation by maintaining overall chromatin structure\r\n",
      "CC       and, in particular, that of constitutive heterochromatin by stabilizing\r\n",
      "CC       histone methylation. Recruits and targets histone methyltransferases\r\n",
      "CC       KMT5B and KMT5C, leading to epigenetic transcriptional repression.\r\n",
      "CC       Controls histone H4 'Lys-20' trimethylation. Probably acts as a\r\n",
      "CC       transcription repressor by recruiting chromatin-modifying enzymes to\r\n",
      "CC       promoters. Potent inhibitor of E2F-mediated trans-activation,\r\n",
      "CC       associates preferentially with E2F5. Binds to cyclins A and E. Binds to\r\n",
      "CC       and may be involved in the transforming capacity of the adenovirus E1A\r\n",
      "CC       protein. May act as a tumor suppressor. {ECO:0000269|PubMed:15750587}.\r\n",
      "CC   -!- SUBUNIT: Interacts with AATF and RINT1. Component of the DREAM complex\r\n",
      "CC       (also named LINC complex) at least composed of E2F4, E2F5, LIN9, LIN37,\r\n",
      "CC       LIN52, LIN54, MYBL1, MYBL2, RBL1, RBL2, RBBP4, TFDP1 and TFDP2. The\r\n",
      "CC       complex exists in quiescent cells where it represses cell cycle-\r\n",
      "CC       dependent genes. It dissociates in S phase when LIN9, LIN37, LIN52 and\r\n",
      "CC       LIN54 form a subcomplex that binds to MYBL2. Interacts with USP4 (By\r\n",
      "CC       similarity). Interacts with KMT5B, KMT5C and USP4. Interacts with PML\r\n",
      "CC       (By similarity). Interacts with RBBP9 (By similarity). {ECO:0000250,\r\n",
      "CC       ECO:0000250|UniProtKB:O55081}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q64700; Q155P7: Cenpf; NbExp=3; IntAct=EBI-2271232, EBI-2211248;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus.\r\n",
      "CC   -!- PTM: During G0 and early G1 phase of the cell cycle, phosphorylated on\r\n",
      "CC       Ser-636 and on 5 sites within the domain B. Phosphorylation on Ser-669\r\n",
      "CC       in G1 leads to its ubiquitin-dependent proteolysis (By similarity).\r\n",
      "CC       {ECO:0000250}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; U36799; AAB48991.1; -; mRNA.\r\n",
      "DR   EMBL; U50850; AAC52598.1; -; mRNA.\r\n",
      "DR   EMBL; U47333; AAC52555.1; -; mRNA.\r\n",
      "DR   EMBL; AK160027; BAE35570.1; -; mRNA.\r\n",
      "DR   CCDS; CCDS22518.1; -.\r\n",
      "DR   RefSeq; NP_001268929.1; NM_001282000.1.\r\n",
      "DR   RefSeq; NP_001268930.1; NM_001282001.1.\r\n",
      "DR   RefSeq; NP_035380.3; NM_011250.4.\r\n",
      "DR   AlphaFoldDB; Q64700; -.\r\n",
      "DR   SMR; Q64700; -.\r\n",
      "DR   BioGRID; 202820; 19.\r\n",
      "DR   CORUM; Q64700; -.\r\n",
      "DR   IntAct; Q64700; 5.\r\n",
      "DR   MINT; Q64700; -.\r\n",
      "DR   STRING; 10090.ENSMUSP00000034091; -.\r\n",
      "DR   iPTMnet; Q64700; -.\r\n",
      "DR   PhosphoSitePlus; Q64700; -.\r\n",
      "DR   EPD; Q64700; -.\r\n",
      "DR   jPOST; Q64700; -.\r\n",
      "DR   MaxQB; Q64700; -.\r\n",
      "DR   PaxDb; Q64700; -.\r\n",
      "DR   PeptideAtlas; Q64700; -.\r\n",
      "DR   ProteomicsDB; 254996; -.\r\n",
      "DR   Antibodypedia; 4299; 476 antibodies from 39 providers.\r\n",
      "DR   DNASU; 19651; -.\r\n",
      "DR   Ensembl; ENSMUST00000034091.8; ENSMUSP00000034091.8; ENSMUSG00000031666.16.\r\n",
      "DR   GeneID; 19651; -.\r\n",
      "DR   KEGG; mmu:19651; -.\r\n",
      "DR   UCSC; uc012gid.2; mouse.\r\n",
      "DR   AGR; MGI:105085; -.\r\n",
      "DR   CTD; 5934; -.\r\n",
      "DR   MGI; MGI:105085; Rbl2.\r\n",
      "DR   VEuPathDB; HostDB:ENSMUSG00000031666; -.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00950000183202; -.\r\n",
      "DR   HOGENOM; CLU_008943_0_0_1; -.\r\n",
      "DR   InParanoid; Q64700; -.\r\n",
      "DR   OMA; MHWLACA; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; Q64700; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   Reactome; R-MMU-1538133; G0 and Early G1.\r\n",
      "DR   Reactome; R-MMU-69231; Cyclin D associated events in G1.\r\n",
      "DR   BioGRID-ORCS; 19651; 2 hits in 79 CRISPR screens.\r\n",
      "DR   ChiTaRS; Rbl2; mouse.\r\n",
      "DR   PRO; PR:Q64700; -.\r\n",
      "DR   Proteomes; UP000000589; Chromosome 8.\r\n",
      "DR   RNAct; Q64700; protein.\r\n",
      "DR   Bgee; ENSMUSG00000031666; Expressed in parotid gland and 243 other tissues.\r\n",
      "DR   ExpressionAtlas; Q64700; baseline and differential.\r\n",
      "DR   Genevisible; Q64700; MM.\r\n",
      "DR   GO; GO:0000785; C:chromatin; ISO:MGI.\r\n",
      "DR   GO; GO:0005694; C:chromosome; ISO:MGI.\r\n",
      "DR   GO; GO:0005829; C:cytosol; ISO:MGI.\r\n",
      "DR   GO; GO:0005730; C:nucleolus; ISO:MGI.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IDA:MGI.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; IDA:MGI.\r\n",
      "DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:MGI.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:MGI.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; ISO:MGI.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:InterPro.\r\n",
      "DR   CDD; cd20606; CYCLIN_RBL2; 1.\r\n",
      "DR   CDD; cd00043; CYCLIN_SF; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 3.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DR   PANTHER; PTHR13742:SF8; RETINOBLASTOMA-LIKE PROTEIN 2; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 2.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Cell cycle; Chromatin regulator; DNA-binding; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Repressor; Transcription; Transcription regulation;\r\n",
      "KW   Tumor suppressor.\r\n",
      "FT   CHAIN           1..1135\r\n",
      "FT                   /note=\"Retinoblastoma-like protein 2\"\r\n",
      "FT                   /id=\"PRO_0000167842\"\r\n",
      "FT   REGION          1..43\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          414..1021\r\n",
      "FT                   /note=\"Pocket; binds E1A\"\r\n",
      "FT   REGION          414..613\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT   REGION          614..824\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT   REGION          661..698\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          825..1021\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT   REGION          930..994\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1..16\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        661..696\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        939..971\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         410\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         414\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         636\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355,\r\n",
      "FT                   ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         639\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355,\r\n",
      "FT                   ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         659\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         669\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         684\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         942\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355,\r\n",
      "FT                   ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         946\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         960\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         965\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         967\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         968\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         975\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         976\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         980\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         1031\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         1064\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         1076\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         1108\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   CONFLICT        209..251\r\n",
      "FT                   /note=\"Missing (in Ref. 3; AAC52555)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        341\r\n",
      "FT                   /note=\"A -> P (in Ref. 1; AAB48991)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        342\r\n",
      "FT                   /note=\"A -> P (in Ref. 3; AAC52555)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        381\r\n",
      "FT                   /note=\"R -> T (in Ref. 2; AAC52598)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        428\r\n",
      "FT                   /note=\"T -> S (in Ref. 2; AAC52598)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        431\r\n",
      "FT                   /note=\"S -> T (in Ref. 2; AAC52598)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        443\r\n",
      "FT                   /note=\"R -> Q (in Ref. 2; AAC52598)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        483..492\r\n",
      "FT                   /note=\"Missing (in Ref. 1; AAB48991)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        768\r\n",
      "FT                   /note=\"A -> R (in Ref. 2; AAC52598)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        826\r\n",
      "FT                   /note=\"P -> A (in Ref. 3; AAC52555)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        947..948\r\n",
      "FT                   /note=\"PT -> RA (in Ref. 3; AAC52555)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1023\r\n",
      "FT                   /note=\"A -> S (in Ref. 2; AAC52598)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1044\r\n",
      "FT                   /note=\"V -> I (in Ref. 2; AAC52598)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   1135 AA;  127485 MW;  F509E68A156929B2 CRC64;\r\n",
      "     MASGGNQSPP PPPAAAASSE EEEEDGDAAD RAQPAGSPSH QIQQRFEELC SRLNMDEAAR\r\n",
      "     AEAWSSYRSM SESYTLEGND LHWLACALYV ACRKSVPTVS KGTAEGNYVS LTRILRCSEQ\r\n",
      "     SLIEFFNKMK KWEDMANLPP HFRERTERLE RNFTVSAVIF KKYEPIFQDI FKYPQEEQPR\r\n",
      "     QQRGRKQRRQ PCTTSEIFHF CWVLFIYAKG NFPMISDDLV NSYHLLLCAL DLVYGNALQC\r\n",
      "     SNRKELVNPN FKGLSEDCHP KDSKASSDPP CVIEKLCSLH DGLVLEAKGI KEHFWKPYIR\r\n",
      "     KLFEKKLLKG KEENLTGFLE PGNFGESFKA VNKAYEEYVL AAGNLDERVF LGEDAEEEVG\r\n",
      "     TLSRCLSAAS GTESAERTQM RDILQQHLDK SKALRVCTPL TGVRYVQENS PCVTPVSTAA\r\n",
      "     HSLSRLHTML SGLRNAPSEK LERILRSCSR DPTQAIADRL KEMYEIYSQH FQPDENFSNC\r\n",
      "     AKEIANKHFR FAEMLYYKVL ESVIEQEQKR LGDMDLSGVL EHDAFHRSLL ACCLEVVAFS\r\n",
      "     HKPPGNFPFI AEIFDVPHYH FYKVIEVFIR AEDGLCREVV KHLNQIEEQI LDHLAWKTKS\r\n",
      "     PLWDRIRDNE NRVPTCEEVM PPQNLERTDE IYIAGSPLTP RRVGEVRADA GGLGRSITSP\r\n",
      "     TTLYDRYSSP TVSTTRRRLF ENDSPSEGST SGRIPPQPLV NAVPVQNVPG ETVSVTPVPG\r\n",
      "     QTLVTMATAT VTANNGQTVT IPVQGIANEN GGITFFPVQV NVGGQAQAVA GSIQPLSAQA\r\n",
      "     LAGSLSSQQV TGTTLQVPGP VAIQQISPGG QQQNPGQPLT SSSIRPRKTS SLALFFRKVY\r\n",
      "     YLAGVRLRDL CIKLDISDEL RKKIWTCFEF SIIQCTELMM DRHLDQLLMC AIYVMAKVTK\r\n",
      "     EDRSFQNIMR CYRTQPQARS QVYRSVLIKG KRRNSGSSES RSHQNSPTEL NTDRASRDSS\r\n",
      "     PVMRSNSTLP VPQPSSAPPT PTRLTGASSD VEEEERGDLI QFYNNIYRKQ IQAFAMKYSQ\r\n",
      "     ANAQTDTPPL SPYPFVRTGS PRRVQLSQSH PIYISPHNNE AMPSPREKIF YYFSNSPSKR\r\n",
      "     LREINSMIRT GETPTKKRGI LLDDGSESPA KRICPENHSA LLRRLQDVAN DRGSQ\r\n",
      "//\r\n",
      "ID   RBBP6_HUMAN             Reviewed;        1792 AA.\r\n",
      "AC   Q7Z6E9; Q147T5; Q15290; Q6DKH4; Q6P4C2; Q6YNC9; Q7Z6E8; Q8N0V2; Q96PH3;\r\n",
      "AC   Q9H3I8; Q9H5M5; Q9NPX4;\r\n",
      "DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   01-OCT-2003, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 180.\r\n",
      "DE   RecName: Full=E3 ubiquitin-protein ligase RBBP6;\r\n",
      "DE            EC=2.3.2.27;\r\n",
      "DE   AltName: Full=Proliferation potential-related protein;\r\n",
      "DE   AltName: Full=Protein P2P-R;\r\n",
      "DE   AltName: Full=RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};\r\n",
      "DE   AltName: Full=Retinoblastoma-binding Q protein 1;\r\n",
      "DE            Short=RBQ-1;\r\n",
      "DE   AltName: Full=Retinoblastoma-binding protein 6;\r\n",
      "DE   AltName: Full=p53-associated cellular protein of testis;\r\n",
      "GN   Name=RBBP6; Synonyms=P2PR, PACT, RBQ1; ORFNames=My038;\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).\r\n",
      "RA   Kudo E., Itakura M.;\r\n",
      "RT   \"Retinoblastoma binding protein 6 (RBBP6), mRNA.\";\r\n",
      "RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,\r\n",
      "RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,\r\n",
      "RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,\r\n",
      "RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,\r\n",
      "RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,\r\n",
      "RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,\r\n",
      "RA   Hunkapiller M.W., Myers E.W., Venter J.C.;\r\n",
      "RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE\r\n",
      "RP   [LARGE SCALE MRNA] OF 1-1727 (ISOFORM 4), AND NUCLEOTIDE SEQUENCE [LARGE\r\n",
      "RP   SCALE MRNA] OF 1427-1792 (ISOFORMS 1/2/4).\r\n",
      "RC   TISSUE=Bone, and Kidney;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-55 (ISOFORMS 1/2/3/4).\r\n",
      "RC   TISSUE=Fetal brain;\r\n",
      "RA   Mao Y.M., Xie Y., Zheng Z.H.;\r\n",
      "RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 117-1792 (ISOFORM 2).\r\n",
      "RC   TISSUE=Spleen;\r\n",
      "RA   Ma X., Qu X., Sun L., Wu S., He F.;\r\n",
      "RT   \"The cDNA sequence for the human PACT gene.\";\r\n",
      "RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 150-1792 (ISOFORM 1).\r\n",
      "RA   Camargo A.A., Moreira E.S., Simpson A.J.G.;\r\n",
      "RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [7]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 150-1146 (ISOFORM 1).\r\n",
      "RC   TISSUE=Lung carcinoma;\r\n",
      "RX   PubMed=8595913; DOI=10.1006/geno.1995.0017;\r\n",
      "RA   Sakai Y., Saijo M., Coelho K., Kishino T., Niikawa N., Taya Y.;\r\n",
      "RT   \"cDNA sequence and chromosomal localization of a novel human protein, RBQ-1\r\n",
      "RT   (RBBP6), that binds to the retinoblastoma gene product.\";\r\n",
      "RL   Genomics 30:98-101(1995).\r\n",
      "RN   [8]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1165-1792 (ISOFORMS 1/2).\r\n",
      "RC   TISSUE=Hepatoma;\r\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\r\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\r\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\r\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\r\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\r\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\r\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\r\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\r\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\r\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\r\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\r\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\r\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\r\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\r\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\r\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\r\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\r\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\r\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\r\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\r\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\r\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\r\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\r\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\r\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\r\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\r\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\r\n",
      "RA   Isogai T., Sugano S.;\r\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\r\n",
      "RT   cDNAs.\";\r\n",
      "RL   Nat. Genet. 36:40-45(2004).\r\n",
      "RN   [9]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1264-1792 (ISOFORMS 1/2).\r\n",
      "RC   TISSUE=Amygdala;\r\n",
      "RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;\r\n",
      "RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,\r\n",
      "RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,\r\n",
      "RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,\r\n",
      "RA   Wiemann S., Schupp I.;\r\n",
      "RT   \"The full-ORF clone resource of the German cDNA consortium.\";\r\n",
      "RL   BMC Genomics 8:399-399(2007).\r\n",
      "RN   [10]\r\n",
      "RP   SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=12064457; DOI=10.1002/jcp.10084;\r\n",
      "RA   Gao S., Witte M.M., Scott R.E.;\r\n",
      "RT   \"P2P-R protein localizes to the nucleolus of interphase cells and the\r\n",
      "RT   periphery of chromosomes in mitotic cells which show maximum P2P-R\r\n",
      "RT   immunoreactivity.\";\r\n",
      "RL   J. Cell. Physiol. 191:145-154(2002).\r\n",
      "RN   [11]\r\n",
      "RP   ERRATUM OF PUBMED:12064457.\r\n",
      "RA   Gao S., Witte M.M., Scott R.E.;\r\n",
      "RL   J. Cell. Physiol. 192:359-360(2002).\r\n",
      "RN   [12]\r\n",
      "RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND OVEREXPRESSION IN ESOPHAGEAL\r\n",
      "RP   CANCER.\r\n",
      "RX   PubMed=15475430; DOI=10.1158/1078-0432.ccr-04-0841;\r\n",
      "RA   Yoshitake Y., Nakatsura T., Monji M., Senju S., Matsuyoshi H.,\r\n",
      "RA   Tsukamoto H., Hosaka S., Komori H., Fukuma D., Ikuta Y., Katagiri T.,\r\n",
      "RA   Furukawa Y., Ito H., Shinohara M., Nakamura Y., Nishimura Y.;\r\n",
      "RT   \"Proliferation potential-related protein, an ideal esophageal cancer\r\n",
      "RT   antigen for immunotherapy, identified using complementary DNA microarray\r\n",
      "RT   analysis.\";\r\n",
      "RL   Clin. Cancer Res. 10:6437-6448(2004).\r\n",
      "RN   [13]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244; SER-245; SER-246;\r\n",
      "RP   SER-247; SER-360; SER-770; SER-772; SER-861; SER-1179 AND SER-1328, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;\r\n",
      "RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;\r\n",
      "RT   \"Global, in vivo, and site-specific phosphorylation dynamics in signaling\r\n",
      "RT   networks.\";\r\n",
      "RL   Cell 127:635-648(2006).\r\n",
      "RN   [14]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-516, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=16964243; DOI=10.1038/nbt1240;\r\n",
      "RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;\r\n",
      "RT   \"A probability-based approach for high-throughput protein phosphorylation\r\n",
      "RT   analysis and site localization.\";\r\n",
      "RL   Nat. Biotechnol. 24:1285-1292(2006).\r\n",
      "RN   [15]\r\n",
      "RP   INTERACTION WITH MDM2.\r\n",
      "RX   PubMed=17470788; DOI=10.1073/pnas.0701916104;\r\n",
      "RA   Li L., Deng B., Xing G., Teng Y., Tian C., Cheng X., Yin X., Yang J.,\r\n",
      "RA   Gao X., Zhu Y., Sun Q., Zhang L., Yang X., He F.;\r\n",
      "RT   \"PACT is a negative regulator of p53 and essential for cell growth and\r\n",
      "RT   embryonic development.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 104:7951-7956(2007).\r\n",
      "RN   [16]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Embryonic kidney;\r\n",
      "RX   PubMed=17525332; DOI=10.1126/science.1140321;\r\n",
      "RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,\r\n",
      "RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,\r\n",
      "RA   Gygi S.P., Elledge S.J.;\r\n",
      "RT   \"ATM and ATR substrate analysis reveals extensive protein networks\r\n",
      "RT   responsive to DNA damage.\";\r\n",
      "RL   Science 316:1160-1166(2007).\r\n",
      "RN   [17]\r\n",
      "RP   FUNCTION, AND INTERACTION WITH YBX1.\r\n",
      "RX   PubMed=18851979; DOI=10.1016/j.jmb.2008.09.060;\r\n",
      "RA   Chibi M., Meyer M., Skepu A., Rees D.J.G., Moolman-Smook J.C., Pugh D.J.;\r\n",
      "RT   \"RBBP6 interacts with multifunctional protein YB-1 through its RING finger\r\n",
      "RT   domain, leading to ubiquitination and proteosomal degradation of YB-1.\";\r\n",
      "RL   J. Mol. Biol. 384:908-916(2008).\r\n",
      "RN   [18]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-516, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18220336; DOI=10.1021/pr0705441;\r\n",
      "RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;\r\n",
      "RT   \"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient\r\n",
      "RT   phosphoproteomic analysis.\";\r\n",
      "RL   J. Proteome Res. 7:1346-1351(2008).\r\n",
      "RN   [19]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-516; SER-1179;\r\n",
      "RP   THR-1468; SER-1646 AND SER-1648, AND IDENTIFICATION BY MASS SPECTROMETRY\r\n",
      "RP   [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;\r\n",
      "RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,\r\n",
      "RA   Elledge S.J., Gygi S.P.;\r\n",
      "RT   \"A quantitative atlas of mitotic phosphorylation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).\r\n",
      "RN   [20]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1328, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=18318008; DOI=10.1002/pmic.200700884;\r\n",
      "RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,\r\n",
      "RA   Zou H., Gu J.;\r\n",
      "RT   \"Large-scale phosphoproteome analysis of human liver tissue by enrichment\r\n",
      "RT   and fractionation of phosphopeptides with strong anion exchange\r\n",
      "RT   chromatography.\";\r\n",
      "RL   Proteomics 8:1346-1361(2008).\r\n",
      "RN   [21]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-516; SER-1179; SER-1277;\r\n",
      "RP   SER-1328 AND SER-1648, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE\r\n",
      "RP   ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [22]\r\n",
      "RP   SUBCELLULAR LOCATION, INTERACTION WITH NEK6, AND PHOSPHORYLATION.\r\n",
      "RX   PubMed=20873783; DOI=10.1021/pr100562w;\r\n",
      "RA   Vaz Meirelles G., Ferreira Lanza D.C., da Silva J.C., Santana Bernachi J.,\r\n",
      "RA   Paes Leme A.F., Kobarg J.;\r\n",
      "RT   \"Characterization of hNek6 interactome reveals an important role for its\r\n",
      "RT   short N-terminal domain and colocalization with proteins at the\r\n",
      "RT   centrosome.\";\r\n",
      "RL   J. Proteome Res. 9:6298-6316(2010).\r\n",
      "RN   [23]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244; SER-245; SER-246;\r\n",
      "RP   SER-247; SER-516; SER-861; SER-1179 AND SER-1328, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;\r\n",
      "RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,\r\n",
      "RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;\r\n",
      "RT   \"Quantitative phosphoproteomics reveals widespread full phosphorylation\r\n",
      "RT   site occupancy during mitosis.\";\r\n",
      "RL   Sci. Signal. 3:RA3-RA3(2010).\r\n",
      "RN   [24]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-780; SER-1179 AND SER-1328,\r\n",
      "RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;\r\n",
      "RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,\r\n",
      "RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;\r\n",
      "RT   \"System-wide temporal characterization of the proteome and phosphoproteome\r\n",
      "RT   of human embryonic stem cell differentiation.\";\r\n",
      "RL   Sci. Signal. 4:RS3-RS3(2011).\r\n",
      "RN   [25]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-516; SER-768;\r\n",
      "RP   SER-770; SER-772; SER-815; SER-861; SER-873; SER-957; THR-984; SER-1179;\r\n",
      "RP   SER-1221; SER-1277; SER-1328; SER-1341 AND SER-1347, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [26]\r\n",
      "RP   FUNCTION, AND INTERACTION WITH ZBTB38.\r\n",
      "RX   PubMed=24726359; DOI=10.1016/j.celrep.2014.03.030;\r\n",
      "RA   Miotto B., Chibi M., Xie P., Koundrioukoff S., Moolman-Smook H., Pugh D.,\r\n",
      "RA   Debatisse M., He F., Zhang L., Defossez P.A.;\r\n",
      "RT   \"The RBBP6/ZBTB38/MCM10 axis regulates DNA replication and common fragile\r\n",
      "RT   site stability.\";\r\n",
      "RL   Cell Rep. 7:575-587(2014).\r\n",
      "RN   [27]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-984 AND SER-1277, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;\r\n",
      "RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,\r\n",
      "RA   Ye M., Zou H.;\r\n",
      "RT   \"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteomics 96:253-262(2014).\r\n",
      "RN   [28]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1106 AND LYS-1169, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;\r\n",
      "RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,\r\n",
      "RA   Vertegaal A.C.;\r\n",
      "RT   \"System-wide analysis of SUMOylation dynamics in response to replication\r\n",
      "RT   stress reveals novel small ubiquitin-like modified target proteins and\r\n",
      "RT   acceptor lysines relevant for genome stability.\";\r\n",
      "RL   Mol. Cell. Proteomics 14:1419-1434(2015).\r\n",
      "RN   [29]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1169, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=28112733; DOI=10.1038/nsmb.3366;\r\n",
      "RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,\r\n",
      "RA   Nielsen M.L.;\r\n",
      "RT   \"Site-specific mapping of the human SUMO proteome reveals co-modification\r\n",
      "RT   with phosphorylation.\";\r\n",
      "RL   Nat. Struct. Mol. Biol. 24:325-336(2017).\r\n",
      "RN   [30]\r\n",
      "RP   STRUCTURE BY NMR OF 1-81.\r\n",
      "RX   PubMed=16396680; DOI=10.1186/1472-6807-6-1;\r\n",
      "RA   Pugh D.J.R., Ab E., Faro A., Lutya P.T., Hoffmann E., Rees D.J.G.;\r\n",
      "RT   \"DWNN, a novel ubiquitin-like domain, implicates RBBP6 in mRNA processing\r\n",
      "RT   and ubiquitin-like pathways.\";\r\n",
      "RL   BMC Struct. Biol. 6:1-1(2006).\r\n",
      "RN   [31]\r\n",
      "RP   STRUCTURE BY NMR OF 159-309.\r\n",
      "RG   RIKEN structural genomics initiative (RSGI);\r\n",
      "RT   \"Solution structure of the zinc finger CCHC domain and of the RING finger\r\n",
      "RT   from the human retinoblastoma-binding protein 6 (retinoblastoma-binding Q\r\n",
      "RT   protein 1, RBQ-1).\";\r\n",
      "RL   Submitted (APR-2008) to the PDB data bank.\r\n",
      "RN   [32] {ECO:0007744|PDB:3ZTG}\r\n",
      "RP   STRUCTURE BY NMR OF 249-335, AND DOMAIN.\r\n",
      "RX   PubMed=22130672; DOI=10.1074/jbc.m110.217059;\r\n",
      "RA   Kappo M.A., Ab E., Hassem F., Atkinson R.A., Faro A., Muleya V.,\r\n",
      "RA   Mulaudzi T., Poole J.O., McKenzie J.M., Chibi M., Moolman-Smook J.C.,\r\n",
      "RA   Rees D.J., Pugh D.J.;\r\n",
      "RT   \"Solution structure of RING finger-like domain of retinoblastoma-binding\r\n",
      "RT   protein-6 (RBBP6) suggests it functions as a U-box.\";\r\n",
      "RL   J. Biol. Chem. 287:7146-7158(2012).\r\n",
      "RN   [33] {ECO:0007744|PDB:6E5X}\r\n",
      "RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 554-568, INTERACTION WITH\r\n",
      "RP   EBOLAVIRUS VP30 (MICROBIAL INFECTION), AND FUNCTION (MICROBIAL INFECTION).\r\n",
      "RX   PubMed=30550789; DOI=10.1016/j.cell.2018.08.044;\r\n",
      "RA   Batra J., Hultquist J.F., Liu D., Shtanko O., Von Dollen J., Satkamp L.,\r\n",
      "RA   Jang G.M., Luthra P., Schwarz T.M., Small G.I., Arnett E., Anantpadma M.,\r\n",
      "RA   Reyes A., Leung D.W., Kaake R., Haas P., Schmidt C.B., Schlesinger L.S.,\r\n",
      "RA   LaCount D.J., Davey R.A., Amarasinghe G.K., Basler C.F., Krogan N.J.;\r\n",
      "RT   \"Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of\r\n",
      "RT   Ebola Virus Replication.\";\r\n",
      "RL   Cell 175:1917-1930.e13(2018).\r\n",
      "CC   -!- FUNCTION: E3 ubiquitin-protein ligase which promotes ubiquitination of\r\n",
      "CC       YBX1, leading to its degradation by the proteasome (PubMed:18851979).\r\n",
      "CC       May play a role as a scaffold protein to promote the assembly of the\r\n",
      "CC       p53/TP53-MDM2 complex, resulting in increase of MDM2-mediated\r\n",
      "CC       ubiquitination and degradation of p53/TP53; may function as negative\r\n",
      "CC       regulator of p53/TP53, leading to both apoptosis and cell growth (By\r\n",
      "CC       similarity). Regulates DNA-replication and the stability of chromosomal\r\n",
      "CC       common fragile sites (CFSs) in a ZBTB38- and MCM10-dependent manner.\r\n",
      "CC       Controls ZBTB38 protein stability and abundance via ubiquitination and\r\n",
      "CC       proteasomal degradation, and ZBTB38 in turn negatively regulates the\r\n",
      "CC       expression of MCM10 which plays an important role in DNA-replication\r\n",
      "CC       (PubMed:24726359). {ECO:0000250|UniProtKB:P97868,\r\n",
      "CC       ECO:0000269|PubMed:18851979, ECO:0000269|PubMed:24726359}.\r\n",
      "CC   -!- FUNCTION: (Microbial infection) [Isoform 1]: Restricts ebolavirus\r\n",
      "CC       replication probably by impairing the vp30-NP interaction, and thus\r\n",
      "CC       viral transcription. {ECO:0000269|PubMed:30550789}.\r\n",
      "CC   -!- CATALYTIC ACTIVITY:\r\n",
      "CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +\r\n",
      "CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-\r\n",
      "CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;\r\n",
      "CC         EC=2.3.2.27;\r\n",
      "CC   -!- PATHWAY: Protein modification; protein ubiquitination.\r\n",
      "CC   -!- SUBUNIT: Interacts with p53/TP53 and RB1 (By similarity). Interacts\r\n",
      "CC       also with MDM2 and YBX1 (PubMed:17470788). Interacts also with MDM2 and\r\n",
      "CC       YBX1 (PubMed:18851979). Interacts with NEK6 (PubMed:20873783).\r\n",
      "CC       Interacts with ZBTB38 (PubMed:24726359). {ECO:0000250|UniProtKB:P97868,\r\n",
      "CC       ECO:0000269|PubMed:17470788, ECO:0000269|PubMed:18851979,\r\n",
      "CC       ECO:0000269|PubMed:20873783, ECO:0000269|PubMed:24726359}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) [Isoform 1]: Interacts with ebolavirus\r\n",
      "CC       VP30. {ECO:0000269|PubMed:30550789}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q7Z6E9; Q16629: SRSF7; NbExp=3; IntAct=EBI-2117026, EBI-398885;\r\n",
      "CC       Q7Z6E9; P46937: YAP1; NbExp=2; IntAct=EBI-2117026, EBI-1044059;\r\n",
      "CC       Q7Z6E9-3; P49821: NDUFV1; NbExp=3; IntAct=EBI-11743772, EBI-748312;\r\n",
      "CC       Q7Z6E9-3; O76024: WFS1; NbExp=3; IntAct=EBI-11743772, EBI-720609;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus. Chromosome. Cytoplasm,\r\n",
      "CC       cytoskeleton, microtubule organizing center, centrosome.\r\n",
      "CC       Note=Colocalizes with mitotic chromosomes. Colocalizes with NEK6 in the\r\n",
      "CC       centrosome.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=4;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=Q7Z6E9-1; Sequence=Displayed;\r\n",
      "CC       Name=2;\r\n",
      "CC         IsoId=Q7Z6E9-2; Sequence=VSP_018284;\r\n",
      "CC       Name=3;\r\n",
      "CC         IsoId=Q7Z6E9-3; Sequence=VSP_018281, VSP_018282;\r\n",
      "CC       Name=4;\r\n",
      "CC         IsoId=Q7Z6E9-4; Sequence=VSP_018283;\r\n",
      "CC   -!- TISSUE SPECIFICITY: Highly expressed in the placenta and testis.\r\n",
      "CC       Expressed at lower levels in the brain, heart, kidney, liver and lung.\r\n",
      "CC       Overexpressed in esophageal cancer. {ECO:0000269|PubMed:15475430}.\r\n",
      "CC   -!- DOMAIN: Contains a N-terminus DWNN domain, a zinc-finger domain and a\r\n",
      "CC       C4C4 zinc-binding RING finger domain (PubMed:22130672). The ring finger\r\n",
      "CC       may indeed be a U-box domain (PubMed:22130672).\r\n",
      "CC       {ECO:0000269|PubMed:22130672}.\r\n",
      "CC   -!- PTM: Phosphorylated by NEK6. {ECO:0000269|PubMed:20873783}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=AAG43155.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=AAH63524.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=AAL05625.1; Type=Frameshift; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=AAL68925.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=CAA59445.1; Type=Frameshift; Evidence={ECO:0000305};\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AB112074; BAC77636.1; -; mRNA.\r\n",
      "DR   EMBL; AB112075; BAC77637.1; -; mRNA.\r\n",
      "DR   EMBL; CH471145; EAW55789.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; BC029352; AAH29352.1; -; mRNA.\r\n",
      "DR   EMBL; BC063524; AAH63524.1; ALT_SEQ; mRNA.\r\n",
      "DR   EMBL; BC073938; AAH73938.1; -; mRNA.\r\n",
      "DR   EMBL; BC101139; AAI01140.1; -; mRNA.\r\n",
      "DR   EMBL; BC101140; AAI01141.1; -; mRNA.\r\n",
      "DR   EMBL; BC101141; AAI01142.1; -; mRNA.\r\n",
      "DR   EMBL; BC101142; AAI01143.1; -; mRNA.\r\n",
      "DR   EMBL; BC114353; AAI14354.1; -; mRNA.\r\n",
      "DR   EMBL; BC114354; AAI14355.1; -; mRNA.\r\n",
      "DR   EMBL; BC118667; AAI18668.1; -; mRNA.\r\n",
      "DR   EMBL; BC139830; AAI39831.1; -; mRNA.\r\n",
      "DR   EMBL; AF063596; AAG43155.1; ALT_SEQ; mRNA.\r\n",
      "DR   EMBL; AY072922; AAL68925.1; ALT_SEQ; mRNA.\r\n",
      "DR   EMBL; AF352051; AAL05625.1; ALT_FRAME; mRNA.\r\n",
      "DR   EMBL; X85133; CAA59445.1; ALT_FRAME; mRNA.\r\n",
      "DR   EMBL; AK026954; BAB15600.1; -; mRNA.\r\n",
      "DR   EMBL; AL359564; CAB94869.1; -; mRNA.\r\n",
      "DR   CCDS; CCDS10621.1; -. [Q7Z6E9-1]\r\n",
      "DR   CCDS; CCDS10622.1; -. [Q7Z6E9-2]\r\n",
      "DR   CCDS; CCDS45444.1; -. [Q7Z6E9-3]\r\n",
      "DR   PIR; A57640; A57640.\r\n",
      "DR   PIR; T50609; T50609.\r\n",
      "DR   RefSeq; NP_008841.2; NM_006910.4. [Q7Z6E9-1]\r\n",
      "DR   RefSeq; NP_061173.1; NM_018703.3. [Q7Z6E9-2]\r\n",
      "DR   RefSeq; NP_116015.2; NM_032626.5. [Q7Z6E9-3]\r\n",
      "DR   PDB; 2C7H; NMR; -; A=1-81.\r\n",
      "DR   PDB; 2YSA; NMR; -; A=159-206.\r\n",
      "DR   PDB; 2YUR; NMR; -; A=249-309.\r\n",
      "DR   PDB; 3ZTG; NMR; -; A/B=249-335.\r\n",
      "DR   PDB; 6E5X; X-ray; 1.50 A; B=554-568.\r\n",
      "DR   PDBsum; 2C7H; -.\r\n",
      "DR   PDBsum; 2YSA; -.\r\n",
      "DR   PDBsum; 2YUR; -.\r\n",
      "DR   PDBsum; 3ZTG; -.\r\n",
      "DR   PDBsum; 6E5X; -.\r\n",
      "DR   AlphaFoldDB; Q7Z6E9; -.\r\n",
      "DR   BMRB; Q7Z6E9; -.\r\n",
      "DR   SMR; Q7Z6E9; -.\r\n",
      "DR   BioGRID; 111865; 227.\r\n",
      "DR   DIP; DIP-46897N; -.\r\n",
      "DR   IntAct; Q7Z6E9; 53.\r\n",
      "DR   MINT; Q7Z6E9; -.\r\n",
      "DR   STRING; 9606.ENSP00000317872; -.\r\n",
      "DR   GlyCosmos; Q7Z6E9; 3 sites, 1 glycan.\r\n",
      "DR   GlyGen; Q7Z6E9; 4 sites, 1 O-linked glycan (4 sites).\r\n",
      "DR   iPTMnet; Q7Z6E9; -.\r\n",
      "DR   MetOSite; Q7Z6E9; -.\r\n",
      "DR   PhosphoSitePlus; Q7Z6E9; -.\r\n",
      "DR   BioMuta; RBBP6; -.\r\n",
      "DR   DMDM; 74762440; -.\r\n",
      "DR   EPD; Q7Z6E9; -.\r\n",
      "DR   jPOST; Q7Z6E9; -.\r\n",
      "DR   MassIVE; Q7Z6E9; -.\r\n",
      "DR   MaxQB; Q7Z6E9; -.\r\n",
      "DR   PaxDb; Q7Z6E9; -.\r\n",
      "DR   PeptideAtlas; Q7Z6E9; -.\r\n",
      "DR   ProteomicsDB; 69396; -. [Q7Z6E9-1]\r\n",
      "DR   ProteomicsDB; 69397; -. [Q7Z6E9-2]\r\n",
      "DR   ProteomicsDB; 69398; -. [Q7Z6E9-3]\r\n",
      "DR   ProteomicsDB; 69399; -. [Q7Z6E9-4]\r\n",
      "DR   Antibodypedia; 26070; 364 antibodies from 30 providers.\r\n",
      "DR   DNASU; 5930; -.\r\n",
      "DR   Ensembl; ENST00000319715.10; ENSP00000317872.4; ENSG00000122257.20. [Q7Z6E9-1]\r\n",
      "DR   Ensembl; ENST00000348022.6; ENSP00000316291.4; ENSG00000122257.20. [Q7Z6E9-2]\r\n",
      "DR   Ensembl; ENST00000381039.7; ENSP00000370427.3; ENSG00000122257.20. [Q7Z6E9-4]\r\n",
      "DR   Ensembl; ENST00000452655.6; ENSP00000390537.2; ENSG00000122257.20. [Q7Z6E9-3]\r\n",
      "DR   GeneID; 5930; -.\r\n",
      "DR   KEGG; hsa:5930; -.\r\n",
      "DR   MANE-Select; ENST00000319715.10; ENSP00000317872.4; NM_006910.5; NP_008841.2.\r\n",
      "DR   UCSC; uc002dmg.4; human. [Q7Z6E9-1]\r\n",
      "DR   AGR; HGNC:9889; -.\r\n",
      "DR   CTD; 5930; -.\r\n",
      "DR   DisGeNET; 5930; -.\r\n",
      "DR   GeneCards; RBBP6; -.\r\n",
      "DR   HGNC; HGNC:9889; RBBP6.\r\n",
      "DR   HPA; ENSG00000122257; Tissue enhanced (bone).\r\n",
      "DR   MIM; 600938; gene.\r\n",
      "DR   neXtProt; NX_Q7Z6E9; -.\r\n",
      "DR   OpenTargets; ENSG00000122257; -.\r\n",
      "DR   PharmGKB; PA34253; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000122257; -.\r\n",
      "DR   eggNOG; KOG0314; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00940000157561; -.\r\n",
      "DR   HOGENOM; CLU_239162_0_0_1; -.\r\n",
      "DR   InParanoid; Q7Z6E9; -.\r\n",
      "DR   OMA; ECIRTFL; -.\r\n",
      "DR   OrthoDB; 150979at2759; -.\r\n",
      "DR   PhylomeDB; Q7Z6E9; -.\r\n",
      "DR   TreeFam; TF350543; -.\r\n",
      "DR   PathwayCommons; Q7Z6E9; -.\r\n",
      "DR   Reactome; R-HSA-9013422; RHOBTB1 GTPase cycle.\r\n",
      "DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.\r\n",
      "DR   SignaLink; Q7Z6E9; -.\r\n",
      "DR   SIGNOR; Q7Z6E9; -.\r\n",
      "DR   UniPathway; UPA00143; -.\r\n",
      "DR   BioGRID-ORCS; 5930; 802 hits in 1209 CRISPR screens.\r\n",
      "DR   ChiTaRS; RBBP6; human.\r\n",
      "DR   EvolutionaryTrace; Q7Z6E9; -.\r\n",
      "DR   GeneWiki; RBBP6; -.\r\n",
      "DR   GenomeRNAi; 5930; -.\r\n",
      "DR   Pharos; Q7Z6E9; Tbio.\r\n",
      "DR   PRO; PR:Q7Z6E9; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 16.\r\n",
      "DR   RNAct; Q7Z6E9; protein.\r\n",
      "DR   Bgee; ENSG00000122257; Expressed in buccal mucosa cell and 201 other tissues.\r\n",
      "DR   ExpressionAtlas; Q7Z6E9; baseline and differential.\r\n",
      "DR   Genevisible; Q7Z6E9; HS.\r\n",
      "DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.\r\n",
      "DR   GO; GO:0005829; C:cytosol; TAS:Reactome.\r\n",
      "DR   GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell.\r\n",
      "DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.\r\n",
      "DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.\r\n",
      "DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.\r\n",
      "DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.\r\n",
      "DR   GO; GO:0006974; P:DNA damage response; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0048568; P:embryonic organ development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006397; P:mRNA processing; IEA:InterPro.\r\n",
      "DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.\r\n",
      "DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006275; P:regulation of DNA replication; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0061053; P:somite development; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB.\r\n",
      "DR   CDD; cd16620; vRING-HC-C4C4_RBBP6; 1.\r\n",
      "DR   Gene3D; 4.10.60.10; Zinc finger, CCHC-type; 1.\r\n",
      "DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.\r\n",
      "DR   InterPro; IPR014891; DWNN_domain.\r\n",
      "DR   InterPro; IPR033489; RBBP6.\r\n",
      "DR   InterPro; IPR003613; Ubox_domain.\r\n",
      "DR   InterPro; IPR025829; Zn_knuckle_CX2CX3GHX4C.\r\n",
      "DR   InterPro; IPR001878; Znf_CCHC.\r\n",
      "DR   InterPro; IPR036875; Znf_CCHC_sf.\r\n",
      "DR   InterPro; IPR001841; Znf_RING.\r\n",
      "DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.\r\n",
      "DR   PANTHER; PTHR15439:SF0; E3 UBIQUITIN-PROTEIN LIGASE RBBP6; 1.\r\n",
      "DR   PANTHER; PTHR15439; RETINOBLASTOMA-BINDING PROTEIN 6; 1.\r\n",
      "DR   Pfam; PF08783; DWNN; 1.\r\n",
      "DR   Pfam; PF04564; U-box; 1.\r\n",
      "DR   Pfam; PF13696; zf-CCHC_2; 1.\r\n",
      "DR   SMART; SM01180; DWNN; 1.\r\n",
      "DR   SMART; SM00184; RING; 1.\r\n",
      "DR   SMART; SM00343; ZnF_C2HC; 1.\r\n",
      "DR   SUPFAM; SSF57756; Retrovirus zinc finger-like domains; 1.\r\n",
      "DR   SUPFAM; SSF57850; RING/U-box; 1.\r\n",
      "DR   PROSITE; PS51282; DWNN; 1.\r\n",
      "DR   PROSITE; PS50158; ZF_CCHC; 1.\r\n",
      "DR   PROSITE; PS50089; ZF_RING_2; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Acetylation; Alternative splicing; Chromosome; Cytoplasm;\r\n",
      "KW   Cytoskeleton; DNA damage; DNA replication; Host-virus interaction;\r\n",
      "KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Transferase; Ubl conjugation; Ubl conjugation pathway;\r\n",
      "KW   Zinc; Zinc-finger.\r\n",
      "FT   CHAIN           1..1792\r\n",
      "FT                   /note=\"E3 ubiquitin-protein ligase RBBP6\"\r\n",
      "FT                   /id=\"PRO_0000234354\"\r\n",
      "FT   DOMAIN          4..76\r\n",
      "FT                   /note=\"DWNN\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00612\"\r\n",
      "FT   ZN_FING         159..176\r\n",
      "FT                   /note=\"CCHC-type\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00047\"\r\n",
      "FT   ZN_FING         259..300\r\n",
      "FT                   /note=\"RING-type; degenerate\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00175\"\r\n",
      "FT   REGION          326..347\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          371..410\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          532..601\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          549..571\r\n",
      "FT                   /note=\"(Microbial infection) Interaction with Ebolavirus\r\n",
      "FT                   VP30\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30550789\"\r\n",
      "FT   REGION          621..640\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          645..799\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          847..1290\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          982..1139\r\n",
      "FT                   /note=\"Interaction with RB1\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          1321..1348\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1360..1665\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1433..1544\r\n",
      "FT                   /note=\"Interaction with p53\"\r\n",
      "FT                   /evidence=\"ECO:0000250\"\r\n",
      "FT   REGION          1682..1792\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOTIF           560..565\r\n",
      "FT                   /note=\"PPxPxY\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:30550789\"\r\n",
      "FT   COMPBIAS        553..601\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        645..685\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        686..729\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        735..766\r\n",
      "FT                   /note=\"Basic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        772..786\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        904..929\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        982..1029\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1036..1070\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1083..1165\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1175..1217\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1218..1233\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1234..1255\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1256..1279\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1361..1434\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1448..1579\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1597..1625\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1647..1665\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1683..1722\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1729..1750\r\n",
      "FT                   /note=\"Basic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1774..1792\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         130\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P97868\"\r\n",
      "FT   MOD_RES         244\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         245\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         246\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         247\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         360\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         516\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:16964243,\r\n",
      "FT                   ECO:0007744|PubMed:18220336, ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         768\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         770\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         772\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         780\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21406692\"\r\n",
      "FT   MOD_RES         815\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         861\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         873\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         957\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         984\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163,\r\n",
      "FT                   ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         1179\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1221\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1271\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P97868\"\r\n",
      "FT   MOD_RES         1277\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         1328\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983,\r\n",
      "FT                   ECO:0007744|PubMed:18318008, ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1341\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1347\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1468\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648\"\r\n",
      "FT   MOD_RES         1646\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648\"\r\n",
      "FT   MOD_RES         1648\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332\"\r\n",
      "FT   MOD_RES         1651\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P97868\"\r\n",
      "FT   CROSSLNK        1106\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:25755297\"\r\n",
      "FT   CROSSLNK        1169\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:25755297,\r\n",
      "FT                   ECO:0007744|PubMed:28112733\"\r\n",
      "FT   VAR_SEQ         102..117\r\n",
      "FT                   /note=\"IDDSSASISLAQLTKT -> VCKNTISHFFYTLLLPL (in isoform\r\n",
      "FT                   3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_018281\"\r\n",
      "FT   VAR_SEQ         118..1792\r\n",
      "FT                   /note=\"Missing (in isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_018282\"\r\n",
      "FT   VAR_SEQ         431..1270\r\n",
      "FT                   /note=\"Missing (in isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_018283\"\r\n",
      "FT   VAR_SEQ         652..685\r\n",
      "FT                   /note=\"Missing (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|Ref.1, ECO:0000303|Ref.5\"\r\n",
      "FT                   /id=\"VSP_018284\"\r\n",
      "FT   VARIANT         43\r\n",
      "FT                   /note=\"D -> H (in dbSNP:rs16973796)\"\r\n",
      "FT                   /id=\"VAR_051306\"\r\n",
      "FT   VARIANT         555\r\n",
      "FT                   /note=\"V -> A (in dbSNP:rs16973840)\"\r\n",
      "FT                   /id=\"VAR_026216\"\r\n",
      "FT   VARIANT         1208\r\n",
      "FT                   /note=\"K -> I (in dbSNP:rs3743968)\"\r\n",
      "FT                   /id=\"VAR_051307\"\r\n",
      "FT   CONFLICT        223\r\n",
      "FT                   /note=\"I -> T (in Ref. 5; AAL68925)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1633\r\n",
      "FT                   /note=\"D -> H (in Ref. 5; AAL68925)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   STRAND          1..8\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2C7H\"\r\n",
      "FT   STRAND          12..25\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2C7H\"\r\n",
      "FT   HELIX           26..37\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2C7H\"\r\n",
      "FT   TURN            41..43\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2C7H\"\r\n",
      "FT   STRAND          44..53\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2C7H\"\r\n",
      "FT   STRAND          63..65\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2C7H\"\r\n",
      "FT   STRAND          70..76\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2C7H\"\r\n",
      "FT   TURN            162..164\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YSA\"\r\n",
      "FT   HELIX           171..173\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YSA\"\r\n",
      "FT   HELIX           176..178\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YSA\"\r\n",
      "FT   STRAND          197..199\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YSA\"\r\n",
      "FT   HELIX           255..257\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YUR\"\r\n",
      "FT   STRAND          260..262\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YUR\"\r\n",
      "FT   STRAND          273..275\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YUR\"\r\n",
      "FT   HELIX           283..290\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YUR\"\r\n",
      "FT   STRAND          291..294\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YUR\"\r\n",
      "FT   STRAND          297..299\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YUR\"\r\n",
      "FT   TURN            306..309\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:2YUR\"\r\n",
      "FT   HELIX           313..326\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:3ZTG\"\r\n",
      "SQ   SEQUENCE   1792 AA;  201564 MW;  550F7BBA5125DA06 CRC64;\r\n",
      "     MSCVHYKFSS KLNYDTVTFD GLHISLCDLK KQIMGREKLK AADCDLQITN AQTKEEYTDD\r\n",
      "     NALIPKNSSV IVRRIPIGGV KSTSKTYVIS RTEPAMATTK AIDDSSASIS LAQLTKTANL\r\n",
      "     AEANASEEDK IKAMMSQSGH EYDPINYMKK PLGPPPPSYT CFRCGKPGHY IKNCPTNGDK\r\n",
      "     NFESGPRIKK STGIPRSFMM EVKDPNMKGA MLTNTGKYAI PTIDAEAYAI GKKEKPPFLP\r\n",
      "     EEPSSSSEED DPIPDELLCL ICKDIMTDAV VIPCCGNSYC DECIRTALLE SDEHTCPTCH\r\n",
      "     QNDVSPDALI ANKFLRQAVN NFKNETGYTK RLRKQLPPPP PPIPPPRPLI QRNLQPLMRS\r\n",
      "     PISRQQDPLM IPVTSSSTHP APSISSLTSN QSSLAPPVSG NPSSAPAPVP DITATVSISV\r\n",
      "     HSEKSDGPFR DSDNKILPAA ALASEHSKGT SSIAITALME EKGYQVPVLG TPSLLGQSLL\r\n",
      "     HGQLIPTTGP VRINTARPGG GRPGWEHSNK LGYLVSPPQQ IRRGERSCYR SINRGRHHSE\r\n",
      "     RSQRTQGPSL PATPVFVPVP PPPLYPPPPH TLPLPPGVPP PQFSPQFPPG QPPPAGYSVP\r\n",
      "     PPGFPPAPAN LSTPWVSSGV QTAHSNTIPT TQAPPLSREE FYREQRRLKE EEKKKSKLDE\r\n",
      "     FTNDFAKELM EYKKIQKERR RSFSRSKSPY SGSSYSRSSY TYSKSRSGST RSRSYSRSFS\r\n",
      "     RSHSRSYSRS PPYPRRGRGK SRNYRSRSRS HGYHRSRSRS PPYRRYHSRS RSPQAFRGQS\r\n",
      "     PNKRNVPQGE TEREYFNRYR EVPPPYDMKA YYGRSVDFRD PFEKERYREW ERKYREWYEK\r\n",
      "     YYKGYAAGAQ PRPSANRENF SPERFLPLNI RNSPFTRGRR EDYVGGQSHR SRNIGSNYPE\r\n",
      "     KLSARDGHNQ KDNTKSKEKE SENAPGDGKG NKHKKHRKRR KGEESEGFLN PELLETSRKS\r\n",
      "     REPTGVEENK TDSLFVLPSR DDATPVRDEP MDAESITFKS VSEKDKRERD KPKAKGDKTK\r\n",
      "     RKNDGSAVSK KENIVKPAKG PQEKVDGERE RSPRSEPPIK KAKEETPKTD NTKSSSSSQK\r\n",
      "     DEKITGTPRK AHSKSAKEHQ ETKPVKEEKV KKDYSKDVKS EKLTTKEEKA KKPNEKNKPL\r\n",
      "     DNKGEKRKRK TEEKGVDKDF ESSSMKISKL EVTEIVKPSP KRKMEPDTEK MDRTPEKDKI\r\n",
      "     SLSAPAKKIK LNRETGKKIG STENISNTKE PSEKLESTSS KVKQEKVKGK VRRKVTGTEG\r\n",
      "     SSSTLVDYTS TSSTGGSPVR KSEEKTDTKR TVIKTMEEYN NDNTAPAEDV IIMIQVPQSK\r\n",
      "     WDKDDFESEE EDVKSTQPIS SVGKPASVIK NVSTKPSNIV KYPEKESEPS EKIQKFTKDV\r\n",
      "     SHEIIQHEVK SSKNSASSEK GKTKDRDYSV LEKENPEKRK NSTQPEKESN LDRLNEQGNF\r\n",
      "     KSLSQSSKEA RTSDKHDSTR ASSNKDFTPN RDKKTDYDTR EYSSSKRRDE KNELTRRKDS\r\n",
      "     PSRNKDSASG QKNKPREERD LPKKGTGDSK KSNSSPSRDR KPHDHKATYD TKRPNEETKS\r\n",
      "     VDKNPCKDRE KHVLEARNNK ESSGNKLLYI LNPPETQVEK EQITGQIDKS TVKPKPQLSH\r\n",
      "     SSRLSSDLTR ETDEAAFEPD YNESDSESNV SVKEEESSGN ISKDLKDKIV EKAKESLDTA\r\n",
      "     AVVQVGISRN QSHSSPSVSP SRSHSPSGSQ TRSHSSSASS AESQDSKKKK KKKEKKKHKK\r\n",
      "     HKKHKKHKKH AGTEVELEKS QKHKHKKKKS KKNKDKEKEK EKDDQKVKSV TV\r\n",
      "//\r\n",
      "ID   TASOR_HUMAN             Reviewed;        1670 AA.\r\n",
      "AC   Q9UK61; A1L3A4; B5ME28; Q9H2F7; Q9UPP7;\r\n",
      "DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   05-MAY-2009, sequence version 3.\r\n",
      "DT   03-MAY-2023, entry version 138.\r\n",
      "DE   RecName: Full=Protein TASOR {ECO:0000305};\r\n",
      "DE   AltName: Full=CTCL tumor antigen se89-1 {ECO:0000303|PubMed:11149944};\r\n",
      "DE   AltName: Full=Retinoblastoma-associated protein RAP140 {ECO:0000303|PubMed:18726359};\r\n",
      "DE   AltName: Full=Transgene activation suppressor protein {ECO:0000303|PubMed:26022416};\r\n",
      "GN   Name=TASOR {ECO:0000303|PubMed:26022416, ECO:0000312|HGNC:HGNC:30314};\r\n",
      "GN   Synonyms=C3orf63 {ECO:0000312|HGNC:HGNC:30314}, FAM208A\r\n",
      "GN   {ECO:0000312|HGNC:HGNC:30314}, KIAA1105 {ECO:0000303|PubMed:10470851};\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT ARG-1046.\r\n",
      "RC   TISSUE=Fetal brain;\r\n",
      "RX   PubMed=18726359; DOI=10.1007/bf02882285;\r\n",
      "RA   Li Q., Wen H., Ao S.;\r\n",
      "RT   \"Identification and cloning of the cDNA of a Rb-associated protein\r\n",
      "RT   RAP140a.\";\r\n",
      "RL   Sci. China, Ser. C, Life Sci. 43:637-647(2000).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RX   PubMed=16641997; DOI=10.1038/nature04728;\r\n",
      "RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,\r\n",
      "RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,\r\n",
      "RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,\r\n",
      "RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,\r\n",
      "RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,\r\n",
      "RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,\r\n",
      "RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,\r\n",
      "RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,\r\n",
      "RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,\r\n",
      "RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,\r\n",
      "RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,\r\n",
      "RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,\r\n",
      "RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,\r\n",
      "RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,\r\n",
      "RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,\r\n",
      "RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,\r\n",
      "RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,\r\n",
      "RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,\r\n",
      "RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;\r\n",
      "RT   \"The DNA sequence, annotation and analysis of human chromosome 3.\";\r\n",
      "RL   Nature 440:1194-1198(2006).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-598 (ISOFORM 1).\r\n",
      "RC   TISSUE=Cerebellum;\r\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\r\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\r\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\r\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\r\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\r\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\r\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\r\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\r\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\r\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\r\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\r\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\r\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\r\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\r\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\r\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\r\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\r\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\r\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\r\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\r\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\r\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\r\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\r\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\r\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\r\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\r\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\r\n",
      "RA   Isogai T., Sugano S.;\r\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\r\n",
      "RT   cDNAs.\";\r\n",
      "RL   Nat. Genet. 36:40-45(2004).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 376-1670 (ISOFORM 3).\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 523-1274 (ISOFORM 4), AND VARIANTS ARG-1046\r\n",
      "RP   AND VAL-1435.\r\n",
      "RC   TISSUE=Testis;\r\n",
      "RX   PubMed=11149944; DOI=10.1073/pnas.98.2.629;\r\n",
      "RA   Eichmueller S., Usener D., Dummer R., Stein A., Thiel D., Schadendorf D.;\r\n",
      "RT   \"Serological detection of cutaneous T-cell lymphoma-associated antigens.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 98:629-634(2001).\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 941-1274 (ISOFORM 1), AND VARIANT\r\n",
      "RP   ARG-1046.\r\n",
      "RC   TISSUE=Brain;\r\n",
      "RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;\r\n",
      "RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N., Tanaka A.,\r\n",
      "RA   Kotani H., Nomura N., Ohara O.;\r\n",
      "RT   \"Prediction of the coding sequences of unidentified human genes. XIV. The\r\n",
      "RT   complete sequences of 100 new cDNA clones from brain which code for large\r\n",
      "RT   proteins in vitro.\";\r\n",
      "RL   DNA Res. 6:197-205(1999).\r\n",
      "RN   [7]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-927, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;\r\n",
      "RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;\r\n",
      "RT   \"Global, in vivo, and site-specific phosphorylation dynamics in signaling\r\n",
      "RT   networks.\";\r\n",
      "RL   Cell 127:635-648(2006).\r\n",
      "RN   [8]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-927, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=16964243; DOI=10.1038/nbt1240;\r\n",
      "RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;\r\n",
      "RT   \"A probability-based approach for high-throughput protein phosphorylation\r\n",
      "RT   analysis and site localization.\";\r\n",
      "RL   Nat. Biotechnol. 24:1285-1292(2006).\r\n",
      "RN   [9]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;\r\n",
      "RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,\r\n",
      "RA   Greff Z., Keri G., Stemmann O., Mann M.;\r\n",
      "RT   \"Kinase-selective enrichment enables quantitative phosphoproteomics of the\r\n",
      "RT   kinome across the cell cycle.\";\r\n",
      "RL   Mol. Cell 31:438-448(2008).\r\n",
      "RN   [10]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;\r\n",
      "RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,\r\n",
      "RA   Elledge S.J., Gygi S.P.;\r\n",
      "RT   \"A quantitative atlas of mitotic phosphorylation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).\r\n",
      "RN   [11]\r\n",
      "RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR\r\n",
      "RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY\r\n",
      "RP   [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19413330; DOI=10.1021/ac9004309;\r\n",
      "RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;\r\n",
      "RT   \"Lys-N and trypsin cover complementary parts of the phosphoproteome in a\r\n",
      "RT   refined SCX-based approach.\";\r\n",
      "RL   Anal. Chem. 81:4493-4501(2009).\r\n",
      "RN   [12]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-633; SER-636; SER-927 AND\r\n",
      "RP   SER-979, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [13]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-633; SER-636; SER-927;\r\n",
      "RP   THR-982 AND SER-1103, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE\r\n",
      "RP   ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;\r\n",
      "RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,\r\n",
      "RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;\r\n",
      "RT   \"Quantitative phosphoproteomics reveals widespread full phosphorylation\r\n",
      "RT   site occupancy during mitosis.\";\r\n",
      "RL   Sci. Signal. 3:RA3-RA3(2010).\r\n",
      "RN   [14]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-927 AND SER-1103, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;\r\n",
      "RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,\r\n",
      "RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;\r\n",
      "RT   \"System-wide temporal characterization of the proteome and phosphoproteome\r\n",
      "RT   of human embryonic stem cell differentiation.\";\r\n",
      "RL   Sci. Signal. 4:RS3-RS3(2011).\r\n",
      "RN   [15]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-344; SER-673; SER-800;\r\n",
      "RP   SER-927; SER-971; SER-979; THR-1049; SER-1103 AND SER-1552, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [16]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-927 AND SER-1103, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;\r\n",
      "RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,\r\n",
      "RA   Ye M., Zou H.;\r\n",
      "RT   \"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteomics 96:253-262(2014).\r\n",
      "RN   [17]\r\n",
      "RP   FUNCTION, SUBCELLULAR LOCATION, AND IDENTIFICATION IN THE HUSH COMPLEX.\r\n",
      "RX   PubMed=26022416; DOI=10.1126/science.aaa7227;\r\n",
      "RA   Tchasovnikarova I.A., Timms R.T., Matheson N.J., Wals K., Antrobus R.,\r\n",
      "RA   Goettgens B., Dougan G., Dawson M.A., Lehner P.J.;\r\n",
      "RT   \"Epigenetic silencing by the HUSH complex mediates position-effect\r\n",
      "RT   variegation in human cells.\";\r\n",
      "RL   Science 348:1481-1485(2015).\r\n",
      "RN   [18]\r\n",
      "RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH MORC2.\r\n",
      "RX   PubMed=28581500; DOI=10.1038/ng.3878;\r\n",
      "RA   Tchasovnikarova I.A., Timms R.T., Douse C.H., Roberts R.C., Dougan G.,\r\n",
      "RA   Kingston R.E., Modis Y., Lehner P.J.;\r\n",
      "RT   \"Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease\r\n",
      "RT   mutation in MORC2.\";\r\n",
      "RL   Nat. Genet. 49:1035-1044(2017).\r\n",
      "RN   [19]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-586; LYS-823; LYS-832 AND\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RP   LYS-872, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=28112733; DOI=10.1038/nsmb.3366;\r\n",
      "RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,\r\n",
      "RA   Nielsen M.L.;\r\n",
      "RT   \"Site-specific mapping of the human SUMO proteome reveals co-modification\r\n",
      "RT   with phosphorylation.\";\r\n",
      "RL   Nat. Struct. Mol. Biol. 24:325-336(2017).\r\n",
      "RN   [20]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=29211708; DOI=10.1038/nature25179;\r\n",
      "RA   Liu N., Lee C.H., Swigut T., Grow E., Gu B., Bassik M.C., Wysocka J.;\r\n",
      "RT   \"Selective silencing of euchromatic L1s revealed by genome-wide screens for\r\n",
      "RT   L1 regulators.\";\r\n",
      "RL   Nature 553:228-232(2018).\r\n",
      "RN   [21]\r\n",
      "RP   FUNCTION, AND INTERACTION WITH ZNF638.\r\n",
      "RX   PubMed=30487602; DOI=10.1038/s41586-018-0750-6;\r\n",
      "RA   Zhu Y., Wang G.Z., Cingoez O., Goff S.P.;\r\n",
      "RT   \"NP220 mediates silencing of unintegrated retroviral DNA.\";\r\n",
      "RL   Nature 564:278-282(2018).\r\n",
      "CC   -!- FUNCTION: Component of the HUSH complex, a multiprotein complex that\r\n",
      "CC       mediates epigenetic repression (PubMed:26022416, PubMed:28581500). The\r\n",
      "CC       HUSH complex is recruited to genomic loci rich in H3K9me3 and is\r\n",
      "CC       required to maintain transcriptional silencing by promoting recruitment\r\n",
      "CC       of SETDB1, a histone methyltransferase that mediates further deposition\r\n",
      "CC       of H3K9me3, as well as MORC2 (PubMed:26022416, PubMed:28581500). Also\r\n",
      "CC       represses L1 retrotransposons in collaboration with MORC2 and,\r\n",
      "CC       probably, SETDB1, the silencing is dependent of repressive epigenetic\r\n",
      "CC       modifications, such as H3K9me3 mark. Silencing events often occur\r\n",
      "CC       within introns of transcriptionally active genes, and lead to the down-\r\n",
      "CC       regulation of host gene expression (PubMed:29211708). The HUSH complex\r\n",
      "CC       is also involved in the silencing of unintegrated retroviral DNA by\r\n",
      "CC       being recruited by ZNF638: some part of the retroviral DNA formed\r\n",
      "CC       immediately after infection remains unintegrated in the host genome and\r\n",
      "CC       is transcriptionally repressed (PubMed:30487602). Plays a crucial role\r\n",
      "CC       in early embryonic development (By similarity). Involved in the\r\n",
      "CC       organization of spindle poles and spindle apparatus assembly during\r\n",
      "CC       zygotic division (By similarity). Plays an important role in\r\n",
      "CC       maintaining epiblast fitness or potency (By similarity).\r\n",
      "CC       {ECO:0000250|UniProtKB:Q69ZR9, ECO:0000269|PubMed:26022416,\r\n",
      "CC       ECO:0000269|PubMed:28581500, ECO:0000269|PubMed:29211708,\r\n",
      "CC       ECO:0000269|PubMed:30487602}.\r\n",
      "CC   -!- SUBUNIT: Component of the HUSH complex; at least composed of TASOR,\r\n",
      "CC       PPHLN1 and MPHOSPH8 (PubMed:26022416). Interacts with MORC2; the\r\n",
      "CC       interaction associateS MORC2 with the HUSH complex which recruits MORC2\r\n",
      "CC       to heterochromatic loci (PubMed:28581500). Interacts with ZNF638;\r\n",
      "CC       leading to recruitment of the HUSH complex to unintegrated retroviral\r\n",
      "CC       DNA (PubMed:30487602). Interacts with INPP5A, EML1, SV1L, GPSM2,\r\n",
      "CC       ITGB3BP, CNTN1, ETFA, PSMD8, S100A10, MPHOSPH8, TMEM100, ALB, PARPBP,\r\n",
      "CC       HCFC2, NCBP1 and SETDB1 (By similarity). {ECO:0000250|UniProtKB:Q69ZR9,\r\n",
      "CC       ECO:0000269|PubMed:26022416, ECO:0000269|PubMed:28581500,\r\n",
      "CC       ECO:0000269|PubMed:30487602}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q9UK61; Q99549: MPHOSPH8; NbExp=3; IntAct=EBI-308354, EBI-2653928;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26022416,\r\n",
      "CC       ECO:0000269|PubMed:28581500}. Chromosome {ECO:0000269|PubMed:26022416,\r\n",
      "CC       ECO:0000269|PubMed:28581500}. Note=Localizes to chromatin.\r\n",
      "CC       {ECO:0000269|PubMed:26022416, ECO:0000269|PubMed:28581500}.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=4;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=Q9UK61-1; Sequence=Displayed;\r\n",
      "CC       Name=2;\r\n",
      "CC         IsoId=Q9UK61-2; Sequence=VSP_027030, VSP_027032;\r\n",
      "CC       Name=3;\r\n",
      "CC         IsoId=Q9UK61-3; Sequence=VSP_027033, VSP_027034;\r\n",
      "CC       Name=4;\r\n",
      "CC         IsoId=Q9UK61-4; Sequence=VSP_027031;\r\n",
      "CC   -!- MISCELLANEOUS: [Isoform 1]: Gene prediction based on partial mRNA data.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the TASOR family. {ECO:0000305}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=AAG34913.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=AAI29988.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AF180425; AAD55098.1; -; mRNA.\r\n",
      "DR   EMBL; AC099781; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AK094486; -; NOT_ANNOTATED_CDS; mRNA.\r\n",
      "DR   EMBL; BC129987; AAI29988.1; ALT_INIT; mRNA.\r\n",
      "DR   EMBL; AF273053; AAG34913.1; ALT_INIT; mRNA.\r\n",
      "DR   EMBL; AB029028; BAA83057.1; -; mRNA.\r\n",
      "DR   CCDS; CCDS2877.1; -. [Q9UK61-2]\r\n",
      "DR   CCDS; CCDS46853.1; -. [Q9UK61-3]\r\n",
      "DR   CCDS; CCDS87094.1; -. [Q9UK61-4]\r\n",
      "DR   CCDS; CCDS93292.1; -. [Q9UK61-1]\r\n",
      "DR   RefSeq; NP_001106207.1; NM_001112736.1. [Q9UK61-3]\r\n",
      "DR   RefSeq; NP_056039.2; NM_015224.3. [Q9UK61-2]\r\n",
      "DR   RefSeq; XP_005265056.1; XM_005264999.1.\r\n",
      "DR   RefSeq; XP_011531854.1; XM_011533552.2.\r\n",
      "DR   PDB; 6SWG; X-ray; 2.51 A; C=1013-1095.\r\n",
      "DR   PDB; 6TL1; X-ray; 2.03 A; A/B=110-332.\r\n",
      "DR   PDBsum; 6SWG; -.\r\n",
      "DR   PDBsum; 6TL1; -.\r\n",
      "DR   AlphaFoldDB; Q9UK61; -.\r\n",
      "DR   SMR; Q9UK61; -.\r\n",
      "DR   BioGRID; 116873; 101.\r\n",
      "DR   CORUM; Q9UK61; -.\r\n",
      "DR   DIP; DIP-56150N; -.\r\n",
      "DR   IntAct; Q9UK61; 33.\r\n",
      "DR   MINT; Q9UK61; -.\r\n",
      "DR   STRING; 9606.ENSP00000417509; -.\r\n",
      "DR   GlyCosmos; Q9UK61; 3 sites, 2 glycans.\r\n",
      "DR   GlyGen; Q9UK61; 5 sites, 2 O-linked glycans (5 sites).\r\n",
      "DR   iPTMnet; Q9UK61; -.\r\n",
      "DR   PhosphoSitePlus; Q9UK61; -.\r\n",
      "DR   SwissPalm; Q9UK61; -.\r\n",
      "DR   BioMuta; FAM208A; -.\r\n",
      "DR   DMDM; 229462994; -.\r\n",
      "DR   EPD; Q9UK61; -.\r\n",
      "DR   jPOST; Q9UK61; -.\r\n",
      "DR   MassIVE; Q9UK61; -.\r\n",
      "DR   MaxQB; Q9UK61; -.\r\n",
      "DR   PaxDb; Q9UK61; -.\r\n",
      "DR   PeptideAtlas; Q9UK61; -.\r\n",
      "DR   ProteomicsDB; 84729; -. [Q9UK61-1]\r\n",
      "DR   ProteomicsDB; 84730; -. [Q9UK61-2]\r\n",
      "DR   ProteomicsDB; 84731; -. [Q9UK61-3]\r\n",
      "DR   ProteomicsDB; 84732; -. [Q9UK61-4]\r\n",
      "DR   Antibodypedia; 1875; 29 antibodies from 13 providers.\r\n",
      "DR   DNASU; 23272; -.\r\n",
      "DR   Ensembl; ENST00000355628.9; ENSP00000347845.5; ENSG00000163946.14. [Q9UK61-4]\r\n",
      "DR   Ensembl; ENST00000431842.6; ENSP00000399410.2; ENSG00000163946.14. [Q9UK61-2]\r\n",
      "DR   Ensembl; ENST00000493960.6; ENSP00000417509.2; ENSG00000163946.14. [Q9UK61-3]\r\n",
      "DR   Ensembl; ENST00000683822.1; ENSP00000508241.1; ENSG00000163946.14. [Q9UK61-1]\r\n",
      "DR   GeneID; 23272; -.\r\n",
      "DR   KEGG; hsa:23272; -.\r\n",
      "DR   MANE-Select; ENST00000683822.1; ENSP00000508241.1; NM_001365635.2; NP_001352564.1.\r\n",
      "DR   UCSC; uc003dic.5; human. [Q9UK61-1]\r\n",
      "DR   AGR; HGNC:30314; -.\r\n",
      "DR   CTD; 23272; -.\r\n",
      "DR   DisGeNET; 23272; -.\r\n",
      "DR   GeneCards; TASOR; -.\r\n",
      "DR   HGNC; HGNC:30314; TASOR.\r\n",
      "DR   HPA; ENSG00000163946; Low tissue specificity.\r\n",
      "DR   MIM; 616493; gene.\r\n",
      "DR   neXtProt; NX_Q9UK61; -.\r\n",
      "DR   OpenTargets; ENSG00000163946; -.\r\n",
      "DR   PharmGKB; PA128395774; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000163946; -.\r\n",
      "DR   eggNOG; ENOG502QUY9; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00530000063735; -.\r\n",
      "DR   HOGENOM; CLU_004573_0_0_1; -.\r\n",
      "DR   InParanoid; Q9UK61; -.\r\n",
      "DR   OMA; AHSNGAQ; -.\r\n",
      "DR   OrthoDB; 2969374at2759; -.\r\n",
      "DR   PhylomeDB; Q9UK61; -.\r\n",
      "DR   TreeFam; TF336055; -.\r\n",
      "DR   PathwayCommons; Q9UK61; -.\r\n",
      "DR   SignaLink; Q9UK61; -.\r\n",
      "DR   BioGRID-ORCS; 23272; 29 hits in 1168 CRISPR screens.\r\n",
      "DR   ChiTaRS; FAM208A; human.\r\n",
      "DR   GenomeRNAi; 23272; -.\r\n",
      "DR   Pharos; Q9UK61; Tbio.\r\n",
      "DR   PRO; PR:Q9UK61; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 3.\r\n",
      "DR   RNAct; Q9UK61; protein.\r\n",
      "DR   Bgee; ENSG00000163946; Expressed in secondary oocyte and 206 other tissues.\r\n",
      "DR   ExpressionAtlas; Q9UK61; baseline and differential.\r\n",
      "DR   Genevisible; Q9UK61; HS.\r\n",
      "DR   GO; GO:0000792; C:heterochromatin; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.\r\n",
      "DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.\r\n",
      "DR   GO; GO:0008595; P:anterior/posterior axis specification, embryo; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0060809; P:mesodermal to mesenchymal transition involved in gastrulation; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0045869; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; IMP:UniProtKB.\r\n",
      "DR   GO; GO:0090309; P:positive regulation of DNA methylation-dependent heterochromatin formation; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0097355; P:protein localization to heterochromatin; IDA:UniProtKB.\r\n",
      "DR   CDD; cd22569; TASOR_PBD; 1.\r\n",
      "DR   InterPro; IPR046432; TASOR.\r\n",
      "DR   InterPro; IPR022188; TASOR_DUF3715.\r\n",
      "DR   PANTHER; PTHR16207:SF1; PROTEIN TASOR; 1.\r\n",
      "DR   PANTHER; PTHR16207; UNCHARACTERIZED; 1.\r\n",
      "DR   Pfam; PF12509; DUF3715; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Acetylation; Alternative splicing; Chromosome;\r\n",
      "KW   Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome; Repressor;\r\n",
      "KW   Transcription; Transcription regulation; Ubl conjugation.\r\n",
      "FT   INIT_MET        1\r\n",
      "FT                   /note=\"Removed\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19413330\"\r\n",
      "FT   CHAIN           2..1670\r\n",
      "FT                   /note=\"Protein TASOR\"\r\n",
      "FT                   /id=\"PRO_0000295728\"\r\n",
      "FT   REGION          1..110\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          921..947\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1532..1558\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1638..1670\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        90..110\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1542..1558\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1656..1670\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         2\r\n",
      "FT                   /note=\"N-acetylalanine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19413330\"\r\n",
      "FT   MOD_RES         344\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         633\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         636\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         673\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         800\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         843\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q69ZR9\"\r\n",
      "FT   MOD_RES         927\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:16964243,\r\n",
      "FT                   ECO:0007744|PubMed:17081983, ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,\r\n",
      "FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         971\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         979\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         982\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:20068231\"\r\n",
      "FT   MOD_RES         1049\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1103\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,\r\n",
      "FT                   ECO:0007744|PubMed:24275569\"\r\n",
      "FT   MOD_RES         1552\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   CROSSLNK        586\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        823\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        832\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        872\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   VAR_SEQ         1..396\r\n",
      "FT                   /note=\"Missing (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:18726359\"\r\n",
      "FT                   /id=\"VSP_027030\"\r\n",
      "FT   VAR_SEQ         921..981\r\n",
      "FT                   /note=\"Missing (in isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:11149944\"\r\n",
      "FT                   /id=\"VSP_027031\"\r\n",
      "FT   VAR_SEQ         942..982\r\n",
      "FT                   /note=\"Missing (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:18726359\"\r\n",
      "FT                   /id=\"VSP_027032\"\r\n",
      "FT   VAR_SEQ         1495..1512\r\n",
      "FT                   /note=\"ALLENDEKDEEDMSLDSG -> DAVLTLTPLELGVGISQH (in isoform\r\n",
      "FT                   3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_027033\"\r\n",
      "FT   VAR_SEQ         1513..1670\r\n",
      "FT                   /note=\"Missing (in isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_027034\"\r\n",
      "FT   VARIANT         38\r\n",
      "FT                   /note=\"Q -> P (in dbSNP:rs958755)\"\r\n",
      "FT                   /id=\"VAR_059595\"\r\n",
      "FT   VARIANT         831\r\n",
      "FT                   /note=\"A -> G (in dbSNP:rs17056999)\"\r\n",
      "FT                   /id=\"VAR_033350\"\r\n",
      "FT   VARIANT         998\r\n",
      "FT                   /note=\"V -> I (in dbSNP:rs2291498)\"\r\n",
      "FT                   /id=\"VAR_055092\"\r\n",
      "FT   VARIANT         1046\r\n",
      "FT                   /note=\"T -> R (in dbSNP:rs9835332)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10470851,\r\n",
      "FT                   ECO:0000269|PubMed:11149944, ECO:0000269|PubMed:18726359\"\r\n",
      "FT                   /id=\"VAR_033351\"\r\n",
      "FT   VARIANT         1435\r\n",
      "FT                   /note=\"I -> V (in dbSNP:rs2291498)\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:11149944\"\r\n",
      "FT                   /id=\"VAR_033352\"\r\n",
      "FT   CONFLICT        941\r\n",
      "FT                   /note=\"P -> I (in Ref. 6; BAA83057)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1129\r\n",
      "FT                   /note=\"N -> S (in Ref. 1; AAD55098)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1135\r\n",
      "FT                   /note=\"E -> G (in Ref. 1; AAD55098)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   STRAND          113..115\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           121..131\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           137..141\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          143..151\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           154..169\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           174..177\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          180..186\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   TURN            188..190\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           191..197\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   TURN            212..214\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          215..221\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          226..228\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          235..243\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          247..251\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          255..257\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          276..280\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           283..285\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           294..297\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          299..302\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          307..310\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   STRAND          317..327\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6TL1\"\r\n",
      "FT   HELIX           1016..1038\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6SWG\"\r\n",
      "FT   HELIX           1075..1091\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:6SWG\"\r\n",
      "SQ   SEQUENCE   1670 AA;  189032 MW;  A8BE5ED05A96C897 CRC64;\r\n",
      "     MATAVETEAC QPTDASWESG GGGDDEMKQA LPELESSQQN GGGGGLNIAE PSGGAGREEN\r\n",
      "     AGAEAAQSLS HEQPQDSSEA GAAALPRGPE EPERPVRRSF QIPRKSREKK ALFQPLTPGS\r\n",
      "     REFEDVVNIL HSSYLEPTSV TNFNYRRACL VHNELLEKEF TEKRRELKFD GRLDKELSES\r\n",
      "     YAFLMVDRYQ VQTICEKGLH VGQSKITILG SPSMGVYLSR YADLLQANPL DTGAMGDVVI\r\n",
      "     FKIMKGKIKS IYDPMGVKSL ESMLNKSALD PTPKHECHVS KNANRITSLL AYRAYELTQY\r\n",
      "     YFYEYGFDEL RRRPRHVCPY AVVSFTYKDD IQTPKFVPSS RSNSFNTDRN IDKYNYTLWK\r\n",
      "     GQLLNKGKLL CYISLRSATR AFLPIKLPEK LDVETVMSID HLKQKIPPAL FYKETYLGPN\r\n",
      "     EVLKNGMYCS LYEVVEKTRI GSNMESLLQK LDREKLVLVK PLGDRGYLFL LSPYQMVPPY\r\n",
      "     EYQTAKSRVL HALFLFQEPR SIVTSQKGST NAAPQERHES MPDVLKIAQF LQFSLIQCRK\r\n",
      "     EFKNISAINF HSVVEKYVSE FFKRGFGSGK REFIMFPYDS RLDDKKFLYS APRNKSHIDT\r\n",
      "     CLHAYIFRPE VYQLPICKLK ELFEENRKLQ QFSPLSDYEG QEEEMNGTKM KFGKRNNSRG\r\n",
      "     EAIISGKQRS SHSLDYDKDR VKELINLIQC RKKSVGGDSD TEDMRSKTVL KRKLEDLPEN\r\n",
      "     MRKLAKTSNL SENCHLYEES PQPIGSLGHD ADLRRQQQDT CNSGIADIHR LFNWLSETLA\r\n",
      "     NARHSDASLT DTVNKALGLS TDDAYEELRQ KHEYELNSTP DKKDYEQPTC AKVENAQFKG\r\n",
      "     TQSLLLEVDA TSKYSVAIST SEVGTDHKLH LKEDPNLISV NNFEDCSLCP SVPIEHGFRR\r\n",
      "     QQSKSNNVEE TEIHWKLIPI TGGNARSPED QLGKHGEKQT PGMKSPEEQL VCVPPQEAFP\r\n",
      "     NDPRVINRQR SSDYQFPSSP FTDTLKGTTE DDVLTGQVEE QCVPAAEAEP PAVSETTERT\r\n",
      "     VLGEYNLFSR KIEEILKQKN VSYVSTVSTP IFSTQEKMKR LSEFIYSKTS KAGVQEFVDG\r\n",
      "     LHEKLNTIII KASAKGGNLP PVSPNDSGAK IASNPLERHV IPVSSSDFNN KHLLEPLCSD\r\n",
      "     PLKDTNSDEQ HSTSALTEVE MNQPQHATEL MVTSDHIVPG DMAREPVEET TKSPSDVNIS\r\n",
      "     AQPALSNFIS QLEPEVFNSL VKIMKDVQKN TVKFYIHEEE ESVLCKEIKE YLIKLGNTEC\r\n",
      "     HPEQFLERRS KLDKLLIIIQ NEDIAGFIHK IPGLVTLKKL PCVSFAGVDS LDDVKNHTYN\r\n",
      "     ELFVSGGFIV SDESILNPEV VTVENLKNFL TFLEELSTPE GKWQWKVHCK FQKKLKELGR\r\n",
      "     LNAKALSLLT LLNVYQKKHL VEILSYHNCD SQTRNAPELD CLIRLQAQNI QQRHIVFLTE\r\n",
      "     KNIKMLSSYT DNGIVVATAE DFMQNFKNLV GYHNSITEEN LPQLGANENL ESQSALLEND\r\n",
      "     EKDEEDMSLD SGDEISHIEV CSNFHSEIWE KETKGSRGTD QKKNTQIELQ SSPDVQNSLL\r\n",
      "     EDKTYLDSEE RTSIDIVCSE GENSNSTEQD SYSNFQVYHS QLNMSHQFSH FNVLTHQTFL\r\n",
      "     GTPYALSSSQ SQENENYFLS AYTESLDRDK SPPPLSWGKS DSSRPYSQEK\r\n",
      "//\r\n",
      "ID   ARI4B_HUMAN             Reviewed;        1312 AA.\r\n",
      "AC   Q4LE39; A1L465; Q3MHV4; Q5HY99; Q5T2C2; Q5T2C3; Q5T2C4; Q5T2C5; Q5T2C6;\r\n",
      "AC   Q6P600; Q86UX1; Q86WR4; Q9H915; Q9NYU3; Q9NZB6; Q9NZG4; Q9P2W4; Q9UF62;\r\n",
      "AC   Q9Y6E1;\r\n",
      "DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   03-APR-2007, sequence version 2.\r\n",
      "DT   03-MAY-2023, entry version 157.\r\n",
      "DE   RecName: Full=AT-rich interactive domain-containing protein 4B;\r\n",
      "DE            Short=ARID domain-containing protein 4B;\r\n",
      "DE   AltName: Full=180 kDa Sin3-associated polypeptide;\r\n",
      "DE            Short=Sin3-associated polypeptide p180;\r\n",
      "DE   AltName: Full=Breast cancer-associated antigen BRCAA1;\r\n",
      "DE   AltName: Full=Histone deacetylase complex subunit SAP180;\r\n",
      "DE   AltName: Full=Retinoblastoma-binding protein 1-like 1;\r\n",
      "GN   Name=ARID4B; Synonyms=BRCAA1, RBBP1L1, RBP1L1, SAP180;\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION, AND TISSUE\r\n",
      "RP   SPECIFICITY.\r\n",
      "RX   PubMed=11481388; DOI=10.1093/jnci/93.15.1159;\r\n",
      "RA   Cao J.-N., Gao T.-W., Stanbridge E.J., Irie R.;\r\n",
      "RT   \"RBP1L1, a retinoblastoma-binding protein-related gene encoding an\r\n",
      "RT   antigenic epitope abundantly expressed in human carcinomas and normal\r\n",
      "RT   testis.\";\r\n",
      "RL   J. Natl. Cancer Inst. 93:1159-1165(2001).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, DOMAIN, TISSUE\r\n",
      "RP   SPECIFICITY, AND IDENTIFICATION IN A MSIN3A COREPRESSOR COMPLEX WITH SIN3A;\r\n",
      "RP   SAP130; SUDS3; ARID4B; HDAC1 AND HDAC2.\r\n",
      "RX   PubMed=12724404; DOI=10.1128/mcb.23.10.3456-3467.2003;\r\n",
      "RA   Fleischer T.C., Yun U.J., Ayer D.E.;\r\n",
      "RT   \"Identification and characterization of three new components of the mSin3A\r\n",
      "RT   corepressor complex.\";\r\n",
      "RL   Mol. Cell. Biol. 23:3456-3467(2003).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION, AND TISSUE\r\n",
      "RP   SPECIFICITY.\r\n",
      "RX   PubMed=15247124; DOI=10.1158/1055-9965.1136.13.7;\r\n",
      "RA   Cui D., Jin G., Gao T.W., Sun T., Tian F., Estrada G.G., Gao H., Sarai A.;\r\n",
      "RT   \"Characterization of BRCAA1 and its novel antigen epitope identification.\";\r\n",
      "RL   Cancer Epidemiol. Biomarkers Prev. 13:1136-1145(2004).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).\r\n",
      "RC   TISSUE=Synovium;\r\n",
      "RA   Tanaka M.;\r\n",
      "RT   \"Rheumatoid arthritis antigenic protein similar to retinoblastoma binding\r\n",
      "RT   protein 1 (RBP1).\";\r\n",
      "RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).\r\n",
      "RC   TISSUE=Brain;\r\n",
      "RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M., Ohara R.,\r\n",
      "RA   Okazaki N., Koga H., Nagase T., Ohara O.;\r\n",
      "RT   \"Preparation of a set of expression-ready clones of mammalian long cDNAs\r\n",
      "RT   encoding large proteins by the ORF trap cloning method.\";\r\n",
      "RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RX   PubMed=16710414; DOI=10.1038/nature04727;\r\n",
      "RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,\r\n",
      "RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,\r\n",
      "RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,\r\n",
      "RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,\r\n",
      "RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,\r\n",
      "RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,\r\n",
      "RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,\r\n",
      "RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,\r\n",
      "RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,\r\n",
      "RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,\r\n",
      "RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,\r\n",
      "RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,\r\n",
      "RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,\r\n",
      "RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,\r\n",
      "RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,\r\n",
      "RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,\r\n",
      "RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,\r\n",
      "RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,\r\n",
      "RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,\r\n",
      "RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,\r\n",
      "RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,\r\n",
      "RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,\r\n",
      "RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,\r\n",
      "RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,\r\n",
      "RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,\r\n",
      "RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,\r\n",
      "RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,\r\n",
      "RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,\r\n",
      "RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;\r\n",
      "RT   \"The DNA sequence and biological annotation of human chromosome 1.\";\r\n",
      "RL   Nature 441:315-321(2006).\r\n",
      "RN   [7]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE\r\n",
      "RP   [LARGE SCALE MRNA] OF 1-651 (ISOFORM 2), AND NUCLEOTIDE SEQUENCE [LARGE\r\n",
      "RP   SCALE MRNA] OF 1-424.\r\n",
      "RC   TISSUE=Hippocampus, Kidney, and Lung;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [8]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1149 (ISOFORM 2), AND\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1147-1312.\r\n",
      "RC   TISSUE=Adipose tissue, and Testis;\r\n",
      "RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;\r\n",
      "RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,\r\n",
      "RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,\r\n",
      "RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,\r\n",
      "RA   Wiemann S., Schupp I.;\r\n",
      "RT   \"The full-ORF clone resource of the German cDNA consortium.\";\r\n",
      "RL   BMC Genomics 8:399-399(2007).\r\n",
      "RN   [9]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 440-1312 (ISOFORM 1).\r\n",
      "RA   Cao J., Irie R.F., Stanbridge E.J.;\r\n",
      "RT   \"Human breast carcinoma-associated antigen isoform I.\";\r\n",
      "RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [10]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 547-1312.\r\n",
      "RA   Liu T., Tao J., Zhang J., Li W., Ye M., Zhou J., Wu J., Shen Y., Yu M.,\r\n",
      "RA   Chen S., Mao M., Chen Z.;\r\n",
      "RT   \"Human Rb binding protein homolog gene, partial CDS.\";\r\n",
      "RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [11]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 828-1312.\r\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\r\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\r\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\r\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\r\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\r\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\r\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\r\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\r\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\r\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\r\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\r\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\r\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\r\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\r\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\r\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\r\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\r\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\r\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\r\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\r\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\r\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\r\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\r\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\r\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\r\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\r\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\r\n",
      "RA   Isogai T., Sugano S.;\r\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\r\n",
      "RT   cDNAs.\";\r\n",
      "RL   Nat. Genet. 36:40-45(2004).\r\n",
      "RN   [12]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-717, AND IDENTIFICATION BY\r\n",
      "RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;\r\n",
      "RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;\r\n",
      "RT   \"Global, in vivo, and site-specific phosphorylation dynamics in signaling\r\n",
      "RT   networks.\";\r\n",
      "RL   Cell 127:635-648(2006).\r\n",
      "RN   [13]\r\n",
      "RP   INTERACTION WITH ARID4A.\r\n",
      "RX   PubMed=17043311; DOI=10.1101/gad.1452206;\r\n",
      "RA   Wu M.Y., Tsai T.F., Beaudet A.L.;\r\n",
      "RT   \"Deficiency of Rbbp1/Arid4a and Rbbp1l1/Arid4b alters epigenetic\r\n",
      "RT   modifications and suppresses an imprinting defect in the PWS/AS domain.\";\r\n",
      "RL   Genes Dev. 20:2859-2870(2006).\r\n",
      "RN   [14]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-666; SER-675; SER-790;\r\n",
      "RP   THR-793; THR-1150; SER-1152; SER-1153; SER-1155 AND SER-1159, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;\r\n",
      "RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,\r\n",
      "RA   Elledge S.J., Gygi S.P.;\r\n",
      "RT   \"A quantitative atlas of mitotic phosphorylation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).\r\n",
      "RN   [15]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19413330; DOI=10.1021/ac9004309;\r\n",
      "RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;\r\n",
      "RT   \"Lys-N and trypsin cover complementary parts of the phosphoproteome in a\r\n",
      "RT   refined SCX-based approach.\";\r\n",
      "RL   Anal. Chem. 81:4493-4501(2009).\r\n",
      "RN   [16]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-790; THR-793; SER-1014 AND\r\n",
      "RP   THR-1026, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Leukemic T-cell;\r\n",
      "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\r\n",
      "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\r\n",
      "RA   Rodionov V., Han D.K.;\r\n",
      "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\r\n",
      "RT   reveals system-wide modulation of protein-protein interactions.\";\r\n",
      "RL   Sci. Signal. 2:RA46-RA46(2009).\r\n",
      "RN   [17]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-675; SER-778; SER-790 AND\r\n",
      "RP   THR-793, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma;\r\n",
      "RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;\r\n",
      "RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,\r\n",
      "RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;\r\n",
      "RT   \"Quantitative phosphoproteomics reveals widespread full phosphorylation\r\n",
      "RT   site occupancy during mitosis.\";\r\n",
      "RL   Sci. Signal. 3:RA3-RA3(2010).\r\n",
      "RN   [18]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;\r\n",
      "RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,\r\n",
      "RA   Bennett K.L., Superti-Furga G., Colinge J.;\r\n",
      "RT   \"Initial characterization of the human central proteome.\";\r\n",
      "RL   BMC Syst. Biol. 5:17-17(2011).\r\n",
      "RN   [19]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-276; SER-778; SER-790 AND\r\n",
      "RP   THR-793, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;\r\n",
      "RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,\r\n",
      "RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;\r\n",
      "RT   \"System-wide temporal characterization of the proteome and phosphoproteome\r\n",
      "RT   of human embryonic stem cell differentiation.\";\r\n",
      "RL   Sci. Signal. 4:RS3-RS3(2011).\r\n",
      "RN   [20]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483; SER-666; SER-675;\r\n",
      "RP   SER-778; SER-1029 AND SER-1153, AND IDENTIFICATION BY MASS SPECTROMETRY\r\n",
      "RP   [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Cervix carcinoma, and Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [21]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-429, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=25218447; DOI=10.1038/nsmb.2890;\r\n",
      "RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,\r\n",
      "RA   Vertegaal A.C.;\r\n",
      "RT   \"Uncovering global SUMOylation signaling networks in a site-specific\r\n",
      "RT   manner.\";\r\n",
      "RL   Nat. Struct. Mol. Biol. 21:927-936(2014).\r\n",
      "RN   [22]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-429, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;\r\n",
      "RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,\r\n",
      "RA   Vertegaal A.C.;\r\n",
      "RT   \"SUMO-2 orchestrates chromatin modifiers in response to DNA damage.\";\r\n",
      "RL   Cell Rep. 10:1778-1791(2015).\r\n",
      "RN   [23]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-429 AND LYS-440, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;\r\n",
      "RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,\r\n",
      "RA   Vertegaal A.C.;\r\n",
      "RT   \"System-wide analysis of SUMOylation dynamics in response to replication\r\n",
      "RT   stress reveals novel small ubiquitin-like modified target proteins and\r\n",
      "RT   acceptor lysines relevant for genome stability.\";\r\n",
      "RL   Mol. Cell. Proteomics 14:1419-1434(2015).\r\n",
      "RN   [24]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-429; LYS-440; LYS-462; LYS-517\r\n",
      "RP   AND LYS-751, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE\r\n",
      "RP   ANALYSIS].\r\n",
      "RX   PubMed=28112733; DOI=10.1038/nsmb.3366;\r\n",
      "RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,\r\n",
      "RA   Nielsen M.L.;\r\n",
      "RT   \"Site-specific mapping of the human SUMO proteome reveals co-modification\r\n",
      "RT   with phosphorylation.\";\r\n",
      "RL   Nat. Struct. Mol. Biol. 24:325-336(2017).\r\n",
      "CC   -!- FUNCTION: Acts as a transcriptional repressor (PubMed:12724404). May\r\n",
      "CC       function in the assembly and/or enzymatic activity of the Sin3A\r\n",
      "CC       corepressor complex or in mediating interactions between the complex\r\n",
      "CC       and other regulatory complexes (PubMed:12724404). Plays a role in the\r\n",
      "CC       regulation of epigenetic modifications at the PWS/AS imprinting center\r\n",
      "CC       near the SNRPN promoter, where it might function as part of a complex\r\n",
      "CC       with RB1 and ARID4A. Involved in spermatogenesis, together with ARID4A,\r\n",
      "CC       where it functions as a transcriptional coactivator for AR (androgen\r\n",
      "CC       receptor) and enhances expression of genes required for sperm\r\n",
      "CC       maturation. Regulates expression of the tight junction protein CLDN3 in\r\n",
      "CC       the testis, which is important for integrity of the blood-testis\r\n",
      "CC       barrier. Plays a role in myeloid homeostasis where it regulates the\r\n",
      "CC       histone methylation state of bone marrow cells and expression of\r\n",
      "CC       various genes involved in hematopoiesis. May function as a leukemia\r\n",
      "CC       suppressor (By similarity). {ECO:0000250|UniProtKB:A2CG63,\r\n",
      "CC       ECO:0000269|PubMed:12724404}.\r\n",
      "CC   -!- SUBUNIT: Component of a Sin3A corepressor complex consisting of SIN3A,\r\n",
      "CC       SAP130, SUDS3/SAP45, SAP180, HDAC1 and HDAC2 (PubMed:12724404).\r\n",
      "CC       Interacts with ARID4A (PubMed:17043311). Interacts with AR (By\r\n",
      "CC       similarity). {ECO:0000250|UniProtKB:A2CG63,\r\n",
      "CC       ECO:0000269|PubMed:12724404, ECO:0000269|PubMed:17043311}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       Q4LE39; P14921: ETS1; NbExp=2; IntAct=EBI-2680990, EBI-913209;\r\n",
      "CC       Q4LE39-3; Q9BTE6-2: AARSD1; NbExp=3; IntAct=EBI-11957452, EBI-9357295;\r\n",
      "CC       Q4LE39-3; Q9NQM4: DNAAF6; NbExp=3; IntAct=EBI-11957452, EBI-10239299;\r\n",
      "CC       Q4LE39-3; P63172: DYNLT1; NbExp=3; IntAct=EBI-11957452, EBI-1176455;\r\n",
      "CC       Q4LE39-3; Q96JC9: EAF1; NbExp=3; IntAct=EBI-11957452, EBI-769261;\r\n",
      "CC       Q4LE39-3; I6L957: HNRNPA2B1; NbExp=3; IntAct=EBI-11957452, EBI-1642515;\r\n",
      "CC       Q4LE39-3; Q5HYW2: NHSL2; NbExp=3; IntAct=EBI-11957452, EBI-2859639;\r\n",
      "CC       Q4LE39-3; Q96HA8: NTAQ1; NbExp=3; IntAct=EBI-11957452, EBI-741158;\r\n",
      "CC       Q4LE39-3; Q92569: PIK3R3; NbExp=3; IntAct=EBI-11957452, EBI-79893;\r\n",
      "CC       Q4LE39-3; Q9H8W4: PLEKHF2; NbExp=3; IntAct=EBI-11957452, EBI-742388;\r\n",
      "CC       Q4LE39-3; Q6ZRT6: PRR23B; NbExp=3; IntAct=EBI-11957452, EBI-12845180;\r\n",
      "CC       Q4LE39-3; Q9NS25: SPANXB1; NbExp=3; IntAct=EBI-11957452, EBI-17197485;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355}.\r\n",
      "CC       Cytoplasm {ECO:0000269|PubMed:11481388, ECO:0000269|PubMed:15247124}.\r\n",
      "CC       Note=Cytoplasmic in breast cancer cells. {ECO:0000269|PubMed:15247124}.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=4;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=Q4LE39-1; Sequence=Displayed;\r\n",
      "CC       Name=2;\r\n",
      "CC         IsoId=Q4LE39-2; Sequence=VSP_024231;\r\n",
      "CC       Name=3;\r\n",
      "CC         IsoId=Q4LE39-3; Sequence=VSP_024234, VSP_024235;\r\n",
      "CC       Name=4;\r\n",
      "CC         IsoId=Q4LE39-4; Sequence=VSP_024230, VSP_024232, VSP_024233;\r\n",
      "CC   -!- TISSUE SPECIFICITY: Highly expressed in the testis and in breast, lung,\r\n",
      "CC       colon, pancreatic and ovarian cancers. Expressed at low levels in the\r\n",
      "CC       thymus, prostate and ovary. {ECO:0000269|PubMed:11481388,\r\n",
      "CC       ECO:0000269|PubMed:12724404, ECO:0000269|PubMed:15247124}.\r\n",
      "CC   -!- DOMAIN: The C-terminus mediates interaction with mSin3A corepressor\r\n",
      "CC       complex. {ECO:0000269|PubMed:12724404}.\r\n",
      "CC   -!- DOMAIN: The N-terminus is involved in transcriptional repression by\r\n",
      "CC       HDAC-independent mechanisms. {ECO:0000269|PubMed:12724404}.\r\n",
      "CC   -!- DOMAIN: The ARID domain is involved in stabilizing the mSin3A\r\n",
      "CC       corepressor complex on DNA. {ECO:0000269|PubMed:12724404}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=AAD41239.1; Type=Frameshift; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=AAF23433.3; Type=Frameshift; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=BAB14428.1; Type=Erroneous initiation; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=BAE06114.1; Type=Erroneous initiation; Evidence={ECO:0000305};\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AF214114; AAF28341.2; -; mRNA.\r\n",
      "DR   EMBL; AY220790; AAO63590.1; -; mRNA.\r\n",
      "DR   EMBL; AF208045; AAF23433.3; ALT_FRAME; mRNA.\r\n",
      "DR   EMBL; AB030181; BAA89794.1; -; mRNA.\r\n",
      "DR   EMBL; AB210032; BAE06114.1; ALT_INIT; mRNA.\r\n",
      "DR   EMBL; AL133418; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AL391994; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; BC048959; AAH48959.1; ALT_TERM; mRNA.\r\n",
      "DR   EMBL; BC062536; AAH62536.1; ALT_TERM; mRNA.\r\n",
      "DR   EMBL; BC104632; AAI04633.1; ALT_TERM; mRNA.\r\n",
      "DR   EMBL; BC130418; AAI30419.1; -; mRNA.\r\n",
      "DR   EMBL; BX648820; CAI46047.1; -; mRNA.\r\n",
      "DR   EMBL; AL133594; CAB63731.1; -; mRNA.\r\n",
      "DR   EMBL; AF227899; AAF36964.1; -; mRNA.\r\n",
      "DR   EMBL; AF083249; AAD41239.1; ALT_FRAME; mRNA.\r\n",
      "DR   EMBL; AK023144; BAB14428.1; ALT_INIT; mRNA.\r\n",
      "DR   CCDS; CCDS31060.1; -. [Q4LE39-2]\r\n",
      "DR   CCDS; CCDS31061.1; -. [Q4LE39-1]\r\n",
      "DR   PIR; T43497; T43497.\r\n",
      "DR   RefSeq; NP_001193723.1; NM_001206794.1. [Q4LE39-1]\r\n",
      "DR   RefSeq; NP_057458.4; NM_016374.5. [Q4LE39-1]\r\n",
      "DR   RefSeq; NP_112739.2; NM_031371.3. [Q4LE39-2]\r\n",
      "DR   RefSeq; XP_011542514.1; XM_011544212.2. [Q4LE39-1]\r\n",
      "DR   PDB; 7DM4; NMR; -; A=1-151.\r\n",
      "DR   PDBsum; 7DM4; -.\r\n",
      "DR   AlphaFoldDB; Q4LE39; -.\r\n",
      "DR   SMR; Q4LE39; -.\r\n",
      "DR   BioGRID; 119708; 188.\r\n",
      "DR   ComplexPortal; CPX-3321; SIN3A histone deacetylase complex.\r\n",
      "DR   ComplexPortal; CPX-3322; SIN3B histone deacetylase complex.\r\n",
      "DR   ComplexPortal; CPX-3323; SIN3A histone deacetylase complex, ES cell-specific variant.\r\n",
      "DR   CORUM; Q4LE39; -.\r\n",
      "DR   IntAct; Q4LE39; 95.\r\n",
      "DR   MINT; Q4LE39; -.\r\n",
      "DR   STRING; 9606.ENSP00000264183; -.\r\n",
      "DR   GlyGen; Q4LE39; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; Q4LE39; -.\r\n",
      "DR   PhosphoSitePlus; Q4LE39; -.\r\n",
      "DR   BioMuta; ARID4B; -.\r\n",
      "DR   DMDM; 143955276; -.\r\n",
      "DR   CPTAC; CPTAC-1754; -.\r\n",
      "DR   EPD; Q4LE39; -.\r\n",
      "DR   jPOST; Q4LE39; -.\r\n",
      "DR   MassIVE; Q4LE39; -.\r\n",
      "DR   MaxQB; Q4LE39; -.\r\n",
      "DR   PaxDb; Q4LE39; -.\r\n",
      "DR   PeptideAtlas; Q4LE39; -.\r\n",
      "DR   ProteomicsDB; 62238; -. [Q4LE39-1]\r\n",
      "DR   ProteomicsDB; 62239; -. [Q4LE39-2]\r\n",
      "DR   ProteomicsDB; 62240; -. [Q4LE39-3]\r\n",
      "DR   ProteomicsDB; 62241; -. [Q4LE39-4]\r\n",
      "DR   ABCD; Q4LE39; 1 sequenced antibody.\r\n",
      "DR   Antibodypedia; 20807; 170 antibodies from 31 providers.\r\n",
      "DR   DNASU; 51742; -.\r\n",
      "DR   Ensembl; ENST00000264183.9; ENSP00000264183.3; ENSG00000054267.22. [Q4LE39-1]\r\n",
      "DR   Ensembl; ENST00000349213.7; ENSP00000264184.4; ENSG00000054267.22. [Q4LE39-2]\r\n",
      "DR   Ensembl; ENST00000366603.6; ENSP00000355562.2; ENSG00000054267.22. [Q4LE39-1]\r\n",
      "DR   Ensembl; ENST00000421364.5; ENSP00000394663.1; ENSG00000054267.22. [Q4LE39-3]\r\n",
      "DR   GeneID; 51742; -.\r\n",
      "DR   KEGG; hsa:51742; -.\r\n",
      "DR   MANE-Select; ENST00000264183.9; ENSP00000264183.3; NM_016374.6; NP_057458.4.\r\n",
      "DR   UCSC; uc001hwq.3; human. [Q4LE39-1]\r\n",
      "DR   AGR; HGNC:15550; -.\r\n",
      "DR   CTD; 51742; -.\r\n",
      "DR   DisGeNET; 51742; -.\r\n",
      "DR   GeneCards; ARID4B; -.\r\n",
      "DR   HGNC; HGNC:15550; ARID4B.\r\n",
      "DR   HPA; ENSG00000054267; Low tissue specificity.\r\n",
      "DR   MIM; 609696; gene.\r\n",
      "DR   neXtProt; NX_Q4LE39; -.\r\n",
      "DR   OpenTargets; ENSG00000054267; -.\r\n",
      "DR   PharmGKB; PA134940494; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000054267; -.\r\n",
      "DR   eggNOG; KOG2744; Eukaryota.\r\n",
      "DR   eggNOG; KOG3001; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00940000158149; -.\r\n",
      "DR   HOGENOM; CLU_007419_0_0_1; -.\r\n",
      "DR   InParanoid; Q4LE39; -.\r\n",
      "DR   OMA; XCTGQKR; -.\r\n",
      "DR   OrthoDB; 445024at2759; -.\r\n",
      "DR   PhylomeDB; Q4LE39; -.\r\n",
      "DR   TreeFam; TF106427; -.\r\n",
      "DR   PathwayCommons; Q4LE39; -.\r\n",
      "DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.\r\n",
      "DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.\r\n",
      "DR   Reactome; R-HSA-9679191; Potential therapeutics for SARS.\r\n",
      "DR   SignaLink; Q4LE39; -.\r\n",
      "DR   BioGRID-ORCS; 51742; 96 hits in 1172 CRISPR screens.\r\n",
      "DR   ChiTaRS; ARID4B; human.\r\n",
      "DR   GeneWiki; ARID4B; -.\r\n",
      "DR   GenomeRNAi; 51742; -.\r\n",
      "DR   Pharos; Q4LE39; Tbio.\r\n",
      "DR   PRO; PR:Q4LE39; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 1.\r\n",
      "DR   RNAct; Q4LE39; protein.\r\n",
      "DR   Bgee; ENSG00000054267; Expressed in choroid plexus epithelium and 198 other tissues.\r\n",
      "DR   ExpressionAtlas; Q4LE39; baseline and differential.\r\n",
      "DR   Genevisible; Q4LE39; HS.\r\n",
      "DR   GO; GO:0005829; C:cytosol; IDA:HPA.\r\n",
      "DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.\r\n",
      "DR   GO; GO:0016580; C:Sin3 complex; NAS:ComplexPortal.\r\n",
      "DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0097368; P:establishment of Sertoli cell barrier; IEA:Ensembl.\r\n",
      "DR   GO; GO:0036124; P:histone H3-K9 trimethylation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0034773; P:histone H4-K20 trimethylation; IEA:Ensembl.\r\n",
      "DR   GO; GO:0030336; P:negative regulation of cell migration; NAS:ComplexPortal.\r\n",
      "DR   GO; GO:1902455; P:negative regulation of stem cell population maintenance; NAS:ComplexPortal.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; NAS:ComplexPortal.\r\n",
      "DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; NAS:ComplexPortal.\r\n",
      "DR   GO; GO:1902459; P:positive regulation of stem cell population maintenance; NAS:ComplexPortal.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006349; P:regulation of gene expression by genomic imprinting; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:Ensembl.\r\n",
      "DR   CDD; cd16883; ARID_ARID4B; 1.\r\n",
      "DR   CDD; cd20460; Tudor_ARID4B_rpt1; 1.\r\n",
      "DR   CDD; cd20462; Tudor_ARID4B_rpt2; 1.\r\n",
      "DR   Gene3D; 2.30.30.140; -; 3.\r\n",
      "DR   Gene3D; 1.10.150.60; ARID DNA-binding domain; 1.\r\n",
      "DR   InterPro; IPR012603; ARID4A/B_PWWP.\r\n",
      "DR   InterPro; IPR028853; ARID4B_ARID/BRIGHT.\r\n",
      "DR   InterPro; IPR001606; ARID_dom.\r\n",
      "DR   InterPro; IPR036431; ARID_dom_sf.\r\n",
      "DR   InterPro; IPR016197; Chromo-like_dom_sf.\r\n",
      "DR   InterPro; IPR002999; Tudor.\r\n",
      "DR   InterPro; IPR025995; Tudor-knot.\r\n",
      "DR   InterPro; IPR047476; Tudor_ARID4B_rpt1.\r\n",
      "DR   InterPro; IPR047474; Tudor_ARID4B_rpt2.\r\n",
      "DR   PANTHER; PTHR13964:SF24; AT-RICH INTERACTIVE DOMAIN-CONTAINING PROTEIN 4B; 1.\r\n",
      "DR   PANTHER; PTHR13964; RBP-RELATED; 1.\r\n",
      "DR   Pfam; PF01388; ARID; 1.\r\n",
      "DR   Pfam; PF08169; RBB1NT; 1.\r\n",
      "DR   Pfam; PF11717; Tudor-knot; 1.\r\n",
      "DR   SMART; SM01014; ARID; 1.\r\n",
      "DR   SMART; SM00501; BRIGHT; 1.\r\n",
      "DR   SMART; SM00333; TUDOR; 2.\r\n",
      "DR   SUPFAM; SSF46774; ARID-like; 1.\r\n",
      "DR   SUPFAM; SSF54160; Chromo domain-like; 1.\r\n",
      "DR   SUPFAM; SSF63748; Tudor/PWWP/MBT; 2.\r\n",
      "DR   PROSITE; PS51011; ARID; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   3D-structure; Alternative splicing; Chromatin regulator; Coiled coil;\r\n",
      "KW   Cytoplasm; DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Transcription; Transcription regulation;\r\n",
      "KW   Ubl conjugation.\r\n",
      "FT   CHAIN           1..1312\r\n",
      "FT                   /note=\"AT-rich interactive domain-containing protein 4B\"\r\n",
      "FT                   /id=\"PRO_0000282863\"\r\n",
      "FT   DOMAIN          306..398\r\n",
      "FT                   /note=\"ARID\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00355\"\r\n",
      "FT   DOMAIN          572..624\r\n",
      "FT                   /note=\"Tudor-knot\"\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   REGION          124..166\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          266..306\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          458..577\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          465..473\r\n",
      "FT                   /note=\"Antigenic epitope\"\r\n",
      "FT   REGION          635..680\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          708..894\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          909..1212\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1130..1137\r\n",
      "FT                   /note=\"Antigenic epitope\"\r\n",
      "FT   REGION          1252..1288\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COILED          728..754\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COILED          1231..1270\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COMPBIAS        144..166\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        274..306\r\n",
      "FT                   /note=\"Acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        479..531\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        532..566\r\n",
      "FT                   /note=\"Acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        645..660\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        724..747\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        748..762\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        777..851\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        863..890\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        909..927\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        992..1007\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1010..1053\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1079..1107\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1144..1191\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1194..1210\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1273..1288\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         276\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21406692\"\r\n",
      "FT   MOD_RES         295\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q9JKB5\"\r\n",
      "FT   MOD_RES         296\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q9JKB5\"\r\n",
      "FT   MOD_RES         483\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         666\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         675\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         717\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17081983\"\r\n",
      "FT   MOD_RES         778\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         790\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:21406692\"\r\n",
      "FT   MOD_RES         793\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,\r\n",
      "FT                   ECO:0007744|PubMed:21406692\"\r\n",
      "FT   MOD_RES         1014\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332\"\r\n",
      "FT   MOD_RES         1026\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:19690332\"\r\n",
      "FT   MOD_RES         1029\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1150\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648\"\r\n",
      "FT   MOD_RES         1152\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648\"\r\n",
      "FT   MOD_RES         1153\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648,\r\n",
      "FT                   ECO:0007744|PubMed:23186163\"\r\n",
      "FT   MOD_RES         1155\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648\"\r\n",
      "FT   MOD_RES         1159\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:18669648\"\r\n",
      "FT   CROSSLNK        429\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:25218447,\r\n",
      "FT                   ECO:0007744|PubMed:25755297, ECO:0007744|PubMed:25772364,\r\n",
      "FT                   ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        440\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:25755297,\r\n",
      "FT                   ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        462\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        517\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        751\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   VAR_SEQ         1..319\r\n",
      "FT                   /note=\"Missing (in isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|Ref.4\"\r\n",
      "FT                   /id=\"VSP_024230\"\r\n",
      "FT   VAR_SEQ         529..614\r\n",
      "FT                   /note=\"Missing (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:11481388,\r\n",
      "FT                   ECO:0000303|PubMed:15247124, ECO:0000303|PubMed:15489334,\r\n",
      "FT                   ECO:0000303|PubMed:17974005\"\r\n",
      "FT                   /id=\"VSP_024231\"\r\n",
      "FT   VAR_SEQ         1112..1122\r\n",
      "FT                   /note=\"ACTGQKRVKDA -> GEKENVYVDLF (in isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|Ref.4\"\r\n",
      "FT                   /id=\"VSP_024232\"\r\n",
      "FT   VAR_SEQ         1123..1312\r\n",
      "FT                   /note=\"Missing (in isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|Ref.4\"\r\n",
      "FT                   /id=\"VSP_024233\"\r\n",
      "FT   VAR_SEQ         1150..1153\r\n",
      "FT                   /note=\"TNSS -> SAPH (in isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_024234\"\r\n",
      "FT   VAR_SEQ         1154..1312\r\n",
      "FT                   /note=\"Missing (in isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334\"\r\n",
      "FT                   /id=\"VSP_024235\"\r\n",
      "FT   CONFLICT        15\r\n",
      "FT                   /note=\"D -> G (in Ref. 2; AAO63590)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        79\r\n",
      "FT                   /note=\"V -> A (in Ref. 2; AAO63590)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        330\r\n",
      "FT                   /note=\"R -> Q (in Ref. 1; AAF28341 and 3; AAF23433)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        400\r\n",
      "FT                   /note=\"A -> P (in Ref. 4; BAA89794)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        436\r\n",
      "FT                   /note=\"I -> IEFCGR (in Ref. 3; AAF23433)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        437\r\n",
      "FT                   /note=\"K -> Q (in Ref. 4; BAA89794)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        559..561\r\n",
      "FT                   /note=\"DNN -> ATI (in Ref. 4; BAA89794)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        568\r\n",
      "FT                   /note=\"C -> S (in Ref. 4; BAA89794)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        575\r\n",
      "FT                   /note=\"V -> A (in Ref. 4; BAA89794)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        584\r\n",
      "FT                   /note=\"N -> H (in Ref. 4; BAA89794)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        605\r\n",
      "FT                   /note=\"L -> S (in Ref. 9; AAF36964)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        616\r\n",
      "FT                   /note=\"D -> G (in Ref. 9; AAF36964)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        813\r\n",
      "FT                   /note=\"D -> G (in Ref. 2; AAO63590)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        915..917\r\n",
      "FT                   /note=\"RLQ -> LP (in Ref. 3; AAF23433)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        940\r\n",
      "FT                   /note=\"L -> R (in Ref. 3; AAF23433)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1000\r\n",
      "FT                   /note=\"K -> E (in Ref. 1; AAF28341 and 9; AAF36964)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1001\r\n",
      "FT                   /note=\"T -> Q (in Ref. 3; AAF23433)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1032\r\n",
      "FT                   /note=\"S -> P (in Ref. 2; AAO63590)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1087\r\n",
      "FT                   /note=\"S -> N (in Ref. 2; AAO63590)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1118\r\n",
      "FT                   /note=\"R -> G (in Ref. 8; CAI46047)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1144\r\n",
      "FT                   /note=\"K -> T (in Ref. 3; AAF23433 and 10; AAD41239)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1243..1244\r\n",
      "FT                   /note=\"IR -> NQ (in Ref. 3; AAF23433 and 10; AAD41239)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1290\r\n",
      "FT                   /note=\"V -> A (in Ref. 1; AAF28341 and 9; AAF36964)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   STRAND          15..20\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          23..42\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   TURN            43..45\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          48..52\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   HELIX           53..55\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          56..58\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          65..69\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          75..92\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          98..102\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   HELIX           103..105\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          106..111\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   STRAND          133..136\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "FT   TURN            146..148\r\n",
      "FT                   /evidence=\"ECO:0007829|PDB:7DM4\"\r\n",
      "SQ   SEQUENCE   1312 AA;  147809 MW;  E4175FF80F5217EE CRC64;\r\n",
      "     MKALDEPPYL TVGTDVSAKY RGAFCEAKIK TAKRLVKVKV TFRHDSSTVE VQDDHIKGPL\r\n",
      "     KVGAIVEVKN LDGAYQEAVI NKLTDASWYT VVFDDGDEKT LRRSSLCLKG ERHFAESETL\r\n",
      "     DQLPLTNPEH FGTPVIGKKT NRGRRSNHIP EEESSSSSSD EDEDDRKQID ELLGKVVCVD\r\n",
      "     YISLDKKKAL WFPALVVCPD CSDEIAVKKD NILVRSFKDG KFTSVPRKDV HEITSDTAPK\r\n",
      "     PDAVLKQAFE QALEFHKSRT IPANWKTELK EDSSSSEAEE EEEEEDDEKE KEDNSSEEEE\r\n",
      "     EIEPFPEERE NFLQQLYKFM EDRGTPINKR PVLGYRNLNL FKLFRLVHKL GGFDNIESGA\r\n",
      "     VWKQVYQDLG IPVLNSAAGY NVKCAYKKYL YGFEEYCRSA NIEFQMALPE KVVNKQCKEC\r\n",
      "     ENVKEIKVKE ENETEIKEIK MEEERNIIPR EEKPIEDEIE RKENIKPSLG SKKNLLESIP\r\n",
      "     THSDQEKEVN IKKPEDNENL DDKDDDTTRV DESLNIKVEA EEEKAKSGDE TNKEEDEDDE\r\n",
      "     EAEEEEEEEE EEEDEDDDDN NEEEEFECYP PGMKVQVRYG RGKNQKMYEA SIKDSDVEGG\r\n",
      "     EVLYLVHYCG WNVRYDEWIK ADKIVRPADK NVPKIKHRKK IKNKLDKEKD KDEKYSPKNC\r\n",
      "     KLRRLSKPPF QTNPSPEMVS KLDLTDAKNS DTAHIKSIEI TSILNGLQAS ESSAEDSEQE\r\n",
      "     DERGAQDMDN NGKEESKIDH LTNNRNDLIS KEEQNSSSLL EENKVHADLV ISKPVSKSPE\r\n",
      "     RLRKDIEVLS EDTDYEEDEV TKKRKDVKKD TTDKSSKPQI KRGKRRYCNT EECLKTGSPG\r\n",
      "     KKEEKAKNKE SLCMENSSNS SSDEDEEETK AKMTPTKKYN GLEEKRKSLR TTGFYSGFSE\r\n",
      "     VAEKRIKLLN NSDERLQNSR AKDRKDVWSS IQGQWPKKTL KELFSDSDTE AAASPPHPAP\r\n",
      "     EEGVAEESLQ TVAEEESCSP SVELEKPPPV NVDSKPIEEK TVEVNDRKAE FPSSGSNSVL\r\n",
      "     NTPPTTPESP SSVTVTEGSR QQSSVTVSEP LAPNQEEVRS IKSETDSTIE VDSVAGELQD\r\n",
      "     LQSEGNSSPA GFDASVSSSS SNQPEPEHPE KACTGQKRVK DAQGGGSSSK KQKRSHKATV\r\n",
      "     VNNKKKGKGT NSSDSEELSA GESITKSQPV KSVSTGMKSH STKSPARTQS PGKCGKNGDK\r\n",
      "     DPDLKEPSNR LPKVYKWSFQ MSDLENMTSA ERITILQEKL QEIRKHYLSL KSEVASIDRR\r\n",
      "     RKRLKKKERE SAATSSSSSS PSSSSITAAV MLTLAEPSMS SASQNGMSVE CR\r\n",
      "//\r\n",
      "ID   BRE1B_HUMAN             Reviewed;        1001 AA.\r\n",
      "AC   O75150; A0A024QZG0; Q6AHZ6; Q6N005; Q7L3T6; Q8N615; Q96T18; Q9BSV9; Q9HC82;\r\n",
      "DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   12-SEP-2018, sequence version 5.\r\n",
      "DT   03-MAY-2023, entry version 189.\r\n",
      "DE   RecName: Full=E3 ubiquitin-protein ligase BRE1B;\r\n",
      "DE            Short=BRE1-B;\r\n",
      "DE            EC=2.3.2.27 {ECO:0000269|PubMed:16307923, ECO:0000269|PubMed:19410543};\r\n",
      "DE   AltName: Full=95 kDa retinoblastoma-associated protein;\r\n",
      "DE            Short=RBP95;\r\n",
      "DE   AltName: Full=RING finger protein 40;\r\n",
      "DE   AltName: Full=RING-type E3 ubiquitin transferase BRE1B {ECO:0000305};\r\n",
      "GN   Name=RNF40; Synonyms=BRE1B, KIAA0661;\r\n",
      "OS   Homo sapiens (Human).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\n",
      "OC   Homo.\r\n",
      "OX   NCBI_TaxID=9606;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), SUBCELLULAR LOCATION, TISSUE\r\n",
      "RP   SPECIFICITY, SUBUNIT, INTERACTION WITH RB1, AND MUTAGENESIS OF LEU-109;\r\n",
      "RP   CYS-111 AND GLU-113.\r\n",
      "RC   TISSUE=Fetal brain;\r\n",
      "RX   PubMed=10944455; DOI=10.1006/bbrc.2000.3242;\r\n",
      "RA   Wen H., Ao S.;\r\n",
      "RT   \"RBP95, a novel leucine zipper protein, binds to the retinoblastoma\r\n",
      "RT   protein.\";\r\n",
      "RL   Biochem. Biophys. Res. Commun. 275:141-148(2000).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).\r\n",
      "RC   TISSUE=Brain;\r\n",
      "RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;\r\n",
      "RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,\r\n",
      "RA   Nomura N., Ohara O.;\r\n",
      "RT   \"Prediction of the coding sequences of unidentified human genes. X. The\r\n",
      "RT   complete sequences of 100 new cDNA clones from brain which can code for\r\n",
      "RT   large proteins in vitro.\";\r\n",
      "RL   DNA Res. 5:169-176(1998).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).\r\n",
      "RC   TISSUE=Teratocarcinoma;\r\n",
      "RX   PubMed=14702039; DOI=10.1038/ng1285;\r\n",
      "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\r\n",
      "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\r\n",
      "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\r\n",
      "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\r\n",
      "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,\r\n",
      "RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,\r\n",
      "RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,\r\n",
      "RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,\r\n",
      "RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,\r\n",
      "RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,\r\n",
      "RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,\r\n",
      "RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,\r\n",
      "RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,\r\n",
      "RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\r\n",
      "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\r\n",
      "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\r\n",
      "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\r\n",
      "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,\r\n",
      "RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,\r\n",
      "RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,\r\n",
      "RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,\r\n",
      "RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,\r\n",
      "RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,\r\n",
      "RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,\r\n",
      "RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,\r\n",
      "RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,\r\n",
      "RA   Isogai T., Sugano S.;\r\n",
      "RT   \"Complete sequencing and characterization of 21,243 full-length human\r\n",
      "RT   cDNAs.\";\r\n",
      "RL   Nat. Genet. 36:40-45(2004).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).\r\n",
      "RC   TISSUE=Cervix, and Rectum tumor;\r\n",
      "RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;\r\n",
      "RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,\r\n",
      "RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,\r\n",
      "RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,\r\n",
      "RA   Wiemann S., Schupp I.;\r\n",
      "RT   \"The full-ORF clone resource of the German cDNA consortium.\";\r\n",
      "RL   BMC Genomics 8:399-399(2007).\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RX   PubMed=15616553; DOI=10.1038/nature03187;\r\n",
      "RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,\r\n",
      "RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,\r\n",
      "RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,\r\n",
      "RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,\r\n",
      "RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,\r\n",
      "RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,\r\n",
      "RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,\r\n",
      "RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,\r\n",
      "RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,\r\n",
      "RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,\r\n",
      "RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,\r\n",
      "RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,\r\n",
      "RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,\r\n",
      "RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,\r\n",
      "RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,\r\n",
      "RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,\r\n",
      "RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,\r\n",
      "RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,\r\n",
      "RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,\r\n",
      "RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,\r\n",
      "RA   Myers R.M., Rubin E.M., Pennacchio L.A.;\r\n",
      "RT   \"The sequence and analysis of duplication-rich human chromosome 16.\";\r\n",
      "RL   Nature 432:988-994(2004).\r\n",
      "RN   [6]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,\r\n",
      "RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,\r\n",
      "RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,\r\n",
      "RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,\r\n",
      "RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,\r\n",
      "RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,\r\n",
      "RA   Hunkapiller M.W., Myers E.W., Venter J.C.;\r\n",
      "RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [7]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).\r\n",
      "RC   TISSUE=Brain, Mammary gland, Skin, and Uterus;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [8]\r\n",
      "RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, AND IDENTIFICATION IN A COMPLEX WITH\r\n",
      "RP   RNF20 AND UBE2E1.\r\n",
      "RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;\r\n",
      "RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P.,\r\n",
      "RA   Reinberg D.;\r\n",
      "RT   \"Monoubiquitination of human histone H2B: the factors involved and their\r\n",
      "RT   roles in HOX gene regulation.\";\r\n",
      "RL   Mol. Cell 20:601-611(2005).\r\n",
      "RN   [9]\r\n",
      "RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBUNIT.\r\n",
      "RX   PubMed=19410543; DOI=10.1016/j.cell.2009.02.027;\r\n",
      "RA   Kim J., Guermah M., McGinty R.K., Lee J.S., Tang Z., Milne T.A.,\r\n",
      "RA   Shilatifard A., Muir T.W., Roeder R.G.;\r\n",
      "RT   \"RAD6-mediated transcription-coupled H2B ubiquitylation directly stimulates\r\n",
      "RT   H3K4 methylation in human cells.\";\r\n",
      "RL   Cell 137:459-471(2009).\r\n",
      "RN   [10]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;\r\n",
      "RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,\r\n",
      "RA   Bennett K.L., Superti-Furga G., Colinge J.;\r\n",
      "RT   \"Initial characterization of the human central proteome.\";\r\n",
      "RL   BMC Syst. Biol. 5:17-17(2011).\r\n",
      "RN   [11]\r\n",
      "RP   INTERACTION WITH WAC.\r\n",
      "RX   PubMed=21329877; DOI=10.1016/j.molcel.2011.01.024;\r\n",
      "RA   Zhang F., Yu X.;\r\n",
      "RT   \"WAC, a functional partner of RNF20/40, regulates histone H2B\r\n",
      "RT   ubiquitination and gene transcription.\";\r\n",
      "RL   Mol. Cell 41:384-397(2011).\r\n",
      "RN   [12]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Erythroleukemia;\r\n",
      "RX   PubMed=23186163; DOI=10.1021/pr300630k;\r\n",
      "RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\r\n",
      "RA   Mohammed S.;\r\n",
      "RT   \"Toward a comprehensive characterization of a human cancer cell\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteome Res. 12:260-271(2013).\r\n",
      "RN   [13]\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;\r\n",
      "RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,\r\n",
      "RA   Ye M., Zou H.;\r\n",
      "RT   \"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver\r\n",
      "RT   phosphoproteome.\";\r\n",
      "RL   J. Proteomics 96:253-262(2014).\r\n",
      "RN   [14]\r\n",
      "RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-578 AND LYS-579, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=28112733; DOI=10.1038/nsmb.3366;\r\n",
      "RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,\r\n",
      "RA   Nielsen M.L.;\r\n",
      "RT   \"Site-specific mapping of the human SUMO proteome reveals co-modification\r\n",
      "RT   with phosphorylation.\";\r\n",
      "RL   Nat. Struct. Mol. Biol. 24:325-336(2017).\r\n",
      "CC   -!- FUNCTION: Component of the RNF20/40 E3 ubiquitin-protein ligase complex\r\n",
      "CC       that mediates monoubiquitination of 'Lys-120' of histone H2B\r\n",
      "CC       (H2BK120ub1). H2BK120ub1 gives a specific tag for epigenetic\r\n",
      "CC       transcriptional activation and is also prerequisite for histone H3\r\n",
      "CC       'Lys-4' and 'Lys-79' methylation (H3K4me and H3K79me, respectively). It\r\n",
      "CC       thereby plays a central role in histone code and gene regulation. The\r\n",
      "CC       RNF20/40 complex forms a H2B ubiquitin ligase complex in cooperation\r\n",
      "CC       with the E2 enzyme UBE2A or UBE2B; reports about the cooperation with\r\n",
      "CC       UBE2E1/UBCH are contradictory. Required for transcriptional activation\r\n",
      "CC       of Hox genes. {ECO:0000269|PubMed:16307923,\r\n",
      "CC       ECO:0000269|PubMed:19410543}.\r\n",
      "CC   -!- CATALYTIC ACTIVITY:\r\n",
      "CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +\r\n",
      "CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-\r\n",
      "CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;\r\n",
      "CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:16307923,\r\n",
      "CC         ECO:0000269|PubMed:19410543};\r\n",
      "CC   -!- PATHWAY: Protein modification; protein ubiquitination.\r\n",
      "CC   -!- SUBUNIT: Component of the RNF20/40 complex (also known as BRE1 complex)\r\n",
      "CC       probably composed of 2 copies of RNF20/BRE1A and 2 copies of\r\n",
      "CC       RNF40/BRE1B. Interacts with UBE2E1/UBCH6. Interacts with RB1 and WAC.\r\n",
      "CC       {ECO:0000269|PubMed:10944455, ECO:0000269|PubMed:16307923,\r\n",
      "CC       ECO:0000269|PubMed:19410543, ECO:0000269|PubMed:21329877}.\r\n",
      "CC   -!- INTERACTION:\r\n",
      "CC       O75150; Q9Y2J4: AMOTL2; NbExp=3; IntAct=EBI-744408, EBI-746752;\r\n",
      "CC       O75150; Q9Y2J4-4: AMOTL2; NbExp=3; IntAct=EBI-744408, EBI-10187270;\r\n",
      "CC       O75150; Q8IYE0-2: CCDC146; NbExp=3; IntAct=EBI-744408, EBI-10247802;\r\n",
      "CC       O75150; Q9NRI5-2: DISC1; NbExp=3; IntAct=EBI-744408, EBI-11988027;\r\n",
      "CC       O75150; Q68J44: DUSP29; NbExp=3; IntAct=EBI-744408, EBI-1054321;\r\n",
      "CC       O75150; P42858: HTT; NbExp=12; IntAct=EBI-744408, EBI-466029;\r\n",
      "CC       O75150; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-744408, EBI-16439278;\r\n",
      "CC       O75150; Q09161: NCBP1; NbExp=4; IntAct=EBI-744408, EBI-464743;\r\n",
      "CC       O75150; P06400: RB1; NbExp=3; IntAct=EBI-744408, EBI-491274;\r\n",
      "CC       O75150; Q5VTR2: RNF20; NbExp=10; IntAct=EBI-744408, EBI-2372238;\r\n",
      "CC       O75150; Q86XK3: SFR1; NbExp=3; IntAct=EBI-744408, EBI-1104535;\r\n",
      "CC       O75150; Q7KZS0: UBE2I; NbExp=6; IntAct=EBI-744408, EBI-10180829;\r\n",
      "CC       O75150; Q6PEW1: ZCCHC12; NbExp=3; IntAct=EBI-744408, EBI-748373;\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10944455}.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=3;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=O75150-1; Sequence=Displayed;\r\n",
      "CC       Name=3;\r\n",
      "CC         IsoId=O75150-3; Sequence=VSP_016682, VSP_016683;\r\n",
      "CC       Name=4;\r\n",
      "CC         IsoId=O75150-4; Sequence=VSP_016681;\r\n",
      "CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expressed at higher level\r\n",
      "CC       in testis, heart and pancreas, while it is only weakly expressed in\r\n",
      "CC       lung, skeletal muscle and small intestine.\r\n",
      "CC       {ECO:0000269|PubMed:10944455}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the BRE1 family. {ECO:0000305}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=BAA31636.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};\r\n",
      "CC       Sequence=CAE45869.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AF122819; AAG13723.1; -; mRNA.\r\n",
      "DR   EMBL; AB014561; BAA31636.2; ALT_INIT; mRNA.\r\n",
      "DR   EMBL; AK027406; BAB55092.1; -; mRNA.\r\n",
      "DR   EMBL; BX640763; CAE45869.1; ALT_SEQ; mRNA.\r\n",
      "DR   EMBL; CR627431; CAH10518.1; -; mRNA.\r\n",
      "DR   EMBL; AC106886; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; CH471192; EAW52197.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; CH471192; EAW52200.1; -; Genomic_DNA.\r\n",
      "DR   EMBL; BC004527; AAH04527.2; -; mRNA.\r\n",
      "DR   EMBL; BC006133; AAH06133.1; -; mRNA.\r\n",
      "DR   EMBL; BC011769; AAH11769.1; -; mRNA.\r\n",
      "DR   EMBL; BC018647; AAH18647.1; -; mRNA.\r\n",
      "DR   EMBL; BC030802; AAH30802.2; -; mRNA.\r\n",
      "DR   CCDS; CCDS10691.1; -. [O75150-1]\r\n",
      "DR   CCDS; CCDS55994.1; -. [O75150-4]\r\n",
      "DR   PIR; JC7363; JC7363.\r\n",
      "DR   RefSeq; NP_001193962.1; NM_001207033.1.\r\n",
      "DR   RefSeq; NP_001193963.1; NM_001207034.1. [O75150-4]\r\n",
      "DR   RefSeq; NP_001273501.1; NM_001286572.2. [O75150-1]\r\n",
      "DR   RefSeq; NP_055586.1; NM_014771.3. [O75150-1]\r\n",
      "DR   AlphaFoldDB; O75150; -.\r\n",
      "DR   SMR; O75150; -.\r\n",
      "DR   BioGRID; 115149; 252.\r\n",
      "DR   CORUM; O75150; -.\r\n",
      "DR   IntAct; O75150; 64.\r\n",
      "DR   MINT; O75150; -.\r\n",
      "DR   STRING; 9606.ENSP00000325677; -.\r\n",
      "DR   GlyCosmos; O75150; 1 site, 1 glycan.\r\n",
      "DR   GlyGen; O75150; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; O75150; -.\r\n",
      "DR   MetOSite; O75150; -.\r\n",
      "DR   PhosphoSitePlus; O75150; -.\r\n",
      "DR   BioMuta; RNF40; -.\r\n",
      "DR   EPD; O75150; -.\r\n",
      "DR   jPOST; O75150; -.\r\n",
      "DR   MassIVE; O75150; -.\r\n",
      "DR   PaxDb; O75150; -.\r\n",
      "DR   PeptideAtlas; O75150; -.\r\n",
      "DR   ProteomicsDB; 49814; -. [O75150-1]\r\n",
      "DR   ProteomicsDB; 49815; -. [O75150-3]\r\n",
      "DR   ProteomicsDB; 49816; -. [O75150-4]\r\n",
      "DR   Antibodypedia; 13809; 277 antibodies from 32 providers.\r\n",
      "DR   DNASU; 9810; -.\r\n",
      "DR   Ensembl; ENST00000324685.11; ENSP00000325677.6; ENSG00000103549.22. [O75150-1]\r\n",
      "DR   Ensembl; ENST00000357890.9; ENSP00000350563.5; ENSG00000103549.22. [O75150-4]\r\n",
      "DR   GeneID; 9810; -.\r\n",
      "DR   KEGG; hsa:9810; -.\r\n",
      "DR   MANE-Select; ENST00000324685.11; ENSP00000325677.6; NM_014771.4; NP_055586.1.\r\n",
      "DR   UCSC; uc002dzq.4; human. [O75150-1]\r\n",
      "DR   AGR; HGNC:16867; -.\r\n",
      "DR   CTD; 9810; -.\r\n",
      "DR   DisGeNET; 9810; -.\r\n",
      "DR   GeneCards; RNF40; -.\r\n",
      "DR   HGNC; HGNC:16867; RNF40.\r\n",
      "DR   HPA; ENSG00000103549; Low tissue specificity.\r\n",
      "DR   MIM; 607700; gene.\r\n",
      "DR   neXtProt; NX_O75150; -.\r\n",
      "DR   OpenTargets; ENSG00000103549; -.\r\n",
      "DR   PharmGKB; PA34440; -.\r\n",
      "DR   VEuPathDB; HostDB:ENSG00000103549; -.\r\n",
      "DR   eggNOG; KOG0978; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00390000002866; -.\r\n",
      "DR   InParanoid; O75150; -.\r\n",
      "DR   OMA; THIEIMT; -.\r\n",
      "DR   OrthoDB; 53681at2759; -.\r\n",
      "DR   PhylomeDB; O75150; -.\r\n",
      "DR   TreeFam; TF323183; -.\r\n",
      "DR   PathwayCommons; O75150; -.\r\n",
      "DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.\r\n",
      "DR   SignaLink; O75150; -.\r\n",
      "DR   SIGNOR; O75150; -.\r\n",
      "DR   UniPathway; UPA00143; -.\r\n",
      "DR   BioGRID-ORCS; 9810; 396 hits in 1203 CRISPR screens.\r\n",
      "DR   ChiTaRS; RNF40; human.\r\n",
      "DR   GeneWiki; RNF40; -.\r\n",
      "DR   GenomeRNAi; 9810; -.\r\n",
      "DR   Pharos; O75150; Tbio.\r\n",
      "DR   PRO; PR:O75150; -.\r\n",
      "DR   Proteomes; UP000005640; Chromosome 16.\r\n",
      "DR   RNAct; O75150; protein.\r\n",
      "DR   Bgee; ENSG00000103549; Expressed in ventricular zone and 149 other tissues.\r\n",
      "DR   ExpressionAtlas; O75150; baseline and differential.\r\n",
      "DR   Genevisible; O75150; HS.\r\n",
      "DR   GO; GO:0033503; C:HULC complex; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.\r\n",
      "DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0000151; C:ubiquitin ligase complex; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0017075; F:syntaxin-1 binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IEA:Ensembl.\r\n",
      "DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.\r\n",
      "DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0071894; P:histone H2B conserved C-terminal lysine ubiquitination; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010390; P:histone monoubiquitination; IBA:GO_Central.\r\n",
      "DR   GO; GO:1901800; P:positive regulation of proteasomal protein catabolic process; IEA:Ensembl.\r\n",
      "DR   GO; GO:1902916; P:positive regulation of protein polyubiquitination; IEA:Ensembl.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.\r\n",
      "DR   GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl.\r\n",
      "DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB.\r\n",
      "DR   CDD; cd16815; RING-HC_RNF40; 1.\r\n",
      "DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.\r\n",
      "DR   InterPro; IPR013956; E3_ubiquit_lig_Bre1.\r\n",
      "DR   InterPro; IPR018957; Znf_C3HC4_RING-type.\r\n",
      "DR   InterPro; IPR001841; Znf_RING.\r\n",
      "DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.\r\n",
      "DR   InterPro; IPR017907; Znf_RING_CS.\r\n",
      "DR   PANTHER; PTHR23163:SF4; E3 UBIQUITIN-PROTEIN LIGASE BRE1B; 1.\r\n",
      "DR   PANTHER; PTHR23163; RING FINGER PROTEIN-RELATED; 1.\r\n",
      "DR   Pfam; PF00097; zf-C3HC4; 1.\r\n",
      "DR   SMART; SM00184; RING; 1.\r\n",
      "DR   SUPFAM; SSF57850; RING/U-box; 1.\r\n",
      "DR   PROSITE; PS00518; ZF_RING_1; 1.\r\n",
      "DR   PROSITE; PS50089; ZF_RING_2; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Acetylation; Alternative splicing; Chromatin regulator; Coiled coil;\r\n",
      "KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Transferase; Ubl conjugation; Ubl conjugation pathway;\r\n",
      "KW   Zinc; Zinc-finger.\r\n",
      "FT   CHAIN           1..1001\r\n",
      "FT                   /note=\"E3 ubiquitin-protein ligase BRE1B\"\r\n",
      "FT                   /id=\"PRO_0000055839\"\r\n",
      "FT   ZN_FING         948..987\r\n",
      "FT                   /note=\"RING-type\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00175\"\r\n",
      "FT   REGION          1..32\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          116..146\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          518..652\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COILED          44..91\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COILED          189..377\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COILED          437..525\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COILED          627..946\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COMPBIAS        604..619\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        633..652\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         20\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q3U319\"\r\n",
      "FT   MOD_RES         42\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q5VTR2\"\r\n",
      "FT   MOD_RES         355\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q5VTR2\"\r\n",
      "FT   MOD_RES         517\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q3U319\"\r\n",
      "FT   MOD_RES         528\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q5VTR2\"\r\n",
      "FT   MOD_RES         585\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q3U319\"\r\n",
      "FT   CROSSLNK        578\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   CROSSLNK        579\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:28112733\"\r\n",
      "FT   VAR_SEQ         332..431\r\n",
      "FT                   /note=\"Missing (in isoform 4)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:14702039\"\r\n",
      "FT                   /id=\"VSP_016681\"\r\n",
      "FT   VAR_SEQ         822..838\r\n",
      "FT                   /note=\"DAQLLTVQKLEEKERAL -> WPPPACRLELERWGSWP (in isoform\r\n",
      "FT                   3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:10944455\"\r\n",
      "FT                   /id=\"VSP_016682\"\r\n",
      "FT   VAR_SEQ         839..1001\r\n",
      "FT                   /note=\"Missing (in isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:10944455\"\r\n",
      "FT                   /id=\"VSP_016683\"\r\n",
      "FT   VARIANT         463\r\n",
      "FT                   /note=\"R -> H (in dbSNP:rs11556801)\"\r\n",
      "FT                   /id=\"VAR_055021\"\r\n",
      "FT   VARIANT         615\r\n",
      "FT                   /note=\"R -> Q (in dbSNP:rs7195142)\"\r\n",
      "FT                   /id=\"VAR_055022\"\r\n",
      "FT   MUTAGEN         109\r\n",
      "FT                   /note=\"L->S: Abolishes interaction with RB1.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10944455\"\r\n",
      "FT   MUTAGEN         111\r\n",
      "FT                   /note=\"C->M: Abolishes interaction with RB1.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10944455\"\r\n",
      "FT   MUTAGEN         113\r\n",
      "FT                   /note=\"E->Q: Abolishes interaction with RB1.\"\r\n",
      "FT                   /evidence=\"ECO:0000269|PubMed:10944455\"\r\n",
      "FT   CONFLICT        56\r\n",
      "FT                   /note=\"N -> D (in Ref. 3; BAB55092)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        96\r\n",
      "FT                   /note=\"R -> L (in Ref. 1; AAG13723)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        108\r\n",
      "FT                   /note=\"L -> P (in Ref. 3; BAB55092)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        172\r\n",
      "FT                   /note=\"S -> G (in Ref. 3; BAB55092)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        387\r\n",
      "FT                   /note=\"E -> K (in Ref. 4; CAH10518)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        562\r\n",
      "FT                   /note=\"K -> E (in Ref. 4; CAE45869)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        600\r\n",
      "FT                   /note=\"S -> F (in Ref. 4; CAE45869)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        714\r\n",
      "FT                   /note=\"D -> N (in Ref. 3; BAB55092)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   1001 AA;  113678 MW;  408A6E5A9CC25E41 CRC64;\r\n",
      "     MSGPGNKRAA GDGGSGPPEK KLSREEKTTT TLIEPIRLGG ISSTEEMDLK VLQFKNKKLA\r\n",
      "     ERLEQRQACE DELRERIEKL EKRQATDDAT LLIVNRYWAQ LDETVEALLR CHESQGELSS\r\n",
      "     APEAPGTQEG PTCDGTPLPE PGTSELRDPL LMQLRPPLSE PALAFVVALG ASSSEEVELE\r\n",
      "     LQGRMEFSKA AVSRVVEASD RLQRRVEELC QRVYSRGDSE PLSEAAQAHT RELGRENRRL\r\n",
      "     QDLATQLQEK HHRISLEYSE LQDKVTSAET KVLEMETTVE DLQWDIEKLR KREQKLNKHL\r\n",
      "     AEALEQLNSG YYVSGSSSGF QGGQITLSMQ KFEMLNAELE ENQELANSRM AELEKLQAEL\r\n",
      "     QGAVRTNERL KVALRSLPEE VVRETGEYRM LQAQFSLLYN ESLQVKTQLD EARGLLLATK\r\n",
      "     NSHLRHIEHM ESDELGLQKK LRTEVIQLED TLAQVRKEYE MLRIEFEQNL AANEQAGPIN\r\n",
      "     REMRHLISSL QNHNHQLKGD AQRYKRKLRE VQAEIGKLRA QASGSAHSTP NLGHPEDSGV\r\n",
      "     SAPAPGKEEG GPGPVSTPDN RKEMAPVPGT TTTTTSVKKE ELVPSEEDFQ GITPGAQGPS\r\n",
      "     SRGREPEARP KRELREREGP SLGPPPVASA LSRADREKAK VEETKRKESE LLKGLRAELK\r\n",
      "     KAQESQKEMK LLLDMYKSAP KEQRDKVQLM AAERKAKAEV DELRSRIREL EERDRRESKK\r\n",
      "     IADEDALRRI RQAEEQIEHL QRKLGATKQE EEALLSEMDV TGQAFEDMQE QNGRLLQQLR\r\n",
      "     EKDDANFKLM SERIKANQIH KLLREEKDEL GEQVLGLKSQ VDAQLLTVQK LEEKERALQG\r\n",
      "     SLGGVEKELT LRSQALELNK RKAVEAAQLA EDLKVQLEHV QTRLREIQPC LAESRAAREK\r\n",
      "     ESFNLKRAQE DISRLRRKLE KQRKVEVYAD ADEILQEEIK EYKARLTCPC CNTRKKDAVL\r\n",
      "     TKCFHVFCFE CVRGRYEARQ RKCPKCNAAF GAHDFHRIYI S\r\n",
      "//\r\n",
      "ID   RBL2_RAT                Reviewed;        1135 AA.\r\n",
      "AC   O55081;\r\n",
      "DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   01-JUN-1998, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 157.\r\n",
      "DE   RecName: Full=Retinoblastoma-like protein 2;\r\n",
      "DE   AltName: Full=130 kDa retinoblastoma-associated protein;\r\n",
      "DE            Short=p130;\r\n",
      "DE   AltName: Full=PPAR-alpha-interacting complex protein 128;\r\n",
      "DE            Short=PRIC128;\r\n",
      "DE   AltName: Full=Retinoblastoma-related protein 2;\r\n",
      "DE            Short=RBR-2;\r\n",
      "DE   AltName: Full=pRb2;\r\n",
      "GN   Name=Rbl2;\r\n",
      "OS   Rattus norvegicus (Rat).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Rattus.\r\n",
      "OX   NCBI_TaxID=10116;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RC   STRAIN=Sprague-Dawley; TISSUE=Spleen;\r\n",
      "RX   PubMed=9247086; DOI=10.1016/s0925-4439(97)00037-9;\r\n",
      "RA   Sawada Y., Nomura H., Endo Y., Umeki K., Fujita T., Ohtaki S., Fujinaga K.;\r\n",
      "RT   \"Cloning and characterization of the rat p130, a member of the\r\n",
      "RT   retinoblastoma gene family.\";\r\n",
      "RL   Biochim. Biophys. Acta 1361:20-27(1997).\r\n",
      "RN   [2]\r\n",
      "RP   PROTEIN SEQUENCE OF 276-288 AND 829-838, AND SUBUNIT.\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=12189208; DOI=10.1073/pnas.182426699;\r\n",
      "RA   Surapureddi S., Yu S., Bu H., Hashimoto T., Yeldandi A.V., Kashireddy P.,\r\n",
      "RA   Cherkaoui-Malki M., Qi C., Zhu Y.-J., Rao M.S., Reddy J.K.;\r\n",
      "RT   \"Identification of a transcriptionally active peroxisome proliferator-\r\n",
      "RT   activated receptor alpha-interacting cofactor complex in rat liver and\r\n",
      "RT   characterization of PRIC285 as a coactivator.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 99:11836-11841(2002).\r\n",
      "RN   [3]\r\n",
      "RP   INTERACTION WITH RBBP9.\r\n",
      "RX   PubMed=9697699; DOI=10.1038/1258;\r\n",
      "RA   Woitach J.T., Zhang M., Niu C.-H., Thorgeirsson S.S.;\r\n",
      "RT   \"A retinoblastoma-binding protein that affects cell-cycle control and\r\n",
      "RT   confers transforming ability.\";\r\n",
      "RL   Nat. Genet. 19:371-374(1998).\r\n",
      "RN   [4]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-636; THR-639; SER-946;\r\n",
      "RP   SER-1064 AND SER-1108, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE\r\n",
      "RP   ANALYSIS].\r\n",
      "RX   PubMed=22673903; DOI=10.1038/ncomms1871;\r\n",
      "RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,\r\n",
      "RA   Olsen J.V.;\r\n",
      "RT   \"Quantitative maps of protein phosphorylation sites across 14 different rat\r\n",
      "RT   organs and tissues.\";\r\n",
      "RL   Nat. Commun. 3:876-876(2012).\r\n",
      "CC   -!- FUNCTION: Key regulator of entry into cell division. Directly involved\r\n",
      "CC       in heterochromatin formation by maintaining overall chromatin structure\r\n",
      "CC       and, in particular, that of constitutive heterochromatin by stabilizing\r\n",
      "CC       histone methylation. Recruits and targets histone methyltransferases\r\n",
      "CC       KMT5B and KMT5C, leading to epigenetic transcriptional repression.\r\n",
      "CC       Controls histone H4 'Lys-20' trimethylation. Probably acts as a\r\n",
      "CC       transcription repressor by recruiting chromatin-modifying enzymes to\r\n",
      "CC       promoters. Potent inhibitor of E2F-mediated trans-activation,\r\n",
      "CC       associates preferentially with E2F5. Binds to cyclins A and E. Binds to\r\n",
      "CC       and may be involved in the transforming capacity of the adenovirus E1A\r\n",
      "CC       protein. May act as a tumor suppressor (By similarity). {ECO:0000250}.\r\n",
      "CC   -!- SUBUNIT: Interacts with AATF, KMT5B and KMT5C. Component of the DREAM\r\n",
      "CC       complex (also named LINC complex) at least composed of E2F4, E2F5,\r\n",
      "CC       LIN9, LIN37, LIN52, LIN54, MYBL1, MYBL2, RBL1, RBL2, RBBP4, TFDP1 and\r\n",
      "CC       TFDP2. The complex exists in quiescent cells where it represses cell\r\n",
      "CC       cycle-dependent genes. It dissociates in S phase when LIN9, LIN37,\r\n",
      "CC       LIN52 and LIN54 form a subcomplex that binds to MYBL2. Interacts with\r\n",
      "CC       USP4 (By similarity). Part of the peroxisome proliferator activated\r\n",
      "CC       receptor alpha (PPAR-alpha) interacting complex (PRIC). Interacts with\r\n",
      "CC       RINT1 (By similarity). Interacts with PML (By similarity). Interacts\r\n",
      "CC       with RBBP9 (PubMed:9697699). {ECO:0000250, ECO:0000269|PubMed:9697699}.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus.\r\n",
      "CC   -!- PTM: During G0 and early G1 phase of the cell cycle, phosphorylated on\r\n",
      "CC       Ser-636 and on 5 sites within the domain B. Phosphorylation on Ser-669\r\n",
      "CC       in G1 leads to its ubiquitin-dependent proteolysis (By similarity).\r\n",
      "CC       {ECO:0000250}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; D55627; BAA24196.1; -; mRNA.\r\n",
      "DR   RefSeq; NP_112356.1; NM_031094.1.\r\n",
      "DR   AlphaFoldDB; O55081; -.\r\n",
      "DR   SMR; O55081; -.\r\n",
      "DR   BioGRID; 249630; 5.\r\n",
      "DR   IntAct; O55081; 1.\r\n",
      "DR   STRING; 10116.ENSRNOP00000017361; -.\r\n",
      "DR   iPTMnet; O55081; -.\r\n",
      "DR   PhosphoSitePlus; O55081; -.\r\n",
      "DR   PaxDb; O55081; -.\r\n",
      "DR   GeneID; 81758; -.\r\n",
      "DR   KEGG; rno:81758; -.\r\n",
      "DR   AGR; RGD:3541; -.\r\n",
      "DR   CTD; 5934; -.\r\n",
      "DR   RGD; 3541; Rbl2.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   InParanoid; O55081; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   PhylomeDB; O55081; -.\r\n",
      "DR   Reactome; R-RNO-1538133; G0 and Early G1.\r\n",
      "DR   Reactome; R-RNO-69231; Cyclin D associated events in G1.\r\n",
      "DR   PRO; PR:O55081; -.\r\n",
      "DR   Proteomes; UP000002494; Unplaced.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IDA:RGD.\r\n",
      "DR   GO; GO:0005634; C:nucleus; ISO:RGD.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.\r\n",
      "DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:RGD.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; ISO:RGD.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:InterPro.\r\n",
      "DR   CDD; cd20606; CYCLIN_RBL2; 1.\r\n",
      "DR   CDD; cd00043; CYCLIN_SF; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 3.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   PANTHER; PTHR13742:SF8; RETINOBLASTOMA-LIKE PROTEIN 2; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 2.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 3.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Cell cycle; Chromatin regulator; Direct protein sequencing; DNA-binding;\r\n",
      "KW   Nucleus; Phosphoprotein; Reference proteome; Repressor; Transcription;\r\n",
      "KW   Transcription regulation; Tumor suppressor.\r\n",
      "FT   CHAIN           1..1135\r\n",
      "FT                   /note=\"Retinoblastoma-like protein 2\"\r\n",
      "FT                   /id=\"PRO_0000167843\"\r\n",
      "FT   REGION          1..43\r\n",
      "FT                   /note=\"Disordered\"\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          414..1021\r\n",
      "FT                   /note=\"Pocket; binds E1A\"\r\n",
      "FT   REGION          414..613\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT   REGION          614..824\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT   REGION          649..698\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          806..825\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          825..1021\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT   REGION          932..995\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        654..691\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        939..971\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         410\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         414\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q64700\"\r\n",
      "FT   MOD_RES         636\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         639\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         659\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         669\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         684\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         942\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q64700\"\r\n",
      "FT   MOD_RES         946\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         960\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         965\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         967\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         968\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         975\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         976\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         980\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         1031\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         1064\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         1076\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q08999\"\r\n",
      "FT   MOD_RES         1108\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "SQ   SEQUENCE   1135 AA;  127818 MW;  6C42A87E163B4298 CRC64;\r\n",
      "     MASGGNQSSP PPPAAAASSE EEEEDGDTAD RAQPAGSPSH QIQQRFEELC SRLNMDEAAR\r\n",
      "     AEAWSSYRSM SESYTLEGND LHWLACALYV ACRKSVPTVS KGTAEGNYVS LTRILRCSEQ\r\n",
      "     SLIEFFNKMK KWEDMANLPP HFRERTERLE RNFTVSAVIF KKYEPIFQDI FKYPQEEQPR\r\n",
      "     QQRGRKQRRQ PCTTSEIFHF CWVLFIYAKG NFPMISDDLV NSYHLLLCAL DLVYGNALQC\r\n",
      "     SNRKELVNPN FKGVSEDGHP RDSHPSSDPP CVIEKLCSLH DGLVLEAKGI KQHFWKPYIR\r\n",
      "     KLFEKKLLRG KEENLTGFLE PGNFAESFKA VNKAYEEYVL ATGSLDERIF LGEDAEEEVG\r\n",
      "     TFSRCVSAAS GTESAERTQM RDILQQHLDK SKTLRVCNPL TGVRYVQENS PCVTPVSTAT\r\n",
      "     HSLNRLHTML AGLRNAPSEK LEQILRSCSR DPTRAIADRL REMYEIYSQH FQPDENVSNC\r\n",
      "     AKEMANKHFR FAEMLYYKVL ESVIEQEQKR LGDMDLSGVL EQDAFHKSLL ACCLEVVAFS\r\n",
      "     YKPPGNFPFI AEIFDVPHYH FYKVIEVFIR AEDGLCREVV KHLNQIEEQI LDHLAWKTKS\r\n",
      "     PLWDRIRDNE NRVPTCEEVT PPHNLERTDE IYIAGSPLTP RRVGEVRTDA GGLGRSVTSP\r\n",
      "     TTLYDRYSSP TVSTTRRRLF ESDSPSEGST AGRIPPQPLV NAVPVQNVSG ETVSVTPVPG\r\n",
      "     QTLVTMATAT VTANNGQTVT IPVQGIANEN GGITFFPVQV NVGGQAQAVT GSIQPLSAQA\r\n",
      "     LAGSLSSQQV TGTTLQVPGP VAIQQISPGG QQQNQGQPLT SSSIRPRKTS SLSLFFRKVY\r\n",
      "     YLAGVRLRDL CTKLDISDEL RKKIWTCFEF SIVQCPELMM DRHLDQLLMC AIYVMAKVTK\r\n",
      "     EDKSFQNIMR CYRTQPQARS QVYRSVLIKG KRRNSGSCEN RSHQNSPTEL NTDRASRDSS\r\n",
      "     PVMRSNSTLP VPQPSSAPPT PTRLTGANSD IEEEERGDLI QFYNNIYRKQ IQTFAMKYSQ\r\n",
      "     ANSQMDTPPL SPYPFVRTGS PRRVQLSQSH PIYISPHKNE AMLSPREKIF YYFSNSPSKR\r\n",
      "     LREINSMIRT GETPTKKRGI LLDDGSESPA KRICPENHSA LLRRLQDVAN DRGSH\r\n",
      "//\r\n",
      "ID   RB_CHICK                Reviewed;         921 AA.\r\n",
      "AC   Q90600; Q788Q6; Q90599; Q91016;\r\n",
      "DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   01-NOV-1996, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 123.\r\n",
      "DE   RecName: Full=Retinoblastoma-associated protein;\r\n",
      "DE   AltName: Full=p104;\r\n",
      "DE   AltName: Full=pRb;\r\n",
      "DE            Short=Rb;\r\n",
      "GN   Name=RB1;\r\n",
      "OS   Gallus gallus (Chicken).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\r\n",
      "OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;\r\n",
      "OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae;\r\n",
      "OC   Phasianinae; Gallus.\r\n",
      "OX   NCBI_TaxID=9031;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA], AND NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-72.\r\n",
      "RC   STRAIN=SPAFAS;\r\n",
      "RX   PubMed=8180136;\r\n",
      "RA   Boehmelt G., Ulrich E., Kurzbauer R., Mellitzer G., Bird A., Zenke M.;\r\n",
      "RT   \"Structure and expression of the chicken retinoblastoma gene.\";\r\n",
      "RL   Cell Growth Differ. 5:221-230(1994).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RX   PubMed=8193168; DOI=10.1016/0167-4781(94)90103-1;\r\n",
      "RA   Feinstein R., Bolton W.K., Quinones J.N., Mosialos G., Sif S., Huff J.L.,\r\n",
      "RA   Capobianco A.J., Gilmore T.D.;\r\n",
      "RT   \"Characterization of a chicken cDNA encoding the retinoblastoma gene\r\n",
      "RT   product.\";\r\n",
      "RL   Biochim. Biophys. Acta 1218:82-86(1994).\r\n",
      "RN   [3]\r\n",
      "RP   INTERACTION WITH FOWL ADENOVIRUS 1 PROTEIN GAM-1 (MICROBIAL INFECTION).\r\n",
      "RX   PubMed=10400747; DOI=10.1128/jvi.73.8.6517-6525.1999;\r\n",
      "RA   Lehrmann H., Cotten M.;\r\n",
      "RT   \"Characterization of CELO virus proteins that modulate the pRb/E2F\r\n",
      "RT   pathway.\";\r\n",
      "RL   J. Virol. 73:6517-6525(1999).\r\n",
      "CC   -!- FUNCTION: Tumor suppressor that is a key regulator of the G1/S\r\n",
      "CC       transition of the cell cycle. The hypophosphorylated form binds\r\n",
      "CC       transcription regulators of the E2F family, preventing transcription of\r\n",
      "CC       E2F-responsive genes. Both physically blocks E2Fs transactivating\r\n",
      "CC       domain and recruits chromatin-modifying enzymes that actively repress\r\n",
      "CC       transcription. Cyclin and CDK-dependent phosphorylation of RB1 induces\r\n",
      "CC       its dissociation from E2Fs, thereby activating transcription of E2F\r\n",
      "CC       responsive genes and triggering entry into S phase. RB1 also promotes\r\n",
      "CC       the G0-G1 transition upon phosphorylation and activation by\r\n",
      "CC       CDK3/cyclin-C. {ECO:0000250|UniProtKB:P06400,\r\n",
      "CC       ECO:0000250|UniProtKB:P13405, ECO:0000250|UniProtKB:P33568}.\r\n",
      "CC   -!- SUBUNIT: Interacts with and sequesters the E2F1 transcription factor.\r\n",
      "CC       Interacts with SUV39H1, KMT5B and KMT5C (By similarity). {ECO:0000250}.\r\n",
      "CC   -!- SUBUNIT: (Microbial infection) Interacts with, and is inhibited by fowl\r\n",
      "CC       adenovirus 1 protein GAM-1. {ECO:0000269|PubMed:10400747}.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P13405}.\r\n",
      "CC   -!- PTM: Phosphorylated in G1, thereby releasing E2F1 which is then able to\r\n",
      "CC       activate cell growth. Dephosphorylated at the late M phase.\r\n",
      "CC       Phosphorylation of domain C promotes interaction between the C-terminal\r\n",
      "CC       domain C and the Pocket domain, and thereby inhibits interactions with\r\n",
      "CC       heterodimeric E2F/DP transcription factor complexes (By similarity).\r\n",
      "CC       {ECO:0000250}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=AAA19644.1; Type=Frameshift; Evidence={ECO:0000305};\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; X72218; CAA51019.1; -; mRNA.\r\n",
      "DR   EMBL; U00113; AAA19644.1; ALT_FRAME; mRNA.\r\n",
      "DR   EMBL; X72217; CAA51018.1; -; Genomic_DNA.\r\n",
      "DR   PIR; S45298; S45298.\r\n",
      "DR   RefSeq; NP_989750.1; NM_204419.1.\r\n",
      "DR   AlphaFoldDB; Q90600; -.\r\n",
      "DR   SMR; Q90600; -.\r\n",
      "DR   STRING; 9031.ENSGALP00000027407; -.\r\n",
      "DR   PaxDb; Q90600; -.\r\n",
      "DR   GeneID; 386582; -.\r\n",
      "DR   KEGG; gga:386582; -.\r\n",
      "DR   CTD; 5925; -.\r\n",
      "DR   VEuPathDB; HostDB:geneid_386582; -.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   InParanoid; Q90600; -.\r\n",
      "DR   PhylomeDB; Q90600; -.\r\n",
      "DR   PRO; PR:Q90600; -.\r\n",
      "DR   Proteomes; UP000000539; Unassembled WGS sequence.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0035189; C:Rb-E2F complex; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030308; P:negative regulation of cell growth; ISS:UniProtKB.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0031175; P:neuron projection development; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:InterPro.\r\n",
      "DR   CDD; cd20599; CYCLIN_RB; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 6.10.140.1380; -; 1.\r\n",
      "DR   Gene3D; 6.10.250.530; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 2.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   Pfam; PF08934; Rb_C; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Cell cycle; Chromatin regulator; DNA-binding; Host-virus interaction;\r\n",
      "KW   Nucleus; Phosphoprotein; Reference proteome; Repressor; Transcription;\r\n",
      "KW   Transcription regulation; Tumor suppressor.\r\n",
      "FT   CHAIN           1..921\r\n",
      "FT                   /note=\"Retinoblastoma-associated protein\"\r\n",
      "FT                   /id=\"PRO_0000331619\"\r\n",
      "FT   REGION          1..31\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          603..634\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          873..921\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOTIF           853..869\r\n",
      "FT                   /note=\"Bipartite nuclear localization signal\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P13405\"\r\n",
      "FT   COMPBIAS        610..634\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        891..912\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   CONFLICT        63\r\n",
      "FT                   /note=\"Q -> E (in Ref. 2; AAA19644)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        163\r\n",
      "FT                   /note=\"E -> S (in Ref. 2; AAA19644)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        411\r\n",
      "FT                   /note=\"S -> C (in Ref. 2; AAA19644)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        619\r\n",
      "FT                   /note=\"N -> G (in Ref. 2; AAA19644)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        791..792\r\n",
      "FT                   /note=\"VP -> A (in Ref. 2; AAA19644)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   921 AA;  104436 MW;  8527B7B4ACB12F36 CRC64;\r\n",
      "     MPPKPLRRAG AARSQRTSPE GGAGTASPPG GTRLEVGEAE FVALCDALKA PDSVREKAWM\r\n",
      "     TYQSLAAADG ASAYNKKKKE TWGVCIFIVA IDLDEMTFTF TELLKSLSIS VCTFFQFLKE\r\n",
      "     VDVNMDTVST KVDSTVSRLK KKYDVLLALY HKFERTCGLI YLEQPSSEIS AELSSVLVLK\r\n",
      "     NYWITFLLAK GKVLQMEDDL VISFQLLLCV LDYFIKLSPP AMLKEPYKSA VTALTVNGST\r\n",
      "     RTPRRGQNRN ARASKQIDTD TKVIEILCKE HDCNLDEVKN VYFTSFIPFL NSLGVVASNG\r\n",
      "     LPEVDVLSKQ YDELYLKNKD IDARLFLDHD ETLQPDVIAC SQLERTPRKN NPDEEVNHVL\r\n",
      "     PQTPVRAAMN TIQQLMMILN SATDKPSDTL IAYFNNCTVN PEDSILKRVE SLGHIFKKKF\r\n",
      "     AEAVGQGCAE IGSQRYQLGV RLYYRVMESM LKSEEERLSV HNFSKLLNDN IFHTSLLACA\r\n",
      "     LEIVMATYGR TASQSDGTSA ETDLSFPWIL NVFDLKAFDF YKVIESFIKV EPSLTRDMIK\r\n",
      "     HLERCEHRIM ESLAWQSDSP LFDLIKQSKE REGQTDQPEP TSTLNLPLQH NHTAADLYLS\r\n",
      "     PVRSPKKKAS GHPQSGTSNP DAQPSATSQT QKPQKSTSLS LFYKKVFRLA YLRLHTLFFR\r\n",
      "     LLSEHPDLEP LIWTLFQHTL QNESELMRDR HLDQIMMCSM YGICKVKNVD LRFKTIVSAY\r\n",
      "     KELPNTNQET FKRVLIREEQ YDSIIVFYNL VFMQKLKTNI LQYASNRPPT LSPIPHIPRS\r\n",
      "     PYQFSNSPRR VPAGNNIYIS PLKSPYKFSD GFHSPTKMTP RSRILVSIGE TFGTSEKFQK\r\n",
      "     INQMVCNSES HVKRSAEPSD APKPLKRLRF DIEGQDEADG GKHLPQESKF QQKLAEMTST\r\n",
      "     RTRMQKQKLN DGNDTSANEE K\r\n",
      "//\r\n",
      "ID   RBBP6_MOUSE             Reviewed;        1790 AA.\r\n",
      "AC   P97868; P70287; Q3TTR9; Q3TUM7; Q3UMP7; Q4U217; Q7TT06; Q8BNY8; Q8R399;\r\n",
      "DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   16-MAY-2006, sequence version 5.\r\n",
      "DT   03-MAY-2023, entry version 175.\r\n",
      "DE   RecName: Full=E3 ubiquitin-protein ligase RBBP6;\r\n",
      "DE            EC=2.3.2.27;\r\n",
      "DE   AltName: Full=Proliferation potential-related protein;\r\n",
      "DE   AltName: Full=Protein P2P-R;\r\n",
      "DE   AltName: Full=RING-type E3 ubiquitin transferase RBBP6 {ECO:0000305};\r\n",
      "DE   AltName: Full=Retinoblastoma-binding protein 6;\r\n",
      "DE   AltName: Full=p53-associated cellular protein of testis;\r\n",
      "GN   Name=Rbbp6; Synonyms=P2pr, Pact;\r\n",
      "OS   Mus musculus (Mouse).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Mus; Mus.\r\n",
      "OX   NCBI_TaxID=10090;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE\r\n",
      "RP   [LARGE SCALE MRNA] OF 546-1148 (ISOFORM 2), AND NUCLEOTIDE SEQUENCE [LARGE\r\n",
      "RP   SCALE MRNA] OF 1356-1790 (ISOFORMS 1/2).\r\n",
      "RC   STRAIN=C57BL/6J;\r\n",
      "RC   TISSUE=Corpora quadrigemina, Corpus striatum, Embryo, Head, and Lung;\r\n",
      "RX   PubMed=16141072; DOI=10.1126/science.1112014;\r\n",
      "RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,\r\n",
      "RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,\r\n",
      "RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,\r\n",
      "RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,\r\n",
      "RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,\r\n",
      "RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,\r\n",
      "RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,\r\n",
      "RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,\r\n",
      "RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,\r\n",
      "RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,\r\n",
      "RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,\r\n",
      "RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,\r\n",
      "RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,\r\n",
      "RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,\r\n",
      "RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,\r\n",
      "RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,\r\n",
      "RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,\r\n",
      "RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,\r\n",
      "RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,\r\n",
      "RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,\r\n",
      "RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,\r\n",
      "RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,\r\n",
      "RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,\r\n",
      "RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,\r\n",
      "RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,\r\n",
      "RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,\r\n",
      "RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,\r\n",
      "RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,\r\n",
      "RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,\r\n",
      "RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,\r\n",
      "RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,\r\n",
      "RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,\r\n",
      "RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,\r\n",
      "RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;\r\n",
      "RT   \"The transcriptional landscape of the mammalian genome.\";\r\n",
      "RL   Science 309:1559-1563(2005).\r\n",
      "RN   [2]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RC   STRAIN=C57BL/6J;\r\n",
      "RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;\r\n",
      "RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,\r\n",
      "RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,\r\n",
      "RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,\r\n",
      "RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,\r\n",
      "RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,\r\n",
      "RA   Eichler E.E., Ponting C.P.;\r\n",
      "RT   \"Lineage-specific biology revealed by a finished genome assembly of the\r\n",
      "RT   mouse.\";\r\n",
      "RL   PLoS Biol. 7:E1000112-E1000112(2009).\r\n",
      "RN   [3]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).\r\n",
      "RC   STRAIN=FVB/N-3; TISSUE=Mammary tumor;\r\n",
      "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\r\n",
      "RG   The MGC Project Team;\r\n",
      "RT   \"The status, quality, and expansion of the NIH full-length cDNA project:\r\n",
      "RT   the Mammalian Gene Collection (MGC).\";\r\n",
      "RL   Genome Res. 14:2121-2127(2004).\r\n",
      "RN   [4]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 154-1790 (ISOFORM 2), INTERACTION WITH RB1,\r\n",
      "RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.\r\n",
      "RC   STRAIN=BALB/cJ;\r\n",
      "RX   PubMed=9037032; DOI=10.1073/pnas.94.4.1212;\r\n",
      "RA   Witte M.M., Scott R.E.;\r\n",
      "RT   \"The proliferation potential protein-related (P2P-R) gene with domains\r\n",
      "RT   encoding heterogeneous nuclear ribonucleoprotein association and Rb1\r\n",
      "RT   binding shows repressed expression during terminal differentiation.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 94:1212-1217(1997).\r\n",
      "RN   [5]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 204-1790 (ISOFORM 1), INTERACTION WITH TP53\r\n",
      "RP   AND RB1, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.\r\n",
      "RC   STRAIN=BALB/cJ; TISSUE=Testis;\r\n",
      "RX   PubMed=9010216; DOI=10.1038/sj.onc.1200825;\r\n",
      "RA   Simons A., Melamed-Bessudo C., Wolkowicz R., Sperling J., Sperling R.,\r\n",
      "RA   Eisenbach L., Rotter V.;\r\n",
      "RT   \"PACT: cloning and characterization of a cellular p53 binding protein that\r\n",
      "RT   interacts with Rb.\";\r\n",
      "RL   Oncogene 14:145-155(1997).\r\n",
      "RN   [6]\r\n",
      "RP   SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.\r\n",
      "RX   PubMed=12064457; DOI=10.1002/jcp.10084;\r\n",
      "RA   Gao S., Witte M.M., Scott R.E.;\r\n",
      "RT   \"P2P-R protein localizes to the nucleolus of interphase cells and the\r\n",
      "RT   periphery of chromosomes in mitotic cells which show maximum P2P-R\r\n",
      "RT   immunoreactivity.\";\r\n",
      "RL   J. Cell. Physiol. 191:145-154(2002).\r\n",
      "RN   [7]\r\n",
      "RP   ERRATUM OF PUBMED:12064457.\r\n",
      "RA   Gao S., Witte M.M., Scott R.E.;\r\n",
      "RL   J. Cell. Physiol. 192:359-360(2002).\r\n",
      "RN   [8]\r\n",
      "RP   SUBCELLULAR LOCATION.\r\n",
      "RX   PubMed=12384997; DOI=10.1002/jcp.10163;\r\n",
      "RA   Gao S., Scott R.E.;\r\n",
      "RT   \"P2P-R protein overexpression restricts mitotic progression at prometaphase\r\n",
      "RT   and promotes mitotic apoptosis.\";\r\n",
      "RL   J. Cell. Physiol. 193:199-207(2002).\r\n",
      "RN   [9]\r\n",
      "RP   INTERACTION WITH TP53.\r\n",
      "RX   PubMed=14566974; DOI=10.1002/jcp.10381;\r\n",
      "RA   Gao S., Scott R.E.;\r\n",
      "RT   \"Stable overexpression of specific segments of the P2P-R protein in human\r\n",
      "RT   MCF-7 cells promotes camptothecin-induced apoptosis.\";\r\n",
      "RL   J. Cell. Physiol. 197:445-452(2003).\r\n",
      "RN   [10]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-985; SER-1179; THR-1272 AND\r\n",
      "RP   SER-1329, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Liver;\r\n",
      "RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;\r\n",
      "RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;\r\n",
      "RT   \"Large-scale phosphorylation analysis of mouse liver.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).\r\n",
      "RN   [11]\r\n",
      "RP   DISRUPTION PHENOTYPE, AND FUNCTION.\r\n",
      "RX   PubMed=17470788; DOI=10.1073/pnas.0701916104;\r\n",
      "RA   Li L., Deng B., Xing G., Teng Y., Tian C., Cheng X., Yin X., Yang J.,\r\n",
      "RA   Gao X., Zhu Y., Sun Q., Zhang L., Yang X., He F.;\r\n",
      "RT   \"PACT is a negative regulator of p53 and essential for cell growth and\r\n",
      "RT   embryonic development.\";\r\n",
      "RL   Proc. Natl. Acad. Sci. U.S.A. 104:7951-7956(2007).\r\n",
      "RN   [12]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1179 AND SER-1329, AND\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;\r\n",
      "RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,\r\n",
      "RA   Thibault P.;\r\n",
      "RT   \"The phagosomal proteome in interferon-gamma-activated macrophages.\";\r\n",
      "RL   Immunity 30:143-154(2009).\r\n",
      "RN   [13]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-361; THR-985; SER-1179;\r\n",
      "RP   SER-1278; SER-1329; SER-1648 AND SER-1651, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Lung, Pancreas,\r\n",
      "RC   Spleen, and Testis;\r\n",
      "RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;\r\n",
      "RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,\r\n",
      "RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;\r\n",
      "RT   \"A tissue-specific atlas of mouse protein phosphorylation and expression.\";\r\n",
      "RL   Cell 143:1174-1189(2010).\r\n",
      "RN   [14]\r\n",
      "RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-130, AND IDENTIFICATION BY MASS\r\n",
      "RP   SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RC   TISSUE=Embryonic fibroblast;\r\n",
      "RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;\r\n",
      "RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,\r\n",
      "RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;\r\n",
      "RT   \"SIRT5-mediated lysine desuccinylation impacts diverse metabolic\r\n",
      "RT   pathways.\";\r\n",
      "RL   Mol. Cell 50:919-930(2013).\r\n",
      "RN   [15]\r\n",
      "RP   FUNCTION.\r\n",
      "RX   PubMed=24726359; DOI=10.1016/j.celrep.2014.03.030;\r\n",
      "RA   Miotto B., Chibi M., Xie P., Koundrioukoff S., Moolman-Smook H., Pugh D.,\r\n",
      "RA   Debatisse M., He F., Zhang L., Defossez P.A.;\r\n",
      "RT   \"The RBBP6/ZBTB38/MCM10 axis regulates DNA replication and common fragile\r\n",
      "RT   site stability.\";\r\n",
      "RL   Cell Rep. 7:575-587(2014).\r\n",
      "CC   -!- FUNCTION: E3 ubiquitin-protein ligase which promotes ubiquitination of\r\n",
      "CC       YBX1, leading to its degradation by the proteasome (By similarity). May\r\n",
      "CC       play a role as a scaffold protein to promote the assembly of the\r\n",
      "CC       p53/TP53-MDM2 complex, resulting in increase of MDM2-mediated\r\n",
      "CC       ubiquitination and degradation of p53/TP53; may function as negative\r\n",
      "CC       regulator of p53/TP53, leading to both apoptosis and cell growth\r\n",
      "CC       retardation (PubMed:17470788). Regulates DNA-replication and common\r\n",
      "CC       fragile sites (CFS) stability in a ZBTB38- and MCM10-dependent manner.\r\n",
      "CC       Controls ZBTB38 protein stability and abundance via ubiquitination and\r\n",
      "CC       proteasomal degradation, and ZBTB38 in turn negatively regulates the\r\n",
      "CC       expression of MCM10 which plays an important role in DNA-replication\r\n",
      "CC       (PubMed:24726359). {ECO:0000250|UniProtKB:Q7Z6E9,\r\n",
      "CC       ECO:0000269|PubMed:17470788, ECO:0000269|PubMed:24726359}.\r\n",
      "CC   -!- CATALYTIC ACTIVITY:\r\n",
      "CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +\r\n",
      "CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-\r\n",
      "CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;\r\n",
      "CC         EC=2.3.2.27;\r\n",
      "CC   -!- PATHWAY: Protein modification; protein ubiquitination.\r\n",
      "CC   -!- SUBUNIT: Interacts with MDM2 and YBX1 (By similarity). Interacts also\r\n",
      "CC       with p53/TP53 and RB1. Interacts with NEK6 (By similarity). Interacts\r\n",
      "CC       with ZBTB38 (By similarity). {ECO:0000250|UniProtKB:Q7Z6E9,\r\n",
      "CC       ECO:0000269|PubMed:14566974, ECO:0000269|PubMed:9010216,\r\n",
      "CC       ECO:0000269|PubMed:9037032}.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus. Chromosome. Cytoplasm,\r\n",
      "CC       cytoskeleton, microtubule organizing center, centrosome {ECO:0000250}.\r\n",
      "CC       Note=Colocalizes with mitotic chromosomes. Co-localizes with NEK6 in\r\n",
      "CC       the centrosome (By similarity). {ECO:0000250}.\r\n",
      "CC   -!- ALTERNATIVE PRODUCTS:\r\n",
      "CC       Event=Alternative splicing; Named isoforms=3;\r\n",
      "CC       Name=1;\r\n",
      "CC         IsoId=P97868-1; Sequence=Displayed;\r\n",
      "CC       Name=2;\r\n",
      "CC         IsoId=P97868-2; Sequence=VSP_018287;\r\n",
      "CC       Name=3;\r\n",
      "CC         IsoId=P97868-3; Sequence=VSP_018285, VSP_018286;\r\n",
      "CC   -!- TISSUE SPECIFICITY: Highly expressed in testis. Expressed at lower\r\n",
      "CC       levels in brain, heart, kidney, liver, lung, skeletal muscle, spleen,\r\n",
      "CC       thymus and tongue. {ECO:0000269|PubMed:9010216,\r\n",
      "CC       ECO:0000269|PubMed:9037032}.\r\n",
      "CC   -!- DEVELOPMENTAL STAGE: Expression is reduced during terminal\r\n",
      "CC       differentiation. Expression is induced in the G2/M phase of the cell\r\n",
      "CC       cycle (at protein level). {ECO:0000269|PubMed:12064457,\r\n",
      "CC       ECO:0000269|PubMed:9037032}.\r\n",
      "CC   -!- DOMAIN: Contains a N-terminus DWNN domain, a zinc-finger domain and a\r\n",
      "CC       C4C4 zinc-binding RING finger domain (By similarity). The ring finger\r\n",
      "CC       may indeed be a U-box domain (By similarity).\r\n",
      "CC       {ECO:0000250|UniProtKB:Q7Z6E9}.\r\n",
      "CC   -!- PTM: Phosphorylated by NEK6. {ECO:0000250}.\r\n",
      "CC   -!- DISRUPTION PHENOTYPE: Early embryonic lethality before 7.5 dpc,\r\n",
      "CC       accompanied by accumulation of p53 and widespread apoptosis.\r\n",
      "CC       {ECO:0000269|PubMed:17470788}.\r\n",
      "CC   -!- SEQUENCE CAUTION:\r\n",
      "CC       Sequence=AAC72432.1; Type=Frameshift; Evidence={ECO:0000305};\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AK045635; BAC32441.1; -; mRNA.\r\n",
      "DR   EMBL; AK079129; BAC37553.1; -; mRNA.\r\n",
      "DR   EMBL; AK081261; BAC38179.1; -; mRNA.\r\n",
      "DR   EMBL; AK144758; BAE26051.1; -; mRNA.\r\n",
      "DR   EMBL; AK160656; BAE35944.1; -; mRNA.\r\n",
      "DR   EMBL; AK161231; BAE36255.1; -; mRNA.\r\n",
      "DR   EMBL; AC125221; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; BC025874; AAH25874.1; -; mRNA.\r\n",
      "DR   EMBL; U83913; AAC72432.1; ALT_FRAME; mRNA.\r\n",
      "DR   EMBL; U28789; AAB49620.1; -; mRNA.\r\n",
      "DR   CCDS; CCDS52387.1; -. [P97868-1]\r\n",
      "DR   PIR; T42727; T42727.\r\n",
      "DR   RefSeq; NP_035377.2; NM_011247.2. [P97868-1]\r\n",
      "DR   RefSeq; NP_778188.1; NM_175023.3.\r\n",
      "DR   RefSeq; XP_006507533.1; XM_006507470.3. [P97868-2]\r\n",
      "DR   AlphaFoldDB; P97868; -.\r\n",
      "DR   BMRB; P97868; -.\r\n",
      "DR   SMR; P97868; -.\r\n",
      "DR   BioGRID; 202817; 7.\r\n",
      "DR   IntAct; P97868; 2.\r\n",
      "DR   MINT; P97868; -.\r\n",
      "DR   STRING; 10090.ENSMUSP00000049528; -.\r\n",
      "DR   GlyGen; P97868; 1 site, 1 O-linked glycan (1 site).\r\n",
      "DR   iPTMnet; P97868; -.\r\n",
      "DR   PhosphoSitePlus; P97868; -.\r\n",
      "DR   EPD; P97868; -.\r\n",
      "DR   jPOST; P97868; -.\r\n",
      "DR   MaxQB; P97868; -.\r\n",
      "DR   PaxDb; P97868; -.\r\n",
      "DR   PeptideAtlas; P97868; -.\r\n",
      "DR   ProteomicsDB; 255114; -. [P97868-1]\r\n",
      "DR   ProteomicsDB; 255115; -. [P97868-2]\r\n",
      "DR   ProteomicsDB; 255116; -. [P97868-3]\r\n",
      "DR   Antibodypedia; 26070; 364 antibodies from 30 providers.\r\n",
      "DR   DNASU; 19647; -.\r\n",
      "DR   Ensembl; ENSMUST00000052135.14; ENSMUSP00000049528.8; ENSMUSG00000030779.17.\r\n",
      "DR   Ensembl; ENSMUST00000071590.6; ENSMUSP00000071519.6; ENSMUSG00000030779.17. [P97868-2]\r\n",
      "DR   GeneID; 19647; -.\r\n",
      "DR   KEGG; mmu:19647; -.\r\n",
      "DR   UCSC; uc009jow.2; mouse. [P97868-3]\r\n",
      "DR   UCSC; uc009joy.2; mouse. [P97868-1]\r\n",
      "DR   AGR; MGI:894835; -.\r\n",
      "DR   CTD; 5930; -.\r\n",
      "DR   MGI; MGI:894835; Rbbp6.\r\n",
      "DR   VEuPathDB; HostDB:ENSMUSG00000030779; -.\r\n",
      "DR   eggNOG; KOG0314; Eukaryota.\r\n",
      "DR   GeneTree; ENSGT00940000157561; -.\r\n",
      "DR   HOGENOM; CLU_239162_0_0_1; -.\r\n",
      "DR   InParanoid; P97868; -.\r\n",
      "DR   OMA; ECIRTFL; -.\r\n",
      "DR   OrthoDB; 150979at2759; -.\r\n",
      "DR   PhylomeDB; P97868; -.\r\n",
      "DR   TreeFam; TF350543; -.\r\n",
      "DR   Reactome; R-MMU-9013422; RHOBTB1 GTPase cycle.\r\n",
      "DR   Reactome; R-MMU-983168; Antigen processing: Ubiquitination & Proteasome degradation.\r\n",
      "DR   UniPathway; UPA00143; -.\r\n",
      "DR   BioGRID-ORCS; 19647; 27 hits in 76 CRISPR screens.\r\n",
      "DR   ChiTaRS; Rbbp6; mouse.\r\n",
      "DR   PRO; PR:P97868; -.\r\n",
      "DR   Proteomes; UP000000589; Chromosome 7.\r\n",
      "DR   RNAct; P97868; protein.\r\n",
      "DR   Bgee; ENSMUSG00000030779; Expressed in embryonic post-anal tail and 255 other tissues.\r\n",
      "DR   ExpressionAtlas; P97868; baseline and differential.\r\n",
      "DR   Genevisible; P97868; MM.\r\n",
      "DR   GO; GO:0005813; C:centrosome; ISO:MGI.\r\n",
      "DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.\r\n",
      "DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0016607; C:nuclear speck; ISO:MGI.\r\n",
      "DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.\r\n",
      "DR   GO; GO:0032991; C:protein-containing complex; ISO:MGI.\r\n",
      "DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.\r\n",
      "DR   GO; GO:0019901; F:protein kinase binding; ISO:MGI.\r\n",
      "DR   GO; GO:0061630; F:ubiquitin protein ligase activity; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.\r\n",
      "DR   GO; GO:0006974; P:DNA damage response; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0048568; P:embryonic organ development; IGI:MGI.\r\n",
      "DR   GO; GO:0001701; P:in utero embryonic development; IMP:MGI.\r\n",
      "DR   GO; GO:0006397; P:mRNA processing; IEA:InterPro.\r\n",
      "DR   GO; GO:0035264; P:multicellular organism growth; IMP:MGI.\r\n",
      "DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006275; P:regulation of DNA replication; ISS:UniProtKB.\r\n",
      "DR   GO; GO:0061053; P:somite development; IMP:MGI.\r\n",
      "DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB.\r\n",
      "DR   CDD; cd16620; vRING-HC-C4C4_RBBP6; 1.\r\n",
      "DR   Gene3D; 4.10.60.10; Zinc finger, CCHC-type; 1.\r\n",
      "DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.\r\n",
      "DR   InterPro; IPR014891; DWNN_domain.\r\n",
      "DR   InterPro; IPR033489; RBBP6.\r\n",
      "DR   InterPro; IPR003613; Ubox_domain.\r\n",
      "DR   InterPro; IPR025829; Zn_knuckle_CX2CX3GHX4C.\r\n",
      "DR   InterPro; IPR001878; Znf_CCHC.\r\n",
      "DR   InterPro; IPR036875; Znf_CCHC_sf.\r\n",
      "DR   InterPro; IPR001841; Znf_RING.\r\n",
      "DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.\r\n",
      "DR   PANTHER; PTHR15439:SF0; E3 UBIQUITIN-PROTEIN LIGASE RBBP6; 1.\r\n",
      "DR   PANTHER; PTHR15439; RETINOBLASTOMA-BINDING PROTEIN 6; 1.\r\n",
      "DR   Pfam; PF08783; DWNN; 1.\r\n",
      "DR   Pfam; PF04564; U-box; 1.\r\n",
      "DR   Pfam; PF13696; zf-CCHC_2; 1.\r\n",
      "DR   SMART; SM01180; DWNN; 1.\r\n",
      "DR   SMART; SM00184; RING; 1.\r\n",
      "DR   SMART; SM00343; ZnF_C2HC; 1.\r\n",
      "DR   SUPFAM; SSF57756; Retrovirus zinc finger-like domains; 1.\r\n",
      "DR   SUPFAM; SSF57850; RING/U-box; 1.\r\n",
      "DR   PROSITE; PS51282; DWNN; 1.\r\n",
      "DR   PROSITE; PS50158; ZF_CCHC; 1.\r\n",
      "DR   PROSITE; PS50089; ZF_RING_2; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Acetylation; Alternative splicing; Chromosome; Cytoplasm; Cytoskeleton;\r\n",
      "KW   DNA damage; DNA replication; Isopeptide bond; Metal-binding; Nucleus;\r\n",
      "KW   Phosphoprotein; Reference proteome; Transferase; Ubl conjugation;\r\n",
      "KW   Ubl conjugation pathway; Zinc; Zinc-finger.\r\n",
      "FT   CHAIN           1..1790\r\n",
      "FT                   /note=\"E3 ubiquitin-protein ligase RBBP6\"\r\n",
      "FT                   /id=\"PRO_0000234355\"\r\n",
      "FT   DOMAIN          4..76\r\n",
      "FT                   /note=\"DWNN\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00612\"\r\n",
      "FT   ZN_FING         160..177\r\n",
      "FT                   /note=\"CCHC-type\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00047\"\r\n",
      "FT   ZN_FING         260..301\r\n",
      "FT                   /note=\"RING-type; degenerate\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00175\"\r\n",
      "FT   REGION          329..353\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          374..408\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          533..599\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          622..641\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          648..667\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          675..797\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          850..1292\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          983..1139\r\n",
      "FT                   /note=\"Interaction with RB1\"\r\n",
      "FT   REGION          1322..1790\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1434..1544\r\n",
      "FT                   /note=\"Interaction with p53\"\r\n",
      "FT   COMPBIAS        335..352\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        554..599\r\n",
      "FT                   /note=\"Pro residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        687..730\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        736..767\r\n",
      "FT                   /note=\"Basic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        773..787\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        905..930\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        983..1030\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1037..1071\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1084..1165\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1175..1204\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1220..1234\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1235..1256\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1258..1280\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1336..1361\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1362..1436\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1449..1579\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1647..1674\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1675..1723\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1726..1750\r\n",
      "FT                   /note=\"Basic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1774..1790\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         130\r\n",
      "FT                   /note=\"N6-acetyllysine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:23806337\"\r\n",
      "FT   MOD_RES         245\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         246\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         247\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         248\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         361\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         517\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         769\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         771\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         773\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         781\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         816\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         862\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         874\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         958\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         985\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355,\r\n",
      "FT                   ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         1179\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355,\r\n",
      "FT                   ECO:0007744|PubMed:19144319, ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         1272\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355\"\r\n",
      "FT   MOD_RES         1278\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         1329\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:17242355,\r\n",
      "FT                   ECO:0007744|PubMed:19144319, ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         1342\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         1348\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         1469\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         1646\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   MOD_RES         1648\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   MOD_RES         1651\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:21183079\"\r\n",
      "FT   CROSSLNK        1107\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   CROSSLNK        1169\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q7Z6E9\"\r\n",
      "FT   VAR_SEQ         102..123\r\n",
      "FT                   /note=\"IDDASASISLAQLTKTANLAEA -> VCKNTITLFLHNCFYLYNVSVT (in\r\n",
      "FT                   isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334,\r\n",
      "FT                   ECO:0000303|PubMed:16141072\"\r\n",
      "FT                   /id=\"VSP_018285\"\r\n",
      "FT   VAR_SEQ         124..1756\r\n",
      "FT                   /note=\"Missing (in isoform 3)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:15489334,\r\n",
      "FT                   ECO:0000303|PubMed:16141072\"\r\n",
      "FT                   /id=\"VSP_018286\"\r\n",
      "FT   VAR_SEQ         653..686\r\n",
      "FT                   /note=\"Missing (in isoform 2)\"\r\n",
      "FT                   /evidence=\"ECO:0000303|PubMed:16141072,\r\n",
      "FT                   ECO:0000303|PubMed:9037032\"\r\n",
      "FT                   /id=\"VSP_018287\"\r\n",
      "FT   CONFLICT        254\r\n",
      "FT                   /note=\"I -> F (in Ref. 5; AAB49620)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        317..318\r\n",
      "FT                   /note=\"RQ -> GR (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        341\r\n",
      "FT                   /note=\"P -> H (in Ref. 5; AAB49620)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        418\r\n",
      "FT                   /note=\"S -> F (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        421\r\n",
      "FT                   /note=\"V -> S (in Ref. 5; AAB49620)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        580\r\n",
      "FT                   /note=\"P -> L (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        595\r\n",
      "FT                   /note=\"P -> T (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        615..622\r\n",
      "FT                   /note=\"PWVSSGVQ -> ACFSPGVP (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        629\r\n",
      "FT                   /note=\"I -> M (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        636\r\n",
      "FT                   /note=\"P -> L (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        647\r\n",
      "FT                   /note=\"R -> K (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        689\r\n",
      "FT                   /note=\"S -> F (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        703\r\n",
      "FT                   /note=\"Y -> D (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        789\r\n",
      "FT                   /note=\"Q -> R (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        940\r\n",
      "FT                   /note=\"R -> Q (in Ref. 1; BAE36255)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        941\r\n",
      "FT                   /note=\"R -> RNEE (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        956..958\r\n",
      "FT                   /note=\"ETS -> GKF (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        963\r\n",
      "FT                   /note=\"E -> G (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        978\r\n",
      "FT                   /note=\"L -> F (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        982\r\n",
      "FT                   /note=\"D -> E (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1012\r\n",
      "FT                   /note=\"K -> N (in Ref. 5; AAB49620)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1290\r\n",
      "FT                   /note=\"K -> T (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1316\r\n",
      "FT                   /note=\"Q -> H (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1564\r\n",
      "FT                   /note=\"N -> I (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1581\r\n",
      "FT                   /note=\"E -> D (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1591\r\n",
      "FT                   /note=\"P -> L (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1596\r\n",
      "FT                   /note=\"P -> L (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   CONFLICT        1604\r\n",
      "FT                   /note=\"A -> V (in Ref. 4; AAC72432)\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "SQ   SEQUENCE   1790 AA;  199587 MW;  3909C30EB9DD2CE3 CRC64;\r\n",
      "     MSCVHYKFSS KLNYDTVTFD GLHISLCDLK KQIMGREKLK AADSDLQITN AQTKEEYTDD\r\n",
      "     NALIPKNSSV IVRRIPIGGV KSTSKTYVIS RTEPVMGTTK AIDDASASIS LAQLTKTANL\r\n",
      "     AEANASEEDK IKAMMSQSGH EYDPINYMKK TLVGPPPPSY TCFRCGKPGH YIKNCPTNGD\r\n",
      "     KNFESGPRIK KSTGIPRSFM MEVKDPNMKG AMLTNTGKYA IPTIDAEAYA IGKKEKPPFL\r\n",
      "     PEEPSSSSEE DDPIPDELLC LICKDIMTDA VVIPCCGNSY CDECIRTALL ESDEHTCPTC\r\n",
      "     HQNDVSPDAL IANKFLRQAV NNFKNETGYT KRLRKQLPPP PPPVPPPRPL MQRNLQPLMR\r\n",
      "     SPISRQQDPL MIPVTSSSAH SAPSISSLTS NPSALAPSVS GNPSSAPAPV PDITATVSIS\r\n",
      "     VHSEKSDGPF RDSDNKLLPA AALTSEHSKG ASSIAITALM EEKGYQVPVL GTPSLLGQSL\r\n",
      "     LHGQLIPTTG PVRINAARPG GGRPGWEHSN KLGYLVSPPQ QIRRGERSCY RSINRGRHHS\r\n",
      "     ERSQRTQGPS LPATPVFVPV PPPPLYPPPP HTLPLPPGVP PPQFSPQFPP GQPPPAGYSV\r\n",
      "     PPPGFPPAPA NISTPWVSSG VQTAHSNTIP TTQAPPLSRE EFYREQRRLK EEEKKKSKLD\r\n",
      "     EFTNDFAKEL MEYKKIQKER RRSFSRSKSP YSGSSYSRSS YTYSKSRSGS TRSRSYSRSF\r\n",
      "     SRSHSRSYSR SPPYPRRGRG KSRNYRSRSR SHGYHRSRSR SPPYRRYHSR SRSPQAFRGQ\r\n",
      "     SPTKRNVPQG ETEREYFNRY REVPPPYDIK AYYGRSVDFR DPFEKERYRE WERKYREWYE\r\n",
      "     KYYKGYAVGA QPRPSANRED FSPERLLPLN IRNSPFTRGR REDYAAGQSH RNRNLGGNYP\r\n",
      "     EKLSTRDSHN AKDNPKSKEK ESENVPGDGK GNKHKKHRKR RKGEESESFL NPELLETSRK\r\n",
      "     CRESSGIDET KTDTLFVLPS RDDATPVRDE PMDAESITFK SVSDKDKREK DKPKVKSDKT\r\n",
      "     KRKSDGSATA KKDNVLKPSK GPQEKVDGDR EKSPRSEPPL KKAKEEATKI DSVKPSSSSQ\r\n",
      "     KDEKVTGTPR KAHSKSAKEH QEAKPAKDEK VKKDCSKDIK SEKPASKDEK AKKPEKNKLL\r\n",
      "     DSKGEKRKRK TEEKSVDKDF ESSSMKISKV EGTEIVKPSP KRKMEGDVEK LERTPEKDKI\r\n",
      "     ASSTTPAKKI KLNRETGKKI GNAENASTTK EPSEKLESTS SKIKQEKVKG KAKRKVAGSE\r\n",
      "     GSSSTLVDYT STSSTGGSPV RKSEEKTDTK RTVIKTMEEY NNDNTAPAED VIIMIQVPQS\r\n",
      "     KWDKDDFESE EEDVKTTQPI QSVGKPSSII KNVTTKPSAT AKYTEKESEQ PEKLQKLPKE\r\n",
      "     ASHELMQHEL RSSKGSASSE KGRAKDREHS GSEKDNPDKR KSGAQPDKES TVDRLSEQGH\r\n",
      "     FKTLSQSSKE TRTSEKHESV RGSSNKDFTP GRDKKVDYDS RDYSSSKRRD ERGELARRKD\r\n",
      "     SPPRGKESLS GQKSKLREER DLPKKGAESK KSNSSPPRDK KPHDHKAPYE TKRPCEETKP\r\n",
      "     VDKNSGKERE KHAAEARNGK ESSGGKLPCI PNPPDPPMEK ELAAGQVEKS AVKPKPQLSH\r\n",
      "     SSRLSSDLTR ETDEAAFEPD YNESDSESNV SVKEEEAVAS ISKDLKEKTT EKAKESLTVA\r\n",
      "     TASQPGADRS QSQSSPSVSP SRSHSPSGSQ TRSHSSSASS AGSQDSKKKK KKKEKKKHKK\r\n",
      "     HKKHKKHKKH AGADGDVEKS QKHKHKKKKA KKNKDKEKEK DDQKVRSVTV\r\n",
      "//\r\n",
      "ID   RBL1_RAT                Reviewed;        1049 AA.\r\n",
      "AC   D3ZS28;\r\n",
      "DT   31-JUL-2019, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   31-JUL-2019, sequence version 4.\r\n",
      "DT   03-MAY-2023, entry version 91.\r\n",
      "DE   RecName: Full=Retinoblastoma-like protein 1 {ECO:0000305};\r\n",
      "DE   AltName: Full=107 kDa retinoblastoma-associated protein {ECO:0000305};\r\n",
      "DE            Short=p107 {ECO:0000305};\r\n",
      "DE   AltName: Full=pRb1 {ECO:0000305};\r\n",
      "GN   Name=Rbl1 {ECO:0000312|RGD:1595511};\r\n",
      "OS   Rattus norvegicus (Rat).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Rattus.\r\n",
      "OX   NCBI_TaxID=10116 {ECO:0000312|Proteomes:UP000002494};\r\n",
      "RN   [1] {ECO:0000312|Proteomes:UP000002494}\r\n",
      "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\r\n",
      "RC   STRAIN=Brown Norway {ECO:0000312|Proteomes:UP000002494};\r\n",
      "RX   PubMed=15057822; DOI=10.1038/nature02426;\r\n",
      "RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,\r\n",
      "RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,\r\n",
      "RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,\r\n",
      "RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,\r\n",
      "RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,\r\n",
      "RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,\r\n",
      "RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,\r\n",
      "RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,\r\n",
      "RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,\r\n",
      "RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,\r\n",
      "RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,\r\n",
      "RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,\r\n",
      "RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,\r\n",
      "RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,\r\n",
      "RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,\r\n",
      "RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,\r\n",
      "RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,\r\n",
      "RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,\r\n",
      "RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,\r\n",
      "RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,\r\n",
      "RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,\r\n",
      "RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,\r\n",
      "RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,\r\n",
      "RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,\r\n",
      "RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,\r\n",
      "RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,\r\n",
      "RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,\r\n",
      "RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,\r\n",
      "RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,\r\n",
      "RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,\r\n",
      "RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,\r\n",
      "RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,\r\n",
      "RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,\r\n",
      "RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,\r\n",
      "RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,\r\n",
      "RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,\r\n",
      "RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,\r\n",
      "RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,\r\n",
      "RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,\r\n",
      "RA   Mockrin S., Collins F.S.;\r\n",
      "RT   \"Genome sequence of the Brown Norway rat yields insights into mammalian\r\n",
      "RT   evolution.\";\r\n",
      "RL   Nature 428:493-521(2004).\r\n",
      "RN   [2] {ECO:0000305}\r\n",
      "RP   INTERACTION WITH RBBP9.\r\n",
      "RX   PubMed=9697699; DOI=10.1038/1258;\r\n",
      "RA   Woitach J.T., Zhang M., Niu C.-H., Thorgeirsson S.S.;\r\n",
      "RT   \"A retinoblastoma-binding protein that affects cell-cycle control and\r\n",
      "RT   confers transforming ability.\";\r\n",
      "RL   Nat. Genet. 19:371-374(1998).\r\n",
      "RN   [3] {ECO:0007744|PubMed:22673903}\r\n",
      "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=22673903; DOI=10.1038/ncomms1871;\r\n",
      "RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,\r\n",
      "RA   Olsen J.V.;\r\n",
      "RT   \"Quantitative maps of protein phosphorylation sites across 14 different rat\r\n",
      "RT   organs and tissues.\";\r\n",
      "RL   Nat. Commun. 3:876-876(2012).\r\n",
      "CC   -!- FUNCTION: Key regulator of entry into cell division (By similarity).\r\n",
      "CC       Directly involved in heterochromatin formation by maintaining overall\r\n",
      "CC       chromatin structure and, in particular, that of constitutive\r\n",
      "CC       heterochromatin by stabilizing histone methylation. Recruits and\r\n",
      "CC       targets histone methyltransferases KMT5B and KMT5C, leading to\r\n",
      "CC       epigenetic transcriptional repression. Controls histone H4 'Lys-20'\r\n",
      "CC       trimethylation. Probably acts as a transcription repressor by\r\n",
      "CC       recruiting chromatin-modifying enzymes to promoters (By similarity).\r\n",
      "CC       Potent inhibitor of E2F-mediated trans-activation. May act as a tumor\r\n",
      "CC       suppressor (By similarity). {ECO:0000250|UniProtKB:P28749,\r\n",
      "CC       ECO:0000250|UniProtKB:Q64701}.\r\n",
      "CC   -!- SUBUNIT: Component of the DREAM complex (also named LINC complex) at\r\n",
      "CC       least composed of E2F4, E2F5, LIN9, LIN37, LIN52, LIN54, MYBL1, MYBL2,\r\n",
      "CC       RBL1, RBL2, RBBP4, TFDP1 and TFDP2. The complex exists in quiescent\r\n",
      "CC       cells where it represses cell cycle-dependent genes. It dissociates in\r\n",
      "CC       S phase when LIN9, LIN37, LIN52 and LIN54 form a subcomplex that binds\r\n",
      "CC       to MYBL2. Interacts with AATF. Interacts with KDM5A (By similarity).\r\n",
      "CC       Interacts with KMT5B and KMT5C. Interacts with USP4 (By similarity).\r\n",
      "CC       Interacts with RBBP9 (PubMed:9697699). {ECO:0000250|UniProtKB:P28749,\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CC       ECO:0000250|UniProtKB:Q64701, ECO:0000269|PubMed:9697699}.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.\r\n",
      "CC   -!- PTM: Cell-cycle arrest properties are inactivated by phosphorylation on\r\n",
      "CC       Thr-332, Ser-640, Ser-959 and Ser-970 by CDK4.\r\n",
      "CC       {ECO:0000250|UniProtKB:P28749}.\r\n",
      "CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.\r\n",
      "CC       {ECO:0000305}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AABR07054428; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   EMBL; AABR07054429; -; NOT_ANNOTATED_CDS; Genomic_DNA.\r\n",
      "DR   RefSeq; NP_001177995.1; NM_001191066.1.\r\n",
      "DR   AlphaFoldDB; D3ZS28; -.\r\n",
      "DR   SMR; D3ZS28; -.\r\n",
      "DR   MINT; D3ZS28; -.\r\n",
      "DR   STRING; 10116.ENSRNOP00000063017; -.\r\n",
      "DR   PaxDb; D3ZS28; -.\r\n",
      "DR   GeneID; 680111; -.\r\n",
      "DR   KEGG; rno:680111; -.\r\n",
      "DR   AGR; RGD:1595511; -.\r\n",
      "DR   CTD; 5933; -.\r\n",
      "DR   RGD; 1595511; Rbl1.\r\n",
      "DR   eggNOG; KOG1010; Eukaryota.\r\n",
      "DR   HOGENOM; CLU_008943_0_1_1; -.\r\n",
      "DR   InParanoid; D3ZS28; -.\r\n",
      "DR   OrthoDB; 519973at2759; -.\r\n",
      "DR   TreeFam; TF105568; -.\r\n",
      "DR   Reactome; R-RNO-1538133; G0 and Early G1.\r\n",
      "DR   Reactome; R-RNO-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.\r\n",
      "DR   Reactome; R-RNO-69231; Cyclin D associated events in G1.\r\n",
      "DR   PRO; PR:D3ZS28; -.\r\n",
      "DR   Proteomes; UP000002494; Unplaced.\r\n",
      "DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.\r\n",
      "DR   GO; GO:0005634; C:nucleus; ISO:RGD.\r\n",
      "DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.\r\n",
      "DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:RGD.\r\n",
      "DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.\r\n",
      "DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.\r\n",
      "DR   GO; GO:2000773; P:negative regulation of cellular senescence; ISO:RGD.\r\n",
      "DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.\r\n",
      "DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.\r\n",
      "DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.\r\n",
      "DR   GO; GO:0043550; P:regulation of lipid kinase activity; ISO:RGD.\r\n",
      "DR   CDD; cd20605; CYCLIN_RBL1; 1.\r\n",
      "DR   Gene3D; 1.10.472.140; -; 1.\r\n",
      "DR   Gene3D; 1.10.472.10; Cyclin-like; 3.\r\n",
      "DR   InterPro; IPR013763; Cyclin-like_dom.\r\n",
      "DR   InterPro; IPR036915; Cyclin-like_sf.\r\n",
      "DR   InterPro; IPR002720; RB_A.\r\n",
      "DR   InterPro; IPR002719; RB_B.\r\n",
      "DR   InterPro; IPR015030; RB_C.\r\n",
      "DR   InterPro; IPR028309; RB_fam.\r\n",
      "DR   InterPro; IPR024599; RB_N.\r\n",
      "DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.\r\n",
      "DR   PANTHER; PTHR13742:SF20; RETINOBLASTOMA-LIKE PROTEIN 1; 1.\r\n",
      "DR   Pfam; PF11934; DUF3452; 1.\r\n",
      "DR   Pfam; PF01858; RB_A; 1.\r\n",
      "DR   Pfam; PF01857; RB_B; 1.\r\n",
      "DR   SMART; SM00385; CYCLIN; 1.\r\n",
      "DR   SMART; SM01367; DUF3452; 1.\r\n",
      "DR   SMART; SM01368; RB_A; 1.\r\n",
      "DR   SMART; SM01369; Rb_C; 1.\r\n",
      "DR   SUPFAM; SSF47954; Cyclin-like; 2.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Cell cycle; Chromatin regulator; Nucleus; Phosphoprotein;\r\n",
      "KW   Reference proteome; Repressor; Transcription; Transcription regulation;\r\n",
      "KW   Tumor suppressor.\r\n",
      "FT   CHAIN           1..1049\r\n",
      "FT                   /note=\"Retinoblastoma-like protein 1\"\r\n",
      "FT                   /id=\"PRO_0000447676\"\r\n",
      "FT   REGION          385..944\r\n",
      "FT                   /note=\"Pocket; binds T and E1A\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   REGION          385..584\r\n",
      "FT                   /note=\"Domain A\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   REGION          585..779\r\n",
      "FT                   /note=\"Spacer\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   REGION          780..944\r\n",
      "FT                   /note=\"Domain B\"\r\n",
      "FT                   /evidence=\"ECO:0000305\"\r\n",
      "FT   MOD_RES         332\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         369\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         385\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         640\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         650\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         748\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         761\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         959\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         970\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         983\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         992\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         1004\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "FT   MOD_RES         1022\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:P28749\"\r\n",
      "SQ   SEQUENCE   1049 AA;  117818 MW;  68F2C046818BB277 CRC64;\r\n",
      "     MFEDEPHAEG AAAVAAAREA LQALCQELNL DEGSAAEALD DFTAIRGNYS LEGEVIHWLA\r\n",
      "     CSLYVACRKS IIPTVGKGVM EGNCVSLTRI LRSAKLSLIQ FFSKMKKWMD MSNLPQEFRE\r\n",
      "     RIERLERNFE VSTVIFKKFE PIFLDIFQNP YEELPKLPRS RKQRRIPCSV KDLFNFCWTL\r\n",
      "     FVYTKGNFRM IGDDLVNSYH LLLCCLDLIF ANAIMCPNRR DLLNPSFKGL PSDFHAVNFK\r\n",
      "     AAEEPPCIIA VLCDLHDGLL VEAKGIKEHY FKPYISKLFD KKILKGECLL DLSSFTDNSK\r\n",
      "     AVNKEYEEYV LTVGDFDERI FLGADAEEEI GTPRKFAADT QFGKLTSQAS VDCNLQQHFE\r\n",
      "     KKRSFAPSTP LTGRRYLQEK EAVTTPVASA TQSVSRLQSI VAGLKSAPSE QLLTIFESCM\r\n",
      "     RNPMGNIVKI VKGIGETFCQ HYTQSTDKQP GSHIDFAVNR LKLAEILYYK ILETIMVQET\r\n",
      "     RRLHGMDMSV LLEQDIFHRS LLACCLEIVL FAYSSPRTFP WIIDVLGLQP FYFYKVIEVV\r\n",
      "     IRSEEGLSRD MVKHLNSIEE QILESLAWTN NSALWEALRA SANKVPSCEE VIFPNNFEIG\r\n",
      "     NGGSVQGHLP MMPMSPIIHP RVKEVRTDSG SLRKDMQPLS PISVHERYSS PAAGSAKRRL\r\n",
      "     FGDDPPKETL MEKIMAEGTQ LKIAPSSVTA ESLSISPGQA LLTMATTTVT GTTGRKVTVP\r\n",
      "     LHGIANDAGE ITLVPISMNT TQDSTAESLV SLTAQSLIGA SPKQTHLTKT QDAPLTGISK\r\n",
      "     PKRTGSLALF YRKVYHLASV RLRDLCLKLD VSNELRRKIW TCFEFTLVHC PDLMKDRHLD\r\n",
      "     QLLLCAFYIM AKVTKEERTF QEIMKSYRNQ PQANSHVYRS VLLKSIPGEV VAYNGDYEMT\r\n",
      "     DGDIEDATKT PNCSSEPVKE ERGDLIKFYN AIYVGRVKSF ALKYDLSNQD HIMDAPPLSP\r\n",
      "     FPHIKQQPGS PRRISQQHSI YVSPHKNASG LTPRSALLYK FNGSPSKKAK KRVIAISGDA\r\n",
      "     ESPAKRLCQE NDDVLLKRLQ DVVSERANH\r\n",
      "//\r\n",
      "ID   ARI4B_RAT               Reviewed;        1228 AA.\r\n",
      "AC   Q9JKB5;\r\n",
      "DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.\r\n",
      "DT   01-OCT-2000, sequence version 1.\r\n",
      "DT   03-MAY-2023, entry version 114.\r\n",
      "DE   RecName: Full=AT-rich interactive domain-containing protein 4B;\r\n",
      "DE            Short=ARID domain-containing protein 4B;\r\n",
      "DE   AltName: Full=180 kDa Sin3-associated polypeptide;\r\n",
      "DE            Short=Sin3-associated polypeptide p180;\r\n",
      "DE   AltName: Full=Histone deacetylase complex subunit SAP180;\r\n",
      "DE   AltName: Full=Retinoblastoma-binding protein 1-like 1;\r\n",
      "GN   Name=Arid4b; Synonyms=Rbbp1l1, Sap180;\r\n",
      "OS   Rattus norvegicus (Rat).\r\n",
      "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\n",
      "OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;\r\n",
      "OC   Murinae; Rattus.\r\n",
      "OX   NCBI_TaxID=10116;\r\n",
      "RN   [1]\r\n",
      "RP   NUCLEOTIDE SEQUENCE [MRNA].\r\n",
      "RA   Kholodilov N.G., Neystat M., Burke R.E.;\r\n",
      "RT   \"Upregulation of rat homolog of human retinoblastoma-binding protein\r\n",
      "RT   (RBBP1) in substantia nigra following developmental striatal target\r\n",
      "RT   injury.\";\r\n",
      "RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.\r\n",
      "RN   [2]\r\n",
      "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-295; SER-296; SER-581;\r\n",
      "RP   SER-588; SER-703 AND THR-706, AND IDENTIFICATION BY MASS SPECTROMETRY\r\n",
      "RP   [LARGE SCALE ANALYSIS].\r\n",
      "RX   PubMed=22673903; DOI=10.1038/ncomms1871;\r\n",
      "RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,\r\n",
      "RA   Olsen J.V.;\r\n",
      "RT   \"Quantitative maps of protein phosphorylation sites across 14 different rat\r\n",
      "RT   organs and tissues.\";\r\n",
      "RL   Nat. Commun. 3:876-876(2012).\r\n",
      "CC   -!- FUNCTION: Acts as a transcriptional repressor. May function in the\r\n",
      "CC       assembly and/or enzymatic activity of the Sin3A corepressor complex or\r\n",
      "CC       in mediating interactions between the complex and other regulatory\r\n",
      "CC       complexes.Plays a role in the regulation of epigenetic modifications at\r\n",
      "CC       the PWS/AS imprinting center near the SNRPN promoter, where it might\r\n",
      "CC       function as part of a complex with RB1 and ARID4A. Involved in\r\n",
      "CC       spermatogenesis, together with ARID4A, where it functions as a\r\n",
      "CC       transcriptional coactivator for AR (androgen receptor) and enhances\r\n",
      "CC       expression of genes required for sperm maturation. Regulates expression\r\n",
      "CC       of the tight junction protein CLDN3 in the testis, which is important\r\n",
      "CC       for integrity of the blood-testis barrier. Plays a role in myeloid\r\n",
      "CC       homeostasis where it regulates the histone methylation state of bone\r\n",
      "CC       marrow cells and expression of various genes involved in hematopoiesis.\r\n",
      "CC       May function as a leukemia suppressor. {ECO:0000250|UniProtKB:A2CG63,\r\n",
      "CC       ECO:0000250|UniProtKB:Q4LE39}.\r\n",
      "CC   -!- SUBUNIT: Component of a Sin3A corepressor complex consisting of SIN3A,\r\n",
      "CC       SAP130, SUDS3/SAP45, SAP180, HDAC1 and HDAC2. Interacts with ARID4A (By\r\n",
      "CC       similarity). Interacts with AR (By similarity).\r\n",
      "CC       {ECO:0000250|UniProtKB:A2CG63, ECO:0000250|UniProtKB:Q4LE39}.\r\n",
      "CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355}.\r\n",
      "CC   -!- DOMAIN: The C-terminus mediates interaction with mSin3A corepressor\r\n",
      "CC       complex. {ECO:0000250|UniProtKB:Q4LE39}.\r\n",
      "CC   -!- DOMAIN: The N-terminus is involved in transcriptional repression by\r\n",
      "CC       HDAC-independent mechanisms. {ECO:0000250|UniProtKB:Q4LE39}.\r\n",
      "CC   -!- DOMAIN: The ARID domain is involved in stabilizing the mSin3A\r\n",
      "CC       corepressor complex on DNA. {ECO:0000250|UniProtKB:Q4LE39}.\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\r\n",
      "CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\r\n",
      "CC   ---------------------------------------------------------------------------\r\n",
      "DR   EMBL; AF245512; AAF61271.1; -; mRNA.\r\n",
      "DR   RefSeq; NP_445873.1; NM_053421.1.\r\n",
      "DR   AlphaFoldDB; Q9JKB5; -.\r\n",
      "DR   SMR; Q9JKB5; -.\r\n",
      "DR   STRING; 10116.ENSRNOP00000010836; -.\r\n",
      "DR   iPTMnet; Q9JKB5; -.\r\n",
      "DR   PhosphoSitePlus; Q9JKB5; -.\r\n",
      "DR   PaxDb; Q9JKB5; -.\r\n",
      "DR   GeneID; 84481; -.\r\n",
      "DR   KEGG; rno:84481; -.\r\n",
      "DR   UCSC; RGD:619919; rat.\r\n",
      "DR   AGR; RGD:619919; -.\r\n",
      "DR   CTD; 51742; -.\r\n",
      "DR   RGD; 619919; Arid4b.\r\n",
      "DR   eggNOG; KOG2744; Eukaryota.\r\n",
      "DR   eggNOG; KOG3001; Eukaryota.\r\n",
      "DR   InParanoid; Q9JKB5; -.\r\n",
      "DR   OrthoDB; 445024at2759; -.\r\n",
      "DR   PhylomeDB; Q9JKB5; -.\r\n",
      "DR   Reactome; R-RNO-3214815; HDACs deacetylate histones.\r\n",
      "DR   PRO; PR:Q9JKB5; -.\r\n",
      "DR   Proteomes; UP000002494; Unplaced.\r\n",
      "DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.\r\n",
      "DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IBA:GO_Central.\r\n",
      "DR   GO; GO:0097368; P:establishment of Sertoli cell barrier; ISO:RGD.\r\n",
      "DR   GO; GO:0036124; P:histone H3-K9 trimethylation; ISO:RGD.\r\n",
      "DR   GO; GO:0034773; P:histone H4-K20 trimethylation; ISO:RGD.\r\n",
      "DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.\r\n",
      "DR   GO; GO:0006349; P:regulation of gene expression by genomic imprinting; ISO:RGD.\r\n",
      "DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.\r\n",
      "DR   GO; GO:0007283; P:spermatogenesis; ISO:RGD.\r\n",
      "DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.\r\n",
      "DR   CDD; cd16883; ARID_ARID4B; 1.\r\n",
      "DR   CDD; cd20460; Tudor_ARID4B_rpt1; 1.\r\n",
      "DR   CDD; cd20462; Tudor_ARID4B_rpt2; 1.\r\n",
      "DR   Gene3D; 2.30.30.140; -; 2.\r\n",
      "DR   Gene3D; 1.10.150.60; ARID DNA-binding domain; 1.\r\n",
      "DR   InterPro; IPR012603; ARID4A/B_PWWP.\r\n",
      "DR   InterPro; IPR028853; ARID4B_ARID/BRIGHT.\r\n",
      "DR   InterPro; IPR001606; ARID_dom.\r\n",
      "DR   InterPro; IPR036431; ARID_dom_sf.\r\n",
      "DR   InterPro; IPR002999; Tudor.\r\n",
      "DR   InterPro; IPR047476; Tudor_ARID4B_rpt1.\r\n",
      "DR   InterPro; IPR047474; Tudor_ARID4B_rpt2.\r\n",
      "DR   PANTHER; PTHR13964:SF24; AT-RICH INTERACTIVE DOMAIN-CONTAINING PROTEIN 4B; 1.\r\n",
      "DR   PANTHER; PTHR13964; RBP-RELATED; 1.\r\n",
      "DR   Pfam; PF01388; ARID; 1.\r\n",
      "DR   Pfam; PF08169; RBB1NT; 1.\r\n",
      "DR   SMART; SM01014; ARID; 1.\r\n",
      "DR   SMART; SM00501; BRIGHT; 1.\r\n",
      "DR   SMART; SM00333; TUDOR; 1.\r\n",
      "DR   SUPFAM; SSF46774; ARID-like; 1.\r\n",
      "DR   SUPFAM; SSF63748; Tudor/PWWP/MBT; 1.\r\n",
      "DR   PROSITE; PS51011; ARID; 1.\r\n",
      "PE   1: Evidence at protein level;\r\n",
      "KW   Chromatin regulator; Coiled coil; DNA-binding; Isopeptide bond; Nucleus;\r\n",
      "KW   Phosphoprotein; Reference proteome; Transcription;\r\n",
      "KW   Transcription regulation; Ubl conjugation.\r\n",
      "FT   CHAIN           1..1228\r\n",
      "FT                   /note=\"AT-rich interactive domain-containing protein 4B\"\r\n",
      "FT                   /id=\"PRO_0000282865\"\r\n",
      "FT   DOMAIN          306..398\r\n",
      "FT                   /note=\"ARID\"\r\n",
      "FT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00355\"\r\n",
      "FT   REGION          123..167\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          266..307\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          437..466\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          479..525\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          539..606\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          620..802\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          825..1129\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   REGION          1168..1204\r\n",
      "FT                   /note=\"Disordered\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COILED          1141..1186\r\n",
      "FT                   /evidence=\"ECO:0000255\"\r\n",
      "FT   COMPBIAS        144..167\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        274..306\r\n",
      "FT                   /note=\"Acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        487..509\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        558..573\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        637..663\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        711..735\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        739..754\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        777..802\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        825..843\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        908..923\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        925..969\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        995..1023\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1060..1104\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1110..1126\r\n",
      "FT                   /note=\"Basic and acidic residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   COMPBIAS        1189..1204\r\n",
      "FT                   /note=\"Polar residues\"\r\n",
      "FT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\r\n",
      "FT   MOD_RES         276\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         295\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         296\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         482\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         579\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         581\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         588\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         630\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         691\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         703\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         706\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0007744|PubMed:22673903\"\r\n",
      "FT   MOD_RES         930\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         942\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         945\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         1066\r\n",
      "FT                   /note=\"Phosphothreonine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         1068\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         1069\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         1071\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   MOD_RES         1075\r\n",
      "FT                   /note=\"Phosphoserine\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   CROSSLNK        428\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   CROSSLNK        461\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "FT   CROSSLNK        664\r\n",
      "FT                   /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain with\r\n",
      "FT                   G-Cter in SUMO2)\"\r\n",
      "FT                   /evidence=\"ECO:0000250|UniProtKB:Q4LE39\"\r\n",
      "SQ   SEQUENCE   1228 AA;  137080 MW;  DE50F198D9E46C6C CRC64;\r\n",
      "     MKALDEPPYL TVGTDVSAKY RGAFCEAKIK TAKRLVKVKV TFRHDSSTVE VQDDHIKGPL\r\n",
      "     KVGAIVEVKN LDGAYQEAVI NKLTDASWYT VVFDDGDEKT LRRSSLCLKG ERHFAESETL\r\n",
      "     DQLPLTNPEH FGTPVIGKKT NRGRRSNHIP EEESSSSSSD DDEDDRKQTD ELLGKVVCVD\r\n",
      "     YISLDKKKAL WFPALVVCPD CSDEIAVKKD NILVRSFKDG KFTSVPRKDV HEITSDTAPK\r\n",
      "     PDAVLKQAFD QALEFHKSRT IPANWKTELK EDSSSSEAEE EEEEEDDEKE KEDNSSEEEE\r\n",
      "     EIEPFPEERE NFLQQLYKFM EDRGTPINKR PVLGYRNLNL FKLFRLVHKL GGFDNIESGA\r\n",
      "     VWKQVYQDLG IPVLNSAAGY NVKCAYKKYL YGFEEYCRSA NIDFQMALPE KVLNKPCKDC\r\n",
      "     ENKEIKVKEE SDAEIKEVNV EDSKNMIPKE ETPAEDESER KENIKPSLGS KKGLLECIPA\r\n",
      "     QSDQEKEANI TKLEEKESLE DKDGATARAE EALSTEVDAE EEQARSGYDE WIKADKIVRP\r\n",
      "     ADKNVPKIKH RKKIKNKLDK EKDRDEKYSP KNCKLRRLSK SPFQSNPSPE MVSKLDLADA\r\n",
      "     KNSDTGHIKS IEITSILNGL QASESSAEDS EQEEERCAQD PESSSKDESK VEHSAHSRSE\r\n",
      "     LISKEELSSP SLLEENKVHP DLVIAKTVSK SPERLRKDVE AISEDTDFEE EDEITKKRKD\r\n",
      "     VKKDTTDKAL KPQTKTWGKD RYCIQTNCLQ SGSPGKKEDR TKSKEPLCTG NSSNSSSDED\r\n",
      "     EEEKSKAKMT PTKKYNGLEE KRKSLRTTSF YSGFSEVAEK RIKLLNNSDE RLQNNRAKDR\r\n",
      "     KDVWSSIQGQ WPKKTLKELF SDSDTEAAAS PPHAAPDEGT VEESLQTVAE EESCSPNMEL\r\n",
      "     EKPLPTSVDS KPVEEKPLEV SDRKTEFPSS GSNSVLNTPP TTPESPSSVT VTETSQQQSS\r\n",
      "     VTVSVPLPPN QEEVRSIKSE TDSTIEVDSV VGELQDLQSE GNSSPAGFNA SVSSSSSNQP\r\n",
      "     EPEHPEKACT GQKRVKDTQG VGSSSKKQKR SHKATVVNNK KKGKGTNSSD SEDLSAGESV\r\n",
      "     TKTQAIKSVP TGMKTHNSKS PARIQSPGKC GKNGDKDPDL KEPSNRLPKV YKWSFQMSDL\r\n",
      "     ENMTSAERIS ILQEKLQEIR KHYLSLKSEV ASIDRRRKRL KKKERESAAT SSSSSSPSSS\r\n",
      "     SITAAVMLTL AEPSMSSASQ NGMSVECR\r\n",
      "//\r\n"
     ]
    }
   ],
   "source": [
    "!curl -H \"Accept: text/plain; format=flatfile\" \"https://rest.uniprot.org/uniprotkb/search?query=(reviewed:true)%20AND%20(protein_name:Retinoblastoma-associated%20protein)&fields=accession\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "b5061b76",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\x1f\\x08\\x00\\x00\\x00\\x00\\x00\\x00\\x00io0W\\x08\\x03/N\\x02X\\n%\\x15\\x16eg<\\x17\\x01%\\x12\\x12\\x19ImMYJ\\\\<3(5k\\\\\\x05N\\x18/`3W;\\x0cS\\x02u93\\r\\x12~j\\x1d+;\\x13KCQd\\x03~\\x0bv\\x7f\\x11L#~U\\x1bw\\x0fz_h\\t]}\\tW\\x7f^_\\x14I{\\x06}*]mC#\\x02\\x19\\x7f\\x1e dNkv\\x0b!\\x04\\x0bxiy~dG\\x00z\\x06mX;\\x17\\x12x\\x7f7u\\x0eZ*4)Z2\\x13PEQBlK\\x7ftDk\\x07R`n{nB\\x0b\\x0fop^!4W+K~W\\x07_F?\\x041T^\\x05]\\x0e\\x12\\x1e?\\x02aLhs\"\\x0b?\\x00T\\x00\\x1f\\x01\\x04\\x1eG_ZKp\\x02\\x0e\\x0b\\x05(\\x00\\x11K?\\x08\\x16=T\\x01\\x0f3?Gq\\x08),\\x19>qv\\x16yrW\\x1b5\\'\\x06:\"d\\x0fH/\\x12f\\t!^.O2GNz\\x04\\x19}t\\x01\"\\x13x\\'\\x07_kc\\x06\\x0eC\\x7f\\n\\x055a\\x1d_A!\\x10?N\\x0bt\\x1eb= PHw\\x11Z\\x12\\n\\x12m\\x1a9$\\n\\x08Tgv:?\\x18q0S|EQe\\r\\x08A5v{\\x00M9uAS5A^.6\\x15`q6y#?\\x07h%xrSgf\\ue4cb}}NXj h\\x13\\x0c`\\x00E\\x00\\x04r\\x0f~\"M69\\tl\\x18a4x\\x1a\\x017v\\x10S.\\x05H3@\\x08\\x061(F\\x11;\\x1a\\r\\x08#{.8\\x02\\x1cnD\\x02m\\x0b\\x06\\x189 v\\x10G@\\x0e|\\x7f3\\x02\\x0f\\x1f\\x00\\tNoTHcT\\x06g8\\x1aY(`\\x004GIt^\\x02\\x015 T\\x1e\\x04r;lK%\\x17t>\\x0b?H\\x00\\x1b)\"\\x01\\x0c\\x0c \\t\\x08oJ\\x0f\\x1bo@\\x10\\x17\\x15h`\\x10f\\x0c\\t{\\x11phN\\\\&9uQZ93\\x04\\x12\\x00>10!>z6\\x01\\x1c0^\\'\\x1eNY\\x1b=\\x13?,Q\\x7fV~k\\x0eTIyy\\x1c~\\x0cIe~T\\x1a#\\x0c>f\\x0ftz^:p\\x1fes\\x1e\\x19m\\x0f\\x1f\\x11\\x0fw*r5\\\\cs-i\\x7fH\\x07\\rz`\\x11y\\x18!4\\x187jCh4~\\x12l5|\\n;\\x06\\x13\\x1dt!\\x1a\\x7f.8V\\x0fg}\\x03pn h\\x161tf\\x1a].&)#0O$CXz\\x01v\\x082&h\\x10\\x05\\nI\\x02(\\x13\\x11\\x05\\'\\x04\\x1c\\x03\\'\\x1b-8\\x1c7`\\x1e7zcho>A[k(\\x08\\x19i\\x1c\\x19m\\x1ed<\\'\";\\x05w\\x07`\\x07?\\x1e\\x02n<!*\\x06q-\\x03qc2B_\\x127$8\\x08`^3v\\x1e8\\x00)T\\x17~\\x08\\x7f\\x02\\x19*(\\x08?\\x18+N\\x08\\nC(A\\x05\\x7fiI]\\x03@F`S_@\\x03qb3`FdTK\\x06(\\t/bPQmW;U45YD\\x17&N0xvT{j\\x03#W\\x1fb:HP\\x10txa\\x0fj#\\x1fw-\\x1a*\\x04R7hr\\x00ZG\\x06\\x04E\\x11_\\x05-U\\x0e\\x1fu\\x04sW$Ps\\x13^J\\x19xU;W%Y\\x1a\"h5\\x06\\x0f\\x0cnf\\\\w \\x01F\\x06V\\x12x_Ai>VPf& \\x1ah \\x1ahuU\\'\\x15L\\x06#QV\\x05Q?YJ% \\x0cz+n\\x0cQ\\x1f\\n\\r\"!\\x03+p\\u05ca\"}o*^\\x12\\x15%.T\\n\\'Y;\\x9fA\"z{5G\\\\wP5Ys%aOmdO\\x08s\\x08Y~\\x0c38Lbd[\\x05\\'\\x0f3\\x10\\x01:7\\x1c\\rj\\x19\\'2YV.\\\\/1>\\x1400J8@[g\\x1fn\";\\x02p0\\x1e\\x01=TTN>\\x1a\\x0b$7=\\x11\\x04V\\u0601\\'fx^U\\x06L9;y>I`F.m\\x00x,\\x17\\x06\\u06ddav\\x0c\\x1b/$\\x04%U\\x07C|\\x14|\\x04Vd*Os\\x1fF\\r3Mk^\\x07.&*Z\\x1dD;%\\\\_z|U\\x1dt(l7mzV;h8]xa\"\\x1a8\\x02L%=rKR\\x04tC6\\nA>N\\x1b<I^\\x05rt?\\x08IE\\x0b!Yqm;\\tV\\x01|!=\\x06?\\x14dM/\\x07Ej{t\\x19Kb\\x02&\\x009u\\x1ah\\x118zo\"E99h,?\\x04]\\x15`Jz\\x16LV\\x1e,Ya?dEai`\\x06\\x0f*4 \\x00s<\\x0e3\\x08\\x14#\\\\v\\tw\\x192mcce{#_]4z\\x05\\x16ij!\\x07\\x16\\x0fy\\x1f\\x04)Y,\\x1bsjx\\x13#R\\nv\\x190Bnf\\x19\\x18\\x0b<_U{\\x1b\\x199\\x0ba`r&Op7ei\\x17q\\x15&`\\x12\\\\aJd_u\\x1eK\\x15Y7$IM4NuocnpE~weu;vkn\\x19vukhS{S#\\x1e}GW\\x7fw\\x0f}\\x04^rOv^\"\\x0bB\\']\\x16\\x0bf\\x13?\\x1c m\\x13\\x0f\\x04[\\x1d\"\\u05cfHo%YH~}\\x12&(\\x12wb(}6\\\\\\'\\t3\\x145_OB&!\\x11E><(\\\\\\x070\\x7fHS+L(z!{3[F\\x06l\\'TE+%OUwyrI\\x1eOr$\\x12\\x14@\\nP\\x0b)NtFs\\x14\\x7f\\x11\\x1e%\\'&j\\x0ccv,\\x17\\x06Nq\\x1bMs4bfhe\\x7f\\x19[o9Km\\x14|1E*\\x1a\\x12f\\x08Xx\\x1c\\x07/=|0_\\x1fE\\x11fB! \\x0bf?\\x02\\x13A_D\\\\S\\x16\\'b,,\\x17K[1OBnS.~3(x\\x14B#{\\x08\\r[-g{QlP\\x11\\x1ab\\x0c!\\x15\\rEz\\x14K\\x08)\\x05\\'oF%NR\\x16(\\x05\\x13oV(\\x14\\x1cF1RlRlM1w\\x15W\\x17\\\\\\x18z+4tPdg{Fze7CXB_\\x0eIWiHvf c\\'j!s\\x1fgxC\\x1fxh\\x15s;wFe\\x0eba(.Z\\x02_,5\\n~/Qw\\'G\\x00_\\x1d,uG\\x11\\x12x C\\t\"\\x7f^_=:o~0c\\x05(\\x12dA[\\x06\\x19L\\x17;\\\\\\x04+j6\\x16BT\\x00S ^yxpWA\\x12{\\x13\\x075Uz6\\x07(~\\'=\\x7fZ^C\\x1c;\\x15jd\\x19d\\x07L\\x01Zd.F#\\x14\\rY)b\\x0f\\x12-LSNdCE2\\x0e8EXhar\\x18t\\x07\\re\\x07<Hmm\\x14\\x04])Ft_\\x0b:\\x19)QRVl\\x0fSv[\\x1384>(xFdK^>\\x10\\x1b>~\\x0eU`\\x7f7R3WX:\\x1d\\x1b\\x02~#U8\\x1dG\\x0b? \\x7f,bkOeZN,9\\x0bCq\\x1dv6\\x0fo\\x13\\x085Vj\\\\O^m\\x02\\x0brJ\\x05^5\\rI\\x0b/\\x0b`s?YY+k6<ae\\x03\\x180r%6np\\x0fV\\x02t^\\x05\\x1c9,\\x02U\\x05>vIuRD)r\\x1ahZZ5\\t\\x15\\x01\\'M!_>H\\x1f\\x12\\tn}0nUu\\x7f{\\'m\\r\\x1aQ\\x13kZ\\x1e>\\x14\\x16Ax\\x04i\\x19@d2F{r\\x0b~\\x1aD!b\\x03F\\x08BC*O-{cC\\x1fT,0\\\\tlme]M?G\\x006Gs,\\x0e&^\\n\\x15\\x02D^\\x01\\x03cl{0<\\x03\\t\\x1aT\\x01\\x0fc\\x7fP\\r1T >\\x1aQ@\\x13Pa\\x04\\x06m\\x0f_\\x1ddo\\x00g\\x19d_5\\x02\\x10\\x00\\r,V<c\\x00\\x01{c?t?\\r{Is ;\\x1c^\\x00bK\\x0e:mAa@vG:\\x16Is$\\x14Y\\tP\\x00Su\\x18T\\x12~\\x07%\\x15H\\x06mL))<$,6\\x10\\x1aY2z-\\x1b+|\\t\\x16\\x07\\x13.Wq\\x0bw\\x1e$l\\x05bx`BDE\\x04TqhQhC\\'\\x0em\\t\\x0eY\\x00h_BD\\x13!\\x03\\x06,c\\x1fU\\\\#}wv\\x08d 3p\\x13+\\x1fS8Xr\\x1ff\\x075\\x1d3;D7L\\x1fNe}O\\x15\\x0f~tZ\\x05/\\x18\\x1e\"GJt\\x17DeAFc,pJ4DPiC}AS\\x0c=\\x03\\x00+Fy\\t9R>-3!41\\x0c\\x1a\\x10`+bB\\x02\\x1a\\r\\x18\\x1d\\x06\\x0cF\\x08XQIE4\\x11]\\x003Si\\x01WG|[J~\\x14T{f;\\x1d\\x10(;>0\\x19\\x18\\x10 \\x03G&Sm0_)@\\x1a#5TD{.dc*;F\\x11Hg\\x13\\x0ec!FnkQ\\x04N\\x03\\x1e\\'!hR1UZ-;1\\x06\\x03\\r}8\\x19c\\t]?lMm#\\x1a<1U>[9X0IZQu_\\x12\\x06D9\\x07(p3|m\\\\\\x06\\x0f\\x07f\\x7f+{\\x11YT\\x01I\\x11V7Ep0SpI&\\n,qXVty\\x16X9f\\x1cGb\"Om$2X/b2\\x16b\\t0LRO\\tU[c\\x10[;)z299$Nu[gI\\x08NtW\\x08,}!7d\\x05\\x10\\x00Dp\\x11\\x03y@\\x12\\x07\\x18\\x13o\\x13O2/>\\x06T\")pg$,W\\x0e/e2HL`W:q\\x0e\"JT O_g2g\\x1b\\tvD1*\\x1d\\x00^#y\\x08\\x01\\x1bvUy\\tfk\\x03NB\\n8wP|Lf\\x7f\\x07:v<}\\x18@;pa\\x1eAp\\x03hF\\x02\\x18TeA^Aq/\\x0b{\\x7f)\\x1fjM\\x03\\x1fGJ\\x1bKq\\x0fV>8\\x0et^ps\\x16\\x04\\x04P(T!G;O\\x01f=U?^\\\\\\x0fO\\x03 \\x10Tk=CHI\\x02MZ=6@p\\x07\\x02y\\x03&KR$l/BB\\x17\\x19zAgM;{Bf`?@@;><\"> \\x047\\x007FB\\x03\\x1b\\x18v-\\x1bO)\\x08\\n\\x11\\x1a2b20\\x14Z\\x05%g&7|\\x1aR\\x02@\\x0eoE(S\\nCj2$56\\x00Zo\\x07$dJ\\x11\\nuw/>tm\\x14&Um\\tL$@wK]n0y@E_^\\x19% ?\\x0b%Cw@l\\x01Z\\x16{f\\x1c\\x17U\\x17)D(ja\\x1eBOG\\x00=\\x17=0\\x104w\\x007\\x16\"h9@:\\x10>!(r{\\x08Z=EhRi\\x19:fM>/P.V8b#N0]Z( 1\\x16\\x10\\x04:\\x0f#{\\x15\\x02*#w*\\x08\\x1dN\\x1d\"N#\\x05\\ti\\x18\\x008LS,w\\x15\\x134E`\\\\K:,c1o6GlF\\x0cE}=\\x1a&x$\\x1djx\\x01I\\x08bTpIvfIL\\x0f%pg3K\\x02T\\x10\\x1b\\x02 \\t\\x02\\x0bg\\x01V!\\x11\\x11\\x02C>_z \\x13h?1\\x11\\x15J=\\x11\\x05iHm\\x07\\x16cjh^\\x01gH\\x07\\x18#%c/g\\x04+|9X\\x05YW\\x15{/Z\\x02\\x10klS$T\\x10\\x0eh\\x08&\\x04RBb\\x13\"}p\"\\x1b`\\x0eh/F~x\\x02\\\\\\'o\\x01L\\x102Bi^%KJR/Z=5xri0G\\x0eVqibrV\\x1c\\x064S\\x01!wl*+`NZ)u\\x04&RvI\\x08t\\nf1k3N\\x0b\\x15L<bP+CP5}\\x0fi\\r\\x08>5q\\x7ff\\x12Z\\n5J-PY[jL\\x1dyzl9v0|Dt[\\x18\\x18Q?\\x16\\x10rSC\\x02\"@\\x0ei\\x0514164\\x11On=5~\\x12q\\x1eC\\x1fVwh[\\x1ap0\\x0e\\x1e\\'X\\x11\\x10xt4SdP{4QumP3\\x15\\tjx>,\"pXU H@V|\\x12]\\r\\x7f\\x0b@fk\\x00CYO\\x05c^o#/\\'\\x18.V!)`y;\\x06\\x18mrYK`*mi\\x15N0X|&-<2w0\\x0f\\\\?w\\x10\\x1c2[n \\x1e\\x1bm\\u05fee\\x0e&`b\\t\\x13Fpb\\t.I|M|vNn\\U0009e140tAKBJ\\x0c`|\\t\\'7j\\x07Ch\"{].\\x04z\\x00^/%\\x0c1q#\\x00\\x01veom\\x05\\x0fiT\"0%M0}\\x17+WK-\\x07\\x15LX\\r\\x1a %p24Gzc}4\\x104I|h~e\\x19N\\x02\\x0bVH?`#-1wN(s\\x11\\x08r85LfR*&/4BaI/FI\\rZ\\x06%%\\'#\\x04\\nrCy)s{h\\x086{b#)G[(6HO\\tKD\\x06\\x12\\x18o`FR90y^\\x13gzR\" %(%QTNveD\\x1b\\x7f\\x1e#%;ks3\\x1c7n\\x00\\x1ck\\'if#bUZ)\\x02\\x1c.jW@)\\x02rh\\x1aP\\x1e$/T$iAhql\\x0cM~R`u\\x04\\x1c}\\x1aXgt%e9s[#\\x1b\\x1a\\x06;\\x00M?\\x18>h-CX2\\x08#\\t\\\\\\x16*K\\x93C*[Z?n79Wzeq^\\x1d\\x06xt\\x13F\\':\\x11*\\x10#?OnD\\x0eO!v\\x04/\\x1beu(G\\x01\\\\R\\x1du-Df >\\x0bT\\x17L\\\\Xfo/\"6\\x1e^utS\\x1cH\\nBW|5 \\x1e(\\\\(:\\x00]{tkq4\\x1b6\\x08\\x1e\\x04hPA7y>Md:\\n\"22\\x19D\\x11M_5\\t]GRh\\x00\\x1dHK`\\x17s2|.k4Q\\x07ovx/-\\x06H\\x0cRD|8t/(ku\\x12t,\\x1du)V\\x15&HEpy>64\\x04jcLo`\\x0em_\\x1c[\\x08&\\x13Lk.7g\\x13[v4=[mX\\n\\x0c\\x14-+&\\x11\\x1dnd+l\\x165%DgnD\\rCC%#6lob>;g{v-\\x14\\x14tW\\x02\\x7f</bi_ \\x01\\r}ng|kbW5Y\\x15hRW\\x08Rsl$];\\x0cc{ fx-a\\x02IY\\x0epnM~\\x15d,r\\x1eJ\\ue5be~\\x12qr/\\x1d\\x18\\x1c;{\\x19q\\x19.$\\x0c\\t<AKiu\\x7f\\x0e\\u05f8\\x16\\r0s\\x81B5pi\\x06USyQ{f]^\\x1aix\\x04!O\\x04$&\\x01xBVkhb,|a\\x12]W\\x7f2-\\x06J7Vzq2&\\\\9Frh#`\\x1aB6\\x14>s6r\\x0bra\\x0e\\x11P\\tM<\\x05\\x119c\\x05NhOr\\x02!]\\x1d\\x04xu\\t\\x12I \\u05f7Arir`M\\x17+7\\x1e\\x030\\x7f0\\x0b,gl\\x014dY_PPG\\x04T!u+M{\\x1e\\x00%Ts]\\x05bE]Is}?k\\x7f\\ue77d\"%\\x0b*Le\\x15S\\x08\"O\\x08]\\x13%cK2Dx?R}%+\\x1e*#g\\x1281A!\\x11\\x1cUSJv$Y\\\\uCY\\'_|\\x19std\\tV]T\\\\\\x1dy\\x96\\x14>MzfcX\\x0b*:\\x07\\x157L*YR*|%GS\\x1d~B\\x17MG\\x0cFd\\x04z!L!\\n;\\x07\\x04D=1>z\\x1cr{xc\\x1a@\\x00Zq)JW\\x00\\x0cZ\\\\\\t#gU\\x1cn\\x02$\".%\\x11?n(\"\\x0752\\x10}S$t9d{rolm:$k[OGS\\x059:\\x0c\\x19x\\x17J\\x18=?\\x00Sq\\x1c\\x1e/\\x1co\\x7fG-\\x1b;v\\x06\\n\\t\\x18\\x0ee<SWc|%\\x0c\\x10\\rI/4{J&\\x1b\\x1b$\\x1c1\\x08\\x11X-\\x11b(\\x063<&p\\x0f\\r\\x03v(N{~M\\'$3W&\\x11Gob.w\\x188``\\r1#\\x125#B\\'g\\x171_+\\x0c\\x7fB|\\'\\n\\x04\\x01\\x7fJd\\x13M+\\n\\x17\\x11zl:\\x07nmn&\\x1f~\\\\>T\\x0f6o#Y\"\\x19U8LNA~:\\x0f=\\np^o\\x1bMU\\x19bk3/\\x08\\x1b.\\'r\\x15dd7\\x0f\\x0e9JH\\rM\\x1b%34M^uLE]mUD:D\\x13MVC\\x0epfGP\\x0bW1\\x1b?\\x05 v\\x12JA\\x1f29$J/\\x01!\\x02\\t\\x02l-TyI\\x144\\x16y\\'ROS3%U2~\\x06pU\\x06\\\\\\r+?U\\x14D\\n .\\x00ZT\\x07;w^}^p\\x04\\x0cw4a\\x1cG=5I0\\x06{Q!X0@EU9&\\x19xEwo\\x7f\\x17s89sG0qL;1#=\\x18JY.L#\\x18tPU1/ e8q\\x05\\'s F\\x1dR`ov\\x16\\x02=\\x08\\x0ex,u3wZ{{w%?\"l/f\\x0f8?.\\x0cM|\\tH@JT\\x0c%4dR\\x0c2O^$\\x1f)xra \\x17W\\x053\\x0c\\x10Yg^i/S%\\x01lK&\\x14n\\x01L/\\x04YIeL~-v\\t}}\\x06]ZWv]yeYw2W^e\\x14\\\\\\x17v_H{z\\x0bXq]KR\\x10t5W3;k\\x06;\\x0b\\x0ecwaXkj1X\\x12d\\x7fv\\ue961\\x04\"\\x1e\\x02\\x10TQKKx7N\\rW5$KT*jPxr\\x033bp\\x1fn\\x05\\x1f\\x13Aiz}?}<\\x1e\\x1d{S\\x0bm\\x05\\x17[0pIf\\x17VE*uTby2Z*\\x067\\x00\\n:3]\\x18\\x03}Wx\\\\\\x0f\\x7fjKq\\x1emFKr:L,\\x1bYs1y\\x03<\\x15K\\x1a^Nf{Q\\x11m\\x06~\\x1dP&\\x1f_qX+3\\x083p\\\\-\\x01dM%mJ=C7\\x03^&Op\\x1dc:dYRiy*eig\\x0e\\x1b7Ic^eC\\x08gsa$U\\x12<W^\\n#\\'}.NEh\\x7fH=_/Y\\x0e\\x1em0\\'W\\x1c5nv\\x08d<vr\\x0f\\x1d\\x04s] KK\\x0b3lQ~~6t|T\\x15\\x1b6~}|NQM.\\x12\\x04!\\x11\\x0b\\x13\\x14A8\\x1e\\x01#u=7m^?v0v8<\\x0f\\x13l{4\\x13\\x04Pr\\x02\\x0b!<s~P%.u(av1\\x1e\\x13tB8n\\x07fg\\x1b,\\x13pw\\x18\\x18\\x06\\x1bXV|i?Hpg\\x14lv\\x1e\\x0czh\\x07\\x1b?i\\x1c8.\\x03\\x1e\\x1b\\n .\\x07\\x15W\\x019B\\x0cQ1\\rYK|m\\x04K\\th/_.\\x1bdg:pI\\x0c\\x13\\nIv$j%}WSJ(\\x1f\\r;M\\x1b\\x02(\\x17\\x06}7\\'&7.\\tJ\\x05{TjYfI@A|f\\x7f\\x02\\'<\\x1a..\\\\\\x1dK<C;M\\x00(|.\\t 9\\x01]GvE\\x11w\\'\\x1b&r0\\x12\\x0b>\\x1b&=Yk\\x16\\x1eK\\x144I3rg]cY=&~-\\x1c~\\x14+ n@Ru^~nN6\\x0fXJkr\\'\\x7f\\x04\\x1f\\x14N~\\x0c p\\nh\\x7f*Y8&7~\\x15a\\x0cQ5V\\tYr,\\x0bI!&dy\\x1e/lPv?A`TM<\\x17&/h7\"\\x145\\x0eAR@pQ\\x1a8\\x18q\\x1dtB\\x17)\\'\\x1a\\x08q\\x06va:\\x7fu\\x1f\\x14\\U000bdcff_ \\x7fF}-\\x93Q{r\\x1a7b\\r~FAexN\\n-n+;uZ[V.Z\\x0b/K=\\x14l\\x1f;\\x07c?R\\x0b<x*M\\x0b\\x13\\x14#,\\x16\\x19[\"n8!,`\\x12\\x13@\\x08f;G\\r&`/%2zNeI5=41Y%\\x15\\x0e4_g\\x06\\x1d]1?7\\x07\\x7fU\\x01`Y!^\\x120r^7\\x7f@5I2v\\x1dJ@#y5zU\\x08j6S8<\\x16g{\\x19+578*4\\x0fAf#^\\x085+TJRp&\\x05(l_\"\\x15\\x11Zd`;zrk\\r\\x1cr\\x18MRjtK\\x1f<su\\neV5>\\n\\x1e\\x11hy\\x7fsKRHpa~\\x1a{XK\\x0c^_^\\x1c\\x18\\'q5-?\\r|\\x0cZ:\\\\D\"8\"d\\r?WZm{\\nOgx+\\x19#\\x05\\x14A\\x1cfXn:o*\\x02\\x1cjBEEDG\\x1c;\\nA\\x16Gx[`CRTkE\\x00%Ed\\x00\\x0f]^r8?O\\r*k\\x19\\x02tn:\\x13y5?u\\x1cz_\\x7f\\x15\\x14\\x1dM\\x17Gr\\x0c\\x05\\x08\\x0cXj\\x18X\\x16\\'Y@.9I#\\x12\\x18\\x08C\\x06\\x1ejkh(s?eC\\x13\\x1d\\x0fG\\x170k\"FvF\\t\\x1f\\r\\x8bx\\x12F2xt}i(R\\x010e:\\x15jE]O.R\\x19vqMx[#\\x10I9-d\\\\\\x1fJY2-kPm\\x95F.~\\x1a\\x07gqCmw)!\\x08F~<\\x05O!F\\x05]]\\u05fdK\\x0c;Oh:{V\\x1c\\x1b[\\x1eV!{\\x17de\\x0cSD+c\\x0ck|;l\\x05j?!?7 ; tLr(;w_\\x1aZg2M3M\\tan\\u07b4L\\x13\\x1ac=jnY\\x1bv3n\\x0fwN7;;\\x1e#tn:NkM1Q>7wtv[k7nz}8t#k\\x19uu\\x1bF\\x1fwnjuvjm7UM\\x0fF\\x1dZFkl\"\\x12\\x16v]m;v&\\x1b}t\\x1bQ4.\\t\\x19Vw\\x00]\\x175jE4kf^o7Q1\\x1en\\x1d7f~\\x1aNgd5\\x05?}wTxxgZF\\x1b}g6>4\\x1a\\x1buz7\\x0fvnM\\x1e\\x197j\\x1a\\x00v\\x1e\\x1awx4Hn~\\x03mn\\x04ZwyoY1n7}s\\x07Ow\\x11\\x10F][z\\x06WUW\\x14;wj\\x0e\\x1cf4[a7Ywk8F#fm\\x0e,16A:\\x00pY\\x01ni(\\x1e\\x0e7nw3n\\x1c=\\x04t~\\r=7us(f\\x0bdiZ\\u0378\\x1dw]\\x1a73\\x1a\\x03lfq?P;u@\\x03qQowujV\\x17\\x05\\x12h6=\\x13@:0\\x1fo \\x0cV~|\\x00}\\x19}oAvZk3\\x1e\\x1ca\\x1fMN?n5~ C}koj^f\\x0eaAQ\\x18X pV\\x1bxV\\x0b\\tw\\x1a8:VSkY\\x19A6ff [C`\\x1dh?P\\x1e%z1g\\x1a:x\\x1b|!]_M*Te]S&/Wj\\x158)h\\x06?5EkFE7j\\x1c\\x1fQ\\x148BS\\x1f{QezS\\x06,\\\\Qn+\\x08\\u07bd#;[f\\x17Ze\\x0co\\x0c=m{x\\x04\\x18$\\rN@B\\x0e#,c:;C{+Hx\\x13$.$\\x0b+{=k{\\x11\\x0eO\\x12nHL\\x13v;\\x08x\\'?I7/\\x11\\x12TXd\\x03\\x1f.i.I2FIrA0\\x03a\\x03\\x16so\\'a\\tH\\x1c9\\x13\\x04I*\\rF\\x03v\\x7fEove\\x1d\\x13d\"q}%n\\x1f]j[_q\\x08jL<jG3\\x1b!i+R/VfKP.\\x1a\\\\SKJjRWJiA{p\\x01\\'\\x0c}\\x05\\x11OQt-\\x10NG~\\x00(egk\\x08vH\\x05qssv\\x1d:%;M\\x1cz\\x0e);/`O\\x1f`\\x1f.\\x08P\\x07Z:>q\\x08F\\x13 -\\x0b\\rR\\x10\\x1e-{`zC\\x15M\\x1f\\x00)0\\x1d:rBz\\x1f7_\\t$QZ_}%\\\\\\x070p\\x06\\x19\\x13\\x08C\\\\&l\\x7f\\x1f&tE\\x1f9UE\\x06]Y\\x05\\x10jnb8\"lyK\\x12p\\x02_\\x1aU\\x16\\x08\\x0c\\toR\\x16sfC\\x15bZd.\\x11\\t\\x04\\x7fRLE`}\\x16yMSdn%H2O\\x0fK\\x07I]@|(\\x0fHw\\x13UaxUR}-1)ks\\x10,i\\x19+\\x1a\\x11fp\\x1f\\x13x?9\\x19cYiUr-Fj\\x1b:ik\\x0c\\x01\\x0ekF\\x19\\x1b?KU\\x0edAT\\x05^lBwj/\\x1bn!`!o\\x0c\\x8a_\\x12V>zV<7oVB1P,7Im\\x03P3@b;pjsaUv@\\x13$C\\x0ep\\x10\\x1dbr\\x0b&d\\x11\\x10\\nksZ\\x16s\\x16\\x03\\x19\\x18 T6\\x13K\\x16kn\\U000a59b0+21\\x0cu\\x14\\x0e@IJ\\x08Rr\\x19Pu;\\x1c\\x13b\\x18F.\\x13Z\"\\\\Mt\\x1fv\\x14e,\\x12\\x14\\x00ni\\rt\\x00\\x1a;[\\nryMk@b\\x12\\x17\\x1d\\x06c0{vw\\x1cc5p\\x0er\\x05C\\x14\\x101\\x10\\x11u{\\'\\x19-Jlr\\x07pYcX,)`+-\\x0f2F7?ok$\\x1d@\\x9d E \\x1cH\\x02\\x10)l62\\x01@\\x04dF?UFM\\x0bFAO9\\x00\\x144{q[G\\x16\\x18X\\x05c\\x08-J1s\\x00t},/s) @\\x00\\x0e|\\x077Y+{-\\x18zm?e\\x16E\\x1c,W2*-s`\\x06+l`5m\\x17\\x03 suAj~\\x02h\\nH\\x0b\\x11hj\\x1389\\x7f8/>R$AU\\x05.I34\\x10wk\\x18;\\x10u\\x06}_\\r=N\\x03\\x7f\\x00\\x1fQ@\\x1as[xWj\\x1e8 7*\\x1d\\\\\\x01uw\\\\=3\\x03)8M*z\\x07\"1\\x1c \\r\\x1d%a0?u\\x12.D\\x9d\\x15J\\x04CS\\x0b\\x15D3B5^U\\u06dd\\x19|\\x0e\\x04j=\\x03\\x0e\\x04QD\\x0ed\\x1d\\x048\\x03E\\x13T\\x0c\"9\\x1d\\\\\\x0eTUQ}=\\x03U\\x17h\\x1aZ=x\\x01\\x12\\x7f\\x06\\x11\\x15Eq}\\x0edQDE\\\\g\\x03\\x105\\x1c]P\\x0c3*>c\\x0fTI\\x02Q<%\\x03UV\\x14\\x0e4I\\x05\\x0e\\x0cC\\x01<\\x04Lc\\x1d\\x182/*\\x05Q0\\x14Q^\\x0f\\x01U\\x11_\\x08{ +\\r\\x1dB\\x13v?N,v4fM)\\u07b7Qo,^ZH\\x0c\\\\!vB2!\\u07b6ii\\x03\\x0c\\t<#5\\x13x\\x04/\\\\D*L;Oavvn\"wz+]r\\x18\\takzOS\\x03\\x16\\x01\\\\!\\n\\x10A]*&j=2n\\r\\x11HukC5Wm\\r7Y:I\\x12\\x0c!4m\\x1a\\x14qo8(X\\x7f\\x11&Uuhhy[\\x19G?#2\\x0f\\tP9jP\\x1bnW@h7%H6\\x0f\\x05\\x1a(Tp\\x0f\\x0f\\x16]sva\\x03\\x14#}+*1(V#\\x02qzehh\\x01P\\x0eKzN\\x0e\\x05m \\x00\\x18Q24~KR31\\x11\\x1ba}/calPE\\x18\\x132\\' >ee\"\\'\"DBy\\x11?L\\x1c\\x02\\x02ss.b\\x13xjCSE\\x02s{ISuWR7vujo\\x1aG4\\tw*^+\\x7fi{!|dz6|l\\x7fU\\x01 \\x16E\\x14/@\\x06\\x1eYHLoK\\'jd^i\\x1az7?\\x1bs\\x04kWfs \\x1ew:\\x12\\x1a\\t\\x06\\x0f\\x7f\\x0e]w_}~\\x14H\\rEY\\'wVi\\x11%\\\\A\"\\x05Qr\\x06R\\x93@5\\x15y\\x17)rdz\\x0b`eU\\x06\\x04A5]%\\x11$EK>bf5AQD-\\x17-}\\x07:.^gt=\\x19\\x1b^>\\x04q$5\\x05\\uf8c53e\\x08i\\\\%HN\\x1dca14A|\\tT\\x11R\\x03\\x08\\x04\\x08))\\x03)U\\x0b\\x01\\x1f\\x1bAcN)\\x19B\\r<+\\x08,)V5\\x06\\x0f2x%\\x0c\\x7f~\\t?h:_\\x0f\\x0fa>\\x1dU\\x1c\\x19&P\\x19\"RE8WQ%\\x04\\x10]][\\rT^\\x0fVe\\x15*2`Kp\\n\\x03A b5(\\x05\\x10|\\x1c\\x08`{DU\\x04\\x01\\x13}J@\\x11TT^c\\x00:p=s!U\\x1b\\x0e\\x0b\\x7f\\r@z^$_7T5\\x7f:\"GHe0J2tYE!z{%\\x19+MyW\\x1f\\x0eL5\\x03+]_#bm\\x05\\x07j7zY\\x18\\x1eL/*\\\\:\\x14\\x19\\x05`3WP,\\x08\\x03\\x05@\\x00PpX1\\x1a*$\\x1fa!KdHtR\\x03\\x1a2\\x13g2\\x0c%\\x12C^\\x06w\\x1aY\\x19&IU_$vT%+kq1\\x0c\\x0fq\\x0c\\x0c\\x15M5@pS&2\\n:0V}\\\\2l\\x05l_$`7Alg\\x15}a%[k+\\x17g\\x1a\\x021#ZeM\\x14O2\\x16Q\\x10U2Z\\x19\\x1e4:!#g!\\n\\x02D[aeuU=C4^54[4%h \\x03%\\x1dq?\\x13fCIE\\x08xETN(\\x0e%UV\\x0f\\x163PR\\rY\\u058cD{CIy\\x19%C/c$hf()q\\x05\\x19Q\\x04t<p3~o\\x0c\\x00zN\\x7fpuGa,F%\\x7fOhwa%\\x14^U\\x7f8CWp5\\x132:%\\rf]=\\x1fU)\"\\x1d\\x0fGxRaF0.]_4\\x18T?_\\x1bD\\x19h\\t:/*u!V+;\\x19 \\n0%9i1!et\\nj\\x07\\x197@T&Pa/\\x12\\x1fIxb0c\\x17\"vkPrU5DYUfHDV\\x04I~&wF\\x07g\\x17Y\\x10,AST\\x1ez=\\r?\\x16d\\x16hn~c\\x15;*j1)\\x08qM\\x1cxs9Is]n\\x05c7\\x199r-\\x1dpK\\x7fj/dZ\\x18Ok[=\\x15.+w:8\\x15x\\x10h-@;h\\x1d]~\\x009#|E}8,\\x111=\\x18\\x1eu82n[mjb\\x19}\\\\m\\x00>:QrLtB+H\"p|U-\\nSG-Q=\\x14@6\\x1fPuJx:x\\x1dM?5<*Tu|MO;\\x13ZR\\x13&\"-\\x1auKaZ\\t\\tL_N.9)qd lZ\\x07hQjU`\\x14/>p=Z| RRmt#J\")^AY:z\\x7fI\\x1b\\x1ej\"(\"=K?34qoCztJk\\x1dJu5!!\\')\\x0ce\\x14W\\x10R]R+UF+NWZgvk \\x05\\n\\x1fy*;\\tdf\"l\\x07:\\x02&bWj:\\x19EO\\x0cJ\\r\\x178^\\x07X\\x05b\\x19g\\x105]}ST\\x1a\\x00\\x00sJ\\x1eW\\x1f`~{\\x19\\'{>\\x0c\\x16\\tL\\x0b<-w_\\x139[(X\\x05j{j=v*wta&h\\x055dA\\x192g\\x04q\\t\\x1a-w@?;Dk{\\x1cX*\\x1b\"\\x1e##o[u\\x03~37t\\x10I>(p\\\\\\x02\\x02\\x1a2/Fv\\tX\\x06Y]\\x02l[L{\\x08\\x1a\\x06\\x1ex:.\"kiB):47l\\x12#N\\x1anO8\\x04\\x08\\x05L&n\\x10-BV\\x15\\x03>r:m)\\x7f\\x06hm\\x02E&s\\'.RVcI<}\\x0f\\x0bz\\x02g\\x8fx9\\x06 {Fx\\x1f3Z:\\x19\\x10\\u07b4\\x03:\\x1b\\x11Cqv\\x1c&:\\x1eG]\\x1eH\\x1a\\x0b\\x06\\x16Z\\x04C?aL\\n R\\x009PJ\"\\x01bU\\'0G\\x02\\x07!V7\\x18Ml@o@\\x07wA/*pGZg\\t+tQ\\x06[\\x06~\\x18\\x1c\"+Hz\\x11LJ\\x17\\t!U\\r/\\x07xe\\x17\\x14@RDyQQFI\\x19\\x1bb\\u07bbkI S\\n\\x1c\"\\x08gr4n \\x19\\x05\\rI\\x10)1i\\x18$\\nJ_N7\\nO8\\x0e\\x00Tw:3\\x0bZ>zk6)4IJHh.=\\n-\\x04MqT#obn\\x06;w=M\\x13n\\x0e:8\\x19\\x08La\\x16h\\x19x\\x19kS\\n=\\'\\x15cW\\x10\\U000d3405\\x0c\\x0eC0C<z\\x02V\\x1d\\x05\\\\\\x01=>q\\x02,}a\\x1dlj\\x1f\\x015\\x1c\\x04\\x13\\x1dpz >\\x00\\x03R4+\\x02\\x16\\x11ze\\x19\\x08\\x1d+?\\x0e\\x0f >v[\\x188{\\x00\\x07I\\x0e6\\x04\\tiqU<)i}\\x022vg!\\x16z?\\x00\\x1b\\x0b\\'@\\x00\\x7f$L`I6)\\x1bPPi\\x11%K#|\\r\\x1d]Vcj\\x16\\x01i2\\x163uo\\x10F\\x0bC\\x06s@vmo`\\x14ut}\\x13sJzg\\x03\\x0c\\x1dtE\\x10\\x11a\\x06xNEf\\x18w$C\\x10\\x15\\x07\\x11Os}1vu0|d%d\\x13t,\\r_\\x15nT\\x06*\\x04 Cv/3`\\t/h`\"lRbe{^y|\\x0fIL(][hdP\\x08&7lS_D<\\x02(1 x7<gb\\x10\\x02\\n6v\\u0cf7~0_~2Ot?\\x16S\\x01-da\\x1e\\x19<\\x0f\\x10l<93?(#?5W]c(\\x02W4\"kjJJe6[*\\x13=wT\\x16V\\tw.g\\x04.`Ck\\rad\\x07R%\\r\\x02^E.\\nPe~7c27{oC4rV\\x13\\t.ZVP\\x04[c$\\x16\\x108tP54A\\x14tvS\\x05!gbx\\x04zS8r^Z\\'nR\\x02O3\\x10V\\x12^2^VLh7b3U\\x16\\x05db\\x17\\x04KbPt\\x08\\x1cT\\x0c\\x0ekmcx\\x7f*\\x14P\\x10_MT\\x10bEr25\\x15L,\\x16-LbO&v\\x0e\\x15_$#v7n\\\\sA;du\\x15Fg(Okj!*.\\x0b*r2wL\\x14~\\x0e\\x1f\\x1a?O\\x13\\x0e_r\\x0c;M\\x04A\\x1fTB\\x1f~\\x1e\\x11Y\\'8!KrSw\\x06\\x1f%Ffpd%{t\\x05bf\\x127t\\x12lJZ!tm9\\t\"i\\x13UPVD^P\\r^z6%|\\x07,j\\x1a\\\\Hkr=O(Z^\\x1c\\x12D\\x11\\x12 \\x7f\\x1dHJR\\x06e7\\x13t\\'\\x1f3I\\x0c\\\\iv\\x17yv!z&/Cbftm.ArP~*Y1\\x1f$^hl%>\\x03]/4ivgoPM4+UN\\x17rX}K([8sH\\'H\\'\\x04\\x17Q{X:8e!mi`i(n`\\x1cUNd\\u05fet\\x14\\x0e|t\\x11\\x17[5ivzQK4\\t0}g\\x1b9\\x18\\x17!f7\\x7f*\\x16\\\\vS\\x18B<v^9:\\x10Vhgx\\x17e4+,\\x11>iC?bF-O4T9\\x07QP(\\t\\x0b.g7Tz\\x1c%\\x16seaL`5\\x1b.pz\"\\x1c\\x0be1r\\x07^&_\\x03\\x17we:8r|K\\x7f3G\\x7fh\\x0c2r\\x02ZXb\\x01\\x11v/][#|W7Wlk\\'H#Y\\x16\\x01g\\x13?\\x1c\\x12b\\x93\\u1fffvg?y/!L\\x02*A\\x0f1\\x14&`\\x19\\x02#`DNl\\t|*yT\\x15\\tU\\x17x[K\\x17\\x13Y<*\\x04r\\x1d2OlD.U)N\\x1f&z(\\x0f4<O\"`\\x19\\x02!T,,B<z7[\\x02Ot\\x11\\'6\\x03\\x12,\\x0bXk\\x06\\x04\\'\\x14\\\\\\x19Rl\\x7ffv\\x1f\\x19]$\\x08x\\x18=C{#V5U\\x05A_\\x1dcl;!Is<+LBfi2^J&%ak\\r((\\x12(Y\\x06pE}7s\\x16?BQ_N\\x1fh\\x19\\x05yA?\\x1f&J1\\x02f75)Yg\\x11N3g\\x088:s$V!yriz(|!4F~\\x1f^[\\x11\\x0bE9^v6yYD~?\\x1fR1nR\\x14%\\x18\\x0e\\x1e\\'\\x17\\x19-;=\\\\f~=sbE\\x019lRl\\x1b\\x7fN\\x17\\x19+&hv0iE\\x19m=d1vp\\x19](-S\\x14zZL\\r*\\x16Ns%g\\x088Ph\\x1eM#b6*\\x15\\nra:,\\x02*Yg7{K\\x02&w?L\\x02MsaVR\\x11<O\\x02BZr8u>\\x0e\\x14^]vp@zg\\x03=\\x1e\\x0b\\x0bi\\'aNd7n6\\x14(xbK9r)iMZCBkNt-<?F1,9\\x03|=wvpZdQQ\\x17\\x1d4;MNKW\\x7fT@+v^2YLzn\\x00^<S)SrVjMbvu%Y/\\x17\\rwF\\x10w#\\x1bK;?,9n*/wo\\nJ&^TLk\\x14\"!z\"_D\\x05,\\x1f$ewo:\\'g\\n[~.C3\\x02?hE\\x04Rk\\x05\\x19\\x16#u\\x07*{~j\\x0b_X/\"\\x11n]J#Wt/xXB\\x17kWzvo:q\\x16\\x10Pn4S\\x00{\\x0b&qrMv*v\\t\\x0b\\x12c\\x07\\x13F7G\\x0e\\x03\\x7fB\\\\B%\\x0fn#6%@d\\x1f=,\\x14:\\x0feN3*\\x0bR\\x0f\\'$\\x1d[\\x1di9KQpAg\\x1b4]\\x17ZZH}?U\\x04\\tFa,(VE(\\x10b\\'\\nAz34a\\x1f\\x1f*N}34c8>vQq\";^BUP\\x14X\\x12\\x01?\\t\\x19}\\x05Ob\\\\`\\x12-1\\n\\x11\\x1a8\\x0e^$X1b/D}Vb3^,Z~34KDPS.nBB%\\x15\\\\+|+!\\tvImH8H;G\\u07b9\\x0ewFv\\x18~Hk\\x02\\rP.?m\"xFh].\\x16?-Z\\x7f\\x1dObQXO3D\\n9;I~(VJz34%I&\\x7f\\x04\\x1a\\x05Jv\\x18\\x15\\x1f\\n}Z\\x14dtn]\\x1fR\\x0fTzw<\\x14+\\x1b\\x0e(?o\\x1d(QQD}=CW\\x14\\'r%b\\x19\\x1f=\\x0co\\\\l\\x19\\x12*5R\\x0e?-:4bBU\\nBC+!E6\\x1f4{~^6\\x0c\\'I)XG@\\nZI\\x04\\x12g!SE\\x1ab7f)?K^\\x172jI\\nV|3C\\\\lVp/\\x1bVm+$b8/GT89#,II~B\\x1bCGg\\x0ff#ck\\t7[C[\\x06L\\x17\\x1e)\\x1c9gSV\\x02yx>Bb8m3\\x1b_\\x13$a^\\x07>\\x1cn{fu-\\x7f03v=\\x1e9\"Wo\\x0b9`7z\\x001jn\\x1b\\x01\\x13Ee\\x1b:xs#EzruI/\\\\o&7;\\x02\\x90tnaTzrx~?\\x0ckkS_}!GHY/\\x18X\\x1d\\x07=\\x18\\t\\x1adMAbMR\\x03yS\\x13X2r\\x01PPt^.1I8\\x04Q, x\\x07\\\\\\x18S\\x04nZH*ANr\\'?M\\x1bL\\x07\\x15uQ8Z\\x018rNR.C\\\\\\\\#?8\\x1bu&>14K_\\x16>W|1$:G^?pz0J\\x19RqQmN\\'Y|Y%\\x13\\x1eEV>hIp\\x17xg\\x08\\x136:%v^\\x07\\x0f.q\\x00\\x08\\x189\\x0f\\x02m\\'G\\x18p\\x18pO\\x15\"\\'K\\x1aF(_\\x18#n\\x1bc+\"G\\x10/PeL\\x03\\x1f8\\x08c\\x0fZ7~oo7\"X\\\\t|q\\x1czW`vP.$\\x12\\x0cEB\\x10O\\x1b;WW@6>s%^]604\\x07kz\\x1d)|Bt}A\"\\x15v\\x0f\\x18\\x17m9O>v\\x19,F\\x00 8\\x0e|\\x1e>7`\\x04\\\\L\\r\\\\jP\\x19\\x01\\x01=92\\x05\\t\\x19V 7\\x1cd<C\\x0c\\x186/X\\x06MeQ.\\x1b,\\x1dBHr&uR=|bB:s\\x13\\x08L(dVfD5\\x05Ef\\x08X9sj\\x1c\\x08Q\\x05K \\x11\\x04UiWtvDxO#i\\x13%\\x02gy`\\ra\\x1e\\x12^\\x0bAK\\x0e`|\\x06/*jI\\x13\\x0e+\\t\\x0b\\u05c8\\r \\x05R\\x16%\\x1ewd\\'\\x03\\n\\\\D6A]E1V\\x0cD\\x1e#9 \\x16v\\x197,\\x7fC\\x7f)w^\\x04}i\\x0bx\\x08\\uf6f9\\x0f\\x01*C`M86\\x08\\x1fi:\\u07b2\\x03f\\x0f6\\x0e_KD\\x13\\x06\\x1f\\x06z+\\x13\\x1b\\x02!>L?\\x0b\"l3y@j\\roa\\x00c!\\x102\\t\\x13v%BV]Wj\\x04!\\x0ca\\x1d\\x00\\x12@/\\x182E-6\\x1fI\\x06j&\\x894tl\\x14{\\x06d@/*>m`\\x14<\\x10\\x7f4\\x1fci\\x12d^4\\tMF\\x19*\\x05I\\x17W\\x1a\\\\!\\x1d\\x15\\x1c&<$E:\\x10$E\\x1by)\\x0cvI1^~1\"\\'+7\\x0c\\n\\x04L35\\x19]oY\\x1fSB^\\x1e\\x13aP\\x1dDXrt?\\x01a*V|\\x12v`}%f\\x7flq{$K*gk\\\\{_RD%\\x1a/Nu\\x100c\\x1d\\x7f\\x1f]}7\\\\7 \\n\\'ln\\x15\\r1\\x1e\"G\\x16\\x1aR76u;vs$\\ns}qWq`=\\x11@M,\\x05JuKbP,\\x03\\x06\\x18c\\x02\\x124r\\x13]+\\x1f3\\ntl@\\x06\\x133\\x11\\x05>\\x01\\x15F`{=a<K\\x060zA\\x15^\\x03*\\x00z\\x0c\\x00Y.%\\x15\\x18%Z0!v\\x03R~\\x1d\\x7f\\x06{Is ;\\x1c^\\x00bK\\x0eX(F{g6 0 ;#a\\'\\t\\x07[$Pd\\x12z\\'@\\x01\\x18OadRK\\x1d\\x180\\x07uL))<$,6\\x10\\x1aY2]\\x10(6W\\x13&\\x17- \\x0f\\x0c\\'\\\\P\\t3h\\nr\\x1b=Q\\x11\\x011Z~\\x14\\'Cc\\x03u\\x16;\\x002\\x10p7\\x11g\\x08\\x7fN4 d\\x06o\\x04(kW6kwGk\\x00J\\x062\\x037>]{%1j&\\x19y\\x00_Q9C\\x0cyQ}\\x14_T7\\x0f\\x1fI\\x17m\\x18|U \\x01I\\x01-\\x12<zDwAT\\x16\\x0bi4X\\x00wci\\x06d\\x16\\x05~D5gP1\\x1dX\\x1d\\x07XI5\\nNyl\\ta%\\x00[9\\x16\\x17\\x17hH\\'\\x086`7GjJ*L\\x19\\x02J\\x0bb=kR\\x003Q\\x16@I\\x04\\x19He}tN\\x0c?2jJ\\x060F\\r\\x1e&s$\\x1bS!6@\"?s\\\\-0N\\x18bD\\x1fET8q8\\n\\x1aL)\\x1eSu\\x19l\\x13\\x1bo0P7!8z{\\x05<H>b\\x1e\\x1es[3\\x1ex\\x05U\\x1c%]%.>i@s@M\\x087SWt7\\x1dn\\'d\\x1e3Ep\\x10f$8DZ%!^.KKG\\x0b\\x16N!\\t\\x110\\x0cB0LsB\\x1cs#|a7\\x1c%W<D\\x07Pk\\\\5u\\uee44$G\\x7fBUb\\x06 j\\x16r]0ADf\\'hE\\x0c8C:ohi?DLV\\x1c;p`c}|s\\x06d\\x08\\x04\\x01}xpEX{NHu~\\x1d/\\x16wt`FDuyG\\x11W\\x1d\\x17NxRl.W\\x0ep\\x04:4kz\\x00q\\x0cx2\\x1fl)Lq@\\x0e}\\'yN\\x1d,o0\\x0eM!\\x14X H/Qb\\x1eJA\\x04d.A\\x08)\\x00o5\\x19\\x19=#c\\x02d\\x07S\\x19\\x10>c>(lBY]5\\x10\\x1eG\\x18>}p&\\x0c\\x18T)|\\x0e0i\\x03\\x12\\x0c=`X2\\t \\x085g\\x0f9\\x02Pm&~f=j\\x16\\x00\\x020]&`q9Y&5x\\x08t\\x08\\x1b\\x01Lt\\x12U\\x0b}&m\\x03|m~\".\\'N\\x0fM:/p\\x1a^\\x184IE?\\x06\\x03\\x02]+1`!4%\\x13\\x01hDj3y\\x08tS\\x04Q0u%?dN@\\x12\\x14\\x16%gB_x\\x14\\x1a\\x1bx\\x15`\\x00e\\x12\\\\]jRI*#CY\\x02\\x1e\\x04\\t~-p5\\n}wof\\x07\\x02G\\x7fr\\x18K%@\\n1q\\x07O\\x089=V\\x10b0vB\\x0eeKIB??@\\\\\\tR\\x06C\\x08`wi\\x08f\\x10\\r\\x17 \\x18794\\x12\\x1bD:\\x14;M\\x15rI 7L\\x0bPG0\\\\(Xy% \\x058~@\\x04fjai8,A~ {\\x197s\\x18!c\\x01T>\\x13PH\\x02W^\\rXd\\x18c\\x12:aK\\x01I?\\x7f\\r\"S^F@Lt\\x1dL\\x1a\\x004D\\x05\\n::5Gf\\x1c/\\x10\\x109`u\\x07{h_\\x1d\\\\$@pA8y\\x11=\\\\[bA\\x01Os1\\x04#\\x04x,q\\x07~\\\\\\x163\"b).Y\\x15K_/*\\t)=d\\x12G&`_\\x1ccVqv\\x02.l\\x10`h[]<\\x0f8T-\\x1d>oP$X)G\\x0c\\x05z\\x19j^\\x08F\\x0f!\\x01\\x16\\x14\\x0cPBPB\\x0fn\\x0c+ccFT\\x1b X/d~\\x1c\\x18kk\\x11m!vC\\x1c[.DS\\x17:]@\\x16\\x1au\\x08\\'\\\\dV\\x18(\\x11G!:a\\x1ci\\x01\\x00_1\"D!\\x02iVg!^\\u0558yL{\\x1b:}s<j$.&11\\x10I\\x13e\\\\Pd\\x05\\x1c.^\\x05R-_cfq_i\\x18(/\\rO,*\\na8\\x1d]\\x0b?k\\x13;vko\\x13\\x1fLC#\\x16I\\x1e\\x0bs\\x1c\\x0e?2\\x010X=D\\x0eUZ7Q +);\\rvpjoD5 \\'x\"6\\x0f\\x16M\\x15DM\\x04\\x04qkD2kZ$_11\\x04\\x07\\x00fQv\\x12\\x7f,lbO\\x0fU,|O_4J{q_Qo*`K\\x0fb\\',\\x08;ukJ\\x0c\\n\\x12!O={NwK !dd2X\\x08:}k3,\\x00Lv\\x18\\n\"H\\x02vL]@Tj$\\x04\";tzH|>Q\\n\\x02n\\x0c\\'PScY\\x141\\x10wAt]\\x1e7\\'*Tm6(}\\x02q\\x106\\x16\\x1aVq \\x1d\\x0c\\x0b!W[,eQx\\x06h[\\x06+^\\x19]\\x02\\x11pDWL;k8!jVe-3L6\\x04\\x0452b>D){\\x07Q?l8lTv]G\\x1c<2JFw=33jAPU\\x19Nrio6&\\x03r.\\x00B?4M1\\x07\\x075\"\\nY\\x03\\x18b\\x13\\x00\\x10w^?|O\\x03J8\\'\\x03>eEK&h\\x1e;\\x0b\\x07.pWH\\x1dL.`\\x04x2l\\x02DX;\\x04eDE\\x1b{\\x8aOmhMV\\x10cg\\n6\\x16\\'\\x0c{br{\\x1aI3d`\"\\x11Sd\\x12F%\\x1e1u&\\x1ffus\\x16g=ZR&:\\rt8}[G\\\\\\x10\\x00Z6.tNF3\\x03uIR5(?,\\x02\\x14q(EsVMuM@C\\x03\\x1fu!2d\\\\\\x06N\\x074u A#\\x08]\\x12quXu\\x19-;5QxF\\x19n|\\x14\\x9b D\\x10\\x1c\\x14\\tT<S8C\\nOp\\n\\x0e\\x1a@z(\\x17\\x0cs|-Z\\x7f3(rn\\\\\"ijol5\\x05n\\x12wlOd&\\x01C2:=p5\\x12\\x07x]J3x.=hYk<qZG%C\\x1c/jOMq;?Qf\\x0ew\\x1a`[-e(gTA8\\x0c\\x05f6#\\'b|#@7j\\x1f+\\x0cDr$X\\x18\\x1fTDR`7\\x1a\\x04#$\\x0eL\\x0c~G\\x1eC($\\x12i*Qq\\x18\\x0c\\n0E$\\x0b\\x12H\\x0bEXI\\x02@<\\x1fu*\\x1ez\\x14M3lo3+\\x11)eA-\\x10\\x17\\x0fE+\\x07p|\\x0ci\\x04\\x0f\\x12\\x1eJNcEI\\x17\"b?iFN4)\"\\x10!\\x18d\\x07I|\\x14U#\\x11\\x05q$\\x08P\\x05\\x02\\x04<E`)eBUJB/c_\\t<\\x1fMA#c^yRP(A!P0nuhn>4gO\\'b&;\\x12bhQU(\\t\\x14\\x14REq3I.d@\\x1aD\\x1bB\\x11I\\x7ft^#B+\\x162\\x0f\\x19&5&\\x179 Pj\\x1c\\x10|\\x1d8n|yy\\x13&s;\"$.-;Xid)6\\x1es\\x13,$7\\x0b>l\\x05bA\\x14)\\x12)\\x0c&L\\x1ec\\x08\\x05T\\x06\\x02T\"\\x1b[rhE\\x12:Dx\\x0f\\x00zI\\x1ckr\\x16\\x14\\x11sQQ\\x13\\x13a\\ty\\x1fUI9;\\x18H\\x08\\x05JK_Q`\\x155XUe`KK\\x03O1\\x04w?DPY[\\x16Ru+\\x107A@\\x04!58c\\x1eL.1g@e3Q\\'3jUhfH,\\x17u;{n\\x19\\x1d\\tQ;\\\\\\x03q\\x14\\x1a 5\\'DU>UqjrHD\\r2\"\\t\\x10\\x07n\\x03\\x0eQ~)&#\\x07-&NU\\x18\\x1dj\\x03\\\\\"yxpd\\x16@W\\x1a=]OnA\\r\\x11r\\x17\\x02{\\x195e\\'\\x01:MI5\\rQC=!+Lj;3{v\\x00t@m-840\\x1f!z\\x10\\x07.\\x00\\x05oJ+gJSc8BH9#b\\x00C]l\\x06v}!k\\x05fj<~\\n*\\x13k1vF9AVD J\\x14\"e0\\x12[+<QY4Q)\\x06uR,\\x1e#Me!\\x10PW\\x0e\\x06*dgO=^\\x1f$\\x0f#\\x1cz5\\x10OWJp\\n+El(HM5\\x0c^)hc>4tw@`_\\x05\\x00\\x1bK\\x01l\\x16\\t\\x0ev\\x11S\\x17\\x14(Hu\\'xAp %S \\x01H\\x11>\\x07T iUH\\x12@Nsc\\x10E\\x16f5,\\x012L@{r+\\x10e8B\\x10\\x17YN%z2YWcSx\\x13\\x04\\rJz@Edf81!L3:+ECUGC\"hrJ\\'FY/+rBmi9\\x13\\x01sp\\tCzL`i\\x1dW\\x17\\x12\\t\\x07)\\x16:\\x01\\x12r\\x14\\x15843v\\x0c%N[jDrb\\x05\\x11L*\\x18\\x12~\\x18L(_\\x05\\x03.\\r\\x14\\x1eKk\\x063\\x1fnHa\"\\x1a%I490\\x1c~&\\x04gw\\x10)0\\x0c$\\x10\\x04\\x042a\"(\\'X\\x0c\\x18\\x05\"9\\x140tEW\\x0fuf4l\\x06y1j$z\\x1cB\\x0be]3\\x0czM<>NN</iJFB\\x0esF-*u\\x0e7B\\x1cg\\x0b\\reia\\rM!>\"Z\\x07\\x103\\x080\\x022P\\nBXb\\x0eb\\nbduHu\\x0fo !Q\\x1c)N\\x10# DL\\x004;[\\x1c\\x144!&880dT Cb=m_cU\\x06vK*\\x01,\\x0bb\\x10`\\x144w4WL#FGt]\\x18\\x1aJ(\\x0eTa3\\x13\\x11$-]2BfXa)bn\"\\x1eV#\\x1e\\x15\\nq.%V,\\\\\\x11D.7r\\x12\"N\\x12M\\x12NwM00\\x18\\x00L\\n!$E30vbt0\\x17=\\x10\\x15\\x01=\\x15])|Y~Gk\\x19\\x11$D[@\\x16\\x18Y\\x13tRFO8M)RT\\x0bPk^\\x7f&0n`\\x01\\t\\x0c)qd%3\\x0cj\\x0c<&0u\\x1f\\x07,G[>?;4\\x1dgr^\\tb\\x14\\uf344]\\x1e\\x0f\\x1fH\\tAV\\nD\\x08\\x00\\t\\x07I/`\\x10\\x1a?\\tRtS\\x0fg=\\tt <.2ZA\\x0c\\x0eVdvi\\x18nUwp-0%I,K\\x1b%\\x1e)U|#O{\\x15]\\x05F\\u07bdw#L}T!`VwP{~\\x05QQuM\\x15h\\x08\\r,.F8\\\\K\\x02\\r bJk  0B\\x12aR~IQc \\x16\\txxV6( (E\\x15ce9\\x1669\\x0caM8^$`zk*\\x16#yt$xn\\\\k[Oe]<:\\x0ev\\rp\\x00p\\x08>7itO{N<*Jl(Jn\\x14Q\\x07\\x1f\\x07Q4JGU\\x12j\\x06@c\\\\!w\\' Tr,\\x15\\x1fc\\x05\\x17\"\\\\\\x0b+JH\\x05f\\x1bW\\x1c\\x02V\\x0e\\x03\\x1d\"Su\\x0e\\x07,dM;Vb\\x01\\x08\\x18&*f\\x13w)[Apr.\")%\\x15x\\x1f\\x08/E\\t8\\x12OD#\\x123W\\x17\\x00hwa\\x13\\x1f\\x11SXP,\\r\\x1e\\x1e3,\\x1eXt\\x14}O,b6Gl,\\x14C-\\x1a\\u07b3\\x14\\x01j\\x18e<7\\x82w\\x1ax\\x17\\x08\\x13euc)\\x1bxRvxk%\\x1ep%]tsm\\x115\\x07mTn}\\x07hf\\x087B:l\\x1c,\\x06$8u^4q\\x1c f\\nbH\\x034E\\x16dv\\x07-\\x1a3#@%P\\x15(f\\x0c|{;7rIsLTcB(u\\n\\x16\\x12/g-<bMCk\\x16he9G~>)N@\\x1buAKN1j(!1\\x1bTX\\x08\\x15<,w\\x1dx\\t/~Q\\x14WD\\x00|\\x11b80\\x03\\x12K\\x02*\\'Y\\x0b\\x06PYk\\x17R$)8U\\x1a\\x1b\\x15z\\x1bt_2wTEVl\\x12x<L\\x10\\x7fK{bn{\\\\)_lDAEQLx\\x0c\\x1aU\\x18\\x0f\\x04\\x07\\x1a\\x1bLZ~E\\x1d\\x08@L,D\\x11s\"=wV+\\'\\x05vdF\\x15#gjjQC^:_I)\"\\x16Zsgxz\\x17rH+\\x01n8k4,}\"\\x05\\x04\\x1c;\\rH)G\\nINBi1&\\x14D\"EI$\\x15e\\x04E\\'k?\\\\gWo:\\n_b+sbap\\x18K\\x1aDwIx!\\x10\\x17d\\x10%/#+4z\\x0bd]\\n-\\x02l\\x07<|s3BRNRr2IM\\x16\\x15\\r\\x0c0\\x027\\x1a}}> \\x11U\\r}&E\\x03j\\x08k&q[>\\x07 \\x04oaI};@-=V$\\x0bi!\\'{\\x07w\\x19Cs~g55\\x15MK\\x14\\x08GY5_D;\\x06j-t\\x18\\x18\\x0e\\x19V\\x18(\\x11\\t=OV\\x18-\\x10v~d>I\\x03&\\r\\x05Z\\x08h\"w9e5\\x14W\\x1a\\t\\x0f\\x11C\\x04j\\x1b@j\\x05AD.)JG)407\\x0e&\\x02/\\x0eFxD\\x0c=\\\\\\x00\\x15\\x17\\x17f:b{\\x08jAJp^\\x19pT/d\\x01\\x15x\\x7fR\\x03$J\\x18B!DP\\x0535<4])Xs@LBI#C\\x03kQ3Ru\\x00jKjz\\x1d&V:\\x00V.P\\x17VbtwXM\\x17w9;+&\\x12 `\\x1c=:\\x12\\x18\\\\\\x1c\\x1b\\x15\\x04\\x0fx&D\\x0c{y`!EBYN{L=2\\x01\\x13y9\\x02DV<w/DN\\x1d\\x14\\x01Xe\\x11^AT\\x16\\x17.\\x1d\\x10e\\x01\\x08k[kfQ\\x11gU[{B\\\\[|\\x1d^\\\\^I\\r*\\x19IC\\x12VayG\\x0f\\r\\t>pB&U%.\\x12D hB\\x145HQgh\"`j.\\nDq!jFa[\\x13kYgK\\'pm,\\x134d4h\\x058v\\x0b+g\"\\x7fcVU;&U\\x7fi9,g\\x1a\\x1a\\x16\\x0boE\\x15$l\\x07s2iOO5D\\x16M\\x1bH\\x06N)EL]Yzz]\\x11r^6i$ix%A/J\\x1e!9\\x16XJ`\\x04V\\x1e**^uXL6HRC/+oa\\x062<\\x1ac7\\x1b97\\x1f\\x00\\x18\\x10\\x037P[a)P\\x13Wz\\x1e0\\x01;d& *\\ngES\\x193\\x13\\x06\\x14C6dh(,\\x058`,\\x1eYj;\\x06VU\\x13\\x064.\\x043c@Oh\\x07\\x05\\x0c<q\\x18\\r?N&9\\x00\\x08\\x1ajcA/2Mr=)sf*IRskM\\x05Q\\x08?\\\\;v\\x13V3X\\x17&j\\x171H\\x10N(\\x12\\x08\\x16oR{l{\\x059QH\\x10\\x05\"c`L\\x1b*\\nr0,Oz,\\x11kEMA.\\x17W:;\\'a\\x03\\x1baW;w&)<\\x07+>Q,c\\x07[\\t6\\x0688\\t<2n\\r(Dt#D5\\x0cpH4\\t\\x11_~_\\x17{\\x13W\\nF\\no$\\x0bJt~\\x0c3U#U\\x15Z\\x11\\x1aG\\x14YV\\x02c3fe\\x12H8\\\\\\ued2ch</%bNv_zI\\x17^\\x06T\\x15/8\\x1a\\x0eh\\x138D\\x1elN\"y&eIj{\\x042W\\x1a\\x14\\x04\\x04\\x16|3*I\\'\\x1aHtc\\x11$j=8\\x7fOk0x\\x19xidY\\x1b\\u05cdao9UADnu\\x10nEn,0=\\nS=\\x05+\\x18\\x12\\x18<W1;\\x1en\\x15y=A*D>^\\x1egx\\x02pbhoI\\x16\\x19|\\t(T\\'U1\\x0bq\\x15VVv \\x0bkg%\\x00`\\x19Kn\\x1dkB/`(n|^\\x15Yj\\x1cp)\\x0f\\x06+vM=Dn:h\\x08q\\x02\\n*\\rIq\\x0c}&I\\x021`\\x1dS[d DXYfovB>E\"\\x1az\\x7fnQzk,\\x1a]>\\x1a>e\\x0c37)\\x02T5\\x1e\\x08LXY\\x0e\\x16(TE\\x1dR\\x19\\x0ba\\n;f!wB=9\\x10ok6|E x\\x01~PN#\\x12#},\\x08\\u0530W\\x05\\x10\\').Vgb\\\\/k%\\x08Q_0|W\"\\x02W,f\\x0fO\\x1cJ\\tzy7SV\\x7f\\x10xUL6Au9>\\x1bz\\x11w>X\\x1eWf\\u0382[_=tfuU5T(9@Sva\\x0b\\x1a0I[:$\\\\\\'AWq~i%I\\x12\\tWyE\\x0c\\x083(>p-um\\x1d+PkQJsJ!T1>\\x1a7\\ngA\\x11WI+Z\\x1acQB_-RBl$IE\\rM{7a9N-g9v>IMHU;u\\x16`G^A,\\x05\\x1b\\x159wE\\x18_\\x16%\\U000f2528\\x07>-:7\\x01\\x10\\u05c9Nh*[*c\\rf\\x06\\x11\\t\\x0ck8I5\\t\\x1e6h&\\x1ef\\x1fO5O\\\\jw@\\x0c|Q\\r\\'=\\x1aT\\\\Ogai*:tc-\\x11B?Mu\\x13K\\x14pa\\x13\\x19\\x18=l.l64z1\"\\x1f\\x13LSF\\x14H\\x07E\\x1f>:+Ham\\x151y7Y\\tw;\\'\\x11j$0mh&Uv\\'O\\x02;\\tIIB5I\\x1fI5n\\x0eh\\x17\\x0e$0\\x19\\rm@E=e]X\\n!K\\x1b:sZtkbJwO`68\\x08tF\\x0e\\x02\\x0e\\x08\\x1f4E$=\\nH6L\\x0bq\\x0eyQx\\x18\\x1b\\x12\"N~F\\x12XD%#XTl\\tw\\x14K%!~K\\x05fY\\t\\x15\\x1dg7&=\\x02iE;\\x1a)iI\"L4j\\x01?I32@Kf\\x04Zbj\\x19QE^g\\x13uBK&%z5- \\u2e7a\\x02#\\x0e}IW4sNWUF]$\\x19\\x07O:\\tv8a^h<!\\x7f&3o(J;Y`\\x12L,MHr\\x1b-Cv`@\\x0cQ\\x16oN@Pu#a$6\\x07 p{>XO\\x08+\\x0b\\x12\\x1e&\\'y8F*r\\x13\\x11\\x18\\x0f9\\x17\\x02j=TuPWpp;J[\\x10$=z]\\x08Q\"\\x13\\n\"RQ.\\x16;rvKg\\x1d\\x06\\x19kwa:em7*\\x07F\\x0ctN-k/B^\\x04E?YS\\x7fA$L\\x17\\x00!b\\u05f80Lv\\x1b8{n#WI& vFLH\\x7f+\\x1aZT\\x05J\\x00\\x03/\"\\x12l6\\x0eU|\\x0e7XO\\x16vVD#5i[;\\x1a;\\x7ff\\x1e)$.\\x1dN\\x02-\\x08vbWx\\x12!\\x01KN\\x1d%8XR\\x15\\x08\\x04%9\\x13s^mK,\\'L!N0\\x14Q-q\\x07a/b5-[A!sFXVC*#5\\x02*N&\\x18\\x074A\\x1c\\rR\\x07\\x12nPD\\x147\\x0354d%-Fb\\x174\\x11+\\x17t9cL\\x0c:u/\\t!_\\x12\\x13\\nUxh\\r\\x1bY7QyU5?l-b\\x1d03cDpWY\\x03\\x016\\tmMl3\\x01MiN\\x108+1N]Y3yyOh\\x05$2z#\\x0b\\x07\\\\l<\\x0cI,mHI[-\\x1a\\x03I\\x1e\\x05\\x14\\x0f}q,;?$b@\\x17\\u07bcwt\\x155\\x10\\x07:d=!o-0;H:T\\x0f]aT\\x13eg\\x18`\\x7fM\\x17x<\\x07r\\x12\\\\S\\x1e\\x0151w\\x0e\\r\\x15Ch\\x7fw}Ghi\\n\\x1c\\x0f\\x17UI\\x14\\x08zFz(zD\\x1bGqI=\\t\\x01Ak\\x1c/#EH\\'p\\rk\\'W\\x12=9\\x7f\\x134=W\\x11%$M\\x02qBP\"\\x1e3\\x1cK,W\\x13\\x0e@\\nhAMR\\x0c06`@\\x08/C4<\\x01\\x0b\\x12h\\x14\\x12{u=lBV|ghE\\x04E\\x10IL,8Ir?\\x17 %Q^bHQ\\x13V_U.\\x0c%vp\\x17!E~q/9\"EIv\\x05Mz\\r*=c]|o6\\x18pU\\x1f#\\x12Q|Y\\n\\'<+|\\x191\\x1beBJ\\x0ekaG\\x19\\x08Ai8V#\\x1b\\x11<lI2N\\U000debd3\\x16:HO\\x1e.%\\x19.\\x19\\x05.9R~0j`\\',-\\r}Z:J\\x1a\\x08H\\x0c\\x7f9\\x1eq\\x1dyJRw\\x0eQ&Z>=.S&\\x0bg{)^;DDt#72\\x08\\x11\\x0fF$0)D\\x19\\u038d\\x04\\x11xl4R\\x1aO\\\\udn94\\x07\\'\\x0fxcD\\x1eY\\x1c\\rx\\'*$~\\x0e(l1_pp\\ts\\tQR%=\\x15\\x013!\\x183;)B\\nco\\x01,\\x12D37^OniA\\x183q\\x00\\x19-u%:\\x0f7\\x1a\\x17845\\x0cz!Dar%Q\\x08>bzXsLZoG]`x\\tS2\" *~\\x0bpRjoeDe>!iEe<AH\"H2B\\x12Mt/OX=+\\x16>Q*7pv]iDl4\\x7fE\\x11G>Ae\\x19e^\\x13\\x1e\\x04&\\x05X.\\x06$6%s\\x1c\\x13v\\x13cK/\\x173Q\\'\\x1eE%&\\x08|~OV6h+\\x04_Hmi*hoR\\x1c:{a\\x1an8voQ\\x17W\";r\\x0f#+KV/]34\\x10\\x12v\\x1dZR|,\\x12V{~{v\\x06\\x03#gE\\x16DT%f\\x18E$GLoYA`\\x1euhX2k0u $\\x06V9D4\\x1d5Y&p^[q\"#T\\x0b\\'\\x14RG9Z*\\x1fN\\x10V2AdgEp\\x08B54P747\\x0b()\\x02NJ<Aw7_.^]V\\x1b\\x1a\\x12\\x1bV%\\x010%h~\\x0cY,U+z\\x17U\\x7f\\x1flQL\\x17RB\\x1d\\x18j>F9G<}2\\x11db\\x18>\\x00\\x13`%JG<[X=dE,I20#D\\x10[C_SAh;\\x0eKHjs>!<\\u05f919_ *\\x18Rt%>+v3s=[\\x14\\x07\\x0ewXY~\\x0bD5\"kuJC/p\\x04sC/\\x17-\\x1e7\\x1dK8\\x0b\\'EQo` $\\nt\\x17\\x15Y\\u07bd\\x13U>\\x1fk\\x16f\\x13\"52\\x06\\nS\\x03&)\\x02,wX\\x07\\\\}=\\x03\\x07\\x17z\\x14Vdm\\x085\\x03K9l\\x117p\\x03\\x05\"\"zQC+ob^flc\\x10ZM{E|(f\\x06\\\\\\x0e(\\x0bRY\\x154-;IY#Y\"#wMKv@\\x1b1\\nmp}\\x12SF:\\taK \\x10Lm9(8Bf\\x1d(!h3e4\\x1cT5\\x16;B\\x119\\x18t\\rT\\t\\x01*\\x06\\x1a&-6#Y.RUxm8%\\x1dd\\x03H\\x0by]E!\\x10c>Q\"\\x13\\x11^U#(;\\x18i\\x0c\\x1c!9ld%nh\\x1aY\\x05\\x11xAZR\\x1fBsA#P[\\x12&JZ<Z8\\x10\\x14\"\\x1f74K?D]8=b\\x1e\\x11Y\\x11\\x17Hf,lc\\x0e\\U000dde98g^\\\\IvfC%\\x05F\\x0fEj\\x1f\\x19&EGvF9\\x15T-\\x17-l\\x08\\x7fF {*aP;j!\\x17(\\x08y^8\\U00068e40:\\x06\\x07!^\\x19\\x07svmR\\x14o(i1]6[\\\\\\x16A\\x15A(\\x06#SO\\\\70.x;L\"; ZMMs]|{v-W\\npM\\'Ix{K\\x1a%E6\\x0e|V\\t!M3\\x14<\\x06\\x05}K{\\rvKF;\\x7fYi\\x10k\\x01\\r5FLKZ[%(\\x04+N<.\\x17frY*Kz\\\\\\x036\\x15J\\x0b`\\x12\\x03(x5iJR\\x10m;\\\\$Hz`PN\\x0cB+\\x7f&[R%hv\\x1fJB{\\x1e\\x18]\\x05\\x1fA[\\x03oidLz\\x0b|G\"\\x18ek2w0rn\\x0f\\'\\x0b*WA{b9+5%\\x1e\\x7fc(M\\'\\x11gRpqmY:\\x04[n]E#\\x1d,@GH\\x12C;TjQ5\\x13\")\\x08\\x1aSND9)SIRt_%\\x19 \\x14ofD\\x05+\\x0c}$9`2_\\x1aq\\x1dXp:\\x170JWo\\x15l\\x18Gj\\\\-.%\\x13\\x16\\x06\\x1e-Y\\\\[E4Q@4b\\\\Ll`\\x12$HP\\x03|= \\x1b3\\x16\\u061dR\\x14~\\x16VaJ(\\x10h\\x18y=\\x1fQ;,y{Op>yT\\x08RU^PMCZi Hrn<k+G_ND|(1L B\\tF3m]E\\'w\\x10C!N\\'l\\nV\\x0b\\x16I( lc3(\\x05O&iLo\\n<>\\x12J9\\x1e\\ta8&I|Q=m\\x01!\\x1b\\x16Bu\\x08K(*I<u^\\x02\\ty\\x1d/=oJ*aekQDYKXUxW DH\\x0fCI\\x12\\x04V8i\\x07J\"M!rW@<KD`\\x12g/C]b)hn6\\'V>cyN\\x12: ?: B,\\t9$\\x12\\x0b<Ww8))<M&\"\\x154 J$\\x19ZQ;u;b#Zl_UjKy\\x0ea\\x19YaYhh\\x10A0Jc]>\\x1dX\\x1a\\x02\\x1fHkhK7Ww}\\x1eu\\x17R\\x187F3lL\\x06Po\\x19\\x04GgEw\\'G|\\x1f\\n\\x08o\\x0fgYJo\\x03tl90EyQ/\\x08\\x12 j\\x05\\x0b\\x00F<K+v\\x18\\x04\\x06\\x18-\\x01M27\\x10>\\x0c1\\x07\\'g*\\x0e\\x04J =\\x03\\\\bsrayJ7\\\\\\x06\\'ee/\\r\\x12S44MyL\\x0bA\\x0bu\\x17\\x1c?\\x1dc\\x1ea\\x08adAY Lp\\x14\\x05Q?\\x0fb*I*ko\\x00N\\tuetX\\x0cb3VNtM)\\x12\\x06\\x0e\\x03\\x05\\x07FY>z1\\x16=/\\x0cTW\\x01\\x14\\x0cP7\\x00+)os[\\x00*.\\x0b\\x0bgR~p&\\x12[\\x00Pw`3.8.I]8p&wL\\x1d\\x05\\x13/>\"FaIXTG\\x18o\\x02)\\x06cc0.z\\x11Xp#O\\t0O\\x10`\\x14~2\\x05L\\r4\\\\~*FF\\x18uEPe:VMSe\\'h6\\x14E\\nk}\\x15\\x1bOD(;!%@`u7\\x1a9w\\x7f>\\x17keW2D^.\\x0cj\\x0b(\\x1f\\x15bu\\x0bkODJ0{!j\\x04\\x04d^G~3\\x1cj`\\x08o1\\x14\\x1d\"*x\\x08`\\x10\\x0e\\x01h\\t&!Q\\r1 \\x0epO\\x16/jRU}}{u\\x0cz8\\x1dr<[\\x7fQ\\x7fx\\x04i,c\\x16\\x0fX0Kl=2(\\x14kMY\\x1e[\\x1bx~)hON-w\\x12\\x12GOU9\\',t\\x16fIe\\x02d\\x15()*+%M\\x04\\x02I\\x0b\\x1a]Z>\\x06\\x01RRHy [b&}\\x1e+\\x17V?t\\x0cO9\\x07Y_]\\x1bK{l.\\x12Qga3:M\\x08[~<mo\\x07\\x1f]m\\x06^g \\x13W)\\x0f+s\\x1ekC_\\\\3V,`Cym\\x82\\x15^.`\\x1f;\\x19\\x11M+\\x0f?2vj< yr,\\r~\\x11`p\\r\\x00*#,t\\x16P:l_^:\\x11y\\x0bWw~&gBw\\x00Xgrt\\u0602*(_\\x0fyF\\x06z\\x12[<#_u3[<:\\x19!\\x0eyu3Cc*o\\x1d\\x0c7x[<Cn>d&=%=\\x1brz \\x03^=\\x13\\x15{d7\\x15k\\x0e\\\\b\\x13QG=Ge\\x10%EW^\\x03pKI2JW\\x12)I\\x0b=bahj\\uf115xYk\"pd[!^\\x1d\\x0eY4z\\tywe,\\x07p\\t\\n\\x7fLd\\x0f\\x0c\\x13Ur^?\\x1b\\rf8j\\u07b7\\x06\\x17jB\\x0b9$N1I\\x19?aw\\x0f\\\\:\\x1f~\\x05w\\x1f8+-\\x99r_y^w0x\\x0bB\\x16s$+\\x13YL5\\x0bG\\x05R\\x13E\\x1ceGG\\x1e(\\x13|(q%1;n}^\\x01S=~CV3m\\x0fjW>\\x04_\\x07w\\ts\\x0ec~6\\x1d\\x1ejkI\\x0c}m5\\x1c8\"\\x18W\\x18\\\\o7o\\x1bQDIo\\x07xXe\\r/a^?H=(|Fu)oZ\\x0fB\\x19WY#I\\x11Q.\\x14\\x10V\\x06S\\x0f7dV`\\'\\x1f\\x7fT|;f$a\\x03U\\x06z\"|~BR?TN~c7\\x1eV\\tld\\\\wTL\\x11olF\\x1af~4t\\nRs:(t\\x11)\\x0e\\x17y5\\ta8UfS\\x06\\x1dG\\x06dQ9\\x05\\r-uWn\\x06..%.{}yC!u^b(W\\x1eRZGK\\x18\\x12vl<Cs%\\x01nGXk\\x1b\\x14D7sHU\\x14\\x17u\\x03lr4d+ZW\\t\\x19O^Xr\\t\\x7f\\x14kDl|2~[2K\\x1f]~\\x1d-k]w\\x01Or\\rm;9\\x19Za\\x07 \\x18s[X4mWA7\\x18X\\x01\\x1f\\x04\\x17lk[g6EP)!b#G\\x17;\\x026\\x0228\\x07\\x0fd\"$@0\\t]\\x12f\\x7f\\x17j\\x1f\\x05\\x136\\x1c^{nTZ\\x17qNfz-\\x1a\\x1dwKh;bzIVs\\x19\\x0b\\x18Ko\\\\n#!r\\x10W{&-@\\x0f\\x1d{\\x024-Bae%A\\x14>;\\x02\\x10;vTs]S\\x1c+{Rd=\\x16EgEn4YSA3\\x07t=AZgSg\\x08t\"\\U000a4b29\\x05\\x1ddKx.dC\\x0eRQ\\x0bq+w\\x05np]|\\\\3\\x1cD\\x11Y(8*^\\x07\\x11 d\\x00g\\x08J\\x01P@v\\x16\\x7f\\x01hx*zEb\\'\\x18\\tZ2Ema\\x7f\\x17o\\x00k\\x01_p\\x7fXfb>\\x07Zv\\x04w*h\\x19Y\\x03xy\\x1ag\\x0eHa\\x03x\\x17\\x07{\\x1b\\x01bZE\\x07`=i\\x05[Gzru@\\x18o#\\x9cE\\x0585\\x02|\\x00,RA`BV-3\\r$\\x0b_:},\\x1e/\\x07=yA\\r7t`\\x0f/\"!U\\t8\\x0f\\x05B\"lrST\\x10c3/\\x18\\n|4\\x1dP\\x0cn\\x02BcMA,%.~\\x03\\x1fH@t\\x0e\\x05\\x08>b%.\\x01Sx3<bk\\x1de\\x0eR{,\\x02\\x00hT\\x10\\x00s}\\x10]\\x18 h]=\\x1711\\x1f5%kY`u\\x0cY:bXlmwn~PGnX=6f\\x179[$\\x08Umk0\\x0e4_;y,/,>\\x11\\x14oO+/\\x13K\\x1b\\x01\\x1eSal\\x1a\\x01\\x1aM7^\\x14\\x10l-i8Koxy4h2wV)\\x0f\\uf8a1\\x1f}r\"\\x1f]Q\\x130[;1] LrBJT1,u\\x00Uz\\x0eU\\'k\\x16WkLe_R\\x11@.m\\x03\\x1b\\x11\\x05Cgb?\\x1c\\n\\x0e\\x87\\x03J\\x08\\x11_\\x177p4$\\x061\\x07IJ\\x199BG\\\\p-[nz#_\\x1dH?yu\\'\\x02I|b~lSE\\t?U)Y*\\x05I\"R\\txaZA$UJoHLM\\x15\\x13\\x17\\x1c\\x1c?CO\\x14h)2/%wQL/m{PceLc$0\\\\C\\x02\\x07\\x11\\r\\x1cUun6\"$g/.\\ns*5+\\x14K!, |i\\x1aAU\"g\\x7fr\\x18&fi$E02\\x18V\\x0b\\x1d_zvI\\x05\\x1bPQ\\x18FS\\\\\\x1bE(r\\x1e[_hTZC[`s\\x10d\\x03C.\\x18Nf8u\\x03(l\\x1dzrC:7\\x0b)Q8GN\\x12\\x1dr2Z,xt3\\x08B\"rLC\\x14%Ii\\x1b\\x02mKY9qyzbWZ\\'UR]I\\x17ulC\\x08S\\x17-\\x13((dc~\\x08\\x7f]@\\tj(J\\t\\x0b\\x00\\t/5\\x1cG\\x0c%\\x13\\x08dN  p\\x12ry/57 \\x15\\'*\\x123E0QE\\x10\\x0b\\ru\\r\\x11SN\\x07N\\x02\\x1cMn-+GmO|#!\\x143Z~8-\\x12?`ZZ@JY<\\x0bk\\x15\\x1a\\x1fMCV\"9|\\n\\x19NM4>\\x7fw.]dG\\x1cc\\x1et\\x1e9\\x16\\x0bz~<h#ppV\\x0f4\\x01uit~a+xI`\\x04.8TB\\x11Y/\\nwY]\\n\\x01\\x13C3{|\\x03H t\\x19\\x02nZ#]\\x07;\\x1b\\x07[w[4\\x14+x\\x02Y{c\\x03\\x7f\\x14gW\\x16Os\\ueb677o7aN\\x11TI\\x0f\\x02[$&\\x01h\\x01-Mt<\\x18\\x7f{7RP\\x1cX^Q\\x04A|`e].a2;s0X`\\x07I$ewRI\\x01!6`\\x18svs\\x0e(i@2\\x17\\x85wK\\x17\\x00!I)\\x05\\x01.{mh\\x03\\x180MA\\rz\\x1bl?t\\x0cM<r\\nEP\\x19\\x1cy1O\\x04\\n>ot]U\"|vtl\\x0eu\\x18s\\x1c\\x03\\x15\\x02\\x17\\x14[\\x04Y\\x1bM\\x7f\\x15oo2o(X\\x12\\x06b\\x01W\\x03\\x0e/P\\'0.\\x06P\"G2/jzy&+Zv\\x10X\\x15 q>\\tK\"Gg1w)\\x05`\\x021eUT\\x7fU\\\\kI!\\x0b ^\\x16Ax\\x00\\x17-pE\\x0c\\\\?)) F\\x1bET3ku`\\x1a$\\x1a:*\\x1bk:< N\\x1d \\x17\\x0fDBv5Hb9\\nGbJAK<\\x02_>\\x1a$\\n*fZ\"!\\x01$\\n0K|\\x05l\\r(6\\x15j\\x15:uX^YS\\x183`\\x05\\x1d\\x0b\\x04xL90\\x1aA/\\x7f\\x15]SX|B\\x0b\\x0f\\x1c];xk\\x0c.~rR}C\\u05ee\\x0cx50oS4\\ue393\\x1f+\\x07\\x7f|\\x053.cjpy/Y >\\\\\"_\\x0bD\"\\x11\\x7f\\x0fgd\\x17X\\x0b\\x18\\x073v\\x01:ka\\x0f/Qt\\x0bY\\x1b\\x0f\\x0fAQci\\x00.;H[\\x12]9?7tX\\\\@(\\x03F&\\x16B\\x0cW pW\\x16H\\x059\\x0b\\x00h$^X^LXbv\\nd\\x0b5~\\t5A.d\\x18a\\x1c7\\x01YR\\x05\\x0c8x?\\x04\\x00t\\x1b|p\\x18rT\\x06\\x7fh\\x07\\x07=H\\x14\\x1bI~\\x19!\\x15Y6.g\\x15\\x01f[`t\\x19^,$\\x02\\'P\\t4\\x081w~\\\\VBU}z?c\\x105\\tt~!KwN\\x07 \\x1bN\"Rp\\x120v=;DIQ :\\x1e&p N..\\x1c\\\\$Q\\x13B04k\\x18M/\\x08)4\\x17<\\x171\\x0bB\\x1aENA7l\\'\\x10<\\x07F\\x05[\\x07\\x1aPBa?Az)fP\\x07S3\\x1cxI\\x17\\x14\\'qr^_\\x1b-\\x15*#\\x1dH\\x05,kbY6[f\\x14\\x7f\\x16w\\x16\\x15d?\\x15/fZ9t\\x17E\\x18R\"\\t\\x19\\x16jkx_4{\\x02$\\x06\\x1e\\x0cyA.R(-j\\x08\\x1d%x\\x12C\\x14a\\x0e\\x19Cg\\'vf\\x0c\\x12\\x01\\n_\\x0cajf(g\\x0clRQ.H]a\\x03?j\\x0fF!,~\\x1a\\x18:|}U5%msTq\\uefc5\\x16dAwUa+\\r]& \\x0f\\x07\\rA04j\\x0f\\rIV\\x19$f3\\x1a-)lzu\\x1e\\x16\\x7f3QC\\x0e\\x19H)jfAN\\x112fV{\\x11naFE-!kFv\\nU$\\x0e4\\x1b}\\x1b\\x0c:32M?S\\x1f\\x0c\\x01^\\r59\\u05fa[oz}Pkn\\x07>4?wGGz5\\x1fSj6ZVYQcTwzzlu\\x1a~k#ky5\\x1bcav\\x1bV[\\x1fn;\\x1fXZf\\x0b\\x1e5]?v{Z\\x1a^=55\\x18\\x1d\\'c{7\\x10=l9ln_\\x1b\\rm\\x18>eSo\\x07^6#\\x0e~\\x0cuajQ~T5Q\\x1f{:V\\x1f^\\x7f\\x07q8zG{\\x00\\\\\\x1aL\\rl[O~:z\\x0f:u\\x0cIvS4oV\\x1fu?|t)OO^u;V^\\x1fv}\\x1fVc\\x1c=YCkd\\x03<VsTZg\\x00vFyl-X4wGzi\\x06Ta\\x1b^}ju\\u06dd{S\\x1bQ\\r\\x00\\x19t\\x16 S\\x04+8\\x06\\x07Mk4\\x1a>7aQe6G\\x01\\x00=V\\x17y|\\x1av\\x1fu0Uo\\rz<6[S\\x1bnU\\x13`X\\x07v]v\\x1avqd>~\\x0cZ}}%\\x04Pae`O\\x0fQ\\x7f\\x02N=\\x1c\\x0cF\\x00k{\\x02Y\\x024i\\x00\\r\\x16\\tV\\x1d~4\\x18uz}MXj;;Y\\x13\\x06?tZ\\x1b>_kZ\\x03!\\x06\\x0eY\\x01\\x0fG}\\u05ec\\x1e>\\x97z|4D\\x03\\x16b|\\x13UF5Y\\x15\\x04.\\x18Rj aZC@\\x07^A7Z\\x01\\'b\\x1don}w\"[o+\\x12\\x1c6\\x1e\\x00;w\\x07c~{tQp\\ue3c0\\n\\x14|\\t5\\\\jo\\x0f7e=9kPGPm\\x1aKm`(-Xpk\\r\\'\\x05*{s\\r\\x03G\\x19m8\\x18}i\\x01G\\x0f%\\x01pdvjH\\x1dc\\x1fa-{}_c\\x1dTaMd|`>\\x145)P\\x11I{}^H0\\x02*\\r-X@\\x16#[?/,o04f\\\\v\\x13\\n\\x02.\\x07$n\\x0el\\x7fFv0h\\x1f\\x197G\\x02C\\x19D\\x16p\\x00\\x11\\x1bf\\x01\\x7fXn\\x10+\\tdxs\\x0f\\r\\x03\\x07\\x1e\\x7fm\\x088cN\\x1fPyyx\\x19v\\x0f\\x08*7\\x16c\\x02\\x15i=LuL 5wSwv\\x1bj-a\\x04D\\x1f1\\\\=j$~\\x00\\x07us\"/J%^)\\x11w\\x05>\\x17n)^-\\t|\\x16O,#Fwq\\x16\\x166\\x01d.\\x1fn<V=\\x15\\x0e&h-+c\\x07\\x05uH5\\t\\x11~G-\\x7f<lN\\x11\\x1e\\x03\\x1e\\x1634\\x03==\\x1fE\\x06\\x04p%@u>PD{Z=\\x0c%^K@z\\x0bX\\x0b\\x06\\x00[r7K\\x1aG\\x07\\x14\\\\Lm^{7 zOd\\x1b#\\x17\\x1aD~fc\\x05,L\\x08]:SN\\x0c2\\x04Xh\"D/\\x10\\x11o%%!sc*7\\r%H<Me7a\\x15b@\\x0cXap\\r\\x0c\\x1cx\\\\\\x048saeX\\x12\\x0c\\x19q\\x05\\x1f\\x8et0i#~|K(\\x0b@\\x0fv!#5\\x17\\x1c\\x17&)s5@v\\x05%f!dfT@\\x00w\\x13X\\x03\\x03\\x0e\\x12\\r\\x06B}s@1\\x12\\x0evGAow\\x04 kK;c\\x0e\\x1d\\x00X[27t&\\x0ece%H<I,Z\\x1dp\\ny\\x18\\x1f\\x00m$an\\x0fn\\x05:bVo\\x080\\x12yeCO>(\\x1f1t\\x05\\x01 \\'a.a1\\x15\\r\\x13-Cij=`\\x1c\\x10X\\x00^\\x01\\x7f\\x19\\\\\\x17\\x1b\\x1d\\x0eya`\\tT\\x1f\\x0eM90\\x89S\\x03vV\\x1c`\\'\\x10%%Lnosc\\'6\\x1c:\\x0ba9\\x062.\\x192Bu`2n\\x16\\x08\\x19\\x18<o\\x07\\x1d\\x1f}&,\\x11>}pH3mNQxllfM|PNy];?\\x03h&\\x0bh\\x1d@\\x14qH\\x1c\\x07\\x04\\t&:(s\\x0c~\\x075?*p\\x0b\\x010O<g}5(z\\x0f{\\x19x\\x1a?{\\x0eUI_\\x13\\x03>nJ\\x1a\\x0f<{t\\x05\\x07n\\x0e!\\x0cQ6\\x10\\x08x%\\x10 ?%\\x1d sI-0q8;\\x04\\t\\x06y(<M\\x02\\x18\\x1c\\x0e)\\x0c\\x18)\\x13 \\x109\\x10\"\\r\\'C\\x08\\x1ddS \\x0b\\'w\\x10\\x1fn1C\\t\\x18(?\\x04;/u5rC%-G,\\x1ac5\\x1aEVbhG\\x009wLcLBQ\\x1a\\x16F[\\x12\\x1b6\\x02o-\\t\\x1bDB\\u0605(UwIX\"+G@Ah= )\\\\B O\\x07\\x04E\\x115\\x1c|[\\x1dm \\x03$\\x12xk~\\x19k\\U000e794a2w4)\\x08CnR\\x7f\\x03->)B\\x02N\\x16$ dNKE\\x1aF#5\\x18\\x0ctf^&\\x1cl]TBlJGO/\\u05fdah$\\x19Y3E^R\\x05@U\\x12Ap7)eZ\"\\x08ZdV\\x1f\\x12z\\x14Z\\x15RfgUeR\\x05YHcM*MD\\x12z\\x18HT1p3{\\nYS#\\x0b\\x12\\x08,k:Qy$wl.(\\x1f[\\x05Cf.;}xc\\x1d=\\x08;\\u058chE3\\x0f .s\\x01\\x14\")\\x14Q,*}=%M(\\tG\\rmF6K{\\x0f \\x02\\x1cT\\x1cXGC#\\x1a+D\\x12\\x0f\\x13[\\x18_T\\x1bK,l}wBW\\x1e\\x1580kznGfFf~uQY\\x10xYwiB3\\x06\\x1c7)m\\x1be\\x0eS\\x0e\\x07ns\\x15u;\\x1c\\x04]s\\nh\\x125\\x11_G4ve?DK\\x0cBDOBRT.HE#\\no\\'\\'>S\\x0f= \\x1fn; \\x1a$\\x1d\\x16=J\\x045$cU<f;\\x14vWiu+[W8\\u1cc9F\\x1bs;\\n\"-2\\x0b&dn#m\\x02r\\x1d\\x17p\\x00\\x08(qx\\x0e\\x1cmak@A=7 -|\\x12s8E\\x0b63%-\\x1dnx[ox\\x0c^.>pcgn\\x1ezc\\x1a=\\x1fhK}@\\x18\\x13aa\\x17\\x04Cjn#}\\x1d9UP\\r}4$Q\\x03/\\x18o>\\x1ad%\\x0447yfM]@w9\\x02~&\\n+4YR\\x1a\\x1d`\\x1fB\\x1c2}\\x06*!#\\\\\\x01Xnq|d8cXHS\\x0f\\x13s\\x13~Ud#Z{\\x1azNn-t|4&x{k\\x08\\x1eu\\x198-\\u07bce?<o7\\n\\nQ\\x1a\\x04C\\x7f\\x06[\\x1eq\\x1c\\x01/Z\\x7f1#G<<$HFs<}.\\x11\\x00\\'\"UM)ygp3\\x15\\x00\\\\`&K7\\x0b]:D[aC\"\\x05-:17Y8!.9\\'D[j\\x14C\\x17S\\x1f;\\x13x0\\x14Jf5&J611u+|\\x18\\x02W\\n!Iy\\x00\\x01Y),`\\'f\\x08i\\x18*\\x13(:)R>t2\\'$*(\\x7fNZ7Xc\\x1f=8K\\x0c.\\u05f9xtTrRsIX}\\x19e2\\x0b\\x7f;{UYwTMUO6Hkx,TF|2~T4p>F/I\\x195\\'\\x1cpUL\\x0cpo\\\\:g\\\\`c\\x0b7\\\\xJI~\\x17Ro,\\x1fmf\\x1d2\\x1e,%\\\\2\\x1fH*3fOM\\x7fe.[PcW\\x13~D|G3f;|G3Ic\\x1b~D\\x05^J5\\x1a4p?\\x02e=S\\x10r~<cA4a\\x15bN\\\\\\\\{lOD\\x1e\\x13\\\\nCoaT)i\\x05kcZd\\x05r\\x15V%*I9W\\rI2{7Oh\\x7f\\u07betB>.0,i\\x1a\\x07qmt\\x12<3\\x1eK[\\x0f>X\\x10&\\x1e\\x1fDW(B0\\\\R1z:V8Z_D)_!%5*s_\\\\4\\x15IUi\\x17gUIBB\\x17ipf-/j \\x18-\\x12]\\x1f \\x05\\x19oAH\\n}X\\x14oDU\\x13~-\\x1b,\\'Ye.\\x07%\\x19Y\\x16.\\x0cp?efH:K\\x1e\\u0df0.\\x1a\\x04K4PF$oH8\\x0c!*!`:\\x18\\x18J\\\\v\\x1ahqQ\\x05IZq1\"@\\x166+0\\x1f\\x06!>Az!In=a\\x18AT(>>hEFC\\x1b\\x11\\x17\\\\\\x03s4>!+\\x05\\x12Z<5L\\x0ch\\x08\\x17fN\\x0fHF\\x02\\x0b>(00bC\\x10\\x1f#`pu\\x13L\\x1d=\\x1c~)\\x08\\x0f#1u\\x12j\\x05hDc\\x0c}\\r\\x1aT?\\x1aFi\\x0c\\x1eeqin#2JEEH+\\x16\\x15dN\\x0cy! \\x1a{{>K]{0o\\x15W=s\\x16^`5g{Gy-\"\\x07e\\x08rA\\x0b!wH\\x0b3{ZhELpuK<\\'\\x0cK\\x08\\x12_Z[\\x12u=\\x01N\\x02mn`N&4Z\\x08\\x17>&%:by\\x0c\\x00\\x14!kr6V\\r\\n>H\\x0bD#\\x1c\\x1d:x\\x1d\\t\\x1bE2=?TQVC_s_o7\\x1aw\\x1e\\'ysC\\x1a&aD`ic<Va\"\\x15>dm>}\\x1d#\\\\\\x10)[XGh5\\x08\\x12:+\\x07q\\x16\\\\\\r?V\\x1c{2\\\\\\x10\\x07\\x1b`;\\x00&\\r5X/g\\x0b|l7#OZ\\x01\\x0c>d0kO\\x06Gb;|\\x11}-\\x18\\r]m_f^o\\x0b\\x0bN\\x08 \\x1b,a\\x0cC~\\x03\\x03\"\\x033+u^\\x00\\x11Y`{\\x1ey\\rbP:^\\x19HK\\x13@(\\x14.\\\\wT\\x01}\\x1e5N\\x01az\\nA70h{p\\x1fe`7\\r\\n0\\x193\\x0cV\\x01\\x16\\x00QrrX)[\\t\\x10E<g?\\x1d}k\\x0bL[\\x03>\\x1bu\\x04\\x0f\\x0b\\x01\\x04f+-<6hc\\x0c Ia\\tWdd`\\n!h:l)V\\x0e\\x1b\\x17n[\\x01f\\'q\\x13v](|\\x08.+{pq+]6},^\\x19E\\x0b\\r\\'\\\\W9w]Xl73F(\\x02o4tvf\\x03\\x00dk_B\\x10=CA\\x1dKwdYb<<:\\x1d\\x0c\\x1aolh\\x00J^dn81t\\x02|m\\x0eO&y\\x1d\\x06xf\\x073\\x17\\u05ceN\\x13=x\\x1a?!\\x02\\x01\\rd\\x1eE8\\x1eUxv\\x01U\\x11=.\\x11\"=\\x1dQ!f\\x07-\\x10%t\\x06=GwcZwt8D!yrD\\x1c\\'[f0Bj@u4\\n=\\x17pA[8>[VD(4[#vv\\x01L\\x05@^\\x11g#\\x02GgztXw\\x04Nt\\x1e\\x18\\x1f\\x18&6\\r8.!T\\x1bWnmX\\x1aQw\\x0bJ>yB\\x12v)FK6H~t\\x02!\\x1admM #\\n|\\x03}\\x17N\\x1c\\x11\\rAct\\x1d\\x03u;,n\\x0eiL`qC4\\n_ATu\\x1dc?\\x1cHm#f\\x11[1\\'p\\x1e\\x07c0@\\x15\\x11\\x7f\\tK\\'yGI\\x18\"7;o\\x0e^\\x18/ JL\\x04JK\\x0e\"S\\x1dri#\\tM\\x14>ay\\x12-\\n$7\\x01\\x15?C\\x12yC\\x1e-tGEz\\x1cI_:\\x10^ZP&|\\\\B\\x10\\x13sNN\\x18!)*JQw\\x14A`c(d`9`H.H_\\x0bHrM2\\x04:krW\\x18LN>=RU\\x0fFt|\\x10\\x0b*Ww\\x16T&o&\\x18T~){]i\\x0fH\\x00>S88C\\x13\\x05\\nJ \\x00W+7fj}\\ue57bg*\\x12\\x03(\\x1c\\x18nh0{S~\\x01<KZ\\x02~fA\\x07a\\x105P@d_\\x01S\\x03NJ\\x1d(SE\\x1diltw\\x1b\\x04\\x0f{ujc\\rc\\x1fK\\x05\\'%\\x10Mo|5w{\\tK~\\x01kW7}{K?3vG{DtR,%v-u~Ow\\\\2\\x14KbfrL|\\x0ckR,DG^zPP3\\x000cQ%a\\x17\\x00ZP}xzr}.eiK&wW\\\\1-\\x10M`\\x1f\\x14QzML\\t\\x08\\x07=X\\t.\\x1eFw7\\x00zt\\x0b\\x0f\\x0bBRt\\x04s\\x10\\x06Y5\\x03(\\r\\x170d;S\\x03rmR\\x1d\\x16\\'\\'K7qF\\x0ca C\\x0eC (,Co\\x0cMg\\x14v\\x7f\\x07c0r\\tK\\x01fXX/S\\x19p(m!7Q[1\\x17tL\\x19o\\'~\\x1el#{b\\x13\\x08<\\x1e>Q!s\\x0e\\' d\\n\\t#_;d=\\x1cXj\\x1c\\x0f\\x1eK\\x18\\x04/\\x1fw5X0/\\x0c\\x1aMnTpa6\\nI^7\\x1c\\x0e-\\r%\\tn\\x17Cf}S5~!d|~?czc\\x1a\\x1a \\x14`@7j1\\x0f\\x00ij\\x14:|5%\\x0e\\x00\\x0f\\x1a\\x7fCa_Prk{\\x02Gi\\x9b/\\x19{k\\'\\x02MT1mBC\"\"\\tj~\\x02]:q\\x13V\\x1d4\\x04\\x0b$Uhwv\\x15\\'!I\\x05wpF6\\x08\\x01]Yz_\\x1b9\\x1d{@ab\\n,V:@\\x1flZ2n\\x07[^($A\\x19g<\\x11\\x0b_\\x13yz3C\\x0133o\\x11IJ\\'B|N\\x1eLKQ]Gc\\x1c\\x06ru+FQ\\x17\\x13) \\x04\\x00B%44d!=\\x1c\\x7fSAr{\\x07\\x08)\\x17K\\x16~ln\\x1b^H\\x10\\x02#,\\x1c+L+$#\\x17K{\\x024.)\\n%D{\\x14P9*KR\\x7f\\x15o2\\x01d\\x14HLx\\x14D\\x1a`\\x1bl7\\x03\\x02S\\x0eD\\x1a\\x1b\\x11C\\x10rvQu\\x1a\\x07\\x015n{\\x00w2s\\x039`\\x102gNi&n\\x19$2\"cUT%L\"l0p&\\x10+i\\x98b(Ts\\x15T\\x05)\\x16X,Mz/ GL\\x16T9U{h{yXq\\\\X\\x11|-{IY\\x10\\x03\\x11\\x02\\x14EK,\\'\\x10\\x08\\x19yV\\x1d|O*^g\\x1d>\\x0f%qQ\\x041;V\\x06\\x0cZw\\x16;|z9\\x02\\x1c\\x1abBU&\\x17W\\x177j3\\x1aVG8\\x01K#lCWyze8]>\\x1a>eI5a\\x1dL533gI*NM}\\x14nn`O\\x17;4`cf\"c4\\x00\\t-gRU\\x19M\\x01A)(\\x16}7$\\x03)pol\\x0b\\x0b5 \\x06\")%U?xO,\\x17$\"i\\x08;E`\\x13C\\n\\x12\\x12(=\\x06+o@:!3\\\\!9P\\tk\\x7fI\\u0e64kq4H\\x08GQ2]\\x0cF\\x0eFyT=\\x16/QSnC\\x02e7\\x05%cOw*\\x05a\\x0b\\t\\\\z5G\\x05>n8\\x1b\\x14U\\x7f.l[\\x1fb#f\\x0bv\\x1br2P2\\x19Cm\\x16}\\x0fE\\x14\\x0er\\x1an\\x1frjw^\\t?\\x19\\t[X?_+o\\tgX8dC\\x11a\\x16RTrH\"\\r\\x00A$6TK\\x17<\\x1b\\x03P\\x1221!.8<R\\x08*@EJE?\\x00ab\\x08v\\x17wK\\x19I\\x03\\x18\\x0b:zz\\r`-\\x05>e\\x1e:+\\x16\\x02KY\\x07\\x01&M{BQt,\\x19\\x0e\\x18wr[d\",dRVRA!\\x14\\x14\\x01<4\\x1cw \\x19v\\x19VJa\\x13\\x12{6p/a/@\\x02Bd\\x0e|IJ\\x7fd!\\x16)[vQ\\'pJ=\":CY\\x12L\\x0fBN5^\\x06,\\x0c3dA$\\x06v{-g9vg\\x04\\x00k-\\x1byZ:u\\x16 Q\\x1f3Yrv\\x15aHoG\\x10\\x0bH\\x14nQ|\\\\\\x03O}o\\x02Bt^\\x1ca\\x03)I\\x07 \\x147Ghy`Wgws~)!\\x0cS\\x13d\\x16F\\x0c-L\\x03fN1H\\x05\\x08U1jC\\x19C4\\t7n1fj[<\\x03\\x1bEE\\r \\x055\\r5=4nO4:\\x1cJM37A&\\x10\\x0f\\x18s>\\x01A\\x11\"/&JyEKp-+G=J^F!{\\x17\\x18rFHW26pxhJ\\x82\\x034f=c\\x018\\x92\\x0b~38Ki+ZrMnIg\\x13/E|\\x0b\\x1d\\n58rT+\\x163q\\x03wGY$-B~\\x1dW[+\\x11\\'#$)#`\\rv\"\\x17\\x06(\\u0603*S[y\\x00\\x10\\nQQk\\x18GlC\\x16H\\x02fR\\x00fw>I7\\x1d\"Xe*=xG\\x1d@>=\\x13e/nJ\\x13*>E\\nZ\\x04!:bV{]%*\\rA\\\\]gzPujn\\x1dF~z;f\\x1fZhlI\\x13n\\x1cQ\\x06W h5\\nj15Ewx\\x05hcHC5`\\x00A>\\x03\\x03\\x07pIW|\\x03#zR|\\'rqCga\\x107]\\r\\tvb\\x1d\\u074b[) <\\x0f=%1\\x01g>G]\\x1dUf\\x17$F$,\\x1eu{SdM\\x19\\x1e\\rw)F*wieJ=~\\x01z;{\\x18 Rs:6V`2\\x07*s\\x0e\\x0f^4}:\\x15h %O>iZ\\x050};cg!1\\rt|\\x11>\\x0e(]<4\\x0f}S\\x00\\tN$\\x13zrGUI0d>f!\\tmIL\\tdGXG\\x18z=v4\\x16+\\r|\\x078zF(\\rX\\x06*\\x00\\x0e\\x7f\\x1c\\x7fqQ{&Ea\\x10h\\x1d^x>\"\"^qb\\x02nVswf\\x15 (s]\\x14UYYYYY@`ds\\x7f\\x12\\x18\\'u6FV\\x18_5=hOlyO\\x19\\x1bd>>$\\u0ba6)a\\x13De6\\x1fB}YQr\\x7f\\x1a\\x17\\x1b9{F\\x12\\x1c\\x0f_\\x1bX/{s@,\\x0cCV\\x12#Z4}\\x1fX0%C\\x187]U^\\x06\\x11:E\\x1ck[Q6\\n`{VY.-aa\\x19\\x1dwD\\n92Kt,oQY\\x1a{\\x15^<bq?u>0EIKq\\x1e\\x1eD{Oa F^+\\x1aTorG$pt]0\\x08\\x07lBV|7\\x0cV;\\x1f[\\x11$;0X\\x11Rx\\n>\\x01crKz\\x1eh?\\x1cC-\\x19:x\\x19^)AMjG,HFuFQF8$MnE\\x06i\\x14\\x1a\\x0e\\x13li5D$\\x10p<[\\x17=ioP\\rv\"\\x1bO \\\\\\x0cA\\x0c/gr$\\x15\\x0c*\\x03Rz\\x00dN5\\x04:_VBd`R2F_Z9\\x06B\\x16Ae:sRi^\\'K4o\\x1b\\'\\x1d\\x00L\\x03)\\x0eoek\\x14|-\\x03\\n5]`\\x00\\x7fBUd[g]2f\\tVJd6\\x1ek0aF7QBFmV\\x1e7*K,Nny\\x03_&[hX\\x0eB+\\t)\\x134\\x10\\x03fU\\x05aW-\\x1a#+\\x1a*~}2&\\nVCgq(\\nW% UtS\\x0fcE.~p\\x02\\x18$\\x11\\x03a\\x0cT\\'XTJ=\\'@\\x058\\x18A=\\x7ft\\x0fQ 8twat\\x1ce\\x13\\x1d\\x05[>K)g\\x076yX\\x13\\x0eXY\\x01-|O,aW8w\\x17mzr\\x15,)%\\x16+\\x14+,#&oqsQ?DJ\\r*\\x1b[a%At\\x04E%rA\\x001@,\\x0b\\x06[7-\\x1aGp\\x01U ]\\x82z(|Z_JOhLU%2B\\x05tl2u)4r\\rQ\\n8Ij-o\\x03I\\x03$oDaRq?\\x01^e\\x1bB/\\x03^\\x12T$oVO\\x1dz\\x190\\x12\\x0e\\x1b\\x18*14-?@\\x1a5D=Z$L\\x1f\\x00^\\x14x$hF7\\x03wq~;\"!Ijj\\x13R@+QX*d8C5cF.E\\x14,%Ij1&(B8\\x01d;W7>\\x15F>\"$9\\x03U\\x13J\\x11_\\x1fNx\"5\\x01Xgj)\\x02XG\\x1fcq\\x12q\\r_j+o!(Q?9_9$tNf\\x1a~\\x15)BdH}}}qJg+\\x01WY2|m\"_\\x06\\x17o.ftH:z{l{~TUM\\x06&m42\\x1f^\\x19VY3t#pOE6*)^\\x1c\\x0eU67N[`V\\x152X-\\\\Xx+\\x7f[\\x0caoCg\\x14e8\\x06[8z$+UF\\x19U`?wz=g&\\x0c`Lc/H2k~\\'7#Ha97\\x1c/$3qu\\x1aqlk\\x13~\\x1b_[\\x7f\\x187yz>\\rZG\\x1cO\\x01\\x12\\x16I.]\\x0bZf\\x19\\x03[$!\\x1bMs0^j|>\\x1cB\\x1c_0b\\x16?G&f,K]cW%\\u07ba2\\x13\\x14P\\x18UDT\\t\\x10}>{1\\x07\\\\u5\\n+K*\\x1d\\x06J/VswNT,\\x17\\x0c~<V>\\x1a(:Ccu\"|3\\x00]xU1\\x0f\\x11\\U00036ad3%9W,<R/=sj;\\x1e\\nOO.\\x0f\\u07b6}N;\\x1c\\x1dX\\x08\\x11 {5\\x04\\'Ww^J\\x1c@o% e7kWfm{&<\\x04u\\\\DCh\\x0151T^\\'\\x1fr\\x13Rou\\x12DZ]\\x14\\x0en+)]\\x18\\x12&\\x13z$\\x06~\\'\\x1e8iq,[n]\\x1b~I\\x1f\\x1ac0q40{No>q\\tZ3?5\\t\\x0e>\\x18\\x0e\\\\79\\x019Z\"A)\\x15\\\\h A\\x10\\x08X+|g{g\\taba,hMD\\x0cv\\x0b?ar`\\'\\no`\\x03]\\x7fuboXQ}\\x11\\n\\x1c02z2\\t:\\x19-\\tuoZ!D\\'Z(\\x1f\\x7fd\\x14bH>\\'f>\\x18\\x02!^$WK^e\\x00\\x14\\x03k\\x02\\x06\\x07h1\\x1dM\\x1b7!o\\x1d\\x1d/`\\x04r0\\x12\\x07FN<0cl\\U0008f1f2\\tf\\x02cwG//;GbxxH .Hl\\x00;$60\\x0c\\x17\\x1fc{rhZ\\x16r:]\\x06\\\\\\x1b:gb`\\x15ZFI\\n;K\\x143(Q?Zu1tqh3\\x7f+;;b6\\x0bWqVQPZusf60_\\n\\x1d\\x00\\x12)%Jh\\x16/h\\x02R{\\x07\\x1d,TFf\\'>Yx)fg8Nl0\\x1dS\\x0c]wA\\x1d3\\x1eA2={q(K\\x14^@v\\x03&2u+BRsQ\\x1f|R1)l9r\\ueeae?7\\x061z-Wv\\x12\\x15fb\\tLg5MTl\\x01<mnnTO\\x01.\\ne\\x05o\\x1c\\'crpCd^\\x04\\x11;^ `=,\\x17\\x0f$b\\x03G6u[\\x19=u\\x1a\\\\5mZ\\x18(fYT)0dt\\x1b} X\\x16-+i5\\x1b\\x02I\\x12jb\\x0f&\\x075\\x16\\n&Kwy\\x19&;kYP\\x1cv\\x00 4X+{3@ptWoi\\x02}\\x14\\x1dXx\\x01K[0z\\x19\\x19\\x1bBrM<f.9\\n\\x06`s~\\x19`\\ncqOkub\\\\\\x0c\\x06:J\\x08eb$\\x0b\\x15aO-\"\\x05$\\x1bg`kbzT\\x7fyXa\\rQU&g\\x0fD)u2\\x0b]n\\x12nJBU\\x06\\x1f_\\x04G`\\x12R!\\x04\\'a \\x1d/O\\x177%)T5\\x1f0\\x01/&d\\x16;5\\x02$V;O%9N\\x14K$ Iu\\x19\\n=4\\x0bAayY\\x13Di`\\\\z\\x1boiePvF\\x10je\\x1df8E>_bq\\x1dqsZ?`^S\\x15Rt\\x18> AOBgs>L\\x06Q8T\\x13=8=F;,<\\x1a\\rk~\\x1dfh\\tRW{\\x16\\x08k\\x0e]jd5$\\x17aSUVVGRl\\x16ul \\x1b=*6\\n&U{/},6\\x087/_d\\rb?el\\x13r\\x19]\\x0bNor\\x14o\\nlY\\x1fS\\x0b.\\x0c\\'}%\\x1c\\x1bv\\x04+bI=\\x1aJ\\x15F\\x1d\\x15F19\\x15Ug6S1\\x15\\r\\x7f{H\\x03:\\x0b\\x00\\x03%\\x06U\\x12x<\\x1a]G\\n5\\n#\\\\3?\"\\x7f]c\\\\,\\x0fk\\r%3\\x0exe8#3\\x9bNG|8c\\x7fd3-\\'h( _1\\x14\\x1a-U>\\x17\\x01G\\uf186c\\x08\\x1fKV\\x1fY)\"K\\x12XmLM\\x1f \"}\\x07\\x1aZ`kJO5\\x1a=L9&=\\x06={\\x02\\x1e&f6XT\\x07\"\\x0f%]3~TL[154Qb\\x0c\\x0fXQ\\t4F\\x07)j|h]A\\x1a1T-Y&4\\r?\\x1ez;n\\x0e\\x14xeAO\\x14\\x0650,K6*\\x03@Q=m)\\x1d~xP\\x0c\\x066\\r\\x14E^WS\\x0c\\x18X\\x03AQ\\x1e&5jW\\x01\\rj,R-)d<\\x1c6\\x1e\\x1aHZ\\x01N\\x07\\x18S6&-}\\x0b>\\x10j`\\x1b\\x16\\x00Ua6d\\x1eK@\\x19v\\x15.\\x0cYzG\\x1a(d\\r]I\\x19j\\x0f\\x0f\\x03@X\\x19\\x0fL\\'\\x0fe,uu4e2@\\n+O\\x0c\\x0eTeUaF\\x1d\\x13\\x0e>V\\x15Hk\\x12\\x10\\x0bXF\\x0cTS\\x15\\x04&(dh\\x18c\\x1dV\\x15\\x15f\\x0fiNle\\x023-\\x06n\\x07|/AijamLY&dO\\x02|2zc[C\\t6%]\\'\\nz@\"ET?\\'\\x1bKcib,\\x15:Y\\x034\\x1aG\\x00bM$|2x<\\x180e\\x01\\x1b\\x19\\x00\\x1e4Kv\\x048M&fo\\x03M\\x06\\x0eT4s0P?Tu1\\x14m8&5mP\\x1aL\\x02\\x1c\\x1d<\\x18K5\\x9a\\riV\\x0f82\\x18XV4} 6>Pi24\\x01\"[\\x03fm6Y$\\ue0ee\\\\cu`\\x04\\x1a\\x00Hf\\x19\\x0fFwb\\x02-`Ff1y\\x00\\x03]\\x01\\u0383a>\\x0f\\x0fT0\\x0f:&X\\x13Po\\x14\\x18n004\\t\\x0540U@W[fdo0M-U~t\\x0e~\\x00C\\u07b8\\x05z\\ru\\nX\\x14d\\x14x\\x11m\\x1ci:RSjJJ!6\\x0e\\x04o\\x05tC73\\x7f\\u07b5\\x0faR$\\x7fo:@\\x07ln}s&;(vI&hj&AK\\x1d\\x10;K\\x16BV&620s1{\\n&d,uB@\\x19SFf\\x07\\x03F!]?\\'wR\\x17&q\\x175o2u9Kf9IBzsT\\x01<GjzZu0\\x03\\x07\"Y!]Ko\\x06CP8L*9?\\x16d\\x1e?HJL%`W\\na}\\nAo\\x04\\x07i6\\x0bY`qBL0<\\x16\\u037861#T\\x15{\\x0b/<\\x11\\x18!hv\\x0eCk\\t\\x15:IQ7]9!TX\\x12g1Hr\\x1a\\x15R\\x0c=$\\x0c\\u05cf+PGf~\\x00U`;?<NF$?(\\x1e\\x02\\x10\\x0e3vwf$1zh6o>^\\x00&f[!{,$\\x08TF;O\\x05V\"?v0K\\r}D\\x0f\\x05\\x161\\x04?\\x1ao\\rGOK/ \\x01\\x12\\x1f\\x1f\\x1fl\\x16y\\x1f\\r\\x1fOi\\x1b\\x1b(AF\\n\\x12\\x0f\\x1dwD\\x0e0\\x0c\\n[00<$;\\x00\\x06;\\x03/sli\\x121Zqd\\x05Nq9a\\x07KvWH+\\x14@N\\x15\\x0ec+f\\x0b.\\x0b9E\\x1d!;Z\\x1flpC#DFSs{Xt\\n\\x17Zdb\\x1d41.\\'4Gn_c5\\x7fm\\x0fz [<\\x10Yx}\\x07:G\\n ,\\x06+C\\x02Lu\\x14p\\x18?$\\x0e\\x0c\\x19\\x07,s\"\\x0f:]8*UN\\x16,gC\\x1b~qx\\x0c\"oaUGR\\x04%#\\x02xl|\\x00V`nl\\x8c\\x033]-6\\x0eG&G\\x064\\x14-(H\\x7f\\x02Jsehz-%\\x17]\"\\x08\\x19U0\\x14Q\\x072>\\x15`2@\\x0cQa\\x17\\n\\x14|O.L\"H\\x1e\\x04Y`N\\x11{h(0\\x1fEV\\t\\x0cr3!<-c+=.9{\\x0c\\x05R5\\x1eL\\x00\\x19v\\x0c~[\\x0b?7\"o\\x1dDJ>\\x05f>6=\\x0foI&C\\rCcn`p*`9\\x1d\\r|c,@qk7\\x04,h\\x15\\x03[\\x11\\x7f\\x10!oiJr es`hm\\x15>unA\\x0f9s2>4Ht:(GE5`9\\x0f?8\\x03@W\\x0bo\\x02q\\x13`q\\\\R#\\x1b=Z\\x02&\\x17&$\"N:R}Rc\\nB\\x18RP3w\\x07H\\x7f`,c\\x1aZsV\\x02\\x16tC\\x10OyCb\\x1eEB\\x12@\\x132\\n-\\x16w2 Gf\\x18vK\\x17-UD)hISnR4\\x00c\\t\\x10\\x17.<\\x19\\r\\x03[{wxw?D&WCS;\\x1elt\\x03\\x1c.r?P] LK\\x03;2g[5`\\x15\\x05;$J\\x1f%<\\x05L6c\\x08\\r\\x9dGZA\\x04Tc^\\x1e\\x18\\t/\\x13e\\x12lpG\\x02q[|\\x12k\\x12+\\x03~+K\\x02eBD$\\x0b\\x10BQeXB\\x1b4<\\x14&\\x1b)?P5-\\x11T\\x04IkKC\\x0cay[F6z\\x0b=PF\\x1aP4\\x03\\x1a.\\x7fCcTq0\\x15\\x012jC\\x1c\\x1dH;MloH\\x1aE\\x16>ksM\\x1d\\x19%u$6#\\x19\\x1f_1\\x1buA}\\x14w\\x0bM\\x18m\\rzjG\\x15\"?\\x1bW\\x06\\x06|D}iC;?mHUJ\\x1dk\\x13v?\\x1c\\x1cvh}l\\x05X~8H\\x06p_s |t\\x1d\\x19\\x02\\x7f)zN!%\\x0ew#/knYQ\\x05#%Af,\\x10)\\x0e\\x0c5\\n\\x1c\\x15>2K4v^;&\\x05`Y\\x10\\x07z&8n#)oQiX$-\\x12\\x1d_\\u070e(\\x1a\\x13<:On:zx7s\\x1c_#\\rF&?A=^E\\x1ah5{CH%?=\\x7fQE2Ng+T9y\\x02\\x1eT\\x10K0\\x1b-\\x17Bk2i\\x1d\\x04ZG\\x0bfW\\x17ku\\x12=p\\t]h\\x01_~\\x0c1j-\\x07\\x1b\\x1cl\"g\\x1a\\x0bVN0sjY|-_fJ5s5dqM2\\x16aF\\x12\\t\\x13n-Y\\n]w3J\\x15w\\x04\\x1fHX(2z\\x0c$\\x93a^\\x05eB\\x1fWL\\x053\\'`YW,LeFw4\\x19,\\n\\x1bHRcNK\\\\g=\\u05f5\\x01[bz\\x7fU?u8> p\\x01S\\x05\\x06n?/-7$n5N\\x10ug\\x08\\x0e?N\\x0f\\x12o\\x152lRZXlJNxJ?5]#F\\x13p~c96aSYv[J`{6I\\n7uf8\\x1e]P\\'%EQx[\\u058c3]{\\x0b\\x12\\x19|\\nEO=0\\nN3\\x0cs\\x0c|\\x7f[\\x04+a\\x03\\x10z$:iV!E\\x1csP?3\\x0b\\x7f~&z=x(\\x1b\\x7frL8\\x17D\\x0e[Hcb\\x13\\x1duYqsL\\x1d\\x0fm3yn;\\x02ll/o1~\\x1f^K<[7kVj1\\r1Y\\x00&r\\x02=$yy\\x06\"`\\x05M)q+\\x14\\x1f\\x0b,&Fd\\x07|\"~pBACo8n\\x0fN\\x1b\\x0f\\x1aJ+\\r)GA\\x05\\x03HJhu*\\rs#:\\x06:\\'xJGql/i_!\\\\\\nk5\\x1ff]x\\x14p9F\\x1bn5jD&4\\x1c1EM\\\\8zu\\x1f`\\rn\\u07bd\\x7f_FU\\x16_7Q&\\x1bq\\tm8<\\tq2\\'74.\\x0c@\\t]EXG@ {Dy`W\\x06`w0\\x04\\x05H\\U0003f90eM\\x0f\\x1a\\x07\\x0b&\\x00M\"B\\U00063842\\x11 RT<\\x11*3DB\\x07fX79\\x04=md\\x08Ba\\x12\\x13B2~\\x13b\\x1dCs\\x13R\\x08+V\\x10/wC\\x0cc}_FQ\\x15Bd\\x1f8#:98Al\\x08&\\x1a?\\x18hISB08\\x03`\\x1f\\x0br]$ky%s\\x02\\x103ekzf\\x0fF!E\\x03,S<S(5\\x1bWq<\\x1d;%BKYo\\x15:dgP}0V^r~\\n/a\\x03\\x12;\\r~)-wP@\\x1aWrm6pnWU\\x1c?\\x03FWv\\x143G[2\\x0fba]>x-~$B\\\\lCw\\x1686\\x1aK8)\\nif\\x0f\\x16kN<,c f0O+\\x11-~\\x06LY9~)-}i\\x1b!*\\x0bfE\\x00\\x17:[\\x08fb1,36Xr\\x16iN`Ol#Gv)JE\\',0s>l\\x16C3of-d\\x124]x\\x16,e7;+tw<l#I\\x0e\\x7f-d\\x014m&+evkrh9~KtcZ\\x0b\\x0bOPwVSZ+Ks6EvSIfY(X\\x04\\x18Ka\\\\h+xsHz\\r%/~u1Q[%6[I9L\\x18;\\x17~\\x1fd58(l\"\\x17P\\x160Frm\\'4p:\\x047\\r\\x063\\x0e\\x0c\"}\\x00WJe\\\\i[+\\x1f224Yy$\\x174;di/y%tY9C\"!J\"}tcfA\\\\Gr(-U\\x1a\"?u}*K\\x1b?0z$xn\\t*iKLPLc&!W NLP:S\\x07c)\\x1d\\n\\x1dUetq\\x1f%y!KS1>EM\\n\\x05h~>\\x13q\\n\\x1f7%-,S*\\x175\\'\\x0bse\"_m\\x1b,S0+J494K\\x0f\\x06yA\\x03m{U+u2*\\x03t$Ih v4\\x13$\\x0c\\x1e<\\x03S1XAg\\x07|\\x0ctqTQu r=!#\\x13=\\x7f?a\\x1eJWt\\x058D\\'CZ\\x17~M89\\x11\\x17{u,)\\x18Rk6/cxL\\x14Z:YqKt\\x079CD^8MK#E3\\x12_l&SN#\\x02Q1\\x08F\\t\\nQNt\\x1fMV1N\\x11_OT\\\\KZh+mQ\\'9\\x19Ka\\x10Q\\x08u\\x07\\x1b\\\\EC*\\x16\\x19\\x04 F@-e\\n1QZ3{^@^u`\\x06JZ}P\\x0f;\\'}\\r<\\x17oQVnWm\\x1f\\x04=\\x18kF?Mgl`\\x07__Y\\x05}rp\\x7f|\\x04\\x00\\x1e#d:\\x01\\x173Mdk4I\\t\\x10y>[~vf5Z[\\x12L|(\\x17\\\\|& ~\\x00=\\x06mqe\\x00~e,zC2VqZ&pnHp\\x0cL9gX3W-$mY\\x17!,_pM}{a$0NJlUV\\x18K\\x19+zGaghnhS\\x15nw\\x18\\\\}\\u0382t\\x16)y\\x0fO2T}#B\\x1803\\x1as\\x7fyFU\\x150\\x18D9Q\\x00}uY?LM+\\x13k@j;\\x15\\\\@^78\\x1cf\\x1a\\x1c:\\x0c0g4?mYz\\\\^9\\x1c\\x7f\\nlz 8[R\\r\\x1eK4R7\\u05cfGW3X\\x16Qz5U].i2\\x0f]{rb\\x0e\\x13:_\\x1auJ&=#i\\n\\x13yN2z\\\\VHl\\x00q#6T|y8Hw$\\x17\"*\\x1bD\\x16IN\\x04x 7\\x16rmT0ZpOiW\\u05cb\\x06l|j6rBYf\\x05kUA\\x0b)\\x05.DW6p\\x1cD>WLb\\x1a\\x0b\\x08\\x0c\\x0c6`y%x\\x10,\\x18-#\\x11\\x114#(3bo8V-\\x16mB~`F]+\\x0caMY*VlB\\r}uStR-\\x00w`\\x05{0s\\x0f\\x0cQQ5l\\x1f\\x18Eg\\x08P!M\\x0bQ\\x04&yoh\\x1e~NvtU\\x02L9jzW!=\\x18\\x05o>h\"9r8L\\\\n>\\x18,-0\\x005*W\\x1eE\\x16\\x1ev>1\\x1a|\\x06.!x/\\x1f\\x1f]FB;;[#47\\x1a\\x1c$\\x07,Q\\t4!\\ti\\x02Q\\x16d(i6Wj\\x15\\x03Nb\\x11\"zRr \\x04|~Cl\\x192_2\\x1d|{\\x04\\x00{;U_:kPNb|*ar]ND\\x04OP~y[+S\\x0b\\x0cww_\\x0b\\x18a*\\x1618\\x1b\\x1d\\t_@\\x1c(h\\toDy1S}\"=I(<;1Y-:eLF\\x1a\\r?\\t-N\\x1em\\x0e7EiKn=f\\x0bwCz[\\x16y\\'gt\\x05\\u0381uJeW,BzV5\\x13]\\x01|\\x1b`\\x042oR3,D7A01fy\\nG[fg\\x03LHS\\x00\\x0f\\x01\\x11lPL(\\nBz%\\x1c\\x13IMyzw\\x16 \\x11P\\'Cx;2m%Cv[v{2\\x12m>{\\x03>\\x11\\x04r\\x178BY8\\x07cY)V\\x14c[\\x7f\\x19:Dt8MbZZb}:|h<.OS\\x0e[\\n$5q3\\x19c[xEMA9\\x16|s\\x02X\\x0eCc7trI~m\\x07^D[)O{/TV\\x0b%WS;0}\\x13\\t\\x1ewi\\x08|pdA2k=r x\\x07\\x01SK$\\x0f\\x0bEk7\\x1c*:97 U[\\x03>\\x12\\x1b3EO&E9R\\x0bcz\\x02=V~\\x1cI3l\\x16i(ClK\\x0c=\\x1f;m)eD\\x04 y3\\x16NJT(`\\x10\"[yL(\\\\A\\x1cj\\x05\\x18e$o\\x12\\x1e\\x1a\"2q:l]-T/.\\x152Q.ikljW%4%8hQAr\\x03\"d.VeFK$t=s,@,\\x11F5\\x11\\x0fl%X\\x07=\\x04\\x06Ie*?W\\x0fYPEc\\x15h#4]\\x12\\x11mX\\x10Ts\\x0bOJr\\x0b&AY~2v\"xVL\\x19\\x02W\\x11\\x08\\x17\\x18!t83\\x03\\t\\nl=E\\x05\\x10p=q)jz\\x01jt\\x01(Y5PJK\\t\\nJ,o\\x06)-b`\\x0fK\\x12E)\\x1f\\x1fWe&\\x03\\x16\\x05\\x17W[U.*B\\x11\\x16;G&3\\x07VzQ\\x17^\\x08\\x1d\\x06,\\x0b\\x14et3\\x0b=VZ\\x03#Y:CP\\x1ce\\x7faiB%=w\\x1e\\x1c|3G^\\n\\x16lx=\\x7f\\x15\\x0f*LgNp\\x06rz\\x02Z]S\\x1f\\tK_p=\\x1d\\x06oA\\x01i i\\x03\\x7f&$fm{\\x03\\x05p\\x11jGUxw\\\\z,wk\\x1cwz\"\\x06\\x1d\\x0b\\x1e\\x13a/\\x00/Pp\\x15@\\x0f:}\\x10AY.z\\x10C!&F\\x0fWM.~U\\x0c%\"\\x14\\x1c\\x01k\\x0f9P\\x7f\\x19x{8$v/~tYn\\x01F%\\x08E7>qr\\x00Y\\x04sK]oU8uU%~IVU_1|\\x7fy\\x06c:q&\\x13bitPZ{^./\\x0cm\\x01\\rOv;u6\\x0b+)c|{#u\\x14;r8?QTc<1\\x1de\\t*\\x16\\x0f\\x10\\x0f}\"O\\x00\\x03}:\\x02,Sg*X\\x18\\tbpNaH\\r\\x11\\x0f>Mz\\x07\\x0c]:[,cv$+\\x12ji\\x0eV\\x19)L\\x0cl*z$aqj=;Y@=QHS/\\r3\\'\\x0f4pV_0\\x10lk\\x02J{]U\\x1eX\\x19H,4Ku{,$`@D!_\\x17H\\r\\x0e\\x0b?\\x07B8cq>0$JE\\x0e\\x13*a$KxdeR((s5\\x1f9\\x14xm\\x1a?\\x00^n/\\x07\\' :\\x1dg\\x1e\\\\;O5T3V\\x12BiYI\\x04NC-Q\\x15\\x04V\\x14|^$y8J3E[}e[,I(\\x1dr.\\x1fE%oF\\x1bkh^GxLU>I\\x08dcu.;\\x01M*\\x1c\\x14P,Bi?W\\\\\\x06F\\x15pW(EDB@#~xe&U#Q\\x11\\x1auWTh*\\x06j\\x0e\\x06!G^v\\x00+2X\\x0f7K>k ESek,\\x15bW1=CpknPHv4mZ\\tvb%=M!A\\x16\\x1abv\\x07\\\\X174HF$b\\x02\\x06C.Y\\x04C\\n\\u07bai,*\\x136ls)Qm$\\x0c.<{hsO$E|b\\tZ}Dg,o6F(w\\x0b,z14wF\\x06p*\\x16\\x06\\x17U1L\\x1d\\x0cj\\rg8sy3>b0qtk\\x7fO\\r\\x7fvsY\\x0e\\\\7zZ\")\\x14h\\u05f7!\\x1f\\x14}\\x14\\x1bE\\x1d\\x13GO,z[]\\x1b\\x0e\\u0603\\x17{\\x1b$GC)q2^G`\\x13x.?rZ\\r\\rrVKWw=\\x1f]g\\x15jwzv)*=2\\x1cW8P\\x1c.U\\x1eoi\\x16o\\n\\x19\\x1e0=-\\nZ5r\\x06M2:;w[\\x148\\x18|d\\x1b>\\x0bd\\x12Zj2\\x12)VHj\\x1c<ru\\x157Ht]ocA\\n\\x0cmoa\\x0c \\x07\\x00Ql\\\\!\\r@\\x0fV\\x16FW\\'Pp3@\\x0b/?,}W\\x14zgsk6`\\x19\\x15&\\x13S_~{{+Y\\x1b\\x11\\x02\\tIEF\\t\\x7f%\\x1e+sf3\\x1c1y*QE\\x13hK\"\\\\!,r\\x06,j[\\x08+c!FZH4.\\x10Nh-]1\\x0bZ\\x12iZtaeXF\\x0bvx\\x1cLb\\x19(\\x17uw;n\\x0fmp:\\x1b\\x1cj\\x19\\x17`}M}J\\x19E\\x05\\r;%>\\x0b\\x06xtJ\\x08\\x03<N|\\x1f@F(Qt\\x06\\x07\\x1c;/A\\x08\\x11v0\\x08\\x04ez[l\\x0bS0zf\\x7fiUAbJ4dt\\x1b}&X\\x16M6@4fnfC\\x06wU\\x1a5<D}>\\x1c\\x0bip\",\\x1f\\x1dy5_\\x13_,)\"\\x1c\\x11`u\\x0c,Y]\\x19\\x0c4\\x18aB@c\\x12|z!!gV>Z\\\\32\\x1abRx]D\\x10|}\\x019CR\\x1c\\x13\\x0c+var\\x02hQ\\x0e\\x06B(i0\\x17D=?1N\\x04^\\x11Suviqa\\x13uin\\x1e\\x03f*\\x11L\\\\[{H}\\x0c\\x15E\\x02vs\\x05F}Yr+{\\x1f\\x1d_@7z\\x19!((\\x15\\x0c_>QCo\\x15\\x06Y\\x15\\x12\\x13]f\\x00rV>\\x03go{RQju<,\\x01*.\\r5$r|\\te2-y#B\\x04D&I$E\\tJ\\x18Zr\\x0c%\\x12D/3eg\\x04J}U\\x05w+\\x1dJ\\x02Mw!\\x08/@k.\\x1bTz\\x17dg\\u07b8sPJ\\x18\\x0b3\\r`E\\t&@54^1\\t$(o\\x12Z\\x02\\x06e\\x1d \\n$\\x00^&\\t\\nW\\x1b\\u05ec\\x0bM\\x06\\x16X[\\x071`\\x111By,=T\\x10\\t56#\\x16~jx^v\\x01HLUofQ`O!8,<#Yi\\x1a2x\\x12*L\\x07b\\x10o/\\x15ko_\\x16w\\\\q/ZT(58\\x0c4\\x7f#?\\x18.U\\x18<_\\x17YgwB_+\\'M^bkeP\\x7f1=-{q\\x0c\\x0bZ1X/\\x13^n_K\\\\?A4xQO?RhQ,]z\\t\\r\\x0e\\x1b\\x18~\\x01_\\x11\\x088_/2\\x1a[ow\\x16s\\x0cU\\x12?Y3\\x14W\\x03KyzjA=jiM\\x08\\x02F~ -I,+X`\\x1a\\x05j\\\\e_fy\\nZ\\x17^\\x1a|~M\\x06\\x0bw\\x18f\\x12zaX\\'\\x03HvL0Z\\n;<\\x1ekr7!q`\"`_w\\\\EX\\x0f_@TJpb4aqvd6Qs&fn\\x15=^\\x1b\\x1a\\x1ft]:6eL\\x1ch\\x7f\\x05\\x19^v\\x08l\\x19+N*x1\\x17\\U000caddegWs\\x01_p>9k\\x11U\\x1axAM\\x02\\x01^l/sW?aG\\t0\\x1bRN\\x1c\\x7f\\x0f&C\\x7fmQ]\\r97\\x02~L\\x13e\"\"\\x07,_Z]\\u07fc\\x1b*z\\x086+XRq)nO\\rk\"|;CWfK\\x089fC?z\\ryV\\\\+uTC>\\x0c)g6i]a\"x.\\x03z[\\x04O\\x12i\\nv_\\n\\x02+7?0UL\\nu+obO\\x1c\\x7f\\x05\\x1b=\\x0b\\x11@?T\\x13\\x7fM\\x07F\\x16`^CixJ+\\x05\\rT8`JPRD\"!\\x0fKG\\\\3-*YH\\x94x8j\\x025\\x08j\\x1bZ\\rO=.&l]C|s\\x1d\\x1a\\x0cZ\\u07b2|\\x082#qe&:\\x027\\x0cRc\\x03C\\x064\\ua956r\\x0e\\x19V\\x7fB\\x18\\x11y\\x1a|\\x1cr\\x0f4y(r%M=rK^\\x1atKKmM\\n<lp\\x7f<_2:\\x1a$\\x041d\\x1cn\\x19\\'\\x1f0W>%Uw+\\rTLl;`ZL\\x1d,\\n\"E^qi\\x02B\\'bloP,qzU\\x01_x]\\x04Q,K6\\x00yW8D9l\\\\:K:\\x0b_z>\\x16g]?Flq K6c^}i;<G\\x129\\x1c\\x00G,u{a\\x0b\\x08LHA)\\x95Z[L2kc5LUh\\x12\\x1b/\\u06ddSt\\x02~jaB\\x0b\\x14W2Pk6\\x1au?P\\x07g8\\'lb\\x15v2-Rg9xc*VA(VZ\\x0f]a*\\'\\x07y\\x0e\\x1f4F*K}\\x11sRm\\x1c,\\x08\\n0Y\\x0e\\x12Os\\x7fUl\\x14\\u0557F>\\x16\\x1b\\x1b|$2\\n@t\\x7f?\\x0c6s\\x02D\\x1cAb]b)8|\\rI7%kU2PlU\\x1f5GC\"YJ\"c}\\x17[\\t\\\\y]\\x150,X1\\x15\\r\\x7f{\\x15$FZ,P\\x13\\x0cLn9\\x7f]c5/>Ji\\x0c,IgsP2\\x01\\x10\\x18|C\\x1a#sB5+sV\\x08ke[Nv\\uf36e\\x14np\\x15\\x00(Q\\x0bQ\\r\\rc \\x19)?\\x11c*lHc\\x19\\x19djJWQTE1*i@\\x1bL\\x0c?1\\x15S\\x1f&rO:\\x1e\\x0c\\x06b7I\\x0c\\x15m<T&\\x0fnWe\\x0f&.\\r-\\x13~\\x18<\\x13u\\x0b\\x07b\\x1dES\\x1f4{lXY(A6\\x06Q&\\rzD\\x1b\\x0f\\x01dmZ6:U\\x07]0$M3\\x15a`Kjz2L\\x1b\\x10uLU\\x1a5EmSU@+\\x1d]@<t\\x07zW50S\\x01A\\x19D4k`>(A\\x1b\\x03@\\x0e<-\\x1blu\\x15[q\\x06n\"mmcbnc\\x00sj%Y2j=tucOtc60\\'\\x03y2J4{&ca&`N\\nc`)bj:@6Mu\\x1fZ@\\x1e\\x039\\x0c%2-fu\\x00D\\x0fX@\\t@2T\\x07}7U\\x18Dyd`\\x1a=g\\x18R,`qO\\x03\\x06L\\x18\\x0cL[\\x00[\\x15{,I\\x010\\x06\\x03\\x0f&\\x0f&=h0\\x047\\x14MG[\\x00<(M@`\\x0e\\x1dk\\x00\\x0c6Rem\\x1d\\x1e`:$\\x15\\x0b\\x14T\\x13\\x08-x}Iw86\\r\\x1d?6\\r\\x06XU\\x0fF\\x05\\\\,\\x04]5z=]}P-\\x04\\x13~V-\\x056\\x10&2Umb= W`v\\x03U\\x1f\\x0f\\'\\x1da\\x010\\x02\\x07U\\'$,!)\\x16|\\x03kHR@\\x1f6\\x1c<\\x0c`.nqs[\\x16;\\x15A4Y\\x06kXR,\\x12vF]\\x1b`%a\\',JaIMyrZ+v7PwCX%\\x16Vc);o}s\\'*9\\x02\\x1dY\\x1e\\x06hRQFUH\\x1fK\\x1dMG5\\x07\\x0e\\x1f\\x00\\x10K\\x08Fp47\\x1f\\x1e\\x00$\\x1dt\\x16&O&=A{1Q2=ts\\x00\\x1a6{X):p\\x1ce$/bi\\x13\\x1aXORf\\x1flG!N0SQ\\x1b*\\tA\\x13\\x1bm\\x05\\x0c\\x10P@A\\x1e\\x160\\x17\\n#a}\\n\\x02o\\x04\\x07i6\\x0bCn\\x01\\tv0<\\x16\\x15iz-\\x0e\\x15\\x120nn<\\x1bFXyJ%kd~\\x0f%E sou\\x1aIaG9Q]i~\\x03\\n\\u038dB\\x15+\\x10\\x08vmVb4\\r(<*W\\x01h#Z3?n*{{y\\x11\\x0c\\x1d(M,\\U00099b73\\\\y\\x06wC*:|zsu\\x19D\\x0f\\x03w|\\x03\\x18\\x11 Z_y-\\x06/\\rG`OK\\x0fx\\x0e~2pwl~\\x10,5~?\\x00)x;.}Tj[\\x04DpwL:dA\\'_$s\\x03\\t\\x03wFVS:\\x013\\x15W.#\\x13\\x05q,16\\x17io\\x18RVH06 \\tIhna(\\x18u\\nG!h6@\\x12cj2m~4?d\\x7f\\x07\\x001\\x00\\x19Kc=zo(;7D\\x14\\x12\\x00j?W\\x06Ovqm&|\\x13H8E\\n7pa\\x0f4|/8\\x0e\\x11.0\\x10uTb\\x1alSRC\\x0cj8Y`\\x0eL\\x12$ys<\\x148\\x1c\\x7f\\\\om^\\x0c@\\r,sD}}\\x07`|u\\x07\\x02[k6\\x004\\x1fEu\\x1cHLeV?J|8jy\\x08\\x7f\\n7\\n9[`sGU\\x1bv\\x1ftrLCHwU>\\x19%\\x05{S\\x1ex\\x19\\t\\x02c\\xa0r\\x05R\\x07!Y\\x1cl\\x0c9u\\x03\\x033wSv\\x05\\x06\\x1a\\x11\\x0e\\n\\t`)\\x10\\x05h6\\x0b[:q\\x1f:\\x10s7\\x10Bh|%\\tVpdvBT[?$\\x0cqX\\x0f\\x1bf\\x00Q|ZXDN}\\x1a|vp\\x08 -8um\\x13N\\n@7\\x00\\x195/</nr:WJ a\\x02\\x00h\\x02n|2ViX\\x7f\\x04g}@0\\x14\\x1f\\x10Xo\\x022C-Du\\x1f\\x18;7:\\rI\\x0e{9H4]w0\\\\;,#\\x0eK*\\x06Ba\\x1d`\\x1ch\\x01?wB!6N\\x10/1a\\t\\x0e\\n\\x07q\\x7f8\\x0bo\\x180\\x07.6\\rD\\x08e6\\x1291#\\x04=\\x10X:\\x07 \\x01\\x03zh/]rWS0@0Hj\\x01N\\x0ezBd-tD3\\x19%F8\\x1b \\x0ez\\x10\\x1e\\x1f\\x1aF\\x0fO$&Ky>j\\x08:\\x12II\\r\\x06U\\x0c}\\t\\x0bn<z\\x01;\\x01Qz8&rRD\\x19\\x14[\\x07\\tZm00\\r4#\\x12\\x08>\\x1ca\\x1fYFy&\\x1e\\tj@u\\x15P\\n\\x001_\\x17C\\x1bd\\x104B\\\\4\\x00C\\x17\\x07\"H^\\x08TA\\x00M.\\tE{2\\x1b(2P\\x03nM8\\x19\\u0590eT\\x16-m\\x1d^*v\\x17\\x1a;\\t-986&-c\\x0f!zHZ\\x1bI\\x1f;\\x0etw\\x06\\x1dA\\n,]\\x1c~t\\x00;%\\x0bT~U=Z\\x13#\\x7f\\x1f-LGa\\x13V+\\x02\\x14\\x1aZ\"vWDd9\\uf7afB\\x0b\\x13\\x1b\\x1eo\\x1bXp\\x0b$F\\x11Kg$:ZA]VC\\x12#5\\x1a\\x0c=\\n[pO\\x0b\\x198\\x1eNK\\n\\xad\\x00Z\\x12ZI7(i\"uG}ru#N\\x04\\x14C\\x08zG;\\x0eC:\\'E[\\x12F^\\x08F`\\x04\\x00\\x18\"72>|?\\x7f\\x17\\'^iB\\x0f_\\x1dvi>W:.7\\x0cC\\x1d\\x07\\x18T\\x19#h5\\\\a\\x1dqc+jDtet\\x1c\\x18CAgc@Im FHX$K\\x1dO\\t22WtPGqH\\x12Di\\t$Z\\x13\\\\\\x05n`\\x11@\\x1a\\\\yzS4\\ue40d\\x02\\x7f *j5\\x19&\\x1e\\x1ev:yM\\x0e\\x18-hA\\x169`\\tp PK<1\"4\\x1aKwZ5N\\x10L8!~\\x002B|!\\r\\x10Ni\\x17yLub.D\\x14PKl\\x14\\x19\\x1eo]\\\\18\\x0eWQNTu~\\x18SOnWgO\\x10ZKj\\x0c1N\\x14(6\\x7f7B&^6\\x08j\\x19/f&]rmg\\x0b_93oN<|z+2\\x15\\x16~=TbB,\\n\\x1a.\\x19zY:TwI\\x1cZ\\x089Vuy%/p:}\\x0buA(eN\\x7f\\x00KUo~L,[o\\x02HB\\x0b;\\x7f(M~5d\\x0bif\\rBs*X\\x16>y\\x03->s\\x17pYnOz^kW6r\\x1b:lym\\x07\\\\[o ^\\x117DF^k\\x14f7]\\x04G*efBW^LBVtN<2\\tO\\x0f0\\n8V!C^cNa^Hi\\'[\\x02\\x13-l/`(6\\x0bYr[\\x1ef%<l17.\\x1fa[?\\x0c]4W)\\x1fw!Kc\\nd\\x01/df7%K1rN^4%FT\\x18Atx3$UL`ix\\x17#\\x16h<9K\\x05\\x1e$Xy\\x1baB5\\x19\\tC-Lp?4N\\x04?k\\x1fE\\x1a\\x13Y\\x95&p\\x1dfK\\x10.K\\x1b?\\U0001ef35\\x12\\x01\\n\\x1a\\u07b5V\\x06C\\x0b/\"g\\x7fN\"fdimhTk[).rl6?BK\\x13xzGVY4O-\\x0b- )CL*6]-R\"-\\x02,D\\x19%$\\x13+\\x7fxo|4g#^S($s]\"\\x1f`aC\\uef0a$\\x14\\x04A\\u05c8\\x02\\t{o!aU\\x01s]\"!@6_Kl\\x1e\\x14Vr\"\\x02\\x01\\x10ckNs]\\\\MA\\x14\\x16|*\\x0e?/\\x00B+Ctk;5\\x18EoKe}\\'7DM(f^\\x15x\"\\u05faf*U/$=#y ^\\x0b\\x15\\x15@*S%)$5V(d1\\x0bdi1qN\\\\p\\x1f\\x18IQP7\\x7f\\x1ca\\x0bJk8%R^h;$)Fb\\x04)aii\\t$\\x07u[;94KKh\\x14s\\x19p\\x05PH+(~\\x04\\x1a%XX\\x18\\x04\"\\x7f9\\x11\\x0bEqb(FXOffh\\x074?\\x02\\x19{\\x1f\\x18,\\x16\\x1dpVm<*0\\x19|W,4+\\x16s\\x07\\x1a2|8\\x17sgddY|L=3d~/XlfAAbk&[2o\\x162!;[l/\\'j\\x12*\\\\\\x10bl?\\x17\\x19-$~22\\\\1d\\n\\x06d4{\\nz\\x0b\\x1e]\\x01\\x11c54l\\x0b\\x07\"[q\\x0faf\\x1a|9XA0+O~ImwX{3HK\\x0e\\r7\\\\\\x01=L.\\x1a.0%qD\\x11b3@\\n\\rE4\\x0b3\\x0ewzHUdQ)Y]\"H\\x13`K\\x18X\\x17V,\\x1eZ\\x06\\x0fc\\'IXl.\\x06\\x14\\x7f8!&\\x00,\\x1ekZ 3Y4Gh{\\x7f\"D\\x05>d~Wz_tSX;Ahfb!>i\\'>;1\\x04k)8\\x0f\\x17W1f>>H>cU1I\\x0b\\x07Cygkz\\tHUG~&lSzhfyf\\x0e3\\x08b~\\x19fg1w\\x1dDfCR_\\x19<\\t`*Yxk\\x00o\\x19{t\\x19|\\x01-i\\nmI.$x\\x0f5y#~3e\\tlUV8a\\x0cM]\\x17j#sp\\t4mF2{\\x15<IN~\\'5%U\\x1b\\x01Mv\\x11\\x1fH(a\\x195Ey\\tn\\x19\\uefef\\x0f\\\\\\x1d\"e\\x02\\n]\\x14sIx\\x13\\x1e~\\x0e=90*yY\\x00;2\\x12>8\\x0f\\tVb\\\\y{ \\x1a3\\x1e]?N\\x10x[x%[C@y),}\\x7f\\x05\\x13\\'L\\x1d}3{/\\x10f\\x0e/NPV\\x18Iz0V%hwg\\x0cD\\x19V5gP3[\\x1exHA6;Q4\\n5w;hn\\'\\x01F\\x7f\\x02V&\\x7fGx#QR}\\\\\\x12F)I>\\x06X{\\x00FH{`\\x06B\\x0f{\\x10\\x05\\x1dU;-K:W_\\x05P:@\\x0c!P;\"\\x12\\x19OC%`Vi/\\'\\x008km)ew\\x1e|\\x00E\\x04!\\x01J(9{\\nT_\\x7fwJ\\x0f\\x10\\x13\\x01R\\x04h5\\x05\\x7f\\x163m\\x7f\\x0fs\\x0b|MY\\x19!\\x05D}_\\'/b}O\\x7f\\n\\x7ff\\x03\\x17\\x13Z\\x14~\\x1aWs\\x1c(Q@\\\\M\\x03_\\x0b\\x7f\\x18:\\x0bwJg\\x0ci\\x7f\\x00\\n\\u05fdF\\x10Z\\x1arzV\\x7fmL7`\\x7f\\x07\\x18I?]n0_ t\\x1eI 3\\nl\\x13:o?\\x07C/\\x04\\rqZ9i\\x13\\x0b3OuNE\\x03# FV\\x7fM!1O/L\\r3?\\\\\\x08r\\x1e\\x10:D\\x13U~0\\x1er{/\\\\+L=\\n\\x19\\x01fWS{D@%Lq\\x11\\x00\\x14+\\x13t\\t;J\\x129,}\\x14\\x1a\\x1d\\x12z\\'Fast\\x1aJWH\\r5`k$uQB_c&`Ti\\x0e4\\th#\\x19\\x17X!Q\\x11rt=I{9\\x15U8L)dL_J#kvo\\x14}4T;\\u07bfnrhP\\x1a\\x0c}m\\x17\\u07b35|5mU;\\x00s#M\\x0cBC&T{\\x07\\x07`\\x06t=|B?\\x0e>py\\x06%>\\x1d\\x07fi0*b\\x01\\x13X6\\x04}@Fy\\x00V>MW#\\x1d\\x1bP\\x0bQ\\x0fF\\x14\\x10\\x08\\x05,\\n!\\x0eo\\x1e~\\x1e\\x15`\\\\;O!d\\x1f3\\x02\\x10h\\x18\\x02\\x1a`ZP\\x11R\\x0f\\\\B<kt\\x1d\\x19\\n\\x03\\x01 \\x06X\\x16G\\x0cCJ>~iw\\x1f\\x0f!\\x03L\\'\\x11N#\\x12\"+3\\x0bP\\t\\x1bd\\\\1\\x1d&.\\x1cL~\\x08;I:taS#bJa#BTz!X$\\x1c#<H\\x0bDshuph2\\x17<y\\x14M+\\x10\\x0bl\\x11\\x19#QOE`\\x191n\\x1f~C\\x01\\x04!+\\x08\\x17{4g\\x08N*DK;Wf7\\x0cv\\td )\"UQ.!\\x00\\x06)y\\x19~\\x06|lqf\\x17\\u05c9\\rW\\x03]xn\\x7f.T\\x18wsdO\\x00K1cH&}\\x15]`\\x05mnBU#&\\'=$$(Zs6Y#=p\\x19?P{J;:.L%]Q(\\x1e\\x1c<\\x14\\x11\\x08a$\\r\\x08s{\\x025\\n0U\\x1b8M\\x0cXB\\x12tC\\x1ak\\x17\\x0c[\\x00U#~5&?2pz\\x12v;\"P\\x0e\\x10Eb`@l\\x13Hy{>G\\x02CRA|tS4D\\tE\\x1aLX_*@?O\\x1dS;\\r\\x11#Lw\\x14\\x02cyG#!h(<=\\x0cQ;I\\x0b\\x0c\\\\nh\\x08\\x8e\\x15X=$\\x01\\x0f\"p\\x14xE9\\x13]eC\\x1cRK]:iD\\x16:\\x1f91bpq\\x02\\x13w(\\x0c\\ueb48\\x04(\\x1cs|M`\\x0cQ\\x16L1mH6L\\x1b\\x0c\\rVe0!\\x0e?H\\x1ab\\x0cy\\x0c,6\\x84\\x1bl0!\\x19u\\x19\"GW\\teH\\x07M~bnNas\\x0e\\x0b\\x06ASx0F\\x7fvg;v#Gt98{\\x14TyU\\x17e%yo\\x7f\\uf765;\\x1a \\uedcd\\x1e5]xx6\\x14;\"*}&\\x0ct| \\x7f\\x00\\nrPV0)\\x07\\x1cy\\x08~IHh+x7H<>\\nJ/g+l\\x03\\x11\\x18kA\\x7f\\x16i\\x10\\ue049j.i\\x0b\\x0b\\x05\\x0b4x\\x1f^=K\\x12\\x17DKCx\\x01jVjo\\x18r=\\x07I3\\x0c,6`ZzfyXm\\x16\\'ulK\\x06,Y\\x01\\x192W\\x03ZtO\\x1f,WZWa?D^\\x00QKd)HL$w/^DyR(\"SPH\\x1d\\x1a\\x19o\\x10l$b\\x06\\x19\\x1c\\x1a.\\x03\\x18\\x1eS\\x1akWf\\x02\\x05l\\tk\\'pU\"1\\'zt,>\\x05\\x04`HH-*:Uf\\'j~,vRI\\x0fX*W\\x1e\\x16;\\x11]<,\\x1fH\\t/.9\\x01CdDur)z\\x15q\\'\\x0c]!JrVk\\x04Q\\nv#_~G7\\x04\\x086\\x0eD\\x11|mFkR{5\\x0b\\']`as\\x15\\x05d\\x15\\x1dZUUez{K\\x13,o)|~t+;c0fC[\\x04\\x1f\\x07\\x116zO@-d{sMHT\\nP|is9Vx\\x19\\x0f\\x1a6IZ/F!Jv`O:\\x033,T\\x17P~\\n~_o\\x0c`s893W3K[2\\x11\\x9anrzn0%\\x00yc6(7-D\\x17v\\x10\\x1d\\x14Ia1;\\x0fm\\n-l7tR`[gOy2Fe\\ry]\\'\\x08_Cy\\xa0\\x1cOn\\x1c_0\\x11k\\x18YofdPO\\x10u`\\x13:LK\\x11PJv)?XGk\\x0f0{\\x07\"\\x03e;wE>\\x18]EFX\\x16\\x11+\\x7f\\t2\\x16El6\\x18\\x0bd\\U000811fe%;\\x16rvXJ\\x0fG`%hT&\\x11\\x13I\\x1bZ\\x18\\x1e-\\x108CT\\x00fL\\t-tZ\\x14p9)fY6u C4=m0Z\\x04>{8\\x15h>\\x7fBo\\x04mO\\x14\\x0cqBc\\x1348V\\x14i<\\x05\\t@\\'b\\x14~Jo\\x11\\x14g.\\x13|\\r\\t@\\x19\\x17x_<\\x03pg\\x0b\\x07K\\x0b\\x18Z<X&m:&#\\x05\\x14\\x06\\x06\\x04\\x07R0*di\\x11GJ}:\\x0cF\\\\:\\x7f\\x02|H\\x1frWg\\x0eZK8u\\x11\\x7fs\\x0b\\x02N(z[\\nr6l}\\x04m`{Jd1+y6}aQV0DAkD4&\\x15\\x03\\x03jE%\\x1dF:($Bd\\x8e__hW}gM[^L\\x17<|v\\tjeT#/iTM5l\\r:w\\x02,\\x05\\x15CaW<Q8U+,Y\\x18(\"\\'\\x1cmJz_ |\\x08\\x1f\\x1f\"8sMU?83WT(k\\x15QQ V;%Q%v\\x1e\\\\\\x7f\\x16X?==1JhL\\x048fl*}o\\x15SkW6^\\x0c\\n\\x00K|;lFvfX=|`B4\\x1a\\x1f\\x04\\x11/&%!\\x1f\">0v\\x1f\\x1e|40q/2[\\x1c4;\\x0b3%\\r|V\\x01p\\x13\\x07F\\x03g\\x07 |\\x03f,\\x1e\\x1ezC?1\\x1en^\\x15%V\\x05\\'6\\x0b+!acjObD\\x0e\\x1aJO\\x1cv,]S3\\'|(:]\\'Vj\\\\qQrLv4rc04\\x0c0\\x02\\x17|rpABS\\x1f\\x18}G\\x184M X\\x17a\\tb&Vw.@F\\':{\\x07!f{\\x11C?\\x11pj\\\\olnj&P\\x02\\x11J&&$35TEe5\\x10\\x103SEcc%8\\x0btI\">J|_E$,\\x02\\x0c\\x7ff>s\\x0fdk\\x1f]\\x03h(q\\x187]p^!q\\x1e\\x02.UWUK\\x07&H g\\x0f(`xaiTLC`_d\\x10/b^USY5`;.\\x19D4u\\x17x$Xac]\\x1bMA\\x1b\\n0\\x11z5\\x0c_n.md\\x0e\\x07Yc\\x15u5W\\x1a\\x12Oz\\x05z\\r,\\x1bE\\x1dV\\x1di|z_l0EG[!Y\\x031?V?|c@Ya*VV\\x02lGB\\x1fdB=\\x01\\n\":\\x17O\\x0eWkD/\\x18\\t\\x0b[[m,)~\\x0f\\\\h# \\x15sg444<)69-+i2[\\x17\\'lO]\\x7fS\\x06h#|uPsb\\x0ej\\x15aX$*4\\x1b\\x15}\\x06Z|\\x14+Ea:`l]e\\\\T}\\x1fD\\'b$jj82;|.C5n\\x05\\x01ql-\\x15Skt[1%}\\nv.\\x1f\\x15\\x12\\x11l\\x18H;DWu\\x1e}}\\t\\x11,Q1^{. \\x11$2lW \\x04V*f`\\x05z4qc\\x11,Hq\\x06E>_i\\x00\\x0bEs,^\\r*CN)\\x08\\t\\x00.7\\x05Oq\\x11+<Uf\\x03yhB P\\x00yn\\x16alHI.{:7zO\\x1d\\r\\x05Wz\\x17k\\x0c,G8a\\x1d-R*O\"B\\x1b:+4\\x02\\tZm3{Of\\x15 *:o\\'E{\\x11a`v[nE\\x16\\x03HA\\x06~=MB\\\\<Pw|C\\x0fUya\\x13>\\\\EO<tD,~\\x05b?\\x1f\\x7f|ie\\x0e\\x169\\x10\\x06P$Ul7\\x15z\\x1f\\x13\\x12`}\\x01ES:\\'CaU9Z>ed}C\\x12lU\\x1fvbjk\"Q^DaUD\\x07O!@\\x19\\x0c26\\x0b6HLvU4EHXidjjWe\\x15E5NAeT\\x1b_uSW^wGO\"mG\\x02:I;]Wv\\x197Wf\\\\Ox6y}\\x19P\\x05Qw\\nKqm(Hz&)x[8T\\x05Z!-N\\n2$eH7eq{\\x0fG\\x13$\\\\m#pv\\x0b$j\\x1d+8\\x1cN\\x11pG\\x07h\\x7f\\x01m\\x13r\\x1c+\\t$b1c6{H:A+\\\\FIcH$\\x15&\\x7f\\x01\\x18bSZ0xY\\x02HL?\\x13QQ&w,;Cr$pm\\x04\\x18\\x12;\\x11$oC\\x1e\\x14\\x18e\\x18o#\\t^\\n:\\r`K\\x1c\\x1e8F-bI?\\x06*i0\\x01aC)w\\x07UZa[\\x1bpZ*Owy\\x02]y\\x17\\x1d%)_7t#j4\\'[Q\\x08;)t\\x0bT\"+\\x03\\x19y\\x16xlH2\\'\\x02V*}Q\\x03\\n\\n,\\x0b\\x0ejaN\\x159$,I`\\\\<D\\x7fx]\\x0f4^g\\t\\t\\x0b\\x04!\\x19[gI\\x00*\\x1b\\nv\\x7fK\\x07d~K\\x0fWa9J\\tWb[\\'k^5p\\t^{g:ryEa+!^hWF/\\x0e\\x18W\\x17\\x14\\'[{v4\\x01:?-mA3+\\x06$dkU57\\\\U\\rXi_R15Z<],\\x0enU:\\x02\\x01,\\x18\\n{Or\\x02\\x08`Jdl\\x152Z\"\\x14b,`|Ye|\\x1d\\x17V[RF#}\\x054&\\x0e`\\x16a#X;Asl\\x0eG2Q\\t\"\\rFt-\\nf-\\x130Kl\\x17=\\x17\\x050\\x1f);v]\\x191~n:TmA\\x0fi9{`/\\x08$\\x0b\\x1e/\\x1e\\x1eA%Y,sGwnv\\n5Jx9WlA)iWr\\x05V.yI\\\\\\r0{zw\"!\\x13\\x158B\\nqZ`WM2\\x03NTu2\\x1bXl1\\x03<=q\\x14%9^*\\x1d]AD?7(\\x1bYd!=+\\x1fSXlgm^,fn-9*\\x05Ej.ILAh!||;\\n%\\x1fO*m\\x16?;&\\x07b4`}\\x14$/1l K%O8\\x11%i%TbvG2fCt{\\x12>d$*\\x03k10cu}uTe?\\'\\x11upd3w+\"`\\x1dCe\\x11/4AzA{ b5x\\x00R\\uaafb/\\x06BXNrhs+7\\x18\\x18\\\\\\x1af(%K<\\x037\\x1f\\x15+\\x03\\x1a]wF[=_E!\\x16>\\x16(.^0\\x07>56e-7m\\nK^esV\\x05-\\x1fFGpFx5kq<}KM<+3f\\x1e&qR\\x114\\x04\\x0b;^`hpSjQ}\"7p&;{[Ws\\u0380}ZTL?i!CC*Vb\\x0eY\\x10\\x113M]Hd*>oEa0*\\x18OCee~\\x04`W1lF{\\tNm&Z,\\x03W\\x1b/Km%[[R*-#\\x01Eq9^\\'&;Z; rt^5ipe]}RW\\x02.\\x1cX1eb\\x06~\\x01\\x04\\x17\\x13\\x0b4Ei,x\\x00k\\x15j5]\\x15|\\x11D:W\\x16P@\\nc.qg[S}\\x0c0a*L\\x0c C\\x15S\\x17aZ\\x1f\\x11\\'s\\x16\\no\\x03f\\x16o\\x1f-1#ICF9;$RLag:\\x18\\x0c7,\\x1aoz@\\x1b`e}\\x11F\\x05(^Zx^A}I^\\\\zV\\x0c\\x05G%~a\\x12z\\x02hf\\x1bX}PW\\tAykWVc\\x16W\\x16W@\\x1d?p9r|a`x+r>!\\x009\\x07{;P1$_w\\x7foO8DN\\x19\\x049\\x0cR\\x04.\\x14N\\x19:}]\\x1c_Sh>4Gy/m\\x03\\rWuU\\x1dy7GH<\\x1d^wt]g^o\\x04dzn\\x1b9WOc\\x067t\\'.\\x1a\\x0fltSekiny7Q{px\\x1b][q\\x7foX}YH\\x1dK\\x0f\\x19=\\x18}0=c9\\x00eji\\x03;\\x18{{N\\\\u[h2MI;\\x18w:\\x1e{=\\x7fbj1{c\\\\z\\x13{[\\x1f1eu\\'gc@c`\\x0eC\\x0692\\r\\x01JML\\x13wl}lv\\x7f8zD\\x1fuwg\\x0fun\\x04\\x02e56\\x1d,c\\x01G\\n\\x1f[\\x03\\x12;g}od=VUg\\x03(:Yg\\x19\\x0b7mS\\r7p{=^\\x194=gy01i:.\\x10r`h~\\x17\\x18=\\x115-\\x1epkZ#\\x18<mG\\x0fo\\x0e\\x1eiU\\x01F\\r<Khkp\\x188|]\\x1b\\x03\\x01%!<( @0sF\\x0e\\x06E\\x1bF\\x00\\rU3\\x06?BcRm\\x1dx \\x03c\\x1boy1\\rlw\\x00Y\\x00\\x1dc\\x10Q \\x06cM=sU=}i\\x03{c\\x06:1A\\x00ygc\\x1d\\x18|4-1~\\x1f\\x1c]\\x1bY}sM`7\\x1awanGslq\"\\x07\\x00~\\x0b@\\x02\\x11</T\\x10W\\x1dX\\x0b\\x11\\x02zk\\x1an c\\x0ff:FG:\\x0b\\x19\\x13 gH58`:7\\x0cT=\\x04h-\\x19{\\x00W<:`\\x01/\\x01m\\x03cu=L=M\\x1f\\rHc\\x01 \\x03A}O\\x1b\\x18c\\rUWw,>ic\\x11g\\x0co\\x04\\x01Lkc\\x1f1\\x005u\\'\\x16XA\\x1d\\x1d[\\x07\\x04B\\x03\\x08l]3~\\x181\\r\\x04\\x0b2\\rj|\\x07\\x04Qo\\x0cg\\x01nl\\x18{h,\\x1f\\x05;z8h\\x07]72\\t\\u07b2U`&\\x0f\\x1ft\\x00\\t\\x18\\x03j\\x07c\\x1b\\x14\\x0c\\x176F#\\x17(\\x00 \\x02\\x15kv\\x18A]Zo8A6q\\x1fz\\x0c\\x1frOT\\x1b\\x1eto\\x044t[MM\\x07\\x11\\x01,\\x1b 4GP>\\x00\\x178\\x14\\x00[#`\\x1e#\\x14\\x04y:\\t%\\x03>\\rAOx2Y\\x00y\\x06# E\\x07\\x080\\x03 #\\x1d@,O4Wt@?M\\x0f\\x16\\x0c@\\x1b\\x13\\x16+Z=R!V\\x17m0i2EXvGtTEIVL?(zSN92dZ*)\\x1b7l^&\\x1e\\x1b\\\\`f\\x1aoWKfy\\x1c}\\x17p\\x11/uo\\x035Lou\\x06\\x0c\\x16{7\\x170Yw\\x1e\\x18\\x1aO,}W\\x00z\\ng/$\\x0c38UH\",\\x1cNHT=yrGrS.e-\\x12Q\\x00\\x14\\x10h\\x00RS\\x006\\x0c\\x02\\x0e\\x1beB\\x12QK\\x14[\\x12-\\x08a`!+\\x11X3l\"7d\\x0eVrG\\x18MkWnomxe \\x1aKnYr`!L~\\x1b_\\x01Hl\\x03_Nlh\\x19$/tJ]\\x0cHtR0:\\x7f%.U\\x12e`[4\"\\x07#| d\\x0fb e\\x0f\\x13\\x1fL2A\\x1c}@!\\x1bbO\\x05\\U0002f39c>i\\x1bH\\x1f{$kH:w@\\x04#v>\\r*\\x06\\x13YAWQ*jb2y}gM\\x1d/4Xi.Vc0\\x0c*jz8A&j{\\x1c&iIHl\\x10\\x1fY\\x07QHSr\\x1c>lcyQ\\x003H\\x02r\\x03jR8\\'<N\\x18\\x04G\\x10!?tP\\x120^o%\\x1eaee_a>\\x02&~\\\\D\\t9q6q\\x10</$G+\\x0b?\\x00)x\\x05!}fvv\\x02pl\\x048+]<\\x02\\x12&hY8t\\x02f.\\x16s~o`]:Q\\x19\\x15\\\\5@:6o\\x1f\\r)vPp\\x1bh\\x07P{[D0]\\x1feqmy\\x02V^ax\\x01O\\x02O@s+\\x19Nwce\\x03w\\x10=MhVR\\x03]U>*`\\x10a\\x06\\x16 d\\x18L\\x023d\\x19N\\x07\\x10\\r\\x032\\x0f7D\\x01%\\x0f+\\x11~\\x1c(A \\x0c\\x0c1\\x0b#z?3rT\\x19:;\\x1d\\x0e\\x1d i1Q\\x06V}I_\\x0cl}7\\'4]U\\x0f\\x0fS\\x16/iA*\\t\\tO\\tzK\\x1a\\x16h?\\x0e~o2e\\x06f\\x023D\\x0f\\x17<6|\\x07|`$G\\x04\\x11h.AT\\x19T{\\x10\\x19c\\x0cair\\x02b_!|\\rUZ\\x19~G4.1\\\\,\\x17\\x17e6w\\x0exFez\\x07[;\\x1fwDK\\x12`NC\\x01]P\\x04mM-\\x15\\x006\\x14l)\\x07\\x1c4`\\x12v8\\x1bZ\\x18c5)\\x00\\x16=Z2Hh@>\\x14\\x06i\"\\x02c\\x0e~\\x13?O;2\\x07\";, \\x05?#\\x10\\x18%H\\x194>\\x18!d+#K&]Kl6mZ)Z#A:J\\x13a\\x02=,x_1\\x0fDar<p\\x11G3f\\x1e/q\\x0b0#]N$\\x07dI\\x15ZMjT\\x0f/0J&\\x150E\\x10\\x0bQr\\x15\\x0f!s\\x1c|\\x1eH\\x17,Q!h\\\\,;/:ZF\\x00~R0Qe\\x1dXQ\\x108nO\"T\\x0c,0M{\\x19\\x00\\x02\\\\`\\'_t.Q@ST$/,uQ\\x0ew\\rS\\x1alKq3\\x06)^gJ)\\x11D\\x1a(16(z\\'k\\\\\\n[otV8gIBv\\x10&wAoD\\naD\\x1c,!,\\x1a\\x1cH-Q@lt|]&\\x05\\t\\nie\\tRWJ\\x0e;{4\\x14qlU%Hsdk\\x1dL6-d8%4qr oj\\x042 f\\x16|vmG;e&B&\\r&\\x1f\\x0fx\\x1ex\\x16_\"\\x0b\\x01K\\x0e\\x01j:*I/Yz]1L-\\x15\\x17lx\\x1dK7\\x07\\x12lfM\\x07./tJD6\\nr\\x14v\\x05<G,U-NiaYu\\x15o\\x088N\\x12/8~y}\\x10Xc\\x08jeEwa>/%Vn\\t$\\x17B[sW\\x1f\\x13z.\\x04q=`]6\\x0cj$074\\x15oA\"\\x06l[C(=9\\x7f!v\\x18`I_\\x1dzCXd79I?(qo3\\'}\\x1a\\x03B.L\\x02/ \\x02z)_)\\x7fS\\x08\\x18I4O,/b\\x05S#\\x12?CB\\x11Q9?\\x0f/V\\x0e/\\x1a-\\x0e\\x17\\x7f\\x085a[\\x10/vC z/^2\\x0fu\\\\X[f]=2xX\\t\\x13)6ybMfwe$0+=\\x00Y#_-zk*@\\x0b\\x061\\x19O^>Ae>g,m`lwh\\x0b\\x0b\\x18YV:pJ\\ue1aa6W0w\\x18D\\u07bc\\nOzD3\\x11vp:\\'\\'p~u\\x160\\x14V\\x07fk`u\\x04:\\x07qN\\x0fum!\\x11s/SyysS\\x0c\"\\x0b\\nIxP/3\\x0eJ\\x0f 4\\x06$*DrDc!e\\x02P\\x1d\"\\x03\\x06\\n\\x183\\x01IO4v\\x02M6\\x1a\\x12`\\x7f]\\x04`8\\x19x|q\\x0eA-ODX|;hWp\\x11ul\\x04]\\x0f\\x19\\x01X&Jg\\x107\\x17kogqxZd\\x0b1\\x03;!z9b0t\\x065NfaBTwMxj\\x14`\\x18?DZ6\\x1b\\x10!>r\\x11\\x13R8DLj~5d\\x0ebbK\\x1dh\\x07Xs\\x17\\x02$\\x0b\\x00/F\\x16[J=] J-m\\\\.\\x7f\\x1e8<\\x1a\\'ZK\\x1e8/SkRTOJ\\u07bc\\x186\\x14EUOe]\\x00Q+WC::uI\\x04h\\x06ir8Z85Q\\x17SUK/Kk$RMgW\\x16Ir=Kn\\u07be%[\\x7f\\rz\\x0b\\\\jh>U[.V\\x1d\\tvAXQ\\x19,\\x1f4rvOT.gkq\\\\\\tQizgF\\x17S\\x0fX\\t\\x1e6Gs_\\trVW4;FVY\\t,%J,+eX*\\t\\x15DF\\x07#]f,o)kfE\\x029Y\\x08K1RE%(+x*{U\\x05P \\x130\\x1fJ\\x16WkgZ{9}!zfC\\\\\\x0czC|3\\x7fD{Pj9EVXR5,RkhV5Qy\\x123\\\\]o8Uh=*ExLv+j=JE_8fAyh.C\\x1fw].\\x0b_kmaB\\x0cQ?\\\\YHmchv_\\x7f2}Y05\\x18q7eF\\x18Mo\\x1b]L\\x03?\\x1duTsmQl]N$E\\x1dxA>u\\x0e\\x1ctXkyh3\\x13s!]OZ`ed9[*U\\x1ep\\x1c\\x17Y\\'\\'Ki\\n+\\\\\\x11z\\x0fF2b]@R{h!)5&KWws\\x08#[\\x1b\\x02i7;\\u05fe\\x03\\x08\\x05\\x1dRrjv9<#?JI\\x18W9#\\x1dZ\\x1dM\\x1eO4m^\\x08\\x014\\x16\\x1d\\x03v_\\x16sZ]E\\x1c,\\x06m;y\\x0cr\\x17\\x1crR-;N\\ne9\\x0c\\x0b*(7\\x0c\\x07w )l}Pu_oSjc%JV?(\\x13DQ/#PVEJpH\\x1e\\x16DS2#{L\\x04K}hyJ2\\x7f0\\x1dUm+-%\\\\\\x00\\x0b\":hhVI-\\t\\x18zw/M=zE\\x1f2$W+Y4>}B72.$K\\x08f?,pf?,hp\\x19Yd^_yJ(dI\\x12vB$sEX|=Aw\\x7fVITj/|WF\\'\\x08c]h*\\x0e*XR/\\x17\\x1a\\x1c[oTF(S~1%hc9v\\x02|\\x17j\\x1cmHVy\\tc_H\\x18_jWI\\x1fLW5D\\x15[?Yu]iy::(c\\x174]8\\x7f\\tJ\\x19TAdT36:8v\\x13kU6\\x14CFR0W\\x14\\x7f\\x0bTH<p\\x08Q/Mo\\nZZH\\n!CPTw,cQ(.O3RhZO-Y \\\\\\x1c\\x15\\x11jFk\\x07\\x15\\x13MI\\r\\x00[)|\\x1a\\'3\\x11\\t0-`\\x14>\\x0bb\\x19Nh\\x1a,\\x18\\x01\\x7fEfn\\x04\\x01\\x13b\\x10uAjT\\x15\\x0007~\\x165Me[i^9J0^SWu\\'1V^E\\x1f:1TPH\\x1d\"\\x0b\\x07\\x05HM\\x0cRK^Ji\\x0f^hE\\x1e^/\\x1c \\x0fw\\x19px5\\x07@\"Hd{PN\\rlJ!z\\x1cGG\\nQ\\'\\x17#\\t\\x00\\x19Y:Z\\x0eOA\\x02\\x7f:\\x0fX{1\\x14186R\\x0f\\x16\\x0b\\x1cB Cl\\x15A|h6&l|go\\x13\\x1eh\\x182z\\x031(d&\\x16x\\x06 \\x1a}f&x\\x08d#\\x0b;#o69V\\x11F\\x14IM+GD\\x05Y-\\x16\\x0eA~\\x07\\rf&\\x02YF\\x12b\\x19\\x00|T\\x04+Azn&xfR|$\\x15\\x1260\\x04%aEy>,Z<\\x17\\x1f\\x1dl\\x16MK+\\x19\\x06?\\x1c%\\x13<>\\x12\\x1c-a\\x0bZB2g\\x04\\'ME#]K\\rMg,=tmow\\u05fbs\\x0cQQ\\x02\\x14Y,\\x17t\\x1e\\x16abezE\\'\\x15sO9K}ZSy&\\x0f6\\x05Q\\x1b(0_\\x1e\\x19hn`J}:\\x0fKD|\\x12*|uMJ\\x11x\\x06T>\\x0b&]\\x10}vAT_.\\x1cK^86T+\\x1e4\\'(\\x19\\x19rL\\x1dW;\\x17|4\\x01GZm\\x0fZm\\x0fZ-GZg]5Zg\\x1f{!gm\\x04,\\x07>w*?M\\x1f\\x1f|\\'\\x1dY\\x00M\\x03\\x14\"b\\x0bXx\\x04Jw\\x1a\"V\\x14&\\'4[{\\\\-aUU9Wpi\\\\E{^\\x1e\\x7fL\\x7f y\\x02q\\x13\\x0e8\\x16=\\x05\\x0c\\nk46e?fa\\x19{<\\x07)`\\x19j\\x1e*\\x192<hl\\tAe&>Xup\\r|>[\\rNQyJ\\x1fvwp\\tVO4xn}\\x19oVJ\\x16\\nbn\\x17h&\\\\E\"\\x15\\x17+\\nN\\x1b{3$iT\\x7f*l\"F\\x141\\x13,O_\\x03*f]`\\x10\\x19^87w(MhSO\\x141J2k;x\\x04QMA[M=\\x083D\\x116\\x06\\x1fR\\x1b\\x03^\\x12^\\x02\\x0er,%\\x18\\x17u#3\\x05~3^A\\x1e\\x11XB\\x10W;\\x06I7l\\x19\\x02\\x1df1T\\x06\\x12\\x1b\\x07_\\x1f~wUKgWWyV-F\\x16@?!7Q\\t\\x12iRn\\x18N\\x05~d5H\\x1epDYK\\x12\\x17\\x004l.b\\x10\\x7f\\rk\\x0b?3^%,=Dsv\\x10\"} ?vQ?Z,0\\x17\\x02H!\\x07[fB9)\\x06t\\r\\x1cBa\\x19C\\x06\\x06yMU7O\\x11tM\\x06\\x13\\x02@F\\x1c\\x04\\x0bDfIu\\r\\x0cNP\\x16Ri}2`qt\\x03v\\x03KB.Sz5$#\\x1aM\\x05}G\\x04\\x0f\\x0fN\\x00GK/\\x00E\\x7fGX0X\\x01\\x01Rz\\'J\\x10d\\x02\\x16pKC],`\\n~ lO\\u061dF\\x7f$x\\x12nt(1`}}\\x07:]\\'\\x18a\\x08),\\x05\\x18\\thw~LaDg\\x02bm/0}1\\x19R\\x0bD0K\\x19\\x06\\x0e,*K\\'+LuW\\x1b2\\x04\\x02=I\\x17P=>E9e\\x08k\\x07\\x13tNY\\x1f$+\\x00?\\x1f/i\\x0b\\x10\\x08Fu)\\x01\\'M\\x19\\x01[\\r3\\x17\\x11T~\\x04Q>\\x7f\\x16)g?\\x1b]=2 .2\\x06=\\x03E t`,#}al\\x06[4\\x7fs\\x18lF\\x1689\\x1a7\\x11A@6\\x04v\\x01\\n\\x16o6WzJ\\x0fX\\x1d4\\x13*\\x17\\x075D\\x17:\\x11&\\x10\\x10\\x04\\x07_\\x0f.V\\x0f[t?FX\\x1dHm/@\\x0eV\\x1c`F\\nP\\x1a\\x02v$\\x04Q+&Xj\\x11\\x024ko\\x0b5E\\x05\\x19\\x03B\\x10m*f`\\ry\\x18s\\\\f\\x11`\\x18l`AX{l\\x02N2a\\x1dFU=->\"\\x15<>Q]C\\x17\\x10n\\x02tJ\\x00UV\\x12Q_H\\x17_6J8\\x17pJ\\x19APx\\x1c<w\\x00v(\\x1cs\\x1f( U*nB\\x1bop<b|\\x16y\\x07]H@A=a*v^L\\x19{NQPShI\\x1e\\x08M\\x08kY:}HYE\\x19&4 \\x13\\x08SuZ\\x1fch?\\x08\\x17\\x04\\x7f\\x0c\\x08\\x15\\x1656\\x0490Ih.M\\x1f,}D573D DV\\x7f\\x02\\x0eIB|\\x1b\\x07[0Rf7Mpq)|-6@\\r8`7.FMWt\\x1c\\x06=\\x1f\\x0cg\\'Jg2\\\\AhG\\'jC@\\x15-~\\x7fUQ\\x1fv`79:\\x1eepK\\x11}M9pgph\\x16\\x19<(r\\x17}\\x1b\\x1a]~sm\\x13\\x12\\x103\\x01.{`yKK=&M^Rd)]I\\x05g\\x0b\\x1b-Mz+nc|.\\x16\\r0\\x1eA3\\x03w\\x18{boIIE{%\\x7f\\x03+G\\x02\\x16y\\r8<Gf0fEJ[\\x0f\\x01]\\x045?1\\\\C\\x03\\x079_Vg\\x10=?mxp3*|9\\x1e\\x1bTp|M\\x139.\\x1a[\\x02\\x01U\\x0fHwCe4d\\x1bh\\x10$\\x1a\\x0c--da\\x04t-,\\x10w: >Xhh\\nE\\x1fF|\\x031-O\\x18F,&\\\\}\\r(\\x1d:yJ\\x18\\u07b2\\x10 z~\\x15\"9-m\\x1d\\'\\x06b\\x10\\x14Hx\\r05!9\\x04\\x1f&D/\\x1cOAHbRJ[{R\\x19v\\x19\"t}\\t\"\\x172J\\x04D\\x06k`eNEGD5IX-S>9+U>\\x06%[gEn\\x1e5\\n0 \\x0bC\\x02{\\ue42a\\x114\"G_7\\tb\\x07F\\x10)k=|0S\\tU\\x11+vZ\\x1e\\'\\x15mS7~F\\x7f\\x03\\x1cf%IHC^\\x1fRzE\\x1d.-m\\x11q_%>\\x1cyn`)-EN$ogdW>-}\\x1f]o?-$Tz-gi\\x19&sm>EvGdkKm5)m\\x18\\x11_\\x0cxA\\x02(u\\x05xM_~y\\x0b[\\'\\x13\\x1eO.a\\x0eU\\n<z\\x087\\' A2\\x05&\\x04RT\\r\\r)\\x024@\\x11Rh\\x1e\\x1aeN5.t\\x00*xL!\\x08\\x01\\x1525\\x00`0K\\x12\\x03qSxrW,\\x1b\\x0eXk\\x080\\'i>2\\x11\\x04K2$~N{d\\x02iFOd:>n\\x10f\\x14YF/@\\x01&gL\\x1c\\x1c\\x1eH]O\\'\\x07W\\x03 .l\\n?)mMy\\x01S\\x1e\\x06\\x00C\\x05\\x15n\\x00H\\x14{Tal2$i\\x05bE<e\\'\" tAf`n*e\\x1c o8/\\x00G\\x19gs3\\x1d!K#\\x1fqM^\\x0eA~\\x01]\\x04P\\x1eN\\x0c{cKMiW\\x16%|\\x07\\x17\\x115F\\rr|SP\\x17\\x03\\x06I\\x15n<\\x0fvl\\x00c>$cH&}.<uPPq!0\\t(pd\\x0e9;g6?15s\\x1fxBR\\ta*Dzx\\x0c2r\\U000fcbf6D1\\x0c3m@\\x1cu\\x0b\\x0b sc\\x03RO2U*9K2(]\\x003sn\\x01i\\n\\x92v{G4syN\\n\\x03\\x03b\\x0f8GL))\\x03WN7\\x03HN\\x13UTPE\"9|\\x052\\x052yQ3\\x141t;\\x1f\\rNyf#!h*<=LEi]v\\x1d\\x04W\\x18(n6\\x10\\x1d\\x1bUWP\\x04<\\u05c8\\\\u=;}LNu\\uf38frSNiE7:__e\\x7fM\\x0f51w*o\\x0eeC\\rg#8\\x07\\x12G\\x10\\x1dEa:h\\x15Mx?D4\\x0bx\\x06A!\\'\\r,\\x02v/\\x08\\x1e\\x0bHU0K\\x0f\\x16iD_*Jw &u^\\x13\\x11\\x1e?}k:\\x0b\\x14d&{|_YbKL=^@~\\x0e\\x18<\\x06e2U]`<\\x02`S5{;41H/d9.-tV3\\x7fT{l5\\x0c\\x03\\x16=\\x08Ly$w\\uf1baN*y}\\r/\\u07fb-Mm\\x07\\x13+\\n\\x02\\x1fqE\\x1c\\x8b0B<y.5\\nQ\\rj0kr>i!Q\\x04czq\\x1f\\x1ew`:\\x1byH_=0\\x1a\\x03p\\x07242\\x14\\r(]oi)d3B\\x1bd\\x19`5 kcS=fFkr&5\\x1dbJ=p\\x16[PfPuW%q4U\\n*9q\\x1e\\x1bh!\\x086;\"s~\\x119x\\x11F\\x03\\x0b\"H06\"\\r9O\\x11-\\x07\\x02&*\\x16U9Zg0\\x18?\\t\\nb*za7RC !@m\\x1c\\x19o\\u0378,X\\x02\\x0f34j2>{\\x01ylK\\x00_*J?CK\\x0f-\\x07 \\x073L\\'!\\x7fH@hCY\\x15\"r@\\x15\\x14lU;\\x08\\x17\\x0f\\x11\\x1e\\x13[D\\x7fa\\x0e-p\\x0fI\\x074\\t{86\\x7fy]0UT\\x12}\\'5\\x16f$/kP_\\x18\\x0fi3R9H^+\\x0f~.\\\\\\x07c\"\\x061f\\np@\\x18fL\\x002\\x0eJYPdA\\x7f5<\\\\\\x1em\"\\x1c\\x1anycq%,W/i%e\\x18\\x18pv5{`\\tI7_5\\x1b`\\x1aauab\\x11J^$\\x0bj\\x10`/%\\x0cT(6x*\\x18_~FB\\x0e/1\\x1fY\\x14X\\x0f\\x05!A\\x108f\\x1a>o`%0Xz\\x13.\\x1b_\\x13,\\x1c6/yiIApV\\x1bFTG\\x1194W\\x15\\x0f7j6%*D/jEsK+n\\x1eoLM\\\\K]%/d\\x19n0H7e`\\x12\\x05\\x07D\\x0c>\\x1a\\x07\\x1bn\\x06>\\rOGFOMd\\n6A{5\\x19%\\u0557u.\\x0e(\\x07g>&[}\\x11\\ue698x:>\\x07h\\t\\t,\\x06d]}cKp(\\x14j6GnjD\\x02?\\x05L+|\\x05&O4.Ke\\x05\\x14\\x06\\x02v0|5B/i%E\\x0c\\x15L\\x03=\\x1emcFgIX?CxK\\x1b*\\r\\x16*\"i\\x17\\x03S{\\x0b|x0\\x12R~\\x17V\\t}\\x80%=o\\U000411bbYM\\x13)^Ah\\x1b\\x08\\x130l\\x13\\x01\\x1dDIA\\x06;.,Z\\x03v6*\\x14>Cr\\x12|\\x15l\\x05xx\\x13lh\\x1ey\\\\|H^b]Ske\\x16}&\\x01\\x1dp)\\x1djUoO\\x08:O-jrJq@C\"\\x06\\x03}\\x13\\x14\\x07\\x14\\x1a5Wj\\x168!,p/\\x18\\x16A0\\x1bo\\x15T}uw\\x08`\\x15\\x08~\\x08PLv\\x03J9\\'g_`&M\\x08\\x1dph%EFe!|\\x1bomb;5mK\\t\\x19/b`\"=y+\\x1a\\x0bj)\\u05f7\\x07\\x021?Y\\x12=A\\r\\x135\\x17o\\x03 z\\x07\\x1b7|^\\x04\\x01\\x1aoD6o\\x00Q7s\\x7f+>Co+~E|\\th>\\x12o?RZ\\x0f=\\x7f\\x06q}aR%G?\\x1ecdqel?\\x00\\x14a\\x7fw\\x9b\\x08\\x10K\\x1d^\\x15|@3:-\\x1a_RpUvn\\x13$|u,d8\\x1b\\r<+\\x1b\\x00|\\'R\\x10J`\\x07\\x05s\\x18]ZJ7gFJMVT\\tKyg\\x144BZ{,\\x06f6EoN\\x19sdAYaE\\x16}UEU<~,\\x13ph@\\r+\\\\v\\x06zl\\x0flaWE\\x14f9c6xOx(i0M}c\\x1a,v\\x08\\x04\\r\\x19^>5 \\x1bm\\\\\\\\QNC\\x16&\"fQ+,&>y&\\ueb0cezM-p{\\x11ux\\n\\t\\x0f/9\\n\\x7f\\x1d,mqvkqxIK\\r<c\\x02\\x7fx`E\\x161\\\\ AZ9;$RvI\"\\x142c\\\\p6j\\x0fv\\x1ci`N&)$i0E4qiC&*j\\x14f\\'\\x0b0,][M\\r*&<H3)\\x07c\\x121\\\\ap\\n<?\\\\u_\\x05\\x0e+\\\\;\\x07DbXn\\x01\\x04\\x0fh\\x7f\\x15(-N\\x00o\\x03e\\x14pIU_>u5u(7\\x15\\x14NQ\\x12\\x1f\\x06lm\\x1c!E\\x03\\x1a\\x0fPD\\x16s$|O(9V%U5\\x1bB)g\\x12@\\u07fc2WQH?eZuz\\x1aC_&\\x13}Eo3C.arMLha%zk\\x02\\'5\\x1d\\x03_o(vQP2\\x1a[\\x15j\\x04{S\\t\\x16kz\\x14\\x0c\\x1f.(\\rwt\\x12#d4\\x1fSQ:$/6c\\r~qD2\\x7f~m\\x13r\"0dU$inw\\x1d{sm\\x0f\\x13S\\x1b&zH-Qj7+\\x06\\x18\\x1ch\\x16)\\x1d\\x06TV\\r\\x18\\x04NhqM6W\\'$E60\\x1cND|};]1l-H\\x1bazy<V{jq\\rN\\x15\\x00Z\\x14|T-k\\x07]y\\x17\\x1d\\x1c\\x17\\r+khSZlb\\x14b\\nrHoNlE?\\x1b\\x02MeR[\\x08s,\\x0cew}\\x04])vUcw7pUo\\x19#;\\x17\\x17\\x0cZmJsWf\\x1d\\x06Ti\\x05(qC-6kSEfn{\\x0ee+\\'\\x10\\x0b\\x00xW#r2wp]c\\x110[74\\rVoO\\x1f\\x1b9p\\x15,9ue3n#\\t/U\\x1bj9sH\\x12jw\\'\\x08L;3\\x0ckc_\\u05ffG^\\x19o}z\\x10*^EvFyZ\\x18\\x15\\x03\\x01z&gb\\x01Nm\\x06<]tk0 ?3|Sf\\x06/%dp\\x16\\x1a\\x13;Z,\\x039\\x14VI%Vl@kS}Z(%/,|\\x14\\x07\\x02^;l\\'Y`*aoYlH*ae\\x15gts\\x05Id~\\x10{\\x197\\x00#C+#\\r:x\\x7f^7\\x103\\x15~s\\x81\"\\x1f}R6Pes}MeiVwcm\\x169j?\\x0fv=\\x07R\\x15EZ\\ue1f6_Ww\\x1bCWP\\x1ca\\nqZ`WnZ\\x04N\\x12kE\\tlEJvFDf\\x15YT\\x07\\x0eh\\x13\\x7f*suiJFsIlL2\\x0ce\\r2G`\\x14Y<vc}\\x0b4Y{x:\\ufbcdChJ\\n?;&\\x074\\\\}\\x14$/1l{_\\x1f@\\x056\\x00aqA<xU\\x0f\\x17;U8*[X%r\\'\\x16y\\x11~mr$XQ\\x1eu-)\\x18J\\x1fnU=r?xd3w|)\\x12oU!Q/x\\x19^\\x0brGXY\\x01@D\\x06/xU\\t\\x1b\\x06M\\x19m\\x0c<!X[d\\x10\\x1d!XTksnZ7*\\x1f\\x16%rGvvUH..^\\x02\\x18j4N] \\x14pJuS)\\x14\\x0e\\x18^+r[\\x10S\\x10\\x07vQ\\x18\\tWP\\x05Vz|\\x11;]f,3\\x0693]\\x1cpU2y\\x07n>i{\\x15\\x03D~+J4q8FT>g-qm\\x04^(.\\r\\x00u]ha\\x0e=Hr[\\x14RH]cY\\x1eV\\x15u=b\\x15RT/hAd\\\\*@vI9$8gKDc7\\x19a\\x0bL.\\x10\\x14n{.K\\x1e\\x16a3<\\x0eJ4W?>,;\\x05vsVy?}\\x00,\\x0eXOJ\\x1fq\\x03:\\x08jJ@\\x030\\x18C\\x1a rF\\t +k\\x1e\\x18`_\\x03}Kd_>8+]}{\\t^Cv\\x181;g~\\x1d;[>G\\x14[B-a\\x05\\x12\\x07J\\x11h\\x13K\\x08\\x16+y@#!^.ZD9.\"\\x14|\\x15/\"z/\\x01uI-u}=}\\rHAa\\x02E\\x1f\\x0c0$Z/\\nMl*S\\rg5pP\\x1d\\x0b]\\x02\\\\f\\x17*\\x1c]FIm PJ[\\x02w0\\x14J[<<{L\\x08;\\x0f(8:~>-\\x0b[xL!c\\x18?3Pimt\\x12\\'_\\x02+q&:-$3qk0\\x0f$\\x0b3\\x052W<t?{\\x07u\\x05I\\x17\\x05\\n 6*\\x06 KWA\\x12\\x7fE\\x12\\n&ZG6$M|\\t\\x1d\\x19\\'U\\x16\\x1eO]\\x0e\\x10e\\x1d(\\r4;\\\\\\x0bY\\x7fJ7U@8+\\x10\\x04- D\\x02]`e4^\\x1dYxmdW%y4 -\\x15B\\t\\x12b$q\\x06`<):\\x1fzc\".?FLk\\x07~XNf+\\x15@\\x01Au/pV`~!s]0YX^W)5[RPeU\\\\\\x12_6\\x12(5UYq*\\'@Cd\\x1c\\x7fr\"^kt\\x07LZ\\x7f3P5Fg\\x1c\\ry\\x02R\\x059p\\x1d\\x16^\\x13\\x7f\\x13\\x08w\\'Nv\\x0bJ\\x020l\\x16l9\\x16x(?7T<\"\\x1b\\x1c[\\x08>\\x1c;+,\\x08gTv:p\\x1e\\ue75ex^O[)\\x1b$6QopxIKZ#\\x03#\\x1fp\\x18y7\\x03e*\\x0c?x\\x12Gs~\\x03Y\\x16I\\rMtXkcO5\\'n_uu4L_5]kl?~\\x1dhH\\x06w,sWAMdc6-_S\\x13\\x7f<iZ_Mr]AO=X^wF4}CK{`8{?\\x0eh924x\\x1dk\\x134\\x04?\\x1cw:6M6Lo|o6\\x1ei-sj\\x01G-SpP]\\x7f4\\x1elx1t\\x07F#kb\\x02-V\\x0f60~\\x07^_\\x1d\\x7f4GH\\x064=UOU\\'9&OBhZ\\x0ek]\\x1d\\x1a\\x06:,c\\x08\\x01\\x01d2tmt<0\\'\\x19pz\\x08p\\x18_L\\x07Pa4S4wY1TM\\x0fa\\x1c\\x02hmsON\\x1c?4;}\\x1ezyX5\\x01\\x12L6\\U0010f1a9j1v\\x1d=v\\x06\\t\\x0f\\x1c\\x01\\x01&xiwM`\\x183\\x1d7\\x02\\x0e\\x1c}8\\x112i4\\x02y\\x06Na}kz-*>\\x020{G\\x10 \\x03\\x1eih\\x0335\\x08&\\x039\\x1e5\\x0e\\x0f\\x16\\x01{k\\x13y&2\\x10k\\x07mG\\t\\x08\\x0b\\x0e\\\\=\\x07\\x10\\x10h\\x07>a\\x10;e_]\\x0fC&\\x00.sMr}xUxee\\x03v\\x00\\x05~<c\\x1f}t@<=\\x07uUU=\\x198*pc\\x1f>AG>[u\\x0bqX;@\\x08ANmR{\\x01:Bq|\\x0bo}\\x11ytR\\x1d{ K@m<\\x1fHyc[#O\\x03\\n,zc\"AwU\\x1a765uo\\tbm\\u07be\\x035S7r&t\\x03oy\\x03\\x0f^8J]`>0\\x01\\x1d\\x1cv-\\x1cO\\x1eY=\\x07\\\\7,wY&\\x1234uA  ~>U0\\x0exh\\n=\\x0f\\x1f\\x02\\x19hZ|7-F|\\x0c\\x06^6L)XE%zm\\'\\\\KGI\\x07n\\x06.q-VR$].\\x18zz-{\\x04fD\\x0f\\rfworV0-b{LRW\\'\\x7fTh.7R\\x12\\x1d {74/\\x0c\\x7fBS\\x00}f\\x05\\x00=O\\x04SH{!<IAJ.\\x0e=\\x05^\\x1eIB\\x05GpL_O$\\x02&\\x0b\\x16C\\x14\\x00\\x158\\x19Y\"p\\x1dp\\x1aS7%\\t!n&%?/)L\\x1c/`M\\t+\\x00o\\x13\\n \\\\D\\x7f4vA25h\\x04A/\\x08~\\x7f\\x00\\x06\\x174}\\x0e\\x08FW7k\\x04\\x10\\x1e-EN7#sI:\\x04f\\x7f3\\x02\\x13*\\x1c)|Kn2==\\x10t}\\x1a\\x0fU\\x1b\\x1a\\x11p, iAP\\t9E\\x11\\x1alA,\\\\L7Z\\'ngJB-KcC;f)3\\n\\x0c=\\x0e\\x13\\x17/\\n;c#\\x7f\\x01A|Do\\x1a\\'doo4@\\x08^c\\r\\x13K\\x07\\x03[\\x07QH\\x02$V5\\x1b\\t\\ufefd\\x04\\x7fx7=^\\x1f\\x07UH2)w!\\x16V\\x04\\ta\\x08\\x0c\\x10G!?t\\x10E\\x187\\x12r\\x19,/0I\\x1f;j\\x13?.D98\\x1b8\\x08\\x17q\\x15~\\x1f\\x14<>3\\x0bF\\x1b7{&2A%Y}bX\\x1e0\\tDc\\x19\\x130v/?\\x13jF\\x1cRM\\x1b{\\x1e\\x0f\\x13u\\x1a.\\x040X7N\\x17F- w\\\\u)B\\x1ec\\x14v&Z\\x0f(P\\r\\x1bz\\x1dO@QdmhU\\nKGu\\x1a[.B=\\'gx\\x0b\\x10\\x03@:\\x1d!\\x07#R\"E\\x08HUs}r \\x7f\\x7ft1K#\\x1cW/oMW!eN\\x076`10O]U\\x03rK\\x12\\x0f;[\\\\KLK9\\x030\\x0eZJ\\x17tyN\\x03,\\x18\\riI6y;h4(xbd6_0TaD^\\x18*\\x0eYsvqNRD<F(2vH}nC/3X3:`\\x02$Iav\\x00X5u\\x1eIvY3A5$/ip8L_\\x04(\\x14F\\t>[&{rEx\\x17w/R_d{\\x017{;)Y+yI2$\"\\x0bkP,\\x00,:6s7cx}>\\x0e\\x00\\x10tZ\\x18\\x0esv8ZH\\x00,|FkhIimLci%&{\\u0604C\\x0cCv\\x00sH\\x06I\\x00HgIhF\\x0egR.\\x1f<ecO\\t9@\\x070@ [r\\n)a|\\x1a\\x19\\x164>\\tV}A4\\x19;\\x00\\x1dS\\x11\\x02~Uu>hx\\x0e#9im\\x01\\\\:\\x05|/k\\r +\\x18n\\x7f7m\\x181Z\\x08\\x10\\n\\x17H?z\\x03\\x10hrd\\x06[k4w\\'s\\rhH0+-\\'rmId6^{x{\\x07jw \\u07be2S\\x17@p\\x13(\\x03A\\x15YQd\\x13/ 0\\x0fo\\x1e\\x10)[Vbndzq\\\\3\\x10Tx<3Cs@.C8t&Ked%3[@9\\x7fP|\\x1fKkxQA?7]nI\\x07tD~<\\x1e\\x13E&n`\\x0e\\x10K\\x16M)3:n\\x018XPG\"\\x10\\x1b6q\\x104[\\x06O\\x0fF[o`%X\\x12=p\\u07ba%4xf$\"b7t@\\x164:\\x0e,b:1-}t| 0v\\x04]=\\n7\\x05\\nzQt\\x10\\x01\\x18E~Sfb\\x12Cs:h!8G09n\\x0c\\x1f\\x04\"j\\x1e= k\\x063\"!~\\x1e\\x19MNW\\x1d\\x1499L;`S@<XMqL\\x18FK6^:(7y:53{\\'G\\x10C\\x18g3\\x03cC`\\x0bVZ}\\x95\\x19t\\x07UVG\\x06^w\\'\\x06>ng\\x0e}^/\\x11A4*\\t\"g\\x0c\\x128ZWI\\x07K\\x18v|K8\\x1e3\\x01QE\\',SjNSe\\x00C$\\x1b~\\x15=H^\\n$\\'7*Ut]KlP\\x08taYD\\x05a.7e\\x06kv^sm{%*\"V\\x14&\\x01S\\x07D!\\uf1c4Mn``\\x11\\x7f`0nH8^x\\x05\\x14\\x00bY0{\\x01\\nnE<hyd\\'\\x1e\\x1d!m\\x16E*t\\x7f+;r`B.nv7\\x05{ndx#s\\u05c8?K\\x1dUhdvsXFi<9z)q\\u05caH\\x1f)GTU\\x02R]l\\x1fw-(j\\x12H|u9\\\\\\x04I<\\x10)\\x15\\x05J\\x02\\x15\\x1ejI+_CFax0W2z;/6\\x1at\\r\\t9L2-\\x02Zv-Q\\x19m\\x16W+U$9Z0$Inh\\x19b\\x0f\\x1ew-)R[5\\x13i\\x16\"R\\nlWbrXYd\\x0f\\nv%=+\\x1c:^T\\x13T=^TxV6.8gBK\\u0381\\x19_,\\x19\\x7f\\tm`\\u0383+\\x0e_BY8\"\\x07\\x1cjTRKV\\t\\x11^\\x1cp l\\x1aEub?\\x13Z\\n\\x7fdS`\\x0ea) \\x1fw%\\x1dq0GGKoX,J\\x1cX&(\\x13Cm\\x11%\\nNR?Q7\\x03\\x1eYl\\x17Ab4\\x16]\\x08.)x4Zvj[(W4lV[hK~t\\x7ft5\\'^^<V o\\x14q\\x10or\\x18\\x0eQ\\nICE2@^1CX\\x1e1\\x051L\\x083`\\x19<#?!\\x19x=Sd\\x05%\\'I``p{gE\\x08,<pu#\\x14\\x19NEyF\\x07\\x0f(\\x1d\\x7f__\\x16+Sc\\x12*j2Z\\x14\\x08b5@\\t~=;pJW<<h#7(\\x10_-\\x15^\\nkMF\\'Go8\\x0fx<\\x17+@cD,1bt\\x04C\\x19IO\\x12)\\x0f\\n\\x13ih\\x0e\\x1eNy:=m\\'b\\tPl\\x17tV\\x04d4Cvw{1:+hc]!0Y/\\x10/qv\\x0bj\\x1af`QQE`;\\x02lM\\x0eh<\\x18\\x1a~&J7 UIz0@Bcd{ \\x0c*&^7b\\x05c7@.vg+k\\x0fGwwv\\x18,\\n3b(\\x02t!Ql/4\\x11y\\x01}2\\x04!:\\x05t7l\\x0b8\\t\\x06;|\\x0e\\x166D|<\\x17s\\r}5<Y\\x02\\x02pukn@.\\x1d^y\\x17w\\x03/|wr\\n\\x04hvg2N6~\\x0e{d\\tj\\'WH\\x14Zexm\\x1c@b:\\'\"\"4(\\x05\\x19`?\\x153:0B-r+/eB^;\\r]Z\\x13XM\\t\\\\T0~\\x0e\\x18\\x0b\\rh\\x00\\x1fM\\x01W7O\\x13t\\x05/)mV\\x10x\\x06\\x0cJ=&+\\x15#\\x0c\\x02x!5W\\x10{.\\x1c[K\\x17p|yZi\\n+NU\\'z~N\\x1d\\x05RK\\x17:S\\x0b\\x1aH.W\\t|>R\\x1dv\\t03}[-\\x18A,\\x12?H\\x08r\\x10_+\\tfE<c#\\x13\\x1d.H!p?zj=!f\\x0f$\\x00YMfG\\x00r\\x1d\\x17/kvY\\x05xf\\x12TkE_\\x08v=<Ia)\\x7f~\\x18a\\x07\\x02\\x05T\\'\\x1c=0Nk\\x0c\\x129\\x1aKmfewTrnsI+\\x1deYS^@\\x15\\\\Dge\\rW4W\\x03n`\\x1a+\\x17-// Ph\\'at+m\\x0f&X0_$\\nHISXfGXZj;\\x10I[;\\x19\\x0c\\x05\\x17,U\\x13+\\x15Rk+1Z\\x05~ykmR^E$9\\x13\\x1fp[>P%hJ\\tE*B\\x1cGyCl>6\\x1fc|b>r:U4{}>Cn5\\x1f/\\x0fBW/\\x0f{\\x07~c\\x04YWW\\x1fb\\x16\\x17S`.\\x16\\x0f194\\'Y^95O}3m\\x1f8\\\\?WI\\x7f mZdE\\x13=::(h\\x19z3\\x10\\'\\tzRC]r(nf_>$#\\x13*OME\\x11z4\\x1f]K.e_k\\x19%<\\x03D$.A$r\\x05\\nFA0eWo;9\\x05pe\\x16N0 UxQ\\x1a\\x0e}Pp+\\x15]^?~Bm*\\x1d;h<\\x12b.k^QI[<W\\x12\\'\\'&uIES\\x1b\\x03?N~\\x10\\x1e\\x0e2?\\x18U8#/=cu]K0\\x19&{^Q);}q\\x11|u\\x02W)Q\"+-Nv$<T\\'\\x17\\x17IT>A\\x16R\\x12f?,gh=\\x0ep>\\x08uQ/}D\\x16\\x1aB(\\x1aR_\\x07Q,\\n2b`8WXoNj\\x1el}\\x0b4H\\u05cejXy%;\\x7fLj819\\x03`\\x00_\\x03Z+_3&\\x07#S\\x1eyyB|]6\\x7f0\\'\\x143-|\\x14|Y\\x10h~l7Q\\x08[At_RN\\x0b]{ww\\x07gx\\x11N{KZ2\\x0fR>G\\'\\x9bb\\x04$>[}ptu>y\\x0eN4Lf~/(\\x07e\\x107\\r\\x0f]PlOLM.g\\x7fM\\x10\\x105I\\x0b%r\\'e%z\\x0c$SS<6+\\'~w\\n\\x19\\x07]\\n\\t?,pqw5?F\\\\\\x07Q9O\\x7fJ/@\\x05J$M6\\x11r-ky\\x10\\x10/zp|h\\x12\\x078\\x17C|^?\\x06A2:>&\\x08_\\x18\\u07fbA_%sH3\\x16lc9\\x1d*|-\\x14w\\x05\\x14GA6\\x0b\"\\x140hL)3eqW6l^\\\\{3PGp\\x15K\\x06\\x05H]\\x1bA@Ghx-\\x16V\\x153e\\x1e\\x1bz9|3\\x0c\\x7fl\\x04Q5\\t~`I\\x02S;\\x7fl\\x07iDq\\x1e_yz\\x08KL<;+\\'|\\x151\\x13/j\\x1e,\\x19Rg\\x11@\\x0ciV\\x05\\tS3Z]o\\x11.[`7R\\x1ecFczpGZ@\\x08\\x13b.\\x0c]\\x0bM\\x0e\\x14F&mt\\x0ey`\\x10[O(\"N\"\\x1cM>!eI\\x00\",\\x03\\x1f%\\x10T;\\x017\\x0e.\\x14|wC\\rI\\x16&\"/V\\x02+dz\\x149K$U[g#e%s6:\\x0bo2J\\x1f\\x0f8\\n1g)$Cx*.w\\x1eO!\\r\\x1fj,S;\\x16R$LxUxh\\x17\\x06S~Sm\\re&\\'c1 \\x0e,\\x10/i^16~\\x16\\x1cE#T7`A?O4G\\x0euv\\x12n\\r.Wwh#\\x1a.g\\x1eOzhRlAI}&\\x03c\\x06\\x066]\\x12\\x02Cu\\x0eg(}\\x01U:u>0,/\\x16\\x17\\r=f`x\\r^`[\\x1f\\r\\x18{!\\x00TZ\\x0eHZ-\\\\`\\r\\x15\\x05\\x01yuX>a^0 \\tDv\\tdMG\\x072O\\x17\\x0f11\\x1e{K\\x02JjI/e\\x08F\"4%t\\x076M\\x11^0\\x0e AOmH02lG\\x18$3s\\x083k\\x00~t\\x08uE\\x00\\x1b[k\\x12=\\x01\\x18\\x1fC\\r52\\x0f:vD\\x13@;`\\'\\x04!L\\x19\\x1b`\\x18>c<;<x?4\\x1f\\x17\\x07\\x1e\\'J\\x1bhQ\\x0f9?`\\x196\\x0fGL6\\x00\\ncB7^,\"\\x18~VqW\\x02vJ\\x7f|\\x01B\\x00\\x03\\x19BJ\\r80\"`\\x07\\x15Y6\\tN\\x14\\x1a+pY\\x07\"H\\x10g(tTrPw\\x02A@by\\x06]Uv\\rBq\\x1etI8v\\r0AdNIp\\x1edv\\x04\\x13B\\x00\\x7f\\x03@#6\\x05,\\x03\\x1b 3:+hl\\x10!=\\x0e\\x00 \\x1b f\\x0b3Wo3RP[\\x05\\x1a]m`\\x10nvs\\x18aLC\\x15&[V\\x05\\'\\x1dFoA,\\x11}\\x00\"pu\\x1c\\x139}J\\x10 \\x7f\\x16\\x1eUeA^\\x04<F\\x073HyeF\\'^2:g?|0\\n\\x1b@\\x1b`x\\ue9887t\\x1eb#\\x0bF1#\\x00@\\x1bE\\x0b4fI^Gq\\x0cD8\\x06\\x08pQv4}\\x04c_-\"\\x18\\x06\\x01O1\\x01\"_vi\\x14[\\x10(Rkzx\\x1e/\\x03iI`\\x03DT\\x18\\x03\\x0e\\x1a$\\x1b,0\\x142n4\\x08\\x11m\\rty\\x12Cc\\x02\\x7fx\\x0cCF)^\\\\e\\x1e-2\\x0f\\x12\\x11[/\\x06]\\x19o\\x01Gd\\x1e$o\\nLe\\x1a\\x11\\x07/\\x0bBx\\x1d9k\\x1bv<t\\x16$R{\\x1b\\x15b\\x1a\\x01a\\x12lAD}]Eh;9p\\x14E&xL\\x06\\x07.\\x01\\x1dC\\x11GPx\\x07[\\x030\\x17>e4]\\x12[Kot\\x015S9\\x1a&?Vy`e:\\x16\\x18/A\\x07#p\\x1fd{z4sR!G\\x0fU\\x0fP;Pa)_\\x05|(_VA\\x06xk*\"Y\\x06WA\\x15\\x13\\x148z\\x18N$^~H5-c\\n+6\\x1a/|zHQ\\x15^>X5]\\x7f\\r0G\\' \\x17fXl\\x03\\x0ek7\\x16!H9(.\\x1b#E\\x02,6j\\x1cJeZ\\rF{\\x1f4nD\\x12\\x17\\x05qj\\'k{e)\\rV$\\x1c\\x0cM7kM6\\x1a/y${\\x0bQmR#\\x13D\\x0foUD\\x05\\x1d>c6Y)P\\x15\\x10+5MAj\\nP-m\\x0b\\x166u \\x1esiis(B\\tV*X\\'VS *|<%kjz\\x0erq\\x0c\\x03\\x1cl>1\\x14;ET(~]8\\x01M2\\x15\\t\\nk]sL\\x0fI\"<Nz(.Xs3+x$\\x0f\\x19!+\\x0e:=G]DMpc$H80\"T<#\\\\f/6-\\x01\\x0f,|\\rf/%v\\x0fY2D>pC,p\\x13\\\\I5\\x07\\x15\\x0c3Xp*\\x0f\\x05V\\x00\\x05#4!\\nC9\\x15n\\tcmY=\\x04,0\\\\\\\\`\\x1c@\\x05]Hmh3yi\\x1ck_\\x03`x|u\\x1br9g`Y\\x00knXd\\x13\\x10]_# \\x19W\\x1a\\x0b/jop2\\x19_,u\\x14;\\x16\\x1b\\x02{ <$K\\\\\\x05\\x02t\\nI\\x0bw\\x17o93\\x00pErdAPf?m7*H3m{/au`\\x0b\\x11J]B\\x7fY-l \\x16\\\\\\x0fL-WmuX\\x0br44cF\\x06@\\x00\\x00xU\\x11.r\\x0fGqWr\\n\\x03\\x04RXZRd\\xa0\\x1aojVt<wy\\x13Yik.,[OOh\\x7f\\x0e\\ry\\x00\\x1e\\x0c\\x06hI\\x136D0qCjUc[)q[-|-mf^e^]39xa9\\x1bBW\\x12NP\\x0ew\"\"Sp0{\\x16St\\x8c\\x10\\x1a8-RWa;\\x16\\x12!u\\x063\\x08^-\\x13pfGhv\\x17Q$Z,4=,5\\x0e+\\x0f*.T\\\\&M\\x0e6\\x0bL\\x1c\\x0fQn2MaX\\x1c\\x14#Y2\\x05+\\x02_Fo\\x1a\\x05\\x03#Gk\\x1cM\\x07\\x06R\\x05R\\x135\\x11P\\x1fy\\x7f3_QS ZJ\\x07=\\x05qw\\x16\\tx\\x16,Xvr1g\\x1aB@H#\\t\\x10d\\x05;\\x13\\x1c,>&\\x10[\\x03\\x05\\x14\\x02}&e\\x0f\\x02`8\\x11y\\x04\\x06+Z\\x12^\\x06\\x1c\\\\o\\x10KM\\x12}\\x08\\x05\\x14\\x06x@{\\x1eQ}\\x1a~\\x18Sz\\x16Y=ct\\\\\\x01]#x{M\\x02W\\x00wX)\"3\\x19#;\\x97\\x1b\\x00\\x1a \\x08\\x15\\x17\\x14?\\x1cn\\x12rR]\\x08\\'\\x02L\\x07T\\x1d(Y\\x0e2!\\x1e%o\\x14a<[^wx\\x0bR@+\\nV\\x00(n?S\\x0c8\\x12 \\x05pi[\\x1c9S\\\\.o\\x02[Q\\x14[\\x05\\x17*_cZ^C7\\x1cA\\x0f|E\\x1dHD\\x08RjJT\\x02 Zzb4j\\x03~Mbt\\x1e\\x1b;&?Pb\\x0f\\x1f9mnF}3#WS\\x18\\x18E_\\n\\x08b\\x1c\"\\x1bL\\x1b\\x06C+>_(\\x05# },i<\\x04y\\x140w)V\\x17LB7*\\x01\\\\Sm4\\x15Lm\\x02LG2X6L@W\\x1aQ\\r\\x1aD;qdG@ wVk \\t@iMU->\\x10v?z\\x03r.Z%5FW4B2R4E?%Z\\x194n=L\\n\\x07\\x10y\\x12\\x00Cq\\x19Cl>fde\\x016V:u\\x08E\\x16B0yB\\x02\\x025R\\x1a\\x10\\x06Yod\\x00fnMK\\x17\\x01`m\\x0b!%u\\x1c uR\\x00u5\\x18&RI}L%`3\\x131\\\\w\\x1e.\\x0f\\x04F\\x01\\x192vE@-[XQ\\x05\\x0e,u1Z)\\x0fa{\\x06\\x10\\x16Kl}t\\x14\\x1b&2\\x10&n5$0k\\x00\\x18Y\\x0c@w*;/>\\x11J\\x17[\\x19a[Y/.l}\\x03VlaYZ&|\\x0eW,$\\x06s\\x10\\x03\\x02-\\x00-d\\\\gIs%(O\\x1f \\x16w\\x11*,\\x1dl\\x1d\\tNR\\'{\\x02]t:cE7}{\\x00%\\x03TeC\\\\{Q~\\x00Bvw{G\\x02FN\"HEm\\x04\\x1b\\x1ads\\x1a\\x02c\\x08\\x14\\x0c6q7\\x18\\\\i&/%quq]V\\r\\x0b\\x11g\\x00`Cw\\x0btN}=w`\\x03\\x14-\\x16HDit\\x00!\\x1e\\x01+\\x16.&\\x16SJ\"(iP\\x16LspY;~~\\x13Y\\x18}\\x1a\\x1ao4n\\x88DF\\x0c[5=M2xI(OqcXU\\x119\\x0e5-Q\\x04\\x1f2(?\\r*\\x0cq>\\x1b\\x12y\\x01aP\\x11\\x1b`!bB S8\\x1b%Q\\x02p|e\\t\\x0eWDL\\x13/\\x17C\\x1c>\\uebc2\\x19=4\\x02>\\x1cn\\x01\\x0b\\x15\\x1e\\x06\\x0c\\tA%/87c@AU\\x12!\\x05$/`&{iH\\x14jX\\\\PUd\\x1bi\\x02*|rP}/sjy{B.n@\\'L}Q\\x08xl\\r}w&Q\\x1fDO3by\\x1e9FwFzT7L4H\\n\\ue1ca1RYjz~x\\x0e\\x075\\x00PdP68E*\\rae}r\\n\\x03&4=\\x18\\x1aF\\x05iIA\\x17B/\\r)|MZ\\r\\t+/JaLi$HO0\\x13t\\x1e-\\tzq{(=\\\\}nulLP-Qy@6i\\x03ZKe\\x18j\\x18\\x0b(N]O\\x1e&q\\x0b%%\\t\\trZ=1Yj,R\\x0e,#Nz>\\x06]Mc]\\x10T\\x1d,\\\\\\x113N\\x1abs\\n>q2pkT&\\x0bV\\x08!N\\u0383\\x1e\\x12#\\x7f_\\x08mUTDGc\\x08\\x7fFALw0\\x06[\\x1aGCV[\\x14OwB\\nc\\x156r\\x1fA\\x01G>n&\\x179F_w{I\\n7[\\x0cn\\x1e`\\x00&{$\\\\OI`w\\x14l\\x08gK\\x11\\x19\\x1eg\\x015axRy)ti)G@o\\x08k\\x13<\\x04N]\\x13`@~x1Y?FQ\\n\\x03^=\\x10{|i\\nA:\\x02y\\rV\\x1b\\x02\\x01.|Z\\x1a,xsT\\\\:{\\x00\\x14\\x1f\\x15\\x03\\x13f7NZ+5\\x16\\x0f\\x00\\x18Ro {n\\x03\\x14\\x1bR\\x13?\\x1dY7A3mj\\x10`+I\\'Uzw~ZO#9#\"9r\\x18:S.\\x1d\\n9?qp`p\\x13F\\x048XX\\nh\\x16\\x1ck^.OL\\x12) =Aq\\x0ed\\x0f]MV(?\\x07p\\x18)[*7it\\x1dv1=EGe*`y\\x1b\\x08Lp7g\\x10VC\\x00m\\x1d4=\\'yX\\x0e\\x16\\x18M\\x11u\\x1d\\x0cNI\\x15L uU\"Gs\\nX\\x05%:n/e]\\x03pU7\\x0e]O\\x08zL=\\x04\\x0f\\x0f;}\\x19>\\x04/?y6\\x038<\\x02\\t\\x10n/oG\\\\R\\x1d@\\x12:=u-d.H6O\\x13,\\x01S\\x1a\\\\h\\x00u\\x12z\\x1cE\\x17!Ua\\x01\\x1a6e\\\\7\\x04I*HC$ydH>9\\x16 B\\\\k\\n2^\\x00?lB4%m-Y\\x05.A\\x0cq]}JW\\x03Q:\\'\\r2b\\'M\\x1dLn\\x1bHjm\\x04d?S\\x13``Q\\x04Jpy\\x08i 1#Gi\\x05\\x1e\\x07#f\\x05\\x0f@\\x0f!\\x1exz\\x1e\\x05iB>:\\\\<\\x07L3zYF,\\x11\\x0c\\x06E;t)#.*R\\x06:(\\x15Kg7p2\\x01*4\\x02\\x04wPHw\\x18G=\\x02I4X\\\\,\\x7fpEUrr\\x0b5EU\\x14#x$\\x14t\\x7f\\x1aNZMpi]8\\x04|sb\\x12\\x14T*u\\x1d\\x01\\x14t28\\x00nAU\\x01;C\\x115\\x15\\x16\\x1f\\x10Y#\\x10X?wa:x(6e\\x12x8\\x03\\x00vdAuSF5;^w\\x08g\\x1a-4f.$7w`\\x19ZNBEi}\\x0c0\\t6Qn!\\x1e=\\x16(*\\x14\")R\\'N{\\x1c\\x06| b\\x10\\n\"\\x1bS:C8C\\x19NaD\\x1f\\u0600L,\\x15\\x02\\x13PZ\\r\\x1d;#\\x16GZ|\\x0feE^^\\nz$\\x1dX\\x03f\\x1eI\\x0blbn 29\\x1f\\x14]\\x1aQ-0{S\\x06\\x0f\\x18!V[},C{?Z\\x05\\x1c:\\x15\\x19.~}iMw.GCPi\\x11ACan\\x14\\x11)\\x13k&H\\n_/]+z,j\\x01\\x0b\\x00\\x10T=49@:\\x1eB8\\t\\x10\\x7f#\\x11\\x04_A\\x1d\\x150\\x1a~_\"\\x15\\x03\\x05t_\\x03\\x0bauN\\x17P(I \\x1d@]mP\\x10\\x15P\\x0f:&\\x08W1Az18i*]PD1]\\x149\"W@Yx4\\x02?x&6WI\\x14>E;\\x02\\x7f4\\x1dYSV\\x1bJi\\x02\\x08A\\x1cO!h]\\x18P\\x050_X\\x03O}J0Y\\r\\x1e\\x08jL`t`4v\\x1e<*\\x1f\\'N=p[@[,\\n\\x0cn&NC;JN[}~P\\t\\x01c\\x16Dw\\x11\\x127\\x16\\x1em\\x115xpQ\\x08!4\\\\\\']n9\\na^$\\x01\\x0b\\x03\\x12^\\x03z\\x07BW\\x16$aoP\\\\p c\\x12=t\\x070+N\"\\n?^f<\\x01*t=R+j\\\\u\\x07Di?\"<)B\\'dg):{(,\\x18\\u05fd\\x1a9g>;\\x03Lv\\x15\\x01+\\x12\\x1aBsf\\x18i6qSijMR\\x1eI{eX\\r\\t^Y|%]-.pl_J0*i\\x1b\\x01U\\x01zrG!9nk\\x00z)\\x06T/mL3\\x04Ar\\x04K\\x0e75KZP6N\\x01g__4\\x1b|C3\\x02{\\x15^\")kkL|\\x0bx\\x111#o~\\x01x^K\\x16%\\x1epE.\"\\t\\x11\\x05I\\x14\\x02J\\x00s5S\\n@n\\x11KX\\x06ic5\\x1c_\\x1c4\\n\"\\x0bk;_0\\x15Kee\\nSlH\\x0b\\x14 We e]\\x11\\x17\\x1b\\x04/Uq5\\x19{3\\x06,i Z\\x17/\\x0b+\\x19.\\x15OO\\'\\uffd8s\\x12>R\\U000e6706@YlHv9dc\\x172y\\x05\\x7f\\t\\x18:.AvunW\\x0cK0\\x08TsnW\\r \\x13p0<dwn^\\x142(d\\nNM76yT)\\x1a{{&Oa[<p?\\x17/f;4\\x1f\\x02y?.ywyFG[k\\x19m/\\x15</y\"\\x15ZGmA8q>\\rA)\\x13i)`7~\\x139)\\x17fa\\x17uJ\\x07z\\x0cu_3/n:ip\\x00Ol\\t\\x18\\x04|HU\\nzD7\\x1b\\x7fn]zN&PyiC\\x1c%YQQr\\x17yR\\x0eN\\'0pUXq3[M,1tf3\\x03*USH\\x10XDw79\\nksby\\twneh\\x18l~uN\\'ouRP]6]<\\x03|\\x16e%\\t8\\x1fH[\"O%\\'\\x05K\\x115:r\\x17NuZcTF$3$ImYJN/\\x02/X:M>:X|\\x1d\\\\f\\x1b\\r/\\\\?}\"d\\x0e)qH\\x07\\x1c(x9\\x18uNy^c,%\\x1chHV#\\x14A^H\\x02\\ty+z\\ue1f6Qiq%\\x13 \\x1cQ<JwS|kRE8\\x06G60Q\\n[\\x7fWtn;\\'T=(Iu*s6iL\\x02)\\\\$c]sjhHA\\x0f3h4}N-,|\\'\\x16*~yqn\\x07*cxb\\x07M\\x1a y7qb0O?L\\x06t\\x071\"\\x05\\x1c2K\"\\x11_/\\']\\x13H\\x058z\\x071\\x1eeMC<%\\x11P}d3s^*\\x04\\x1b&.}/,exvo\\x06bG/\\x1c:~O\\x15E-5t[V<\\'n\\x062Ck14\\x1a\"\\x06\\x03hk4\\x1a\\r@\\x02V `\\x06h\\x13OjDG\\x0c\\x1eI)\\x1cX!\\t\\x10.Z]]iF28`\"\\x044I\\x15\\x13\\x0cGa+V!OSmW&D\\x06\\x03lkhrL9\\x12_xN\\x00\\x04^ZL ^\\x1du3i\\x0059Z_}\\x10\\x13T\\x15tGD |M\\nqa_\\x01W^@E* *JGi\\\\.!#Lv\\x03S\\x7fEI3_T\\x0f1\\x068oZs\\\\=\\x10s}\\x06Uw\\x01-T\\x07#dW}s0J.:]\\x05\\x06pyg[\\n/|(Du0\\x11a\\x07S#K\\\\X\\x1aJ5\\'~d\\x06WZUj\"`Z:;{\\x14\\x1b\\x07\\x1bH\\x10UAiw\\x14\\x07\\x0b.wx\\x1e\\x06={*\\x17l\"~g\\x0c\\x10\\x0c*\\x0f4:\\n\\x1ec@2Onpho\\x11#V$9~oE3+g~\\x16YfA<\\rh;\\x027(`\\x04:uMq9<\\x0cWGV;z:1\\x0e<Xl\\t%M\\x18yBM\\x16UZ{\\\\4`YE.HU\\x13p/1\\x0f3\\x1bRQR^{*,X|#c<\\x1e\\x08\"C\\x19^\\x15*\\x1f@\\x08\\x0f\\x0bx\\x0fdcVY[A9_p\\x1b:Bp:[T\\nw\\x0c\\x0fW\\x17V\\x13\\x0fe~.(R;\\x100y7u\\x02BucP \\x80YU\\x05rk\\\\w-r!d>n<#\\x0bH:&S{eEZ\\nJczO`4.CHc^`|\\x08 Y2\\x0eBT<v>\\x16\\x18uU\\x10\\x1fgB\\x0e7n>Q\\x1aN2#3xt>z$k&{w*BT\\x1f\\x19{Cuwf\\x1e\\x06\\x1cAnIvQ\\x00\\x13],\\x1d/^avi\\x1eG\\x17@\\ua954S2U\\x06iWin*Y%}bw9-\\x7f\\x19O\\x01!#s 8ud\\x0e&cLM\\x10QU,7\\x08\\x00fj\\x06UQiI?R9]kX_>u\\x06Bu)Wc\\x1f\\x03FqJ2r6+J\\x15\\x082/vjrRx\\x13t]ZWIE[cvYTt?\\x0b=Zp3%\\x12_{\\x05\\x01U\\x07C\\x16\\x00\\x04h_Nt*O@GBZV\\\\U\\x1dQ~Zr]t9PK7#HJvKZ\\x065Y0x35$Il+cEl(\\x1c\\x1b,-\\x1e,27v\\x1e\\x14i!H\\x192Q;\\x17\\x18%\\x18U3kaK:kM\\x07\\r\\x10f\\x0e\\\\U\\x15S\\x1d\\t\\x1bo\\x1dV\\x02*L0[\\x12\\x7fS\\x057?U\\x01\\x1e$EYp\\x0b:_p.v<>>jK{Wi;k\\x05P]@66&\\x14+\\nc}\\x1f\\x04H^\\x07$KX^O=G\\x0b#ga+\\x07-:l $1OYBTBY6\\'\\x03M\\x14.iO+V\\x13G\\x19\\x7fs\\']\\x17/\\x1a}t\\x19\\x11cw\\U00084a7aggr[,?Hz\\x04@L\\x1e%\\x0c*\\x05/X?G\\x06\\x17\\x16C\\x06\\x06,Q\\x1fy=^o\\x03Ie\\\\\\x13}&4xLKB(9\\x05`\\x05=I\\nbp\\x19\\x01v\\x16\\x11E\\x19PHj\\x18\\x19\\x12*qOzR+\\uefb5N-\\x1d<D\\x08sy\\x7f$\\x12_\\x01\\\\<,\\x076>(\"T/AF\\\\G8\\x0c\\x0cg\\x05u\\n\\x10GmWh\\\\G,A2\\x13\\x19\\r#\\x1cWk\\x05~/1\\\\UyLdAgiu\\n#WP*\\x05Lg\\\\wfE\\x15G):\\x1fTGz\\x05\\'YdP_Xk2l3l\\x13u,t\\x06{I./z![s\\x0f\\x1e9\\u0cfeu\\x17dXj\\x11Mo\\nTc\\r\\x11\\x15\\x16$m}S\\r\\x1eRqX{c\\x11=\\x05\\x1f,^}exo\\x19\\x1bZ^4ucgIaF\\x18\\x1d:\\x0b_nZZ\\\\7)]Cw\"E<\\x15\\x11M2zv\\x1b#cT\\x1eW\\x1f|!0\\x02XPq$5\\x01}~Rs\\x0bG\\x1dTs+|yp\\x1e|Wk:KOW.G0>sZ^\\x06&w!b]H}$}\\U000d67bdfi\\x11/HRl*\\x13d\\x19fH\\\\vc4,`#Lfy\\x03\\x1aV\\x1a\\x15pF5G.e\\x18r-K91MOi9~=\\r^\\x1d;cq\\x1d/3\\x19[\\x0ffx\\x1e|\\x1f\\'C\\x1bC5|-\\x1f=,oiz\\x7f2-F5)V7}{b\\x19}slp\\r9\\'I\\x8f?-wl\\r\\x18-}`lc\\x1cg]K]|35h2C\\x18\\x01o\\t{cq1I:\\x01=M|\\x08c\\x1d\\x1b\\x133\\x0cv5hV80\\x1e\\x1dS\\x18\\x1b\\x0ejD7t\\x1cki:`\\x0c&eA\\x07=\\x13Z\\x18*^2>{}\\x1dK.fBZ\\x1f0M\\x18=7p?~&S\\x1f.>4z\"/3\\x05~hSDktx+\\x1a\\x12/$CC\\x1d}mI\\x06~vp*&>/tX\\x0bbI9G0(x\\x1c#K\\x1b35v{c\\\\B5Y\\x18\\x01\\x03\\x17\\x06X(\\x05$&_\\x17d~!\\x14\\'OG\\x0b# \\x04\\x19M\\x1b\\x1bB{\\x0e(X+v\\x136E\\x07d\\x04IS\\x17tC2@B&W&h|\\x0b\\x07\\x7f`C\\x00\\x05geMbnt?\\x0ft\"`2_\\x03Vo\\x16\\r|;42H^.>\\x15_P_\\x00,+\\x0fZ{i{4&\"^\\\\\\x08RA5E\\x05$\\x15X\\x1eCdivz\\x176{r`cU\\x1f\\x0e\\x135dv\\x10q3yu4\\u0380\\x16\\x1fw\\x1c&-wmf\\x1dKW2\\x1eiSE\\x1b\\\\wZTQ\\x064\\x18Z\\x1300{O=>\\x12[$y\\x7fHz$L\\x0b-q\\x7fwOaGo\\x1a\\'\\x04)]\\x04{=p>\\x12I1\\x0e\\x1c)TQo\\x0f{)\\x19/0\\x1d0Lk\\uec9e}\\x188A\\x11\\x04H7\\x18pDn\\x0c`\\x020^x}\\x05\\x17\\x11e\\x1e&\\x12v\\x1eX^D\\t9 m xZI2VB\\x17n`Pp1\\x0bBz\\x1dc8=Zo \\\\pY4x\\x05;&\\x12La\\x12N\\t3:O\\x0c\"Z&u\\x129+\\x14vy\\x17&Tj_M)6E\\x11!Xqo]Wu<\\x07\\x05\\x13!tR\\x06a\\x05_oa\\x06\\x06\\x1f*uS\\x0f\\x17\\x1dgi\\x03\\x05@\\x0f\\x01D\\x10\\x1b\\x14N\\x1ajKjgO:Wr$\\x1c(Qk\\x04\\x1a\\x0ex|IW\\x0fi*\\\\\\x1b\\x12_VeYihj\\x1a/\\n\\x0fA/Y\\x146\\r\\x08G=G&DAnS]\\'\\x1b@\\x07j\\x0bV\\x05\\x1c\\x06\\x0c&I\\x16\\x1b@O\\\\\\x124b\\x14\\x07\\x7fk\\x00E+\\x9a]swa@R\\x0feAv\\\\\\x15>\\x03ac}Y<7\\x14\\x18$ \\x08\\x1f~,z{GY\\x06Z~H\\x19-\\'CH,Le\\x05\\x06UU\\x18\\x7f]u-\\x0c!WX0y>B!_?bYy\\x18\\x1ee?XT\\x11X\\x0f(z\\x16F\\x0b?G0Qvly`{p?P\\x0f\\rI4&h\\x0fvu[Er|> \\x02Y\\tt9.*\\x1f\"\\tsE\\x05zY4\\x10sX\\t*-+`e\\u0558!\\x7f\\x06\\x08&i;\\x85_{\\x11d*\\x11\\nb\\x00\\'bG+h4)\\x1f\\x19\\x17+iv4\\x7fp~(6~N\\x0biM5%\\x0bDp:X\\x00Et\\x0cT??*:b\\x01F4ps5ZNwn\\x0ftn\\x16M\\x04jbB9JknL\\x1a^\\x11G/\\x1c&\"j\\u038d7`,\\x16\\x0bw\\x0f\\x1aPFx?%F</@\\x1e\\x01?O0\\x15\\x1e\\raf0J`y%\\x18/y\\x0e/>VD*gN%\\x11A4zl\\x08I\\t\\\\KT\\x12x\\x04>x\\x0ea()\\x12m}EH\\x04\\x1a-N!I`\\x0eq\\x16~:\\x12\\rs-KG%F 8r[UeE*\\x1dr8&\\x7fd^_\\x1fR\\x0b3+/\\x1c\\x13cR;jk\\x087dB\\x1bH)&b\\u0604\\x07R:SJ:d](7|nhv\\x0f\\r,PvEpbE^?bd^b\\x0b\\x14EMxOdu\\x00K!JK~0fr\\x00\\x11\\u05ffSU\\x0e_\\'\\'}\\x04,<6z`\\rq\\t\\x08iM`x,)`uLT|2=cTgo3\\x0e%6\\x031;bG}=5\\x1b\\x15K\\x1b%uV4/\\x18\\x06KsG+Q*Q:#\\x1bWRr{!\\x0eZ\\nz\\n\\x16>}+\\x7f\\x08sp\\x11\\x1e\\x14FC\\x1cS\\x12w#|s\\x1bz7 \\x19>F0s\\x19?7e\\x167\\x1a>D\\x10-\\x01a*\\x17X`HMlr(n\\x0b\\x0e@{\\x134^\\x15D\\x0f~\"ccuc\\x06(\\x10kU+@\\'9v;1rj\\x08m2vk\\x07c)NX\\x12\\x01N.B\\x7f/9kx*j%[b\\x12\\x1e\\x07Z\\x07\\x05^yo\\x1e\\x0eukFvql[\\x0c!\\x1e\\x14Y\\x10\\x1b\\x08h\\x01z\\\\Q)8v\\x1f60`O\\x1bJi\\x7fDYEYDFCk\\t\\x18HKiCkKQ[I,V\\x19$Hfq\\x1a\\x1e,\\x14\\x08=\\x10h\\x1dEA:1BV\\x03mUZN]Mkh\\x16M#Ul@\\x154\\x14e8+K/Vf?Lq#P\\x1cg\\\\VV+\\x0bYHJ)w.Wjr0Jze\\x15X\\x08LR@aa\\x12\\x03Z-yvTT\\x1a\\r<`\\x1b\\x00\\x06!;ynW)J^\\'Q;<-g/(Tbw%e(wG@5Q\\x1dc5)\\x1dw\\x1eW6K\\x12^\\x03Gy@K^+\\x1d<\\th<\\x1coW;\\x186iyYp{F*h_Cc$}\\x03U@K\\x05bCwS%c%q\\x15j\\x7f\\x0ej%\\x05wi\\x151+{2N%T5jM3U5\\x0fW{gbfm7$7wgAS~D\\x04s\\x0e<3-VJ\\x18_0jE~dn~\\x05v\\x0eNTScBTj\\x1av\\x10\\x1bI(\\x18\\x08\\x1e+_-^IbZ!1w8%(\\tJ;59y&o\\tm\\\\T:9B|\\x01H}\\x18\\x1e\\x7f\\x04\\x0e\\x1f\\tpD^_0b\\t57\\x1d?GMm\\x7f\\x0fq\\x7f9\\x1c\\x0flxe=uO4}\\x13p,l<s|2\\'6n,h{\\x16Ao\\u05f7{5FgXVN-T}I\\x05j-qb~\\r3|a<\\x08~\\x02Z\\x7f\\x1a\\x18HXUJ-O`w{=j\\x1bi\\x01p,w<h\\x18\\u05ee\\x18\\x02O!zyU\\x7f\\x16JIV%zZj\\x1e@iB:]\\x07ar)G\\x11c)1\\x00\\x16\\x0e\\x03K\\x1f\\x1b\\x01a>+9~\\x7f\\x16R*\\x02_qrwjrL\";$ON|\\x1ap\\x0e\\x18Nw5\\x18!\\x15\\x06dX%/`{wvE\\x166F`M:9%#\\x1f`f5\\x0bIHZOs9%cwMJ-y$\\x06]\\x12bi\\x000&:\\x7fpx\\x19`vXRTEt[{j\\rwNu2)4SqsO=\\x07T%\"({$\\x11J[~3\\x05\\x1a\\x19zc\\x1a#A\\x05\\x13\\x174pu+\\x04]/\\x1fC\\t\\x10jN\\x132\\\\\\x04+h\\x0c:\\x0e\\t\\x10gI\"VlN)\\x13sgN1\\x1be\"2Ql<I?&2K?/r\\x14NNL8*_1Vx3c4\\t\\x7fpfvkT\\x18k\\x13#\\x0b\\x15h\\x1d\\x7f\\x18O}\\x13#ujV]{\\x7fF\\x18UW:1-V;\\rL\\x04\\'\\x06Z{\\x0c_eB6i\\t|\\x0b\\x12>\\tf\\\\\\x1f|p\\x1ac>?\\x13g0\\x04R0\\x191mc\\x19@\\n\\nXlu\\x14/))}]tXYs,\\x07ZXG@L}gY\\x14seU\\nmPJ6\\x1c+EP=Pp:_wnC&(\\t|l6\\x0f&eiHi1A4hF\\\\BbrK>,Q^\\x13b\\x13V)smRN4\\x16:&\\x19w_\\nB[6@\\'^M@=*\"K>\\t4|%\\x10\\x04I-e~\\x0b\\x10ney\\x1cUtEU<\\x16aW4X\\x07lIQF\\x173+~~cM\\x16Gd@\\x16DS!n1+\\x0c\\n#\\x04x\\x15\\x117I^GO$\\x1f\\x03\\t/=\\x03nw^-\\x05g#O\\x1bK`\\x1d^1P;\\x18\"GML-\\x02\\n{\"Gm\\x00%}zZ\\x05&-\\x10l\\x02Os;n\\x02_l\\x1fR\"C\\x19WJ+\\x01\\x12b=6y@vHo2]n>\\x0c\\x1f\\x11i\\x03Sbi0kr4jrMIf\\x0f\\'I;i*#x%B\\x10\\x1d\\x0b|+\\r.K#fzW+w\\t=V1\\x01:,d3=E.oy\\x18]\\x1a\\x19VKrei[iV\\x03MjP>2\\x1c\\x11\\x1f\\x01%OW5^{^%Ls\\x06`\\x19\\x14\\x07KT{\\x13S=\\x1cFKDsr=\\n\\x1e\\x01d\\x17>bf\\x1153bP`\\x1ed\\x07+\\x04/E@.py\\x0b\\x10-c3\"0j\\x1bPuq\\x08\\x08m\\n*\\x1ds\\x06,\\x0fX\\x19t `\\x16`F\\x0c\\x04F\\x0fhtfl&@Q>\\x1a\\x06{\\x02\\x03$}\\x1d\\x1d`NX>2M\\x10m\\x18F{d,Afu7H.Lgd\\x19dw0\\x04X\\x10;[!f\\x15tv\\x7f\\x19M\\\\ [.|\\x15n%~q:y\\x0e1\\x13=\\x069lpb\\x00Sr\\x17J\\x17s\\x1etYaN\\x0c)(\\x00X\\x1fxMa]\\x07+80<\\x07 \\x06\\x02\\x1e\\x19\\x0e\\x15x7~C\\x1dz.k:$$JGo.chsWlInH+x\\x0chG,X/\\x187(\\x12\\x1e[*\\x1dU\\x01`\\x06\\'ic\\x04scD\\x16}.Sr!/\\x10ns*9l\\x17{2Q#FZ#\\x192-;:!,%(d\\x0f\\x0fA:\\x1d:\\x17N4a\\x0c\\x1b\\x10`/\\x0f:k\\x05520\\t(\\x12?d(h\\x11]\\x0033l\\x01E[6\\x19r\\x9a\"P\\x0e3z`,s\\x18\\x06v\\x0bHq4z\\x0c\\'\\x0cL`_05l\\x1e),\\x1a\\x1c0e>E\\x1c}\\x02)<`![;60t;(5C\\x0eXm:pD4\\x04R#FJ;rA\"@rC]\\x10tl W]e!\\x0fx\\x1ddC\\x1e\\x0bx#{\\x1d\\x1e@r\\x19&6T\\x14e\\x15!+b\\x14\\x19qY\\x11jO+RA\\x10JAA7a\\x0e\\x1d;\\ns(|\\x14e\\x11\\rZ\\x16c\\x15\\x14n\\x1aGsTCN\\x03a5\\r~PN#\\x06pIjM%\\x0fT>fp{\\nIH\\x131+\\x0bLDk\\x05\\x1eBZ\\x02/u\\x14~B >Ne,oNOV\\x027\\x06%\\x07.\\tv5\\x0fLL/\\x067\\x16!8F)$f*\\n_\\x03u\\t\\u05ce\\x16\\x0b.\\x00\\x00\\x12\\x13\\x18\\x03\\x1f4\\x1cMuLF0Hg3\\x18\\x14Vg\\x0eEOk&\\x1c7%bn{\\x14.\\x06\\x0b\\x1c(\\x19%5\\x10\\x0c\\x19_f-\\r\\x1a9^[,b\\x0e\\x05\\x05~\\x07\\t5\\n[Hz4d\\x0e!];H\\x00><l1\\x0f|Ne\\x10\\x1daDa\\x01%\\x12\\x04u\\x04/\\rm\\x01\\x14D\\'2exx>bs:I61 /_Bz\\r0\\x13<xBjL\\x17\\x08G6\\t),E\\x18/;l~BaB\\x186{L\\x1b?K=x`u\\x18Kl\\x03|\\x0e\\x03Y\\x05\\x15\\'\\x10\\x18I\\x1eq\\x08\\x1a\\x00xDG!)Jd\\x05 :5gz RX\\x1d.\\x10\\x0e\\x1a_5>\\x0fA_%=\\x12\\x1e`6(za<\\x16]X\\'jF\\x7f\\x01\\x151\\x10\\x08\\x03\\x10dO6T\\x1f\\x04[0u\\x18\\x00?u(\\x0ebd4\\\\o\\x10\\x7f\\x0er]m`c\\x04E\\x0f ]jP\\x1bP=X (%*#F7/\\x01J%0<\\x06m0n3%@\\x0b\\x13D#\\x1e\\x08\\rT:f+\\x02>\\x13:P+WPj\\x11\\x0c)QjiV\\x1cP-5\\x05\\x00\\x10~Y1v\\x199YPG\\x1a\\x03s1\\x04t\\x1aX~/VI\\x19p\\x12(Zr!L\\x1b8\\tI\\x1ao\\x1d\\x016\\t=]-oN\\te&&`w@I\\x06X\\tY\\x1f\\x07x\\x14\\x01i\\x14\\x1c\\x1b\\n\\x03\\'.\\x11K:A\\x0e;:Cn5`L\\r^\\x08\\x12p\\x0b/\\x08WOs-\\x03P\\n\\x1eS0\\'V\\x13\\x15$Xl\\x160D\\x1e\\x17-\\x19\"{K!!XV*\\x10d\\x19%[t$4 S\\x04fZ\\t?\\x08\\x17d\\x00\\x077(@FU\\x0c\\x16\\\\\\u0381-n\\x05(\\x0c\\x12Q\\x04<\\x1d\\x08BLM,b]\\'6AYR\\x06[60\\x1b#\\x11M*\\x1d7\\x196($\\xadQ)\\uf27f\"(\\\\\"x\\x07@Tz6t{L\\x05}wh\\x15tR\\x7fN*6hKZ)SAA\\x1d/CN\\x1cD;\\\\D\\x0fE%T*\\x14\\x0fHL\\re\\x1dzhFf\\x17G\\x12_`l\\'^=Ur[FNDAsT\\x1c/fLt<\\\\\\r(|\\x00\\x10H0^h!}8aH\\x0ew]\\x15+\\x10\\rU\\x13T!?8YR\\x1a,\\x15VZ\\x7fp\\x1dQht$\\x0fNU!\\x0e\\\\\\n\\x10\\x04\\x19\\n-x*tDRlCb\\x07\\x1a\\x12$\\x10$\\x19?%R\\x16l\\u1c8d/\\x16v+6/v[\\x0ei\\x08\\x1d\\x01@\\x04\\x02m\\x15\\x05\\x08\\x19\\x00\"+J\\x106H*^\\x02\\x0c\\x02 5/tY\\x07xYmH0l\\x14NC\\x12]\\t-T3IiS$Uh/`\\x12\\x01^\\x17_hCR[\"2@fWjc\\x0b\\x1d\\x01\\x1eA\\x07\"ve\\x18QC\\x16SI\\x1b$p\\t?J-\\x0e>m\\t\\x06P.\\x16\"\\n30L\\x17EDWxU;\\x12\\x0c<5k9\\x07p\\x1bxC5? |\\nnv[zmUL9:R\\x0fO\\x0ff\\x06\\x1dA9`;\\n\\x14VShEIY4MY(V\\x1a\\x167|\\u0605\\r=%J,ir\\x7fN&\\x03\\n+t\\x0cp\\x05IU0\\x10 hC1$K`<sIR6\\x178vg\\x1e\\x1foIy6z3\\x018Yi`Tp,\\\\&t\\x12bvdEu\\t\\x0fC+t1/\\x7f\\x0eY\\x08:^\\x171\\x1ewn:+7$yxx1\\x15q HG\"\\x02K\\x14\\x17)B\\x13<jBD\\x1cj3p\\x0ed\\x13;&\\x1b\\x06,\\x03L\\x139\\x05`r\\x14|\\x08\\x17?\\x0corr\\\\\\x11xC\\x14\\x16&UZ>r\\x06X^#$O`6Xm\\x0e\\nNM,Ot\\x14\\x17\\x04x.9Bo0K9U\\t~z\\x04Dh9\\x14\\'<\\x0e\\tgA\"\\x194\"\\x12y\\x1c\\x16q\\x0f|fe\\\\\\x14o^h\\n_\\x0e+WBk\\x1b\\x17<\\x101au,N1M+\\\\\\x07\\x02xNf\\x1f%\"ZE@%/\\\\1d^+$f>\\\\0?.w\\x05}\\x02\\x05}`\\x0f$-\\x10\\x01\\x02\\x1aWX\\x02\\'!\\x1dP8d\\x16\\x0eF\\x0c\\x13zB\\x0f*\\x03#P\\r7\\x01\\x11\\x02&Y$\\x0e|t\\x10\\x10$\\t-\\x1d\\x16\\x18\\x08\\x00Q5\\x08@Y G`\\x1es0|\\x1d\\x00O;v,\\x1al:d!nONBR\\x1f9\\x0f@\\x1023\"\\x0eSva\\x1dW\\x0b\\x12z*fpH?\\x19KlN6d\\x1d@#&\\n\\x01R\\x0e@7B:H\\t>\\x04\\x039\\x05\\x1eU!4T>$`u\\x0ck]zQg\\x1cu9z_o eSzC7fzCl|{=W\\x1d]\\uecf82\\x17|twl/bXD]0F\\'`I/?s)F2-~_\\x17&0ci5zd\\x03A6(XG\\x05E\\x14\\x1e\\x0779\\x039\\x02;TZFR$/:FHERV\\\\<dr\\x1e3\\x1f<x\\x03 M,^#``#\\x0cq!\\x04f^wJ\\x1dD)0?\\x06T662Yi\\x0c\\x15=-%\\x11%V;BU7\\x06W\\x0fw,\\x0cj\\x01\\x0fpz/\\n \\x19zz\"\\x18qY<\\x16\\x15|0m>\\x04\\x0bm`l%D_\\x02MfNG\\nn\\x0be\\x00}\\tHn&\\n<\\x0f#8kCbN<\\x1cp62[\\n\\x0b(W\\x1bz)\\x17NDJJ\\x17\\x11-)\\x0e:tpi\\x02]\\x02\"b`CZ0\\x1a(+\\x05K:\\x11cEu\\u07bf_g0ys ;54\\x1bQ$\\nhSlu\\x0cXH7..\\x04c$X@\\x01cqd\\x16\\x15\\x7fy+]\\x08K$YyE:\\x02_hEL\\x03~\\x16\\x10ZF\\x183KYHU;-u;=\\uea1cn,\\x1f,\\x7f6\\x01B+x,H~Aps0Bo\\x11}\\x1bkD_\\x1fg\\x142]Qj) (|\\n\\x1d%[/M7i\\rra\\x1a6:u@,c\\x13LA\\x132$A\\x07\\x08(\\x18K\\x060\\'x#K1Sh\\r\\x02>9\\x0f+g\\x15d/\\x1e\\x7f\\x12,\\x17V\\x1ezAj\\x0fz\\x1a\\x03`AA\\x0fF\\x1b=o\\x1a\\x050\\x117A3mj\\x10`+Q)\\x058N{i=\\x03.\\x13n\\x16)y\\n\\x08\\x16`A\\x00C\\x17\\x02\\x183\\r@+hKaXs\\x17o\\x0c\\x0fLWMuT\\x17\\x1d+w\\x14\\x110J\\x0ed\\x0f\\\\MVdvB%OV}\\x0cqj\\x1f\\x15!+P\\x0f gs\\x15DzcX8sTL;\\n&:q\\x1fn8G#\\r&!.\\x16\\x06\\x154wkY*(\\r6qK\\x1c}N1\\\\/\\x1d6`)6R=dF\\x12> \\x83e\\x15P}\\x1eL5@Z#mC6\\t\\tu\\ru\\\\\\x06\\x16x\\'\\x1eE,|Yy\\x12n\\x17a\\x1a\\x03\\x04L(Xb\\x1a|a#T(\\x14>+lbb;\\x0b/\\x18\\x07`g]\\x05ipP\\x0e[Ju8+SY>\\x17oB.NOj\\x15EtU`e*Z`$9}CxQ\\t\\x15a;ZW\\t&4\\x06/K~L#LSH#.0|5@\\x05Lodl\\'XZ+\\x12\"=\\x1emC\\x9cc\\x14$NH\\x0e\\r^A7!,_\\x01\\x15 \\x07L#\\x15;\\x14(GZ\\x87}\\x07ZHc\\x07\\x16Uk*R\\'xYh\\x1e\\u07b8\\x1d\\x7f&\\x0e#\\x14?\\x11\\x1bh\\x13\\x1a\\x0cv\\x0b\\x0ez\\x04)rIn\\x0ei\\x18p\\x1a^tC-8|Q@\\r)(-I^N89V\"~\\x14&hK\\x02\\x0b\\n,\\'\\x03D\\'-=L<M}n\\x15zz\\x0cYMM\\x0b@^${x\\x11\\x03<nMr\\x1bP Ft\\x0c\\x1bh\\x04we,^\\x12\\t\\x04?\\x16b\\x12\\x1d\\x101\\ty\\x14?1eHj\\x0f\\tKJ*&FP=\\x16:\\x1d\\x1b\\x03\\x1c(8g\\tD\\x1fY\\x15%:GSd\\x19P=\\x17[a$/xVgAzVJlE44JvB4I\\x1fTT\\t\\x1d<*+1\\x1ekz;\\x1d0ky\\x05zrV\\x1aZ\\x16\\x0f4i\\x00l pBnqw\\x1892\\x07SD\\x02/+i.v\\tC\\x12\\x7fhe{\\x01\\x18/C\"QS\\x01)z\\x08\\x1c\\x17\\x1dXCGEzr\\x1bt1xz\\x0e\\'_\\tB,\\u0378\\x0c\\x0b_uQT\\x10f1C\\x05\\x1f/(q:\\rF,|\\x0b&-|\\x18]\\x06\\'EhspmM&fPu:\\x7f\\x1dE\\x0e\\x11gYRxIlCv@MY-hcm\\x01\\x10v\\x0b\\x16!hSTGG<\\tI9j\\x07\\x0bPK.\\x13PTu\\x1c\\x0f9\\x08\\x1arnoW\\rrJ\\x1dNlU9\\x021\\x01/\\nMAl3Sw\\r7\\ty\\x10a J#|\\x02\\x1cLM\\x00tA\\x7fJw8 i=\\\\_2P\\x11h\\x11\\x14H?u`m&\\x07S`\\x1b*\\x1e>mXQ,\\x04G\\x19?|x%mU\\x13\\x01M42n11\\\\nb\\x1e\\u05f7nW\\x19d,R%^\\x19(5\\x0e\\x16JyV<)\\x0e|\\x1e8\\x0c$\\x1a\\x18\\rfg\\x11s\\\\g,\\\\<cV.Vv\\x044/`^$$\\x1dsx\\x14$7Ln4r-;zf\\x04=\\x1b\\x05Iz\\tb2a{aElO\\x17\\x1e\"\\x0cG\\x00`JD\\x13<\\x05).5\\x1d$~\\x08\\x17k$\\x08n\\x18~,H<\\ru\\x04.[@\\x16(xOMkX#0\\rty c@8y\\x1710DaQ\\u074b/\\x10\\t\\x1e\\x0bNi\\x04VT\\x1a^\\x03s\\x03W&\\x1a9zQ;K}\\x18$#.\\x00J6I_H,zFGG0$D{e\\x1a\\x13\\\\e\\rIb-.KA\\x06Wg\\tRW\\x06q\\n*\\x1b\\x0e%\\x0e\\x14Ug\\x00{KZGTdW,%:d\\x0ex(i\\x1aTMS6_\\x01\\n(\\x04|kf%uH\\x1cd\\x1d7\\x06Rj\\x06G\\x15Y\\x15Pt\\x19\\x18i4x\\x7f1m?\\x0feP/j\\tv),\\x15\\x04xE\\x1bz5\\x18\\x10CR\\x7fX\"g*O%\\x12/\\rj\\nVD\\n\\x12\\x15_Z\\x03_ci_>b$/6&u8\\x18\\x01hD^]J[PH@4\\x1b0t\\tG_x\\x11zRb]Fq5L\\x055W*ef.&\\x1cY+z6K{8{mB\\x1aI;_\\x12XA#\\x19\\x0cO\\x1b4l!\\x01R*|Ew\\x00d7Ul\\x1fpG~+r\\x14f<D=w)n\\nc\\x14Z\\x0cFVN&a\\x04=m\\u0604pudtW/\\x0b_t2^Wka2i\\x1c\\x01GN\\x000XW}r(\\x1d~\\x1a2,aVaE<wpsAgn%T\\'oz[gn\\x17h\\tV!~\\x1a\\x1e\\x19\\x03n-YJiry_+w\\x148{ N];w\\x13\\x08\\x1a\\x1e)8w4k*VJ:<w\\x10%RaRVp\\x0e \\x1ccY\\x1b8\\x0e\\x0f7:,5hkvxp6L[mx\\x06V,xVJ~\\x0f~IL6nq`m$\\rHoWpyH\\x1b\\x05\\x1d:dK\\x11v\"Jr\\x17*W/\\x02rk\\nJ?\\x05\"7k9\\ns|gH[ynh3\\x0b`\\x0e.HG0\\x19\\x16,17\\x0f?9Q=\\x18uNa\\x05f)GJ\\x1eU^\\x02dk\\x1fK\\x192XG~h\\x1by[E|lp\\x16\\x13\"\\x0c{+H8lr\\'\\U0007298dOIH\\x168\\x06k\\x19\\x15\\x7f6ohZ8pv-*iwJ=\\x7f\\x15&m;lm\\x15AHr&\\n^\\x1e99M5 Yv4:nmO-,|\\x1b`y5c\\x08\\x1f\\x1e!\\x0fB\\u070fc5M\\x1a yV;JS~\\x12E\\x00AmYn\\x7f\\x10+4k]\\x7f\\x17\\x1e}\\x7f&\\x10L\\x12(>\\x172\\x1a\\x0ca\\x0cP$\"%N5l\\x0em\\x04,Y\\x17lV\\x0b\\x06,exv\\x11G/\\x07~OXX$0>;\\t\\x1bbtci\\riM)\\n\\x1e\\x7f\\x06G\\x0bn\\x16>\\x00mR:%A-WodYi=\\x0b.6`r-_4/ \\t\\t`\\x12H\\x15gc\\x02)xrvI\\x15b\\x1emRm\\x0b\\x1c>(\\\\5=`\\\\axQG~f}+^Q1:B\\x04\\x16UZ\\x02[X\\x0fE\\x16^ZHU&\\u074bv\\x9dFH\\x02EK\\x15nh+K\\r~;8Oi\\x03L\\x7f(pFr>F$Tr\\x11=\\x02/p19L5#k\\'$D\\x1c6\\x06\\x08r\\x169ZGw\\x0e\\x16\\x0bd\\x1di9>\\x0c\\x16]\\x1fk\\x1c\\x17\\x1dA%\\x1f\\x1bnbv\\x7f\\x05(#P`axqF\\x10\\x00!M# \\x1cD\\x1c\\x15!WC\\nh]dr)\\x12TkW\\x07\\x01Q.?Un^4\\x1dYm\\x15^UJ\\x05;cW|(.UA\\x00\\x08~zKRs\\x04\\x14b)K>\\x02\\x06_\"~6d\\x07\\n\\x1d@f\\x05|\\x150QKcx*Xx:.v\\x05/\"\\x1c!\\x1ai^\"dJhzw\\x14r\\x12vjY\\x06\\x1cxa_j\\x17/]z>\\'-[*)-h5~$:\\x06Ud%\\x0c\\x07\\x009\\x17`)N\\t{Pf^H\\x18 \\x1er*_u&!m\\x1arF\\u1ac8*Bu\\x08f\\x16>+<\\x12KWn\\x05g^L\\x1b\\x02rlPo.\\x10\\x15\\x1c\\x04(\\x1e=\\x1e\\x06D*B\\x01\\x06\\x1er\\x1f/\\x04G\\x1dCTZ|>\\x0c\\x17ht$+mj*\\t/K%\\x1b\\x0c?~K\\x17\\x1c\\x01^~\\x18X?7\\x7fIY\\x11\\x10X+_{\\x1c\\x11;_m}9\\x15X;96}nG,y\\x06V*\\x00g\\x04U~j\\x0c-Jg\\x01#+\\u07beyQ\\x17Gq xXco7\\x02\\x1a$\\x1e\\x0e[xSNOY<\\'\\x12QB\\x7f#\\x07\\x03?k:8\\r\\x0317,{~\\x16Gxd(V_/W\\x1ft$$M\\x7f\\x1bi\\x1b8\\x1dk;\\x1bcM\\\\<1\\x1a\\x1a3&71\\r\\x0f5\\x18o\\rw\\x0b8,\\x1f?z\\x16pV{l\\t\\x1dN,yZ&x8L2}k.p\\x14h4!tO\\x13C\\x1fCL<\\\\Gv>|o\\x1d\\x07c\\x18}X4s\\x0fI6e\\r!3Z,X&f{9h,&>G\\x03D3\\x0c\\x1d\\x00{\\x0c\\'ZZ\\x7f\\x02C#\\rfgx}koNe5<`%\\x06c7v,z0E9fi?4ci\\x1a\\x00C7;a\\x7f0\\x00Q\\x0c`\\x16L\\x05\\x13C\\x06CXV_;\\x0e4#m\\x0cc\\x17L8\\x13Xt\\u07fbuZwb;{#\\x0f \\x07Tuooa,=]=og8\\x1f\\x0c7=\\x07\\x06;\\x04J\\x0cs\\x10\\x7f\\x18\\x03\\x19\\r\\x10z.1\\x1a\\x1e=\\x13i\\x04vmv[\\x18\\t1\\x18\\x00;\\t\\x0f\\x05\\x10ya\\x00A=\\x18\\x11V\\x7f9=;7uk\\x0e1\\x05\\x10`\\x08\\x19uG8F\\x1aNnt\\x07\\x03\\x1f\\rf\\x19[\\x18X\\x11~\\x1b=Z0Vo26M&obtm<r{000CO\\x1bj\\x19x\\x009N\\x7fy}8\\x07rA{08o=q\\x065\\x00\\x07\\x19\\x03(@$_]}b5\\x19\\x06 f\\x01~\\x00Z@\\x13\\x1d\\x1a6 <<DRG7.,i9\\x08>`F6<.\\x1bC\\x05t7P\\x07\\x02\\x1df\\x0c4\\x0f\\x17)]\\'\\t4w\\x0cw}0\\x1d 3-w\\x1bN\\x01\\x03\\x1b4\\rp\\x19\\x0c=`!@\\x05\\x06\\x1f\\x7fy=`\\x0cl1$\\x04\\x01k\\ri!h4@c _\\x00\\x07\\x18Enl}96wZOu\\x1f1[&cM\\x1bX}z\\x0bHH5\\x1c [\\x13eNn\\x00F\\'\\x0b\\x00\\x03D\\rv\\x03\\t4i<:\\x1a\\x02x&p[R^\\x1f\\x06\\x015Kb#c\\rHj\\x04Xto\\x00\\x08\\x10[\\r qm\\x1az\\x10H\\x032<Z\\x03,ml\\x01=\\x1a\\x0e@:n,\\x1d>PtX\\t\\x02|Xkx\\x07\\x00A\\x0etf\\x00= dB)KZ\\x7fkg<7\\x16\\x10\\x08p\\x0c4\\x11=\\x19\\rd\\x049n+M| \\x17O\\x1bp\\x01\\x10\\x0e\"\\x05\\x08\\x04Ho\\x00E,\\r\\x00N1\\x0f\\x1d\\x10~7}=\\x1e\\x0e\\x03;\\x1c\\x13\\x19S\\x1bN\\x03@B[mx\\x07}\\r\\x18i\\x1fx\\x06}M@\\x06\\x081!_\\x03\\x13P\\x16\\x03l\\x13\\x1a\\x02\\r@!\\x05a.7zcM,\\x1dO\\x02r6>b\\x14\\x1f`\\x018\\r \\x14\\x0e\\x18\\x08d\\x0bL  !\\x07\\tiO}q\\x7f\\x18r\\x13mT9\\x03\\x1c\\x01\\x07?4An\\x00\\x19\\x02\\x02[\\x04N:t|}\\x17\\x178=\"Vta0.p>\\x0bm!L<\\x05\\x02\\r<\\x04n,\\x07 aM`\\x01zo2\\x04Acu\\'\\x07\\x00Ifht=6\\t\\'-\\x10-\\x0b\\x02\\x0fW\\x1f;0H;\\x1e\\x003\\x1c\"\\x1aO@X\\x00\\x18q\\x7f\\x08\\x08\\ro\\x198c&L\\r\\x02w\\x08YgLF[nw2\\x1e~\\x1f&`d\\x00\\x11`2\\x08l\\npX\\x1fM4\\x1dZ6ch\\x18\"\\n\\x00\\x1d\\x01V\\x1a6\\x08\\x1bk,\\x07y\\tm\\x08d\\x02\\x030\\x02\\x1ea\\x1f{6\\r\\x15?\\x10$q]@\\x024\\x02YH2\\x1e)\\x19\\x141 o\\x01I]\\x7f\\x7f-8\\x08\\x0bq<VZ\\u05f9\\x0fuM\\x06\\x17*\\x04f82ntmX\\x1e\\x1f\\r]\\x0c\\x01\\x7fL\\x13}\\x02Cw\\\\\\x18l\\x05\\x07dmimL\\x1aX\\n:\\x17|\\x07)<\\x1a\\x16\\x1c\\x03@\\x0e\\x1d\\x060\\x02p,\\x0ba\\x1d\\x02,K\\x03jA\\x17AG\\x10\\x0e@A!-V\\x1b<ifh6\\x14\\x06AIC_19.@SF]\\x07\\x04\\x06\\x1c\\r\\x07zG1\\x1eL\\r\\x07`\\u07b7-\\rt\\x0e`}XN_Ec\\x1a&\\x03[\\rgo\\x1eD\\rR\\x05m-_\\x1a\\'h\\x08\\nC-g=mYi;-\\x7fO5\\x1a\\x1d\\r_w`?\\x10_\\x0f[`.DLAjE\\x1dB @\\x18M\\x13XDQ4h<SuBG9%\\x11PWP(b\\x07v\\x0b\\x7f9,\\x06\\x06C.P*\\x0e;\\x07.\\x07\\x07d\\x12Ocp\"<J8\\x16daF;6z\\x1cu:]E\"\\x0bmM_\\x031b\\x01!\\x0bV\\x070=8o\\x1cBV-\\x10\\x0f]\\x1fj\\x1e@\\x13xpKQ|1\\x0cSLm%\\x01Cgp6By@,u\\x18M\\x08\\x06\\x10\\x15\\x0e\\x03\\x04F-8=b mtc8\\x01i\\x18\\x1eD\\x0b.uIZj\\x07!<O\\x05)<`0\\t6jH\\x15\\x01a[:7\\x1cm}\\rw\\x05>2<U\\n\\x1c\\x08V#Q^\\x0e:\\x01$c4p7\\x1a)?rl\\x0eU\\x07g\\x15\\x06\\x1a`y35\\x03\\x06\\'\\x18\"`6WM+?\\x10\\x00\\x10\\x03e$E\\x0b{a\\x180\\x1c\\x07\\x04wuC@\\x02\\x0b\\x06\\x1fe\\x1amH\\x06P\\x06\\x00&DOCft[P]}d\\x1b\"\\x06D^o`-\\x07\\x02e\\x1eB\\x15uF\\x08\\x0c\\x17a\\x06\\rm\\x04\\x0bK\\x06fW&\\x08\\x0f\\\\\\x0c03{V\\x0b4!V55kfApQ:N%W\\x0c1\\x0eW\\x07\\x13\\x1bL\\x13\\x10\\r\"a7p\\rm\\x1a`4\\x17tO&f\\x0e\\x1ei\\x08\\x11\\x0eqo\\x16i1K1-B\\x086\\x1c\\r`[*j+Ne\\x14\\x1b\\x0fZPTK`T\\x00\\x0eq p0G\\r\\x19C0i\"``\\x11x@7\\x14\\x7f]\\x1aD\\x14:\\x1c\\x0c\\x04ro1lS\\x11K#L\\x18\\x03R\\x00Q(t\\x06#[\\x00@\\x081QE-\\x1dg5al\\x05\\x02\\x0et\\x16\\x17udw ?}!UL\\x02aet\\x1d\\x07\\x06\\x02\\rHFLa\\x05b*Cu\\x16\\x1cD:\\t>2t!/\\x13Wx\\x03\\x00rI!\\x16Ev\\x08\\rk\\x04\\x13w\\x01<\\x1bLj!\\x19`!Gj \\x1a\\x01\\x1fbnoD>hxc\\x18`\\\\D\"\\x1d\\x19\\x13d4o \\x084()\\x00\\x7f-\\x1aQ\\x01.m\\x16\\x11GdZpF\\x04&{c Jc[\\x03b\\nM\\x04C\\x06 \\x147nTP{@\\x08kw\\x06\\x02!?3\\x01\\x7f<CH8:\\x02o4\\x15p\\x07Js\\r\\rtX\\x00 \\rM\\x08E\\x1fB\\x1dpad\\'!j\\x1b`/FU4w\\x10\\x0b#\\x06@m=v\\x191\\\\\\x1f<\\x04\\x02mAYh\\x11$\\x06\\t%nK\\x18\\rTHGU{`}\\x03\\x08[\\x0e|>uJ\\x07\\x0eY\\x1b\\x16&\\x071\\x07S\\r\\rc\\x0f[k\\x00W\\x05pMr\\x15\\r\\x16\\x10.Y\\x07G\\x1f\\x14kNh\\x16,l\\x03\\x13PL\\x1dhw\\x1dG8i\\x00aVzN\\x03\\x825\\x18R\\tQU\\x10L8\\x17j\\x16J\\x19~\\t\\x0b\\x06GlC\\x00{\\x05\\x7f(\\x08`hu\\x1f1\\x17jCa0\\x00\\x0bxO\\x11w\\x1e4\\x03\\x10\\x1f!\\t:X\\x08M\\x11\\x04!<n\\nDNHot\\\\e4\\x0e\\x05OwFF\\x1br\\x0e}\\x10\\x0bN9\\x18@\"N\\x1c\\x17^y\\x11\\\\l,,0\\x16\"}\\x02$e\\\\cu\\x16\\x1cP7@Xf\\x11U)\\x02F7.f\\x08\\x1a3LpRa]1\\x16P\\x17`l\\x10<Q\\r!\\x10\\x1eM\\x15X\\x12\\x04\\x06mf\\x19@K%\\x18\\x00>+>\\x0e5\\x11|\\x0f\\ra=~\\x1b\\na8-D\\x08\\u07b5-}\\x047a\\x03pm\\x1f\\x05a\\x06b\\\\\\x15\\x0c\\x12:|E\\x18RL8<uqy\\x0bM_|\\x0f+|Qeb\\x1cO\\x17vUUkJI*[AO*XmvVj7\"j\\x13VVQp^Qb\\x7f.zj>f+\\x02g{\\'\\x0cO\\x1bzK`zKwGkh3`\\\\7O\\x00>u!\\x17H/A,&XzrOU)\\x0c)RK\\x0cxVO\\x00oM&6O\\x133Z\\x1d1~wKp\\x1bxM\\x04\\x03\\x7fB\\x05`\\tz\\x12G`\\r\\x16Kt\\'`A\\x07_b[zg\\x18oL\\x15P&v<\\x176n\\x16F\\x7f\\x05<\\x1f)\\x02}\\x1bu\\x07s/zTc1\\x13/\\rj\\x7fV5\\'_)!~1\\x105V\\x06bEb\\x06UUnIad\\x0f\\x19\\x07u4d?5VWf\\x0f]YJu0?\\x17o\\x19viU^#D+\\x04+6~\\x1f/0uU`T)b\\x11K\\x11\\x1f&hSv>{JrA,\\x15X-68zi~)6#:0B7\".T\\x02].*ek\\nt.h\\x1e\\nK!1;_^olO\\'r\\x050\\x07\\x0br\\x1dr}\\x0f5\\r#ZGr\\x1f\\x01\\x07o\\x0f\\x1ayT6\\'/S?\\x1fop\\nfA6Q[7+\\x1efa\\x14M\\x05B\\x0f]*\\x1dL<?thYF\\x1a3\\x01\\x10?\\t\\x0b\\u0558\\x1b a\\x13N\\'0z6KSK\\x1b-cz\\x1b\\x1f\\x15UQ.JEv%MVxi\\x0cY@\\x06\\x071\\x17\"\\x7f\\nn6yft$`\\x1f6$.I7-\\x19B ;;bjdAeT-fEKjKA!Y;\\x13`=TtMU*a/W\\x12]4\\x01F\\x0e]rD3\\rG\\x11Exb\\twn`v\\x00V\\x18}>B$q\\x15t\\\\RJo,nMJ2\\x1bz\\x17;^ts;5*W\\x1a;\\x1cxJ\\x10Ni\\x03~pCB\\x18[BN\\x0e3\\tJ%\\x07\\x0e\\x04B{\\x14\\x1ef\\x13L\\x01\\x16z9>6KVv)R?\\x16%\\x19],J[V\\x1c\\x15t[\\x03\\x1ejC\\n\\r*\\x17/a\\x0eHi\\x040J!mH?\\x0f\\x15j@%\\x01\\x0fGa\\x19\\x03\\x08Jz\\x04eM6T\\x1ewy9\\x01\\x1dW$X1:s0to/3U\\x0b@Svv2\\x7f6\\\\/>v[\\x1eR\\nl\\x197vTz]!!+%r3,MKc5:Zl#L1\\x156}\\x04q\\xa0\\x1d\"\\x10P\\x15\\x1c5Grl\\t%EJcl+\\x02NL\\x17\\x1a\\x1fG\\x05ou~ j\\x1fCp\\x16WDOc\\x05z$\\x0b\\x107\\x0bX4\"\\x07T0tqw\\x07zlL\\x13H$A8H/\\x146\\\\8+[R:\\x07?ks+U\\x15~m_?q\\\\3f?}K pfgodNw^\\'.\\x18\\x05\\x19|j\\x11\\x07dNp\\x0f6<r\\r|3-W^kuuM_r_#\"M46\\x0f)\\x1e\\x0bl\\x19\\U000b76397\\x16n[L^=LnuWLf*\\x00Wq{\\x14KO K:_\\x01r\\x12V\\x170\\x13W\\x0ben.?\\x1ao\\x07\\x06P\\x16jM b\\r$ g45IVIg{Nv\\x07\\x05:Wo\\x0f\\x08bTF*;y3\\'\\x1a9ZVkh\\x14K<[,%\\x0cB \\x1f\\x19\\x1cHY\\x16Kaf\\x11j\\x0b\\x19{%j\\x14j7m\\x18bRg#@\\x1eM\\x18p>p\\x16=^g\\x03Jgw6\\x0e$t\\x15t/R|\\\\&1h/9?Mvzy)s;=^$%$,=~\\\\=\\x1f\\r\\x14\\x19{\\x7fO\\\\o!\\'wk\\x085?L\\x1aTz\\x7f\\x16fgL\\x1cA]8\\x16{9.lHb$\\x17oe7L\\x0eAw*ev*]v?\\r\\x1doLT/\\x1cn3F3GOHr =\\x7frS9GX)*.oNd\\x07wS ~\\x0e\\x03\\x16<bU\\x1d,S\\x147\\x1dx+a\\x16~#W\\\\&oF^\\x00\\x19^\\x14\\x7fQG(\\\\\\u03802|zwr\\x11\\x0bc>\\x19E-M I\\x12R&\\x10i E\\r\\x00Y\\x07\\x0b7i\\n\\x13\\'\\x02_1*$\\rGCaH\\x7fX<\\x18\\x05:A[\\x1f^O+G[\\x1f?E2+U\\x14\\x00~dJX\\x07+M[YjyT\\r~$-\\x10S2\\t\\x19Vw\"}@BQ:eYT~Q\\x14\\x11!\\x06|PU\\x05\\x05T6D*f8gh\\x18TQ\\x10\\x1e\\x0b7\\x1dQv\\x1a|^+U\\x12/F^~\\x11_KQ*r|A>E8+\\x1e~K\\\\A[\\x0cHKl\\x12(\\x1f</\\x7f/&Ft\\x7fbjm)\\x06R_Ttn\\\\gbU\\x00\\x07Z5\\x17]^Q\\x0fD^ctKCr+F,$T\\x1a&\\'\\x1fV\\x16~\\x00rXJK\\\\XnEyl*\\x0e~\\x04bq4tt\\x0e-,<h\\x02j\\x1fj\\x1aCg{\\x1f\\x06j0\\x0b@K| Vj}s]\\x1e v<\\x13\\x00^0/\\x11r&4%BU{cj662/Xj<0RMYKo\\x0edn+i|\\x0cD98r&GG\\x00je9\\x17jQ\\x7fi{`\\x7f$UsN8Mf\\x1fOY|lWu6V\\'\\x10b\\x15\\\\d\\x07NhzylzK*GYq0/s=WS3+\"59U\\x17%\\x11R\\x13fQZjdw!y&KIZx`]9XEI~{\\x1fXK`\\x10a;@!\\x16& wG\\x0bQx\\x04C8#\\t.\\x1fO\\x1c\\x069\\'}`]iUI1NHM\\'8#=DrkZg~\\x06/\\x1f\\x1cB\\x7f,\\r\\x1fovY-xc\\x7f8g\\\\I9b\\x02D\\x19}D3\\x1d\\n,:hN\\r/Juq\\x14\\x0e\\x0c|]\\x17)W\"2[3_D\\\\AFks.{ XV\\x1bC~OYF\\x17bU~\\x11+b.h\\x16t&\"IYJ\\\\y\\x13%6\\r@ DLVUs\\x19U^\\x07\\x03,s&\\x7fAJdvt=dBfr\\tMz\\x11u1hzleFw\\U000bf11dr%2\\x17njTr\\x01\\x19\\r|+eaF~x}DeVT\\x1b/:y}~=\"E)vE}R(Y^KE6\\x168\\x0b\\x7f[(\\x17je)\\nlFjAR\\x17 \\x14V\\x19\\x14=R/m|\\x12Td{%<MiF7Ee\\x19^PZQ\\\\\\x16f03\\x1d=\\x1fgB|e\\x0c\\x1f|4\\x0fe\\x01&|`wz\\x06~BSh\\x0b\\x1d_I\\x1ag\\x133<=\\x10~B]S-E\\ng>\\x0bJ\\x17(76>q\\'ko7d|b]sVw\\'U7`]JtV\\x125/+ZN\\x1eQy8w\\x7f^H\\x1bL\\t2Basu\\x14moD\\x1bGZw\\x05D{)H$\\x7f\\x18rF\\x1d|Q<\\x157Mr.byPxcD:)Z\\x1cZ#u\\x103y\\x1b9S\\t!R\\x1fPC.UtzBuwy\\x04\\x1c?p\\x13#a}\\x12\\x17?JB*pxKH(Jc;EDV\\x1bsiHh KIOlPrIrFc$$m$T%$\\u05f6W\\\\ 2*d9Ck5\\',F)ZE@]@DRu@$G`@oOm\\x1e?\\x02\\tw\\x1d=y\\x03`k\\t|{_Rw\\x13/5D2Tx\\x05,Fr\\x12s.o!<@\\x0cCf{~d\\x1c\\x08?4of\\x0cGsDw\\x12B:\\x15~5d_&b|g]ZK\\x11K\\'/A&7`0rE,#&KL2Q\\x01h\\x7f{k\\x18MxGG@h\\x0b0zE0}~4oq=Y-\\x1fcJLmn\\x17T)a\\x8e\\x02%v^c\\x7f5 .\\x15 L\\x122X=:;V@fWR5\\x0bK\\x05;rjqwR:;4\\x19$uvX><{H{m\\x06,c\\x13\\x10Twij*SmNyJ?Q|FOp*S5v:\\x14K)b\\x0bK}\\x17q}\\x19M\\x05gI-w+r#zh\\x02<\\'FYW&K<\\x1eip\\x19\\x16Img^/t\\x02[*\\x1a,\\x07o5=XN)]\\x1e\\x10\\x0bWz7,\\x18jY- wlS.\\x18I\\x00r};\\x0fx\\x0boF8w<_\\x02J`5\\x13.v-\\x1c\\x14\\x16>\"\\x13]\\nsT\\x07V\\x1d,PmzR\\x1b0m\\x1a^7{\\x1f;-?jw!\\x13\\x03ok1\\x18u]\\t* \\x03\\x0fs \\n\\no\\x17*\\x1e#[TKC]l}a\\x17\\x7fg#\\'\\t\\x0e}p+hDS,|Os=\\x14\\x08J}^\\x14=\\nb>\\x07Bpw:z{Q\\x07*`6#\\x16u<\\x066n\\n&\\x0c{}z\\x16\\nj\\x0cl\\x02Y\\x1c\\x16P%S\\x10p\\x15HQ\\x18.)\\x16\\x7fs!\\x00b*\\x07}?>b\\x7f\\x08\\U000583675EwM\\x10\\x11y_w\\x0cp:S`hSZ\\x1f`F\"Hi\\x13t\\x13#\\nW\\x0bSVd,\\x1b\\'zq=p7lGr4f\\x1f\\x1cbqf\\x11W~<\\x14-\\t\\x1d-W\\x06oV\\x0fx\\x1f8_t\\x0c`jmp\\x06\\x07I;Q~`\\x0b2S_wZ\\x15\\x08t\\x02[ViR*0\\x1f\\uf8a2TiT+% F./\\uef6226\\x7f{\\x08x\\x19lf]X\\x00A[M1\\x08\\x0f\\x1cOE\\x03\\x03S\\x19 |\\x00\\x1dWebdL:|w/A\\\\YhV.4\\x1b2_iyUuLrt\\x16Xjg^j\\x05\\x1f&mZX\\x13g82b\\x10@c\\x1c40XY&:=hn^7JCjP\\x18qGq$EtT 6\\x1a\\x15U*{$s\\x11M~%/\\x1fx\\x06aUvLE7\\x0cU>jw\\x0bort}\\x02{r$t\\x13I}\\x0e#&5ip\\x0b@2\\x1c\\x0c9\\x18[9\\x184\\x13\\x000/ip\\x1ef\\x7f\\x0c(6]=-\\x0c\\x10QEw!,alB#?kqC\\x04\\x07\\nN\\x06&T|KVJ{$\\x15\\x1czQiG,w{/rx?d\\x15i\\x1d\\n#XN\\n.k\"/{\\x04T~\\x04EJJ^]\\x11!\\x0b<T\\x19E\"\\x14{\\x1c\\x14{\\nE.?\\x1d=YW=4xg\\x11LC\\x1cR\\x17pXrS[S`/\\x1a\\x03W(r$x,~\\x06]<U>B\\x18jfw#\\x7f#\\x1882h(([\\x7f\\x07^\\x0c2\\x17 a9Eu\\x03diO8\\x13\\x06\\x18ipp\\x05AB8B\\x18\\x01y\\x7fEk\\x13PQp\\x18kB`\\x1a%b\\x18ZkiPe\\x1b5Paq\\x01h\\x047)p\\x04Q\\x08j\\x134\"\\x0f8E\\x1cd\\x07Q\\x0bX[\\x18>;mc\\x0c\\x11d\\x01\\x16IO(2\\x0f\\x18=O@a\\x15k\\x186{FLf\\x151qh=\\x1d$zL1\\'\\u05f8m{O0\\x0f\\x13BT\\x061\\x01\\x18*\\x1e\\x0c1\\x13~\\x0b\\x12p6-\\x1a*i0J\\x15\\n\\x10L\\x08y\\x12\\rWD\\x1a\\x12)g\\x1c\\x00i_ 9#>:)\\\\1[b!\\x0e\\x1f\\n\\x0f9v\\x00e\\x03)Q`C|6\\x00\\x02>kL6\\x15\\x06q>43\\r%$6=\\x16ucTwe\\x03V{GM<]4KL\\\\xN2\\x06(i\\x12#s\\x14SA?\\x1eYc=wHG1T{\\x1cCJ.Q\\x1e\\uef04\\x1cyU[JBh\\x186`6\\x0fz\\x0b\\x0b5)0Ir8\\x13\\x03yT6,\\x1dtLXv\\x01f\\x14n\\x05 \\x1e\\x1b_% %Ail!V@&hp\\x1f(yJM\\x07i\\x13E9uC2\\ue404)\\x05\\x127#\\x181t[O,90\\x04qb4\\x02-V(m]/1\\nl\\x0c@Zu1\\x0fi>lUFmT\\x0e\\x1ew\\\\bow}Xi[h\\']oKb]vm\\x15\\x13+Bc|v\\x06$q\\x1ep\\x03(+;\\x1f\\x0c<WS\\x14NG\\x0b\\x15~r$R*;)\\x10\\x07\\x0fr\\x159\\x1b*\\x08s\\x1cr\\x1aJ+V+G\\x0c9<jZ\\'x\\r&~\\x14juVb<\\x07*ZQ\\x16par\"\\x1f}&)?f,\\x119\\x0b}2P_R\\'2C\\x1f\\x07D\\x00C,y\\x081\\n>pZWt\\x15b\\x18\\x00j-\\x07 zx\\x14E \\x13Iz#E,Hb\\\\\\x17F \\x13n\\x0bY/\\'\\')\\x0ei\\x0c\\x0b1y&vXo\\t\\x19a\\x0c\\r_%,Ww\\x13oR\\\\d\\x17\\x1b\\x00\\x038\\\\\\x1a\\x02\\x06Iy*T>3~nYb\\x7f\\x13.hi\\x14s$>a\\x0fS2(T~)z6}P>RM0G\\x03o|B4*o\\x02 ab#\\u0590\\x04Lv8@+E>.pzEkatf?!f3sli5xN]\\x14W2\\x17$}6\\x03Q2;\\x0fW\\\\\\x17ji\\x1aR654V>uk\\re.*eVD\\x1cZh\\x1b\\x06^R?\\x058GGz1va)`nb\\x12z |n KSIqV\\x10:Gu\\x1bI\\x0e;M\\x17||\\n\\x10\\x13R(jB,K8C\\x01b.y\\x14\\x02\\x1e!U\\n?\\x033M\\x19/\\x18`cr`  w8\\x00mVp\\x17,,xIGvszI_p=\\x05*s*E<:ej\\x058\\x03qdZk|\\r0lQ)XZKo-WClqJMAsR`,aH?:3\\x136X`=\\x19.p&<{c\\x7fI`\\x00!N\\x1c\\x16oX\\x15o:ah\\x7ft]R(\\x0e\\'vffd\\x1b\\x04_B$\\x0b\\x07\\x7f\\x0c\\x1e\\x1a\\x0b\\x0f|wM\\x14+\\x13&\\x0b|\\x0bzg\\x19Zb\\U00034fc6}6\\x17Uw\\x08@3\\\\]j|cu\\x1cgzev]\\x13Tz#Gw\\x12\\x14\\x17]\\x7f\\x0f<\\x031\\x7f6\\x0f\\x12\\x7fWE@%}\\x1a,\\x11L\\x03\\x1c\\t}q\\x18U_sQ\\x06tO;H-?\\x12|{F7([/CdG\\x19,x8\\x0c\\'\\x16* F\\x1c\\x7fxG\\x02N_Dy\\x12pl\\rh@N\\x04\\x01yvH]Nia\\x05h}7}X6\\x0e>\\'q#\\x14;\\x0b\\x1599E\\x00##>Tw{Zyl_a\\'\\x7fI\\x06k3\\x19\\x17Yt\\x11\\x0b\\x1a]\\'hh\\x04SxO\\x0f%P0Wq<B\\x18oUo\\x0f\\x1ek1O0yMR\\x04*+aw|ng@\\x01CELKd0\\t  E:\\x1e\\x05\\x07&qQ\\x00U(8(\\\\\\x17cZ\\x04Tw\\x13f\\x03a\\x1b\\n}/eTv3X9&m&\\x0cIyx\\x17F$\\x1fTj\"hE(:M]w\\x1d_\\x04oa\\x13.\\x01XQy*\\x14d\\x1b\\x078\\x1b#WS\\x00dg?oU\\x06M<E_\\x841j8\\x0e\\\\]\\x7fVq\\x14\\x16[T3\\x02Oy7o\\x04\\x11&\\x1a7\\x1a(\\x03\\x10oVA\\x03[^\\x0fp,HEm\\x04=Cb^\\x11\\x1bspi\\x05,\\x0e#)Hu?/\\x11z\\x1fp6\\x16\\x050|x\\x0e^s\\ue9ac-\\x01>:Z\\x16\\x00ls_\\x19x+6\\x13xl,Bl\\x00m\\x08|0a/`mkp\"q\\x02x,0\"oVSLZO\\x08\\x003p\\x064J{;\\x0c\\x1a.O\\x03\\x03\\r9j!fitD\\'m\\x13KOp\\x15]mNgSz\\x0f&*|i\\'*s$C\\x04Y)[QJRA|G_O,e&\\x08Zg\\x01V\\x7f/Z=-&WvZ\\\\\\x0b;\\rcbQ\\'#c\\x0eC[cl_%I5>\\rT\\x0bu{M\\x1f|0%<^D!\\x00\";E9V-L^C7Q9Xu\\x1bKpx*Wwru\\x1bs5:F<oLk,\\x11{\\tO\\x148{_X(?w;kE=u%\\x07(I54[\\x01y_X\"j\\x04\\x15\\x19\\x1dZ\\x14VrG_DxJ\\x10X\\'=r\\x1e\\rVC\\x1cMoc\\n|p \\na\\x00r 8\\x04/\\x1d\\x1d\\x1d~b<\\ty4T\\x1e\\x1f=a]\\x0e$l_=\\x05{\\x07y\\x1f\\t\\'\\x18\\x11\\x01YrD\\x08\\x18/O\\x06L<=J\\x19}\\x1e\\x041\\x1fmxlsI\\\\|\\\\y+loIc?qsu6wIZ\\'\\x16jRO\\x16<K\\x12R&^u\\x18z\\x1fDb~NKf}\\x04l\\x0e8\\x0c$4\\x147/;iFBDo\\x10\\x02T]g6oc<\\t!J50DvKl%\\x05:=GW\\x1dj\\x142g?\\x16\\x0btbKcLuVC,WUy7k\\x14v\\x10A]SF)\\U0004256f!\\x7folN7hTBz+9|\\x05\\x17%Vfg=Nb<Z/dyeg;CQZ%\\nfH-/\\x1f\"\\x1fU\\x06\\x10\\x07o1~\\x14&k:<\\x13!\\x1e\\x1fT\\U000be396w2\\x0boQn\\tmS.<pF~Y&\\x04\\x1e?_h\\x03\\x05l>o\\x13\\x7fA\\x19e\\x12\\x1e\\x17|Onz}oX.y2s\\x12.snI9*x\\x0e\\x0cG?\\'\\x07&\\x04\\\\PU\\x04\\x19bd+e!gG^mV/\\x188Ixz\\x1bm`yyXb\\'Y*O\\x18S\\x00\\x18\\n`\\x1dL{vx\\x16\\x1c\\x0e!dgN\\x0f\\x19_.n\\x0c\\x01cd\"\\x7f\\x1aQ\\x1cK/0ncLn\\x1c\\x0b\\x13.Y\\x1ffTjI\\x1a\\x07F0zUcN{T\\x16S^t\\x13:Ev0.\\x7f~sQIU7\\x08WgSk6t:b(\\x08ZM7RC\\x02z\\x1eINEJ-gg\\x1d+/\\x04\\x1b\"\\x01\\x06B,\\x17K2-\\x1df\\x0b<\\x1flM%V\\x126U^\\x149\\x1e?G]9VU\\x11$S.H\\x00oO +m\\x1aND\\x0e\\x0cG1K?\\'\\x08C9>vL\\x07\\x11QD-x&f\\x17\\x04yP7v\\\\?IyH\\x12p,4K;yo\\x18Gr\\x0eim\\x15l\\x13,\\n\\x13mr8;wd\\x0fS}ReW;y\\x1a\\'VkXn&zTM:u\\x08=\\x11)N\\x18C/\\x18:\\x7f~/^\\x1d\\x08PWAk5\\x18\\x1a+w\\x7fM!:2\\n6B5r_a%?!{W%,g9@wEU*\\x01%<\"/E\\x1d/J!<5wux{f\\x0e,mx\\x17\\x13~4QiSj1\\x1f|}9)u\\x1e#\\x1eXuw${Ly\\x111;<7Eb\\x16eq#<E\\x1cq\\rKS\\x12\\x1d\\x05t\".:mt=\\'V[\\x1er<~\\x0c!iTsml6>o{QtK\\n]8\\x15;xcs\\x1d\\nhZ+T\\x0b[4\\x1b\\x05;kH\\nb%W\"&\\'M^C]%v65j\\'-Q/Jgm[uTm;nI\\x1e\\x1e[uwBr,x.>\\'\\x08\\x05,[tw\\x1c9@%1AND\\x07q\\tIz(\\x14u-#74f\\x18l0\\x19)]Wi\\x05dMvp-J \\x1aYA_s\\x06(\\x1dWRI>+{\\x18]g~bgo=\\x1eBZ#\\x1d\\u0600\\x1c^ytF\\x1b\\\\\\x0e\\rYv\\x1d\\x17EI*Gh3d:~:i]r}w/W\\x10ZWMp\\x1b~L\\x07g\\x10\\x10wEM_6\\U0004b537&~\"<R\\x19W}E7iU2c-*R~v`\"Gl\\x05}\\\\#c^3]A\\x16C~pW\\x0bE\\x0f<,c{=F\\x1eO8c;O1\\x17Sd\\ts%Z\\x15+e\\x01$WC#xG1ixt\\x08VH\\x06O73?N~Uk[%z_Dl\\x17y\\x0e{\\nMo9cS(\\x1bt)\\x12a\\x19z\\x15\\x07~a\\x003a1\\x08v0v\\x1b%6\\x145G\\rqKE_I\\x13(Hh#UzXA,VJp:\\x0emo$dJPa5\\x0e8Z\\x0cu\\x11\\\\\\x12>}m{*TPFKmU\\x11_AN*_?4t\\x1f^DX\\x00K\\x13\\x12to\\x10p?n\\x19A\\'\\x1ej\\\\k\\x0e419g:cX\\x06\\x0cjo\\x00^[{n4R\\x18lJRCH@(]\\x1b\\x10\\x11U1Y,\\x08;Sz6x% krC\\t${Mh\\x08.\\x00O/7\\x03]s.x\\'>\\x03\\x11\\x10\\x06\\x06<\\x0cG<!\\tWy#U},\\x1b)\\x16Q\\\\z-$Wi`\\x00S&\\x15m2*t\\x12o\\x07d\\x1bT9S\\x07hkg\\x0e ^\\x03?\\x15Q>K\\x14(\\x12H(Iy*\\tWR-5Vz\\x10J,ZJQW_\\x1e\\x07RSgTH\\x7fd@x((XhSWUQ8yl8;Hv\\x0fWW\\x1b`ITWjlK[G\\x04q0CNJZt5u\\x1aq)bT_\\x0f\\x12\\n,ORr|K>z6R\\x17\\x0eabM\\x1c0ZI.\\x19\\x00\\x06:.V^D\\x07YJb%?\\x11\\x18XvJm\\x7f\\x19j3Bk\\x05\\x1d_l\\x01!<\\x15LQ\\x04H\\x1b$h?\\x7ff }lW>\\x05\\x14KO\\x05B\\x14W,;\\x01\\x16_I\\x18d<\\x0fg+]`gwj\\x14<S\\x13Ke0le ^sovN~m cjHafn1O3?U<XS<\\x16\\x08-j\\x05\\x04x\\x06\\x19VnTTtEt,vJS\\x16kZ=Dg\\np\\x0f8\\\\&[=l\\x13R\\x10\\x05j-ay^0Ly;Ua\\x16,I<!\\x03/3r0\\x03WkRlsZ\\x11z%\\x17w~c\\\\Jl=w2XWkKh[.~\\x1bok\\'P6z;35Kc\\x0133/\\x06\\\\yq|13&\\x07E\\'*\\r\\'\\x0f$\\x1cZej\\x07A_lK,l\\x7f{\\x12EhyD!s\\x0cXidk>a\\n7j\\x08x\\x12{6XNE\\x05T\\nbq5\\x16%IR)7Kg\\x02]$xV9\\x05sUj\\x05Td\\\\\\x17Krxz\\x16Z,|Y0+RRy.\\x1b\\x0c0^\\x07\\x03eR_UF\\x0cUKtWLT7\\x0b\\x1fgmT\\x19I+\\x06J\\x05\\x0fn9\\x04T&bff*\\x16rdSsk\\x03\\x1dQL!5Xv|Ss_S\\x16\\x15~]\\x04q(\\x0e\\x14;o\\x03\\x01B\\x13)7\\x18#\\\\p\\x1b.#AR_R\\x11]ycEBti+9W\\x0feg\\x10\\x1dc$Y\\\\7\\nw1A\\r+*6:u\\rlC3\\x0ew&V[{c`@\\'\\x00*QfHTj3\\x16U^Oh\\x06Ku\\x08K-`\\r\\x18n^Vm\\r!\\n\\x16\\'Vp6b5TFq\\x16W\\\\\\x12\\x7fMmRr!\\x16;BQ+6uB$B\\x01d\\x10kUmB<*}H\\x0eXgxJ\\\\fasp{C<ztoTz#G]\\x17,_1^;|\\x08b$\\x1d_[\\nP6>ky\\x95rH*my\\x11d\\t\\x15\\x12RChc\\x025\\r\\\\\\x0cuKy%\\u070fP\\x0bRn_;iI\\x06&\\x0f^b;}T<?w*\\x03=zL;VAxsj6^7\\x19/\\x0cM\\x12T\\x12iim\\t\\x11\\x13.2?KAGDn[xW\\x1b\\x08\\x7f\\x16u\\x1e0_s}RI\\x14X#\\x12\\x1d\\x1cI\\x19U&\\x08R;\\x0b`\\x19rc\";z\\x1cy\\x1dv\\x0eRmd\\x7fyI>mk\\x0f\\x16s]S>]\\'G8\\n\\x1d\\x7fy\\x1a\\x1d,\\x1dq\\x05fy\\x00r\\x15C\\\\<\\x02\\x07GZwV\\x1fG.Z-eJ\\x110Y\\x05F/\\x12}.T\\x13EO\\x00R?9@\\tPSEm2\\x11w\\t\\x16;9wK]&Wm@CL\\x1a@\\x08b-5\\x03xAoy9`CsP-@usS\\x1bvp\\x1f\\x1a9\\\\hZdK,5)+=&\\x0fp\\x06ngMaeMEJl=\\x1b]m_3?m.:\\rXk[cS\\x18o\\x08{j6-0\\\\s\\rXR}s\\x01-z\\x14u){\\x05\\x08\\x05?RX\\x02\\x06(>\\rP}\\x12\\x00 j\\x0e_spL]t5n\\\\dg)\\x02yN\\x12nyK$X;X kp[xCW=\\x08t{\\x00\\x15)X1x\\x15Y\\x19|0\\x0eK:}M,Z>fv\\x04D=Hx#xWL\\x17>G\\x7f>\\x15#\"\\x1a[2\\x7fPVsTO\\x07\\x7f1a\\x15b\\x1b(\\n\\x1bqzK\\u070e\\'\\x08/|n*\\x7f+\\x1b\\x14t)#%(\\x05\"o(\\x17RZ:\\x7f\\x0c?W;]\\n\\x17C#\\x17R\\x1ch>\\x1e+!u\\x11oqc(u.zvx\\x0cHo\\x0eX\\x11d}lc}\\t}}\\x1b~;\\x0bzT$._3\\x1fR\\x0f\\x0e}St|\\x7f\\x13j=J\\x08d_)5\\x02YRN\\x1e\\rVW=\\x1fWLm,k\\x12^M\\x16Zwu`WBO(&<[e\\x01w8iS\\x1c\\x14I@|\\x1e\\\\VT7-C^a\\x03G.7{\\\\J|l\\x0bL\\x15{D~\\x16_>hvL_a\\\\9{-nI\\x121V6F\\x1c]*gMhk1\\x04Xr\\x16\\x1b0-|\\x01\\x1c\\x1cU(3W*\\x07#=\\x19\\x1dW\\x19t/yE\\x1f~2>L\\x10&;2c\\x0euuR{1\\x1d[3zb2p\\rM\\x1b*bn\\x19\\x0cm\\x0c\\ru\\x0cw4\\x1d,8NA5\\\\)b~i\\x1bJ\\x0cNW\\x1bna:\\x16qFnm:tlYQ\\r9\\x1d\\r\\x0cv64T\\x1b\\x1dsMc\\x14r\\x11h\\n:\\x19Yf9\\x07\\x03c,KzVOo\\x19wUe8Vc:6I)ZT\\x02k4={\\x0cMm\\x19Abz6{\\x03\\u05f7\\x1d\\x0b\\x04\\x19\\x0cT<\\x05\\x04nR,9\\x14\\x1a:\\x1d\\x13)ehC\\x18v\\x1dpUG5\\rg)\\x02u\\x1dt\\x05M{}M3:\\x1a:z\\x01v\\x06$XCpV_7x4zQ\\x0f(Yn\\x1dvZ#Mcw1\\x0clwA_Z6&z#,`\\x06m\\x07\\x00\\x1f/;\\x02=n\\x19\\x0e\\\\\\x05\\x04\\x00\\x1c[#[\\x1bv\\x0f,\\x19PjmT\\x01a\\x03CmLc;c\\x0c\\x18\\x0b;\\x06?tg\\x1aY@\\ue80d9\\x163\\'j.\\x7f\\x1e(m\\x1bL6\\r\\x087c;C\\x15`5n44c4\\x02\\x15\\x0c0b\\th6XgXm\\x17:\\x1av0\\x16a\\x1d\\x1cY\\x10/GN\\x1c\\x18\\x06L\\x1dc\\x1a]m\\x1b\\x1d\\rw=\\x02jc\\x035r;CM3\\rWuzarlUUf3\\x04\\x0fa\\x19\\x01)\\x02\\x1aq\\x030a{k\\x19C\\x15die\\x0350\\x02AG\\x00P]m`N\\r\\x07-\\x035!\\x1aCP17*\\x01sI_\\x0f25l;\\x1aF\\rxv\\x1a*$qp\\x1e\\x01cA_TW3Z\\x00T\\x08\\x07\\x02\\n\\'\\x04\\x1bDt\\x01>\\x18lc<\\r*\\x01\\x0c1!@:$u:r8 \\x12 \\x18\\x0eu\\x10L\\x13xb\\x10M\\x1dz_D\\r\\x1c\\x06@\\x12`SB\\x1d@!4\\x02gC\\x07;DDO4#Hm\\x17Tp\\x0fPQ\"o\\x1d_Aa\\x0f14\\x1b-mTgj\\x0e\\x0b\\x10v04.jtU0;:0A221\\x00\\x1ej\\x1b\\n#\\x17SYu\\nh:\\x03;V{\\x01Q1\\x0e47qm z\\x1a;\"2`0`t\\x17\\x00QM\\x13A?\\x19H\\x07\\x07Z;\\x18\\x02X@WA\\x12a\\rz\\x10@9\\n(4W\\x14I\\x1cP\\x0eP\\x1b:\"+6l\\x0c&uH9=U\\x07\\x0e%tb\\x1b\\x12x \\x038\\x01!!M`\\x1a(\\x0bN7Y@\\x03D\\x0b\\x7fTu\\x00p.\\x01>\\x17w\\'\\u0590.i\\x0b\\x1fMW\\x17LC|y1\\x06>]T*vTTT]q>T\\x07YiJ]R$ImYuY\\x15MVVQp^q1o|\\x1bg[\\x13i)#Wo\\tt]PwG\\x12Qs6u5O]z|y\\x06&Fzr\\x1d\\x06/K.k\\x01kn\\r5\\t-[\\x011Nmk\\x13\\x12# T\\x01owdQWgm\\x18z3641\".\\x11`BTCk\\x1df]*3\\x08oz?@\\x05_\\x02s-\\x030\\x0e\\x17gxh+\\x16\\x12\\x15S\\x05.>UAu\\x04pbhMp:E4\\x7f9c|&J\\x15\\x1d\\x02+}p\\x06y\\x1eo\"Q5\\x0f&_Mj%S\\x1ak7u\\x7fsCZb\\x0ejwPo:{[}_C*BYO\\x15M)F:no/*\\x051[Y,B~\\x03\\\\_\\x7fN]))\\x10~U7689Zen%6#:0B7\"f,Y\\t\"<f4\\x1c`Sry\\rp${}cr1\\x06:t\\x7f#\\\\{{HOi\\x18O?R$\\x11A\\x0b.T}}o>fAGp4\\\\Y\\x10\\x0elp\\x1eF\\x0fS`EFDlQ\\r(&\\x1b\\x17\\'!Y\\x08M\\x106sz(\\x1ac&\\x0eT\"pA\"Id]cs=#\\x1e$JE(\\x158.\\\\\\x18\\x11v2\\x05\\x07v=\\x16\"M\\x12ft$`\\x1f6\\x14RF\\x03f\\x1a \\t\"F\\x16T\\x13\\x1f|\\x05o\\x0c\\x01\\x7fZJU\\'*X\\x0b4%Gp>I[>.|w,!)\\x06hyP<\\x16\\x1dKd`\\x1cw)x\\x12OlSU\\x15ZkZ\\x0eRx4\\x18j\\n.\\x11\\x7fAM*dSG%mW~CQX\\x06\\x00\\x1b\\x1e\\x7f+\\n}Qx/\\x17f/l#\\x08w\\x0c\\x07=nV\\x05\\x1e})wI6\\x01\\x1bY|B\\x0bP\\x9c\\x0e\\x13!\"@\\x7f\\ts@T X\\x17QF\\x0eqnCX\\x10>\\x12!\\x1b\\x01\\x17C~3)sNH,\\x14>o_D\\x04/.MX`o\\x12\\x05Y\\x16GE\\x15R2nmW\\x1a6\\x14;FS-A/q4W6tnAlX15}\\x12%LD\\u0dcb\\x1e%Ku\\x07MGx\\x160;\\r\\x15\\x1eg\\x7fkRJ &\\x1c\\x0c_^aLUh\\x03\\x11)\\x16~\\x12Pm\\x17NCbvL\\x1a\\x11b\\x03MO\\u05ff6,I/`*\\x1b\\x0e\\x1a%*G\\\\}r$K;9Rk+1FCPn[{e\\x18\\x17au\\x11{nV\\x19S]F5;2Iw(EG\\x0bx?\\x19jp\\x0cW\\x1fC<\\x0fV|4[a\\x19\\x10t\\rKcvwmB\\x1cY)|f\\n%\\x1e\\x07a^<JR\\x1eyyz\\\\N_b>y^2E4\\\\r{e\\x13~4}:\\x1b\\x07z\\x0b\\x1a8N=j^L\\x16\\x16I\\x16:\\x12`@\\x08NN\\x12EWmO\\x11\\x11S#njz}kM\\r\\ue9b0~\\x1a\\x00\\x1bbYxN\"t-CSV}0Y\\x100^]\\n%jj\\x00#\\x1aH)Jj\\\\*A\\'\\x04Vc{\\x1b-&\\x14s\\x1fy@;VI}\\r!\\x1c{-\\u0590\\x1dc_@D\\nd.,;-|\\x0f\\x072WV_3S\\tt\\x1f\\x0bX\\x08v*p1Lv5f4\\nu\\x0e(U=gQ}POe}x<LzaJ\\x120\\x10\\x1e&M\\x17ovC`\\x1e\\x0b6n}(8_\\x15+a|I\\x118qq=Om}}\\x1d*\\x04/{muc_[|+wdiVGuV^;4Hm_(J&e~\\x03\\x19\\t\\x1a3[i8(a\\x1do\\x00\\x01ZJY\\x19\\x16\\x0eXB<{\\x0f/,EIm\\x1a%\\x0f\\x0f$O\\'@#W\\x7f3^\\n<~\\x1ar\\x1ek\\\\\\x189.Uvl-\\x11\\x07}Mb\\x07OLM(\\x0f\\'\\x0bVT=\\x17K)\\x1fr(\\x1e`IQ\\x12\\n2?\\x02cVZ0q\\x08t\\x1aYYjB\"Yxv\\x04y\\x1fj\\x1aCg\\x1f\\x06j0\\x1bxX-,KwXE>:\\x15U\\x1aG\\'\\x17F*Iy\\x10/X(\\x1d V6\\x7f!h0k7|Nj\\x1ce_\\x18F=0Ke))^\\x0b(\\x13^Co,Cb|\\x04\\x7fi\\x1f\\U00044854s\\t\\\\pM}$\\x1fHTrC^Y\\x1f\\x07*Y\\'HVH+\"5h\\x14u\\x18k=MoDKc\\u05ceO;F)\"jd]>,\\x116\\x0e&5MH\\x03\\\\JJ,\\x04z>O@\\x1ew/F\\x10R>}`-I9\\x03;@!\\x04W=\\x04WrT\\x7f\\uf396(DO[V$y\\\\.\\x01Z}`]-sB\\x13\\x15&K\\\\d;\\n\\x11Z\\x07<Y-xc\\x7f8Ks\\t\\x1bU\\\\{\\x11R9f4;WbGq%h\\x12\\u058cf\\x08\\\\F\\';B3w\\x1e:@\\t\\r$uT{\\x19\\x151\\x17f4{7Y3\\x1f4\\x0ezu5?Y7\\x1b4b. A3_!A3_\"h~[;,\\x0b4kAbM*K~H\\x04\\nPD;/&\\x10eY<u-(-%r35W\\x0c+\\x11(DS9\\x13.\\x13vr\\x01| Z\\x17f{-u&Ve\\x12I\\u0379<QJ#a\\x19~\\x1a\\x0b\\x0bK\"3\\x1d`=\\x1fgB|\\x11G\\x0c\\x1f|4\\x0fe\\x01&|\\x08h\\x1fmB\\x0b_Y\\x7f%#9\\x0cT\\\\\\x19\\x1de\\u07b2nL\\x17:O\\x0br^Lyb\\\\o+JNwP\\x15|~P<}Vs=fNr0\\n\\x0b]U+w/2h\\x19vknt/\\x0b\\'Nhs{j\\x07\\x16\\x0f\\\\:Mp\\\\=\\U000c957d|(2\\x1d\\x7f.\\n\\x7f\\t,7xW\\x01!\\'d+EF&\\\\,e\"\\x0b?b\\x0fNc0Ok\\x1e\\x10&7\\x17\\x04]/#K8#\\x1cN\\x15qbTrqKF-\\x13dq^FM\\x07+9\\x1a)\\x12\\x0b%2T\\\\d8n\\x128A\\x1dvV\\x0b/\\x12\\x1f\\x7f!Yh\\x0b5M\\x19~{w,\\x0bR\\'Db\\x10s%\\x04Y\\x17%\\x1fd4d9e^\\x18!5fd\\x11%4\\x15M\\x1b~n\\x19,BfMM{!e\\x03M)nxmTsif?4\\x08B\"tk$%z,//bIa\\x131_H\\x18cN\\x11\\x19\\x07Q?;0 LFK\\x18\\x04a\\x12&v~a$V\\x1a9\\ts\\x14\\x0c\\x10c2%L9r9\\x08a4#o@.\\x11U[/F\\n;F&Uv_\\x03\\nt}@P\\x11ezLuvNy\\x1a\\x1c]\\x1e.j]TN\\'\\x08K$QGRHe\\x1bi wQ\\x04Lrj*S\\x19Ny_\\x04O\\\\m\\\\b\\x0bD}\\x17Q\\x01Tjr\\x14H}\"7\\x133C\\x14NM4b}x?.\\x18\\x0e\\x13*\\x18%\\x0e^c~8\\x0c(3w[8q\\x17\\x04\\x10\\t^Tl_\\x1e9_\\x03bs\\x7f\\x06SaQBVvjw7\\\\n~)\\x13#\\x03j:\\x18Kj\\x1a*\\x17-/Z`@-WOp\\x089\\x12\\x1c\\twSwzlGVE\\x1f?\\x04\\x1eXk\\x1em\\uf2f7\\x0cx?=\\x7f1\\x0f7`4`/8`\\x1e\\r\\ti\\x02\\x1f\\x01\\x0e\\x06\\t\\tpa\\x14\\x14Y7\\x7fz_\\x99\\x00pz_%\\x1e\\x197lNWG%|!0\\x0bW2( z\\x10}\\x0f_`\\x06(8\\n+2\\x1c<\\x12&\\x07\\n?>\\x02\\x1eX}k`\\r\\x14-E\\x0cc>\\x10z\\x02R>r*0\\x18[\\nc\\t>\\x00qf#x\\x18\\x08O\\r;j$\\x13MBL-\\x0b\\x0e[`A8\\x0b;\\x13Ho{=\\x1d\\r>Sf%&>f:Z\\x03\\x02z\\x071yQp\\x1b&q\\x1d?\\ue0a0lF\\x1d&*\\x12=]\\toay\\x04|;x~<w`y$\\x07\\x7fD+x\\x1bDCMi6\\x01F\\x01.\\x04\\r\\x0f9G_I84\\x18`+f{+\\x16\\x03\\x1d%p|[R{\\x06S]:\\x06$}\\x0eF|C\\x12\\x1e2,\\x005\\x18\\rt\\x01pT\\x1b\\na\\x1f&@\\tN\\x01^d|\"[\\x036c|/x\\x08\\x10){CE<{1D\\x0f\\x0445G\\x0e1os4Bs-bJr=c\\x1f\\x13\\x19x?\\x01\\x7f\\x08\\x160~B\\x7fx\\tt\\x03DuPp[/\\x7f_06N\\'m\\x00wo\\x1cf\\x062\\\\p7A5r67y\\x0c+\\'\\\\{>f\\x08j\\n(ly`cS\\x0bs!p\\x0fE|\\x16-\\x7fI9gH#\\x07\\nm*;\\x7f\\na4\\x7f&_=L8\\x1dB{2\\x18\\x01x\\x10;\\x17\\x13\\x7fp\\x03\\x18\\U000cf87f\\x03\\x7f\\x1fS\\x1fi\\x15>L}@7\\x00T0O>N\\x173\\x03QyAqp\\x1ehF1VX9DAVb[a\\x16r>KSd<K>,\\x12j^=\\x08t;tg\\x04EC\\x10a\\x03\\x04+_\\r!\\x02Z7~\\x00rF|\\x11SOb\\x01?k\\x0e\\x013.\\x00_>;(2$}\\x0ex &\\x12\\x15EKf<X{cP\\x16#xMg$\\x17\\t\\x1e?:N1?&\\x0bb\\u0380\\x16\\x03q8.hINf`\\x12/9>|cxb@(z>kEwSjt\\x15&W\\x17\\x1d(VLn\\x11\\x13$P\\x18!\\x13?&6V\\x1d\\x06\\x03pNn\\nI\\x05-\\x1fc\\x0co\\x1f\"B9f;o\\x1e\\x7fa\\x1b8%5\\x03\\x10i\\x18\\x0f`eL%&%T+J4)\\x15EQ~\\\\\\x03\\x10\\x1fD$?\\nV3O}^\\x1e=6f\\\\M<\\x1c\\x16\\x06\\x12xX&J\\x15>]H\\x12(K\\x0b>.\\x1cDE\\x11!\\x1d#P\\x18E\\x1570o\\x1crn]n+\\'[=UM3wO;RzM/\\\\ \\x01/]J`\\\\v (WCQ\\x08Gt\\x0e\"Z\\x1aqBU5{\\x1fc$IM0z\\x08!*&QpS\\x05\\x0b\\x0bp\"\\x06j=?VcN6d\\x1aaA\\x03v0hju~i\\x02=0,W\\x1e\\x14a+]8;gpJ\\x1dtl\\x7f3Wiw^\\x04\\x1c\\x16e{ZAZvg\\x08o`n|?0K~-fp}m\\x06\\x11N3{S\\x10\\x05r5\\x13qFw|L>7V\\x08g3\\\\/\\x135~\\x0c\\x16\\\\1lm\\x17\\x1f9>IQEg\\x1aW;\\x1abaki1y\\x0b}\\x00\\x02\\x1a\\'8|\\x0bVEN\\uecf5Z\\x11\\\\\\x13?,R|\\rX*DQQm\\x18\\x0b\\x07\\x7f\\x1c|D\\x03UgT\\x04\\x0ef\\x02n\\x13\\x1e7\\x0f4x\\x1dgBG|FqOi\\t;/F^:y[T;\\x0ciM\\x7fVC\\'\\n\\x0flM\\x11wZ\\x15\\x00?MGN\\x18.*JFR:{KVgt)\\x15d7\\x1e`\\r\\x03^lVA\\x16VSaL\\x07\\'1\\x1d\\x1fqP\\x0b+|\\x00eNyw:l\\x7f<(oji!\\x06Ii\\x0f\\x1f|R1@yQ^\\x1cc; \\x04\\x15?\\uea8eI\\\\sks$wj,6r\\x11s$\\x1dp\\x18d\\x16P\\'/\\x15+R<KJ\\x0c\\x17\"\\u05ee`IVTO\\x19zK\\x01\\x05\\x1a@\\x1ftrp\\x1bI1Sp\\x0b!3~oE!)_rRI~Q\\x1e\\x16\\x1b,\\x7fQ8.\\n\\x15\\x05eM\\x02|p]\\x1d?PWf\\x1br\\tw}0J\\x15.Nvy:\"OES5?sk\\x06y\\x04\\x08 c\\x1f\\x0c4\\'&qYpv\\x1f~\\rn\\x126|\\x19\\x0ez<\\x19AK\\n9/:\\'DG\\x7f\\\\S\\x0c\\x17cMT*;ca>\\t\\x19]&rxLi1`C\\nw\\x0b0y\"\\x08\\x12<2Fw v$k<[.\\x17\\rJ}\\x15rk\\x01UTcu-\\u05fb>\\x17zW-%.|)b$y\\x18N\\x13Y>3~>|8\\x0e\\x1bq\\x15W?\\x1au5D\\x15dVm\\x14Gh\\x07$b%RNdY\"@\\x12\\x00\\x01\\x10\\x04V\\x0b\\x07x\\x06\\x19SR^^f~*\\\\)\\x11\\n`N7{X\\x160\"\\x1b\\x7fc\\x176X?C+ {xX\\x17\\x14}\\x07R\\x1fg-<k#J\\x11QP&\\nJ<*FR5ob\\x049\\x18\\x0bV=F\\x16cD\\\\hl\\x1b }e$LSPi\\n,\\x03( K\\x07oAt,7\\x0bq\\x05t*.\\x18\\x1eC!\\x17Tm\\r\\rmB\\x07rxe\\x1eN*\\x01_?~a4y*ts(:]m\\x7f_.U]\\x03l6QVl(M\\tm\\r\\',d|7E,a(=e8{u\\x1d$KtLqc1jY\\x16W\\t[\\x14!}+\\x19XUN\\x07,`pu{fwR?\\x16\\x07f\\x12 \\x1eWpY{8\\x0e\\x1dkc-L\\'*u5y[P\\x17\\n6GqkL8`\\x17cK\\x02\\x1a\\\\X[9wJ_\\x0eP\\x13r\\x0ca3\\x1bp\\x05n\\'V\\x02!;\\x1eDf4FP})MykIdH\\'u:i\\x01&yzG\\x01.;CV%\\x125\\x1a#\\x046vn\\x7f/P\\ue58b?\\x0cJ_\\x1cDm=-\\x1eq>\\x7f\\x02\\x13\\x03\\x11f\\x02JZ\\x15^b}\\x19\\x1amef%\\x19.\\x157k~7!K?u\\t@(\\x16\\x11#fGEgI;z\\x1bz\\'+>q&\\x0c3U=SK?}rZ~AG\\\\V\\x18\\\\w-kK^z\\x1er\\x0bh8}!)$`)N)R&b3r\\u05eb\\x15\\x06PXN?\\x14arS[X2`\\x08Bs\\x16O\\x7f\\u070fam-yn\\x02 \\x13t5\\x119\\x03H\\x11oh@\\x1ai\\x12\\x01\\x11^ru\\x16V\\x11\\x11$]J}w\\x1apv\\u074c\\x1eA-,\\r\\x16W`K=)6\\x7fr=Z\\x11{%F%\\x02&\\'W_pS<\\x0c\\x13~v;O_}\\x0e\\x034Oir\\x0f\\x10\\x7fkMOk4Y~\\x13UR=yeIrS\\x1efT\\x16\\x15\\x12?L\\x12XnF[&c\\x0b\\x0f0juy\\x0bm\\x16\\x1fV\\x0f\\x19\\x08\\x00\\x7f\\x1dT\\x17=&6kL6}my\\'\\x1f\\x167\\x19yu^cZGP=\\x0fD\\x0cKp\\x05d\\x066*f\\x1eN_&</\\rPt$$<t.Zw\\x11\\x0f<\\x1ab(y\\x1eF$(W6\\x03ym_Z}\\x01*.[s\\r[H3\\x05\\x08\\x19U\\x03F#1\\x07XUZTA7<8@\",0ue`\\x02YMl\\x13UEzn1@\\uf028\\x03?Bw6zLC7eb7\\x06\\x1art=y\\x06\\x14Hx[\\x1b\\x0c{8\\x1f[\\x7fkzI\\x1frK|IT\\x12\\x07\\x16\\x0fU\\x106B\\x06\\r@%1\\'\\x1agi=k&W)=iR6A\\x0fAS5r~\\x05zu5\\x11z\\x02\\x13\\x086L62$^o!;2\\x14\\rZ\\t_0\\x03}(U\\x06\\x07Z_G\\x04fdl\\x04Im\\x1f4e4\\x06H\\x1c^wAU\\x12s8x\\x0f:,]ENlx\\x0e\\x1ec%42( kZ>x\\x1ao\\x0bxE\\x1f`vCz]?\\x1a3\\x17xF<b7\\x1a:B\\x1fAH\\x03\"3\\x0e\\x7f\\x0e\\x08V]]\\x7f7/N_9\"(\\x1e\\x13{157\\x0cG\\x13A1;u|Ndpgn\\\\E\\x1b$\\x15(R6{I\"Uec/\\x14\\x1eQP9B>T?aW8\\x18gHoB\\rfSy\\x7f*\\x15ZjB\\x16\\x1b_x\\x14,_%<9\\x11{S\\x1c\\x00\\x14?e\\x165O\\x1f\\U001027dap&?S\\x12 (=uV@6}N:UR[\\x05rl\\x08P\\t^h\\x08Q\\x012_e7[P}nd\\x03*I\\x06\\x02{W<a+!\\\\\\'\\t3HaS\\x0eg<P6\\x0bV\\x0b`4R_JGwu54j\\x17F\\x1e:<\\x07z\\x14*3O;oliZ4QRj\\x15by\\'V\\x1f\\x0eThS|>-\\x1728\\x1b\\x1dmxagP=vLq7w7\\x7fprX\"\\x1d\\tyl64YoexZ$\\x1ewwJ\\x0bGXXH\\'\\x01.lJk-Y>/V\\x11\\rz-i#\\x16\\x1c\\x10\\n\\x0eA\\x1ep/\\x1a\\\\^kPi\\n9M|m<\\'Z/d3.\\x1dT5i\\x1aLf\\x17z~\\x1c\\x0cd\\x1f\\'\\x16z<[<\\'>a\\x11Tpj06z=\\x1e/C\\x05V/oo\\x1dr{1\\x12#\\x08*qS.Vqx`b\"\\x17\\x12y&:[e|/\\x7fZrL0nu-\"%c\\x15PJ.)\\x01\\x1eb\\x1f];t8V\\x0bflGrj:\\x0eF{-y\\x16LnV}&\\x12\\x01\\x0b-B.6$OOA/tjBlsBss:u\\x15v\\x11<\\x1cw\\x08n2=]s6\\x11\"@s\"ow\\x8b/)\\x06=*fr\\x0e\\x16F.#.{\\x15=lxu{zKH\\x1bZtd\\x02,DmC,SxM$X>g\\x15\\x19\\x0f&\\x17EoX\\x17\\x1cb?[XX|S\\n72^mz9^vF(WobzJ\\x13l\\x18SVm\\x10\\x03K?szz\\x13M|\\x0b\\x119w.\\rzu\\x07}\\x1dw\\ua62e\\rG~9H:y\\x11F\\x1f\\'\\x00\\\\\\x19_`eq\\x061H31\\x04\\x01Re\\x147w@jVa\\x06bKk{/\\'\\x13x[\\x06z{&;N\\x1a\\x01m@\\x1dl>m\\x12M)\\x0eUCoi4j.FRaS/[AZg9Vi[B{n\\x16~Wfm9\\x1coo |90\\x1a3-\\x1c?QcSt\\x0fk!\\x1c\\x01vzMa=[e\\x13Bg.\\x17{){6\\x7f\\x03\"_|\"\\x148\\x10\\x1eHT[X``\\x17MV\\x19M\\x1f9 h.d\\x13]d8E1/=Y?\\x05J\\\\:\\x05\\t}kQjz\"zJ=n\\x1b<:gr\\x10&`\\x16VEa\\x00N28gry\\x0f6qp\\n$C\\x1abY\\x1a\\n,=\\x1436!i^uX=\\x08\\x1dPPD\\x1ckf\\x11ZwP\\x1d\\x17}t\\x12j6K/Ew/\\x1dfw@W\\x02zd[s&z\\x15@\\x115!\\x04\\x19TXueh?qd}y\\x17LBZ32n\\u07ba\\x1cyKOxa\\x0baya+\\x1c\\xade\\\\\\x15r\\x02.F\\x01bL#/4Q(\\x0f=!j+@\\x05e\\tv\\nQo\\x03\\x7f\\x1c>cp\\\\\\x076\\x1f\\x13cEU\\x07c}\\x08\\x17Y\\x11I>\\x01\\\\z/8\"\\x1d/M6~^rY[Z\\x0c<\\x11bn#2R\\x0c.\\'\\r\\x0f\\r*_\\'e\\x17M\\t.\\x00W2\\x00\\x1cG.Sk\\x17}s?\\x08cSD6x`O,?\\t1\\x19L<\\x11-+\\x16&uG\\x188\\x05E\\x1cy\\tFcG\\x08xI8(\\x04\\x17$\\x0cEBX,|2\\x1e\\tw\\\\+6\\x17c\\x17AP0lf8>uC1C\\x034\\x07VonV4\\x1c\\x0e\\x19\\x07\"\\x14\\x1f\\x13\\n\\x04@pSj\\x07(\\x1f\\x0ci\\x05\\x11xozca(a8!\\rSf i\\x02 \\x1b$4#NM6\\t};`\\x13\\x12pb\\x081\\x1a\\',\\x0c&q\\n#2pH\\x00\\x06\\x98@r\\x12;p\\t\\t`z\\x08\\\\nt`\\x12B?\\x08(!\\x04^\\\\\\x0e#h0,\\'\\x11\\x02GP\\x1e\\x04\\x04~\\x04fI\\x08F@.08\\x0e)\\'\\x0eKt2\\x18s,q/d\\x0es\\x01(\\x13&&\\x0eE\\x1d~ \\x08([\\x13?0\\x0f9t\\x06$W\\x11N4\\x11P :\\x13\\x02pfYv\\tc\\x01i\"4m[o1\\x06\\x199y\\x0c@\\x1c1`Y0\\x194)3aOwNW-c_O`(Lb\\x18c\\tY\\x1d2@\\x0e\\x12@q0\\x1e0\\t\\x00%b>-?aI\\tL<\\'!L\\x18\\x14d\\x05BNm\\x01\\x10\\x10hq\\x98\\x02\\x7fA\\x0fL7C\\nc\\x00s\\x0b0qLwB}\\x05\\x1d\\x14\\x12\\x06`d=\\x022E`G\\x01\\x0c\\r\\x16\\x1d\\x03} -7}e>Cg8\\x11\\x07QS \\':tLx\\x03gY0M\\x0fsa\\x11{&|>\\x13\\x04\\x19aN}\\x0eO\\x13oA\\x03S@p\\x07@H&\\x008\\x059\\x0co\\x02Cs>=G\\x03#r\\x08b\"\\x1eP\\x10\\x00\\x04F\\x00c\\x0c|{NH,\\x10& iaA\\x1c\\x1e\\x0e\\x00f~D\\x1cn\\x01p,f,\\x018\\x1c\\x06\\t0p|&\"\\x17Dq\\x18\\x00\\x1epW%\\tdjF>\\x100&<rp8<L\\x11@r(c!go:\\x03[@\\x13\\x05D\\x1d\\x06#\\t\\x011u\\x13g\\x03Ed\\x00p\\\\\\x1bd!\\x08G \\t}\\x110f:ab\\x13<\\x01\\x16q@XLq ~\\x07 c\\x011\\x13\\x10\\x02aq`5\\x04\\x00\\u058b\\x13\\x1a\\x03\\x111jX\\x1c^\\x062p\\tP\\x16bKqGGCJMJ\\x00\\x19\\x133N\\x02?\\x0ej!`~L\\x10f\\x1c\\x1c\\x05\\r# !\\x18C\\x12z\\x1a\\x03/:\\x00O\\x11\\x00\\tu\\t\\x07\"J0P\\x13W\\x1c\\x07\\x10s\\x02tpw\\'$\\x1c T\\x17 \\t\\x03Y0\\x13?\\x02V\\x16\\x11,yjO\\x15b~\\x057r\\n\\'}\\x0c\\r]FC\\x0c\\x0b5.\\x1f4aG\\x1f\\x06\\x03b\\x0ft#Qu<\\\\,B?VVf?|5z.\\x0b\\x19\\x00=\\x10~\\x08b\\x19-L4\\x17a.W\\r\"5\\x1c](_f /`X\\x08#\\x0b3\\x10~4Y,>\\x7f,s\\x0fV7EcI$2e[\\\\\\x168\\x14SPQii\\x1e&\\x7f;\\x0eO\\x1aTY\\x14T<b*?FZ7Y\\x02#)@4\\x16\\x15\\x1c\\'\\x0b==s?\\x1a\\x1bHHsmd9p.\\x0ffO#\\'Y\\x15}E\\x06cOL-x\\x0cR03:Np$x(D*#m\\x0c\\x00n$W#(\\x0c;6_,\\x042sN2l+e\\'2/\\r\\x7f4hmL]v\\u0a5d$\\x08+\"zoPnn\\x14\\'\\x1b|XB+\\x19L#bq\\x15&!\\n\\U000ca2e3\\x04%0&\\x0f\\x19x\\x1dz]yaa;(\\x0fk\"OUqL`\"m04\\x16[T|d=]\\x12y<fEE\\x04H\\x14?lG(\\x1ft!Xe#{Z\\x155s;-LoToxb7X\\x11{}IjG\\x10\\x1algFY`Mz^IF\\x04N.b\\x1c\\x16h4\\x08kEU\\x06 \\x0b#ie+\\x1c{AQ9\\x7f{Vs.hmoFHq\\'wTMDYl4\"5\\x0b\\x1cjfSZAJZ\\n.VDvY{SMNd\\\\Qh+4.\\x11\\x06.kZzZW+~o\\x1dr@\\x1b\\x0f[\\x04KxTS3]YoXg\\x1d\\x1d/?DtSd*y>R=rEDuO5`\\x1a\\x06\\x10\\rX\\x7fP$tA\\'[$>\\x15g}\\x11\\x19K5\\n\\\\k\\x10yLaV\\'X\\x1aydy1aCL\\U000d7b28.jM*M[^[2l*+\\x14?`\\x1e<qU_}%\\x1eE][,qv>bQ.mQ%\\x10UZ+\\x0b`1\\\\1O\\x0fEKLi\\x1aO3$`L.W\\x07\\x15XjY^\\x12k&O<\\x163YXez(V9QDSHYHf3P\\x034~ c[>\\x0f2\\rdZ^\\x16@J1gl*~OY2_#xI*}x44\\x03\"mujC^-.OT\\x04\\x175NYVH$\\t\\x11\\x06_^W-,b4}:V\\x07tL,Iy\\x14Q\\x17E3\\\\w\\x0f~c\\'\\x0f,Pz5U<W)HjC <Uf;\\x04y$+c\\x11~v\\u058b\\x018_\\x1b*)=Zky\\x004V\\x15}W*\\x00S\\x039L]rZvNul5\\x11b~g\\x053Ua`\\x1cP\\x10e|:o\\x0c>oeU]aGC\\x14&:t\\\\_r\\r\\x04)F6~[\\x19\\\\\\x0e\\x01Rf&WfGp3\\r\\x18] ^,\\x07A^o:\\x1a@6xBZ\\x12\\x05jis[Nq\\x0c2\\x10\\x0b[\\x07J!.XKmnUn&@O\"t0Z\\x16\\x11\\x0b\\x13IZ1\"j\\\\\\x1d\\x13D)\\x1d\\x10\\tHE\\n\\x1d\\x01b\"\\x0cr\\x13Z:re2l\\x16\\x18,ijG*$IQzM_obp$\\x1ff!XG\\t\\x05\\x06Zj\\x06\\x06rp3C`\\x16<wB21|g,N\\x1c\\x08#!\\x13\\x1cc)1mXZ\\x15f\\x1cGWAl \\\\\\x16W\\x07Qd\\x111I\\x14c\\x08\\tQ`;\\x15<fd$\\x1c4\"Nx\\x18\\x08B;tl\\x0f2/ Q4$ \\x10Z\\x07QT\\x13#lv \\x08l3\\\\\\x00\\n\\x08t!\\x028.\\'c;\\x11\"\\x19^#\"LGFpeR@OHda1Fh m1\\x0eh\\x12\\x10xL\"\\x0e\\x08\\x03xc&\\x13\\x1c\\n|n\\x11\\x08\\x1d\\nx+\\x00cq\\x13\\x06LM0\"d\\x1c\\\\\\x05u#\\x01\\x06Ft9\\x00,sFwey\\\\Xf\\x180s2\\x02_a0\\x1e\\x1f0F\\x02\\x1c\\x02\\x16\\x1a-,T\\x060dB\\x1aJF4t;]s02myDjz\\u05f6a[JFC[\\x1bF12\\x1ai\\x14P\\x11P\\x19\\x0c\\x13\\x02P]!\\rMnu\\x1fl\\x1d\\x16tL\\x0b\\x00'"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import requests\n",
    "url = \"https://rest.uniprot.org/uniprotkb/search?query=(reviewed:true)%20AND%20(protein_name:Retinoblastoma-associated%20protein)&fields=accession\"\n",
    "response.text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "dcf337b4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "E1A\n",
      "UniProt ID not found for E1A\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import re\n",
    "\n",
    "# Set the protein name\n",
    "protein_name = \"Retinoblastoma-associated protein\"\n",
    "protein_name = \"human papillomavirus\"\n",
    "protein_name = \"E1A\"\n",
    "protein_name = protein_name.replace(' ','%20')\n",
    "\n",
    "print(protein_name)\n",
    "# Set the UniProt search URL\n",
    "search_url = \"https://rest.uniprot.org/uniprotkb/search?query=(reviewed:true)%20AND%20(protein_name:{0})&fields=accession\".format(protein_name)\n",
    "\n",
    "# Send the HTTP GET request to search for the protein\n",
    "response = requests.get(search_url)\n",
    "requests.get(search_url).text\n",
    "\n",
    "# Extract the UniProt ID from the response using regular expressions or HTML parsing library like BeautifulSoup\n",
    "\n",
    "# If using regular expressions\n",
    "\n",
    "uniprot_id = re.findall('data-isoform-id=\"([A-Z0-9]{6})\"', response.text)\n",
    "\n",
    "# If using BeautifulSoup\n",
    "# from bs4 import BeautifulSoup\n",
    "# soup = BeautifulSoup(response.text, 'html.parser')\n",
    "# uniprot_id = [tag['data-isoform-id'] for tag in soup.find_all('a', {'data-isoform-id': True})]\n",
    "\n",
    "# Check if the UniProt ID was found\n",
    "if uniprot_id:\n",
    "    print(\"UniProt ID for {0}: {1}\".format(protein_name, uniprot_id[0]))\n",
    "else:\n",
    "    print(\"UniProt ID not found for {0}\".format(protein_name))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "7dc64150",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'{\"results\":[{\"primaryAccession\":\"P43268\"},\\n{\"primaryAccession\":\"O75629\"},\\n{\"primaryAccession\":\"Q9UBE0\"},\\n{\"primaryAccession\":\"Q15326\"},\\n{\"primaryAccession\":\"P03254\"},\\n{\"primaryAccession\":\"P03255\"},\\n{\"primaryAccession\":\"Q96L91\"},\\n{\"primaryAccession\":\"Q9Y6B2\"},\\n{\"primaryAccession\":\"P03259\"},\\n{\"primaryAccession\":\"Q09472\"},\\n{\"primaryAccession\":\"O88668\"},\\n{\"primaryAccession\":\"Q96HY7\"},\\n{\"primaryAccession\":\"Q8N140\"},\\n{\"primaryAccession\":\"Q8CHI8\"},\\n{\"primaryAccession\":\"Q9DCR4\"},\\n{\"primaryAccession\":\"B2RWS6\"},\\n{\"primaryAccession\":\"P17678\"},\\n{\"primaryAccession\":\"Q8BGC9\"},\\n{\"primaryAccession\":\"Q8VY78\"},\\n{\"primaryAccession\":\"P0DI12\"},\\n{\"primaryAccession\":\"Q9R1T2\"},\\n{\"primaryAccession\":\"Q4KLP0\"},\\n{\"primaryAccession\":\"Q5PRA2\"},\\n{\"primaryAccession\":\"A2ATU0\"},\\n{\"primaryAccession\":\"Q8IUH2\"}]}'"
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "requests.get(search_url).text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c764034c",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.16"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
